Citrus Sinensis ID: 040010
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 464 | 2.2.26 [Sep-21-2011] | |||||||
| P17801 | 817 | Putative receptor protein | N/A | no | 0.965 | 0.548 | 0.493 | 1e-117 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | yes | no | 0.853 | 0.477 | 0.395 | 9e-77 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.594 | 0.333 | 0.484 | 2e-72 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.622 | 0.331 | 0.465 | 2e-69 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.625 | 0.363 | 0.466 | 1e-68 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.635 | 0.359 | 0.443 | 8e-67 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.618 | 0.329 | 0.447 | 9e-67 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.842 | 0.469 | 0.344 | 3e-58 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.637 | 0.434 | 0.418 | 2e-57 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.603 | 0.429 | 0.410 | 1e-56 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 421 bits (1083), Expect = e-117, Method: Compositional matrix adjust.
Identities = 229/464 (49%), Positives = 296/464 (63%), Gaps = 16/464 (3%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P DF+G D VS C +C+ D C GF Y+ G C+ K+ LF+G P
Sbjct: 355 LPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQ-EGTGSCYPKAYLFSGRTYPTS 413
Query: 61 P-GDMYLKLPVTV---EALEP-AILNGTNPA---CQSNKSDILVGSPSMYYRNTKRAKWS 112
+YLKLP V AL P + + + P C I P ++ +KW
Sbjct: 414 DVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWF 473
Query: 113 YFYWFALAIGAIEVLFIVSGWWLLFRRQGIPSSL---EDGYRALSSQFKRFSYAELKKAT 169
YFY F A +EV FI W+ + +R+ PS L E GY+A++S F+R+SY EL KAT
Sbjct: 474 YFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVKAT 533
Query: 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
FK ELG+G SG VYKGVL D+R VAVK+L ++ QG+EVF AE+S IG+I HMNLVR+W
Sbjct: 534 RKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVIGRINHMNLVRIW 593
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEW 286
GFC+EG HRLLV EYVEN SL LFS L W+ RF +ALG AKGLAYLHHECLEW
Sbjct: 594 GFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEW 653
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
VIHCDVKPENILLD FEPKI DFGL KL RG ++ S +RGT GY+APEW S+LPIT
Sbjct: 654 VIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPIT 713
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
+KVDV+SYGVV+LE+L G R+S +V ++ + L +R + K+ E++ I+ +D
Sbjct: 714 AKVDVYSYGVVLLELLTGTRVSE-LVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLD 772
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450
+L N QA TL ++ +SC++EDR+KRPTM+ VQTLL +
Sbjct: 773 SKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTLLSAD 816
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 9e-77, Method: Compositional matrix adjust.
Identities = 174/440 (39%), Positives = 237/440 (53%), Gaps = 44/440 (10%)
Query: 22 CMKLCLDDFRCSGFSYRLTGERVCFTK--SELFNGYKAPNFPGDMYLKL--PVTVEALEP 77
C CL C G C+ K F GY+ P+ P Y+K+ PV LE
Sbjct: 350 CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLER 409
Query: 78 AILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALAIGAIEVLFIVSG-WWLL 136
A N N+K W A+ G + ++ + G WW
Sbjct: 410 ATKGDDN--------------------NSKVHLW--IVAVAVIAGLLGLVAVEIGLWWCC 447
Query: 137 FRRQGIPSSLEDGYRAL---SSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDER 193
R+ +L Y L S +F+Y EL++ T SFKE+LG GG G VY+GVLT+
Sbjct: 448 CRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT 507
Query: 194 AVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKH 253
VAVK+L + QGE+ F EV+TI +H+NLVR+ GFC++G HRLLVYE++ N SLD
Sbjct: 508 VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 254 LF---SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
LF S+ FL W+ RF +ALGTAKG+ YLH EC + ++HCD+KPENIL+D F K++DF
Sbjct: 568 LFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDF 627
Query: 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370
GLAKL N S +RGT+GY+APEW +NLPITSK DV+SYG+V+LE++ G R N+
Sbjct: 628 GLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKR--NF 685
Query: 371 VVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK--GHFNKNQAATLFRIGISC 428
V + + F E+ E+ + I+D RL + Q + + C
Sbjct: 686 DVSEKTNHKK----FSIWAYEEF---EKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWC 738
Query: 429 VDEDRNKRPTMDSVVQTLLG 448
+ E +RPTM VVQ L G
Sbjct: 739 IQEQPLQRPTMGKVVQMLEG 758
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 145/299 (48%), Positives = 194/299 (64%), Gaps = 23/299 (7%)
Query: 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGK 219
FSY EL+ AT +F ++LG GG G+V+KG L D +AVKRL + QGE+ F EV TIG
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-----FLGWKERFKVALGTAK 274
I H+NLVR+ GFC+EG +LLVY+Y+ N SLD HLF + LGWK RF++ALGTA+
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI----RG 330
GLAYLH EC + +IHCD+KPENILLDS+F PK+ADFGLAKL R FSR+ RG
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR-----DFSRVLTTMRG 657
Query: 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390
T+GY+APEW S + IT+K DV+SYG+++ E++ G R ++E E E F
Sbjct: 658 TRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRR-------NTEQSENEKVRFFPSWA 710
Query: 391 EKILCGEEARIEEIVDPRLKGH-FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448
IL ++ I +VDPRL+G + + ++ C+ ++ + RP M VVQ L G
Sbjct: 711 ATILT-KDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 142/305 (46%), Positives = 194/305 (63%), Gaps = 16/305 (5%)
Query: 158 KRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD--LHQGEEVFWAEVS 215
++F + EL++AT +FK ++G GG G+VYKG L DE +AVK++ + LH G + F E++
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLH-GRQEFCTEIA 561
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTA 273
IG I H NLV++ GFC G LLVYEY+ + SL+K LFS N L W+ERF +ALGTA
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTA 621
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GLAYLH C + +IHCDVKPENILL F+PKI+DFGL+KL + SS F+ +RGT+G
Sbjct: 622 RGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQ-EESSLFTTMRGTRG 680
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKGIR------LSNWVVEDSEGQE----AELT 383
Y+APEW +N I+ K DV+SYG+V+LE++ G + SN V ED+ T
Sbjct: 681 YLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTST 740
Query: 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443
G + + E+ R E+ DPRL+G +A L RI + CV E+ RPTM +VV
Sbjct: 741 GLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVV 800
Query: 444 QTLLG 448
G
Sbjct: 801 GMFEG 805
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 146/313 (46%), Positives = 198/313 (63%), Gaps = 23/313 (7%)
Query: 147 EDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERA-VAVKRLGDLHQ 205
EDG+ L+ K FS+ EL+ ATN F +++G GG GAV+KG L VAVKRL
Sbjct: 440 EDGFAVLN--LKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGS 497
Query: 206 GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL--FSSNFLGWK 263
GE F AEV TIG I H+NLVR+ GFC+E +HRLLVY+Y+ SL +L S L W+
Sbjct: 498 GESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWE 557
Query: 264 ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
RF++ALGTAKG+AYLH C + +IHCD+KPENILLDS++ K++DFGLAKL R
Sbjct: 558 TRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGR----- 612
Query: 324 QFSRI----RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVE-DSEGQ 378
FSR+ RGT GY+APEW S LPIT+K DV+S+G+ +LE++ G R N +V D+ G+
Sbjct: 613 DFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRR--NVIVNSDTLGE 670
Query: 379 ---EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK 435
E E F +I+ G ++ +VD RL G +N + + + I C+ ++
Sbjct: 671 KETEPEKWFFPPWAAREIIQGN---VDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEI 727
Query: 436 RPTMDSVVQTLLG 448
RP M +VV+ L G
Sbjct: 728 RPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 138/311 (44%), Positives = 195/311 (62%), Gaps = 16/311 (5%)
Query: 144 SSLEDGY-RALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD 202
SS ED + LS RF+Y +L+ ATN+F +LG+GG G+VY+G L D +AVK+L
Sbjct: 466 SSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEG 525
Query: 203 LHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN---- 258
+ QG++ F AEVS IG I+H++LVR+ GFC EG HRLL YE++ SL++ +F
Sbjct: 526 IGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV 585
Query: 259 FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
L W RF +ALGTAKGLAYLH +C ++HCD+KPENILLD F K++DFGLAKL R
Sbjct: 586 LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTR 645
Query: 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378
S F+ +RGT+GY+APEW +N I+ K DV+SYG+V+LE++ G + N+ +
Sbjct: 646 -EQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRK--NY----DPSE 698
Query: 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKG-HFNKNQAATLFRIGISCVDEDRNKRP 437
+E F +K+ EE ++ +IVD ++K + + + C+ ED RP
Sbjct: 699 TSEKCHFPSFAFKKM---EEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRP 755
Query: 438 TMDSVVQTLLG 448
+M VVQ L G
Sbjct: 756 SMSKVVQMLEG 766
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 9e-67, Method: Compositional matrix adjust.
Identities = 135/302 (44%), Positives = 189/302 (62%), Gaps = 15/302 (4%)
Query: 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD-LHQGEEVFWAEVSTIG 218
F+Y +L+ TN+F + LG GG G VYKG + E VAVKRL L GE F EV+TIG
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIG 579
Query: 219 KIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAK 274
++HMNLVR+ G+C+E HRLLVYEY+ N SLDK +FSS N L W+ RF++A+ TA+
Sbjct: 580 SMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQ 639
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+AY H +C +IHCD+KPENILLD F PK++DFGLAK+ R +S + IRGT+GY
Sbjct: 640 GIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGR-EHSHVVTMIRGTRGY 698
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394
+APEW SN PIT K DV+SYG+++LE++ G R +AE + +++
Sbjct: 699 LAPEWVSNRPITVKADVYSYGMLLLEIVGGRR------NLDMSYDAEDFFYPGWAYKELT 752
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESE 454
G + VD RL+G + + ++ C+ ++ + RP+M VV+ L G E
Sbjct: 753 NGTSLK---AVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEIN 809
Query: 455 VP 456
+P
Sbjct: 810 LP 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 154/447 (34%), Positives = 223/447 (49%), Gaps = 56/447 (12%)
Query: 19 KEACMKLCLDDFRCSGFSYRLTGERVCFTKS-ELFNGYKAPNFPGDMYLKLPVTVEALEP 77
+E C CL D C+ + + C+ K L +G ++P D ++K+ A P
Sbjct: 394 EERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVP 453
Query: 78 AILNGTNP------ACQS--NKSDILVGSPSMYYRNTKRAKWSYFYWFALAIGAIEVLFI 129
N AC S ++ S YR TK++K + A IG
Sbjct: 454 VTGNRAKKLDWLIIACSVLLGTSAFVIFDTSCSYRKTKKSK-NMMKNQARDIG------- 505
Query: 130 VSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVL 189
R ++ E R F+Y EL +AT F EELG+G G VYKG L
Sbjct: 506 --------RTTATTTANELNLRV-------FTYGELAEATRDFTEELGRGAFGIVYKGYL 550
Query: 190 T----DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244
E VAVK+L L E+ F EV IG+I+H NLVR+ GFC EG +++VYE+
Sbjct: 551 EVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEF 610
Query: 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304
+ +L LF W++R +A+ A+G+ YLH EC E +IHCD+KP+NILLD +
Sbjct: 611 LPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYT 670
Query: 305 PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML-- 362
P+I+DFGLAKL + + + IRGTKGY+APEW N PITSKVDV+SYGV++LE++
Sbjct: 671 PRISDFGLAKLLLM-NQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCC 729
Query: 363 -KGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATL 421
K + L + V+ L + + C + R+E++ + + +
Sbjct: 730 KKAVDLEDNVI---------LINWAYD------CFRQGRLEDLTEDDSEAMNDMETVERY 774
Query: 422 FRIGISCVDEDRNKRPTMDSVVQTLLG 448
+I I C+ E+ RP M +V Q L G
Sbjct: 775 VKIAIWCIQEEHGMRPNMRNVTQMLEG 801
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 130/311 (41%), Positives = 190/311 (61%), Gaps = 15/311 (4%)
Query: 153 LSSQFKRFSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRLG-DLHQGEEV 209
+S+Q FSY EL + T+ F E+ LG+GG G VYKGVL+D R VAVK+L QGE
Sbjct: 320 VSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGERE 379
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFK 267
F AEV I +++H +LV + G+C HRLLVY+YV N +L HL + + W+ R +
Sbjct: 380 FKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVR 439
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQFS 326
VA G A+G+AYLH +C +IH D+K NILLD+ FE +ADFGLAK++Q N+ +
Sbjct: 440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499
Query: 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE--GQEAELTG 384
R+ GT GYMAPE+A++ ++ K DV+SYGV++LE++ G + V+ S+ G E+ L
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRK----PVDTSQPLGDES-LVE 554
Query: 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ R + + + EE +E+VDPRL +F + + +CV KRP M VV+
Sbjct: 555 WARPLLGQAIENEE--FDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVR 612
Query: 445 TLLGCEAESEV 455
L E +++
Sbjct: 613 ALDTLEEATDI 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 122/297 (41%), Positives = 181/297 (60%), Gaps = 17/297 (5%)
Query: 160 FSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRL-GDLHQGEEVFWAEVST 216
F+Y EL +ATN F E LG+GG G V+KG+L + VAVK+L QGE F AEV
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAK 274
I +++H +LV + G+C G+ RLLVYE+V N +L+ HL + W R K+ALG+AK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL+YLH +C +IH D+K NIL+D +FE K+ADFGLAK++ +N+ +R+ GT GY
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD-TNTHVSTRVMGTFGY 446
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIR---LSNWVVEDSEGQEAELTGFIREVKE 391
+APE+A++ +T K DVFS+GVV+LE++ G R +N V+DS L + R +
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS------LVDWARPLLN 500
Query: 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448
+ EE E + D ++ +++ + A + +CV +RP M +V+ L G
Sbjct: 501 R--ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 464 | ||||||
| 224138878 | 809 | predicted protein [Populus trichocarpa] | 0.976 | 0.559 | 0.711 | 0.0 | |
| 224138874 | 799 | predicted protein [Populus trichocarpa] | 0.976 | 0.566 | 0.715 | 0.0 | |
| 255577979 | 748 | receptor protein kinase zmpk1, putative | 0.980 | 0.608 | 0.678 | 0.0 | |
| 359482081 | 803 | PREDICTED: putative receptor protein kin | 0.978 | 0.565 | 0.703 | 0.0 | |
| 359482077 | 803 | PREDICTED: putative receptor protein kin | 0.978 | 0.565 | 0.710 | 0.0 | |
| 359482079 | 801 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.980 | 0.568 | 0.698 | 0.0 | |
| 147791818 | 809 | hypothetical protein VITISV_042870 [Viti | 0.978 | 0.561 | 0.706 | 0.0 | |
| 359482073 | 809 | PREDICTED: putative receptor protein kin | 0.978 | 0.561 | 0.699 | 0.0 | |
| 225440502 | 809 | PREDICTED: putative receptor protein kin | 0.991 | 0.568 | 0.674 | 0.0 | |
| 50234592 | 593 | S-locus-like receptor protein kinase [Pr | 0.961 | 0.752 | 0.643 | 1e-167 |
| >gi|224138878|ref|XP_002322924.1| predicted protein [Populus trichocarpa] gi|222867554|gb|EEF04685.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/454 (71%), Positives = 382/454 (84%), Gaps = 1/454 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P VDF+GFDLNFS + ++CMKLCL D+RC FSYRL GER CFTK LFNGY++P+F
Sbjct: 348 LPHVDFWGFDLNFSASATFDSCMKLCLGDYRCKSFSYRLYGERRCFTKGVLFNGYQSPSF 407
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG++YL+LPV+ E + ILNG++ CQS +S+ +GSPSMY +TKR +W YFY FA A
Sbjct: 408 PGNIYLRLPVSFETSQLGILNGSDLICQSAESETTIGSPSMYNFDTKRTRWVYFYSFASA 467
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IG IE+LF+VSGWW LFR++G P+ EDGY + S F+RF+Y ELKKATN+FKEELG+GG
Sbjct: 468 IGLIEILFVVSGWWFLFRKRGSPNLAEDGYHLVLSPFRRFTYTELKKATNNFKEELGRGG 527
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
SGAVYKG+LTDER VAVKRL +++QGE+VFWAEVSTIGKI HMNL+RMWGFC+EG HRLL
Sbjct: 528 SGAVYKGILTDERVVAVKRLENMYQGEDVFWAEVSTIGKINHMNLMRMWGFCSEGKHRLL 587
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYEY+E QSLDKHLFS FL WK+RFK ALG AKGLAYLHHECLEWV+HCDVKP NILLD
Sbjct: 588 VYEYMEYQSLDKHLFSPTFLEWKDRFKAALGIAKGLAYLHHECLEWVMHCDVKPGNILLD 647
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
SEFEPKIADFGLAKLSQRG NSS FS+IRGTKGYMAPEWA+NLPIT+KVDV+SYGVV+LE
Sbjct: 648 SEFEPKIADFGLAKLSQRGGNSSDFSQIRGTKGYMAPEWATNLPITAKVDVYSYGVVVLE 707
Query: 361 MLKGIRLSNWVVED-SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
++KGI LSNWV+E E E++LT F+R VK KI CGE + IEEIVDPRL G F++NQA
Sbjct: 708 IVKGIPLSNWVIEGREEHDESDLTRFVRVVKRKIQCGETSWIEEIVDPRLNGQFSRNQAT 767
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453
T+ +G+SCV+EDRNKRPTMDSVVQ LL C ES
Sbjct: 768 TIVELGMSCVEEDRNKRPTMDSVVQALLECLDES 801
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138874|ref|XP_002322923.1| predicted protein [Populus trichocarpa] gi|222867553|gb|EEF04684.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/454 (71%), Positives = 381/454 (83%), Gaps = 1/454 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P VDF+GFDLNFS + ++CMKLCL D+RC FSYRL GER CFTK LFNGY++P+F
Sbjct: 346 LPHVDFWGFDLNFSASATFDSCMKLCLGDYRCKSFSYRLYGERRCFTKGVLFNGYQSPSF 405
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG++YL+LPV+ E + ILNG++ CQS +S+ +GSPSMY +TKR +W YFY FA A
Sbjct: 406 PGNIYLRLPVSFETSQLGILNGSDLICQSAESETTIGSPSMYNFDTKRTRWVYFYSFASA 465
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IG IE+LF+VSGWW LFR++G P+ EDGY + S F+RF+Y ELKKATN+FKEELG+GG
Sbjct: 466 IGLIEILFVVSGWWFLFRKRGSPNLAEDGYHLVLSPFRRFTYTELKKATNNFKEELGRGG 525
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
SGAVYKG LTDER VAVKRL +++QGE+VFWAEVSTIGKI HMNLVRMWGFC+EG HRLL
Sbjct: 526 SGAVYKGFLTDERVVAVKRLENMNQGEDVFWAEVSTIGKINHMNLVRMWGFCSEGKHRLL 585
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYEY+E QSLDKHLFS FL WK+RFK ALG AKGLAYLHHECLEWVIHCDVKP NILLD
Sbjct: 586 VYEYMEYQSLDKHLFSPTFLEWKDRFKAALGIAKGLAYLHHECLEWVIHCDVKPGNILLD 645
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
SEFEPKIADFGLAKLSQRG NSS FS+IRGTKGYMAPEWA+NLPIT+KVDV+SYGVV+LE
Sbjct: 646 SEFEPKIADFGLAKLSQRGGNSSDFSQIRGTKGYMAPEWATNLPITAKVDVYSYGVVVLE 705
Query: 361 MLKGIRLSNWVVED-SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
++KGI LSNWV+E E E++LT F+R VK KI CGE + IEEIVDPRL G F++NQA
Sbjct: 706 IVKGIPLSNWVIEGREEHDESDLTRFVRVVKRKIQCGETSWIEEIVDPRLNGQFSRNQAT 765
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453
T+ +G+SCV+EDRNKRPTMDSVVQ LL C ES
Sbjct: 766 TIVELGMSCVEEDRNKRPTMDSVVQALLECLDES 799
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577979|ref|XP_002529861.1| receptor protein kinase zmpk1, putative [Ricinus communis] gi|223530637|gb|EEF32511.1| receptor protein kinase zmpk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/457 (67%), Positives = 382/457 (83%), Gaps = 2/457 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
V +VDFYGFDLN+S+ +S+++C+K+CLDD RC+ FSYRL+GE +CFTKS LFNG+++PNF
Sbjct: 286 VSQVDFYGFDLNYSQSISRDSCLKICLDDCRCAAFSYRLSGEGLCFTKSALFNGFRSPNF 345
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLP ++ PAI NGT+ C S +S +++GSPSMY ++R KW+Y YWFA A
Sbjct: 346 PGSIYLKLPASLANYGPAIANGTDLRCASTESILMLGSPSMYNNASRRVKWAYLYWFAAA 405
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IG IEV+F+ + WW LFRR+G+ ++GY AL+SQF++FSYAELK+AT +FKEELG+G
Sbjct: 406 IGLIEVVFVAAAWWFLFRRRGVEDPAKEGYHALTSQFRKFSYAELKRATRNFKEELGRGA 465
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
SG VYKGVL D R VA+KRLG+ +QGE+VFWAEVSTIG+I MNLVRMWGFC+E H+LL
Sbjct: 466 SGVVYKGVLIDGRVVAMKRLGESYQGEDVFWAEVSTIGRINQMNLVRMWGFCSEKSHKLL 525
Query: 241 VYEYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
VYEY+E QSLDKHLFS NFLGWKERF VALGTAKGLAYLHHECLEWVIHCDVKPENIL
Sbjct: 526 VYEYLEYQSLDKHLFSPTQNFLGWKERFNVALGTAKGLAYLHHECLEWVIHCDVKPENIL 585
Query: 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVI 358
L++EFEPKI+DFGLAKL QRG ++S+FSRIRGTKGYMAPEWA NLPIT+KVDV+SYGV+I
Sbjct: 586 LNTEFEPKISDFGLAKLFQRGGSNSEFSRIRGTKGYMAPEWALNLPITAKVDVYSYGVLI 645
Query: 359 LEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQA 418
LEM+KGIRLSNW+ ED E QE+EL F+R K ++CGEE+ IEE+VD RL G F++ QA
Sbjct: 646 LEMVKGIRLSNWITEDGEEQESELRRFVRVAKRNLVCGEESWIEELVDARLNGQFSRKQA 705
Query: 419 ATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
+ +GISCV+EDRN RP+MDSVVQ LL C+ ES +
Sbjct: 706 VKIVEVGISCVEEDRNVRPSMDSVVQALLECQDESRL 742
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482081|ref|XP_003632709.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/456 (70%), Positives = 376/456 (82%), Gaps = 2/456 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P+ D+YGFDLN+S+ VS EAC K+CLDD C GF+YRLTGE C+ KS LFNGYK+ NF
Sbjct: 343 LPQTDYYGFDLNYSQSVSMEACRKICLDDCLCQGFAYRLTGEGNCYAKSTLFNGYKSSNF 402
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV +E P +LNG++ C+S + ++ V S S+Y +K+ +W Y Y FA A
Sbjct: 403 PGSLYLKLPVDIETSAPTVLNGSDLICESKEVEV-VHSSSVYDTASKKMRWVYLYSFASA 461
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IGAIEVLFIVSGWW LF+ +PSS EDGY ++SS F+RFSY ELKKATN+FK ELG+GG
Sbjct: 462 IGAIEVLFIVSGWWFLFKVHNVPSSAEDGYGSISSPFRRFSYTELKKATNNFKVELGRGG 521
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKGVL DERAVAVK+LGD QGE FWAEVSTIGKIYHMNLVRMWGFC+EG HRL+
Sbjct: 522 FGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGKIYHMNLVRMWGFCSEGRHRLV 581
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS++ LGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 582 VYEHVENLSLDKHLFSTSCLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 641
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADFGLAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+SYGVV+L
Sbjct: 642 NGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGYMAPEWAMNLPITAKVDVYSYGVVVL 701
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRLS WV ED E QEAELT F+R VK KI GE+ +E+ VDPRLKG F++ QA
Sbjct: 702 EMVRGIRLSKWVGEDGEEQEAELTRFVRAVKRKIQYGEDNWVEDTVDPRLKGKFSRQQAT 761
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
L IGISCV+EDR+KRPTM +VVQ LL CE E++V
Sbjct: 762 MLVEIGISCVEEDRSKRPTMATVVQVLLECEGEAQV 797
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482077|ref|XP_003632708.1| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/456 (71%), Positives = 375/456 (82%), Gaps = 2/456 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P+ D+YGFDLN+S+ VS EAC K+CLDD C GF YRLTGE CF KS LFNG+K+ NF
Sbjct: 343 LPQTDYYGFDLNYSQSVSMEACRKICLDDCLCQGFVYRLTGEGNCFAKSTLFNGFKSSNF 402
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV VE P +LNG++ C+S + ++ V S S+Y +K+ +W Y Y FA A
Sbjct: 403 PGSLYLKLPVDVETSAPTVLNGSDLICESKEVEV-VHSSSVYDTASKKMRWVYLYSFASA 461
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IGAIEVLFIVSGWW LFR +PSS EDGY +SS F+RFSY ELKKATN+FK ELG+GG
Sbjct: 462 IGAIEVLFIVSGWWFLFRVHNVPSSAEDGYGPISSPFRRFSYTELKKATNNFKVELGRGG 521
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKGVL DERAVAVK+LGD QGE FWAEVSTIGKIYHMNLVRMWGFC+EG HRL+
Sbjct: 522 FGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGKIYHMNLVRMWGFCSEGRHRLV 581
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS++ LGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 582 VYEHVENLSLDKHLFSTSCLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 641
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADFGLAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+SYGVV+L
Sbjct: 642 NGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGYMAPEWAMNLPITAKVDVYSYGVVVL 701
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRLS WV ED E QEAELT F+R VK KI GE+ +E+ VDPRLKG F++ QAA
Sbjct: 702 EMVRGIRLSKWVGEDGEEQEAELTRFVRAVKRKIQYGEDNWVEDTVDPRLKGKFSRQQAA 761
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
L IGISCV+EDR+KRPTM +VVQ LL CE E++V
Sbjct: 762 MLVEIGISCVEEDRSKRPTMATVVQVLLECEDEAQV 797
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482079|ref|XP_002272157.2| PREDICTED: LOW QUALITY PROTEIN: putative receptor protein kinase ZmPK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/461 (69%), Positives = 375/461 (81%), Gaps = 6/461 (1%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P+ D+YGFDLN+S+ VS EAC K+CLDD C GF+YRLTGE C+ KS LFNGYK+ NF
Sbjct: 343 LPQTDYYGFDLNYSQSVSMEACRKICLDDCLCQGFAYRLTGEGNCYAKSTLFNGYKSSNF 402
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV VE P +LNG++ C+S + ++ V S S+Y +K+ +W Y Y FA A
Sbjct: 403 PGSLYLKLPVDVETSAPTVLNGSDLICESKEVEV-VHSSSVYDTASKKMRWVYLYSFASA 461
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IGAI VLFIVSGWW LFR +PSS EDGY +SS F+RFSY ELKKATN+FK ELG+GG
Sbjct: 462 IGAIVVLFIVSGWWFLFRVHNVPSSAEDGYGPISSPFRRFSYTELKKATNNFKVELGRGG 521
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKGVL DERAVAVK+LGD QGE FWAEVSTIGKIYHMNLVRMWGFC+EG HRL+
Sbjct: 522 FGAVYKGVLVDERAVAVKKLGDSTQGEGEFWAEVSTIGKIYHMNLVRMWGFCSEGRHRLV 581
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS++ LGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 582 VYEHVENLSLDKHLFSTSCLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 641
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADF LAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+ YGVV+L
Sbjct: 642 NGFEPKIADFVLAKLSQRGGPGSGEFSRIRGTKGYMAPEWAMNLPITAKVDVYCYGVVVL 701
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRLS WV ED E QEAELT F+R VK KI GE+ +E+ VDPRLKG F++ QAA
Sbjct: 702 EMVRGIRLSKWVGEDGEEQEAELTRFVRVVKRKIQYGEDNWVEDTVDPRLKGKFSRQQAA 761
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTI 460
L IGISCV+EDR+KRPTM +VVQ LL C+A+ VQT+
Sbjct: 762 MLVEIGISCVEEDRSKRPTMATVVQVLLECDAQ----VQTL 798
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147791818|emb|CAN61835.1| hypothetical protein VITISV_042870 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/456 (70%), Positives = 373/456 (81%), Gaps = 2/456 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P+ D+YGFDLN+S VS EAC K+CL+D C GF+YRLTGE CF KS LFNGYK+ NF
Sbjct: 349 LPQTDYYGFDLNYSPSVSLEACRKICLEDCLCQGFAYRLTGEGNCFAKSTLFNGYKSSNF 408
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV VE P +LNG++ C+S + ++ V S S+Y +K+ + Y Y FA A
Sbjct: 409 PGSLYLKLPVDVETSAPTVLNGSDLICESKEVEV-VHSSSVYDTASKQMRGVYLYSFASA 467
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IGAIEVL IVSGWW LFR +PSS EDGY +SSQF+RFSY ELKKATN+FK ELG+GG
Sbjct: 468 IGAIEVLLIVSGWWFLFRVHNVPSSAEDGYGPISSQFRRFSYTELKKATNNFKVELGRGG 527
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKGVL DERAVAVK+LGD QGE FWAEVSTIGKIYHMNLVRMWGFC+EG HRL+
Sbjct: 528 FGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGKIYHMNLVRMWGFCSEGRHRLV 587
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS++ LGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 588 VYEHVENLSLDKHLFSTSCLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 647
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADFGLAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+SYGVV+L
Sbjct: 648 NGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGYMAPEWAMNLPITAKVDVYSYGVVVL 707
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRLS WV ED E QEAELT F+R VK KI GE+ IE+ VDP LKG F++ QAA
Sbjct: 708 EMVRGIRLSKWVGEDGEEQEAELTRFVRAVKRKIQYGEDNWIEDTVDPXLKGKFSRQQAA 767
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
+ +IGISCV+EDR KRPTM +VVQ LL CE E++V
Sbjct: 768 MMVKIGISCVEEDRIKRPTMATVVQVLLECEDEAQV 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482073|ref|XP_002272276.2| PREDICTED: putative receptor protein kinase ZmPK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/456 (69%), Positives = 373/456 (81%), Gaps = 2/456 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P+ D+YGFDL++S VS EAC K+CL+D C GF+YRLTGE CF KS LFNGYK+ NF
Sbjct: 349 LPQTDYYGFDLDYSPSVSLEACRKICLEDCLCQGFAYRLTGEGNCFAKSTLFNGYKSSNF 408
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV V+ P +LNG++ C+S + ++ V S S+Y +K+ +W Y Y FA A
Sbjct: 409 PGSLYLKLPVDVQTSAPTVLNGSDLICESKEVEV-VHSSSVYDTASKQMRWVYLYSFASA 467
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
IGAIEVL IVSGWW LFR +PSS E+GY +SSQF+RFSY ELKKATN+FK ELG+GG
Sbjct: 468 IGAIEVLLIVSGWWFLFRVHNVPSSAENGYGPISSQFRRFSYTELKKATNNFKVELGRGG 527
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKGVL DERAVAVK+LGD QGE FWAEVSTIGKIYHMNLVRMWGFC+EG HRL+
Sbjct: 528 FGAVYKGVLEDERAVAVKKLGDATQGEGEFWAEVSTIGKIYHMNLVRMWGFCSEGRHRLV 587
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS++ LGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 588 VYEHVENLSLDKHLFSTSCLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 647
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADFGLAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+SYGVV+L
Sbjct: 648 NGFEPKIADFGLAKLSQRGGPGSGEFSRIRGTKGYMAPEWAMNLPITAKVDVYSYGVVVL 707
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRL WV ED E QEAELT F+R VK KI GE+ IE+ VDPRLK F++ QAA
Sbjct: 708 EMVRGIRLLKWVGEDGEEQEAELTRFVRAVKRKIQYGEDNWIEDTVDPRLKEKFSRQQAA 767
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
+ +IGISCV+EDR KRPTM +VVQ LL CE E++V
Sbjct: 768 MMVKIGISCVEEDRIKRPTMATVVQVLLECEDEAQV 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440502|ref|XP_002272467.1| PREDICTED: putative receptor protein kinase ZmPK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/461 (67%), Positives = 372/461 (80%), Gaps = 1/461 (0%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P DFYG D+N VS E C K CL+D C F+YRLTG +CF K LFNG+++PNF
Sbjct: 348 LPHTDFYGSDVNHLTSVSLETCRKTCLEDCLCEAFAYRLTGNGLCFNKIALFNGFRSPNF 407
Query: 61 PGDMYLKLPVTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA 120
PG +YLKLPV VE ++N +NP C+S + +I++ SPSMY K +W Y Y FA A
Sbjct: 408 PGTIYLKLPVDVETSASTLVNVSNPICESKEVEIVLSSPSMYDTANKGMRWVYLYSFASA 467
Query: 121 IGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
+GA+EVLFIVSGWW LFR + S +EDGY +SSQF++FSY ELKKATN+FK ELG+GG
Sbjct: 468 LGALEVLFIVSGWWFLFRVPKVTSPVEDGYGPISSQFRKFSYTELKKATNNFKVELGRGG 527
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
GAVYKG+L DER VAVK+L D+ QGE FWAE+STI KIYHMNLVRMWGFC+EG HRLL
Sbjct: 528 FGAVYKGILEDERVVAVKKLRDVIQGEGEFWAEISTIRKIYHMNLVRMWGFCSEGRHRLL 587
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
VYE+VEN SLDKHLFS+ FLGWKERF VA+GTA+GLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 588 VYEHVENLSLDKHLFSTTFLGWKERFNVAVGTARGLAYLHHECLEWVIHCDVKPENILLD 647
Query: 301 SEFEPKIADFGLAKLSQRGS-NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
+ FEPKIADFGLAKLSQRG S +FSRIRGTKGYMAPEWA NLPIT+KVDV+S+GVV+L
Sbjct: 648 NGFEPKIADFGLAKLSQRGGPGSREFSRIRGTKGYMAPEWAMNLPITAKVDVYSFGVVVL 707
Query: 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419
EM++GIRLSNWV+ED + QEAELT F++ VKEKI C E+ I++ VD RLKG F+++QAA
Sbjct: 708 EMVRGIRLSNWVMEDGKEQEAELTRFVKLVKEKIQCEEDNWIDDTVDRRLKGRFSRHQAA 767
Query: 420 TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTI 460
TL IGISCV+EDR+KRPTM +VVQ LL CE E++V +Q +
Sbjct: 768 TLIEIGISCVEEDRSKRPTMATVVQVLLECEDEAQVQIQEL 808
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|50234592|gb|AAT70497.1| S-locus-like receptor protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-167, Method: Compositional matrix adjust.
Identities = 293/455 (64%), Positives = 354/455 (77%), Gaps = 9/455 (1%)
Query: 4 VDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNFPGD 63
VDFYGFDLN+SE S + C KLC++D RC F YR G++ C+TK LF+G ++P G
Sbjct: 144 VDFYGFDLNYSESTSIQNCTKLCVEDCRCEAFVYR--GQK-CYTKGALFSGLRSPTIEGS 200
Query: 64 MYLKLP--VTVEALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALAI 121
+YL+LP +++E A L N +C++N + +G+ SMY +K +W Y Y FA AI
Sbjct: 201 LYLRLPEPLSMETSPAANLTVFN-SCRTNA--VKIGTSSMYDNPSKTVRWVYLYSFAAAI 257
Query: 122 GAIEVLFIVSGWWLLFRR-QGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGG 180
GA+E LFI+SGWW FRR QG+ + L D YR +SS F+ + YAELKKAT +FKEELG+GG
Sbjct: 258 GAVEFLFILSGWWFFFRRSQGMSAPLVDKYRLISSNFRMYLYAELKKATRNFKEELGRGG 317
Query: 181 SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240
SG VYKGVL DER +AVK L D++Q EEVFWAEVSTI KI HMNLVR WGFC+EG HRLL
Sbjct: 318 SGTVYKGVLADERVIAVKALADIYQAEEVFWAEVSTIEKINHMNLVRTWGFCSEGKHRLL 377
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
+ EYVEN SLDKHLF NFLGWKERFKVA+G AKGLAYLHHECLEWVIHCDVKPENILLD
Sbjct: 378 ISEYVENGSLDKHLFPPNFLGWKERFKVAIGIAKGLAYLHHECLEWVIHCDVKPENILLD 437
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
S FEPKIADFGLAKL QRG ++ S IRGTKGYMAPEWA NL IT+KVDV+SYGVV+LE
Sbjct: 438 SNFEPKIADFGLAKLFQRGGLNAVSSHIRGTKGYMAPEWALNLSITAKVDVYSYGVVLLE 497
Query: 361 MLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAAT 420
++KGIRLSN VV+ +E +EAE+ F+R + KI CGE+ IE+++DPRL+G F +NQAA
Sbjct: 498 IVKGIRLSNRVVDTAEEEEAEMKRFVRIARRKIQCGEDEWIEDMLDPRLEGQFGRNQAAK 557
Query: 421 LFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455
+ +GISCV+EDRNKRPTMDSVVQ LL CE ES +
Sbjct: 558 MVEVGISCVEEDRNKRPTMDSVVQMLLECEEESNI 592
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 464 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.883 | 0.494 | 0.389 | 2.5e-72 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.678 | 0.380 | 0.456 | 8.6e-71 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.612 | 0.325 | 0.47 | 2e-69 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.635 | 0.359 | 0.450 | 2e-67 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.612 | 0.388 | 0.445 | 1.2e-56 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.681 | 0.699 | 0.401 | 2e-56 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.635 | 0.433 | 0.419 | 1.4e-55 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.713 | 0.496 | 0.357 | 5.4e-55 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.629 | 0.405 | 0.409 | 6.1e-55 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.603 | 0.429 | 0.410 | 1.3e-54 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 2.5e-72, P = 2.5e-72
Identities = 177/455 (38%), Positives = 245/455 (53%)
Query: 22 CMKLCLDDFRCSGFSYRLTGERVCFTK--SELFNGYKAPNFPGDMYLKL--PVTVEALEP 77
C CL C G C+ K F GY+ P+ P Y+K+ PV LE
Sbjct: 350 CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLER 409
Query: 78 AILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALAIGAIEVLFIVSG-WWLL 136
A N N+K W A+ G + ++ + G WW
Sbjct: 410 ATKGDDN--------------------NSKVHLW--IVAVAVIAGLLGLVAVEIGLWWCC 447
Query: 137 FRRQGIPSSLEDGYRAL---SSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDER 193
R+ +L Y L S +F+Y EL++ T SFKE+LG GG G VY+GVLT+
Sbjct: 448 CRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT 507
Query: 194 AVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKH 253
VAVK+L + QGE+ F EV+TI +H+NLVR+ GFC++G HRLLVYE++ N SLD
Sbjct: 508 VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 254 LF---SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
LF S+ FL W+ RF +ALGTAKG+ YLH EC + ++HCD+KPENIL+D F K++DF
Sbjct: 568 LFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDF 627
Query: 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370
GLAKL N S +RGT+GY+APEW +NLPITSK DV+SYG+V+LE++ G R N+
Sbjct: 628 GLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKR--NF 685
Query: 371 VVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH--FNKNQAATLFRIGISC 428
V + + F E+ E+ + I+D RL + Q + + C
Sbjct: 686 DVSEKTNHKK----FSIWAYEEF---EKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWC 738
Query: 429 VDEDRNKRPTMDSVVQTLLGC-EAESEVPVQTIPD 462
+ E +RPTM VVQ L G E ++ + +TI +
Sbjct: 739 IQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTISE 773
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 8.6e-71, Sum P(2) = 8.6e-71
Identities = 153/335 (45%), Positives = 211/335 (62%)
Query: 120 AIGAIEVLFIVSGWWLLFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKG 179
++G I ++ +V L +RR+ E G LS+ FSY EL+ AT +F ++LG G
Sbjct: 448 SLGVIVLVLLVVILILRYRRRKRMRG-EKGDGTLSA----FSYRELQNATKNFSDKLGGG 502
Query: 180 GSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239
G G+V+KG L D +AVKRL + QGE+ F EV TIG I H+NLVR+ GFC+EG +L
Sbjct: 503 GFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKL 562
Query: 240 LVYEYVENQSLDKHLFSSNF-----LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKP 294
LVY+Y+ N SLD HLF + LGWK RF++ALGTA+GLAYLH EC + +IHCD+KP
Sbjct: 563 LVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKP 622
Query: 295 ENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSY 354
ENILLDS+F PK+ADFGLAKL R S + +RGT+GY+APEW S + IT+K DV+SY
Sbjct: 623 ENILLDSQFCPKVADFGLAKLVGRDF-SRVLTTMRGTRGYLAPEWISGVAITAKADVYSY 681
Query: 355 GVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH-F 413
G+++ E++ G R ++E E E F IL ++ I +VDPRL+G
Sbjct: 682 GMMLFELVSGRR-------NTEQSENEKVRFFPSWAATILT-KDGDIRSLVDPRLEGDAV 733
Query: 414 NKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448
+ + ++ C+ ++ + RP M VVQ L G
Sbjct: 734 DIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG 768
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 2.0e-69, Sum P(2) = 2.0e-69
Identities = 141/300 (47%), Positives = 194/300 (64%)
Query: 158 KRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD--LHQGEEVFWAEVS 215
++F + EL++AT +FK ++G GG G+VYKG L DE +AVK++ + LH G + F E++
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLH-GRQEFCTEIA 561
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTA 273
IG I H NLV++ GFC G LLVYEY+ + SL+K LFS N L W+ERF +ALGTA
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTA 621
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GLAYLH C + +IHCDVKPENILL F+PKI+DFGL+KL + SS F+ +RGT+G
Sbjct: 622 RGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQ-EESSLFTTMRGTRG 680
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKGIR------LSNWVVEDSEGQEAELT---- 383
Y+APEW +N I+ K DV+SYG+V+LE++ G + SN V ED+ + T
Sbjct: 681 YLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTST 740
Query: 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443
G + + E+ R E+ DPRL+G +A L RI + CV E+ RPTM +VV
Sbjct: 741 GLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVV 800
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 2.0e-67, Sum P(2) = 2.0e-67
Identities = 140/311 (45%), Positives = 197/311 (63%)
Query: 144 SSLEDGY-RALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD 202
SS ED + LS RF+Y +L+ ATN+F +LG+GG G+VY+G L D +AVK+L
Sbjct: 466 SSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEG 525
Query: 203 LHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN---- 258
+ QG++ F AEVS IG I+H++LVR+ GFC EG HRLL YE++ SL++ +F
Sbjct: 526 IGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV 585
Query: 259 FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
L W RF +ALGTAKGLAYLH +C ++HCD+KPENILLD F K++DFGLAKL R
Sbjct: 586 LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTR 645
Query: 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378
S F+ +RGT+GY+APEW +N I+ K DV+SYG+V+LE++ G + N+ + SE
Sbjct: 646 -EQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRK--NY--DPSE-- 698
Query: 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKG-HFNKNQAATLFRIGISCVDEDRNKRP 437
+E F +K+ EE ++ +IVD ++K + + + C+ ED RP
Sbjct: 699 TSEKCHFPSFAFKKM---EEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRP 755
Query: 438 TMDSVVQTLLG 448
+M VVQ L G
Sbjct: 756 SMSKVVQMLEG 766
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 1.2e-56, P = 1.2e-56
Identities = 132/296 (44%), Positives = 185/296 (62%)
Query: 160 FSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRLG-DLHQGEEVFWAEVST 216
FSY EL KAT F EE LG+GG G V+KGVL + VAVK+L +QGE F AEV T
Sbjct: 377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDT 436
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAK 274
I +++H +LV + G+C G RLLVYE+V +L+ HL + + L W+ R ++A+G AK
Sbjct: 437 ISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVGAAK 496
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL-SQRGSNSSQFS-RIRGTK 332
GLAYLH +C +IH D+K NILLDS+FE K++DFGLAK S S+ + S R+ GT
Sbjct: 497 GLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGTF 556
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392
GYMAPE+AS+ +T K DV+S+GVV+LE++ G R S + + S Q L + R + K
Sbjct: 557 GYMAPEYASSGKVTDKSDVYSFGVVLLELITG-RPSIFAKDSSTNQS--LVDWARPLLTK 613
Query: 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448
+ GE + +VD RL+ +++ Q A + +C+ + RP M VV+ L G
Sbjct: 614 AISGES--FDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRALEG 667
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 2.0e-56, P = 2.0e-56
Identities = 137/341 (40%), Positives = 195/341 (57%)
Query: 137 FRRQGIPSSLEDGY-RALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAV 195
F +G +E + R ++ +F +L++AT+ F+ +GKGGSG+V+KGVL D V
Sbjct: 69 FASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQV 128
Query: 196 AVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE---GMHRLLVYEYVENQSLDK 252
AVKR+ +GE F +EV+ I + H NLVR++G+ + R LVY+Y+ N SLD
Sbjct: 129 AVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDI 188
Query: 253 HLF---------SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF 303
+F L W++R++VA+ AK LAYLHH+C ++H DVKPENILLD F
Sbjct: 189 WIFPDRGNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENF 248
Query: 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363
+ DFGL+KL R S + IRGT+GY+APEW I+ K DV+SYG+V+LEM+
Sbjct: 249 RAVVTDFGLSKLIAR-DESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIG 307
Query: 364 GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL--KGHFNKNQAATL 421
G R S VE E ++ +L F R V +K+ E +I EIVD RL ++ + L
Sbjct: 308 G-RRSISRVEVKETKKKKLEYFPRIVNQKM---RERKIMEIVDQRLIEVNEVDEEEVMKL 363
Query: 422 FRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTIPD 462
+ + C+ E KRP M V++ L E VPV PD
Sbjct: 364 VCVALWCIQEKSKKRPDMTMVIEML-----EGRVPVNEPPD 399
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
Identities = 131/312 (41%), Positives = 191/312 (61%)
Query: 153 LSSQFKRFSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRL--GDLHQGEE 208
+S+Q FSY EL + T+ F E+ LG+GG G VYKGVL+D R VAVK+L G QGE
Sbjct: 320 VSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGG-SQGER 378
Query: 209 VFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERF 266
F AEV I +++H +LV + G+C HRLLVY+YV N +L HL + + W+ R
Sbjct: 379 EFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRV 438
Query: 267 KVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQF 325
+VA G A+G+AYLH +C +IH D+K NILLD+ FE +ADFGLAK++Q N+
Sbjct: 439 RVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVS 498
Query: 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE--GQEAELT 383
+R+ GT GYMAPE+A++ ++ K DV+SYGV++LE++ G + V+ S+ G E+ L
Sbjct: 499 TRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRK----PVDTSQPLGDES-LV 553
Query: 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443
+ R + + + EE +E+VDPRL +F + + +CV KRP M VV
Sbjct: 554 EWARPLLGQAIENEE--FDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVV 611
Query: 444 QTLLGCEAESEV 455
+ L E +++
Sbjct: 612 RALDTLEEATDI 623
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 5.4e-55, Sum P(2) = 5.4e-55
Identities = 124/347 (35%), Positives = 189/347 (54%)
Query: 118 ALAIGA-IEVLFIVSGWWLLFRRQGIPS-SLEDGYRALSSQFKRFSYAELKKATNSFKE- 174
A+ + A I V+ + G + RRQ + S Q +F + ++ AT++F
Sbjct: 283 AIVVSAVIFVVLVALGLVIWKRRQSYKTLKYHTDDDMTSPQSLQFDFTTIEVATDNFSRN 342
Query: 175 -ELGKGGSGAVYKGVLTDERAVAVKRLG-DLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC 232
+LG+GG G VYKG+L +E +AVKRL + QG + F EV + K+ H NLVR+ GFC
Sbjct: 343 NKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFC 402
Query: 233 TEGMHRLLVYEYVENQSLDKHLFSSNF---LGWKERFKVALGTAKGLAYLHHECLEWVIH 289
E ++LVYE+V N+SLD LF L WK R+ + G +GL YLH + +IH
Sbjct: 403 IERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIH 462
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K NILLD++ PKIADFG+A+ + Q R+ GT GYM PE+ ++ ++K
Sbjct: 463 RDIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTKS 522
Query: 350 DVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409
DV+S+GV+ILE++ G + S++ D G +T R L ++ ++ ++DP +
Sbjct: 523 DVYSFGVLILEIVCGKKNSSFFQMDDSGGNL-VTHVWR------LWNNDSPLD-LIDPAI 574
Query: 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVP 456
K ++ ++ IGI CV E RP M ++ Q L VP
Sbjct: 575 KESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQMLTNSSITLPVP 621
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 6.1e-55, P = 6.1e-55
Identities = 126/308 (40%), Positives = 188/308 (61%)
Query: 153 LSSQFKRFSYAELKKATNSF--KEELGKGGSGAVYKGVLTDERAVAVKRL-GDLHQGEEV 209
L S FSY EL + T F K LG+GG G VYKG L D + VAVK+L QG+
Sbjct: 352 LGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDRE 411
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFK 267
F AEV I +++H +LV + G+C HRLL+YEYV NQ+L+ HL L W +R +
Sbjct: 412 FKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVR 471
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327
+A+G+AKGLAYLH +C +IH D+K NILLD E+E ++ADFGLA+L+ + + +R
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDT-TQTHVSTR 530
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE--GQEAELTGF 385
+ GT GY+APE+AS+ +T + DVFS+GVV+LE++ G + V+ ++ G+E+ L +
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRK----PVDQTQPLGEES-LVEW 585
Query: 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445
R + K + E + E++D RL+ + +++ + +CV KRP M VV+
Sbjct: 586 ARPLLLKAI--ETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRA 643
Query: 446 LLGCEAES 453
L C+ +S
Sbjct: 644 L-DCDGDS 650
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 1.3e-54, P = 1.3e-54
Identities = 122/297 (41%), Positives = 181/297 (60%)
Query: 160 FSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRL-GDLHQGEEVFWAEVST 216
F+Y EL +ATN F E LG+GG G V+KG+L + VAVK+L QGE F AEV
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAK 274
I +++H +LV + G+C G+ RLLVYE+V N +L+ HL + W R K+ALG+AK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL+YLH +C +IH D+K NIL+D +FE K+ADFGLAK++ +N+ +R+ GT GY
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIAS-DTNTHVSTRVMGTFGY 446
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIR---LSNWVVEDSEGQEAELTGFIREVKE 391
+APE+A++ +T K DVFS+GVV+LE++ G R +N V+DS L + R +
Sbjct: 447 LAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS------LVDWARPLLN 500
Query: 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448
+ EE E + D ++ +++ + A + +CV +RP M +V+ L G
Sbjct: 501 R--ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 464 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd01100 | 73 | cd01100, APPLE_Factor_XI_like, Subfamily of PAN/AP | 9e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| smart00223 | 79 | smart00223, APPLE, APPLE domain | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 6e-54
Identities = 86/280 (30%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
+LG G G VYK + VAVK L + + ++ E+ + ++ H N+VR
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ + H LV EY E L +L L E K+AL +GL YLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW-ASNLPIT 346
IH D+KPENILLD KIADFGLAK + +SS + GT YMAPE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
KVDV+S GV++ E+L G + + + I I+
Sbjct: 178 PKVDVWSLGVILYELLTGKPP---------------------FSGENILDQLQLIRRILG 216
Query: 407 PRLKGHFNK--NQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
P L+ K + + + C+++D +KRPT + ++Q
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 71/192 (36%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC 232
LG+GG G VY + VA+K + D E E+ + K+ H N+V+++G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 233 TEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
+ H LV EY E SL L L E ++ L +GL YLH +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRD 117
Query: 292 VKPENILLDS-EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITSKV 349
+KPENILLDS + K+ADFGL+KL S+ S I GT YMAPE + K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 350 DVFSYGVVILEM 361
D++S GV++ E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 64/196 (32%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
E+LG+G G VY + VA+K + + + E E+ + K+ H N+VR+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + LV EY E L L L E L YLH + ++
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
H D+KPENILLD + K+ADFGLA+ G + F GT YMAPE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKA 176
Query: 349 VDVFSYGVVILEMLKG 364
VD++S GV++ E+L G
Sbjct: 177 VDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 7e-40
Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHM 223
+ ++LG+G G VYKG L + VAVK L + +++ F E + K+ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYLHHE 282
N+V++ G CTE +V EY+E L +L + L + AL A+G+ YL +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG---YMAPEW 339
IH D+ N L+ KI+DFGL++ + R RG K +MAPE
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPES 174
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGE 397
TSK DV+S+GV++ E+ + G++ ++ EV E + G
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIF------------TLGEQPYPGMSNE--EVLEYLKNGY 220
Query: 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
P L+ + + C ED RPT +V+ L
Sbjct: 221 RLPQPPNCPPE------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 2e-38
Identities = 83/290 (28%), Positives = 125/290 (43%), Gaps = 49/290 (16%)
Query: 172 FKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMN 224
++LG+G G VYKG L E VAVK L + EE F E S + K+ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYLH-HE 282
+VR+ G CT+G +V EY+ L L L K+ ++AL AKG+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ----FSRIRGTKGYMAPE 338
+H D+ N L+ KI+DFGL++ + I+ +MAPE
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCG 396
+ TSK DV+S+GV++ E+ + G++ ++ EV E + G
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIF------------TLGEQPYPGMSNE--EVLELLEDG 220
Query: 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
RL +N L+ + + C D RPT +V+ L
Sbjct: 221 Y----------RLP--RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 171 SFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHM 223
+ ++LG+G G VYKG L E VAVK L + +++ F E + K+ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHH 281
N+V++ G CTE ++V EY+ L +L + L + AL A+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG---YMAPE 338
+ IH D+ N L+ KI+DFGL++ + +++G K +MAPE
Sbjct: 122 KN---FIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYKVKGGKLPIRWMAPE 174
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCG 396
TSK DV+S+GV++ E+ + G+E ++ EV E + G
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIF------------TLGEEPYPGMSNA--EVLEYLKKG 220
Query: 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
P L+++ + C ED RPT +V+ L
Sbjct: 221 YRLPKPPNCPPE------------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 64/199 (32%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 174 EELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEVFWA---EVSTIGKIYHMNLVRMW 229
E LG+G G+VY + D +AVK + EE A E+ + + H N+VR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 230 GFCT--EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECLE 285
G E + EYV SL L F E K +GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
++H D+K NIL+DS+ K+ADFG AK +RGT +MAPE
Sbjct: 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 346 TSKVDVFSYGVVILEMLKG 364
D++S G ++EM G
Sbjct: 181 GRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 83/294 (28%), Positives = 122/294 (41%), Gaps = 58/294 (19%)
Query: 174 EELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVR 227
++LG+G G VYKG L VAVK L + EE F E + K+ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHL---------FSSNFLGWKERFKVALGTAKGLAY 278
+ G CTE LV EY+E L +L + L K+ A+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG----SNSSQFSRIRGTKGY 334
L + +H D+ N L+ + KI+DFGL++ + IR +
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEK 392
MAPE + TSK DV+S+GV++ E+ + G L+ EV E
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIF------------TLGATPYPGLSN--EEVLEY 219
Query: 393 ILCGEEARIE--EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ G R+ E L+ + +SC D RPT +V+
Sbjct: 220 LRKGY--RLPKPEYCPDE------------LYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 78/289 (26%), Positives = 121/289 (41%), Gaps = 34/289 (11%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYH-MNLV 226
+LG+G G VY D + VA+K L + E F E+ + + H N+V
Sbjct: 4 ILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLD---KHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
+++ F + LV EYV+ SL+ K + L E + L YLH +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 284 LEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQ----FSRIRGTKGYMAPE 338
+IH D+KPENILLD + K+ DFGLAKL ++S S GT GYMAPE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 339 WASNL---PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395
L +S D++S G+ + E+L G+ + E + ++ I E+ L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILELPTPSLA 236
Query: 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ P +K + + +D R + S +
Sbjct: 237 SP-------LSPSNPELISKA----ASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 96/386 (24%), Positives = 175/386 (45%), Gaps = 45/386 (11%)
Query: 74 ALEPAILNGTNPACQSNKSDILVGSPSMYYRNTKRAKWSYFYWFALA--IGAIEVLFIVS 131
A+ + + G C + + L KR + + +WF + +GA ++ +
Sbjct: 595 AINASAVAGNIDLCGGDTTSGL--------PPCKRVRKTPSWWFYITCTLGAF-LVLALV 645
Query: 132 GWWLLFRRQGIPSSL-----EDGYRALSSQFKRFSYA-ELKKATNSFKEE--LGKGGSGA 183
+ +F R L EDG L + S + + +S KEE + +G GA
Sbjct: 646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGA 705
Query: 184 VYKG-VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242
YKG + + VK + D++ A+ +GK+ H N+V++ G C L++
Sbjct: 706 SYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIH 762
Query: 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE 302
EY+E ++L + L + L W+ R K+A+G AK L +LH C V+ ++ PE I++D +
Sbjct: 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819
Query: 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
EP + +LS G + + Y+APE IT K D++ +G++++E+L
Sbjct: 820 DEPHL------RLSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 363 KGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH--FNKNQAAT 420
G + E + G I V+ C + ++ +DP ++G N+N+
Sbjct: 873 TG--------KSPADAEFGVHGSI--VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922
Query: 421 LFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + + C D RP + V++TL
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
+ +G+G G VYKG+ L VA+K++ + + E+ + + H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA---KGLAYLHHECL 284
G ++ EY EN SL + + F + E VA+ +GLAYLH +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESL-VAVYVYQVLQGLAYLHEQG- 119
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
VIH D+K NIL + K+ADFG+A ++ S + + GT +MAPE
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 345 ITSKVDVFSYGVVILEMLKG 364
++ D++S G ++E+L G
Sbjct: 176 ASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 171 SFKEELGKGGSGAVYKG--VLTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNL 225
E++GKGG G VYK T + VA+K + + E++ E+ + K H N+
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKE-VAIKVIKLESKEKK-EKII-NEIQILKKCKHPNI 59
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHEC 283
V+ +G + +V E+ SL K L S E V KGL YLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
+IH D+K NILL S+ E K+ DFGL+ + S++ + + GT +MAPE +
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 344 PITSKVDVFSYGVVILEMLKG 364
P K D++S G+ +E+ +G
Sbjct: 173 PYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 11/192 (5%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+GKG G V G ++ VAVK L D + F AE S + + H NLV++ G
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+G +V EY+ SL +L S + ++ AL +G+ YL + +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVH 125
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+ N+L+ + K++DFGLAK + +G +S + ++ T APE ++K
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-VKWT----APEALREKKFSTKS 180
Query: 350 DVFSYGVVILEM 361
DV+S+G+++ E+
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 175 ELGKGGSGAVYKGVL-TDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
LG+G SG VYK + A+K++ GD +++ E+ T+ +V+ +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL-RELKTLRSCESPYVVKCYG 66
Query: 231 -FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECLEWV 287
F EG + V EY++ SL L E +A KGL YLH + +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTK--RHI 121
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
IH D+KP N+L++S+ E KIADFG++K L + F GT YM+PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPERIQGESYS 178
Query: 347 SKVDVFSYGVVILEMLKG 364
D++S G+ +LE G
Sbjct: 179 YAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
E++G+G SG VYK + VA+K++ Q +E+ E+ + H N+V +
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLH--HECLE 285
G +V EY++ SL + + NF+ E V +GL YLH +
Sbjct: 82 DSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---- 136
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
VIH D+K +NILL + K+ADFG A+L++ S + + GT +MAPE
Sbjct: 137 -VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS---VVGTPYWMAPEVIKRKD 192
Query: 345 ITSKVDVFSYGVVILEMLKG 364
KVD++S G++ +EM +G
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTDER-----AVAVKRL----GDLHQGEEVFWAEVSTIGKIYH 222
F ++LG+G G V VAVK L + H+ + F E+ + + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD--FEREIEILRTLDH 65
Query: 223 MNLVRMWGFCTEGMHR--LLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYL 279
N+V+ G C + R L+ EY+ + SL +L + + K + KG+ YL
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS-----NSSQFSRIRGTKGY 334
+ IH D+ NIL++SE KI+DFGLAK+ S I +
Sbjct: 126 GSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----W 178
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEML 362
APE +S DV+S+GV + E+
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 72/201 (35%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 176 LGKGGSGAVY--KGVLTDER-AVAV--KRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW- 229
LGKG G V + T + A+ V K+ + E E + + +I H +V++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE---RFKVA-LGTAKGLAYLHHECLE 285
F TE LV EY L HL S + E RF A + A L YLH
Sbjct: 61 AFQTEE-KLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA--LEYLH---SL 112
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
+I+ D+KPENILLD++ K+ DFGLAK LS GS ++ F GT Y+APE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKG 169
Query: 345 ITSKVDVFSYGVVILEMLKGI 365
VD +S GV++ EML G
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 50/288 (17%)
Query: 174 EELGKGGSGAVYKGVLT----DERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVR 227
+ +G G G V +G L E VA+K L ++ F E S +G+ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEW 286
+ G T+ +++ EY+EN SLDK L ++ + + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-----IRGTKGYMAPEWAS 341
+H D+ NIL++S K++DFGL++ S ++ ++ IR T APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA--ELTGFIREVKEKILCGEEA 399
TS DV+S+G+V+ E++ S G+ +++ ++V + + G
Sbjct: 182 YRKFTSASDVWSFGIVMWEVM------------SYGERPYWDMSN--QDVIKAVEDG--Y 225
Query: 400 RIEEIVD-PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+ +D P + L+++ + C +DRN+RPT +V TL
Sbjct: 226 RLPPPMDCP-----------SALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 49/286 (17%)
Query: 176 LGKGGSGAVYKGVLT----DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
+G G G V++G+L E AVA+K L G + + F +E S +G+ H N++R+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHL------FSSNFLGWKERFKVALGTAKGLAYLHHEC 283
G T+ +++ EY+EN +LDK+L FSS L R G A G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSD-- 125
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ---RGSNSSQFSRIRGTKGYMAPEWA 340
+ +V H D+ NIL++S E K++DFGL+++ + G+ ++ +I + APE
Sbjct: 126 MNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAI 182
Query: 341 SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400
+ TS DV+S+G+V+ E++ W + + E +A GF
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--------------- 227
Query: 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
RL + A ++++ + C +DR +RP +V L
Sbjct: 228 -------RLPAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+ +E+G G G V+ G ++R VA+K + + EE F E + K+ H LV+++G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKER-FKVALGTAKGLAYLHHECLEWVIH 289
CTE LV+E++E+ L +L + +E + L +G+AYL VIH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWASNLPIT 346
D+ N L+ K++DFG+ + Q++ GTK + +PE S +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVL----DDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 347 SKVDVFSYGVVILEM 361
SK DV+S+GV++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 5e-19
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQG-----EEVFWAEVSTIGKIYHMNLV 226
+++GKG G VY +D + +K + DL E+ EV + K+ H N++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDAL-NEVKILKKLNHPNII 62
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLG--------WKERFKVALGTAKGLAY 278
+ + E +V EY + L + + G ++ L L Y
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKY 118
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-IRGTKGYMAP 337
LH ++H D+KP+NI L S K+ DFG++K+ S++ ++ + GT Y++P
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSP 172
Query: 338 EWASNLPITSKVDVFSYGVVILEML 362
E N P K D++S G V+ E+
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELC 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 64/207 (30%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK--RLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+G G G VY V L +AVK R+ D + + E+ + + H NLV+ +G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 232 CTEGMHRLLVY---EYVENQSLDKHLFSSNFLGWKERFKV----ALGTAKGLAYLHHECL 284
+HR VY EY +L++ L G V L +GLAYLH
Sbjct: 68 ---EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS--SQFSRIRGTKGYMAPEWASN 342
++H D+KP NI LD K+ DFG A + + + + + GT YMAPE +
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 343 LPITSK---VDVFSYGVVILEMLKGIR 366
D++S G V+LEM G R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+F +ELG G G V+ G + VA+K + + E+ F E + K+ H NLV+++G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 231 FCTEGMHRLLVYEYVENQSL------DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECL 284
CT+ +V EY+ N L K + +L + + + YL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNG- 120
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWAS 341
IH D+ N L+ + K++DFGLA R Q++ +GTK + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLA----RYVLDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFI 386
+SK DV+S+GV++ E+ ++ +SE E+ G+
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK----------RLGDLHQGE-EVFWAEVSTIGKIY 221
E +GKG G VY + +T +AVK R + + +E+ T+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE---RFKVALGTAKGLAY 278
H+N+V+ GF T + + EYV S+ L + ++E RF +GLAY
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRF-FTEQVLEGLAY 123
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH + ++H D+K +N+L+D++ KI+DFG++K S ++ Q ++G+ +MAPE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 339 WASN--LPITSKVDVFSYGVVILEMLKGIR 366
+ ++KVD++S G V+LEM G R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 175 ELGKGGSGAVYKGVLTD------ERAVAVKRLGD---LHQGEEVFWAEVSTIGKIYHMNL 225
ELG+G G VY+G+ E VA+K + + + + E F E S + + ++
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHV 71
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFS-------SNFLG---WKERFKVALGTAKG 275
VR+ G + G L+V E + L +L S + LG ++ ++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG-- 333
+AYL ++V H D+ N ++ + KI DFG+ R + + R G KG
Sbjct: 132 MAYLAA--KKFV-HRDLAARNCMVAEDLTVKIGDFGMT----RDIYETDYYRK-GGKGLL 183
Query: 334 ---YMAPEWASNLPITSKVDVFSYGVVILEML 362
+MAPE + T+K DV+S+GVV+ EM
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD---LHQGEEVFWAEVSTIGKI 220
E + + + +LG G G V++G+ + VA+K L L Q + F EV + ++
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRL 59
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAY 278
H +L+ ++ C+ G ++ E +E SL L S L +A A+G+AY
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
L + IH D+ NIL+ + K+ADFGLA+L + S +I + APE
Sbjct: 120 LEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPE 174
Query: 339 WASNLPITSKVDVFSYGVVILEM 361
AS+ ++K DV+S+G+++ EM
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 59/190 (31%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVK--RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
E++GKG G VYKGVL VAVK R + F E + + H N+V++ G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 232 CTEGMHRLLVYEYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
C + +V E V SL L N L K+ +++L A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
D+ N L+ KI+DFG+++ + G + + + APE + TS+ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 351 VFSYGVVILE 360
V+SYG+++ E
Sbjct: 178 VWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 24/201 (11%)
Query: 176 LGKGGSGAVYKGVLTDER-----AVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRM 228
LG G G VYKGV E VA+K L + + + E + + H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKH-------LFSSNFLGWKERFKVALGTAKGLAYLHH 281
G C L+ + + L + + S L W + AKG++YL
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ L +H D+ N+L+ + KI DFGLAKL + +MA E
Sbjct: 128 KRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 342 NLPITSKVDVFSYGVVILEML 362
+ T K DV+SYGV + E++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 172 FKEELGKGGSGAVYKGVLTDE-RAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
E+LG+G G+VYK + + + VA+K + DL + + E+S + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK----EISILKQCDSPYIVK 62
Query: 228 MWGFCTEGMHRLLVYEYVENQS-LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+G + +V EY S D ++ L +E + T KGL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
IH D+K NILL+ E + K+ADFG++ Q ++ + + GT +MAPE +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 347 SKVDVFSYGVVILEMLKG 364
+K D++S G+ +EM +G
Sbjct: 178 NKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 60/195 (30%), Positives = 108/195 (55%), Gaps = 14/195 (7%)
Query: 175 ELGKGGSGAVYKGVLTDE---RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMW 229
++G+G +G V + T++ + VAVK++ DL Q E+ + EV + +H N+V M+
Sbjct: 29 KIGEGSTGIVC--IATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
G +V E++E +L + + + ++ V L + L+YLH++ VIH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K ++ILL S+ K++DFG +Q + + GT +MAPE S LP ++V
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 350 DVFSYGVVILEMLKG 364
D++S G++++EM+ G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 78/290 (26%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 173 KEELGKGGSGAVYKGVLT----DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+E +G G G V +G L E VA+K L G + F +E S +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE-RFKVAL------GTAKGLAYL 279
+ G T+ +++ E++EN +LD +FL + +F V G A G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMA 336
+ +V H D+ NIL++S K++DFGL++ + ++ ++ G K + A
Sbjct: 123 SE--MNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396
PE + TS DV+SYG+V+ E++ W D Q+ I +++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW---DMSNQDV-----INAIEQ----- 226
Query: 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
D RL + L ++ + C +DRN RP +V TL
Sbjct: 227 ---------DYRLPPPM--DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVF---WAEVSTIGKIYHMNLVR 227
E +G G + VY + L + VA+KR+ DL + + EV + + H N+V+
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 228 MWGFCTEGMHRLLVYEYVENQS-LD--KHLFSSNFLGWKERFKVALGTAKGLAYLHHECL 284
+ G LV Y+ S LD K + L V KGL YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSR--IRGTKGYMAPEWAS 341
IH D+K NILL + KIADFG+ A L+ G + + R GT +MAPE
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK-VRKTFVGTPCWMAPEVME 179
Query: 342 NLP-ITSKVDVFSYGVVILEMLKG 364
+ K D++S+G+ +E+ G
Sbjct: 180 QVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG-FC 232
E +G+G GAV +G T ++ VAVK + + F E + + K++H NLVR+ G
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-VAVKNI-KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 233 TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKV--------ALGTAKGLAYLHHECL 284
G++ +V E + +L NFL + R V +L A+G+ YL + L
Sbjct: 70 HNGLY--IVMELMSKGNL------VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
+H D+ NIL+ + K++DFGLA++ G ++S+ + APE +
Sbjct: 122 ---VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-----VKWTAPEALKHKK 173
Query: 345 ITSKVDVFSYGVVILEML 362
+SK DV+SYGV++ E+
Sbjct: 174 FSSKSDVWSYGVLLWEVF 191
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 56/174 (32%), Positives = 94/174 (54%), Gaps = 9/174 (5%)
Query: 193 RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250
R VAVK++ DL Q E+ + EV + H N+V M+ G +V E++E +L
Sbjct: 45 RQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
+ + + ++ V L K L++LH + VIH D+K ++ILL S+ K++DF
Sbjct: 104 TD-IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
G +Q + + GT +MAPE S LP ++VD++S G++++EM+ G
Sbjct: 160 GFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 44/214 (20%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVR 227
E+LG+G G VYK VA+K++ L EE + E+S + ++ H N+V+
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----------KGLA 277
+ LV+EY + L K+L ++ L +GLA
Sbjct: 63 LLDVIHTERKLYLVFEYCD-MDLKKYL---------DKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
Y H ++H D+KP+NIL++ + K+ADFGLA+ G ++ T Y AP
Sbjct: 113 YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAP 167
Query: 338 EWASNLPI-------TSKVDVFSYGVVILEMLKG 364
E I ++ VD++S G + EM+ G
Sbjct: 168 E------ILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 33/224 (14%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGD--LHQGEEVFWAEVS 215
+++ T K ELG+G G V+ G D+ VAVK L + + + F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS----SNF----------LG 261
+ H N+V+ +G CTEG ++V+EY+E+ L+K L S + F L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 262 WKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321
+ ++A+ A G+ YL + +H D+ N L+ + KI DFG++ R
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDVY 173
Query: 322 SSQFSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEM 361
++ + R+ G +M PE T++ DV+S+GVV+ E+
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 174 EELGKGGSGAVYKGVL----TDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
+ELG G G+V KGV E VAVK L + G++ F E S + ++ H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ G C +G +LV E L K+L + + ++A A G+AYL E +V
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESKHFV 117
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI-RGTKGYMAPEWASNLPIT 346
H D+ N+LL + + KI+DFG+++ GS+ + + R + APE + +
Sbjct: 118 -HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 347 SKVDVFSYGVVILEML 362
SK DV+SYGV + E
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHM---NLV 226
E +G+G GAVY+G V T R VA+K + ++V EV+ + ++ N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTG-RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFK--VALGTAKGLAYLHHECL 284
+ +G +G ++ EY E S+ + + E++ + L Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI---AEKYISVIIREVLVALKYIHKVG- 121
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
VIH D+K NIL+ + K+ DFG+A L NSS+ S GT +MAPE
Sbjct: 122 --VIHRDIKAANILVTNTGNVKLCDFGVAALLN--QNSSKRSTFVGTPYWMAPE-----V 172
Query: 345 IT------SKVDVFSYGVVILEMLKG 364
IT +K D++S G+ I EM G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---------HM 223
E+G+G G VYK L R VA+K++ + EE +ST+ +I H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGI--PLSTLREIALLKQLESFEHP 61
Query: 224 NLVRMWGFC-----TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK---- 274
N+VR+ C + LV+E+V+ D + S K L
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCP------KPGLPPETIKDL 112
Query: 275 ------GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328
G+ +LH ++H D+KP+NIL+ S+ + KIADFGLA++ S + +
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSV 166
Query: 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
T Y APE + VD++S G + E+
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWA------EVSTIGKIYHMNLV 226
E LG G G+VY+G+ L D AVK + G+ A E++ + K+ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 227 RMWGFCTEGMHRLLVY-EYVENQSLDKHLFSSNFLGWKERFKVALGTA---KGLAYLHHE 282
+ G E L ++ E V SL K L + + E + L T GL YLH
Sbjct: 66 QYLGTEREE-DNLYIFLELVPGGSLAKLL--KKYGSFPEPV-IRLYTRQILLGLEYLHDR 121
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WAS 341
+H D+K NIL+D+ K+ADFG+AK S + F +G+ +MAPE A
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQ 175
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
D++S G +LEM G
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 175 ELGKGGSGAV-YKGVLTDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
++G+G +G V V + + VAVK++ DL Q E+ + EV + H N+V M+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
G +V E++E +L + + + ++ V L K L+ LH + VIH D
Sbjct: 86 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDV 351
+K ++ILL + K++DFG +Q + + GT +MAPE S LP +VD+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 352 FSYGVVILEMLKG 364
+S G++++EM+ G
Sbjct: 200 WSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 175 ELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWA---EVSTIGKIYHMNLVRMWG 230
ELG G SG V K + + +AVK + L E + E+ + K +V +G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 231 FCTEGMHRLLVYEYVENQSLDKHL------FSSNFLGWKERFKVALGTAKGLAYLHHECL 284
+ EY++ SLDK L LG K+A+ KGL YLH +
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK-- 119
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
+IH DVKP NIL++S + K+ DFG +S + NS + + GT YMAPE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFG---VSGQLVNSLAKTFV-GTSSYMAPERIQGND 175
Query: 345 ITSKVDVFSYGVVILEMLKG 364
+ K D++S G+ ++E+ G
Sbjct: 176 YSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + +LG G G V++G+ + VAVK L + F AE + K+ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLHH 281
L++++ CT +V E ++ SL ++L L + +A A G+AYL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE- 120
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
+ IH D+ N+L+ K+ADFGLA++ + + G K + APE
Sbjct: 121 --AQNYIHRDLAARNVLVGENNICKVADFGLARVIK----EDIYEAREGAKFPIKWTAPE 174
Query: 339 WASNLPITSKVDVFSYGVVILEML 362
A + K DV+S+G+++ E++
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRL------GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
LG+G G+V K L + + + DL + ++ E+ +V+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK--QIL-RELEINKSCKSPYIVK 63
Query: 228 MWGFCTEGMHRLL--VYEYVENQSLD----KHLFSSNFLGWKERFKVALGTAKGLAYLHH 281
+G + + EY E SLD K +G K K+A KGL+YLH
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+IH D+KP NILL + + K+ DFG +S N S GT YMAPE
Sbjct: 124 R---KIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 342 NLPITSKVDVFSYGVVILEM 361
P + DV+S G+ +LE+
Sbjct: 177 GKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDE------RAVAVKRLGDLHQG--EEVFWAEVS 215
E+ + F EELG+G G VYKG LT +VA+K L + + ++ F E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS----------------SNF 259
+ + H N+V + G CT+ +++EY+ + L + L +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 260 LGWKERFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317
L + +A+ A G+ YL HH +H D+ N L+ KI+DFGL++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 318 RGSNSSQFSR----IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
S+ +R +M PE T++ D++S+GVV+ E+
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 48/277 (17%)
Query: 173 KEELGKGGSGAVYKGVL-TDERAVAVKRLG----DLHQGEEVFWAEVSTIGKIYHMNLVR 227
++GKG G V+K V D+R A+K++ + + EE E + K+ ++R
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSYIIR 63
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFS------SNFLGWKERFKVALGTAKGLAYLHH 281
+ + +V EY EN L K L W+ ++ LG LA+LH
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHS 119
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-IRGTKGYMAPEWA 340
+ ++H D+K N+ LD+ KI D G+AKL S+++ F+ I GT Y++PE
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 341 SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400
+ P K DV++ GVV+ E G D+ Q A + IR V + +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPF-----DANNQGALILKIIRGVFPPVSQMYSQQ 228
Query: 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP 437
+ +++D C+ +D +RP
Sbjct: 229 LAQLID--------------------QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + + +LG G G V+ G VAVK L E F E + K+ H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHD 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHH 281
LV+++ C+E +V EY+ SL L S L + +A A+G+AYL
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
IH D+ NIL+ KIADFGLA+L + +++ G K + APE
Sbjct: 122 RNY---IHRDLAARNILVGENLVCKIADFGLARLIE----DDEYTAREGAKFPIKWTAPE 174
Query: 339 WASNLPITSKVDVFSYGVVILEM 361
A+ T K DV+S+G+++ E+
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 36/92 (39%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
L YLH + +IH D+KP+NILLD + I DF +A + ++ S GT GY
Sbjct: 112 ALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIR 366
MAPE + VD +S GV E L+G R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 172 FKEELGKGGSGAV----YKGVLTDERAVAVKRLG-----DLHQGEEVFWAEVSTIGKIYH 222
F + LG G G V +KG + A+K L L Q E V E + I H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIRH 60
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK-------- 274
LV ++G + + LV EYV L HL S RF A+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG------RFP--EPVARFYAAQVVL 112
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
L YLH + ++ D+KPEN+LLDS+ KI DFG AK + + + + GT Y
Sbjct: 113 ALEYLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEY 164
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGI 365
+APE + VD ++ G++I EML G
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMW 229
E +GKG G VYK + + VA+K + DL + E E E+ + + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
G +G ++ EY S L L + GL YLH E IH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K NILL E + K+ADFG++ Q S S+ + GT +MAPE K
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 350 DVFSYGVVILEMLKG 364
D++S G+ +E+ KG
Sbjct: 180 DIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKR--LGDLHQGEEVF-WAEVSTIGKIYHMNLVRM 228
++G+G G VYK LT E VA+K+ L +G E+ + ++ H N++++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKGLAYLHHECLEWV 287
LV+E+++ L K + + K L +GLA+ H +
Sbjct: 64 LDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI-T 346
+H D+KPEN+L+++E K+ADFGLA+ GS ++ T+ Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 347 SKVDVFSYGVVILEMLKG 364
+ VD++S G + E+L
Sbjct: 178 TPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + T ++LG G G V+ G VA+K L E F AE + + ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWK--ERFKVALGTAKGLAYLHH 281
LVR++ T+ ++ EY+EN SL L + + + +A A+G+A++
Sbjct: 62 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
+ IH D++ NIL+ KIADFGLA+L + +++ G K + APE
Sbjct: 121 KNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR----EGAKFPIKWTAPE 173
Query: 339 WASNLPITSKVDVFSYGVVILEML 362
+ T K DV+S+G+++ E++
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 53/288 (18%)
Query: 176 LGKGGSGAVYKGVLT----DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
+G G G V G L E VA+K L G + F +E S +G+ H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL------GTAKGLAYLHHEC 283
G T+ ++V EY+EN SLD L + +F V G A G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD-- 124
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-----IRGTKGYMAPE 338
+ +V H D+ NIL++S K++DFGL+++ + ++ +R IR T APE
Sbjct: 125 MGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT----APE 179
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398
+ TS DV+SYG+V+ E++ W + + + I+ ++E
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGY----- 226
Query: 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+ +D A L ++ + C +DRN+RP + +V L
Sbjct: 227 -RLPAPMDC----------PAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 175 ELGKGGSGAVYKGVLTDE----RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRM 228
++G+G +G V + E R VAVK + DL Q E+ + EV + H N+V M
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ G ++ E+++ +L + S L ++ V + L YLH + VI
Sbjct: 84 YKSYLVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
H D+K ++ILL + K++DFG +Q + + + GT +MAPE S P ++
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 349 VDVFSYGVVILEMLKG 364
VD++S G++++EM+ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 176 LGKGGSGAVYK-GVLTDERAVAVKR--LGDLHQGE-EVFWAEVSTIGKIYHMNLVRMWGF 231
LGKG G+VYK L+D + A+K LG + Q E E E+ + + H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+G +V EY L K + + +E +++ + +GL LH + +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+H D+K NILL + KI D G++K+ ++ +Q GT YMAPE P +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGRPYSY 180
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
K D++S G ++ EM E + + +++ K+ G+ P
Sbjct: 181 KSDIWSLGCLLYEMATF-------APPFEARSMQ------DLRYKVQRGKY--------P 219
Query: 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ ++++ L S + RP D ++
Sbjct: 220 PIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 174 EELGKGGSGAVYKGVLTDERA--VAVKRLGDLHQGE------------EVFWAEVSTIGK 219
E LG G G VYK + +A+K + ++H +EV+ I +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEI-NVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 220 -IYHMNLVRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERF------KVALG 271
+ H N+VR + E RL +V + +E L +H F+S K+RF + +
Sbjct: 65 QLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEH-FNS-LKEKKQRFTEERIWNIFVQ 121
Query: 272 TAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
L YLH E + ++H D+ P NI+L + + I DFGLAK Q+ S S + GT
Sbjct: 122 MVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVV-GT 176
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEM 361
Y PE N P K DV+++G ++ +M
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 7/190 (3%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLG-DLHQGEEV-FWAEVSTIGKIYHMNLVRMWGF 231
E LGKG G V+KG L D+ VAVK DL Q ++ F +E + + H N+V++ G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 232 CTEGMHRLLVYEYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
CT+ +V E V L + L K+ K AL A G+AYL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
D+ N L+ KI+DFG+++ G SS + K + APE + +S+ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRYSSESD 176
Query: 351 VFSYGVVILE 360
V+SYG+++ E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 174 EELGKGGSGAVYKG-VLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMW 229
+G+G G V K VA+K+ + E+V EV + ++ H N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH-HECLEWVI 288
LV+EYVE L+ S L + +AY H H I
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI----I 122
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITS 347
H D+KPENIL+ K+ DFG A+ + R +S + T+ Y APE +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 348 KVDVFSYGVVILEMLKG 364
VDV++ G ++ E+L G
Sbjct: 182 PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 72/201 (35%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 176 LGKGGSGAV----YKGVLTDE-RAVAVKRLGDLHQGEEVFWAEV-----STIGKIYHMNL 225
LGKG G V KG TDE AV V + + Q ++V + GK H L
Sbjct: 3 LGKGSFGKVLLAELKG--TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 226 VRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHEC 283
++ C + RL V EYV L H+ S F + RF A GL +LH
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHERG 116
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
+I+ D+K +N+LLDSE KIADFG+ K G ++ S GT Y+APE S
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQ 171
Query: 344 PITSKVDVFSYGVVILEMLKG 364
P VD ++ GV++ EML G
Sbjct: 172 PYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE--------EVFWAEVSTIGKIYHMNL 225
E LGKG G VY G+ + +AVK++ +L E EV + + H+N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHEC 283
V+ G C + + E+V S+ L + F E K G+AYLH+ C
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK----LSQRGSNSSQFSRIRGTKGYMAPEW 339
V+H D+K N++L K+ DFG A+ + G++S+ + GT +MAPE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 340 ASNLPITSKVDVFSYGVVILEMLKG 364
+ K D++S G + EM G
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 275 GLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL------SQRGSNSSQFSR 327
L YLH + IH D+KP+NIL+DS K+ DFGL+K+ + + R
Sbjct: 105 ALEYLHSNGI----IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI 365
I GT Y+APE + VD +S G ++ E L GI
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 10/157 (6%)
Query: 213 EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVA--L 270
E+ + ++ H +++RM G E H L E++ S+ L S + +KE +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTE 110
Query: 271 GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP-KIADFGLA-KLSQRGSNSSQFS-R 327
+GL+YLH +IH DVK N+L+DS + +IADFG A +L+ +G+ + +F +
Sbjct: 111 QLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+ GT +MAPE DV+S G VI+EM
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 176 LGKGGSGAVYKGVLTDERA-------VAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLV 226
LG G G VY+G TD VAVK L G Q ++ F E + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHL-------FSSNFLGWKERFKVALGTAKGLAYL 279
++ G C + ++ E +E L +L F L KE + L AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 280 HHECLEWVIHCDVKPENILL-----DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK-- 332
IH D+ N L+ D++ KI DFGLA R S + R G
Sbjct: 123 EQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RDIYKSDYYRKEGEGLL 175
Query: 333 --GYMAPEWASNLPITSKVDVFSYGVVILEML 362
+MAPE + T++ DV+S+GV++ E+L
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 64/209 (30%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 176 LGKGGSGAVYKGVL------TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVR 227
LG G G VY+G+ E VAVK L + Q E F E + K H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDK-------HLFSSNFLGWKERFKVALGTAKGLAYLH 280
+ G E + R ++ E + L + L K+ A AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 281 HECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTK---- 332
IH D+ N LL + P KIADFG+A+ R + + R G
Sbjct: 134 ENHF---IHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYR----ASYYRKGGRAMLPI 185
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEM 361
+M PE + TSK DV+S+GV++ E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGE--EVFWAEVSTIGKIYHMNLVR 227
+ +G G G VYK T E VA+K + L G+ E+ E+S + + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGEL-VAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 228 MWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECL 284
+G +L +V EY SL ++ E V T KGLAYLH
Sbjct: 65 YFG-SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET-- 120
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWA--- 340
IH D+K NILL + + K+ADFG+ A+L+ + F GT +MAPE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYWMAPEVAAVE 176
Query: 341 SNLPITSKVDVFSYGVVILEM 361
K D+++ G+ +E+
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMWG 230
E +GKG G V+KG+ + V ++ DL + E E E++ + + + + +G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL---GTAKGLAYLHHECLEWV 287
+G ++ EY+ S L + F + F++A KGL YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPF----DEFQIATMLKEILKGLDYLHSE---KK 122
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
IH D+K N+LL + + K+ADFG+A Q + + GT +MAPE S
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 348 KVDVFSYGVVILEMLKG 364
K D++S G+ +E+ KG
Sbjct: 181 KADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVKRL----GDLHQGEEV--FWAEVSTIGKIYHMNLVRM 228
LG+G G VY D R +AVK++ +EV E+ + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+G + + EY+ S+ L + L K +G+ YLH ++
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIV 126
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-IRGTKGYMAPEWASNLPITS 347
H D+K NIL DS K+ DFG +K Q +S + + GT +M+PE S
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 348 KVDVFSYGVVILEML 362
K DV+S G ++EML
Sbjct: 187 KADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVRM 228
++G+G G VYK VA+K++ + +E F E+ + K+ H N+VR+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 229 WGFCTEGMHR--LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK--------GLAY 278
T +V+EY++ H + L K K GL Y
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD------HDLTG--LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH ++H D+K NIL++++ K+ADFGLA+ NS+ ++ T Y PE
Sbjct: 116 LHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVITLWYRPPE 171
Query: 339 W---ASNLPITSKVDVFSYGVVILEMLKG 364
A+ +VD++S G ++ E+ G
Sbjct: 172 LLLGATRY--GPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 176 LGKGGSGAVYK-GVLTDERAVAVKR--LGDLHQGEEVFWA-EVSTIGKIYHMNLVRMWGF 231
+G+G G V+K VA+K+ L L G E+ + H +V++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----------KGLAYLHH 281
G +LV EY+ + L S L +ER L A KG+AY+H
Sbjct: 68 FPHGSGFVLVMEYMPS-DL------SEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE--W 339
++H D+KP N+L+ ++ KIADFGLA+L +S T+ Y APE +
Sbjct: 118 NG---IMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 340 ASNLPITSKVDVFSYGVVILEMLKG 364
+ VD+++ G + E+L G
Sbjct: 174 GAR-KYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 172 FKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEE-----VFWAEVSTIGKI-YHMN 224
F + +G+G V + A+K L +E V E + ++ H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK-IEKEVLTRLNGHPG 63
Query: 225 LVRMWGFCT-EGMHRL-LVYEYVENQSLDKHL-----FSSNFLGWKERFKVALGTAKGLA 277
++++ + T + L V EY N L +++ RF A L
Sbjct: 64 IIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT----RFYAAE-ILLALE 116
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL-------------SQRGSNSSQ 324
YLH + +IH D+KPENILLD + KI DFG AK+ + + +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 325 FSRIR-----GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+R R GT Y++PE + P D+++ G +I +ML G
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-14
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 194 AVAVKRLGDLHQGEE----VFWAEVSTIGKIYHMNLVRMW--GFCTEGMHRLLVYEYVEN 247
VA+K L EE F E + ++YH N+V + G G+ V+EYV
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPG 63
Query: 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFE 304
++L + L + L E ++ L LA H++ ++H D+KP+NI++
Sbjct: 64 RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPH 120
Query: 305 PKIADFGLAKL--SQRGSNSSQFSR---IRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
K+ DFG+ L R ++ + +R + GT Y APE P+T D++++G++ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 360 EMLKG 364
E L G
Sbjct: 181 ECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 176 LGKGGSGAVYK-GVLTDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWG 230
LG GG G V V + R A+K + H +E ++E + + H +V+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 231 FCTEGMHRLLVYEYVENQSL-----DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE 285
+ + ++ EY L D+ LF + RF +A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIA-CVVLAFEYLHNRG-- 113
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
+I+ D+KPEN+LLDS K+ DFG AK + G + F GT Y+APE N
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGY 169
Query: 346 TSKVDVFSYGVVILEMLKG 364
VD +S G+++ E+L G
Sbjct: 170 DFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/137 (36%), Positives = 69/137 (50%), Gaps = 9/137 (6%)
Query: 231 FCT--EGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWV 287
FCT H V EY+ L H+ SS F + RF A GL +LH + +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAA-EIICGLQFLHKK---GI 117
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
I+ D+K +N+LLD + KIADFG+ K + G + S GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYNE 175
Query: 348 KVDVFSYGVVILEMLKG 364
VD +S+GV++ EML G
Sbjct: 176 SVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTDER-----AVAVKRLGDLHQGEEVFWA-- 212
EL+K + LG G G V+KG+ E VA+K + D G + F
Sbjct: 4 LKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEIT 57
Query: 213 -EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVAL 270
+ +G + H +VR+ G C G LV + SL H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 271 GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330
AKG+ YL + +H ++ NILL S+ +IADFG+A L +S +
Sbjct: 117 QIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
+MA E T + DV+SYGV + EM+
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH 222
E+++ + K +LG G G VY+GV VAVK L + E F E + + +I H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLH 280
NLV++ G CT ++ E++ +L +L N + +A + + YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAP 337
+ IH D+ N L+ K+ADFGL++L + ++ G K + AP
Sbjct: 122 KKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAP 174
Query: 338 EWASNLPITSKVDVFSYGVVILEM 361
E + + K DV+++GV++ E+
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 176 LGKGGSGAVY------KGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRM- 228
LGKGG G V G + + + KRL +GE++ E + K+ +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE---RFKVALGTAKGLAYLHHECLE 285
+ F T+ LV + L H+++ G+ E F A GL +LH
Sbjct: 60 YAFETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQR--- 114
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
+++ D+KPEN+LLD +I+D GLA + G + GT GYMAPE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171
Query: 346 TSKVDVFSYGVVILEMLKG 364
VD F+ G + EM+ G
Sbjct: 172 DFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + + +LG+G G V+ G VA+K L E F E + K+ H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF--SSNFLGWKERFKVALGTAKGLAYLHH 281
LV+++ +E +V EY+ SL L +L + +A A G+AY+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-- 118
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
E + +V H D++ NIL+ K+ADFGLA+L + ++++ +G K + APE
Sbjct: 119 ERMNYV-HRDLRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPE 173
Query: 339 WASNLPITSKVDVFSYGVVILEM 361
A T K DV+S+G+++ E+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 35/253 (13%)
Query: 172 FKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLHQGEEV-FWAEVSTIGKIYHMN 224
K ELG+G G V+ D+ VAVK L + + F E + + H +
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS---------------NFLGWKERFKVA 269
+VR +G CTEG L+V+EY+ + L++ L S L + +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 270 LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329
A G+ YL L +V H D+ N L+ KI DFG++ R S+ + R+
Sbjct: 129 SQIASGMVYL--ASLHFV-HRDLATRNCLVGQGLVVKIGDFGMS----RDIYSTDYYRVG 181
Query: 330 GTK----GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385
G +M PE T++ D++S+GVV+ E+ + + + ++E E G
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG- 240
Query: 386 IREVKEKILCGEE 398
RE++ C E
Sbjct: 241 -RELERPRTCPPE 252
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 11/195 (5%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMWG 230
E +GKG G VYKG+ + V ++ DL + E E E++ + + + R +G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 231 FCTEGMHRLLVYEYVENQS-LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+G ++ EY+ S LD L L + KGL YLH E IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K N+LL + + K+ADFG+A Q + + GT +MAPE K
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 350 DVFSYGVVILEMLKG 364
D++S G+ +E+ KG
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 55/176 (31%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 195 VAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSL 250
VAVK L Q + E++ + +YH N+V+ G C+E + L+ EYV SL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
+L + L + A +G+AYLH + IH D+ N+LLD++ KI DF
Sbjct: 96 RDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 311 GLAKLSQRGSNSSQFSRIRGTKG----YMAPEWASNLPITSKVDVFSYGVVILEML 362
GLAK G ++ R+R + A E + DV+S+GV + E+L
Sbjct: 152 GLAKAVPEG---HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 4e-13
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMWG 230
E++GKG G V+KG+ + V ++ DL + E E E++ + + + + +G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 231 FCTEGMHRLLVYEYVENQS-LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+ ++ EY+ S LD L L + + KGL YLH E IH
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSE---KKIH 124
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K N+LL E K+ADFG+A Q + + GT +MAPE SK
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 350 DVFSYGVVILEMLKG 364
D++S G+ +E+ KG
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+F +ELG G G V G + VA+K + + E+ F E + K+ H LV+++G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
CT+ +V EY+ N L +L + ++ +G+AYL + IH
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF---IH 123
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWASNLPIT 346
D+ N L+D + K++DFGL+ R +++ G+K + PE +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
SK DV+++GV++ E+ ++ +S E EK+ G +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNS------------ETVEKVSQG-----LRLYR 222
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447
P L + ++ I SC E +RPT ++ ++
Sbjct: 223 PHLA-------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 165 LKKATNSFKEELGKGGSGAVYKG------VLTDERAVAVKRLGDLH-QGEEVFWAEVSTI 217
+K+ K ELG+G G V+ D+ VAVK L D + F E +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----------------SSNFLG 261
+ H ++V+ +G C +G ++V+EY+++ L+K L + LG
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 262 WKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321
+ +A A G+ YL + +H D+ N L+ + KI DFG++ R
Sbjct: 122 LSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMS----RDVY 174
Query: 322 SSQFSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEML 362
S+ + R+ G +M PE T++ DV+S+GV++ E+
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 213 EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVAL 270
E++ + ++ H N+V+ G + H + EYV S+ L +N+ ++E
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVR 113
Query: 271 GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL----SQRGSNSSQFS 326
KGL YLH+ +IH D+K NIL+D++ KI+DFG++K S +
Sbjct: 114 QILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
++G+ +MAPE T K D++S G +++EML G
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 91/312 (29%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFW-----------------AEVST 216
E +GKG G V K V+R D G+ + W +EV+
Sbjct: 6 ETIGKGSFGTVRK----------VRRKSD---GKILVWKEIDYGNMTEKEKQQLVSEVNI 52
Query: 217 IGKIYHMNLVRMWG---------------FCTEG-MHRLLVYEYVENQSLDKHLFSSNFL 260
+ ++ H N+VR + +C G + +L+ E + +++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI----- 107
Query: 261 GWKERFKVALGTAKGLAYLHHECL--EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
W+ ++ L L H+ V+H D+KP NI LD+ K+ DFGLAK+
Sbjct: 108 -WRILTQLLLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--L 160
Query: 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG---IRLSNWVVEDS 375
G +SS GT YM+PE +++ K D++S G +I E+ N
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------ 214
Query: 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK 435
+ +L I+E K R+ ++ L + S ++ D +K
Sbjct: 215 ---QLQLASKIKEGKF---------------RRIPYRYSS----ELNEVIKSMLNVDPDK 252
Query: 436 RPTMDSVVQTLL 447
RP+ + ++Q L
Sbjct: 253 RPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + ++LG G G V+ G + VAVK L + F E + + + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL--------GTAKG 275
LVR++ T+ ++ EY+ SL +FL E KV L A+G
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSL------LDFLKSDEGGKVLLPKLIDFSAQIAEG 115
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK--- 332
+AY+ + IH D++ N+L+ KIADFGLA++ + ++++ G K
Sbjct: 116 MAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIE----DNEYTAREGAKFPI 168
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ APE + T K DV+S+G+++ E++
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 154 SSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEV--- 209
S+ S +EL++ +G G G VYK + R A+K + H+ + V
Sbjct: 65 SAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQ 118
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--K 267
E+ + + H N+V+ ++ E+++ SL+ E+F
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI------ADEQFLAD 172
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGS--NSSQ 324
VA G+AYLH ++H D+KP N+L++S KIADFG+++ L+Q NSS
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
Query: 325 FSRIRGTKGYMAPEWASNLPITSKV----------DVFSYGVVILEMLKG 364
GT YM+PE I + + D++S GV ILE G
Sbjct: 230 -----GTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 31/278 (11%)
Query: 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGE--EVFWAEVSTIGKIYHMNLVRMWG 230
E +G+G G V+ G L D VAVK + + F E + + H N+VR+ G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
CT+ +V E V+ L + L KE ++ A G+ YL + IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+ N L+ + KI+DFG+++ + G +S + + APE + +S+
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 350 DVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409
DV+S+G+++ E + + + + +EA G E LC +
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE--LCPDA----------- 224
Query: 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447
++R+ C + D +RP+ +V Q L
Sbjct: 225 -----------VYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+F +ELG G G V+ G + VA+K + + EE F E + K+ H LV+++G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 231 FCTEGMHRLLVYEYVENQSLDKHL------FSSNFLGWKERFKVALGTAKGLAYLHHECL 284
CT+ +V E++EN L +L S + L + +G+ YL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERNSF 121
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWAS 341
IH D+ N L+ S K++DFG+ R +++ G K + PE +
Sbjct: 122 ---IHRDLAARNCLVSSTGVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPPEVFN 174
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401
+SK DV+S+GV++ E+ +EG+ EV E I G
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVF------------TEGKMPFEKKSNYEVVEMISRG----- 217
Query: 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ P+L T++ + SC E RPT +++ +
Sbjct: 218 FRLYRPKLASM-------TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 165 LKKATNSF--KEELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEVFWAEVSTIGKI- 220
L T F E +G+G G VYK + VA+K + + EE E + + K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 221 YHMNLVRMWGFCTEGMHRL------LVYEYVENQS---LDKHLFSSNFLGWKERFKVAL- 270
H N+ +G + LV E S L K +R K
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK-----GLRKKGKRLKEEWI 115
Query: 271 -----GTAKGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
T +GLAYLH ++ VIH D+K +NILL E K+ DFG++ + +
Sbjct: 116 AYILRETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRR 170
Query: 325 FSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKG 364
+ I GT +MAPE + + ++ DV+S G+ +E+ G
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + ++LG G G V+ G VAVK L E F E + K+ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHH 281
LV+++ +E +V EY+ SL L L +A A G+AY+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-- 118
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
E + + IH D++ NIL+ KIADFGLA+L + ++++ +G K + APE
Sbjct: 119 ERMNY-IHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPE 173
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRL 367
A T K DV+S+G+++ E++ R+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 10/136 (7%)
Query: 232 CTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKV--ALGTAKGLAYLHHECLEWVI 288
C + M RL V EYV L H+ +KE V A A GL +LH + +I
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GII 123
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
+ D+K +N++LD+E KIADFG+ K + G +++ GT Y+APE + P
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TFCGTPDYIAPEIIAYQPYGKS 181
Query: 349 VDVFSYGVVILEMLKG 364
VD +++GV++ EML G
Sbjct: 182 VDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 43/128 (33%), Positives = 70/128 (54%), Gaps = 18/128 (14%)
Query: 243 EYVENQSLDKHLFSS-----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297
E+++ SLD+ L + N LG K+++ +GL YL + ++H DVKP NI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREK--HKIMHRDVKPSNI 131
Query: 298 LLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGV 356
L++S E K+ DFG++ +L +NS GT+ YM+PE T + D++S G+
Sbjct: 132 LVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 357 VILEMLKG 364
++EM G
Sbjct: 187 SLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 175 ELGKGGSGAVY------KGVLTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLV 226
+LG+G G V +G T E+ VAVK L G + E+ + +YH N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 227 RMWGFCTEGMHR--LLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYLHHEC 283
+ G CTE L+ E++ + SL ++L + N + K++ K A+ KG+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY-MAPEWASN 342
+H D+ N+L++SE + KI DFGL K + + + APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 343 LPITSKVDVFSYGVVILEML 362
DV+S+GV + E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 8/193 (4%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGF 231
E++G+G SG VY + + + VA+K++ Q +E+ E+ + + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
G +V EY+ SL + + + + V + L +LH VIH D
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDV 351
+K +NILL + K+ DFG +Q S+ S + GT +MAPE + KVD+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 352 FSYGVVILEMLKG 364
+S G++ +EM++G
Sbjct: 199 WSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 176 LGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMW 229
+GKG G VY G L D + AVK L + EEV F E + H N++ +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 230 GFC--TEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEW 286
G C +EG L+V Y+++ L + S ++ K+ L AKG+ YL +
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF-- 119
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG------YMAPEWA 340
+H D+ N +LD F K+ADFGLA R ++ + G +MA E
Sbjct: 120 -VHRDLAARNCMLDESFTVKVADFGLA----RDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 341 SNLPITSKVDVFSYGVVILEML 362
T+K DV+S+GV++ E++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 174 EELGKGGSGAVYKGVLTDERA----VAVKRLGD--LHQGEEVFWAEVSTIGKIYHMNLVR 227
++LG G G V +G + VAVK L L + F E + + + H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 228 MWGFC-TEGMHRLLVYEYVENQSL----DKHLFSSNFLGWKERFKVALGTAKGLAYLHHE 282
++G T + ++V E SL K + + A+ A G+ YL +
Sbjct: 61 LYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDY--AVQIANGMRYLESK 116
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSN-SSQFSRIRGTKGYMAPEWA 340
IH D+ NILL S+ + KI DFGL + L Q + + + + APE
Sbjct: 117 RF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL-KVPFAWCAPESL 172
Query: 341 SNLPITSKVDVFSYGVVILEM 361
+ DV+ +GV + EM
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 165 LKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH-QGEEVFWAEVSTI 217
+K+ K ELG+G G V+ D+ VAVK L D + F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS-------------SNFLGWKE 264
+ H ++V+ +G C EG ++V+EY+++ L+K L + L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
+A A G+ YL + +H D+ N L+ KI DFG++ R S+
Sbjct: 122 MLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMS----RDVYSTD 174
Query: 325 FSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ R+ G +M PE T++ DV+S GVV+ E+
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-12
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 161 SYAELKKATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIG 218
S + KK F E++G+G SG VY + + + VA+K++ Q +E+ E+ +
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 219 KIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY 278
+ + N+V G +V EY+ SL + + + + V + L +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH VIH D+K +NILL + K+ DFG +Q S+ S + GT +MAPE
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPE 185
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
+ KVD++S G++ +EM++G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRLG-DLHQGE-EVFWAEVSTIGKIYHMNLVRMW 229
E+LG+G VYKG T E VA+K + D +G E+S + ++ H N+VR+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGE-IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK--------GLAYLHH 281
+LV+EY++ + L K++ + R + T K G+A+ H
Sbjct: 65 DVIHTENKLMLVFEYMD-KDLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE--W 339
V+H D+KP+N+L++ E K+ADFGLA+ G + FS T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRL 367
S TS +D++S G ++ EM+ G L
Sbjct: 174 GSRTYSTS-IDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 8/193 (4%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGF 231
E++G+G SG V+ + + + VA+K++ Q +E+ E+ + ++ + N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
G +V EY+ SL + + + + V + L +LH VIH D
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRD 140
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDV 351
+K +N+LL + K+ DFG +Q S+ S + GT +MAPE + KVD+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 352 FSYGVVILEMLKG 364
+S G++ +EM++G
Sbjct: 199 WSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 48/220 (21%)
Query: 176 LGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMWGFC 232
LG G +G V+ V +D ++ VAVK++ L + V A E+ I ++ H N+V+++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV-LTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 233 TEGMHRL--------------LVYEYVE---------NQSLDKH--LFSSNFLGWKERFK 267
L +V EY+E ++H LF L
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL------- 124
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAK-LSQRGSNSSQF 325
+GL Y+H V+H D+KP N+ +++E KI DFGLA+ + S+
Sbjct: 125 ------RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 326 SRIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKG 364
S TK Y +P S T +D+++ G + EML G
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 161 SYAELKKATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIG 218
S + KK F E++G+G SG VY + + + VA++++ Q +E+ E+ +
Sbjct: 14 SVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 219 KIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY 278
+ + N+V G +V EY+ SL + + + + V + L +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH VIH D+K +NILL + K+ DFG +Q S+ S + GT +MAPE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPE 186
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
+ KVD++S G++ +EM++G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 176 LGKGGSGAVYKGVLTDERA----VAVKRLG-DLHQGEEV--FWAEVSTIGKIYHMNLVRM 228
LG+G G+V +G L+ + VAVK + D+H E+ F +E + + H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 229 WGFCTEGMHR------LLVYEYVENQSLDKHLFSSNFLGWKERF------KVALGTAKGL 276
G C E +++ ++++ L L S G E+ K + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
YL + IH D+ N +L + +ADFGL+K G Q + ++A
Sbjct: 127 EYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 337 PEWASNLPITSKVDVFSYGVVILEML 362
E ++ TSK DV+++GV + E+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMW-GF 231
ELG G G VYK + A ++ + EE+ F E+ + + H N+V ++ +
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE---RFKVALGTAKGLAYLHHECLEWVI 288
E +L+ E+ + +LD + G E R+ V + L +LH VI
Sbjct: 72 FYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVI 125
Query: 289 HCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWA-----SN 342
H D+K NILL + + K+ADFG+ AK F GT +MAPE +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKD 182
Query: 343 LPITSKVDVFSYGVVILEM 361
P K D++S G+ ++E+
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLHQGEE--VFWAEVST 216
EL + F EELG+ G +YKG L + VA+K L D++ ++ F E S
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----------SSN-------F 259
+ +++H N+V + G T+ +++EY+ L + L SS+
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 260 LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319
L + +A+ A G+ YL + +H D+ NIL+ + KI+D GL+ R
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLS----RE 173
Query: 320 SNSSQFSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEML 362
S+ + R++ +M PE +S D++S+GVV+ E+
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 60/195 (30%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 175 ELGKGGSGAVYKGV-LTDERAVAVKRLG----DLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
E+G G GAVY VAVK++ ++ + EV + ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
G + LV EY + D L E + G +GLAYLH + IH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IH 144
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL---PIT 346
D+K NILL + K+ADFG A S SS + GT +MAPE +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 347 SKVDVFSYGVVILEM 361
KVDV+S G+ +E+
Sbjct: 199 GKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 267 KVALGTAKGLAYL---HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
K+A+ +GL YL H ++H D+KP NIL++S + K+ DFG +S NS
Sbjct: 107 KIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFG---VSGELINSI 158
Query: 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+ + GT YM+PE T K DV+S G+ I+E+ G
Sbjct: 159 ADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 26/202 (12%)
Query: 172 FKEELGKGGSGAVYKG-VLTDERAVAVK--RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
++E LG G G VYK L R +AVK L + ++ +E+ + K ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 229 WG-FCTEGMHRL-LVYEYVENQSLDKH-LFSSNFLGWKERFKVALGTAKGLAYLHHECLE 285
+G F E +R+ + E+++ SLD + + LG ++A+ KGL YL
Sbjct: 65 YGAFFVE--NRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL------ 111
Query: 286 W---VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
W ++H DVKP N+L+++ + K+ DFG +S + NS + + GT YMAPE S
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFG---VSTQLVNSIAKTYV-GTNAYMAPERISG 167
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
DV+S G+ +E+ G
Sbjct: 168 EQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMW 229
E++G+G G VYK VA+K++ + E V E+S + ++ H N+VR+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 230 GFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLH-HECLE 285
++L LV+E++ + L K++ SS G +G+AY H H
Sbjct: 65 DVVHSE-NKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--- 119
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAK 314
V+H D+KP+N+L+D E K+ADFGLA+
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 54/151 (35%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 216 TIGKIYHMNLVRMWG-FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK 274
T H LV ++ F TE H V EY L H+ + F + F A
Sbjct: 55 TANSERHPFLVNLFACFQTED-HVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC-VVL 112
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ-RGSNSSQFSRIRGTKG 333
GL YLH +++ D+K +N+LLD+E KIADFGL K G +S F GT
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPE 166
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
++APE + T VD + GV+I EML G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN---LVRMWG- 230
ELG G G V K + ++L L + + + ++ N +V +G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
F ++G + + E+++ SLD+ L + + + KV++ +GLAYL + ++H
Sbjct: 72 FYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHR 128
Query: 291 DVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
DVKP NIL++S E K+ DFG++ +L +NS GT+ YM+PE + +
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYSVQS 183
Query: 350 DVFSYGVVILEMLKG 364
D++S G+ ++E+ G
Sbjct: 184 DIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 176 LGKGGSGAVYKGVLT-DERAVAVK--RLGDLHQGEE--VFWA--EVSTIGKIYHMNLVRM 228
LG+G VYK R VA+K +LG+ + ++ F A E+ + ++ H N++ +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 229 WG-FCTEG-MHRLLVYEYVENQSLD-KHLFSSNFLGWKERFKVA------LGTAKGLAYL 279
F + ++ LV+E++E D + + + A L T +GL YL
Sbjct: 68 LDVFGHKSNIN--LVFEFMET---DLEKVIKDKSI----VLTPADIKSYMLMTLRGLEYL 118
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE- 338
H W++H D+KP N+L+ S+ K+ADFGLA+ GS + + + T+ Y APE
Sbjct: 119 HSN---WILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRAPEL 173
Query: 339 -WASNLPITSKVDVFSYGVVILEMLKGI 365
+ + VD++S G + E+L +
Sbjct: 174 LFGARH-YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAV--AVKRLGDLHQGEEVF---WAEVSTIGKIYHMNLV 226
+ELGKG G+VYK VL V A+K + L E F E+ + K +V
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 227 RMWG-FCTEGMHRLLVY---EYVENQSLDKHLFSSNFLGWKER---FKVALGTAKGLAYL 279
+G F EG VY EY++ SLDK ++ KGL +L
Sbjct: 63 DFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR-GTKGYMAPE 338
E +IH DVKP N+L++ + K+ DFG++ G+ + ++ G + YMAPE
Sbjct: 119 KEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171
Query: 339 WAS------NLPITSKVDVFSYGVVILEMLKG 364
N T + DV+S G+ ILEM G
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 5/90 (5%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL +LH + +I+ D+K +N++LD + KIADFG+ K + G N + S GT Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDY 162
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+APE L T VD +S+GV++ EML G
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 176 LGKGGSGAVYKGVLTDERAVAVKRLGDLHQ-------------GEEVFWAEVSTIGKIYH 222
LGKGG G V AV VK G ++ GE++ E + K+
Sbjct: 1 LGKGGFGEVC--------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS 52
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK---GLAYL 279
+V + H LV + L H+++ G E +V +A+ G+ +L
Sbjct: 53 PFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHL 111
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
H +++ D+KPEN+LLD + +++D GLA + G +Q + GT GYMAPE
Sbjct: 112 HSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEI 165
Query: 340 ASNLPITSKVDVFSYGVVILEMLKG 364
P + VD F+ G I EM+ G
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + +LG+G G V+ G VA+K L E F E + K+ H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHH 281
LV ++ +E +V E++ SL L + +L + +A A G+AY+
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-- 118
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
E + + IH D++ NIL+ KIADFGLA+L + ++++ +G K + APE
Sbjct: 119 ERMNY-IHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPE 173
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRL 367
A T K DV+S+G+++ E++ R+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 175 ELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
ELG G G V KG+ E+ VAVK L + + + E + + ++ + +VRM
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G C E +LV E E L+K L + + K ++ + G+ YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF---V 117
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG---TKGYMAPEWASNLPI 345
H D+ N+LL ++ KI+DFGL+K N + ++ G K Y APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-AKTHGKWPVKWY-APECMNYYKF 175
Query: 346 TSKVDVFSYGVVILE 360
+SK DV+S+GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 171 SFKEELGKGGSGAVY------------KGVLTDERA-----VAVKRL---GDLHQGEEVF 210
+F E+LG+G G V+ K ++ A VAVK L + E+ F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED-F 66
Query: 211 WAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE----NQSLDKHLFSSNFLGWKERF 266
EV + ++ N+ R+ G CT ++ EY+E NQ L KH+ ++ L +
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 267 -------KVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319
+A A G+ YL E L +V H D+ N L+ + KIADFG++ R
Sbjct: 127 LSFSTLLYMATQIASGMRYL--ESLNFV-HRDLATRNCLVGKNYTIKIADFGMS----RN 179
Query: 320 SNSSQFSRIRGTKGYMAP----EWASNL--PITSKVDVFSYGVVILEML 362
SS + R++G P W S L T+K DV+++GV + E+L
Sbjct: 180 LYSSDYYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 176 LGKGGSGAVYKGVLTD---ERAVAVKRL-GDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
+GKGG G VY D R VA+K++ DL + + F E + H +V +
Sbjct: 10 IGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGW-KERFK--VALGTA------------ 273
+ C++G Y+E +L K L S W KE +A T+
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTL-KSLLKSV---WQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA-------------KLSQRGS 320
+ Y+H + V+H D+KP+NILL E I D+G A + +R
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 321 NSSQFS---RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
S + +I GT YMAPE +P + D+++ GV++ +ML
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 174 EELGKGGSGAVYKGVLTDERA-VAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
++G+G G V+K + VA+K+ D +++ E+ + ++ H NLV +
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 230 GFCTEGMHRLLVYEYVEN---QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH-HECLE 285
LV+EY ++ L+K+ K K+ T + + + H H C
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK---KIIWQTLQAVNFCHKHNC-- 121
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW-ASNLP 344
IH DVKPENIL+ + + K+ DFG A++ + ++ T+ Y APE +
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQ 177
Query: 345 ITSKVDVFSYGVVILEMLKGIRL 367
VDV++ G V E+L G L
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-11
Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+P V + +S E C + CL + C+ ++Y C + L N ++ +
Sbjct: 17 LPDVKLPDNASAIT-AISLEECREACLSNCSCTAYAYNNGSGG-CLLWNGLLNNLRSLSS 74
Query: 61 PG-DMYLKLP 69
G +YL+L
Sbjct: 75 GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 171 SFKEELGKGGSGAVYKGV---LTDERA---VAVKRL-GDLHQGE-EVFWAEVSTIGKI-Y 221
SF + LG G G V + L+ A VAVK L H E E +E+ + +
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYL 279
H N+V + G CT G L++ EY L L +FL ++ + AKG+A+L
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 280 HHE-CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
+ C IH D+ N+LL KI DFGLA+ SN R +MAPE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 339 WASNLPITSKVDVFSYGVVILEM 361
N T + DV+SYG+++ E+
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 174 EELGKGGSGAVYKGVLTDERA-VAVKR--LGDLHQGEEVF-WAEVSTIGKIYHMNLVRMW 229
E++G+G G V+K + VA+KR L D +G E+ + ++ H N+VR++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT---AKGLAYLHHECLEW 286
LV+EY + Q L K+ S N G + V KGLA+ H
Sbjct: 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN--- 119
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE--WASNLP 344
V+H D+KP+N+L++ E K+ADFGLA+ G +S T Y P+ + + L
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 345 ITSKVDVFSYGVVILEM 361
TS +D++S G + E+
Sbjct: 178 STS-IDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 175 ELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---------HM 223
E+G+G G V+K + R VA+KR+ + GEE +STI ++ H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGM--PLSTIREVAVLRHLETFEHP 64
Query: 224 NLVRMWGFCT-----EGMHRLLVYEYVENQSLDKHLFSSNFLGW-KERFK-VALGTAKGL 276
N+VR++ CT LV+E+V+ Q L +L G E K + +GL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
+LH V+H D+KP+NIL+ S + K+ADFGLA++ S + + T Y A
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLK 363
PE + VD++S G + EM +
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
ELK ELG G G V+K + ++L L + + + ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 224 N---LVRMWG-FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
N +V +G F ++G + + E+++ SLD+ L + + + KV++ KGL YL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPE 338
+ ++H DVKP NIL++S E K+ DFG++ +L +NS GT+ YM+PE
Sbjct: 120 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPE 172
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
+ + D++S G+ ++EM G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 79/312 (25%), Positives = 127/312 (40%), Gaps = 62/312 (19%)
Query: 172 FKEELGKGGSGAV----------YKGVLTDERA-----VAVKRL-GDLHQ-GEEVFWAEV 214
KE+LG+G G V + G E VAVK L D+ + F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 215 STIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL----FSSNF--------LGW 262
+ ++ + N++R+ G C ++ EY+EN L++ L S F +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 263 KERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
+A+ A G+ YL L +V H D+ N L+ + + KIADFG++ R S
Sbjct: 129 ANLLYMAVQIASGMKYL--ASLNFV-HRDLATRNCLVGNHYTIKIADFGMS----RNLYS 181
Query: 323 SQFSRIRGTK----GYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
+ RI+G +MA W S L T+ DV+++GV + EM + + + E
Sbjct: 182 GDYYRIQGRAVLPIRWMA--WESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 377 GQEAELTG-FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK 435
Q E TG F R +I + P +F++ + C D
Sbjct: 240 -QVIENTGEFFRNQGRQIYLSQT--------PLCPS--------PVFKLMMRCWSRDIKD 282
Query: 436 RPTMDSVVQTLL 447
RPT + + L
Sbjct: 283 RPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 63/223 (28%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEV--FWAEVST 216
F+ +LK E+G+G G V K + +AVKR+ +E ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 217 IGKIYH-MNLVRMWG---------FCTEGMHRLL--VYEYVENQSLDKHLFSSNFLGWKE 264
+ + +V+ +G C E M L Y+YV K + LG
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL--KSVIPEEILG--- 110
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
K+A+ T K L YL E +IH DVKP NILLD K+ DFG++ +S
Sbjct: 111 --KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIA 163
Query: 325 FSRIRGTKGYMAPE-WASNL--PITSKVDVFSYGVVILEMLKG 364
+R G + YMAPE + + DV+S G+ + E+ G
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 12/195 (6%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMWGF 231
+G+G G V K + + VA+K+ + + V E+ + ++ H NLV +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
LV+E+V++ LD N L K +G+ + H +IH D
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRD 125
Query: 292 VKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK-V 349
+KPENIL+ K+ DFG A+ L+ G + + T+ Y APE + V
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATRWYRAPELLVGDTKYGRAV 182
Query: 350 DVFSYGVVILEMLKG 364
D+++ G ++ EML G
Sbjct: 183 DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 47/135 (34%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 232 CTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
C + + RL V EYV L H+ + A + GL +LH +I+
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYR 125
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQ-RGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K +N++LDSE KIADFG+ K G + F GT Y+APE + P V
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEIIAYQPYGKSV 182
Query: 350 DVFSYGVVILEMLKG 364
D ++YGV++ EML G
Sbjct: 183 DWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 64/236 (27%), Positives = 97/236 (41%), Gaps = 52/236 (22%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRL-GDLHQGE--------E 208
EL + + + LG+G G V K + VAVK L D + + E
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 209 VFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV----------------ENQSLDK 252
+ IGK H N++ + G CT+ +V EY E S D
Sbjct: 68 MM----KMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 253 HLFSSNFLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFG 311
L K+ A A+G+ +L +C IH D+ N+L+ + KIADFG
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFG 177
Query: 312 LAKLSQRGSNSSQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
LA R + + R + T G +MAPE + T + DV+S+GV++ E+
Sbjct: 178 LA----RDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ LH +IH D+KPEN+L+D K+ DFGL S+ G + +F GT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL---SRNGLENKKFV---GTPDY 159
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIR 366
+APE + D +S G VI E L G
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 164 ELKKATNSFKEELGKGGSGAVY----KGVLTDE--RAVAVKRLGDLHQGEE--VFWAEVS 215
E+ + + ELG+G G VY KGV+ DE VA+K + + E F E S
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS----------SNFLGWKER 265
+ + ++VR+ G ++G L++ E + L +L S K+
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 266 FKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325
++A A G+AYL+ +H D+ N ++ +F KI DFG+ R + +
Sbjct: 122 IQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDY 174
Query: 326 SRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
R +G KG +M+PE + T+ DV+S+GVV+ E+
Sbjct: 175 YR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 36/206 (17%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRL-GDLHQGEE-VFWAEVSTIGKI-YHMNLVRM 228
++LG G G+VY T E VA+K++ + EE + EV ++ K+ H N+V++
Sbjct: 5 KQLGDGTFGSVYLARNKETGEL-VAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 229 WGFCTEGMHRLLVYEYVEN------QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHE 282
E V+EY+E + FS + + + +GLA++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVI-----RSIIYQILQGLAHIHKH 118
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ-FSRIRGTKGYMAPE--- 338
H D+KPEN+L+ KIADFGLA R S ++ T+ Y APE
Sbjct: 119 GF---FHRDLKPENLLVSGPEVVKIADFGLA----REIRSRPPYTDYVSTRWYRAPEILL 171
Query: 339 ---WASNLPITSKVDVFSYGVVILEM 361
S S VD+++ G ++ E+
Sbjct: 172 RSTSYS-----SPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 176 LGKGGSGAVYKGVLTDER-----AVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRM 228
LG G G VYKG+ E VA+K L + + F E + + H +LVR+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 229 WGFC--------TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH 280
G C T+ M + +YV ++ S L W + AKG+ YL
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
L +H D+ N+L+ S KI DFGLA+L + + +MA E
Sbjct: 127 ERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 341 SNLPITSKVDVFSYGVVILEML 362
T + DV+SYGV I E++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 175 ELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEE--VFWAEVSTIGKIYHMNLV 226
ELG+G G VY+G D E VAVK + + E F E S + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFS-----SNFLG-----WKERFKVALGTAKGL 276
R+ G ++G L+V E + + L +L S N G +E ++A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG--- 333
AYL+ + +H D+ N ++ +F KI DFG+ R + + R +G KG
Sbjct: 133 AYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMT----RDIYETDYYR-KGGKGLLP 184
Query: 334 --YMAPEWASNLPITSKVDVFSYGVVILEM 361
+MAPE + T+ D++S+GVV+ E+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 174 EELGKGGSGAVYKG-VLTDERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMWG 230
E+LG+G VYKG + + VA+K + + F A E S + + H N+V +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 231 FCTEGMHRLLVYEYVEN---QSLDKH---LFSSNFLGWKERFKVALGTAKGLAYLHHECL 284
LV+EYV Q +DKH L N + F L +GL+Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV----KLFLFQL--LRGLSYIHQR-- 122
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNL 343
+++H D+KP+N+L+ E K+ADFGLA+ + S +S T Y P+ +
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 344 PITSKVDVFSYGVVILEMLKGI 365
++ +D++ G + +EM++G+
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 40/205 (19%)
Query: 179 GGSGAVYKGV--LTDERAVAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVRMWGFC 232
G G VY+ T E VA+K+L + + +E F E++ + K+ H N+V +
Sbjct: 16 GTYGVVYRARDKKTGE-IVALKKL-KMEKEKEGFPITSLREINILLKLQHPNIVTV---- 69
Query: 233 TE-----GMHRL-LVYEYVEN--QSLDKHLFSSNFLGWKERFKVA------LGTAKGLAY 278
E + ++ +V EYVE+ +SL + + K+ F + L G+A+
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETM--------KQPFLQSEVKCLMLQLLSGVAH 121
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH W++H D+K N+LL++ KI DFGLA+ + GS ++++ T Y APE
Sbjct: 122 LHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRAPE 176
Query: 339 WASNLPI-TSKVDVFSYGVVILEML 362
++ +D++S G + E+L
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + +++LG G G V+ VAVK + E F AE + + + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 224 NLVRMWGFCT-EGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLH 280
LV++ T E ++ ++ E++ SL L S + + + A+G+A++
Sbjct: 62 KLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAP 337
IH D++ NIL+ + KIADFGLA++ + ++++ G K + AP
Sbjct: 120 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIE----DNEYTAREGAKFPIKWTAP 172
Query: 338 EWASNLPITSKVDVFSYGVVILEML 362
E + T K DV+S+G++++E++
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEE----VFWAEVSTIGKIYHMNLVR 227
E++G+G G VYK +T+E +A+K++ L Q +E E+S + ++ H N+VR
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE-TIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVAL-GTAKGLAYLHHECLE 285
+ LV+EY++ L KH+ SS +F K L +G+AY H
Sbjct: 66 LQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--- 121
Query: 286 WVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNL 343
V+H D+KP+N+L+D K+ADFGLA+ G F+ T Y APE +
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 344 PITSKVDVFSYGVVILEML 362
++ VD++S G + EM+
Sbjct: 180 HYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 65/308 (21%), Positives = 120/308 (38%), Gaps = 57/308 (18%)
Query: 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLG--DLHQGEEVFW 211
F + L++ T LG+G G V+ E V VK L + F
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 212 AEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE----------NQSLDKHLFSSNFLG 261
E+ K+ H N+VR+ G C E ++ EY + +S D+ L L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LS 115
Query: 262 WKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321
K++ + A G+ +L + +H D+ N L+ S+ E K++ L+K
Sbjct: 116 TKQKVALCTQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK----DVY 168
Query: 322 SSQFSRIRGTKG---YMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378
+S++ ++R ++APE ++K DV+S+GV++ E+ L + + D E
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-- 226
Query: 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438
+ ++ L L + + L+++ C + RP+
Sbjct: 227 ------VLNRLQAGKL-------------ELPVP--EGCPSRLYKLMTRCWAVNPKDRPS 265
Query: 439 MDSVVQTL 446
+V L
Sbjct: 266 FSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 35/79 (44%), Positives = 46/79 (58%), Gaps = 4/79 (5%)
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS-QFSRIRGTKGYMAPEWASNLPI 345
+I+ D+KPENILLD E K+ DFGL+K S + F GT YMAPE +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEVVNRRGH 175
Query: 346 TSKVDVFSYGVVILEMLKG 364
T D +S+GV++ EML G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL YLH + +IH DVK ENI ++ + I D G A Q + F + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA---QFPVVAPAFLGLAGTVE 221
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEML 362
APE + SK D++S G+V+ EML
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 47/128 (36%), Positives = 63/128 (49%), Gaps = 9/128 (7%)
Query: 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
V +Y+ L HL FL + RF A A L YLH +++ D+KPENIL
Sbjct: 73 FVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN---IVYRDLKPENIL 128
Query: 299 LDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVV 357
LDS+ + DFGL K + + +S F GT Y+APE P VD + G V
Sbjct: 129 LDSQGHIVLTDFGLCKENIEHNGTTSTFC---GTPEYLAPEVLHKQPYDRTVDWWCLGAV 185
Query: 358 ILEMLKGI 365
+ EML G+
Sbjct: 186 LYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 175 ELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEVFWAEVSTIGKIY---------HMN 224
E+G G G VYK VA+K + + E+ +ST+ ++ H N
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGL--PLSTVREVALLKRLEAFDHPN 63
Query: 225 LVRMWGFCT-----EGMHRLLVYEYVENQSLDKHLFSSNFLGW-----KERFKVALGTAK 274
+VR+ C LV+E+V+ Q L +L G K+ + L +
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFL---R 119
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL +LH C ++H D+KPENIL+ S + K+ADFGLA++ S + + T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLK 363
APE + VD++S G + EM +
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 63/196 (32%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 175 ELGKGGSGAVY--KGVLTDERAVAVKRLGDLHQGEEVFW----AEVSTIGKIYHMNLVRM 228
E+G G GAVY + V T+E VA+K++ + W EV + ++ H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G LV EY + D L E + G +GLAYLH I
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL---PI 345
H D+K NILL K+ADFG A L S ++ F GT +MAPE +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLV---SPANSFV---GTPYWMAPEVILAMDEGQY 191
Query: 346 TSKVDVFSYGVVILEM 361
KVDV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMW 229
E++G+G G VYK VA+K++ + E V E+S + ++ H N+V++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK--------GLAYLH- 280
LV+E++ +Q L K + +S G + L K GLA+ H
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSG------IPLPLIKSYLFQLLQGLAFCHS 118
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
H V+H D+KP+N+L+++E K+ADFGLA+ G ++ T Y APE
Sbjct: 119 HR----VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 341 SNLPI-TSKVDVFSYGVVILEML 362
++ VD++S G + EM+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 13/197 (6%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEV------FWAEVSTIGKIYHMNLVRM 228
LG+G G VY D R +AVK++ + E E+ + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 229 WGFCTEGMHRLL--VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+G + M R L E++ S+ L S L K +G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--- 126
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQFSRIRGTKGYMAPEWASNLPI 345
++H D+K NIL DS K+ DFG +K Q S + + GT +M+PE S
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186
Query: 346 TSKVDVFSYGVVILEML 362
K D++S G ++EML
Sbjct: 187 GRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 63/196 (32%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 175 ELGKGGSGAVY--KGVLTDERAVAVKRLGDLHQGEEVFW----AEVSTIGKIYHMNLVRM 228
E+G G GAVY + V T+E VA+K++ + W EV + +I H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G LV EY + D L E + G +GLAYLH + I
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 147
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL---PI 345
H D+K NILL + K+ADFG A ++ S ++ F GT +MAPE +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFV---GTPYWMAPEVILAMDEGQY 201
Query: 346 TSKVDVFSYGVVILEM 361
KVDV+S G+ +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 17/191 (8%)
Query: 176 LGKGGSGAVYKGVLTDERA--VAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCT 233
+GKG G V G D R VAVK + + + F AE S + ++ H NLV++ G
Sbjct: 14 IGKGEFGDVMLG---DYRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 234 EGMHRL-LVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
E L +V EY+ SL +L S + LG K +L + + YL +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF---VHR 126
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
D+ N+L+ + K++DFGL K + ++ + + APE ++K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREKKFSTKSD 181
Query: 351 VFSYGVVILEM 361
V+S+G+++ E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 40/96 (41%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQ--FSRIRG 330
K L Y+H VIH D+KP NILL+S+ K+ADFGLA+ LS+ N +
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 331 TKGYMAPE--WASNLPITSKVDVFSYGVVILEMLKG 364
T+ Y APE S T VD++S G ++ EML G
Sbjct: 175 TRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/221 (30%), Positives = 93/221 (42%), Gaps = 54/221 (24%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEV-STIGKIYHMNL------ 225
EELG+G G V K + +AVKR+ A V S K M+L
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIR----------ATVNSQEQKRLLMDLDISMRS 56
Query: 226 ------VRMWG---------FCTEGMHRLLVYEYVENQSLDKHLF-SSNFLGWKERFKVA 269
V +G C E M L Y + DK L + LG K+A
Sbjct: 57 VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY--KKVYDKGLTIPEDILG-----KIA 109
Query: 270 LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329
+ K L YLH L VIH DVKP N+L++ + K+ DFG +S +S +
Sbjct: 110 VSIVKALEYLH-SKLS-VIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDA 164
Query: 330 GTKGYMAPEWASNLPITS------KVDVFSYGVVILEMLKG 364
G K YMAPE + P + K DV+S G+ ++E+ G
Sbjct: 165 GCKPYMAPERIN--PELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 48/126 (38%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 241 VYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299
V +YV L HL +F + RF A A L YLH +I+ D+KPENILL
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLN---IIYRDLKPENILL 129
Query: 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359
DS+ + DFGL K S ++ S GT Y+APE P VD + G V+
Sbjct: 130 DSQGHVVLTDFGLCKEGIEHSKTT--STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 360 EMLKGI 365
EML G+
Sbjct: 188 EMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 50/137 (36%), Positives = 71/137 (51%), Gaps = 12/137 (8%)
Query: 232 CTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKV--ALGTAKGLAYLHHECLEWVI 288
C + M RL V EYV L + +KE V A A GL +LH + +I
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GII 123
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQ-RGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+ D+K +N++LDSE KIADFG+ K + G + F GT Y+APE + P
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAPEIIAYQPYGK 180
Query: 348 KVDVFSYGVVILEMLKG 364
VD +++GV++ EML G
Sbjct: 181 SVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 31/204 (15%)
Query: 176 LGKGGSGAVYKGVLTDERA---------VAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLV 226
+G G G V+ L +R +A+ + L Q + V E + ++ H ++
Sbjct: 9 VGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVH-NEKRVLKEVSHPFII 64
Query: 227 RMWGFCTEGMHRLL--VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLH-HE 282
R+ F TE R L + EYV L +L +S F F + L YLH E
Sbjct: 65 RL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS-EIVCALEYLHSKE 121
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+++ D+KPENILLD E K+ DFG AK L R + GT Y+APE
Sbjct: 122 ----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------LCGTPEYLAPEVIQ 171
Query: 342 NLPITSKVDVFSYGVVILEMLKGI 365
+ VD ++ G++I EML G
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV-FWA--EVSTIGKIYHMNLVRMW 229
E+LG+G VYKG+ + + VA+K + + E V F A E S + + H N+V +
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 230 GFCTEGMHRLLVYEYVEN---QSLDKH---LFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
V+EY+ Q + +H L N F L +GLAY+H +
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVR----LFMFQL--LRGLAYIHGQ- 122
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASN 342
++H D+KP+N+L+ E K+ADFGLA+ + S +S T Y P+
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
+S +D++ G + +EML+G
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 229 WGFCTEG-MHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ F T+ +H L+ +YV L HL+ +F + R +A L +LH
Sbjct: 72 YAFQTDTKLH--LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQL---G 125
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI- 345
+I+ D+K ENILLDSE + DFGL+K +S GT YMAPE
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGG 184
Query: 346 -TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELT 383
VD +S GV+ E+L G S + V+ + ++E++
Sbjct: 185 HDKAVDWWSLGVLTFELLTGA--SPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 32/79 (40%), Positives = 46/79 (58%), Gaps = 2/79 (2%)
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
VI+ D+KPENILLD + + DFGL KL+ + + + GT Y+APE T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 347 SKVDVFSYGVVILEMLKGI 365
VD ++ GV++ EML G+
Sbjct: 172 KAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 47/127 (37%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
V +YV L HL FL + RF A A + YLH +I+ D+KPENIL
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHSLN---IIYRDLKPENIL 128
Query: 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVI 358
LDS+ + DFGL K ++ S GT Y+APE P VD + G V+
Sbjct: 129 LDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVL 186
Query: 359 LEMLKGI 365
EML G+
Sbjct: 187 YEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMWGFCT 233
LGKG G VY L+ + +A+K + + + E++ + H N+V+ G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 234 EGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTA--KGLAYLHHECLEWVIHC 290
E + E V SL L S L E+ + +GL YLH ++H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132
Query: 291 DVKPENILLDS-EFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLP--IT 346
D+K +N+L+++ KI+DFG +K L+ + F+ GT YMAPE P
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPRGYG 189
Query: 347 SKVDVFSYGVVILEMLKG 364
+ D++S G I+EM G
Sbjct: 190 APADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 176 LGKGGSGAVYKGVLTDERA---VAVK--RLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMW 229
LG+G G+V +G L + + VAVK ++ + E E F +E + + H N++R+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 230 GFCTEGMHR------LLVYEYVENQSLDKHLFSSN------FLGWKERFKVALGTAKGLA 277
G C + + +++ ++++ L L S +L + K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
YL + IH D+ N +L+ +ADFGL+K G Q + ++A
Sbjct: 127 YLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 338 EWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
E ++ T+K DV+S+GV + E+ + VE+SE
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 14/97 (14%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL Y+H V+H D+KP N+L++++ E KI DFGLA RG + + Y
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA----RGFSENPGENAGFMTEY 169
Query: 335 MAPEW-------ASNLPITSKVDVFSYGVVILEMLKG 364
+A W S T +DV+S G ++ E+L
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 40/117 (34%), Positives = 55/117 (47%), Gaps = 14/117 (11%)
Query: 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311
+ + LG K+ + K L YL + VIH DVKP NILLD+ K+ DFG
Sbjct: 108 QGPIPEDILG-----KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFG 160
Query: 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK----VDVFSYGVVILEMLKG 364
+S R +S +R G YMAPE K DV+S G+ ++E+ G
Sbjct: 161 ---ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 42/164 (25%), Positives = 61/164 (37%), Gaps = 51/164 (31%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR------------------ 329
IH D+KP+NIL+D++ K+ADFGL K + + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 330 ---------GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI-------------RL 367
GT Y+APE P + D +S GV++ EML G ++
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242
Query: 368 SNWVVE----DSEGQEAELTGFIREVKEKILCGEEARI---EEI 404
NW E I ++LC E R+ EEI
Sbjct: 243 INWKESLRFPPDPPVSPEAIDLIC----RLLCDPEDRLGSFEEI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 17/157 (10%)
Query: 213 EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL-------DKHLFSSNFLGWKER 265
E+ + + H N++ + + L+ EY +L LF + W
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW--- 105
Query: 266 FKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325
++Y+H ++H D+K NI L K+ DFG++K GS S
Sbjct: 106 --YLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK--ILGSEYSMA 158
Query: 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ GT YM+PE + K D+++ G V+ E+L
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 49/218 (22%)
Query: 172 FKEELGKGGSGAVYK------GVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYH 222
F ++LGKG G+V T E VAVK+L H E F E+ + + H
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGE-VVAVKKLQ--HSTAEHLRDFEREIEILKSLQH 64
Query: 223 MNLVRMWGFCTEGMHRL---LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
N+V+ G C R LV EY+ SL +L ++ + L K L Y
Sbjct: 65 DNIVKYKGVCY-SAGRRNLRLVMEYLPYGSLRDYL---------QKHRERLDHRKLLLYA 114
Query: 280 HHEC--LEWV-----IHCDVKPENILLDSEFEPKIADFGLAKL---------SQRGSNSS 323
C +E++ +H D+ NIL++SE KI DFGL K+ + S
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
F + APE + + DV+S+GVV+ E+
Sbjct: 175 IF--------WYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 26/154 (16%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMW 229
++LG+G VYKG LT + VA+K + H+ F A E S + + H N+V +
Sbjct: 11 DKLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 230 GFCTEGMHRLLVYEYVEN---QSLDKH---LFSSN---FLGWKERFKVALGTAKGLAYLH 280
LV+EY++ Q +D L N FL F++ +GLAY H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAYCH 120
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
V+H D+KP+N+L+ E K+ADFGLA+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 176 LGKGGSGAVYKGVLTDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+G+G G +Y + V + DL + +E EV + K+ H N+V +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 232 CTEGMHRLLVYEYVENQSLDKH-------LFSSN-FLGWKERFKVALGTAKGLAYLHHEC 283
E +V EY + L K LFS + L W +++LG L ++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHDR- 120
Query: 284 LEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQFSRI-RGTKGYMAPEWAS 341
++H D+K +NI L K+ DFG+A+ ++S + + GT Y++PE
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQ 175
Query: 342 NLPITSKVDVFSYGVVILEM 361
N P +K D++S G V+ E+
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLT----DERAVAVK--RLGDLHQGEEVFWAEVSTI 217
EL + + LG G G + +G L E VA+ R G + F AE T+
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD----KH---LFSSNFLGWKERFKVAL 270
G+ H N+VR+ G T G ++V EY+ N +LD KH L + +G +
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLP 114
Query: 271 GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330
G A G+ YL +H + +L++S+ KI+ F Q + + ++ + G
Sbjct: 115 GLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSG 168
Query: 331 TKG--YMAPEWASNLPITSKVDVFSYGVVILEML 362
+ APE +S DV+S+G+V+ E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 14/96 (14%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---- 329
+GL Y+H VIH D+KP N+L++ + E +I DFG+A RG +SS
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA----RGLSSSPTEHKYFMTE 170
Query: 330 --GTKGYMAPEWASNLP-ITSKVDVFSYGVVILEML 362
T+ Y APE +LP T+ +D++S G + EML
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 176 LGKGGSGAVYKGVLTDERA------VAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVR 227
LG+G G V K + VAVK L + E+ +E + + ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLG------------------------WK 263
++G C++ LL+ EY + SL L S +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 264 ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
+ A ++G+ YL L +H D+ N+L+ + KI+DFGL++ +
Sbjct: 128 DLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ S+ R +MA E + T++ DV+S+GV++ E++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 75/275 (27%), Positives = 115/275 (41%), Gaps = 34/275 (12%)
Query: 176 LGKGGSGAVYK-GVLTDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWG 230
LGKGG G V V + A KRL +GE + E + K+ +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 231 FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+ E L LV + L H+++ G++E + A+ L L E ++
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-RALFYAAEILCGLEDLHRENTVY 125
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+KPENILLD +I+D GLA G S R+ GT GYMAPE +N T
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GTVGYMAPEVLNNQRYTLSP 182
Query: 350 DVFSYGVVILEMLKGI-------------RLSNWVVEDSEGQEAELTG---------FIR 387
D + G +I EM++G + V+E E A+ + +
Sbjct: 183 DYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTK 242
Query: 388 EVKEKILCGEEARIEEIVDPRLKG-HFNKNQAATL 421
+ K+++ C EE E P + +F + +A L
Sbjct: 243 DPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 30/133 (22%)
Query: 236 MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295
+HRLL +E Q F FL +++ +GL Y+H V+H D+KP
Sbjct: 96 LHRLLTSRPLEKQ------FIQYFL-----YQIL----RGLKYVHSA---GVVHRDLKPS 137
Query: 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE----WASNLPITSKVDV 351
NIL++ + KI DFGLA++ Q + T+ Y APE W +VD+
Sbjct: 138 NILINENCDLKICDFGLARIQD-----PQMTGYVSTRYYRAPEIMLTWQK---YDVEVDI 189
Query: 352 FSYGVVILEMLKG 364
+S G + EML+G
Sbjct: 190 WSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 62/196 (31%), Positives = 86/196 (43%), Gaps = 19/196 (9%)
Query: 175 ELGKGGSGAVY--KGVLTDERAVAVKRLGDLHQGEEVFW----AEVSTIGKIYHMNLVRM 228
E+G G GAVY + V E VA+K++ + W EV + K+ H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G LV EY + D L E V G +GLAYLH + I
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM---I 137
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL---PI 345
H DVK NILL K+ DFG A + + ++ F GT +MAPE +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFV---GTPYWMAPEVILAMDEGQY 191
Query: 346 TSKVDVFSYGVVILEM 361
KVDV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMW 229
E+LG+G V+KG LT E VA+K + H+ A EVS + + H N+V +
Sbjct: 12 EKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKGLAYLHHECLEWVI 288
LV+EY++ + L +++ + K+ L +GLAY H V+
Sbjct: 71 DIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITS 347
H D+KP+N+L++ E K+ADFGLA+ + + +S T Y P+ + ++
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 348 KVDVFSYGVVILEMLKG 364
++D++ G + EM G
Sbjct: 185 QIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGY 334
L +LH + +I+ D+KPENILLD++ K+ DFGL K S G+ + F GT Y
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEY 166
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
MAPE VD +S G ++ +ML G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 231 FCT--EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+CT + V EY+ L H+ S + A GL +LH + ++
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
+ D+K +NILLD++ KIADFG+ K + G ++ GT Y+APE +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 349 VDVFSYGVVILEMLKG 364
VD +S+GV++ EML G
Sbjct: 177 VDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 38/93 (40%), Positives = 48/93 (51%), Gaps = 12/93 (12%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GT 331
GL LH E +++ D+KPENILLD +I+D GLA G IR GT
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG------ETIRGRVGT 164
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
GYMAPE N T D + G +I EM++G
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 172 FKEELGKGGSGAVYKGVLTDE---RAVAVKRLGDLHQGEEV--FWAEVSTIGKI-YHMNL 225
F++ +G+G G V K + + A+KR+ + ++ F E+ + K+ +H N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA------------ 273
+ + G C + L EY + +L L S L F +A TA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 274 ----KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329
+G+ YL + IH D+ NIL+ + KIADFGL++ Q ++
Sbjct: 131 ADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVK 179
Query: 330 GTKGYMAPEWAS----NLPI-TSKVDVFSYGVVILEML 362
T G + W + N + T+ DV+SYGV++ E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
GL +LH +I+ D+KPEN+LLD++ +I+D GLA + G + ++ GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK--GYAGTPGF 163
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEML 362
MAPE VD F+ GV + EM+
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 176 LGKGGSGAVYKGVLTDERA-VAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMWGF 231
+G+G G V K + + VA+K+ D + EEV E+ + + N+V +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL--- 65
Query: 232 CTEGMHR----LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHH--ECLE 285
E R LV+EYVE N L E + K +Y++ + +
Sbjct: 66 -KEAFRRRGKLYLVFEYVEK----------NMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 286 W-----VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
W ++H D+KPEN+L+ K+ DFG A+ GSN++ ++ T+ Y +PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-YTEYVATRWYRSPELL 173
Query: 341 SNLPITSKVDVFSYGVVILEMLKG 364
P VD++S G ++ E+ G
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF-SRIRGTK 332
+GL Y+H V+H D+KP N+LL++ + KI DFGLA+++ + + F + T+
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 333 GYMAPEWASNLPITSK-----VDVFSYGVVILEMLKG 364
Y APE + + SK +D++S G ++ EML
Sbjct: 174 WYRAPE----IMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMW-GF 231
ELG G G VYK + +A ++ D EE+ + E+ + H N+V++ F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG-TAKGLAYLHHECLEWVIHC 290
E +L+ E+ ++D + + + +V T + L YLH +IH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP-----EWASNLPI 345
D+K NIL + + K+ADFG++ + R + GT +MAP E + + P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 346 TSKVDVFSYGVVILEM 361
K DV+S G+ ++EM
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMW 229
++LG+G V+KG LT E VA+K + H+ A EVS + + H N+V +
Sbjct: 11 DKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKGLAYLHHECLEWVI 288
LV+EY+++ L ++L + L K+ + +GL+Y H ++
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITS 347
H D+KP+N+L++ + E K+ADFGLA+ + + +S T Y P+ + ++
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 348 KVDVFSYGVVILEMLKG 364
+D++ G ++ EM G
Sbjct: 184 PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 41/221 (18%)
Query: 175 ELGKGGSGAVYK----GVLTDER--AVAVKRLGD--LHQGEEVFWAEVSTIGKIYHMNLV 226
++G+G G V++ G+L E VAVK L + + F E + + + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHL--------FSSNFLGWK--------------E 264
++ G C G L++EY+ L++ L S + E
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK----LSQRGS 320
+ +A A G+AYL +H D+ N L+ KIADFGL++ +
Sbjct: 132 QLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
+ + IR +M PE T++ DV++YGVV+ E+
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 50/139 (35%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 232 CTEGMHRLL-VYEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
C + RL V EYV L +F S F + RF A T L +LH
Sbjct: 64 CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHG--- 116
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
VI+ D+K +NILLD+E K+ADFG+ K G ++ F GT Y+APE L
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEILQELEY 173
Query: 346 TSKVDVFSYGVVILEMLKG 364
VD ++ GV++ EM+ G
Sbjct: 174 GPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 39/229 (17%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLHQG--EEVFWAEVS 215
E+ +T F EELG+ G VYKG L +AVA+K L D +G E F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS----------------SNF 259
++ H N+V + G T+ +++ Y + L + L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 260 LGWKERFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317
L + + A G+ +L HH V+H D+ N+L+ + KI+D GL
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLF---- 171
Query: 318 RGSNSSQFSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEML 362
R ++ + ++ G +M+PE + D++SYGVV+ E+
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA--EVSTIGKIYHMNLVRMW 229
++LG+G VYKG LTD VA+K + H+ A EVS + + H N+V +
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKGLAYLHHECLEWVI 288
LV+EY++ + L ++L K+ L +GL Y H V+
Sbjct: 71 DIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITS 347
H D+KP+N+L++ E K+ADFGLA+ + + +S T Y P+ + ++
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 348 KVDVFSYGVVILEMLKG 364
++D++ G + EM G
Sbjct: 185 QIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 46/199 (23%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 176 LGKGGSGAVYKGVLTDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGF 231
+G+G G V+ ++ + + + + Q E + + H N++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY-------LHHECL 284
E ++V EY +L +++ ++R L L + LHH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI--------QKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 285 EWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
+ ++H D+K +NILLD + KI DFG++K+ S+ S+ + GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGK 176
Query: 344 PITSKVDVFSYGVVILEML 362
P K D+++ G V+ E+
Sbjct: 177 PYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKG 333
GL ++H+ +V++ D+KP NILLD +I+D GLA S++ ++S GT G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHG 160
Query: 334 YMAPE-WASNLPITSKVDVFSYGVVILEMLKG 364
YMAPE + S D FS G ++ ++L+G
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 75/313 (23%), Positives = 131/313 (41%), Gaps = 61/313 (19%)
Query: 171 SFKEELGKGGSGAVY------------KGVLTDERA-----VAVKRL-GDLHQ-GEEVFW 211
+FKE+LG+G G V+ K D VAVK L D ++ F
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 212 AEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN----QSLDKHLF-------SSNFL 260
E+ + ++ N++R+ C ++ EY+EN Q L +H +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 261 GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320
+ +A A G+ YL L +V H D+ N L+ + KIADFG+++ G
Sbjct: 128 SYSTLIFMATQIASGMKYL--SSLNFV-HRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 321 NSSQFSRIRGTKGYMAPEWASNLPI-----TSKVDVFSYGVVILEMLKGIRLSNWVVEDS 375
+ RI+G + + W S I T+ DV+++GV + E+L + + + S
Sbjct: 185 ----YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY-SQLS 238
Query: 376 EGQEAELTG-FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRN 434
+ Q E TG F R+ ++ + A + +L+++ +SC +
Sbjct: 239 DEQVIENTGEFFRDQGRQVYLPKPALCPD----------------SLYKLMLSCWRRNAK 282
Query: 435 KRPTMDSVVQTLL 447
+RP+ + TLL
Sbjct: 283 ERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 13/197 (6%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVKRLG------DLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG+G G VY D R +A K++ + + E+ + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 229 WGFCTEGMHRLLV--YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+G + + L EY+ S+ L + L K +G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--- 126
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-IRGTKGYMAPEWASNLPI 345
++H D+K NIL DS K+ DFG +K Q S R + GT +M+PE S
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 346 TSKVDVFSYGVVILEML 362
K DV+S G ++EML
Sbjct: 187 GRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 173 KEELGKGGSGAVYKGVLTDERAVAVKRL--------GDLHQGEEVFW-AEVSTIGKIYHM 223
++ LGKG G VY ++ D++AVA +RL G+L+ E V E + K+ H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLD----------KHLFSSNFLGWKERFKVALGTA 273
+V+ E ++ EY E + LD K L + W + +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
G+ Y+H ++H D+K +NI L + KI DFG+++L + + + GT
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA--TTFTGTPY 170
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEM 361
YM+PE + SK D++S G ++ EM
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 39/103 (37%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 263 KERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
+ RF A A L YLH +++ D+KPENILLDS+ + DFGL K + + S
Sbjct: 97 RARFYAA-EIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQS 150
Query: 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI 365
+ GT Y+APE P + VD + G V+ EML G+
Sbjct: 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 47/224 (20%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVRM 228
+LG+G G VYK + R VA+K++ +H ++ F E+ + K+ H N+V +
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFS----------SNFLGWKERFKVALGTAK---- 274
M E + + S L K+ K
Sbjct: 73 -----IDM----AVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYML 122
Query: 275 ----GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL---------SQRGSN 321
G+ YLH ++H D+K NIL+D++ KIADFGLA+ G
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 322 SSQFSRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKG 364
+ +++ + T+ Y PE T+ VD++ G V EM
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 174 EELGKGGSGAVYKGVLTD-----------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH 222
E LG+G +YKGVL E +V +K LG H+ F+ S + ++ H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS---SNFLGWKERFKVALGTAKGLAYL 279
+LV+++G C + ++V EYV+ LD L + L WK VA A L YL
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYL 117
Query: 280 HHECLEWVIHCDVKPENILL-----DSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTK 332
+ L +H +V +NIL+ + + P K++D G+ S + RI
Sbjct: 118 EDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP--- 169
Query: 333 GYMAPEWASNLP--ITSKVDVFSYGVVILEM 361
++APE N +T D +S+G +LE+
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVKRL----GDLHQGEEV--FWAEVSTIGKIYHMNLVRM 228
LG+G G VY D R +AVK++ +EV E+ + + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 229 WGFCTEGMHRLL--VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+G + + L EY+ S+ L + L + +G++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--- 126
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQFSRIRGTKGYMAPEWASNLPI 345
++H D+K NIL DS K+ DFG +K Q S + + GT +M+PE S
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186
Query: 346 TSKVDVFSYGVVILEML 362
K DV+S ++EML
Sbjct: 187 GRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 42/293 (14%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDER----AVAVKRLGDLHQGE--EVFWAEVSTI 217
E+++ + +G+G G VY+GV AVAVK + E F E +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGL 276
+ H ++V++ G TE +V E L +L + L + + L
Sbjct: 62 RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF--SRIRGTKGY 334
AYL + +H D+ N+L+ S K+ DFGL++ + S + S+ + +
Sbjct: 121 AYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKW 174
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKI 393
MAPE + TS DV+ +GV + E+L G++ V +V +I
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-------------NDVIGRI 221
Query: 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
GE + P TL+ + C D +KRP + L
Sbjct: 222 ENGERLPMPPNCPP------------TLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 176 LGKGGSGAVYKGVLTDERA---VAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVRM 228
+G G G+V + D+R VA+K+L Q E+F + E++ + + H N++ +
Sbjct: 23 VGSGAYGSVCSAI--DKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 229 WGFCT-----EGMHRL-LVYEYVEN--QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH 280
T + LV Y++ Q + H S + K ++ V GL Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----KVQYLV-YQMLCGLKYIH 134
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
+IH D+KP N+ ++ + E KI DFGLA+ ++ + T+ Y APE
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 341 SN-LPITSKVDVFSYGVVILEMLKG 364
N + VD++S G ++ EML G
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 176 LGKGGSGAVYK-GVLTDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWG 230
LGKGG G V V + A K+L +GE + E + K+ +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 231 FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKV--ALGTAKGLAYLHHECLEWV 287
+ E L LV + L H+++ G+ E+ + A GL L E +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPEWASNLP 344
++ D+KPENILLD +I+D GLA G +R GT GYMAPE +N
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEG------ETVRGRVGTVGYMAPEVINNEK 177
Query: 345 ITSKVDVFSYGVVILEMLKG 364
T D + G +I EM++G
Sbjct: 178 YTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 176 LGKGGSGAV------YKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
LGKGG G V G + + + KR+ +GE + E + K+ +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSL- 65
Query: 230 GFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKV--ALGTAKGLAYLHHECLEW 286
+ E L LV + L H++ G++E V A GL LH E
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
+++ D+KPENILLD +I+D GLA G R+ GT GYMAPE N T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYT 179
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392
D ++ G ++ EM+ G S + + + E+ ++EV+E+
Sbjct: 180 FSPDWWALGCLLYEMIAG--QSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYK----GVLTDERA----VAVKRLGDLHQGEEV--FWAE 213
EL + + + LG+G G V G+ D+ VAVK L D +++ +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 214 VST---IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL---------------- 254
+ IGK H N++ + G CT+ ++ EY +L ++L
Sbjct: 68 MEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 255 FSSNFLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313
L +K+ A A+G+ YL +C IH D+ N+L+ + KIADFGLA
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ + + R +MAPE + T + DV+S+GV++ E+
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 174 EELGKGGSGA---VYKGVL---TDERAVAVKRL-GDLHQGEEVFWA---EVSTIGKIYHM 223
E G G G VYK D + A+K+ GD Q + + E++ + ++ H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 224 NLVRMWGFCTEGMHRL--LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK------- 274
N+V + E + L+++Y E+ + F +R + K
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLW--QII--KFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 275 -GLAYLHHECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKL 315
G+ YLH WV+H D+KP NIL+ E KI D GLA+L
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 174 EELGKGGSGAVYKGVLT--DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWG 230
E +GKG G V+K VL + AVK L +H +E AE + + + H N+V+ +G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 231 F-----CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECL- 284
G LV E S+ FL ER + + +AY+ HE L
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFLKRGERMEEPI-----IAYILHEALM 135
Query: 285 -------EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
IH DVK NILL +E K+ DFG++ +Q S + + GT +MAP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAP 193
Query: 338 EWAS-----NLPITSKVDVFSYGVVILEMLKG 364
E + + ++ DV+S G+ +E+ G
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ +LH +IH D+KP NI++ S+ KI DFGLA+ + S + T+ Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
APE + VD++S G ++ EM++G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 13/189 (6%)
Query: 178 KGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237
K +G +Y D++ + +K+ L E + + VST + + + + F T
Sbjct: 15 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMT--YAFHTPD-K 71
Query: 238 RLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297
+ + + L HL KE A GL ++H+ +V++ D+KP NI
Sbjct: 72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANI 128
Query: 298 LLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITSKVDVFSYG 355
LLD +I+D GLA S++ ++S GT GYMAPE S D FS G
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGTAYDSSADWFSLG 183
Query: 356 VVILEMLKG 364
++ ++L+G
Sbjct: 184 CMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
KGL Y+H +IH D+KP N+ ++ + E KI DFGLA+ S+ + T+
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRW 180
Query: 334 YMAPEWASN-LPITSKVDVFSYGVVILEMLKG 364
Y APE N + T VD++S G ++ EML G
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL YLH ++H D+KP N+L++S KI DFGLA++ + S ++ T+
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 334 YMAPEWASNLP-ITSKVDVFSYGVVILEMLKG 364
Y APE TS VD++S G + E+L
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 176 LGKGGSGAVYKGVLTDER-----AVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVR 227
LG G G VYKG+ E VA+K L + +E+ E + + + ++ R
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 73
Query: 228 MWGFC--------TEGMHRLLVYEYV-ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY 278
+ G C T+ M + +YV E++ ++ S L W + AKG+ Y
Sbjct: 74 LLGICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNW------CVQIAKGMNY 124
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
L L +H D+ N+L+ + KI DFGLAKL + +MA E
Sbjct: 125 LEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 339 WASNLPITSKVDVFSYGVVILEML 362
+ T + DV+SYGV + E++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 175 ELGKGGSGAVYKGVLTDERA---VAVKRLGDLHQGEEVFWAEVSTIGKIYHM----NLVR 227
ELG G G V KGV + VA+K L + + E+ E+ +I H +VR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVA------LGTAKGLAYLHH 281
M G C E +LV E L+K L G K+ V+ + G+ YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
+ +H D+ N+LL ++ KI+DFGL+K G++ S + K + APE
Sbjct: 114 KNF---VHRDLAARNVLLVNQHYAKISDFGLSK--ALGADDSYYKARSAGKWPLKWYAPE 168
Query: 339 WASNLPITSKVDVFSYGVVILEML 362
+ +S+ DV+SYG+ + E
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 48/137 (35%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 231 FCTEGMHRLL-VYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
C + RL V E+V L H+ S F + RF A T+ L +LH + +I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDKG---II 118
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+ D+K +N+LLD E K+ADFG+ K G +S F GT Y+APE +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GTPDYIAPEILQEMLYGP 175
Query: 348 KVDVFSYGVVILEMLKG 364
VD ++ GV++ EML G
Sbjct: 176 SVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMWG-F 231
ELG G G VYK + A+A ++ + EE+ + E+ + H +V++ G F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKE-RFKVALGTA-KGLAYLHHECLEWVIH 289
+G +++ E+ ++D + + G E + +V + L YLH +IH
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 290 CDVKPENILLDSEFEPKIADFGLA-----KLSQRGSNSSQFSRIRGTKGYMAPEWA---- 340
D+K N+LL + + K+ADFG++ L +R S GT +MAPE
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-------FIGTPYWMAPEVVMCET 186
Query: 341 -SNLPITSKVDVFSYGVVILEM 361
+ P K D++S G+ ++EM
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 15/95 (15%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL Y+H +IH D+KP NI ++ + E KI DFGLA+ + + T+
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 180
Query: 334 YMAPE----WASNLPITSKVDVFSYGVVILEMLKG 364
Y APE W VD++S G ++ E+L G
Sbjct: 181 YRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEE--VFWAEVSTIGKIYHMNLVRMWG- 230
+ +G G G VYK +A ++ L G++ + E+ + + H N+V +G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 231 -FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
E + + EY SL + L + V T +GLAYLH + +H
Sbjct: 75 YLSREKL--WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMH 129
Query: 290 CDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWAS---NLPI 345
D+K NILL + K+ADFG+ AK++ + F GT +MAPE A+ N
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEVAAVEKNGGY 186
Query: 346 TSKVDVFSYGVVILEM 361
D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 198 KRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS 257
K L DL E+ + IGK H N++ + G CT+ ++ EY +L ++L +
Sbjct: 62 KDLSDLVSEMEM----MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 115
Query: 258 NFLGWKERFKVA----------------LGTAKGLAYL-HHECLEWVIHCDVKPENILLD 300
G + + +A A+G+ YL +C IH D+ N+L+
Sbjct: 116 RPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVT 171
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
KIADFGLA+ + + R +MAPE + T + DV+S+GV++ E
Sbjct: 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231
Query: 361 ML 362
+
Sbjct: 232 IF 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 40/215 (18%)
Query: 174 EELGKGGSGAVYKGVLTD-------------ERAVAVKRLGDLHQGEEV-FWAEVSTIGK 219
E LG+G +Y G+L E V +K L H+ + F+ S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF---SSNFLGWKERFKVALGTAKGL 276
+ H ++V ++G C + ++V E+VE LD LF S+ L +FKVA A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 277 AYLHHECLEWVIHCDVKPENILL-----DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
+YL + L +H +V +NILL D E P I KLS G + SR
Sbjct: 119 SYLEDKDL---VHGNVCTKNILLAREGIDGECGPFI------KLSDPGIPITVLSRQECV 169
Query: 332 K--GYMAPEW---ASNLPITSKVDVFSYGVVILEM 361
+ ++APE + NL I + D +S+G + E+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAA--DKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEE----VFWAEVSTIGKIYHMNLVRM 228
E++G+G G VYKG + VA+K++ L EE E+S + ++ H N+V +
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGW--KERFKVAL-GTAKGLAYLHHECLE 285
+ L++E++ + L K+L S + E K L +G+ + H
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
V+H D+KP+N+L+D++ K+ADFGLA+ G ++ T Y APE P
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 346 TS-KVDVFSYGVVILEM 361
S VD++S G + EM
Sbjct: 179 YSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 32/87 (36%), Positives = 46/87 (52%)
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
L +HH + +IH D+K NILL S K+ DFG +K+ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 336 APEWASNLPITSKVDVFSYGVVILEML 362
APE P + K D+FS GV++ E+L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELL 239
|
Length = 496 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 174 EELGKGGSGAVYKGVLTDER---AVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMW 229
E +GKG G VYK +T+++ AVK L + +E AE + + + H N+V+ +
Sbjct: 28 ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 230 GFCTE-----GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL------GTAKGLAY 278
G + G LV E S+ + L +R A+ G GL +
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTE--LVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH+ +IH DVK NILL +E K+ DFG++ +Q S + + GT +MAPE
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPE 198
Query: 339 WAS-----NLPITSKVDVFSYGVVILEMLKG 364
+ + ++ DV+S G+ +E+ G
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 232 CTEGMHRLL-VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
C + RL V EYV L H+ L + + + L YLH +I+
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYR 120
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K +N+LLDSE K+ D+G+ K R G +S F GT Y+APE V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDYGFSV 177
Query: 350 DVFSYGVVILEMLKG 364
D ++ GV++ EM+ G
Sbjct: 178 DWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 15/98 (15%)
Query: 274 KGLAYLH--HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ-RGSNSSQFSRIRG 330
+GL YLH + VIH D+KP NIL++S + KI DFGLA+ +
Sbjct: 114 RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 331 TKGYMAPE----WASNLPITSKVDVFSYGVVILEMLKG 364
T+ Y APE + T +D++S G + E+L
Sbjct: 169 TRWYRAPELLLSSSR---YTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 18/124 (14%)
Query: 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
+YE ++ + K + + L K L ++H + H D+KPENIL+
Sbjct: 86 LYELIKGR---KRPLPEKRVKS---YMYQL--LKSLDHMHRNG---IFHRDIKPENILIK 134
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQ-FSRIRGTKGYMAPE-WASNLPITSKVDVFSYGVVI 358
+ K+ADFG S RG S ++ T+ Y APE ++ K+D+++ G V
Sbjct: 135 DD-ILKLADFG----SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 359 LEML 362
E+L
Sbjct: 190 FEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 47/135 (34%), Positives = 61/135 (45%), Gaps = 18/135 (13%)
Query: 237 HRL-LVYEYVENQSLDKHL-----FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
RL V EY L HL FS + + RF A L YLH V++
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALGYLHSCD---VVYR 119
Query: 291 DVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K EN++LD + KI DFGL K G+ F GT Y+APE + V
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYGRAV 176
Query: 350 DVFSYGVVILEMLKG 364
D + GVV+ EM+ G
Sbjct: 177 DWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE--------------EVFWAEVSTIGK 219
E LG+G ++KG+ + V G+LH+ E E F+ S + +
Sbjct: 1 ESLGQGTFTKIFKGIRRE-----VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQ 55
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFL---GWKERFKVALGTAKGL 276
+ H +LV +G C G ++V EYV+ SLD +L + L WK L AK L
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQL 109
Query: 277 AY-LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR--IRGTKG 333
A+ LH + + H +V +N+LL E + K + KLS G + + + +
Sbjct: 110 AWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP 169
Query: 334 YMAPEWASN-LPITSKVDVFSYGVVILEMLKG 364
++ PE N ++ D +S+G + E+ G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299
L+ +YV + HL+ + E V + + + L H +++ D+K ENILL
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDE---VRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
Query: 300 DSEFEPKIADFGLAK--LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK-VDVFSYGV 356
DSE + DFGL+K LS+ + F GT YMAPE K VD +S G+
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMAPEIIRGKGGHGKAVDWWSLGI 195
Query: 357 VILEMLKGIRLSNWVVEDSEGQEAELT 383
+I E+L G S + +E ++E++
Sbjct: 196 LIFELLTGA--SPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 49/233 (21%)
Query: 172 FKEELGKGGSGAVYKGVLTDER-------------------AVAVKRLGDLHQGEEVFWA 212
FKE+LG+G G V+ + + + AV + R F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 213 EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFL------------ 260
EV + ++ N++R+ G C + ++ EY+EN L++ L S +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 261 -------GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313
+ VAL A G+ YL L +V H D+ N L+ KIADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL--SSLNFV-HRDLATRNCLVGENLTIKIADFGMS 185
Query: 314 KLSQRGSNSSQFSRIRGTK----GYMAPEWASNLPITSKVDVFSYGVVILEML 362
R + + RI+G +MA E T+ DV+++GV + E+L
Sbjct: 186 ----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 20/134 (14%)
Query: 230 GFCTEG--MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
GFC G H+L + K L + + W + A L YLH + +
Sbjct: 80 GFCEGGDLYHKL-------KEQKGKLLPENQVVEW------FVQIAMALQYLHEK---HI 123
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+H D+K +N+ L K+ D G+A++ + + S + GT YM+PE SN P
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 348 KVDVFSYGVVILEM 361
K DV++ G + EM
Sbjct: 182 KSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 198 KRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL--- 254
K L DL E+ + IGK H N++ + G CT+ ++ EY +L + L
Sbjct: 59 KDLADLISEMEL----MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRAR 112
Query: 255 -------------FSSNFLGWKERFKVALGTAKGLAYLH-HECLEWVIHCDVKPENILLD 300
L +K+ A A+G+ YL C IH D+ N+L+
Sbjct: 113 RPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVT 168
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
+ KIADFGLA+ + S R +MAPE + T + DV+S+G+++ E
Sbjct: 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 361 ML 362
+
Sbjct: 229 IF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/84 (40%), Positives = 48/84 (57%), Gaps = 5/84 (5%)
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR-IRGTKGYMA 336
Y+H E +IH D+K EN+L++ + + DFG A + RGS S+ F I GT A
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIAGTVDTNA 330
Query: 337 PEWASNLPITSKVDVFSYGVVILE 360
PE + P T VD++S G+VI E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF-SRIRGTK 332
+ L Y+H V H D+KP+NIL +++ + KI DFGLA+++ + ++ F + T+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 333 GYMAPEWASNL--PITSKVDVFSYGVVILEMLKG 364
Y APE + T +D++S G + E+L G
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 20/205 (9%)
Query: 174 EELGKGGSGAVYKG---VLTDERAVAVKRLGDLHQGEE--VFWAEVSTIGKIYHMNLVRM 228
+E+G G G V G + V VK L +E +F EV ++ H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFS-----SNFLGWKERFKVALGTAKGLAYLHHEC 283
G C E + LLV E+ L +L S + ++A A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG----SNSSQFSRIRGTKGYMAPEW 339
IH D+ N L ++ KI D+GLA + +R +
Sbjct: 121 F---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 340 ASNL---PITSKVDVFSYGVVILEM 361
+L T K +++S GV + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 198 KRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL--- 254
K L DL E+ + IGK H N++ + G CT+ ++ EY +L ++L
Sbjct: 65 KDLSDLISEMEM----MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 118
Query: 255 ------FSSN-------FLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLD 300
+ N L +K+ A A+G+ YL +C IH D+ N+L+
Sbjct: 119 RPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVT 174
Query: 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360
+ KIADFGLA+ + + R +MAPE + T + DV+S+GV++ E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234
Query: 361 ML 362
+
Sbjct: 235 IF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 14/149 (9%)
Query: 240 LVYEYVENQSLDKHLFSSNFLGWKERFK---VALGTAKGLAYLHHECLEWVIHCDVKPEN 296
L+ +Y+ L HL +ERFK V + + + + L H +I+ D+K EN
Sbjct: 82 LILDYINGGELFTHLSQ------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLEN 135
Query: 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW--ASNLPITSKVDVFSY 354
ILLDS + DFGL+K +S GT YMAP+ + VD +S
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194
Query: 355 GVVILEMLKGIRLSNWVVEDSEGQEAELT 383
GV++ E+L G S + V+ + +AE++
Sbjct: 195 GVLMYELLTGA--SPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 213 EVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT 272
EV+ + + H N+V+ E + +V +Y E L K + + + + E +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 273 AKGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI-RG 330
LA H H+ ++H D+K +NI L + K+ DFG+A++ +++ + +R G
Sbjct: 109 QICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIG 163
Query: 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
T Y++PE N P +K D+++ G V+ EM
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWG 230
E +G G G VYKG V T + A A+K + EE E++ + K +H N+ +G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLA-AIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 231 FCTEGM------HRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHE 282
+ LV E+ S+ + ++ KE + + +GLA+LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
VIH D+K +N+LL E K+ DFG+ A+L + + F GT +MAPE +
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIA 194
Query: 342 -----NLPITSKVDVFSYGVVILEMLKG 364
+ + D++S G+ +EM +G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
IH D+KPEN L+D+ K+ DFGL+K +NS + G+ YMAPE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDF 177
Query: 348 KVDVFSYGVVILEMLKG 364
VD +S G ++ E L G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF-SRIRGTK 332
+GL Y+H V+H D+KP N+LL++ + KI DFGLA+ + S F + T+
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTR 172
Query: 333 GYMAPEWASNLP-ITSKVDVFSYGVVILEML 362
Y APE N T+ +DV+S G + E+L
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL Y+H + IH D+KP N+ ++ + E +I DFGLA+ + + T+
Sbjct: 129 RGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRW 180
Query: 334 YMAPEWASN-LPITSKVDVFSYGVVILEMLKG 364
Y APE N + VD++S G ++ E+LKG
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/126 (31%), Positives = 57/126 (45%), Gaps = 7/126 (5%)
Query: 263 KERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
++ + + LAYLH +IH DVK ENI LD + DFG A ++
Sbjct: 185 EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML-KGIRLSNWVVEDSEGQEAE 381
Q GT +PE + P +K D++S G+V+ EM K + L V+ S Q
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ--- 298
Query: 382 LTGFIR 387
L IR
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDER--AVAVKRLGDLH-----QGEEVFWAEVST 216
++K +F LG G G V +E VA+KR Q + VF +E
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKG- 275
+ I H V ++G + + LV E+V + F+ FL +RF +G
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFV----IGGEFFT--FLRRNKRFPNDVGCFYAA 138
Query: 276 ---LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK 332
L + + + L +++ D+KPEN+LLD + K+ DFG AK+ ++ + GT
Sbjct: 139 QIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTP 192
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE N+ D ++ G+ I E+L G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWG 230
E +G G G VYKG V T + A A+K + EE E++ + K +H N+ +G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLA-AIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 231 FCTE----GM--HRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHE 282
+ GM LV E+ S+ + ++ KE + + +GL++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS- 341
VIH D+K +N+LL E K+ DFG++ +Q + + GT +MAPE +
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 342 ----NLPITSKVDVFSYGVVILEMLKG 364
+ K D++S G+ +EM +G
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL Y+H +IH D+KP N+ ++ + E KI DFGLA+ + + T+
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182
Query: 334 YMAPEWASN-LPITSKVDVFSYGVVILEMLKG 364
Y APE N + VD++S G ++ E+L G
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 10/88 (11%)
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMA 336
YLH + +I+ D+KPEN+LLD++ K+ DFG AK + R F+ + GT Y+A
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFT-LCGTPEYLA 183
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLKG 364
PE + VD ++ GV++ E + G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 175 ELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVRM 228
++G+G G VYK T E VA+K++ L +E F E+ + ++ H N+V +
Sbjct: 14 QIGEGTYGQVYKARDKDTGEL-VALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 229 WGFCTEGMHRL----------LVYEYVENQSLDKHLFSSNFLGWKER-----FKVALGTA 273
T+ L LV+EY+++ + L S + + E K L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFMKQLL--- 126
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL Y H + +H D+K NILL+++ + K+ADFGLA+L + +++ T
Sbjct: 127 EGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 334 YMAPE-WASNLPITSKVDVFSYGVVILEM 361
Y PE +DV+S G ++ E+
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ +LH +IH D+KP NI++ S+ KI DFGLA+ + + + T+ Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
APE + VD++S G ++ E++KG
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 42/135 (31%), Positives = 63/135 (46%), Gaps = 8/135 (5%)
Query: 232 CTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
C + RL LV EYV L H+ L + A L +LH +I+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYR 120
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K +N+LLD++ K+ D+G+ K G +S F GT Y+APE V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRGEEYGFSV 177
Query: 350 DVFSYGVVILEMLKG 364
D ++ GV++ EM+ G
Sbjct: 178 DWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 43/126 (34%), Positives = 58/126 (46%), Gaps = 7/126 (5%)
Query: 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
V EY L HL F + RF A L YLH V++ D+K EN++
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD---VVYRDIKLENLM 127
Query: 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVI 358
LD + KI DFGL K + S+ + GT Y+APE + VD + GVV+
Sbjct: 128 LDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 359 LEMLKG 364
EM+ G
Sbjct: 186 YEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL YLH ++IH D+K N+LL + KIADFGLA+ G + + T
Sbjct: 119 RGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLW 173
Query: 334 YMAPEWA-SNLPITSKVDVFSYGVVILEMLKG 364
Y APE T+ +D+++ G ++ E+L
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR-GSNSSQFSRIRGTKGY 334
L +LH +I+ D+K +N+LLD+E K+ D+G+ K R G +S F GT Y
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNY 162
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV-KEKI 393
+APE VD ++ GV++ EM+ G R +V S+ + ++ +V EK
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221
Query: 394 LCGEEARIEEIVDPR----LKGHFNKNQAATL 421
+ RI + + LKG NK+ L
Sbjct: 222 I-----RIPRSLSVKASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 45/127 (35%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
V EY L HL F + RF A L YLH E + V++ D+K EN++
Sbjct: 72 FVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLM 128
Query: 299 LDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVV 357
LD + KI DFGL K + G+ F GT Y+APE + VD + GVV
Sbjct: 129 LDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVV 185
Query: 358 ILEMLKG 364
+ EM+ G
Sbjct: 186 MYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 11/85 (12%)
Query: 288 IHCDVKPENILLDSEFEPKIADFG-LAKLSQRGSNSSQFSRIR-GTKGYMAPEWASNLPI 345
+H D+KPEN+L+D K+ADFG A+L+ +N S++ GT Y+APE + +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLT---ANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 346 TSK------VDVFSYGVVILEMLKG 364
K D +S GV+ EM+ G
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 54/203 (26%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 176 LGKGGSGAVYKGVLTDER-------AVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG G G VYKG+ + A+ V R + + E + + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 229 WGFC--------TEGMHRLLVYEYV-ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
G C T+ M + +YV EN+ + S + L W + AKG++YL
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNW------CVQIAKGMSYL 125
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
L +H D+ N+L+ S KI DFGLA+L + +MA E
Sbjct: 126 EEVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 340 ASNLPITSKVDVFSYGVVILEML 362
+ T + DV+SYGV + E++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 7/170 (4%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEE--VFWAEVSTIGKIYHMNLVRMWGF 231
+ +G G G VYK + +A ++ L GE+ V E+ + H N+V +G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
+ E+ SL + L + V+ T +GL YLH + +H D
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRD 131
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+K NILL K+ADFG++ +Q + ++ GT +MAPE A+
Sbjct: 132 IKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 32/216 (14%)
Query: 171 SFKEELGKGGSGAVYKGVLTDE---RAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMN 224
F++ +G+G G V + ++ + A+K L + F E+ + K+ +H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY------ 278
++ + G C + + EY +L L S L F GTA L
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 279 -------LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
+ + + IH D+ N+L+ KIADFGL+ RG ++ T
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVY----VKKT 176
Query: 332 KGYMAPEWAS----NLPI-TSKVDVFSYGVVILEML 362
G + W + N + T+K DV+S+GV++ E++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ +LH +IH D+KP NI++ S+ KI DFGLA+ + S + T+ Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
APE + VD++S G ++ EM+KG
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF---LGWKERF 266
F+ S + ++ H++L + G C G ++V E+VE+ LD L + WK
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 267 KVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA-------KLSQRG 319
VA A L+YL + L +H +V +NILL A GLA KLS G
Sbjct: 121 TVAQQLASALSYLEDKNL---VHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPG 169
Query: 320 SNSSQFSRIRGTK--GYMAPEWASNL-PITSKVDVFSYGVVILEM 361
+ + SR + ++APE +++ D +S+G +LE+
Sbjct: 170 VSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 161 SYAELKKATNSFKEELGKGGSG---AVYKGVLTDERAVAVKRLGDLHQGE---EVFWAEV 214
++ LK+ N + +G G G A Y VL +R VA+K+L Q + + + E+
Sbjct: 12 TFTVLKRYQNL--KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 215 STIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGW------KERFKV 268
+ + H N++ + T E ++ L L +N ER
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQK----SLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 269 AL-GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327
L G+ +LH +IH D+KP NI++ S+ KI DFGLA+ + S +
Sbjct: 124 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTP 177
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363
T+ Y APE + VD++S G ++ EM++
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 55/176 (31%), Positives = 78/176 (44%), Gaps = 34/176 (19%)
Query: 273 AKGLAYLHHE-CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
AKG+++L + C IH D+ NILL KI DFGLA+ + SN R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390
+MAPE N T + DV+SYG+++ E+ G + DS+ F + +K
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--------FYKMIK 331
Query: 391 E--KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
E ++L E A E ++ I SC D D KRPT +VQ
Sbjct: 332 EGYRMLSPECAPSE------------------MYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 273 AKGLAYLHHE-CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
A+G+ +L + C IH DV N+LL KI DFGLA+ SN R
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEM 361
+MAPE + T + DV+SYG+++ E+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPI 345
+++ D+KPENILLD+ + DFGL+K + +++ + GT Y+APE
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANL--TDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 346 TSKVDVFSYGVVILEMLKG 364
T VD +S GV++ EM G
Sbjct: 175 TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 4/76 (5%)
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
V+H D+K +NI L + K+ DFG A+ L+ G+ + + GT Y+ PE N+P
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV---GTPYYVPPEIWENMPY 177
Query: 346 TSKVDVFSYGVVILEM 361
+K D++S G ++ E+
Sbjct: 178 NNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 169 TNSFKEE--LGKGGSGAVYKGV-LTDERAVAVKR-----LGDLHQGEEVFWAEVSTIGKI 220
+FK E +GKG VYK + L D R VA+K+ + D ++ E+ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-KEIDLLKQL 59
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLD---KHLFSSNFLGWKER--FKVALGTAKG 275
H N+++ E +V E + L KH F ER +K +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH-FKKQKRLIPERTIWKYFVQLCSA 118
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
L ++H + ++H D+KP N+ + + K+ D GL + S ++ + GT YM
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYM 173
Query: 336 APEWASNLPITSKVDVFSYGVVILEM 361
+PE K D++S G ++ EM
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 42/126 (33%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298
V EYV L HL F + RF A L YLH +++ D+K EN++
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG---KIVYRDLKLENLM 127
Query: 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVI 358
LD + KI DFGL K + ++++ GT Y+APE + VD + GVV+
Sbjct: 128 LDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 185
Query: 359 LEMLKG 364
EM+ G
Sbjct: 186 YEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 42/128 (32%), Positives = 56/128 (43%), Gaps = 31/128 (24%)
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-------SEF--------EPKIAD 309
RF A L YLH L +++ D+KPENILL S+F EP
Sbjct: 106 RFYAAEVLL-ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 310 FGLAKLSQRGSNSSQFSRIR------------GTKGYMAPEWASNLPITSKVDVFSYGVV 357
L K S+R S +S S GT+ Y+APE S S VD ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 358 ILEMLKGI 365
+ EML G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 30/82 (36%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
IH DVKP+N+LLD K+ADFG K+ G GT Y++PE +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVLKSQGGD 221
Query: 347 S----KVDVFSYGVVILEMLKG 364
+ D +S GV + EML G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 36/118 (30%), Positives = 48/118 (40%), Gaps = 41/118 (34%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGL---------AKLSQRGSNSSQFS------------ 326
IH D+KP+NIL+D + K+ DFGL +K Q+G + Q S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 327 ---------RIR-----------GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
R R GT Y+APE T D +S GV++ EML G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|238533 cd01100, APPLE_Factor_XI_like, Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-06
Identities = 19/47 (40%), Positives = 22/47 (46%), Gaps = 1/47 (2%)
Query: 4 VDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSE 50
VDF G DL+ S E C C D C F+Y T + CF KS
Sbjct: 12 VDFRGGDLSTVFASSAEQCQAACTADPGCLAFTY-NTKSKKCFLKSS 57
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 73 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 35/213 (16%)
Query: 173 KEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEE---VFWAEVSTIGKIYHMN 224
+ L +G G ++ G+L D E V VK + D H E + E + + H N
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQN 69
Query: 225 LVRMWGFCTEGMHRLLV-YEYVENQSLDKHLFSSNF--------LGWKERFKVALGTAKG 275
++ + C E V Y Y+ +L L L ++ +A+ A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 276 LAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAK------LSQRGSNSSQFSRI 328
++YLH VIH D+ N ++D E + KI D L++ G N +
Sbjct: 130 MSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN----- 180
Query: 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
R K +MA E N +S DV+S+GV++ E+
Sbjct: 181 RPVK-WMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 174 EELGKGGSGAVYKG-VLTD--ERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+E+G G G V G V + V VK L Q + F E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK--FLEEAQPYRSLQHSNLL 58
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFS---SNFLGWKERF--KVALGTAKGLAYLHH 281
+ G CTE LLV E+ L +L S + + ++A A GL +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA- 340
IH D+ N LL ++ KI D+GL+ + ++ ++APE
Sbjct: 119 NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 341 ---SNLPI---TSKVDVFSYGVVILEMLK 363
NL + T + +V+S GV I E+ +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFE 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWK-ERFKVALGTAKGLAYLHHEC 283
+V M+ H +V EYVE L + L R A T L YLH+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLHNY- 120
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK--LSQRGSN---------SSQFS--RIRG 330
++H D+KP+N+L+ S K+ DFGL+K L +N + +F ++ G
Sbjct: 121 --GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI 365
T Y+APE VD ++ G+++ E L G
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 16/97 (16%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEP-KIADFGLAKLSQRGSNSSQF--SRIRG 330
+ LAY+H + ++ H D+KP+N+L+D K+ DFG AK G S + SR
Sbjct: 181 RALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 331 TKGYMAPEW---ASNLPITSKVDVFSYGVVILEMLKG 364
Y APE A+N T+ +D++S G +I EM+ G
Sbjct: 236 ---YRAPELMLGATNY--TTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 30/176 (17%)
Query: 273 AKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
A+G+ +L +C IH D+ NILL KI DFGLA+ + + + R
Sbjct: 184 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390
+MAPE + T++ DV+S+GV++ E+ G V + E F + +K
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--------FCQRLK 291
Query: 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ G R E P ++RI ++C D +RPT ++V+ L
Sbjct: 292 D----GTRMRAPENATPE------------IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 176 LGKGGSGAVYKGVLTDE---RAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMW 229
+G+G G V K + + A+KR+ + F E+ + K+ +H N++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA---------------- 273
G C + L EY + +L L S L F +A TA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+G+ YL + IH D+ NIL+ + KIADFGL++ Q ++ T G
Sbjct: 123 RGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171
Query: 334 YMAPEWAS----NLPI-TSKVDVFSYGVVILEML 362
+ W + N + T+ DV+SYGV++ E++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+ + YLH +IH D+K ENI ++ + + DFG A N++++ GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV-DINANKYYGWAGTIA 248
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
APE + P VD++S G+V+ EM
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 43/197 (21%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 184 VYKGVLTDERAVAVKRLGDLHQGE----EVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239
+YKG+ ++ V ++ H+G ++ E+ + +I N+++++GF + + L
Sbjct: 36 IYKGIFNNK-EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 240 ----LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH------HECLEWVIH 289
L+ EY L + L L +K + +A+ KGL L+ ++ L
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL----- 149
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL--PITS 347
+ L+ ++ KI GL K+ +S F + Y + + +++ T
Sbjct: 150 ---TSVSFLVTENYKLKIICHGLEKIL----SSPPFKNV-NFMVYFSYKMLNDIFSEYTI 201
Query: 348 KVDVFSYGVVILEMLKG 364
K D++S GVV+ E+ G
Sbjct: 202 KDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
S +E + G + +G ER +A KR+ + E+ +G++ H N++++
Sbjct: 172 STEEAEARRGVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKI-- 228
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNF---LGWKER--FKVALGTAKGL----AYLHH 281
E + R Y+ Q D L+S + WK+R K K L Y+H
Sbjct: 229 ---EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ L IH D+K ENI L+ + + + DFG A ++ + + + GT +PE +
Sbjct: 286 KKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILA 341
Query: 342 NLPITSKVDVFSYGVVILEML 362
D++S G+++L+ML
Sbjct: 342 GDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 32/177 (18%)
Query: 273 AKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
A+G+ +L +C IH D+ NILL KI DFGLA+ + + + R
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390
+MAPE + T++ DV+S+GV++ E+ G V D E F R +K
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--------FCRRLK 290
Query: 391 EKI-LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
E + E EI + I + C + RPT +V+ L
Sbjct: 291 EGTRMRAPEYATPEI-----------------YSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEF 303
VE + ++ L ++ + AKG+ +L +C IH D+ NILL
Sbjct: 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSENN 216
Query: 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363
KI DFGLA+ + + + R +MAPE + T + DV+S+GV++ E+
Sbjct: 217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
Query: 364 -GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLF 422
G V D E F R +KE G R + P ++
Sbjct: 277 LGASPYPGVKIDEE--------FCRRLKE----GTRMRAPDYTTPE------------MY 312
Query: 423 RIGISCVDEDRNKRPTMDSVVQTL 446
+ + C + ++RPT +V+ L
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 176 LGKGGSGAVYKGVLT-DERAVAVKRL------GDLHQGEE---------VFWAEVSTIGK 219
LG+G G V K T + VA+K++ D+ + + E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
I H N++ + EG LV + + + L K + L + + L GL L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK------LSQRGSNSSQFSRIRG--- 330
H + +H D+ P NI ++S+ KIADFGLA+ S S R
Sbjct: 136 HKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 331 ---TKGYMAPE--WASNLPITSKVDVFSYGVVILEMLKG 364
T Y APE + VD++S G + E+L G
Sbjct: 193 KVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 22/150 (14%)
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLA 277
+ N ++++ T +L+ +Y++ D LF L E K+ + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 278 YLH-HECLEWVIHCDVKPENILLDSEFEPKI--ADFGLAKLSQRGSNSSQFSRIRGTKGY 334
LH H +IH D+K EN+L D + +I D+GL K+ G+ S GT Y
Sbjct: 124 DLHKHN----IIHNDIKLENVLYD-RAKDRIYLCDYGLCKI--IGTPSCY----DGTLDY 172
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+PE D ++ GV+ E+L G
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 168 ATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLG--DLH--QGEEVFWAEVSTIGKIYH 222
A ++++G+G VY+ L D VA+K++ DL + E+ + ++ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLD---KHLFSSN-FLGWKERFKVALGTAKGLAY 278
N+++ + E +V E + L KH + K +K + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
+H V+H D+KP N+ + + K+ D GL + S ++ + GT YM+PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPE 176
Query: 339 WASNLPITSKVDVFSYGVVILEM 361
K D++S G ++ EM
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 44/198 (22%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVR 227
++++G+G VY+ L D + VA+K++ + + E+ + ++ H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHL--FSSNFLGWKER--FKVALGTAKGLAYLHHEC 283
E +V E + L + + F ER +K + + ++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR- 125
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
V+H D+KP N+ + + K+ D GL + S ++ + GT YM+PE
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN 181
Query: 344 PITSKVDVFSYGVVILEM 361
K D++S G ++ EM
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEP-KIADFGLAKLSQRGSNSSQFSRIRGTK 332
KG+A+ H V+H D+KP+N+L+D + KIAD GL + S + T
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TL 175
Query: 333 GYMAPE-WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE 379
Y APE + ++ VD++S G + EM + L DSE Q+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL---FPGDSELQQ 220
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 8/83 (9%)
Query: 288 IHCDVKPENILLDSEFEPKIADFG-LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL--- 343
+H D+KP+N+LLD ++ADFG K++Q G + Q S GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEILQAMEDG 181
Query: 344 --PITSKVDVFSYGVVILEMLKG 364
+ D +S GV + EML G
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 175 ELGKGGSGAVYKGVLTD---ERAVAVKRLGDLHQGEEVFWA---EVSTIGKIYHMNLVRM 228
++G+G G VYK D +R A+K++ +G + + E++ + ++ H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 229 WG-FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY-----LHH 281
F + ++ L+++Y E+ F K+ ++ G K L Y +H+
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 282 ECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNS-SQFSRIRGTKGYMA 336
WV+H D+KP NIL+ E KIAD G A+L + + T Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 337 PE-WASNLPITSKVDVFSYGVVILEML 362
PE T +D+++ G + E+L
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 45/183 (24%), Positives = 70/183 (38%), Gaps = 58/183 (31%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGL---------AKLSQRGSNSSQFS------------ 326
IH D+KP+NIL+D + K+ DFGL +K Q+GS+ Q S
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 327 -----RIR-------------------GTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
R++ GT Y+APE T D +S GV++ EML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 363 KG-------------IRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409
G +++ NW + +L+ ++ K+ C E R+ +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 410 KGH 412
K H
Sbjct: 303 KAH 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 33/113 (29%), Positives = 46/113 (40%), Gaps = 36/113 (31%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAK-------------LSQRGSN------SSQFSRI 328
IH D+KP+N+LLD++ K++DFGL LS + S S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 329 R-----------------GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
R GT Y+APE + D +S GV++ EML G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 35/187 (18%)
Query: 188 VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247
+L DER A R +E+ + H +V+ + LL+ EY
Sbjct: 102 MLNDERQAAYAR------------SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 248 QSLDKHLFSSNFLGWKERFKVALGTAK---GLAY---------LHHECLEWVIHCDVKPE 295
L+K + K+R K L + GL + +H + +H D+K
Sbjct: 150 GDLNKQI--------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM---MHRDLKSA 198
Query: 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYG 355
NI L K+ DFG +K + S GT Y+APE + K D++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 356 VVILEML 362
V++ E+L
Sbjct: 259 VILYELL 265
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 288 IHCDVKPENILLDSEFEPKIADFG-LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP-- 344
+H D+KP+NIL+D ++ADFG KL + G + Q S GT Y++PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEDG 181
Query: 345 ---ITSKVDVFSYGVVILEMLKG 364
+ D +S GV + EML G
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 175 ELGKGGSGAVYKGVLTD---ERAVAVKRLGDLHQGEEVFWA---EVSTIGKIYHMNLVRM 228
++G+G G VYK D E+ A+K++ +G + + E++ + ++ H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 229 WG-FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY-----LHH 281
F + ++ L+++Y E+ F K+ ++ K L Y +H+
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 282 ECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNS-SQFSRIRGTKGYMA 336
WV+H D+KP NIL+ E KIAD G A+L + + T Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 337 PE-WASNLPITSKVDVFSYGVVILEML 362
PE T +D+++ G + E+L
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP--- 344
+H D+KP+N+LLD ++ADFG + L + Q + GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 345 --ITSKVDVFSYGVVILEMLKG 364
+ D +S GV + EML G
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 194 AVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251
A+ + R D+ + E+V AE + + + +V+M+ + ++ L+ E++ +
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 252 KHLFSSNFLGWKE-RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
L + L +E +F +A T + +H IH D+KP+N+LLDS+ K++DF
Sbjct: 90 TLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDF 145
Query: 311 GL----------------------------------AKLSQRGSNSSQFSRIRGTKGYMA 336
GL A+ +R FS + GT Y+A
Sbjct: 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV-GTPDYIA 204
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLKG 364
PE D +S GV++ EML G
Sbjct: 205 PEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPE----WAS 341
+IH DVKP+N+LLD K+ADFG K+ + G + GT Y++PE
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGG 220
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
+ + D +S GV + EML G
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 273 AKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
A L YLH +IH D+KP+N+L+ +E K+ DFGL+K++
Sbjct: 114 ALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 32/116 (27%), Positives = 49/116 (42%), Gaps = 30/116 (25%)
Query: 231 FCTEGMHRLLVYEYV-----ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE 285
FC + LL + V E + + K L + GL Y+H
Sbjct: 100 FCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN------------------GLYYIH---RN 138
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAK---LSQRGSNSSQFSRIRGTKGYMAPE 338
++H D+K NIL+ + K+ADFGLA+ LS+ + +R+ T Y PE
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 26/222 (11%)
Query: 176 LGKGGSGAVYKGVLTDE----RAVAVKRL-GDLHQGEEV--FWAEVSTIGKIYHMNLVRM 228
LGKG G+V + L E + VAVK L D+ ++ F E + + + H N++++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 229 WGFCTEGMHR------LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT--------AK 274
G + +++ ++++ L L S +G +E F + L T A
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IG-EEPFTLPLQTLVRFMIDIAS 124
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ YL + IH D+ N +L+ +ADFGL+K G Q + +
Sbjct: 125 GMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
+A E ++ T+ DV+++GV + E++ + VE+SE
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 273 AKGLAYLHHE-CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN----SSQFSR 327
A G+ +L + C +H D+ N+L+ KI DFGLA+ R SN S F
Sbjct: 249 ANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
++ +MAPE N T+ DV+S+G+++ E+
Sbjct: 305 LK----WMAPESIFNNLYTTLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 35/155 (22%), Positives = 52/155 (33%), Gaps = 31/155 (20%)
Query: 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE----EV----FWAEVSTIG-KIYHM 223
+ L G + VY + T + +K +G EV A K+
Sbjct: 3 IKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHH-- 281
W + L+ E++E ++LD+ KE L LA LH
Sbjct: 62 GESDGWSY--------LLMEWIEGETLDEVSEEE-----KEDIAEQLAEL--LAKLHQLP 106
Query: 282 -ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315
L H D+ P NIL+D I D+ A
Sbjct: 107 LLVL---CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 25/99 (25%), Positives = 35/99 (35%), Gaps = 22/99 (22%)
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILL--DSEFEPKIADFGLAKLSQRGSNSSQF 325
V L L LH + K NILL D + G ++ + S
Sbjct: 22 VCLQCLGALRELHRQ---------AKSGNILLTWDGLLKL----DGS--VAFKTPEQS-- 64
Query: 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
R +MAPE T K D++S G+ + E L
Sbjct: 65 ---RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDY 100
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 35/122 (28%), Positives = 48/122 (39%), Gaps = 45/122 (36%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGL---------AKLSQRGSNSSQFS------------ 326
IH D+KP+NIL+D + K+ DFGL +K Q G + Q S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 327 -----RIR-------------------GTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
R++ GT Y+APE T D +S GV++ EML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 363 KG 364
G
Sbjct: 243 VG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPE----WASN 342
IH DVKP+N+LLD K+ADFG K+++ G + GT Y++PE +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
+ D +S GV + EML G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 36.8 bits (85), Expect = 0.002
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 1 VPKVDFYGFDLNFSEHVSKEACMKLCLD-DFRCSGFSYRLTGERVC--FTKSELFNGYKA 57
+P GF S E C CL+ + C F+Y G + C +++S L +
Sbjct: 9 LPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYN-NGTKGCLLWSESSLGDARLF 67
Query: 58 PNFPGDMYLKL 68
P+ D+Y K+
Sbjct: 68 PSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 35/111 (31%)
Query: 288 IHCDVKPENILLDSEFEPKIADFGL---------------------AKLSQRGSNSSQ-- 324
IH D+KP+N+LLD++ K++DFGL + S + NS +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 325 -----------FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+S + GT Y+APE D +S GV++ EML G
Sbjct: 183 ETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 15/110 (13%)
Query: 273 AKGLAYLHHE-CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN----SSQFSR 327
A+G+ +L + C +H D+ N+LL KI DFGLA+ SN S F
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM--LKGIRLSNWVVEDS 375
++ +MAPE + T+ DV+SYG+++ E+ L G +V+ +
Sbjct: 303 VK----WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|128519 smart00223, APPLE, APPLE domain | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.003
Identities = 16/49 (32%), Positives = 20/49 (40%), Gaps = 2/49 (4%)
Query: 2 PKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLT--GERVCFTK 48
VDF G D+N S + C K C RC F++ E C K
Sbjct: 7 KNVDFRGSDINTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLK 55
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. Length = 79 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKER-------FKVALGTAK 274
H N+++ G C E + LLV+EY E L +L W R ++A A
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ---WHRRNSQLLLLQRMACEIAA 110
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312
G+ ++H +H D+ N L S+ K+ D+G+
Sbjct: 111 GVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 464 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.45 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 97.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.51 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.42 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.4 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.12 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.03 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.9 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.85 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.38 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-61 Score=474.19 Aligned_cols=285 Identities=46% Similarity=0.792 Sum_probs=247.4
Q ss_pred CccccCHHHHHHHHhhhc--cccCccCceEEEEEEECCCcEEEEEEcCCccch-hHHHHHHHHHhhhccccceeccceee
Q 040010 156 QFKRFSYAELKKATNSFK--EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQG-EEVFWAEVSTIGKIYHMNLVRMWGFC 232 (464)
Q Consensus 156 ~~~~~~~~el~~~~~~~~--~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~ 232 (464)
..+.|+|.||..||++|. +.||+|+||.||+|.+.++..||||++...... ..+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567799999999999998 489999999999999999999999999876554 67799999999999999999999999
Q ss_pred eeCc-EEeEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 040010 233 TEGM-HRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIAD 309 (464)
Q Consensus 233 ~~~~-~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 309 (464)
.+++ +++||||||+||+|+++|+... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 5999999999999999999765 899999999999999999999999988999999999999999999999999
Q ss_pred ecCccccCCCCCCcceeee-ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH
Q 040010 310 FGLAKLSQRGSNSSQFSRI-RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 310 fgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
||+|+..... ....... .||.+|+|||++..+..|.|+|||||||+|+||+||+++.+..... ....+..|...
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~---~~~~l~~w~~~ 295 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR---GELSLVEWAKP 295 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc---ccccHHHHHHH
Confidence 9999765431 1112222 8999999999999999999999999999999999999988754311 22235566543
Q ss_pred HHHHhhccchhhhhhhcCCccC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLK-GHFNK-NQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
... .+ .+.+++|+++. ..++. +++.++.++|.+|++.+|.+||+|.+|+++|+.+..
T Consensus 296 ~~~---~~---~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLE---EG---KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHH---Cc---chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 333 23 38999999997 66664 789999999999999999999999999999976554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=399.92 Aligned_cols=251 Identities=33% Similarity=0.474 Sum_probs=212.7
Q ss_pred hccccCccCceEEEEEEECCCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCc-EEeEEEEeccC
Q 040010 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-HRLLVYEYVEN 247 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~E~~~~ 247 (464)
+.+.||+|+||+||+|.+.+...||||++...... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34559999999999999977666999999865433 458999999999999999999999999987 79999999999
Q ss_pred CChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCc
Q 040010 248 QSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEW-VIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 248 gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+|.++++. ...+++..++.|+.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 999999987 5789999999999999999999999 66 99999999999999997 99999999998765432 2
Q ss_pred ceeeeccCCCccCccccc--CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 324 QFSRIRGTKGYMAPEWAS--NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
..+...||+.|||||.+. ...|+.|+|||||||+||||+||+.||..... ... .
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------~~~---------------~ 255 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------VQV---------------A 255 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------HHH---------------H
Confidence 234478999999999999 56899999999999999999999999974321 000 2
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..++....+...+......+..++.+||+.||..||++.+++.+|+.+..
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22233334445555577789999999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=387.60 Aligned_cols=261 Identities=27% Similarity=0.390 Sum_probs=223.0
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.++......+.++||+|-||.||.|.+++...||+|.++......+.|.+|+++|++++|+|||+++|+|..++..+|||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45566666788999999999999999988889999999988777889999999999999999999999999998999999
Q ss_pred EeccCCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 243 EYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 243 E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||++|+|.++|.. +..++..+.+.++.|||+||+||++ +++|||||.++|||++++..+||+|||||+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999986 4679999999999999999999999 999999999999999999999999999999544332
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......-...|.|||.+....++.|||||||||+||||+| |+.|+..... .+
T Consensus 358 Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------~e--------------- 412 (468)
T KOG0197|consen 358 Y-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------EE--------------- 412 (468)
T ss_pred e-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------HH---------------
Confidence 2 11223334568999999999999999999999999999999 4555442211 11
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+-+.++...+-..+..++..+.+|+..||+.+|++|||+..+...|+.+...
T Consensus 413 -v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 413 -VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 3344555555566777889999999999999999999999999999887653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=353.53 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=212.7
Q ss_pred ccCHHHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcC--CccchhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 159 RFSYAELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLG--DLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 159 ~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
.++..||+. ...||+|..|+|||+.++ +++.+|+|.+. ......+++.+|+++++..+|||||.++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 356666654 367999999999999985 57889999984 3345568899999999999999999999999888
Q ss_pred c-EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 236 M-HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 236 ~-~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
. ...++||||++|||++++...+.+++....+|+.++++||.|||+. ..||||||||+|||++..|.+||+|||.+.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 5999999999999999998888999999999999999999999964 679999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
.+.+. ...+..||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... ...|+..
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-------~~~~~~L------ 290 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-------YLDIFEL------ 290 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-------CCCHHHH------
Confidence 77653 356788999999999999999999999999999999999999998743111 1112221
Q ss_pred ccchhhhhhhcCCccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNK-NQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+++..- ...+. ...+++..++..||++||.+|||..++++
T Consensus 291 ------l~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 291 ------LCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ------HHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 334444221 12222 36678999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=367.79 Aligned_cols=246 Identities=26% Similarity=0.319 Sum_probs=212.4
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCC----ccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGD----LHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+|...+.||+|||..||.++. ..|+.||+|++.. .....+...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3456667899999999999997 7899999999975 3445567889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|+|++++|..++..+..+++.+++.+..||+.||.|||+ .+|+|||||..|++|+++.++||+|||||..+..+..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence 999999999999988999999999999999999999999 9999999999999999999999999999998875433
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
...+.+|||.|+|||++.....+..+||||+||+||-|++|+.||+.. -+.+..+++.. .
T Consensus 174 -rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------------~vkety~~Ik~------~ 233 (592)
T KOG0575|consen 174 -RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------------TVKETYNKIKL------N 233 (592)
T ss_pred -ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------------hHHHHHHHHHh------c
Confidence 346689999999999999999999999999999999999999999732 12222222221 1
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+. .++........+|+.++|+.||.+|||+++|+.
T Consensus 234 ~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred Cc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 223345566888999999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=384.18 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=218.4
Q ss_pred HHHHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
++......+.++||+|.||.||+|... +.+.||||.++.... ...+|++|++++..++|+|||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455555567789999999999999953 356899999986543 568899999999999999999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------C----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS----------N----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS 301 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~----------~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 301 (464)
+..++|+|||..|+|.++|... . .|+..+.+.||.|||.||.||-+ ..+|||||..+|+|+.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 9999999999999999999621 1 38899999999999999999999 88999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhh
Q 040010 302 EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEA 380 (464)
Q Consensus 302 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 380 (464)
+..+||+||||++.....+.........-..+|||||.+..++||++||||||||+|||++| |+.|++.....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence 99999999999986654333222222334568999999999999999999999999999998 66676643211
Q ss_pred hHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCC
Q 040010 381 ELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESE 454 (464)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~ 454 (464)
++ ++.+-+.++ -+.+.+++.++..|++.||+.+|++||+++||-..|......++
T Consensus 713 -------EV-----------Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -------EV-----------IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------HH-----------HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 01 333444455 46678889999999999999999999999999999998766443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=347.21 Aligned_cols=195 Identities=29% Similarity=0.412 Sum_probs=176.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.++||+|+||+||+|+++ ++..||||.+.... ...+-+..|+++|+.++|+|||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 455667999999999999974 57899999987542 33455789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC------CCeEEeeecCccccCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE------FEPKIADFGLAKLSQRG 319 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfgla~~~~~~ 319 (464)
.+|+|.++|+..+.+++.+...++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+.+...
T Consensus 92 ~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 92 NGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999999999999999999999999999 999999999999999765 45899999999988754
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
. ...+.+|++-|||||+++.+.|+.|+|+||+|++||++++|+.||+.
T Consensus 169 ~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 169 S---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred h---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3 34568899999999999999999999999999999999999999973
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=349.66 Aligned_cols=250 Identities=28% Similarity=0.353 Sum_probs=205.7
Q ss_pred HHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc--------hhHHHHHHHHHhhhccccceeccceeeeeCc
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ--------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM 236 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 236 (464)
.+..+-+.+.||+|+||.|-+|.- ++|+.||||+++.... ......+|+++|++++|||||++.+++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 455566778999999999999995 5789999999974211 1123469999999999999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC---CCeEEeeecCc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE---FEPKIADFGLA 313 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla 313 (464)
..|+||||++||.|.+.+-.+..+....-..++.|++.|+.|||+ ++|+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999998889999999999999999999999 999999999999999765 78999999999
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLP---ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
+..+.. ..+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|..||.....+.. +.
T Consensus 327 K~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------------l~ 391 (475)
T KOG0615|consen 327 KVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------------LK 391 (475)
T ss_pred hccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------------HH
Confidence 988643 3467799999999999997654 33488999999999999999999974322110 11
Q ss_pred HHhhccchhhhhhhcCCcc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRL--KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+ ++...+. .+....+..++...++.++|..||++|||+.|+++
T Consensus 392 e-----------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 E-----------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred H-----------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 1111221 11223456788999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=371.90 Aligned_cols=264 Identities=28% Similarity=0.462 Sum_probs=219.4
Q ss_pred cccCHHHHHHHHhh-----------hccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhc
Q 040010 158 KRFSYAELKKATNS-----------FKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKI 220 (464)
Q Consensus 158 ~~~~~~el~~~~~~-----------~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l 220 (464)
..++|+|--.|-.. +.+.||.|.||.|++|.++- ...||||.|+... ....+|+.|+.+|.+.
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 45777754444443 34579999999999999752 4689999999653 4557899999999999
Q ss_pred cccceeccceeeeeCcEEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE
Q 040010 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 221 ~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll 299 (464)
.||||++|.|+.+.....+||+|||+||+|+.+|..+ +.+++.+...+.++||.||.||-+ .++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 9999999999999999999999999999999999854 579999999999999999999999 889999999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeecc--CCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCcc
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRG--TKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSE 376 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~ 376 (464)
+.+...|++||||++.++++.... ++...| ..+|.|||.+...++|.+|||||||+||||.++ |.+|+ |...+.+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY-WdmSNQd 842 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQD 842 (996)
T ss_pred ccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc-cccchHH
Confidence 999999999999999887665322 222223 458999999999999999999999999999887 66665 3222211
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+...+....+-+.+.+++..+.+|+++|||+|-..||++.+|+.+|.++.
T Consensus 843 ------------------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 ------------------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ------------------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 22223334455667889999999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.61 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=202.3
Q ss_pred HHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC-
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG- 235 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 235 (464)
....+.+.+.||+|+||.||+|.. .++..||||++.... .....+.+|+.++..+ +|+||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 344567788999999999999974 234689999987532 2345688999999999 899999999988754
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------------------------------------------------
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS---------------------------------------------------------- 257 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 257 (464)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4678999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCC
Q 040010 258 ----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333 (464)
Q Consensus 258 ----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 333 (464)
..+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 247888999999999999999999 8999999999999999999999999999986543322222233456788
Q ss_pred ccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCC
Q 040010 334 YMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH 412 (464)
Q Consensus 334 y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 412 (464)
|+|||.+.+..++.++||||||++||||++ |..||...... . ... .....+. .. .
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----~---~~~----~~~~~~~--------~~----~ 297 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----E---EFC----QRLKDGT--------RM----R 297 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----H---HHH----HHHhcCC--------CC----C
Confidence 999999999999999999999999999997 88888632111 0 010 1111111 01 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 413 FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 413 ~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+......+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122334568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.16 Aligned_cols=253 Identities=24% Similarity=0.302 Sum_probs=205.0
Q ss_pred HHhhhccccCccCceEEEEEE-ECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccce-eeeeCcE-EeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWG-FCTEGMH-RLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lv 241 (464)
+.+.+.++||+|.||+|||+. +.+|..+|.|.+.-. .........|+.+|++++|||||++++ -+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456677899999999999998 568999999998732 233456889999999999999999999 4555544 8999
Q ss_pred EEeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 242 YEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECL-EWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 242 ~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
|||+..|+|...|+ .+..+++.+.+++..|++.||..+|...+ ..|.||||||.||+|+.+|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986 34579999999999999999999999552 23999999999999999999999999999988
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
..... -..+.+|||.||+||.+.+.+|+.||||||+||++|||..-+.||... . ...+..++..|
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---------n----~~~L~~KI~qg 243 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---------N----LLSLCKKIEQG 243 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---------c----HHHHHHHHHcC
Confidence 75432 245688999999999999999999999999999999999999999742 1 12233333333
Q ss_pred chhhhhhhcCCccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 397 EEARIEEIVDPRLKGHFN-KNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~-~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+- ..++ ..-...+..|+..|+..||+.||+...++..+.
T Consensus 244 d~------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 DY------------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CC------------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 21 1122 345667888999999999999999544444443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=352.72 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=211.8
Q ss_pred CHHHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcE
Q 040010 161 SYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 161 ~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 237 (464)
.+.||......+.+.||+|.||+||+|.+-+ .||||+++.. ....+.|++||.++++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3445555555667899999999999999855 4999999843 3345779999999999999999999999998887
Q ss_pred EeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 238 RLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.||+.||+|.+|+.+|+-. ..|+..+.+.||.|||+||.|||. ++|||||||+.||+|.+++.+||+||||+..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999999854 579999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCCcceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
..-..........|...|||||+++. .+|+..+||||||+|+|||+||..|+.....+.. -|+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifm------- 604 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFM------- 604 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEE-------
Confidence 44433344455668889999999864 4799999999999999999999999873211110 000
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.|. ..+-+++ .....++..++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 605 -VGr-----G~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 -VGR-----GYLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ecc-----cccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 000 0011111 01234566789999999999999999999999998887654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=348.85 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=216.1
Q ss_pred CccccCHHHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 156 QFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 156 ~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
....++|++|..- +=||+|+.|.||.|++.+ +.||||+++...+ .+++.|++|+|+||+.|.|+|+..
T Consensus 117 e~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~n-etVAVKKV~elkE------TdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISEL-----EWLGSGAQGAVFLGRLHN-ETVAVKKVRELKE------TDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhh-----hhhccCcccceeeeeccC-ceehhHHHhhhhh------hhHHHHHhccCcceeeEeeeecCC
Confidence 3556777777543 349999999999999955 6899998864332 578999999999999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 236 MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
...+||||||+.|-|...|.....+.......|..+||.||.|||. +.|||||||+-||||..+..+||+|||.++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHh
Confidence 9999999999999999999999999999999999999999999999 8899999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.... .....+.||..|||||++.+++.++|+||||||||||||+||..|+....... +
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------------I-- 319 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------------I-- 319 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------------e--
Confidence 6543 33456889999999999999999999999999999999999999987421110 0
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+-.+-...|.-..+..+++-+.-|+.+||+..|.+||++++++..|+=+.
T Consensus 320 -----IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 320 -----IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred -----EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 11222344555677788888999999999999999999999999987543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.41 Aligned_cols=259 Identities=19% Similarity=0.292 Sum_probs=206.2
Q ss_pred ccccCHHHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchh----HHHHHHHHHhhhccccceeccceee
Q 040010 157 FKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE----EVFWAEVSTIGKIYHMNLVRMWGFC 232 (464)
Q Consensus 157 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~ 232 (464)
.+.++++++...+. ..||+|++|.||+|.+ +|+.||||+++...... +.|.+|+.+|++++||||++++|++
T Consensus 12 ~~~i~~~~i~~~~~---~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 12 IKCIESDDIDKYTS---VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ceecCHHHcCCCCC---eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 44566666633211 3699999999999999 67899999997654332 5677999999999999999999998
Q ss_pred ee----CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 233 TE----GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 233 ~~----~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
.+ ....++||||+++|+|.+++.+...++|.....++.+++.||.|||+. .+++||||||+||++++++.+||+
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEc
Confidence 76 357889999999999999998888899999999999999999999972 267899999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---------~~~~ 231 (283)
T PHA02988 166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---------KEIY 231 (283)
T ss_pred ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---------HHHH
Confidence 999998654321 23457889999999876 6899999999999999999999999873210 1111
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
... +........+......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 232 ~~i---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 DLI---------------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHH---------------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111 1111111122234567899999999999999999999999998643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=353.34 Aligned_cols=260 Identities=28% Similarity=0.379 Sum_probs=208.4
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECC--C---cEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTD--E---RAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE 234 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~--~---~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 234 (464)
+|....-.+.++||+|+||.||+|++.. + ..||||..+.. .....+|++|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3344444566899999999999999743 2 23899998842 3455789999999999999999999999999
Q ss_pred CcEEeEEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 235 GMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 235 ~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
...+++|||+|+||+|.++|.... .++..+++.++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999998776 59999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
+........ .....-...|+|||.+....|+.++|||||||++||+++ |..|+..... . ++..+
T Consensus 310 ~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~-------~v~~k 374 (474)
T KOG0194|consen 310 RAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------Y-------EVKAK 374 (474)
T ss_pred cCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------H-------HHHHH
Confidence 765411111 111234568999999999999999999999999999999 7777763211 1 11111
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+ +-...+...+...+..+..++.+||..+|++||||.+|.+.|+.+...
T Consensus 375 I-----------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 375 I-----------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred H-----------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1 111222233445566788888899999999999999999999887653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=372.25 Aligned_cols=259 Identities=29% Similarity=0.403 Sum_probs=209.7
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC--C----cEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCc
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD--E----RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM 236 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~--~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 236 (464)
+......+...||+|.||.||.|...+ + ..||||.++.. .+...+|.+|..+|+.++|||||+++|.|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445555667789999999999999753 3 24999999865 456688999999999999999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 040010 237 HRLLVYEYVENQSLDKHLFSS-------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIAD 309 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 309 (464)
..++++|||++|+|..+|.+. ..|+....+.++.|||+|+.||++ +++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999854 368999999999999999999999 9999999999999999999999999
Q ss_pred ecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHH
Q 040010 310 FGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 310 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
||+|+...............-...|||||.+..+.+|.|+|||||||+|||++| |..|+.... + ...+..+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-n----~~v~~~~--- 917 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-N----FEVLLDV--- 917 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-h----HHHHHHH---
Confidence 999995443322211111223458999999999999999999999999999999 555654221 1 1111001
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.-+.+| +.+..+++.+.+|+.+||+.+|++||++..+++.+..+..
T Consensus 918 ---------------~~ggRL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 918 ---------------LEGGRL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---------------HhCCcc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 112233 3466788899999999999999999999999999887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=326.87 Aligned_cols=241 Identities=25% Similarity=0.251 Sum_probs=200.6
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
....+.+.||+|+||.||.++.. .++.+|+|.+++.. ...+..++|..+|.+++||.||+++-.|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34466789999999999999964 57899999997542 23456789999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+.||.|..+|++...+++..+..++..|+.||.|||+ .+||||||||+|||||++|+++|+||||++..-...
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-- 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-- 179 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--
Confidence 999999999999999999999999999999999999999 999999999999999999999999999998654332
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
..+.+.+||+.|||||++.+..|+..+|+||+|+++|||++|..||.... ...+ .+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~---------~~~~----~~~I--------- 237 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED---------VKKM----YDKI--------- 237 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc---------HHHH----HHHH---------
Confidence 23456899999999999999999999999999999999999999997421 1111 1111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 438 (464)
+-..+ ...+.-...+..+++...++.||++|..
T Consensus 238 --~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 238 --LKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred --hcCcC-CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11111 1112224456788888999999999963
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=345.52 Aligned_cols=257 Identities=30% Similarity=0.382 Sum_probs=201.4
Q ss_pred HHHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.+.||+|+||.||+|+. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|..+
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3445567788999999999999974 235689999997432 2345688999999999 899999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------------------------------------------------
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS---------------------------------------------------------- 257 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 257 (464)
...++||||+++|+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999988532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 258 -----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 258 -----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
..++|.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 147889999999999999999999 899999999999999999999999999998664432
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||...... . .+... +..+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----~---~~~~~----~~~~--- 333 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----S---KFYKM----IKEG--- 333 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----H---HHHHH----HHhC---
Confidence 2221222345678999999999999999999999999999998 77776532110 0 11111 1100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.....+.....++.+|+.+||+.||++||||.+|+++|+.
T Consensus 334 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 ---------YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---------ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0001111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=376.93 Aligned_cols=268 Identities=26% Similarity=0.499 Sum_probs=213.3
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
+++.++... ....+.||+|+||.||+|+. .++..||||++....... ..|++.+++++|||||+++|+|.+....
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 455555443 33446899999999999997 578899999987543322 3568899999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++|+|.+++. .++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.......
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999999995 38999999999999999999997666899999999999999999998875 665543221
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.|++.... .......|.......
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~------ 898 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG----VHGSIVEWARYCYSD------ 898 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC----CCCcHHHHHHHhcCc------
Confidence 1223578999999999999999999999999999999999999853221 122333443332211
Q ss_pred hhhhhhcCCccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 399 ARIEEIVDPRLKG--HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 399 ~~~~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.....++|+.+.. ..+.++..++.+++.+||+.||++||||.+|+++|+++..
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1145566776643 3456777889999999999999999999999999998765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=329.09 Aligned_cols=254 Identities=27% Similarity=0.330 Sum_probs=202.6
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCc--EEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM--HRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~E~~ 245 (464)
....+.||+|+||+||++...+ |...|||...... ...+.+.+|+.+|.+++|||||+.+|...... ..++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4455789999999999999754 8899999887542 12456889999999999999999999754443 689999999
Q ss_pred cCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCccccCCC-CCC
Q 040010 246 ENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRG-SNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~-~~~ 322 (464)
++|||.+++.+.+ .|+......+..||++||+|||+ ++||||||||+|||++. ++.+||+|||+++..... ...
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999998765 79999999999999999999999 99999999999999999 799999999999876641 111
Q ss_pred cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......||+.|||||++..+ ....++|||||||++.||+||+.|+... .....+...
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----------~~~~~~~~~---------- 234 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----------FEEAEALLL---------- 234 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----------cchHHHHHH----------
Confidence 224458899999999999853 3445999999999999999999987621 011111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+........++........+++..|++.||+.|||+.++++..--.
T Consensus 235 --ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 235 --IGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred --HhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1111112244555667889999999999999999999999865443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.27 Aligned_cols=270 Identities=26% Similarity=0.373 Sum_probs=203.5
Q ss_pred hhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhh--hccccceeccceeeeeCc----EEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIG--KIYHMNLVRMWGFCTEGM----HRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~~~~----~~~lv~E~ 244 (464)
++.+.||+|.||.||||.+.+ +.||||++.... .+.|.+|-++.+ .++|+||++++++-..+. ..+||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 456789999999999999955 899999997433 344556555544 568999999999876655 88999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC------LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
.++|||.++| ..+.++|....+|+..+++||+|||++. +++|+|||||++|||+..|++..|+|||||..+..
T Consensus 290 h~kGsL~dyL-~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 290 HPKGSLCDYL-KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred ccCCcHHHHH-HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999999999 5678999999999999999999999865 45799999999999999999999999999998876
Q ss_pred CCCCcceeeeccCCCccCcccccCC-CCC-----ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH------HH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNL-PIT-----SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG------FI 386 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~ 386 (464)
..........+||.+|||||++.+. ++. .+.||||+|.|||||++....++. ......+..+.. -+
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~--~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP--GPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC--CCCCcccCchhHHhcCCCCH
Confidence 6665556668999999999998764 222 378999999999999998765531 011111111111 01
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFN-KNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~ 453 (464)
.++...+ +.+-..|.+.+.+- ..-+..+.+.+..||..||+.|.|+.=|.+++.++.-.+
T Consensus 447 e~mq~~V-------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELV-------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHH-------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111111 11112233322221 134667889999999999999999999999888776543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.53 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=208.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+...++.+.+.||+|++|.||+|...+++.||+|.++......+++.+|++++++++|+|++++++++......+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 44556778899999999999999988888999999986666667899999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997543 78999999999999999999999 89999999999999999999999999999876532211
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+.... .. ... ..+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~----~~~----~~~-------- 217 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----NA----EVL----QQV-------- 217 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----HH----HHH----HHH--------
Confidence 1111223457999999999899999999999999999999 887775211 00 000 011
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
+.......+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 ----DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111222345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=333.34 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=199.0
Q ss_pred HHHhhhccccCccCceEEEEEEECC-----------------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceec
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD-----------------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVR 227 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~ 227 (464)
...+.+.++||+|+||.||++.+.+ +..||+|.+.... .....|.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456677899999999999998532 3369999987532 23467899999999999999999
Q ss_pred cceeeeeCcEEeEEEEeccCCChHHhhhcC-------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 040010 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSS-------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVI 288 (464)
Q Consensus 228 l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 288 (464)
+++++.+....++||||+++|+|.+++... ..++|...+.++.||+.||.|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 999999999999999999999999988532 247889999999999999999999 8899
Q ss_pred ecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCC--C
Q 040010 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI--R 366 (464)
Q Consensus 289 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~--~ 366 (464)
||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+++. .
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999998654332222222344578899999998889999999999999999999754 4
Q ss_pred CCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 367 LSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 367 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
|+.... . .............. .. ......+...+..+.+++.+||+.||++||||.+|.+.|
T Consensus 241 p~~~~~--~----~~~~~~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 241 PYGELT--D----EQVIENAGEFFRDQ-------GR-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCcCC--H----HHHHHHHHHHhhhc-------cc-----cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 443211 0 11111111110000 00 000011122345789999999999999999999999998
Q ss_pred hC
Q 040010 447 LG 448 (464)
Q Consensus 447 ~~ 448 (464)
++
T Consensus 303 ~~ 304 (304)
T cd05096 303 TE 304 (304)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.91 Aligned_cols=247 Identities=31% Similarity=0.484 Sum_probs=192.8
Q ss_pred hccccCccCceEEEEEEEC-----CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 172 FKEELGKGGSGAVYKGVLT-----DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.||.|.||.||+|.+. .+..|+||.++... ...+.|.+|++.+++++|+||++++|+|......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999986 25689999997533 2357899999999999999999999999988889999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.++|... ..+++..+..|+.||+.||+|||+ .+++|++|+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 689999999999999999999999 88999999999999999999999999999876332222
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
...........|+|||.+.+..++.++||||||+++|||++ |+.|+.... ...+...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---------~~~~~~~------------- 217 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---------NEEIIEK------------- 217 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---------HHHHHHH-------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---------ccccccc-------------
Confidence 22233446778999999988889999999999999999999 567764220 1111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
+.+.. ....+......+.+++..||+.||++||||.++++.|
T Consensus 218 --~~~~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 --LKQGQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --HHTTE-ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ccccc-cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111 1112223455688999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.45 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=203.4
Q ss_pred HHHHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
....+.+.+.||+|+||.||+|.+. .+..||+|.++... .....+.+|+..+++++|+|+++++|++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3455677889999999999999863 35689999988543 23456889999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 579999999999999999999999 8999999999999999999999999998765432
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ..... .+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---------~~~~~----~~~--- 222 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---------QDVIK----AVE--- 222 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---------HHHHH----HHH---
Confidence 211 11122345678999999999999999999999999999875 8888753210 01111 111
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+. .....+...+..+.+++..||+.+|++||++.++.+.|.++
T Consensus 223 --------~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 --------DG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 10 01112233456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=342.24 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=201.6
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.+.||+|+||.||+++.. ++..||+|+++.... ....+.+|+++++.+ +|+||++++++|..+
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34455677889999999999998842 235799999975432 335688999999999 899999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------------------------------------------------
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS---------------------------------------------------------- 257 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 257 (464)
...++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 258 ------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 258 ------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
..+++...++++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 147888999999999999999999 89999999999999999999999999999765433221112
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. ... .
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----~~---~~~----------------~ 327 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----SK---FYK----------------M 327 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----HH---HHH----------------H
Confidence 22345678999999998899999999999999999997 99888632110 00 000 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+........+......+.+++.+||+.||++|||+.+|+++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000011111111235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=311.62 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=201.7
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
..++|+|+||+|||++.+ +|+.||||++..+..+ .+..++|+++|++++|+|+|.++.+|......+||+||++..
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 457999999999999975 4899999999765443 356789999999999999999999999999999999999876
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
-|.++=...+.++.....+++.|++.|+.|+|+ ++++||||||+|||++.++.+||+|||+|+.+... ....+..
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTDY 161 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTDY 161 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhhh
Confidence 666655455679999999999999999999999 89999999999999999999999999999987642 2335678
Q ss_pred ccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH---HHhhccchhhhhhh
Q 040010 329 RGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK---EKILCGEEARIEEI 404 (464)
Q Consensus 329 ~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 404 (464)
+.|..|.|||.+.+ .+|...+||||+||++.||++|...|....+- ++-..+...+..+. .++. ...+.+..+
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF-~~N~~F~Gv 238 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIF-SSNPFFHGV 238 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHh-ccCCceeee
Confidence 89999999998877 78999999999999999999999887643211 11111111100000 0000 011111112
Q ss_pred cCCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.-|.....-+ ......+++++..|++.||.+|++-++++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2222211111 234567899999999999999999998763
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=326.34 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=204.0
Q ss_pred HhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.+.||+|+||.||+|.... ...||+|.+.... .....+.+|++++++++|+|++++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45667889999999999998643 2579999987443 234568899999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC
Q 040010 241 VYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
+|||+++++|.+++... ..+++...+.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999998643 458899999999999999999999 89999999999999999999
Q ss_pred eEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHH
Q 040010 305 PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELT 383 (464)
Q Consensus 305 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 383 (464)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------~--- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------Q--- 233 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------H---
Confidence 99999999986543332222334456788999999988899999999999999999998 9888863211 0
Q ss_pred HHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.. ..+ ........+...+..+.+|+.+||+.||.+||++.+|++.|+++
T Consensus 234 ~~~----~~i------------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVI----EMI------------RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHH----HHH------------HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 111 11111122334567799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.54 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=202.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||++.+.++..+|+|.+.......+.+.+|++++++++|+|++++++++......++||||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 45667889999999999999988889999998766556678899999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++........ ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 999998753 468999999999999999999999 89999999999999999999999999998765332211 1122
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...... +..+. ....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---------~~~~~~----i~~~~-----~~~~ 222 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---------YEVVEM----ISRGF-----RLYR 222 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH----HHCCC-----CCCC
Confidence 335568999999998899999999999999999999 8888753210 011111 11110 0111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+ ......+.+++.+||+.+|++||+|.++++.|.
T Consensus 223 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 P-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 112356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.74 Aligned_cols=242 Identities=25% Similarity=0.374 Sum_probs=204.4
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCccchh-HHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
++||+|+.|.||.+.- .+++.||||++....+.. +-+.+|+.+|+..+|+|||+++..+..++++|+|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 5799999999999984 567899999998766655 45789999999999999999999998889999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccC
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt 331 (464)
+.+ ....+++.+...|+.+++.||+|||. ++|+|||||.+|||++.++.+||+|||++........ ......||
T Consensus 359 DvV-t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGT 432 (550)
T KOG0578|consen 359 DVV-TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGT 432 (550)
T ss_pred hhh-hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCC
Confidence 988 44569999999999999999999999 9999999999999999999999999999987665443 35678899
Q ss_pred CCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCC
Q 040010 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKG 411 (464)
Q Consensus 332 ~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 411 (464)
+.|||||++....|++|+||||||++++||+.|..||.... ....-|+ +..---+.+
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyL--------------Ia~ng~P~l-- 489 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYL--------------IATNGTPKL-- 489 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHH--------------HhhcCCCCc--
Confidence 99999999999999999999999999999999999986311 1111111 111111222
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 412 HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 412 ~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+......+.+++.+||+.|+++||++.|+++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 234456678999999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.02 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=206.1
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.++||+|+||.||+|...++..||+|.+.......+.+..|+.++++++|+|++++++.+..+...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 34456778999999999999998888899999987655566789999999999999999999999999999999999999
Q ss_pred CCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 9999999964 3568999999999999999999999 89999999999999999999999999999876433211 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+.... .. ..... +. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~---~~~~~----~~--------~ 219 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS------NS---DVMSA----LQ--------R 219 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC------HH---HHHHH----HH--------c
Confidence 222345678999999988889999999999999999998 888875211 00 11111 10 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.... +........+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 220 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 GYRM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0000 11112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=319.51 Aligned_cols=258 Identities=24% Similarity=0.284 Sum_probs=204.5
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..|.+.++||.|..++||+|.. +.+..||||++.-. ....+.+++|+..|+.++||||++.+..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4477788999999999999994 56799999999733 33457899999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|.+||+.+++... ..+++.....|.+++++||.|||+ ++.||||||+.||||+++|.+||+|||.+..+-.....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999753 469999999999999999999999 99999999999999999999999999988755443322
Q ss_pred cc--eeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 323 SQ--FSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 323 ~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. +....||+.|||||+++. ..|+.|+||||||++..||.+|..||...... ..+...+. +.+
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------------kvLl~tLq-n~p 249 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------------KVLLLTLQ-NDP 249 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------------HHHHHHhc-CCC
Confidence 21 256789999999999543 47999999999999999999999999743211 11111111 111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+... -..+..+-.......+.+++..||+.||.+|||++++++
T Consensus 250 p~~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111 001111112223447889999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.27 Aligned_cols=243 Identities=28% Similarity=0.370 Sum_probs=208.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchh---HHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+ +.+.+|+++++.++|||||.++.+|+...+.|+|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 455678999999999999975 46889999987655444 44788999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
.+ +|..+|.....+++.....|+.++..||.|||+ .+|.|||+||.||||+.++.+|++|||+|+.+..+ ....
T Consensus 84 ~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vl 157 (808)
T KOG0597|consen 84 VG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVL 157 (808)
T ss_pred hh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--ceee
Confidence 86 999999999999999999999999999999999 99999999999999999999999999999977653 3345
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
+.+.|||.|||||.+.+++|+..+|.||+||+|||+.+|+.||... .+... .+.+. -
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------si~~L----v~~I~----------~ 214 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---------SITQL----VKSIL----------K 214 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------HHHHH----HHHHh----------c
Confidence 7789999999999999999999999999999999999999999721 11111 11111 1
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
|+. .++.+....+..++...++.||.+|.|..+++.
T Consensus 215 d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222 234466778999999999999999999998864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=320.07 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=204.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
..+.+.+.||+|+||.||+|... .++.||+|.+........++.+|++++++++|+|++++++++..+...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 34566788999999999999975 47899999988666566788999999999999999999999999999999999999
Q ss_pred CCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~- 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA- 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec-
Confidence 99999998653 368999999999999999999999 899999999999999999999999999998664432111
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...... ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---------~~~~~~----~~~--------- 219 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYE----LLE--------- 219 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHH----HHH---------
Confidence 112234568999999999999999999999999999998 888875321 011111 110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.......+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 220 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 ---KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111112223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=338.15 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=203.2
Q ss_pred HHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccceeccceeeeeCc
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGM 236 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 236 (464)
....+.+.+.||+|+||.||+|+... +..||||+++... ...+.+.+|+++++++. ||||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34456677899999999999998521 3479999997432 23456889999999996 999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC-----------------------------------------------------------
Q 040010 237 HRLLVYEYVENQSLDKHLFSS----------------------------------------------------------- 257 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 257 (464)
..++||||+++|+|.++|...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999887532
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc
Q 040010 258 -------------------------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300 (464)
Q Consensus 258 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 300 (464)
..+++..+..++.|++.||+|||+ .+|+|+||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 247788889999999999999999 8999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchh
Q 040010 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQE 379 (464)
Q Consensus 301 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 379 (464)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 999999999999986543322222233456788999999998899999999999999999997 888876321110
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. . ...... ......+......+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 348 -~---~----~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -T---F----YNKIKS------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -H---H----HHHHhc------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0 0 011110 0011122234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=321.67 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=204.0
Q ss_pred HHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 237 (464)
...++.+.+.||+|+||.||+|...+ +..||||.++.... ..+.+.+|++++++++|+|++++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34567788899999999999998643 47899999975433 35679999999999999999999999999999
Q ss_pred EeEEEEeccCCChHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC
Q 040010 238 RLLVYEYVENQSLDKHLFSS--------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF 303 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 303 (464)
.++||||+++++|.+++... ..+++.....++.|++.|+.|||+ .+++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence 99999999999999999643 247899999999999999999999 8999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhH
Q 040010 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 304 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 382 (464)
.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------- 230 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------- 230 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 999999999975433221111223345778999999999999999999999999999998 9888753211
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
...... ...+. . ...+......+.+++.+||+.||++||++.||++.|++
T Consensus 231 ~~~~~~----~~~~~-----------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 EEVIEC----ITQGR-----------L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHH----HHcCC-----------c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 011111 11110 0 11122334568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.50 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=203.3
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.-.+.||+|.||.||+|+. .+|+.||||+++..... .....+|++.|+.++|+||+.+++.|...+..-||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 44457899999999999995 56899999999855433 355789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ .+|+..|.++. .++......++.++.+|++|+|+ +.|+||||||.|+|++++|.+||+|||+++.........
T Consensus 84 ~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 84 P-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred c-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 7 49999998654 79999999999999999999999 999999999999999999999999999999887655433
Q ss_pred eeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh----
Q 040010 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA---- 399 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 399 (464)
...+-|..|.|||.+.| ..|+..+|+||.||++.||+-|...|....+ - +-+..+++.+....+.
T Consensus 159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----i----dQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----I----DQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----H----HHHHHHHHHcCCCCcccCcc
Confidence 33378999999998765 4799999999999999999998776653211 0 1111111111111100
Q ss_pred --------hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 400 --------RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 400 --------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.+...-.+.+.. .-..+....++|+..++..||.+|+|++|++++=
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 011111222222 2234556679999999999999999999998763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=328.63 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=201.3
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCc----EEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
....+...+.||+|+||.||+|++. ++. .||+|.++... ...+++..|+.+++.++|+||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3445566678999999999999863 333 48999987432 3456788999999999999999999999765 56
Q ss_pred eEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 239 LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
++++||+++|+|.+++... ..+++...+.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccccc
Confidence 7999999999999999764 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .. .+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~---~~~~-~~~----- 225 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------AS---EISS-ILE----- 225 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HH---HHHH-HHh-----
Confidence 4333222223334678999999999999999999999999999998 888875311 00 1110 000
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.......+......+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 226 ----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 226 ----------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----------CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000001111233467899999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=330.65 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=202.5
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeee-Cc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE-GM 236 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~ 236 (464)
...+.+.+.||+|+||.||+|... .++.||+|+++... ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 345777889999999999999742 24689999987532 2335677899999999 89999999998754 46
Q ss_pred EEeEEEEeccCCChHHhhhcC-----------------------------------------------------------
Q 040010 237 HRLLVYEYVENQSLDKHLFSS----------------------------------------------------------- 257 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~----------------------------------------------------------- 257 (464)
..++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999988531
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCcc
Q 040010 258 --NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335 (464)
Q Consensus 258 --~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 335 (464)
..++|..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 268999999999999999999999 899999999999999999999999999998764433322233455677899
Q ss_pred CcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCC
Q 040010 336 APEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFN 414 (464)
Q Consensus 336 aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 414 (464)
|||++.+..++.++|||||||++|||++ |..||....... . +. ..+..+ .....+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-----~---~~----~~~~~~------------~~~~~~ 298 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----E---FC----RRLKEG------------TRMRAP 298 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-----H---HH----HHHhcc------------CCCCCC
Confidence 9999999999999999999999999998 888875321110 0 00 011000 011112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 415 KNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 415 ~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
......+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2334578999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.54 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=202.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++||||+++++++.+....+++|||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 45677899999999999999877778999998865556678999999999999999999999999888899999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++........ ....
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVG 160 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCC
Confidence 999999753 478999999999999999999999 89999999999999999999999999998765432211 1112
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+..... . .... ....+.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~---~~~~----~~~~~~--------- 218 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------S---ETVE----KVSQGL--------- 218 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------H---HHHH----HHhcCC---------
Confidence 335678999999988889999999999999999999 8888753210 0 1111 111000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
....+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 ---RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.06 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=204.2
Q ss_pred HHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc-----c-chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL-----H-QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~-----~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.|+.|.. .++..||+|.+... . ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34566778999999999999985 46799999976543 1 23455678999999998 99999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQ 317 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~ 317 (464)
++||||+.+|.|.+++.+.+++.+.....++.|++.|++|+|+ .+|+||||||+|||+|.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999998899999999999999999999999 999999999999999999 999999999999874
Q ss_pred CCCCCcceeeeccCCCccCcccccCCC-CC-ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLP-IT-SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...+...+..
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------------~~~l~~ki~~ 237 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------------VPNLYRKIRK 237 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------------HHHHHHHHhc
Confidence 1223356788999999999999977 86 78999999999999999999998411 0111111111
Q ss_pred cchhhhhhhcCCccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQ-AATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~-~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
+ .. .++... ...+..++.+|++.||.+|+|+.+|+
T Consensus 238 ~-----------~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 238 G-----------EF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C-----------Cc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 11 111122 56788999999999999999999998
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.82 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=200.9
Q ss_pred HHhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
....+.+.||+|+||.||+|.. .++..+|+|.+.... .....+.+|+++++.++|+|++++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4456778999999999999985 245789999997433 233578899999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC
Q 040010 241 VYEYVENQSLDKHLFSS-----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF 303 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 303 (464)
||||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998521 247899999999999999999999 8999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhH
Q 040010 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 304 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 382 (464)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~------~~-- 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS------NQ-- 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HH--
Confidence 999999999986544332222233445678999999988889999999999999999998 877775311 00
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.. .+.++.......+......+.+++.+||+.||++||++.+|.++|.+
T Consensus 234 -~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -EV----------------IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HH----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 11111111111222334568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=327.78 Aligned_cols=248 Identities=24% Similarity=0.276 Sum_probs=206.8
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.|.+.||.|+|++|++++. ..++.+|||++.... ...+-...|-++|.+| .||.|++|+--|.+...+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 356888999999999999995 458899999997542 2223356688889999 8999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||++||.|.++|.+-+.|+..-...++.+|+.||+|||+ .+||||||||+|||||+|+++||+|||.|+.+......
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999999999999999999999999999999999 99999999999999999999999999999987543222
Q ss_pred -----------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 323 -----------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 323 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
......+||..|.+||++.....+..+|+|+|||+||.|+.|+.||.... +...
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N------eyli--------- 295 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN------EYLI--------- 295 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc------HHHH---------
Confidence 11245889999999999999999999999999999999999999997432 1111
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
++.+++-.. .++....+.+.+|+...|..||.+|+|..+|-+.
T Consensus 296 ---------FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ---------FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222222221 2333344678888889999999999999988764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=316.56 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=203.3
Q ss_pred HHhhhccccCccCceEEEEEEECC----CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|.+.. ...||||.++.... ....|.+|+.++++++|+|++++++++..+...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 345677899999999999999742 45899999875432 345688999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999754 478999999999999999999999 899999999999999999999999999998775322
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .. .... ...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------~~---~~~~----~~~----- 222 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS------NQ---DVIK----AVE----- 222 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC------HH---HHHH----HHH-----
Confidence 2211222345678999999998899999999999999999998 888874211 00 1111 110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+. .....+......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 223 ------~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 ------DG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00011223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.03 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=206.8
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc--hhHHHHHHHHHhhhcc-ccceeccceeeeeCc-EEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGM-HRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lv~ 242 (464)
.+|...++||.|.||.||+|+- .++..||||+++..-. .+-.-++|++.|++++ |||||++...+.+.. .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4577788999999999999995 5688999999986433 2333578999999998 999999999998877 999999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+ .+|++++..+ ..++......|+.||.+||+|+|+ +|+.|||+||+|||+..+..+||+|||||+.....
T Consensus 90 E~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred Hhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC--
Confidence 9995 6999999865 479999999999999999999999 99999999999999999999999999999977654
Q ss_pred CcceeeeccCCCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhh-------hHHHHHHHHHHHh
Q 040010 322 SSQFSRIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA-------ELTGFIREVKEKI 393 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 393 (464)
...+..+.|+.|.|||.+ ....|+.+.|+|++||+++|+.+-+..|....+-+.-... ....|... .++
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg--~~L 240 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG--YNL 240 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH--HHH
Confidence 346778899999999965 5678999999999999999999999988754322110000 00001000 000
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.....-++.....-.+...++. +..+.++++.+|+.-||.+|||+.+.++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000000111222222222333 67889999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=323.84 Aligned_cols=242 Identities=26% Similarity=0.263 Sum_probs=199.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456688999999999999975 57899999986432 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----- 154 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----- 154 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----
Confidence 9999999999888889999999999999999999999 89999999999999999999999999999865432
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . .... ..+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~---~~~~----~~i----------- 210 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN------P---FGIY----EKI----------- 210 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------H---HHHH----HHH-----------
Confidence 223568999999999999999999999999999999999999986321 0 0111 111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~~ 445 (464)
....+ .++......+.+++.+||+.||.+||+ +.++++.
T Consensus 211 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 211 LAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11111 112222456889999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=313.09 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=195.8
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
+.||+|+||.||+|... +++.+|+|..... ......+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999974 6889999987643 23346789999999999999999999999999999999999999999
Q ss_pred HHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeec
Q 040010 251 DKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329 (464)
Q Consensus 251 ~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 329 (464)
.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999754 468999999999999999999999 899999999999999999999999999987544321111111122
Q ss_pred cCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 330 GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 330 gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.+..|+|||.+.+..++.++||||||+++|||++ |..|+..... . . ....+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------~---~----------------~~~~~~~~ 212 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------Q---Q----------------TREAIEQG 212 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------H---H----------------HHHHHHcC
Confidence 3457999999998899999999999999999998 7777642110 0 0 00111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.....+......+.+++.+|++.+|++|||+.+|.++|.
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111222233557889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.07 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=207.1
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
...+.+.+.||.|+||.||+|...++..+|+|.+..... ....+..|+.+++.++|+|++++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 345677789999999999999998899999999986544 4567889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999753 468999999999999999999999 88999999999999999999999999999765432211
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.....++..|+|||.+....++.++||||||+++|+|++ |+.|+.... . .......
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------~---~~~~~~~------------- 217 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------N---HEVYDQI------------- 217 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------H---HHHHHHH-------------
Confidence 123345678999999988899999999999999999998 777875321 0 0111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. .......+....+.+.+++.+||+.||++|||+.++++.|+++
T Consensus 218 --~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 --T-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --H-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 1111122234456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.78 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=197.1
Q ss_pred ccCccCceEEEEEEE---CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 175 ELGKGGSGAVYKGVL---TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+||+|+||.||+|.+ .++..+|+|+++... ...+++..|+.+++.++|+|++++++++. +...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999975 356889999987432 23467889999999999999999999886 45678999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc-eee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ-FSR 327 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 327 (464)
+|.+++.....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999877789999999999999999999999 8999999999999999999999999999987654322111 122
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++..|+|||.+....++.++||||||+++|||++ |+.||.... .. .+... + .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~---~~~~~----i------------~ 212 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK------GN---EVTQM----I------------E 212 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HH---HHHHH----H------------H
Confidence 334578999999988889999999999999999998 888886321 11 11111 1 1
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.......+......+.+++.+||+.||++||++.+|++.|++.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111122223446688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.30 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=201.4
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
...+.+.||+|+||.||+|...++..+|+|.+.........+.+|++++++++|+|++++++++......++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 35677889999999999999887778999998765555667889999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........ ....
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 160 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG 160 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence 999999753 478999999999999999999999 88999999999999999999999999998765432111 1112
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... . ... ... .....
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~----~~~----~~~--------~~~~~ 219 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----S----EVV----ESV--------SAGYR 219 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----H----HHH----HHH--------HcCCc
Confidence 224457999999998899999999999999999999 6777753210 0 000 111 11111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
. ..+......+.+++.+||+.+|++||||.++++.|.
T Consensus 220 ~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 L----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 112224557899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.44 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=198.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCc----EEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|.+. ++. .+++|.+.... ....++..|+..++++.|+||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 345678999999999999973 333 47888876432 223567788889999999999999998864 5578899
Q ss_pred EeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+++|+|.+++.. ...+++.....|+.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999975 4579999999999999999999999 8899999999999999999999999999986544332
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
........++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ....... +..+.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~-------~~~~~--- 228 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR------PHEVPDL-------LEKGE--- 228 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH-------HHCCC---
Confidence 222334557788999999998899999999999999999998 888875321 0111111 11111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
....+. .....+.+++.+||+.||.+|||+.++++.|..+..+
T Consensus 229 --~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 --RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 011111 1234578889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.47 Aligned_cols=247 Identities=25% Similarity=0.276 Sum_probs=198.1
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+...+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++.+++|+|++++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34557899999999999996 568999999886432 2334578899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999888643 468999999999999999999999 899999999999999999999999999998654322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .... ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~----~~~~---------- 216 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREE----VDRR---------- 216 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHH----HHHH----------
Confidence 1234568999999999999999999999999999999999999987432110 0000 0000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
+.... ..++......+.+|+.+||+.||.+||+ ++++++
T Consensus 217 -~~~~~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 217 -VKEDQ--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -hhccc--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000 1122233456889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=318.98 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=201.7
Q ss_pred HHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
.++.+.++||+|+||.||+|...+ +..||+|+++.... ..+.+..|+.++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 456677899999999999998643 47899999975433 2356889999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC
Q 040010 240 LVYEYVENQSLDKHLFS----------------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF 303 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 303 (464)
+++||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999999852 1248889999999999999999999 8999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhH
Q 040010 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 304 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 382 (464)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---------~ 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---------N 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---------H
Confidence 999999999886544332222233456789999999988889999999999999999998 666664210 0
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
..+... +.+... ...+.+.+..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 233 ~~~~~~---------------i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEM---------------IRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH---------------HHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 111111 11223445668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.31 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=199.1
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.||+|... .+..||+|++.... ....++.+|+.+++.++|+|++++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 445677789999999999999853 24679999886432 2345688999999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 239 LLVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998642 246889999999999999999999 899999999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+.... . .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~------~---~~~~~ 232 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------N---EQVLR 232 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------H---HHHHH
Confidence 9999876543322111122345778999999998899999999999999999999 567765221 0 01111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
. . ..... ...+......+.+++.+||+.||++|||+.++++.|++
T Consensus 233 ~----~-----------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 F----V-----------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H----H-----------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 0 00000 01122334568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.89 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=214.5
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.|+.+....|.++||+|-||.|..+...++..||||+++.... ...+|.+|+++|.+++|||||+++|+|..++..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 4677777788899999999999999998889999999986543 34789999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 241 VYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++|||++|+|.+++.... .+.-....+|+.|||.||+||.+ -++|||||.++|+|+|+++++||+|||+++-+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999998663 33445567899999999999999 8899999999999999999999999999986655
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK--GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
++......+..-..+|||+|.+..+++|.++|||+||++|||+++ ..+|+.....+ +.+..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---------~vven-------- 752 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---------QVVEN-------- 752 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---------HHHHh--------
Confidence 544333344555679999999999999999999999999999764 56676532211 11111
Q ss_pred chhhhhhhcCCcc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 397 EEARIEEIVDPRL---KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 397 ~~~~~~~~~d~~l---~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
..++++..- ....+.-++..+.++++.||..+.++|||++++...|...
T Consensus 753 ----~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 753 ----AGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----hhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222332221 1233556778899999999999999999999999888754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.65 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=203.7
Q ss_pred HhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++.+++++|+|++++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 3556678999999999999842 345789999875443 346788999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 242 YEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 9999999999998643 248999999999999999999999 899999999999999999999
Q ss_pred EEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHH
Q 040010 306 KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 384 (464)
+|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.|+..... . .
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~---~ 233 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------T---E 233 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------H---H
Confidence 9999999976544322222233456788999999999999999999999999999999 8888753211 0 1
Q ss_pred HHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
... ....+ .. ...+...+..+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus 234 ~~~----~~~~~-----------~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIE----CITQG-----------RV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHH----HHhCC-----------CC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111 11111 00 01112234568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=313.17 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=206.9
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
++...++.+.++||+|+||.||+|...+++.||+|.+.........+.+|+.++++++|+|++++++++. ....+++||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4556778889999999999999999988999999999876666678999999999999999999999875 456899999
Q ss_pred eccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 244 YVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998643 468999999999999999999999 8899999999999999999999999999976553221
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... +.
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~----~~------ 217 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---------PEVIQN----LE------ 217 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHH----HH------
Confidence 1 1123345678999999988889999999999999999999 8888753210 011111 00
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.......+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 218 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 ------RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001111122234569999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.65 Aligned_cols=236 Identities=25% Similarity=0.275 Sum_probs=192.7
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||+|+||.||++... +++.||+|.+... ......+..|++++++++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 4788999998642 23345678899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 9999888889999999999999999999999 899999999999999999999999999997543222 12344679
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccC
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 410 (464)
|+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..... ... .....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---------~~~~~----~~~-----------~~~~~- 210 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---------VNEMY----RKI-----------LQEPL- 210 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---------HHHHH----HHH-----------HcCCC-
Confidence 999999999999999999999999999999999999986321 11111 111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 040010 411 GHFNKNQAATLFRIGISCVDEDRNKRPTMDSV 442 (464)
Q Consensus 411 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V 442 (464)
.++......+.+++.+||+.||.+||++..+
T Consensus 211 -~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 211 -RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred -CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 1222334567899999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.06 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=203.6
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
+..+.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|++++++++|+|++++++++..+...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 334566788999999999999852 24568999887543 34567899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCC-------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeE
Q 040010 240 LVYEYVENQSLDKHLFSSN-------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 306 (464)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986332 48999999999999999999999 8999999999999999999999
Q ss_pred EeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHH
Q 040010 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 307 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 385 (464)
|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---------~~~ 231 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------NEV 231 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHH
Confidence 999999986543322111223345778999999998899999999999999999999 7877753211 011
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
. .....+. .... +......+.+++.+||+.||.+|||+.+|.+.|+.+...
T Consensus 232 ~----~~i~~~~--------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 I----ECITQGR--------VLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H----HHHHcCC--------cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111111 0011 112234689999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=312.35 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=203.5
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.++||+|+||.||++...++..+|+|.++......+.+.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 34567788999999999999998888899999998765566779999999999999999999998854 56889999999
Q ss_pred CCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++... ..+++..+..++.+++.||+|||+ .+++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-
Confidence 99999999753 368999999999999999999999 889999999999999999999999999998654332111
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.... . .+.... +
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~---~~~~~~----~---------- 216 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------N---REVLEQ----V---------- 216 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------H---HHHHHH----H----------
Confidence 122335668999999988889999999999999999999 777775211 0 011111 1
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
........+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 217 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 --ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111112223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=318.60 Aligned_cols=261 Identities=25% Similarity=0.305 Sum_probs=200.0
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 242 (464)
.+.-.++||+|.||.|||++. .+|+.||+|+++..... ..-..+|+.+|++|+||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 344457899999999999995 57899999999754422 24457899999999999999999988776 7899999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+. +|.-++.+. -.++..+...++.|++.||+|+|. .+|.|||||.+|||||.+|.+||+|||||++......
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99976 787777653 479999999999999999999999 9999999999999999999999999999998776554
Q ss_pred CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.. .+..+-|..|.|||.+.+. .|+..+|+||.||||.||+.|+..+....+.+ .+......+ ....+..
T Consensus 274 ~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-----Ql~kIfklc----GSP~e~~ 343 (560)
T KOG0600|consen 274 AP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-----QLHKIFKLC----GSPTEDY 343 (560)
T ss_pred cc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-----HHHHHHHHh----CCCChhc
Confidence 33 5667789999999988775 79999999999999999999999887543211 111111100 0000000
Q ss_pred -----hh--hhcCC------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 -----IE--EIVDP------RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 -----~~--~~~d~------~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+. ..+-+ .+.+. -.......++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 11111 11111 1123456788889999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.29 Aligned_cols=240 Identities=23% Similarity=0.215 Sum_probs=196.7
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.||+|+||.||++... +++.||+|+++... .....+..|++++++++|+||+++++++..+...++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 68899999987432 23356778999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccce
Confidence 999999888889999999999999999999999 899999999999999999999999999987532221 123446
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .. .. ...+..+ +.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~---~~----~~~~~~~---------~~- 212 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HE---KL----FELILME---------EI- 212 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC------HH---HH----HHHHHcC---------CC-
Confidence 79999999999999999999999999999999999999986321 00 00 0111000 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
.++......+.+++.+||+.||++|| ++.++++
T Consensus 213 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12223345688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=312.73 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=204.0
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.++||+|+||.||+|...++..||+|+++......+.+..|++++++++|+|++++++++.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 45578889999999999999998777789999998665556789999999999999999999998754 55789999999
Q ss_pred CCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+|+|.+++.+. ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 99999999753 468999999999999999999999 89999999999999999999999999999765433221 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||...+..++.++||||||+++|||++ |..|+..... . .. ......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~----~~----~~~~~~-------- 218 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R----EV----LDQVER-------- 218 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----H----HH----HHHHhc--------
Confidence 123346678999999988899999999999999999999 6667652210 0 00 011100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
........+....+.+++.+|++.||++||++.++++.|+..
T Consensus 219 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001112234556788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=322.82 Aligned_cols=197 Identities=25% Similarity=0.283 Sum_probs=173.2
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34556678999999999999975 57889999887532 2346789999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 158 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 158 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----
Confidence 99999999998878899999999999999999999982 259999999999999999999999999987553321
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2345689999999999998999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=329.85 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=220.5
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
.+-.|+++......++||.|-||.||.|+|+. .-.||||.++......++|+.|..+|+.++|||+|+|+|+|+.+...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34567777777778899999999999999965 45799999998888889999999999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 239 LLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
|||+|||.+|+|.++|.+.+ .++--..+.++.||+.||.||.. +++|||||.++|+|+.++..+||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999998543 57777889999999999999999 89999999999999999999999999999988
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
..+.... .....-...|.|||.+....++.|+|||+|||+|||+.| |..|+... .+..
T Consensus 416 tgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---------dlSq----------- 474 (1157)
T KOG4278|consen 416 TGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---------DLSQ----------- 474 (1157)
T ss_pred cCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---------cHHH-----------
Confidence 6543211 222334568999999999999999999999999999998 55565421 1111
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+-+++....+-.-+..+++.+.+|++.||+-+|.+||++.|+-+.++.+...
T Consensus 475 -----VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 475 -----VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred -----HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 2333334444444566788999999999999999999999999988776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=325.18 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=201.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|... +++.||+|+++... .....+..|++++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456688999999999999975 47899999987432 2345678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++.....+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..... .
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~ 154 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y 154 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----c
Confidence 9999999999888889999999999999999999999 8999999999999999999999999999976543 2
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....+.. ....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~----~~~~~i~~---------~~~~ 216 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----N----ETWENLKY---------WKET 216 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----H----HHHHHHHh---------cccc
Confidence 2345689999999999999999999999999999999999999863211 0 00010000 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+...............+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11000000012335568889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.36 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=202.6
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.++||+|++|.||++...++..+|+|.+.......+.+.+|++++++++|+|++++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 34567778999999999999998877789999987655556778999999999999999999998754 56789999999
Q ss_pred CCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 99999999753 358999999999999999999999 88999999999999999999999999999765433211 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||...+..++.++||||||+++|||++ |..|+..... . ..... ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~----~~~~~----~~~-------- 218 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----R----EVLEQ----VER-------- 218 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H----HHHHH----HHc--------
Confidence 122345678999999988899999999999999999999 7777753210 0 01111 100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
......+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 219 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 ----GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00111223345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=326.34 Aligned_cols=243 Identities=25% Similarity=0.246 Sum_probs=199.6
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 34567789999999999999975 57899999986432 23356889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|.+++.+...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 999999999999888889999999999999999999999 89999999999999999999999999999865432
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .. .....+.
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~-------~~~~~i~-------- 228 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------PF-------RIYEKIL-------- 228 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC------HH-------HHHHHHh--------
Confidence 223569999999999999999999999999999999999999986321 00 0111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
...+ .++......+.+++.+||+.||.+||+ +.++++
T Consensus 229 ---~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 229 ---AGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---cCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 111122346789999999999999997 577663
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=299.69 Aligned_cols=232 Identities=28% Similarity=0.285 Sum_probs=198.7
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
++...||.|+||.|...+.+ +|..+|+|+++... ...+...+|-.+|+.+.||.++++++.+.+..++++||||+
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 45578999999999999975 57899999998542 23355778999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+||.|..+|.+.++++.+.+..+|.+|+.||+|||+ ..|++|||||+|||||.+|.+||+|||.|+.... .+
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT 198 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RT 198 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC-----cE
Confidence 999999999999999999999999999999999999 9999999999999999999999999999987653 26
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
.+.+|||.|+|||.+...++..++|.|||||++|||+.|..||..... ..+.+++.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------~~iY~KI~----------- 254 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------IQIYEKIL----------- 254 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------HHHHHHHH-----------
Confidence 778999999999999999999999999999999999999999984321 12223332
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKR 436 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~R 436 (464)
...+ .++.-....+..|+...++.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222 2344445567788888889998888
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=316.11 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=199.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+++.+ +++.||+|+++... ...+.+.+|+++++.++|+||+++++++..+...++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456788999999999999985 57889999987532 23456789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++++..+......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 158 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NY 158 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cc
Confidence 998887666555679999999999999999999999 89999999999999999999999999999875432221 22
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh------ccchh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL------CGEEA 399 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 399 (464)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ .... ......... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-----QLFT-IQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHHhhCCCCHHHHHhhhccc
Confidence 34568999999999998899999999999999999999999986421100 0000 000000000 00000
Q ss_pred hhhhhcCCccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLK------GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~------~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.......+... ..........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0011123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=330.24 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=203.2
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhcc-ccceeccceeee
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIY-HMNLVRMWGFCT 233 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 233 (464)
.++....+.+.+.||+|+||.||+|++. .+..||+|+++.... ....+.+|+++|.++. |+||++++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455555667789999999999999864 246899999975422 2346889999999997 999999999999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcC--------------------------------------------------------
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSS-------------------------------------------------------- 257 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~-------------------------------------------------------- 257 (464)
.....++|+||+++|+|.++++..
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999999999998632
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 258 ------------------------------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 258 ------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
..+++...+.++.|++.||+|||+ .+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence 136778889999999999999999 89999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccC
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVED 374 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~ 374 (464)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986543222111223356788999999998889999999999999999998 7878753211
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. +... +.+........+......+.+++..||+.+|.+||++++|++.|+.+
T Consensus 348 ----~----~~~~---------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 ----N----EQFY---------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----h----HHHH---------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0000 00111111111222346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=318.77 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=203.4
Q ss_pred HHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeCc
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGM 236 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 236 (464)
....+.+.+.||+|+||.||++... +...+|+|.+.... .....+.+|++++.++ +|+|++++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3344566788999999999999864 23689999987532 2335688999999999 7999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc
Q 040010 237 HRLLVYEYVENQSLDKHLFS----------------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 300 (464)
..+++|||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999853 2468999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchh
Q 040010 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQE 379 (464)
Q Consensus 301 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 379 (464)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-------
Confidence 999999999999987654332222223345678999999988899999999999999999998 877765211
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.... .... ........+......+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 240 --~~~~----~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 --VEEL----FKLL------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHH----HHHH------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0000 0111 111111122334567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.96 Aligned_cols=200 Identities=26% Similarity=0.303 Sum_probs=174.7
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+....+.+.++||+|+||.||++... ++..+|+|.+.... .....+.+|++++++++|+||++++++|.++++.++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34456677789999999999999975 57889999886432 2346688999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.+++.....+++.....++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999998878899999999999999999999972 369999999999999999999999999987553221
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2335689999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.12 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=199.6
Q ss_pred hhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.||+|+||.||+|+.. ....+++|.+..... ....+.+|+.+++.++|+||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999853 235789998875432 3456889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEE
Q 040010 243 EYVENQSLDKHLFSS------------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298 (464)
Q Consensus 243 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 298 (464)
||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 999999999987531 247899999999999999999999 89999999999999
Q ss_pred EcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccc
Q 040010 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEG 377 (464)
Q Consensus 299 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 377 (464)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----- 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA----- 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 99999999999999976543322222233445678999999988899999999999999999999 888875211
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. .... .+........+......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 235 -~~---~~~~----------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 -PE---RLFN----------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HH---HHHH----------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 00 1111 11111111112233457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.05 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=198.0
Q ss_pred HHHHhhhccccCccCceEEEEEEECC---------------CcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceecc
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTD---------------ERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRM 228 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~---------------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l 228 (464)
.+..+.+.+.||+|+||.||++...+ ...||+|.++.. ......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34556777899999999999987532 235899998753 2234568899999999999999999
Q ss_pred ceeeeeCcEEeEEEEeccCCChHHhhhcC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSS------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 229 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
++++......++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 99999999999999999999999998542 147899999999999999999999 899999999999
Q ss_pred EEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhC--CCCCCccccC
Q 040010 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG--IRLSNWVVED 374 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg--~~p~~~~~~~ 374 (464)
|++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||+++ ..|+.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 99999999999999999765433221112233456789999999888999999999999999999984 444432110
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.. .......... ..+.......+...+..+.+|+.+||+.||++||||.+|++.|.
T Consensus 239 ----~~----~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 ----EQ----VIENTGEFFR---------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ----HH----HHHHHHHhhh---------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 01 1111000000 00000000111123457999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=322.58 Aligned_cols=240 Identities=24% Similarity=0.233 Sum_probs=195.5
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.||+|+||.||++... ++..||+|.++.. ......+..|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999964 6889999998743 223355778999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+|..++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence 999999888889999999999999999999999 899999999999999999999999999987532221 122345
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ... ..+....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~----~~~---------------~~~~~~~ 211 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E----RLF---------------ELILMEE 211 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----H----HHH---------------HHHhcCC
Confidence 699999999999999999999999999999999999999863210 0 000 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
. .++......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 I--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 11223345678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=324.86 Aligned_cols=244 Identities=24% Similarity=0.257 Sum_probs=200.1
Q ss_pred HHhhhccccCccCceEEEEEEECC--CcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD--ERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|...+ +..||+|++... ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 446778899999999999998643 368999988642 22345678899999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 9999999999999888889999999999999999999999 89999999999999999999999999999865432
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . .....+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~-------~~~~~i-------- 240 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------L-------LIYQKI-------- 240 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------H-------HHHHHH--------
Confidence 2345799999999999998899999999999999999999999863210 0 001111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
..... .++......+.+++.+|++.||.+|+ ++.++++.
T Consensus 241 ---~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 ---LEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---hcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111 11222234577899999999999995 88888764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.96 Aligned_cols=266 Identities=26% Similarity=0.329 Sum_probs=202.8
Q ss_pred hhccccCccCceEEEEEEE-----CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEE
Q 040010 171 SFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLV 241 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 241 (464)
.+.+.||+|+||+||.+.. .++..||+|.++... .....+.+|++++++++|+|++++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5667899999999988753 356789999987543 2456788999999999999999999988653 468899
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 87 ~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999965 459999999999999999999999 8999999999999999999999999999986654322
Q ss_pred Ccc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ........... ....
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-------~~~~~~~~~~~---~~~~ 232 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-------EEMIGPKQGQM---TVVR 232 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-------hhhhccccccc---chhh
Confidence 111 122335667999999988889999999999999999999999875432110 00000000000 0001
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+.+.++.......+......+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222222233344567999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.33 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=200.8
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCc----EEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDER----AVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||+||+|.+ .++. .||+|.++.. .....++.+|+.++..++|+|++++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 3456678899999999999985 3443 4899998643 23456788999999999999999999998754 5779
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
++||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999764 579999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
..........++..|+|||...+..++.++||||||+++|||++ |..|+.... ......+ +..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~-------~~~~-- 227 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP------AREIPDL-------LEKG-- 227 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH-------HHCC--
Confidence 32211222345678999999998899999999999999999998 888875211 1111111 0000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
.....+......+.+++..||+.||++||++.++++.|+.+...
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 ----------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00011122345688999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=307.38 Aligned_cols=248 Identities=31% Similarity=0.409 Sum_probs=197.9
Q ss_pred cccCccCceEEEEEEECC----CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
++||+|+||.||+|.+.. +..+|+|.+..... ..+++.+|+++++.+.|+|++++++++. +...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999885543 4567899999999999999999999876 4568999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc-ee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ-FS 326 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 326 (464)
++|.+++.....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999877789999999999999999999999 8899999999999999999999999999986644332211 11
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ... ..... ..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~------~~~---~~~~~----~~~~-------- 215 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK------GAE---VIAML----ESGE-------- 215 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC------HHH---HHHHH----HcCC--------
Confidence 2234567999999998899999999999999999998 888875321 111 11111 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....+......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00112223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.06 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=207.0
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+....+.+.+.||+|+||.||++...++..+|||.+.......+.+.+|+.++++++|+|++++++++......+++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34455677789999999999999988888999999987666677899999999999999999999999988999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999999754 378999999999999999999999 8899999999999999999999999999986643211
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .. ..... ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~----~~~~~----~~------- 218 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----NR----EVLEQ----VE------- 218 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----HH----HHHHH----HH-------
Confidence 11122334568999999998899999999999999999999 888875221 00 11111 10
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.......+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 219 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 -----RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000111112224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.27 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=194.3
Q ss_pred hccccCccCceEEEEEEECCCc---EEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC------cEEe
Q 040010 172 FKEELGKGGSGAVYKGVLTDER---AVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRL 239 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~---~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 239 (464)
+.+.||+|+||.||+|.+.+.. .+|+|.++.. ....+.+..|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 5678999999999999975432 6899988743 23346788999999999999999999987432 3568
Q ss_pred EEEEeccCCChHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 240 LVYEYVENQSLDKHLFS------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
+++||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 2358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
................+++.|+|||...+..++.++||||||+++|||++ |+.||.... .. .. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~---~~----~~~ 226 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE------NS---EI----YDY 226 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC------HH---HH----HHH
Confidence 87644322111122345678999999999999999999999999999999 677765311 00 11 111
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
...+. .. ..+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 227 ~~~~~----------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGN----------RL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCC----------CC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 00 11122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.12 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=198.9
Q ss_pred hhhccccCccCceEEEEEEEC-C-CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-D-ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|+||.||++... + +..||+|.+.... .....+..|+.+++.++||||+++++++..+++.++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999854 3 5678888765433 333567889999999999999999999999999999999999
Q ss_pred CCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 247 NQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 247 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|+|.+++.. ...+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988753 3468999999999999999999999 89999999999999999999999999999876543322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ......+.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---------~~~----~~~~~~~~----- 287 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---------REI----MQQVLYGK----- 287 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------HHH----HHHHHhCC-----
Confidence 223456799999999999999999999999999999999999999863210 111 11111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ ..+......+.+++..||+.||++||++.+++.
T Consensus 288 --~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 --YD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01 112223456889999999999999999998864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.63 Aligned_cols=256 Identities=29% Similarity=0.383 Sum_probs=202.3
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeCcE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 237 (464)
...+.+.+.||+|+||.||++... .+..||+|+++... ...+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 345667789999999999999741 24579999987543 2335688999999999 79999999999999999
Q ss_pred EeEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 238 RLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
.+++|||+++|+|.+++.... .+++.+...++.|++.||+|||+ ++|+|+||||+||+++.++.++++|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 48999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
..............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----~---~~--------- 253 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----S---KF--------- 253 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----H---HH---------
Confidence 544322111222346778999999998899999999999999999998 88887532110 0 00
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.+.++.......+......+.+++.+|++.+|++|||+.+|++.|+..
T Consensus 254 -------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 -------YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001111111111122345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.88 Aligned_cols=251 Identities=29% Similarity=0.388 Sum_probs=197.0
Q ss_pred HhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.+.||+|++|.||+|.+.+ +..||+|.+.... .....|..|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 34556789999999999999753 5678999886432 334568899999999999999999999998889999
Q ss_pred EEEeccCCChHHhhhcCC-------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeee
Q 040010 241 VYEYVENQSLDKHLFSSN-------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADF 310 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Df 310 (464)
||||+++++|.+++.... .++|..++.++.||+.||+|||+ .+++|+||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986532 58999999999999999999999 8899999999999998764 5999999
Q ss_pred cCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHH
Q 040010 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 311 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
|+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... . ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~----~~~~-- 232 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----Q----EVME-- 232 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H----HHHH--
Confidence 99986633221111112233567999999998899999999999999999997 8888753210 0 0111
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.+........+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 233 --------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --------------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111222334467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=309.71 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=197.4
Q ss_pred hhccccCccCceEEEEEEECC----CcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcE------
Q 040010 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH------ 237 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 237 (464)
.+.+.||+|+||.||+|.+.. +..||+|+++... .....+.+|++.++.++|+|++++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999999743 3679999987432 234578999999999999999999998866544
Q ss_pred EeEEEEeccCCChHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 238 RLLVYEYVENQSLDKHLFSS------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
.++++||+++|+|..++... ..+++.....++.|++.||.|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998532 368999999999999999999999 899999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~------~~---~~~~--- 226 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE------NH---EIYD--- 226 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC------HH---HHHH---
Confidence 9986654332222222345678999999988899999999999999999999 777765211 00 1111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
....+. ....+......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 227 -~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 -YLRHGN------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHcCC------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111110 0112223455789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.32 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=202.8
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCc
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM 236 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 236 (464)
+....+.+.+.||+|+||.||+|...+ +..||+|.+.... .....+.+|+.+++.++|+|++++++++..+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344456677899999999999998643 3689999987443 33456889999999999999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeE
Q 040010 237 HRLLVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 306 (464)
..++||||+++|+|.+++... ..++|..++.++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 999999999999999998632 247899999999999999999999 8999999999999999999999
Q ss_pred EeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHH
Q 040010 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 307 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 385 (464)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~---~~ 230 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS------NE---EV 230 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC------HH---HH
Confidence 999999976544332222233456788999999988889999999999999999998 777775211 00 11
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
... . .+.. ....+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 231 ~~~----~-----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 LKF----V-----------IDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHH----H-----------hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 0 0110 011122235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.31 Aligned_cols=260 Identities=25% Similarity=0.311 Sum_probs=204.3
Q ss_pred HHHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFC 232 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 232 (464)
++....+.+.+.||+|+||.||++... +...+|+|.++.. .....++..|+++++.+ +|+|++++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444566788899999999999999852 2346999999753 23345688899999999 799999999999
Q ss_pred eeCcEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
......++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 9999999999999999999999643 248999999999999999999999 899999999999
Q ss_pred EEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCc
Q 040010 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDS 375 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~ 375 (464)
|+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 9999999999999999876543222111222334568999999988889999999999999999998 777764211
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...... .+.. ......+......+.+++.+||+.+|++||||.+|++.|..+.+
T Consensus 248 ------~~~~~~----~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 248 ------VEELFK----LLKE------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ------HHHHHH----HHHc------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111111 1110 11111222344578889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.62 Aligned_cols=240 Identities=25% Similarity=0.268 Sum_probs=195.2
Q ss_pred cccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.||+|+||.||++.. .+++.||+|.++... .....+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999986431 2234577899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence 9999999999888889999999999999999999999 899999999999999999999999999987543222 12
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---------~~~---------------~~~~ 212 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---------KKT---------------IDKI 212 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---------HHH---------------HHHH
Confidence 2345699999999999988899999999999999999999999863210 011 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
..... ..+......+.+++.+||+.||++|| ++.++++
T Consensus 213 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 213 LKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111 11222345688999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=304.79 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=197.3
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
+.||+|+||.||+|...++..+|+|.+..... ....+.+|+++++.++|+|++++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875432 2346889999999999999999999999999999999999999999
Q ss_pred HhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 252 KHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 252 ~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
+++... ..+++..+..++.+++.+|.|||+ .+++|+||||+||+++.++.+||+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 998653 468999999999999999999999 89999999999999999999999999998754332211 1112234
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCcc
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 409 (464)
+..|+|||++.+..++.++||||||+++||+++ |..||..... . ... .... . ..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~---~~~----~~~~--------~----~~ 211 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------Q---QAR----EQVE--------K----GY 211 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------H---HHH----HHHH--------c----CC
Confidence 667999999998899999999999999999998 8888753211 0 000 0110 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 410 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
....+......+.+++.+|++.+|++||++.+++++|.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11112233467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.10 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=194.9
Q ss_pred ccCccCceEEEEEEEC---CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 175 ELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999864 355799999875432 34668899999999999999999998864 57899999999999
Q ss_pred hHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc-ceee
Q 040010 250 LDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS-QFSR 327 (464)
Q Consensus 250 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 327 (464)
|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999874 4579999999999999999999999 899999999999999999999999999998654332211 1122
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++..|+|||.+.+..++.++||||||+++||+++ |..|+..... . .... .+ .
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~---~~~~----~~------------~ 212 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------P---EVMS----FI------------E 212 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------H---HHHH----HH------------H
Confidence 234578999999988889999999999999999996 8888863210 0 1111 11 1
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.......+......+.+++..||+.+|++||++.+|.+.|+..
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111122333456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.76 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=201.7
Q ss_pred HHhhhccccCccCceEEEEEEECC-C---cEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-E---RAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+...+.||+|+||.||+|.... + ..+|+|.++... ...+.+..|++++++++|+|++++.+++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345566789999999999999752 2 379999987542 3346788999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999754 578999999999999999999999 889999999999999999999999999998664432
Q ss_pred CCcc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.|+.... . ......+ .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------~---~~~~~~i----~---- 224 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------N---HEVMKAI----N---- 224 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------H---HHHHHHH----h----
Confidence 2111 111223457999999988889999999999999999998 898875321 0 1111111 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. ........+....+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 225 -------~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 -------D-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011111223446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.46 Aligned_cols=241 Identities=25% Similarity=0.245 Sum_probs=196.6
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.||+|+||.||++... +++.||+|++... ......+.+|+++++.++|+||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999964 5889999998743 223456788999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+|..++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence 999999888889999999999999999999999 899999999999999999999999999987533211 123346
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ... ..... .+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~----~~~----~~~~~---------~~~~ 213 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E----KLF----ELILM---------EDIK 213 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----H----HHH----HHhcc---------CCcc
Confidence 799999999999988999999999999999999999999863210 0 010 11100 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
++......+.+++.+||+.||++|| ++.++++.
T Consensus 214 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 ----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1222345678899999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.24 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=198.2
Q ss_pred hhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.++||+|+||.||++... ++..+|+|.+.... .....+.+|+++++.++|+||+++++++..+...+++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 455689999999999999742 35689999887543 34467899999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 243 EYVENQSLDKHLFSS---------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 243 E~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence 999999999998643 248999999999999999999999 89999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..... . ...
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~---~~~ 234 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------T---EAI 234 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------H---HHH
Confidence 99999975543221111222335678999999999999999999999999999998 7877752110 0 001
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
. ....+. ....+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 235 ~----~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 E----CITQGR------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H----HHHcCc------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 010000 001112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=313.17 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=201.2
Q ss_pred HHhhhccccCccCceEEEEEEECC-----------------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceecc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-----------------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRM 228 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l 228 (464)
..+.+.+.||+|+||.||++...+ +..||+|.+.... ...+.+.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 346677899999999999998642 2468999987543 345678899999999999999999
Q ss_pred ceeeeeCcEEeEEEEeccCCChHHhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSN-----------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 229 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
++++..+...++++||+++++|.+++.+.. .+++...+.++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999997554 68999999999999999999999 8999999999999
Q ss_pred EEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCccccCc
Q 040010 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK--GIRLSNWVVEDS 375 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--g~~p~~~~~~~~ 375 (464)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--- 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--- 238 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---
Confidence 999999999999999976543332222334456778999999988889999999999999999998 445553211
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
... ........... .+.......+...+..+.+++.+||+.||++|||+.+|++.|..
T Consensus 239 --~~~----~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 --DQQ----VIENAGHFFRD---------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --hHH----HHHHHHhcccc---------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 000 11111000000 00111111122234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.03 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=203.3
Q ss_pred HHHHhhhccccCccCceEEEEEEECC-----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeee-CcE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMH 237 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 237 (464)
....+.+.+.||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++++++|+|++++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34556677899999999999999765 6889999987542 234668899999999999999999998766 577
Q ss_pred EeEEEEeccCCChHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 040010 238 RLLVYEYVENQSLDKHLFSS--------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIAD 309 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 309 (464)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998642 458999999999999999999999 8999999999999999999999999
Q ss_pred ecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHH
Q 040010 310 FGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 310 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.|+.... .. .+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~---~~~~~ 231 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID------PF---EMAAY 231 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC------HH---HHHHH
Confidence 999986543322111223346778999999988889999999999999999999 888875311 11 11111
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
...+ .. + .........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 232 ----~~~~--------~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 232 ----LKDG--------YR--L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ----HHcC--------CC--C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1000 00 0 111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.52 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=203.3
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
..+.+.+.||.|+||.||++... ++.||+|.+.......+.+.+|+.+++.++|+|++++++++......++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 34567789999999999999975 68899999986655567899999999999999999999999989999999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----- 156 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc-----
Confidence 99999997655 79999999999999999999999 899999999999999999999999999998663221
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....+..|+|||.+.+..++.++||||||+++||+++ |+.|+.... . .... ....
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~---~~~~----~~~~---------- 213 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------L---KDVV----PHVE---------- 213 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------H---HHHH----HHHh----------
Confidence 12334567999999988889999999999999999997 888875221 0 0110 1100
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.......+...+..+.+++.+||+.+|++|||+.+++++|.++
T Consensus 214 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 --KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0001111222346788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.44 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=204.9
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeee
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCT 233 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 233 (464)
+....+.+.+.||+|+||.||++... ++..||+|.+.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44555677789999999999999741 24579999887432 3346788999999999 8999999999999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
.....+++|||+++|+|.+++... ..+++.++..++.|++.||.|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 999999999999999999998642 357889999999999999999999 8999999999999
Q ss_pred EEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCcc
Q 040010 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSE 376 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~ 376 (464)
++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 999999999999999987654333222333456778999999988889999999999999999998 66666421
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
....... .+..+. ....+......+.+++.+||+.+|++||||.+|++.|.++..
T Consensus 244 ----~~~~~~~----~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 ----PVEELFK----LLKEGH------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----CHHHHHH----HHHcCC------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111111 111110 011122345678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.78 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=199.4
Q ss_pred HHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeee-C
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE-G 235 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~ 235 (464)
....+.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++.++ +|+|+++++++|.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345677889999999999999973 346789999997532 2345688999999999 78999999998864 4
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------------------------------------------------
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS---------------------------------------------------------- 257 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------------------------- 257 (464)
...+++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999988532
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 258 ---------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 258 ---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 136788889999999999999999 89999999999999999999999999999765433222222234
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
.++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . .. ......+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~---~~----~~~~~~~~---------- 299 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----E---EF----CRRLKEGT---------- 299 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----H---HH----HHHHhccC----------
Confidence 45678999999988899999999999999999997 87777532110 0 00 01111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
....+......+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 300 --~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 300 --RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000111123468899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.51 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=195.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 240 (464)
+.+.+.||+|+||.||+|+.. ++..||||++... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456788999999999999964 5789999998743 22335688999999999999999999987533 35799
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||+. ++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 6899999877889999999999999999999999 899999999999999999999999999998653322
Q ss_pred CC-cceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH--------
Q 040010 321 NS-SQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV-------- 389 (464)
Q Consensus 321 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 389 (464)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV------HQLDLITDLLGTPSPET 231 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH------HHHHHHHHHhCCCCHHH
Confidence 11 12234578999999999865 67899999999999999999999998632110 000000000
Q ss_pred HHHhhccchhhhhhhcCCccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFN---KNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+...........+.+.....+. ......+.+++..||+.||++|||+.++++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000000000 0123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=307.34 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=204.3
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+...++.+.++||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+|++++.+++.+ ...+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4455677888999999999999998888889999988655556778999999999999999999999887 778999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999753 468999999999999999999999 88999999999999999999999999999765432211
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
......++..|+|||++....++.++|+||||+++||+++ |+.|+.... .... .. ....+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~---~~----~~~~~----- 219 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEV---IR----ALERG----- 219 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHH---HH----HHhCC-----
Confidence 1222345678999999998889999999999999999999 777775211 0000 01 11000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
............+.+++.+|++.+|++||++.++.+.|+.
T Consensus 220 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001112334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.85 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=192.6
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.+|+|.++... .....+..|+.++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 57899999987432 2334577888888776 799999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987532211 12234
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... ......++.. . +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~---~-----------i~~~ 220 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-DQNTEDYLFQ---V-----------ILEK 220 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-ccccHHHHHH---H-----------HhcC
Confidence 67899999999999999999999999999999999999999643221111 1111111111 1 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
.. .++......+.+++.+||+.||++||+.
T Consensus 221 ~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QI--RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1222334567899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.74 Aligned_cols=246 Identities=30% Similarity=0.420 Sum_probs=202.8
Q ss_pred cccCccCceEEEEEEECC----CcEEEEEEcCCccch--hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQG--EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++.... +..+++|.+...... .+.+..|++.++.++|+|++++++++..+...+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999754 788999999865443 57789999999999999999999999999999999999999
Q ss_pred CChHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 248 QSLDKHLFSS---------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 248 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 689999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
...........++..|+|||.+....++.++||||||+++|||++ |..|+.... ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---------~~~~~----~~~~--- 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---------NEEVL----EYLR--- 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---------HHHHH----HHHH---
Confidence 432222344567889999999988899999999999999999999 588876321 01111 1111
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+ ......+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 --------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 --------K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0011122233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=330.66 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=211.5
Q ss_pred ccccCccCceEEEEEEE-CCC----cEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 173 KEELGKGGSGAVYKGVL-TDE----RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~-~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.++||+|+||+||||.+ ++| -+||+|++... .+...++..|+-+|.++.|+|+++++|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 35799999999999996 443 47899988754 445788999999999999999999999998776 88999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+.|+|.++++. +..+.....+.|..|||+||.|||+ +++|||||.++|||+.+-..+||.|||+++....+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 99999999975 4689999999999999999999999 9999999999999999999999999999999887766555
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....-.+.|||-|.+....|+.++|||||||++||++| |.+|++..... + +.+
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------------e------------I~d 911 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------------E------------IPD 911 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------------H------------hhH
Confidence 555556778999999999999999999999999999988 88887743211 1 223
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
++....+-+-+..+..++..++.+||..|++.||+++++...+.++.-
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 332222334466677889999999999999999999999999887653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.25 Aligned_cols=257 Identities=25% Similarity=0.278 Sum_probs=205.1
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---------------hhHHHHHHHHHhhhccccceecccee
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---------------GEEVFWAEVSTIGKIYHMNLVRMWGF 231 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~g~ 231 (464)
..|.+.++||+|.||.|-+++. .+++.||||++..... ..+..++|+.+|++++|+|||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 4566778999999999999996 4688999999864321 12467899999999999999999998
Q ss_pred eee--CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 040010 232 CTE--GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIAD 309 (464)
Q Consensus 232 ~~~--~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 309 (464)
..+ .+..|||+|||..|.+...=-....|+..+++++..++..||+|||. ++||||||||+|+||++++++||+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeec
Confidence 754 57899999999998876544333349999999999999999999999 9999999999999999999999999
Q ss_pred ecCccccCCCC---CCcceeeeccCCCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhH
Q 040010 310 FGLAKLSQRGS---NSSQFSRIRGTKGYMAPEWASNLP----ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 310 fgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 382 (464)
||.+....... .........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||....
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---------- 323 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---------- 323 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----------
Confidence 99998663321 122244578999999999887633 3568899999999999999999997321
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...+ ...++...+.-....+..+++..|+..+|++||++|.+..+|.....-..+
T Consensus 324 ---~~~l-----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ---ELEL-----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---HHHH-----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1122 233444444433344677889999999999999999999999887765544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=305.99 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=202.5
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||++.+.++..+|+|.+.........+.+|++++++++|+|++++++++......++||||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45677899999999999999877889999999866666678999999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG 160 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence 999999754 468999999999999999999999 88999999999999999999999999998765432211 1112
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..++.+|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..... ....+ .....
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~~~~~----~~~~~-----~~~~~ 222 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---------SEVVE----TINAG-----FRLYK 222 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---------HHHHH----HHhCC-----CCCCC
Confidence 234568999999998899999999999999999998 8888753110 11111 11100 01111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+.. ....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 223 ~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 211 2356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=325.70 Aligned_cols=250 Identities=22% Similarity=0.240 Sum_probs=201.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||+|+++... .....+..|++++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456788999999999999975 68899999987432 3345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC----
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS---- 320 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 320 (464)
+++++|.+++.+...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 9999999999888889999999999999999999999 999999999999999999999999999998654432
Q ss_pred -----------------------CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccc
Q 040010 321 -----------------------NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEG 377 (464)
Q Consensus 321 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 377 (464)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~---- 235 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL---- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH----
Confidence 00112345689999999999999999999999999999999999999863210
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-MDSVVQT 445 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-m~~V~~~ 445 (464)
. .... ++. ... ..+.-.........+.+++..|++ ||.+||+ +.++++.
T Consensus 236 -~----~~~~----~i~--------~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 -Q----ETYN----KII--------NWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -H----HHHH----HHh--------ccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 0000 110 000 011000011134568888899997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=309.14 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=201.1
Q ss_pred HHhhhccccCccCceEEEEEEECC-C---cEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-E---RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+.+.+.+.||+|+||.||+|.... + ..||||.+... ......|..|+.+++.++|||++++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678899999999999999753 2 36999998753 22346799999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999998753 578999999999999999999999 899999999999999999999999999987664432
Q ss_pred CCcceeeec---cCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 321 NSSQFSRIR---GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 321 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
......... .+..|+|||.+.+..++.++||||||+++||+++ |..|+.... .. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~------~~---~~~~~i------- 224 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------NQ---DVINAI------- 224 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC------HH---HHHHHH-------
Confidence 221111111 2457999999999999999999999999999886 888875221 00 111110
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
... .....+.+.+..+.+++.+||+.+|.+||+|.+|+.+|+++
T Consensus 225 -----~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 -----EQD----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----HcC----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00111223345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=311.44 Aligned_cols=257 Identities=24% Similarity=0.305 Sum_probs=200.7
Q ss_pred HHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.||+|..++ +..||+|.+..... ....+.+|+.+++.++|+|++++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4556777899999999999997532 45899998874432 334578899999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 239 LLVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
++||||+++|+|.+++... ..+++.....++.|++.||.|||+ ++|+||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999632 245678889999999999999999 899999999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---------~~~~~~ 232 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---------NEQVLK 232 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---------HHHHHH
Confidence 9999876543222111222345678999999998899999999999999999999 566764211 011111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+.+... ...+......+.+++.+||+.||++|||+.++++.|.....
T Consensus 233 ---------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 233 ---------------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ---------------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 1111111 01122334679999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.29 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=206.6
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceecccee
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGF 231 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~ 231 (464)
.++...++.+.+.||+|+||.||++... .+..||+|.++... ...+++.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3555667888899999999999999742 12368999887532 2346788999999999 79999999999
Q ss_pred eeeCcEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 232 CTEGMHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 232 ~~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
|..+...++++||+++|+|.+++... ..++|..+..++.|++.||+|||+ .+++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 99999999999999999999998642 248899999999999999999999 89999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccC
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVED 374 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~ 374 (464)
||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 240 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--- 240 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999986544322222223344567999999999999999999999999999998 77776421
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~ 453 (464)
....+... +. . ......+......+.+++.+||+.+|++||||.++++.|..+....
T Consensus 241 ------~~~~~~~~----~~-----------~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 241 ------PVEELFKL----LK-----------E-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ------CHHHHHHH----HH-----------c-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111 11 0 0011112233456889999999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=321.90 Aligned_cols=256 Identities=27% Similarity=0.360 Sum_probs=213.3
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC---C--cEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcE
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD---E--RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~---~--~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 237 (464)
|.++.....+.||.|-||.||+|++.+ | -.||||..+.. ....+.|+.|..+|+.+.||||++++|.|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 444444566789999999999999643 2 36899988753 33457799999999999999999999999875 6
Q ss_pred EeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 238 RLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.|+|||.++-|.|..+|+.+ ..|+..+...++.||..+|+|||+ .++|||||..+|||+...-.+|++||||++..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 79999999999999999854 579999999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
....... .+...-...|||||.+....+|.+||||.|||.+||++. |.+||.+....+
T Consensus 542 ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------------- 600 (974)
T KOG4257|consen 542 EDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------------- 600 (974)
T ss_pred cccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------------------
Confidence 7654332 234455668999999999999999999999999999876 899998754332
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+-..+...-+.+.+..++..+..|+.+||..+|.+||.+.++...|+.+.
T Consensus 601 -----VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 601 -----VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -----eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11122223344667888999999999999999999999999988886543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.45 Aligned_cols=242 Identities=25% Similarity=0.300 Sum_probs=193.6
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||+|+||+||++... +++.+|+|.+.... ...+.+..|+++++.++|+|++++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999964 67899999986432 1235577899999999999999999999999999999999999999
Q ss_pred HHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 251 DKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 251 ~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
..++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988743 3468999999999999999999999 8999999999999999999999999999976544322 123
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .. .. ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----~~----~~-----------~~~~~~ 215 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NK----EL-----------KQRILN 215 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----HH----HH-----------HHhhcc
Confidence 45789999999999999999999999999999999999999864321100 00 00 011111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
... .++......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 111 12233456688999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.37 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=198.5
Q ss_pred hhhccccCccCceEEEEEEECC-C--cEEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-E--RAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~--~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||+|...+ + ..+++|.++.. ....+.+..|+++++++ +|||++++++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4566789999999999999754 3 34788888743 23346788999999999 79999999999999999999999
Q ss_pred eccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 244 YVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 244 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
|+++++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 99999999999643 248899999999999999999999 89999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---------~~~~ 228 (297)
T cd05089 161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---------AELY 228 (297)
T ss_pred CCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHH
Confidence 9999986432111 1111223557999999988899999999999999999998 8888853210 1111
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~ 453 (464)
.. . ........+......+.+++.+||+.+|.+|||+.++++.|+.+.+..
T Consensus 229 ~~----~------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EK----L------------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HH----H------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 1 011111112233456889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=304.93 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=203.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|+.. +++.||||.+... ......+.+|+++++.++|+|++++++++......++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456788999999999999964 6889999987532 22335688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 245 VENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 245 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+++++|.+++.. ...++......++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988852 3458899999999999999999999 899999999999999999999999999988654322
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+..... ....+... +
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~~~~~~----~------- 220 (267)
T cd08228 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLFSLCQK----I------- 220 (267)
T ss_pred H--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-------cHHHHHHH----H-------
Confidence 1 12234688899999999888899999999999999999999999853211 01111111 1
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.....+ ..........+.+++.+||+.+|++||++.+|++.|.++
T Consensus 221 -~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 221 -EQCDYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -hcCCCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111111 111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=310.74 Aligned_cols=266 Identities=24% Similarity=0.309 Sum_probs=199.9
Q ss_pred HhhhccccCccCceEEEEEEEC-----CCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeee--CcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-----DERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 240 (464)
.+.+.+.||+|+||.||++..+ ++..||+|.+..... ..+.+.+|++++++++|+|++++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3456678999999999999853 477899999875433 34678899999999999999999998743 356889
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 469999999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCcc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCcc---chhhhHHHHHHHHHHHhhc
Q 040010 320 SNSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE---GQEAELTGFIREVKEKILC 395 (464)
Q Consensus 320 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 395 (464)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..++........ ............
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 234 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH------- 234 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH-------
Confidence 22111 1112234469999999888899999999999999999998776543211000 000000000000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.+.+........+......+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 -----LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -----HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111112223445789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.06 Aligned_cols=243 Identities=28% Similarity=0.365 Sum_probs=204.5
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
.+.||+|.||.||||... .++.||+|++.-. ....+...+|+.+|..++++||.+.+|.+..+..++++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 378999999999999964 5789999998743 3344678899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeec
Q 040010 250 LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329 (464)
Q Consensus 250 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 329 (464)
+.+.|.....++.....-|..++..||.|||. .+.+|||||+.|||+..+|.+|++|||.+........ ...+.+
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfv 172 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFV 172 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh--cccccc
Confidence 99999888888888888999999999999999 8899999999999999999999999999987655432 236789
Q ss_pred cCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCcc
Q 040010 330 GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409 (464)
Q Consensus 330 gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 409 (464)
||+.|||||++....|+.|+||||||++.+||.+|..|+.......- . ..+.+-.-|.+
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--l-------------------flIpk~~PP~L 231 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--L-------------------FLIPKSAPPRL 231 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--E-------------------EeccCCCCCcc
Confidence 99999999999998999999999999999999999999864322100 0 00122223334
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 410 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+ .....+.+++..||+.||+.|||+.++++.
T Consensus 232 ~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33 444568899999999999999999998863
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=307.48 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=193.5
Q ss_pred cccCccCceEEEEEEECC-Cc--EEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTD-ER--AVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||+|.+.+ +. .+++|.++.. ....+.+..|++++.++ +|+|++++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 5788988743 23446788999999999 799999999999999999999999999
Q ss_pred CChHHhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 248 QSLDKHLFSSN----------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 248 gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
|+|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 47899999999999999999999 899999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||.... .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---------~~~~~~~-- 223 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---------CAELYEK-- 223 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---------HHHHHHH--
Confidence 98532211 11111234567999999988899999999999999999997 888875311 0111111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. .......+......+.+++.+||+.||.+|||+.++++.|.++.
T Consensus 224 --~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 --LP------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --Hh------------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 10 11111112223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.14 Aligned_cols=244 Identities=27% Similarity=0.329 Sum_probs=208.4
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+++.||.|+-|.|-.|+. .+|+.+|||++... ......+.+|+-+|+.+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 34567899999999999996 57999999998754 12234467899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|-|.+++-.++.|...++.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+-..+. .
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---l 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---L 167 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc---c
Confidence 9999999999999999999999999999999999999 899999999999999999999999999998765443 3
Q ss_pred eeeeccCCCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPIT-SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
..+.+|++.|.+||.+++.+|. .++||||.|||||.|+||+.||+.. -++.+..++..|.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------------Nir~LLlKV~~G~------ 228 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------------NIRVLLLKVQRGV------ 228 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------------cHHHHHHHHHcCc------
Confidence 4567899999999999999985 6999999999999999999999821 1233333333332
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
-+++.+...++..|+..|+..||++|.|+.||++.
T Consensus 229 -------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 -------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 12344556678899999999999999999999985
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.56 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=196.3
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||+|.++... .....+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999975 57899999997432 2234577899999888 799999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence 9999999877889999999999999999999999 899999999999999999999999999987432211 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......+... . +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~---~-----------~~~~ 220 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-DQNTEDYLFQ---V-----------ILEK 220 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-cccchHHHHH---H-----------HHcC
Confidence 67999999999999999999999999999999999999999643221110 1111111111 1 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPT------MDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs------m~~V~~ 444 (464)
.. ..+......+.+++.+||+.||.+||+ +.++++
T Consensus 221 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 221 QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 112223446788999999999999997 667753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.20 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=203.9
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++.. .++..+|||.+.... ....++.+|+.+++.++|+|++++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 55667899999999999996 478899999876422 2335788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 245 VENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 245 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998863 3468999999999999999999999 899999999999999999999999999987654332
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. ......++..|+|||++.+..++.++||||||+++|||++|..|+.....+ ...... .
T Consensus 161 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~----~-------- 219 (267)
T cd08229 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-------LYSLCK----K-------- 219 (267)
T ss_pred c--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-------HHHHhh----h--------
Confidence 2 123356888999999998889999999999999999999999998532110 001110 0
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.....+.+ ........+.+++.+||+.||++||||.+|+++++++
T Consensus 220 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 IEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111111111 1123455788999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.96 Aligned_cols=238 Identities=27% Similarity=0.303 Sum_probs=200.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+|...||+|.||.|+.+.++ +++.+|||.+++. ....+..+.|-+++.... ||-+++++..++..+++++|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 467789999999999999985 4679999999864 334466788888888875 9999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+.||+ ..++...+.++...+..++..|+.||.|||+ ++|||||||.+|||||.+|++||+|||+++..... ..
T Consensus 450 y~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g~ 523 (694)
T KOG0694|consen 450 YVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--GD 523 (694)
T ss_pred ecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC--CC
Confidence 999999 4444466789999999999999999999999 99999999999999999999999999999865432 23
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.+.+.+|||.|||||.+.+..|+..+|+|||||+||||+.|..||....+ +. + ...
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----ee--------~-----------Fds 579 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----EE--------V-----------FDS 579 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----HH--------H-----------HHH
Confidence 57889999999999999999999999999999999999999999974211 11 1 122
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
++... ..++.-...+.+.++...+..||++|..+
T Consensus 580 I~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22111 23556667788999999999999999888
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.46 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=198.7
Q ss_pred HhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.+.||+|+||.||++... ++..||+|.+.... ....++.+|+.++++++|+|++++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 3556678999999999999864 46789999987543 234678899999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEE
Q 040010 241 VYEYVENQSLDKHLFSS----------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 298 (464)
+|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheE
Confidence 99999999999998632 247888999999999999999999 89999999999999
Q ss_pred EcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccc
Q 040010 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEG 377 (464)
Q Consensus 299 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 377 (464)
+++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~----- 237 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA----- 237 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 99999999999999875543221111222334667999999998899999999999999999998 777765211
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
..+... ... +.... ..+......+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 238 ----~~~~~~----~~~-----------~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ----HEEVIY----YVR-----------DGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHH----HHh-----------cCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011111 111 11110 1122334578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=315.13 Aligned_cols=239 Identities=28% Similarity=0.327 Sum_probs=190.9
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||+|... +++.||+|.++... ...+.+..|..++... +|+||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47789999987432 2234455677777654 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999997543322 22344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .+. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---------~~~~~----~i~-----------~~ 211 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---------DELFD----SIL-----------ND 211 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---------HHHHH----HHH-----------cC
Confidence 6799999999999998999999999999999999999999863210 01111 110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD-SVV 443 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~-~V~ 443 (464)
...++......+.+++.+||+.||++||++. +++
T Consensus 212 --~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 --RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111222344578899999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.68 Aligned_cols=246 Identities=27% Similarity=0.357 Sum_probs=200.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|++|.||++... +++.|++|.+... ......+.+|+++++.++|+|++++++++.+....++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345678999999999999974 5789999988632 334567889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++... ..+++.....++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 999999999764 578999999999999999999999 89999999999999999999999999998866543221
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....|++.|+|||+..+..++.++|+||||+++|||++|+.|+.... .. ... ....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~----~~~----~~~~--------- 214 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QG----ALI----LKII--------- 214 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HH----HHH----HHHH---------
Confidence 233568889999999999899999999999999999999999986321 00 001 1110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. .....+......+.+++.+||+.+|++||++.++++.
T Consensus 215 --~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 --RG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --cC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 0111222344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=321.83 Aligned_cols=265 Identities=19% Similarity=0.215 Sum_probs=197.5
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
..|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 34667789999999999999974 57899999653 2346789999999999999999999999999999999995
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|..++.....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYY 241 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccc
Confidence 7899888877789999999999999999999999 8999999999999999999999999999975432211 1233
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc-------cchh
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC-------GEEA 399 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 399 (464)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+.......... .....+..+...... ....
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~--~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC--DSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC--chhHHHHHHHHHhcCChhhcCcchhH
Confidence 4679999999999999999999999999999999999998875322111000 000000111000000 0000
Q ss_pred hhhhh---------cCCccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEI---------VDPRLKGHF--NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~---------~d~~l~~~~--~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.+. ..+.....+ ..+....+.+|+.+||+.||.+|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 001000000 0123557889999999999999999999985
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.98 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=191.0
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.++||+|+||.||+++.. +++.||||.+.... .....+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 44578999999999999975 57899999986432 2346788999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|... ...++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 157 ~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 227 (353)
T PLN00034 157 GSLEGT----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNS 227 (353)
T ss_pred Cccccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccc
Confidence 998653 345677888999999999999999 8999999999999999999999999999986543221 1234
Q ss_pred eccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 328 IRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
..||..|+|||.+.. ...+.++|||||||++|||++|+.||...... .|...... ..
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---------~~~~~~~~-~~-------- 289 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---------DWASLMCA-IC-------- 289 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---------cHHHHHHH-Hh--------
Confidence 568999999998743 23456899999999999999999998732110 11111100 00
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. .............+.+++.+||+.||++|||+.|+++.
T Consensus 290 ~----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 M----SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred c----cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00011122334568899999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.91 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=209.2
Q ss_pred HHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+-++.|.+.||+|.||.|-++.. ..|+.||||.++.... +.-.+++|+++|+.++||||+.++.+|++.+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 445678889999999999999985 6799999999875432 33447899999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||..+|.|++++.+...|+..+...+++||..|+.|+|+ ++++|||||.+|||||.++++||+||||+.++....
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999998776543
Q ss_pred CCcceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
-..+++|++.|.+||.+.+.+| .+.+|-|||||+||-|+-|..||+.. +....+ +++.
T Consensus 208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---------Dhk~lv----rQIs----- 266 (668)
T KOG0611|consen 208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---------DHKRLV----RQIS----- 266 (668)
T ss_pred ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---------hHHHHH----HHhh-----
Confidence 2456889999999999999988 47899999999999999999999742 111111 1121
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
..... ..+.+....-|++|||-.||++|-|+.+|...-
T Consensus 267 ------~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 ------RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11111 122344567789999999999999999998653
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=313.68 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=200.7
Q ss_pred HHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
...+.+.+.||+|+||.||++... ....+|+|.++... .....+..|+++++++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345567789999999999999742 24578999887532 2345688999999999 699999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll 299 (464)
...+++|||+++|+|.+++... ..+++.+...++.|++.||.|||+ .+++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 9999999999999999998642 358999999999999999999999 899999999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccch
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQ 378 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 378 (464)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------ 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------ 241 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999986543222211222334567999999988899999999999999999999 777764211
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
...... ....+ .....+......+.+++.+||+.+|++|||+.++++.|.++.
T Consensus 242 ---~~~~~~----~~~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 242 ---VEELFK----LLREG------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHH----HHHcC------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 011111 11100 001112233456889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.47 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=195.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||.|+||.||+|... +++.||+|.++... .....+.+|++++++++|+||+++++++..+...++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 566788999999999999975 57899999886432 234567899999999999999999999999999999999997
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+ +|.+++... ..+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~ 160 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cc
Confidence 5 898888654 468999999999999999999999 8999999999999999999999999999976543221 12
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch------
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE------ 398 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 398 (464)
....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..... .. .+............
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~----~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KE----ELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHHHhCCCChHHhhcc
Confidence 33567899999998765 5689999999999999999999999863211 11 11111110000000
Q ss_pred ---hhhhhhcCCccCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ---ARIEEIVDPRLKGHF----NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ---~~~~~~~d~~l~~~~----~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........+...... .........+++.+|++.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111111110000 0112345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.23 Aligned_cols=235 Identities=26% Similarity=0.280 Sum_probs=191.1
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||+|+++.. ....+.+..|..++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 5789999998743 22345577888888876 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987543221 12334
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ..+. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---------~~~~----~~i~-----------~~ 211 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---------DDLF----EAIL-----------ND 211 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---------HHHH----HHHh-----------cC
Confidence 5799999999999999999999999999999999999999863210 0111 1111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
.. ..+......+.+++.+||+.||++||++
T Consensus 212 ~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 EV--VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 10 1111234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.42 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=197.1
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCc--EEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DER--AVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|... ++. .+|+|.++.. ......+.+|++++.++ +|+|++++++++..+...++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567789999999999999974 343 5688877643 23446788999999999 899999999999999999999
Q ss_pred EEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 242 YEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 9999999999998643 257899999999999999999999 899999999999999999999
Q ss_pred EEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHH
Q 040010 306 KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 384 (464)
||+|||++....... ......++..|+|||++.+..++.++||||||+++|||+| |..||..... .+
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------~~ 231 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------AE 231 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---------HH
Confidence 999999986432111 1111234567999999988889999999999999999998 8888753211 01
Q ss_pred HHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.... .. .......+......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 232 ~~~~----~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 232 LYEK----LP------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHH----Hh------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 10 00000111223446889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.36 Aligned_cols=241 Identities=26% Similarity=0.285 Sum_probs=194.0
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||+|+.. +++.||+|+++.. ....+.+..|.+++..+ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 4789999998743 22334577888888866 799999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|...+.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987543221 12334
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ... ..+. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~----~~~----~~i~-----------~~ 211 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----D----DLF----ESIL-----------HD 211 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----H----HHH----HHHH-----------cC
Confidence 5689999999999999999999999999999999999999863211 0 111 1111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRP-------TMDSVVQT 445 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-------sm~~V~~~ 445 (464)
.. ..+......+.+++..||+.||++|| ++.++++.
T Consensus 212 ~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 212 DV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 10 01111234678899999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=323.77 Aligned_cols=198 Identities=23% Similarity=0.224 Sum_probs=171.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||+|... +++.||+|++.... .....+..|++++++++|+||+++++++.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999864 57899999986432 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-- 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 322 (464)
+++|+|.+++.+...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999999888889999999999999999999999 89999999999999999999999999997643211000
Q ss_pred -------------------------------------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHH
Q 040010 323 -------------------------------------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359 (464)
Q Consensus 323 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ 359 (464)
.......||+.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012356999999999999889999999999999999
Q ss_pred HHHhCCCCCCc
Q 040010 360 EMLKGIRLSNW 370 (464)
Q Consensus 360 elltg~~p~~~ 370 (464)
||++|+.||..
T Consensus 240 elltG~~Pf~~ 250 (381)
T cd05626 240 EMLVGQPPFLA 250 (381)
T ss_pred HHHhCCCCCcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.96 Aligned_cols=249 Identities=23% Similarity=0.269 Sum_probs=198.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCc--------
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-------- 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 236 (464)
.|.+.+.||+|+||+||++.. .+++.||||++... ......+.+|+..+..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 567778999999999999985 46899999998643 223456788999999999999999888764322
Q ss_pred EEeEEEEeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 237 HRLLVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
..++||||+++|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 367999999999999998642 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....+. .
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---------~~~~~~----~ 256 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---------MEEVMH----K 256 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---------HHHHHH----H
Confidence 987654332222345679999999999999999999999999999999999999986321 111111 1
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+. . ...+......+.+++..||+.||.+||++.++++.
T Consensus 257 ~~~~~-------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGR-------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCC-------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 1 11223344578899999999999999999999763
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.65 Aligned_cols=237 Identities=23% Similarity=0.229 Sum_probs=193.2
Q ss_pred cccCccCceEEEEEEE----CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 174 EELGKGGSGAVYKGVL----TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.||+|+||.||++.. .+++.+|+|++.... .....+..|++++++++|+||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999875 357899999987432 233456789999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence 99999999877889999999999999999999999 899999999999999999999999999987654321 1233
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ...... +..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------~---~~~~~~---------------i~~ 212 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------R---KETMTM---------------ILK 212 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------H---HHHHHH---------------HHc
Confidence 4678999999999998889999999999999999999999986321 0 011111 111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDS 441 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~ 441 (464)
... .++......+.+++.+||+.||++||++.+
T Consensus 213 ~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 110 112223456788999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=300.93 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=204.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|... +++.||+|.++.. ....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 566788999999999999986 7889999988632 22346788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 245 VENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 245 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+++++|.+++.+ ...+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998853 3468999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....... ...
T Consensus 161 ~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~----~~~------ 221 (267)
T cd08224 161 TA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLCK----KIE------ 221 (267)
T ss_pred cc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-------cHHHHHh----hhh------
Confidence 11 2335688899999999888899999999999999999999999853211 1111111 110
Q ss_pred hhhhcCCccCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 401 IEEIVDPRLKGHFNK-NQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~-~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. ......+. .....+.+++.+||+.+|++|||+.+|+++|.++.
T Consensus 222 -----~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 -----K-CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----c-CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 01111122 34557889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.18 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=197.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
++||.|+||.||++...+++.||+|.+..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987799999998875433 4567899999999999999999999999999999999999999999
Q ss_pred Hhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 252 KHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 252 ~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
+++.. ...+++.....++.+++.||+|||+ ++++||||+|+||+++.++.+||+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99965 3568999999999999999999999 8999999999999999999999999999976543221111112234
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCcc
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 409 (464)
+..|+|||.+.+..++.++|+||||+++|||++ |..|+..... . .... . +....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~---~~~~----~------------~~~~~ 212 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------Q---QTRE----R------------IESGY 212 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------H---HHHH----H------------HhcCC
Confidence 567999999988899999999999999999999 6766642210 0 0000 0 10111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 410 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
....+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11122234557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.48 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=197.4
Q ss_pred HHhhhccccCccCceEEEEEEEC-----------------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceecc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-----------------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRM 228 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-----------------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l 228 (464)
..+.+.+.||+|+||.||++... +...+|+|+++... .....+..|+++++.++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 44677789999999999998532 23468999987532 334678999999999999999999
Q ss_pred ceeeeeCcEEeEEEEeccCCChHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSS-----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 229 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
++++..+...+++|||+++++|.+++... ..+++.+...++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998643 247788999999999999999999 8899999999999
Q ss_pred EEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh--CCCCCCccccCc
Q 040010 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK--GIRLSNWVVEDS 375 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--g~~p~~~~~~~~ 375 (464)
+++.++.++|+|||++................++..|++||...+..++.++||||||+++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999976543322111222334678999999888889999999999999999998 5556542111
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.... .......... ......+ .+......+.+++.+||+.||++||+|.+|++.|..
T Consensus 240 ---~~~~-~~~~~~~~~~-------~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ---EQVI-ENTGEFFRDQ-------GRQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHH-HHHHHHHhhc-------cccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0101 0000000000 0000011 112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=314.89 Aligned_cols=240 Identities=28% Similarity=0.306 Sum_probs=194.7
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||+|.++... .....+..|.+++..+ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47899999987432 2334567888888887 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.+...+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987532221 12234
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||.... . .... ..+ ...
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~---~~~~----~~i-----------~~~ 211 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------E---DELF----QSI-----------LED 211 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------H---HHHH----HHH-----------HcC
Confidence 568999999999999999999999999999999999999986321 0 0111 111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTM-----DSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm-----~~V~~ 444 (464)
.. .++......+.+++.+||+.||.+|||+ .++++
T Consensus 212 ~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 212 EV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 1122234568899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.17 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=197.1
Q ss_pred cccCccCceEEEEEEECC--C--cEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTD--E--RAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|++|.||+|.+.+ + ..||+|.++.... ..+.+..|+.++++++|+|++++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 2 3699999986543 45678999999999999999999999888 889999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-cc
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQ 324 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 324 (464)
++|.+++.+.. .++|.....++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 68999999999999999999999 89999999999999999999999999999876543221 11
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... . ........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~---~~~~~~~~------------ 215 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------S---QILKKIDK------------ 215 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------H---HHHHHHHh------------
Confidence 123457789999999998899999999999999999999 9988753211 0 11111000
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.... ...+...+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus 216 -~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGER--LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCc--CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000 0111223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.72 Aligned_cols=242 Identities=24% Similarity=0.231 Sum_probs=195.0
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.||+|+||.||++.. .++..||+|.++.. ......+..|++++..++|+||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 46889999998743 223356778999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+|..++.....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccc
Confidence 9999998888899999999999999999999962 579999999999999999999999999987533221 122345
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .... .... ....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~---~~~~----~i~~---------~~~~ 214 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------E---KLFE----LILM---------EEIR 214 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------H---HHHH----HHhc---------CCCC
Confidence 699999999999999999999999999999999999999863210 0 0100 0000 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
+ +......+.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 F----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 122334678899999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.13 Aligned_cols=239 Identities=25% Similarity=0.318 Sum_probs=192.2
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||+|... +++.||+|.++.. ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 4689999998753 22334566788888764 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence 9999999877889999999999999999999999 899999999999999999999999999987532221 12345
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . .... ..+. ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~---~~~~----~~i~---------~~~~ 213 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD------E---EELF----QSIR---------MDNP 213 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC------H---HHHH----HHHH---------hCCC
Confidence 679999999999999999999999999999999999999986321 0 0111 1111 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD-SVV 443 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~-~V~ 443 (464)
. ++......+.+++.+||+.||++||++. ++.
T Consensus 214 ~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 C----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 1112334578899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=315.84 Aligned_cols=249 Identities=24% Similarity=0.236 Sum_probs=197.0
Q ss_pred hhhccccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 239 (464)
+.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+..|++++..+ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678899999999999985 357899999986421 2234577899999999 5999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999888889999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ ..... ....
T Consensus 159 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~----~~~~---- 224 (332)
T cd05614 159 EKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-----QSEVS----RRIL---- 224 (332)
T ss_pred CCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-----HHHHH----HHHh----
Confidence 221 23346799999999998765 478999999999999999999999864221110 11111 1110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
-.++.+ +......+.+++.+||+.||++|| ++.++++
T Consensus 225 -----~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 -----KCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----cCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011222 222345678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=314.82 Aligned_cols=239 Identities=26% Similarity=0.284 Sum_probs=192.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccc-cceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYH-MNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||+|... +++.||+|++... ....+.+..|.+++..++| ++++++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456788999999999999975 4678999998743 2234567789999999976 468889999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 156 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--K 156 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--C
Confidence 99999999999888889999999999999999999999 899999999999999999999999999987532221 1
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... . ... . .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~----~~~----~-----------~ 212 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----D----ELF----Q-----------S 212 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----H----HHH----H-----------H
Confidence 23456799999999999999999999999999999999999999863210 0 011 1 1
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
+.... ..++......+.+++.+||+.||.+||+.
T Consensus 213 i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111 11122234567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.06 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=195.2
Q ss_pred ccCccCceEEEEEEECC-------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 175 ELGKGGSGAVYKGVLTD-------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.||+|+||.||+|+..+ +..+|+|.+.... .....+.+|+.+++.++|+||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2579999886433 34567889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-----CeEEeeecCc
Q 040010 246 ENQSLDKHLFSS-------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-----EPKIADFGLA 313 (464)
Q Consensus 246 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfgla 313 (464)
++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.+. .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999632 348899999999999999999999 8899999999999999887 8999999999
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
................++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ... ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~------~~~---~~~----~ 225 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN------NQE---VLQ----H 225 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC------HHH---HHH----H
Confidence 76543322222223345678999999999999999999999999999998 888875211 000 111 0
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
+. .......+......+.+++.+||+.+|.+||++.+|++.|.+
T Consensus 226 ~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 VT------------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Hh------------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 000111122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.49 Aligned_cols=253 Identities=24% Similarity=0.273 Sum_probs=200.3
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++++++|+|++++++++..+...++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 3466778999999999999996 467899999987443 33456788999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.....+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--cc
Confidence 999999999877889999999999999999999999 8999999999999999999999999999986543211 12
Q ss_pred eeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 326 SRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ .. ... ..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~-----~~~------~~ 224 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LF-----LMS------KS 224 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------he-----eee------cC
Confidence 3356888999999874 34578899999999999999999998853211000 00 000 00
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
....+.... .......+.+++.+||+.+|++|||++++++.|
T Consensus 225 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011111111 112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.55 Aligned_cols=239 Identities=26% Similarity=0.287 Sum_probs=192.1
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||+|.++.. ......+..|..++... +|+|++++++++.+.++.++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999975 5789999998743 22334566788888754 899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence 9999999887889999999999999999999999 899999999999999999999999999987432211 12345
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .. .. ...+.. ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~------~~---~~----~~~~~~---------~~~ 213 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD------ED---EL----FESIRV---------DTP 213 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HH---HH----HHHHHh---------CCC
Confidence 679999999999999999999999999999999999999986321 00 11 111110 011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD-SVV 443 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~-~V~ 443 (464)
.+ +......+.+++.+||+.||++||++. ++.
T Consensus 214 ~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HY----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 112234578899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.43 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=189.9
Q ss_pred ccCccCceEEEEEEECC---CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 175 ELGKGGSGAVYKGVLTD---ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.++++++|+|++++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 69999999999998643 3579999887543 233568889999999999999999999999999999999999999
Q ss_pred hHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 250 LDKHLFSS-----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 250 L~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998642 246788888999999999999999 8999999999999999999999999999875433222111
Q ss_pred eeeeccCCCccCcccccCC-------CCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 325 FSRIRGTKGYMAPEWASNL-------PITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .... .. ... +
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~-~~---~~~----~ 225 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVL-TY---TVR----E 225 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHH-HH---Hhh----c
Confidence 2234567889999987542 35889999999999999996 9888863211 0000 00 000 0
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
. ...+.++.+... ....+.+++..|+ .+|++|||+.+|++.|+
T Consensus 226 ~---~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 Q---QLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred c---cCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 112222332222 2335777888999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.20 Aligned_cols=196 Identities=26% Similarity=0.355 Sum_probs=167.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++|+||+++++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3566789999999999999975 67899999987432 22345778999999999999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 159 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT 159 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence 6 577777754 3578999999999999999999999 899999999999999999999999999987543221 11
Q ss_pred eeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 234568899999998765 4588999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.56 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=197.1
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceee-eeCcEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC-TEGMHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++ .++...++++||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 4567789999999999999875 6789999886543 345688999999999999999999976 455678999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+++.+.. .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99999987543 58999999999999999999999 899999999999999999999999999987543322
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+... ........ +..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---------~~~~~~~~----~~~--------- 214 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---------PLKDVVPR----VEK--------- 214 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---------CHHHHHHH----Hhc---------
Confidence 22334568999999998899999999999999999998 88776521 11111111 110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
......+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 215 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 ---GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011112223345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=305.78 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=205.2
Q ss_pred HhhhccccCccCceEEEEEEEC-----CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeee--CcEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-----DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 239 (464)
.+.+.+.||+|+||.||++.+. ++..+|||.++.... ..+.+.+|++.++.++|+|++++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3456688999999999999864 367899999986555 36789999999999999999999999877 56889
Q ss_pred EEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997644 69999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCcc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh-hhH-HHHHHHHHHHhhc
Q 040010 319 GSNSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE-AEL-TGFIREVKEKILC 395 (464)
Q Consensus 319 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~ 395 (464)
...... .....++..|+|||...+..++.++||||||+++|||++|+.|+........... ... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 234 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR------- 234 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-------
Confidence 322111 1123345679999999888999999999999999999999988764221110000 000 000000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.+.+........+......+.+++.+||+.+|++||||.+|+++|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 -----LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -----HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111112223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.27 Aligned_cols=244 Identities=25% Similarity=0.294 Sum_probs=192.4
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||+|+||.||++... +|+.+|+|.+.... .....+..|++++++++|+||+++++++..+.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999964 58899999986422 2234556799999999999999999999999999999999999999
Q ss_pred HHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 251 DKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 251 ~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9888643 368999999999999999999999 899999999999999999999999999987654322 12345
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.|+..|+|||++.+..++.++|||||||++|||++|+.|+....... ..... ... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-----~~~~~----~~~-----------~~~~~ 214 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-----AKEEL----KRR-----------TLEDE 214 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-----hHHHH----HHH-----------hhccc
Confidence 68999999999998889999999999999999999999986321110 00011 111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
+.. ........+.+++..||+.||++||++.|+++.+
T Consensus 215 ~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 100 0112344678999999999999999997765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.43 Aligned_cols=249 Identities=23% Similarity=0.276 Sum_probs=199.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+...+.||+|++|.||++... +++.+|+|.+.... .....+.+|++++++++|+||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 345678999999999999964 57899999876322 12246788999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++++|.+++.....+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 999999999999887889999999999999999999999 89999999999999999999999999998765432211
Q ss_pred c-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 S-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~---------------- 216 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--------MAAI---------------- 216 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--------HHHH----------------
Confidence 1 11234578899999999998999999999999999999999999863210 0000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
............+......+.+++.+||+.+|++|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111111112233345568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.56 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=191.0
Q ss_pred hhhccccCccCceEEEEEEEC--CCcEEEEEEcCCccc---hhHHHHHHHHHhhhc---cccceeccceeee-----eCc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT--DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKI---YHMNLVRMWGFCT-----EGM 236 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 236 (464)
|.+.+.||+|+||.||++... ++..||+|+++.... ....+.+|+.+++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 556788999999999999863 467899998864322 223456777777665 6999999999885 345
Q ss_pred EEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 237 HRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..++||||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 6899888643 458999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . .+..+.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~----~~~~i~~~~~ 226 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----D----QLGKILDVIG 226 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----H----HHHHHHHHhC
Confidence 65433 1234456899999999998889999999999999999999999998743210 1 1111111100
Q ss_pred ccchhhh-------hhhcCCccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARI-------EEIVDPRLKG---HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~-------~~~~d~~l~~---~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+... .....+.... ....+....+.+++.+|++.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 0000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.54 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=201.1
Q ss_pred HHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|... .+..+|+|.++... ...+.+..|+.++++++|||++++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34566789999999999999863 23479999987533 2345788999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++++|.+++... ..+++.+...++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999754 468999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.... .....++..|+|||++.+..++.++||||||+++||+++ |..|+..... .+.... +..+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---------~~~~~~----~~~~-- 225 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---------QDVIKA----IEEG-- 225 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---------HHHHHH----HhCC--
Confidence 2111 112223567999999998899999999999999999887 9888753210 011111 1000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.....+...+..+.+++.+|++.+|.+||+|.++++.|..+
T Consensus 226 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00011222345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.84 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=201.7
Q ss_pred HHhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC--cEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHR 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 238 (464)
.++...+.||+|+||.||.+.+ .++..||+|.++... .....+.+|+++++.++|+|++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3455667899999999999984 347789999987432 2346788999999999999999999998765 568
Q ss_pred eEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 239 LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999999654 468999999999999999999999 999999999999999999999999999998665
Q ss_pred CCCCC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCcc------chhhhHHHHHHHHH
Q 040010 318 RGSNS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE------GQEAELTGFIREVK 390 (464)
Q Consensus 318 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~ 390 (464)
..... .......++..|+|||.+.+..++.++||||||+++|||++++.|......... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV---- 236 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH----
Confidence 43221 112234567789999999888899999999999999999998776532211000 0000011110
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.... + ......+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 237 ~~~~-----------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLE-----------E-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHH-----------c-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0010 0 001111223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.00 Aligned_cols=239 Identities=25% Similarity=0.272 Sum_probs=192.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+..|..++..+ +|++++++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 356678999999999999975 46799999987432 2234566788888777 58999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~ 156 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--V 156 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--C
Confidence 99999999999887889999999999999999999999 899999999999999999999999999987543221 1
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . .... .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~---~~~~---------------~ 212 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------D---ELFQ---------------S 212 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------H---HHHH---------------H
Confidence 23346789999999999999999999999999999999999999863210 0 1111 1
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
+..... .++......+.+++.+|++.||.+|++.
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111111 1222344567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=302.77 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=195.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeC------cEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG------MHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~l 240 (464)
.+.+.+.||+|+||.||+|... +++.||+|.+.........+..|+.++.++ +|+|++++++++... ...++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 3556678999999999999974 578899999976666667788999999998 699999999998653 46899
Q ss_pred EEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 241 VYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 99999999999998753 468999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCCCcceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
.. .......|+..|+|||++. ...++.++|||||||++|||++|+.|+..... ......
T Consensus 164 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--------~~~~~~------ 227 (272)
T cd06637 164 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFL------ 227 (272)
T ss_pred cc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--------HHHHHH------
Confidence 22 1223466899999999885 34688899999999999999999999853210 000000
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+.+ ........+.+++.+||+.||.+|||+.++++
T Consensus 228 -------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 -------IPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -------HhcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000001111 11123346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.77 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=205.4
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
....+.+.+.||+|+||+||++... +++.+|+|.+... ....+.+.+|+++++.++|+|++++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3445677789999999999999964 5788999987643 334567899999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++++|.+++.....+++.....++.+++.||.|||+. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999999998777899999999999999999999962 469999999999999999999999999986543221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......+. ......+... ..
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~------------~~ 223 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG-QDDPMGILDL------------LQ 223 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh-hhhhhHHHHH------------HH
Confidence 22356899999999998889999999999999999999999998743221110 0011111111 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.+...........+....+.+++.+||+.||++|||+.||+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111111112445688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=315.57 Aligned_cols=236 Identities=28% Similarity=0.308 Sum_probs=189.0
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHH-HhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVS-TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||+|++.... .....+..|.. +++.++|+||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 68899999986432 12234445544 56789999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987532221 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .... ...+ ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---------~~~~----~~~i-----------~~~ 211 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---------TAEM----YDNI-----------LNK 211 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---------HHHH----HHHH-----------HcC
Confidence 679999999999999999999999999999999999999986321 0111 1111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD 440 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~ 440 (464)
.+ .........+.+++.+||+.||.+||++.
T Consensus 212 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 PL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 01112245688899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.41 Aligned_cols=198 Identities=24% Similarity=0.263 Sum_probs=172.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||++... +++.||+|+++... .....+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 345678999999999999865 57899999987432 2235678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-- 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 322 (464)
+++|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 9999999999888899999999999999999999999 89999999999999999999999999998754321100
Q ss_pred -------------------------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 323 -------------------------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 323 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=321.11 Aligned_cols=249 Identities=20% Similarity=0.205 Sum_probs=195.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||||++.... .....+.+|++++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 445678999999999999975 57899999987432 2335578899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc-
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS- 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 323 (464)
+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999999888889999999999999999999999 899999999999999999999999999987543211100
Q ss_pred -----------------------------------ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 040010 324 -----------------------------------QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLS 368 (464)
Q Consensus 324 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~ 368 (464)
......||+.|+|||.+....++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011245999999999999999999999999999999999999998
Q ss_pred CccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 040010 369 NWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT---MDSVVQ 444 (464)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs---m~~V~~ 444 (464)
..... . ... ..+.... ..+..+ . .....+.+.+++..|+. +|.+|++ +.++++
T Consensus 240 ~~~~~-----~----~~~----~~i~~~~----~~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDNP-----Q----ETY----RKIINWK----ETLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCH-----H----HHH----HHHHcCC----CccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 63210 0 000 1110000 000000 0 01123456778888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=305.17 Aligned_cols=248 Identities=25% Similarity=0.282 Sum_probs=198.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+...+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 445678999999999999964 68899999986432 2234577899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888643 469999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ......+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-----~~~~----~~~~~~~--------- 217 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKR----EEVERRV--------- 217 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-----hhHH----HHHHHHh---------
Confidence 2334689999999999988999999999999999999999999863211 0000 0110000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
.. ....++......+.+++..||+.||++|| ++.++++.
T Consensus 218 ---~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 ---KE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---hh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 01112233455688999999999999999 78888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.02 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=201.6
Q ss_pred HHhhhccccCccCceEEEEEEECC-C----cEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-E----RAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~----~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||.||+|...+ + ..+|+|.+.... ....++.+|+.++++++|+|+++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 445667899999999999999643 3 268999887543 344678899999999999999999999987 78899
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++|+|.+++.+. ..+++...+.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999764 469999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
..........++..|+|||.+....++.++|+||||+++||+++ |+.|+.... ..++... +..+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---------~~~~~~~----~~~~-- 227 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---------AVEIPDL----LEKG-- 227 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---------HHHHHHH----HhCC--
Confidence 32221222334568999999988889999999999999999999 988876321 0111111 1000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.....+......+.+++.+||..||.+||++.++++.|..+..
T Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ----------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0001111233467889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=285.36 Aligned_cols=242 Identities=27% Similarity=0.320 Sum_probs=204.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.++.+.||+|.||.||.|+.+ ++..||+|++..+ .+.+.++.+|+++-+.++||||++++|++.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 366789999999999999964 5678999998754 33457899999999999999999999999999999999999
Q ss_pred ccCCChHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLF--SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
.++|+|...|+ ....++......++.|+|.||.|+|. ++++||||||+|+|++.++..|++|||-+.... .
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~ 176 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 176 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC----C
Confidence 99999999998 45689999999999999999999999 999999999999999999999999999987544 2
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......+||..|+|||...+...+..+|+|++|++.||++.|..||..... .+...++. -.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------------~etYkrI~------k~ 237 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------------SETYKRIR------KV 237 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------------HHHHHHHH------Hc
Confidence 335678899999999999999999999999999999999999999974321 11111111 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
++.+| ......+.+++..|+..+|.+|.+..||+.
T Consensus 238 ~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 DLKFP-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred cccCC-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12222 334456788999999999999999999975
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=300.74 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=191.9
Q ss_pred cccCccCceEEEEEEECC----CcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeee-eCcEEeEEEEecc
Q 040010 174 EELGKGGSGAVYKGVLTD----ERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCT-EGMHRLLVYEYVE 246 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~E~~~ 246 (464)
+.||+|+||.||+|.+.+ ...+|+|++... ....+.+..|+.+++.++|+|++++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998632 357999988643 223467889999999999999999999875 4556889999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--c
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS--S 323 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~ 323 (464)
+|+|.+++.+. ..+++.....++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999754 457888889999999999999999 89999999999999999999999999999754332111 1
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......++..|+|||.+.+..++.++||||||+++|||++|..|+.... ... .... ....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~---~~~~----~~~~~~------ 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSF---DITV----YLLQGR------ 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHH---HHHH----HHhcCC------
Confidence 1123446778999999988899999999999999999999765543111 011 1111 111010
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. ..+...+..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 220 --~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 --RL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 111122456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.71 Aligned_cols=249 Identities=21% Similarity=0.218 Sum_probs=196.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.+.+.||+|+||.||++... +++.||+|.+... ....+.+..|+.+++.++|+||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 45667789999999999999975 5789999998642 223345778999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|.+++.+ ..++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~- 197 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM- 197 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 99999999998854 458888899999999999999999 8999999999999999999999999999976543221
Q ss_pred cceeeeccCCCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 323 SQFSRIRGTKGYMAPEWASNL----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ....
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------~~~~------------ 256 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------VGTY------------ 256 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---------HHHH------------
Confidence 112345799999999988653 478999999999999999999999863210 0111
Q ss_pred hhhhhhcCCc--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040010 399 ARIEEIVDPR--LKGHFNKNQAATLFRIGISCVDEDRNK--RPTMDSVVQT 445 (464)
Q Consensus 399 ~~~~~~~d~~--l~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPsm~~V~~~ 445 (464)
..+++.. +.-.........+.+++..||+.+|.+ |||+.++++.
T Consensus 257 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 ---SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111 100011123456788999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=298.65 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=189.3
Q ss_pred cccCccCceEEEEEEECCCc-----------EEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 174 EELGKGGSGAVYKGVLTDER-----------AVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.||+|+||.||+|.+.+.. .+++|.+.........+.+|+.++++++|+|++++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999986433 57888876554446788999999999999999999999988 7789999
Q ss_pred EeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-------CeEEeeecCcc
Q 040010 243 EYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-------EPKIADFGLAK 314 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~Dfgla~ 314 (464)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999998655 79999999999999999999999 8999999999999999888 79999999997
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHHH
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
.... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+..... ..+.....
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~---------~~~~~~~~- 220 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS---------SEKERFYQ- 220 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc---------hhHHHHHh-
Confidence 6543 1223466789999998776 789999999999999999995 555542210 00000000
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+... .+......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 --------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --------------DQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------------cCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00001167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=304.08 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=185.4
Q ss_pred ccCccCceEEEEEEECC-------------------------CcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceecc
Q 040010 175 ELGKGGSGAVYKGVLTD-------------------------ERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRM 228 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l 228 (464)
.||+|+||.||+|.+.. ...|++|.+..... ....+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 13589998875433 34568889999999999999999
Q ss_pred ceeeeeCcEEeEEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----
Q 040010 229 WGFCTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---- 303 (464)
Q Consensus 229 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---- 303 (464)
+++|.+....++||||+++|+|..++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 4678999999999999999999999 8999999999999997644
Q ss_pred ---CeEEeeecCccccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHH-hCCCCCCccccCccch
Q 040010 304 ---EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEML-KGIRLSNWVVEDSEGQ 378 (464)
Q Consensus 304 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~ell-tg~~p~~~~~~~~~~~ 378 (464)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----- 227 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----- 227 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-----
Confidence 3799999987643221 12346788999998865 56899999999999999985 68877753211
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.....+ ... ...+... ....+.+++.+||+.+|++||||.+|++.|.
T Consensus 228 -~~~~~~----~~~-------------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 -SEKERF----YEK-------------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHH----HHh-------------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000000 000 0011111 1235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=300.98 Aligned_cols=248 Identities=27% Similarity=0.357 Sum_probs=199.1
Q ss_pred hhccccCccCceEEEEEEECCCcEEEEEEcCCcc-------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH-------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
...+.||.|+||.||+|...+++.+|+|.+.... .....+.+|++++++++|+|++++++++.+....+++||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 3457899999999999998888999999886432 122458889999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC---
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS--- 320 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 320 (464)
|+++++|.+++.+...+++.....++.|++.||+|||+ .+|+|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999877789999999999999999999999 889999999999999999999999999987643211
Q ss_pred -CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 -NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~-----~~----- 221 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--------LAAMFY-----IG----- 221 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--------HHHHHH-----hh-----
Confidence 11112345688999999999998999999999999999999999999863210 000000 00
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...-..+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 222 -~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 -AHRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -hccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011112 2233456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.74 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=197.0
Q ss_pred hhccccCccCceEEEEEEEC-CCc----EEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
...+.||+|+||.||+|... ++. .+|+|.+..... ...++.+|+.+++.++|+|+++++|+|... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 34468999999999999863 343 578998875432 234688999999999999999999998754 4679999
Q ss_pred eccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 244 YVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 244 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999998764 368999999999999999999999 89999999999999999999999999999866543322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ......+. ..+.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~~~~~~~~-------~~~~---- 228 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------TREIPDLL-------EKGE---- 228 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-------HCCC----
Confidence 22233445778999999998899999999999999999997 888875321 01111110 0000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
.. ..+......+.+++..||..+|++||++.++++.|..+...
T Consensus 229 ------~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ------RL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 11112334688999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.34 Aligned_cols=242 Identities=26% Similarity=0.292 Sum_probs=190.5
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHh---hhccccceeccceeeeeCcEEeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTI---GKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.||+|+||.||++... +++.||||+++... ...+.+..|.+++ +.++|+||+++++++..+...++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999975 57899999987432 2234466666554 5678999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++++|..++. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05589 82 EYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-- 155 (324)
T ss_pred cCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence 9999999998885 4579999999999999999999999 899999999999999999999999999987432211
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .+
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---------~~~~~----~i--------- 213 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---------EEVFD----SI--------- 213 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHH----HH---------
Confidence 223446799999999999999999999999999999999999999863210 01111 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
..... .++......+.+++.+||+.||.+||+ +.++++
T Consensus 214 --~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 214 --VNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --HhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11110 112223456788999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.34 Aligned_cols=242 Identities=20% Similarity=0.195 Sum_probs=193.5
Q ss_pred hhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.....||+|+||.||.++- ++|..+|+|+++.+.- ..+-.+.|=.+|....+++||+|+-.|++..++||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 3446899999999999995 4589999999986532 3355778889999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC------
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG------ 319 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 319 (464)
+||++..+|.+.+.|+......++.+++.|+.-||+ .++|||||||+|+|||..|++||+||||+.-....
T Consensus 224 PGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 224 PGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred CCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999999999999999999999999999999999999 99999999999999999999999999998532110
Q ss_pred --------------CC-Cc-------c-----------------eeeeccCCCccCcccccCCCCCccchhHHHHHHHHH
Q 040010 320 --------------SN-SS-------Q-----------------FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILE 360 (464)
Q Consensus 320 --------------~~-~~-------~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~e 360 (464)
.. .. . .....|||.|||||++.+..|+..+|+||+|||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 00 00 0 013569999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040010 361 MLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438 (464)
Q Consensus 361 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 438 (464)
|+.|.+||..... .......+.|. .-+.-| -......+..+|+.+|+. ||++|..
T Consensus 381 mLvGyPPF~s~tp-----~~T~rkI~nwr------------~~l~fP-----~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 381 MLVGYPPFCSETP-----QETYRKIVNWR------------ETLKFP-----EEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHhCCCCCCCCCH-----HHHHHHHHHHh------------hhccCC-----CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999984321 11111111110 111111 112223667888889888 9999976
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=317.65 Aligned_cols=248 Identities=19% Similarity=0.139 Sum_probs=197.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||+|+++... .....+..|+.+++.++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456788999999999999974 67899999987532 2345688899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 158 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV- 158 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence 9999999999765 679999999999999999999999 89999999999999999999999999999866443221
Q ss_pred ceeeeccCCCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 324 QFSRIRGTKGYMAPEWAS------NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||..... . .... ++...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~----~~~~----~i~~~- 224 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----A----KTYN----NIMNF- 224 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----H----HHHH----HHHcC-
Confidence 223356899999999886 45678999999999999999999999863210 0 0111 11100
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..... . .........+.+++..|++ +|.+|||+.++++
T Consensus 225 ----~~~~~--~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 ----QRFLK--F--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----CCccC--C--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 0 0011234557788889998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=297.31 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=201.5
Q ss_pred HhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+|++++++++..+...++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 35566789999999999999865 78999999875543 67899999999999999999999999999999999999999
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|.+++.. ...+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN 157 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence 999999975 4578999999999999999999999 8899999999999999999999999999986654321 123
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... . ......
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~~-----~--------~~~~~~ 216 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AIF-----M--------IPNKPP 216 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hhh-----h--------hccCCC
Confidence 3457889999999998899999999999999999999999986321100 000 0 000001
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+ ..+......+.+++.+||+.||++|||+.+|++
T Consensus 217 ~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=298.86 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=186.3
Q ss_pred cccCccCceEEEEEEECC-------------CcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 174 EELGKGGSGAVYKGVLTD-------------ERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~-------------~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
+.||+|+||.||+|++.+ ...|++|.+..... ....+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 23589998875433 3356888999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC-------eEEeeec
Q 040010 240 LVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE-------PKIADFG 311 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-------~kl~Dfg 311 (464)
+||||+++++|..++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998753 569999999999999999999999 89999999999999987664 8999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
++...... ....++..|+|||.+. +..++.++||||||+++|||++ |+.|+..... ... ..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---------~~~-~~- 220 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL---------AEK-ER- 220 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch---------hHH-HH-
Confidence 98654321 2245778899999886 5678999999999999999984 6666542110 000 00
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+...... ........+.+|+.+||+.||++||++.+|++.|.
T Consensus 221 --------------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 --------------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --------------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000000 00112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=300.96 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=198.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+...+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++|+|++++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455578999999999999864 5778999988743 233456889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++++|||++........ ..
T Consensus 85 ~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06642 85 GGGSALDLLK-PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hh
Confidence 9999999885 4578999999999999999999999 8999999999999999999999999999976543221 12
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..... +....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---------~~~~~------------~~~~~ 217 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---------RVLFL------------IPKNS 217 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---------hHHhh------------hhcCC
Confidence 2345788999999999989999999999999999999999987532110 00000 00011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+. ........+.+++.+||+.+|++||+|.+|++.
T Consensus 218 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPT----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111 222344568899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=301.07 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=186.7
Q ss_pred cccCccCceEEEEEEECC---CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTD---ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
++||+|+||.||+|...+ ...+++|.+.... .....+.+|++.++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998543 3578888876432 23456889999999999999999999999999999999999999
Q ss_pred ChHHhhhcCC-----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 249 SLDKHLFSSN-----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 249 sL~~~l~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+|.+++.... ..++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999996532 35678889999999999999999 899999999999999999999999999986543322111
Q ss_pred ceeeeccCCCccCccccc-------CCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 324 QFSRIRGTKGYMAPEWAS-------NLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
......++..|+|||++. ...++.++||||||+++|||++ |..|+.... ... ..... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~----~~~~~---~~~ 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----DEQ----VLKQV---VRE 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----HHH----HHHHH---hhc
Confidence 122334567899999864 3457889999999999999999 666664211 011 01110 000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
+ ...+.++.+. ......+.+++..|| .||++|||+.+|++.|.
T Consensus 226 ~----~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 Q----DIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c----CccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 1112222222 223345667778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.80 Aligned_cols=239 Identities=26% Similarity=0.286 Sum_probs=192.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E 243 (464)
+++.+.||+|+||.||++... +++.||+|++... ....+.+..|..++..+. |++++++.+++......++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 466789999999999999964 5789999998743 223355778888888885 5778889999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--V 156 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--c
Confidence 99999999999888889999999999999999999999 899999999999999999999999999987543221 1
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ... . .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~---~~~----~-----------~ 212 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------D---ELF----Q-----------S 212 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------H---HHH----H-----------H
Confidence 12345689999999999999999999999999999999999999863210 0 011 1 1
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
+..... .++......+.+++.+|++.+|.+|++.
T Consensus 213 i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 1122234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=299.06 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=199.5
Q ss_pred hhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHH---HHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~---~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.||+|+||+||++.... ++.+|+|.+......... ...|+.++++++|+||+++++++......++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 466889999999999999865 568999999866544332 3559999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.....+++..+..++.|+++||++||+ .+++|+||||+||++++++.++|+|||++.... .......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFN 156 (260)
T ss_dssp TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccccccc
Confidence 99999999877889999999999999999999999 899999999999999999999999999997641 1122344
Q ss_pred eeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...++..|+|||.+. +..++.++||||+|+++|+|++|..|+..... ............. . .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~------~~~~~~~~~~~~~----------~-~ 219 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS------DDQLEIIEKILKR----------P-L 219 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH------HHHHHHHHHHHHT----------H-H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc------hhhhhhhhhcccc----------c-c
Confidence 567899999999998 88899999999999999999999999874300 0011111111000 0 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...... .......+.+++..||+.||++|||+.++++
T Consensus 220 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0001267999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.45 Aligned_cols=242 Identities=20% Similarity=0.257 Sum_probs=192.6
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.+|+|+++... ...+.+..|+.++.++ +|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999974 56899999997532 2334577899998888 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence 9999999877889999999999999999999999 899999999999999999999999999987532211 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+... . +...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---~~~~~~~~---~-----------~~~~ 218 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---NTEDYLFQ---V-----------ILEK 218 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---ccHHHHHH---H-----------HHhC
Confidence 67999999999999999999999999999999999999999643222111 11111111 1 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
.. ..+......+.+++.+||+.||.+||++
T Consensus 219 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PI--RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC--CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11 1122234567889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=284.30 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=206.6
Q ss_pred HHhhhccccCccCceEEEEEE-ECCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 240 (464)
.+|.+.+.||+|||+-||.++ +.++..+|+|++.... ++.+..++|++.-++++|||++++++++..+ ...||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 456788899999999999999 5678899999998654 5667889999999999999999999987443 45899
Q ss_pred EEEeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 241 VYEYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
+++|...|||.+.+.. +..++..+.+.|+.++.+||.+||+.. +++.||||||.|||+.+++.+++.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999999873 347999999999999999999999955 46999999999999999999999999998755
Q ss_pred CCCCCC-------cceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHH
Q 040010 317 QRGSNS-------SQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 317 ~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
.-.-.. ........|..|.|||.+. +..+++++|||||||+||+|+.|..||+......+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg---------- 249 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG---------- 249 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC----------
Confidence 322111 1122355788999999875 44689999999999999999999999974322110
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+-...+..+++.-.-+..-.+.+.+++.+|++.||.+||++.+++..+...
T Consensus 250 ------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 001222333332111222567899999999999999999999999988764
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=300.04 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=192.9
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
..||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++|+||+++++++..++..++++||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999964 56789999887543 34567899999999999999999999999999999999999999999
Q ss_pred HhhhcC-CCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCccccCCCCCCcceee
Q 040010 252 KHLFSS-NFL--GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 252 ~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+++... ..+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++........ ....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cccc
Confidence 999754 445 888899999999999999999 89999999999999976 67899999999876543221 1223
Q ss_pred eccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 328 IRGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
..+++.|+|||++.+. .++.++||||||+++|||++|+.|+...... ....+... ..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~~~~~~------------~~--- 227 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVG------------MF--- 227 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhhHhhhh------------hh---
Confidence 4578999999998654 3789999999999999999999998632110 00000000 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+....++....+.+.+++.+||+.+|++|||+.++++
T Consensus 228 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 --KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111223334566889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.85 Aligned_cols=256 Identities=27% Similarity=0.335 Sum_probs=201.8
Q ss_pred HHHHhhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
.+.++.+.+.||.|+||.||+|...+ ...||||...... ...+.+.+|+.++++++|+|++++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34456777899999999999998643 2478999887543 344678999999999999999999998875 4578
Q ss_pred EEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+||||+++|+|.+++... ..+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999764 468999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
..... .....++..|+|||.+....++.++||||||+++||+++ |..||..... . ..... ...+.
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~----~~~~~----~~~~~ 225 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----N----DVIGR----IENGE 225 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----H----HHHHH----HHcCC
Confidence 32111 122334568999999988889999999999999999996 9988863211 0 01111 11110
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.. ..+......+.+++.+|+..+|.+|||+.++++.|.++..
T Consensus 226 --------~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --------RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 1112334578899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.99 Aligned_cols=198 Identities=22% Similarity=0.203 Sum_probs=170.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|++++++++|+||+++++++.+..+.++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 445678999999999999864 67899999886432 2335678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-- 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 322 (464)
+++|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999999887889999999999999999999999 89999999999999999999999999999632210000
Q ss_pred ---------c----------------------------------ceeeeccCCCccCcccccCCCCCccchhHHHHHHHH
Q 040010 323 ---------S----------------------------------QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359 (464)
Q Consensus 323 ---------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ 359 (464)
. ......||+.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001246999999999999999999999999999999
Q ss_pred HHHhCCCCCCc
Q 040010 360 EMLKGIRLSNW 370 (464)
Q Consensus 360 elltg~~p~~~ 370 (464)
||++|+.||..
T Consensus 240 elltG~~Pf~~ 250 (377)
T cd05629 240 ECLIGWPPFCS 250 (377)
T ss_pred hhhcCCCCCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.24 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=197.9
Q ss_pred hhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccch--hHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQG--EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+.....||+|+||.||+|+.. +.+.|++|.+...... .+.+..|++++++++|+|++++++++.+....++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 445568999999999999964 3467999988754433 46789999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 242 YEYVENQSLDKHLFSSN---------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999997544 68999999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---------~~~~~~--- 230 (275)
T cd05046 164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---------EEVLNR--- 230 (275)
T ss_pred ccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---------HHHHHH---
Confidence 875432211 11233446778999999988889999999999999999999 6667642110 011111
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.. ...+....+......+.+++.+||+.+|.+||++.+++++|.
T Consensus 231 -~~-----------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 -LQ-----------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -HH-----------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11 011111111223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.62 Aligned_cols=198 Identities=23% Similarity=0.221 Sum_probs=170.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|++++++++|+||+++++.+.++...++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345678999999999999964 57899999987432 2335688899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC---
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN--- 321 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 321 (464)
+++|+|.+++.+...+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999999887789999999999999999999999 8999999999999999999999999999753211000
Q ss_pred ------------------------------------------CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHH
Q 040010 322 ------------------------------------------SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVIL 359 (464)
Q Consensus 322 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ 359 (464)
........||+.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012346899999999999999999999999999999
Q ss_pred HHHhCCCCCCc
Q 040010 360 EMLKGIRLSNW 370 (464)
Q Consensus 360 elltg~~p~~~ 370 (464)
||++|+.||..
T Consensus 240 elltG~~Pf~~ 250 (382)
T cd05625 240 EMLVGQPPFLA 250 (382)
T ss_pred HHHhCCCCCCC
Confidence 99999999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.86 Aligned_cols=262 Identities=26% Similarity=0.316 Sum_probs=199.8
Q ss_pred hhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhh--ccccceeccceeeeeC----cEEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGK--IYHMNLVRMWGFCTEG----MHRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~lv~E~ 244 (464)
.+.+.||+|.||.||+|.++ |+.||||++.... ++.+.+|.++.+. |+|+||+.+++.-..+ ..+|||++|
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 45578999999999999994 5789999997543 4456677777665 5999999999875433 578999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHE-----CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
.++|||.|+|.+ ..++-...++++..+|.||++||.+ .++.|.|||||+.|||+..++...|+|+|||......
T Consensus 291 He~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 291 HEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred ccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 999999999965 8899999999999999999999974 4678999999999999999999999999999765544
Q ss_pred CC--CcceeeeccCCCccCcccccCCC----C--CccchhHHHHHHHHHHHhC----------CCCCCccccCccchhhh
Q 040010 320 SN--SSQFSRIRGTKGYMAPEWASNLP----I--TSKVDVFSYGVVILEMLKG----------IRLSNWVVEDSEGQEAE 381 (464)
Q Consensus 320 ~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DV~S~Gvvl~elltg----------~~p~~~~~~~~~~~~~~ 381 (464)
.. ....+..+||.+|||||++...- + -..+||||||.|+||+... +.||....+.+...+..
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 22 23345678999999999886431 1 1368999999999998644 34555433332211110
Q ss_pred HHHHHHHHHHHhhccchhhhhhhcCCccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 382 LTGFIREVKEKILCGEEARIEEIVDPRLKGHF-NKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
. ++. ..+-+.|.+...+ +.+.+..+.+++..||..||.-|-|+--+-+.|.++.+
T Consensus 450 r---------kVV------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 450 R---------KVV------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred h---------cce------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 0 000 1111233333222 24678889999999999999999999999999988765
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=315.32 Aligned_cols=265 Identities=22% Similarity=0.257 Sum_probs=196.0
Q ss_pred hhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc-----EEeEE
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-----HRLLV 241 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 241 (464)
...+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3457899999999999996 468899999986432 23456889999999999999999999998766 78999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
+||+. ++|.+.+.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99996 5888888777889999999999999999999999 8999999999999999999999999999986543322
Q ss_pred CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH----HHHhhcc
Q 040010 322 SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV----KEKILCG 396 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 396 (464)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+....... ...+...
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 159 -KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred -ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHHHHHHh
Confidence 122334678999999988764 5799999999999999999999998642211 0000000000 0000000
Q ss_pred chhhhhhhcCCccCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 397 EEARIEEIVDPRLKG-------HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~-------~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......+....... ....+..+.+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 0111224568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.12 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=187.3
Q ss_pred cccCccCceEEEEEEECCC---cEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTDE---RAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
++||+|+||.||+|...++ ..+++|.++... ...+.+.+|+.+++.++|||++++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 356677766432 34567999999999999999999999999999999999999999
Q ss_pred ChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 249 SLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 249 sL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+|.+++.+. ..+++.....++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 346677788999999999999999 8899999999999999999999999999864322211111
Q ss_pred eeeeccCCCccCcccccC-------CCCCccchhHHHHHHHHHHHhCC-CCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 325 FSRIRGTKGYMAPEWASN-------LPITSKVDVFSYGVVILEMLKGI-RLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.....++..|+|||++.. ..++.++||||||+++|||+++. .|+.... .. ........ +
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~----~~~~~~~~----~ 224 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----DR----EVLNHVIK----D 224 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----HH----HHHHHHHh----h
Confidence 234557889999998743 34578999999999999999864 4553210 01 11111111 0
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
. ...+.++.+...++ ..+.+++..|| .+|++||++.+|++.|.
T Consensus 225 ~---~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 Q---QVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred c---ccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0 12334444433333 45677888899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.55 Aligned_cols=249 Identities=21% Similarity=0.231 Sum_probs=195.2
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.+.+.||+|+||.||++... +++.+|+|.+... ......+..|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45667789999999999999975 4788999998642 223455788999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|.+++.. ..++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 123 EYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 99999999999854 468899999999999999999999 8999999999999999999999999999986543221
Q ss_pred cceeeeccCCCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 323 SQFSRIRGTKGYMAPEWASNL----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ....
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---------~~~~------------ 256 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---------VGTY------------ 256 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---------HHHH------------
Confidence 112346799999999998654 378899999999999999999999963210 0111
Q ss_pred hhhhhhcCCc--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040010 399 ARIEEIVDPR--LKGHFNKNQAATLFRIGISCVDEDRNK--RPTMDSVVQT 445 (464)
Q Consensus 399 ~~~~~~~d~~--l~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPsm~~V~~~ 445 (464)
..+++.. +.-.........+.+++..|++.++.+ ||++.++++.
T Consensus 257 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 ---SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111 110111123455777888888755543 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=298.81 Aligned_cols=247 Identities=28% Similarity=0.348 Sum_probs=199.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc----------hhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ----------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
+.+...||+|++|.||+|... +++.+|+|.+..... ..+.+..|+.++++++|+|++++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999864 578999998864321 124578899999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+++|||+++++|.+++.....+++.....++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 9999999999999999877889999999999999999999999 8899999999999999999999999999986653
Q ss_pred CCCCc----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 319 GSNSS----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 319 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~----~~-~-- 223 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQA----IF-K-- 223 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHH----HH-H--
Confidence 21111 11234588899999999988899999999999999999999999863210 000 00 0
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+. .+......+.+++.+||+.||.+||++.+|++
T Consensus 224 ------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 ------IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111122 22334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.36 Aligned_cols=240 Identities=26% Similarity=0.294 Sum_probs=189.5
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHH-HHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEV-STIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.+|+|++.... .....+..|. .+++.++|+||+++++++......++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 56789999986432 2223344444 356778999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.....++......++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence 9999999887888999999999999999999999 899999999999999999999999999987543221 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i---------------~~~ 211 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------AEMYDNI---------------LNK 211 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---------HHHHHHH---------------HhC
Confidence 6799999999999999999999999999999999999999863210 0111111 101
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ .........+.+++.+|++.||.+||++.+.+.
T Consensus 212 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 212 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred Cc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 10 111123446788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=303.08 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=199.4
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
++.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+..|+.+++.+.|+|++++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 455667899999999999996 467899999887533 344668899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.+ ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~ 174 (296)
T cd06654 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (296)
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccC
Confidence 9999999854 468999999999999999999999 8999999999999999999999999999876443221 122
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+... ..+
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~---------------~~~ 231 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLI---------------ATN 231 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHH---------------hcC
Confidence 34688899999999888899999999999999999999999863211 0011000 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......+......+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 100011122344568889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.75 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=196.3
Q ss_pred hhhccccCccCceEEEEEEECC--CcEEEEEEcCCcc-----------chhHHHHHHHHHhhh-ccccceeccceeeeeC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD--ERAVAVKRLGDLH-----------QGEEVFWAEVSTIGK-IYHMNLVRMWGFCTEG 235 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~ 235 (464)
+.+.+.||+|+||.||+|.... ++.+|+|.+.... .....+..|+.++.+ ++|+|++++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999999865 6789999875221 122446778888865 7999999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 236 MHRLLVYEYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
...+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988742 34689999999999999999999952 569999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ......
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---------~~~~~~---- 223 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---------MLSLAT---- 223 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---------HHHHHH----
Confidence 998654432 2344568899999999998889999999999999999999999875221 001111
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.+.+..............+.+++.+||+.||++||++.||..+++
T Consensus 224 -----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 -----------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111011122356889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.38 Aligned_cols=241 Identities=27% Similarity=0.305 Sum_probs=190.8
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHH-HhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVS-TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +|+.+|+|++.... .....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999964 68899999986431 22344555554 46778999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence 9999999888889999999999999999999999 899999999999999999999999999987532211 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .... ..... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---------~~~~----~~~~~-----------~~ 211 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---------VAEM----YDNIL-----------HK 211 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---------HHHH----HHHHH-----------cC
Confidence 679999999999999999999999999999999999999986321 0011 11111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+ .........+.+++.+|++.+|.+||++.+.++.
T Consensus 212 ~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 212 PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 10 0111223457789999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.99 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=194.8
Q ss_pred hhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|++++++++|+|++++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4567899999999999986 46789999988643 23346788999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
++|..+. .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++....... ...
T Consensus 84 ~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~ 152 (279)
T cd06619 84 GSLDVYR----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKT 152 (279)
T ss_pred CChHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccC
Confidence 9997653 57888999999999999999999 899999999999999999999999999997654321 233
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ......... . .....+
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~----~--------~~~~~~ 218 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--LMPLQLLQC----I--------VDEDPP 218 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc--cchHHHHHH----H--------hccCCC
Confidence 56899999999999989999999999999999999999998642211110 000011000 0 000011
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+. .......+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 11233467899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.12 Aligned_cols=198 Identities=22% Similarity=0.215 Sum_probs=171.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||||.+.... .....+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456688999999999999964 57899999986432 2345678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC---
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN--- 321 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 321 (464)
+++|+|.+++.....++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999999999888889999999999999999999999 8999999999999999999999999999753211000
Q ss_pred --------------------------------------CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh
Q 040010 322 --------------------------------------SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363 (464)
Q Consensus 322 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt 363 (464)
........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000123469999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 040010 364 GIRLSNW 370 (464)
Q Consensus 364 g~~p~~~ 370 (464)
|+.||..
T Consensus 240 G~~Pf~~ 246 (376)
T cd05598 240 GQPPFLA 246 (376)
T ss_pred CCCCCCC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.65 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=199.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.++||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456689999999999999975 58899999987432 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 245 VENQSLDKHLFSS-----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 245 ~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
+++|+|.+++.+. ..+++...+.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988631 246678889999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCC----------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccc
Q 040010 314 KLSQRGSNS----------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEG 377 (464)
Q Consensus 314 ~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 377 (464)
+........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~---- 236 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG---- 236 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch----
Confidence 865221100 011235699999999999999999999999999999999999999863110
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhCCCC
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-TMDSVVQTLLGCEA 451 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-sm~~V~~~L~~~~~ 451 (464)
..... ...+.++.-. ....+.+..+.+++.+|++.||++|| ++.++.+.|+...+
T Consensus 237 ~ki~~------------------~~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RKISY------------------RDVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh------------------hhhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0000111100 00123345678899999999999995 57778777766543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.02 Aligned_cols=245 Identities=25% Similarity=0.319 Sum_probs=199.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||.|++|.||+|... +++.+|+|.+.... .....+.+|+++++.++|+|++++.+++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999975 57899999986432 334568899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++... .+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++....... ...
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (274)
T cd06609 83 GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRN 156 (274)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccc
Confidence 99999998654 89999999999999999999999 8899999999999999999999999999987654321 123
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... .. .....
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---------~~~~~----~~--------~~~~~ 215 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---------MRVLF----LI--------PKNNP 215 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---------HHHHH----Hh--------hhcCC
Confidence 35688899999999988899999999999999999999999863210 00100 00 11111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+... .....+.+++.+||+.+|++|||++++++
T Consensus 216 ~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 13456888999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=296.36 Aligned_cols=244 Identities=25% Similarity=0.296 Sum_probs=198.2
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
...+.||+|++|.||+|... ++..|++|.+.... ...+.+..|+++++.++|+|++++++++..+...++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 44578999999999999986 78899999886432 234668899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.+...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--- 156 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--- 156 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc---
Confidence 99999999999877789999999999999999999999 899999999999999999999999999988654432
Q ss_pred ceeeeccCCCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... .. ...... .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~-~~~~~~------------~ 215 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GV-AAVFKI------------G 215 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HH-HHHHHH------------H
Confidence 123456888999999987766 8999999999999999999999986321 00 000000 0
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. ......+......+.+++.+||+.+|++||++.++++
T Consensus 216 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RS---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hc---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 0001112223456788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.92 Aligned_cols=193 Identities=25% Similarity=0.355 Sum_probs=159.5
Q ss_pred cccCccCceEEEEEEEC---CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee--CcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~E~~~~g 248 (464)
.+||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++|+||+++++++.. +...+++|||+. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 57999999999999964 45789999987543 23456789999999999999999998843 467899999986 4
Q ss_pred ChHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE----cCCCCeEEeeecCccc
Q 040010 249 SLDKHLFS---------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL----DSEFEPKIADFGLAKL 315 (464)
Q Consensus 249 sL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~ 315 (464)
+|.+++.. ...+++.....++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 78777642 1258899999999999999999999 899999999999999 4567899999999987
Q ss_pred cCCCCCC-cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 040010 316 SQRGSNS-SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWV 371 (464)
Q Consensus 316 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~ 371 (464)
....... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 6433211 22344678999999998876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.15 Aligned_cols=239 Identities=24% Similarity=0.370 Sum_probs=187.5
Q ss_pred cccCccCceEEEEEEECC--------CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.||+|+||.||+|.... ...+|+|.+.... ...+.+..|+.+++.++|+|++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 2348888876443 3346788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC--------eEEeeecCccc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE--------PKIADFGLAKL 315 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Dfgla~~ 315 (464)
+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 468999999999999999999999 89999999999999987765 58999998865
Q ss_pred cCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
... .....++..|+|||++.+ ..++.++||||||+++|||++|..++..... .. .... .
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-----~~---~~~~-~----- 217 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----SQ---KKLQ-F----- 217 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-----HH---HHHH-H-----
Confidence 432 123457889999999876 4589999999999999999999654331110 00 0000 0
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.... ...+......+.+++.+||+.||++|||++++++.|+
T Consensus 218 ----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 ----------YEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------HHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0111122346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=295.79 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=200.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+...+.||.|+||.||+|... ++..||+|.+... ......+.+|+++++++.|+|++++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 445578999999999999975 5789999988643 2344678899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.. ..+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++++|||++........ ...
T Consensus 86 ~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06640 86 GGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccc
Confidence 9999999854 568999999999999999999999 8999999999999999999999999999976543321 123
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...++..|+|||.+.+..++.++||||||+++|||++|..|+...... ... ..+.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---------~~~----------------~~~~ 214 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---------RVL----------------FLIP 214 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---------hHh----------------hhhh
Confidence 345788999999998888999999999999999999999987632110 000 0011
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..............+.+++..||+.+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111123344566778999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=310.08 Aligned_cols=236 Identities=26% Similarity=0.301 Sum_probs=188.4
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHH-HhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVS-TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||+++.. +++.||+|++.... .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999974 57899999986432 12234455554 57889999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|..++.....++......++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence 9999999877889999999999999999999999 899999999999999999999999999987532211 12344
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .... ...+ ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---------~~~~----~~~i-----------~~~ 211 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---------VSQM----YDNI-----------LHK 211 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---------HHHH----HHHH-----------hcC
Confidence 678999999999998899999999999999999999999986321 0111 1111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD 440 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~ 440 (464)
.+ ..+......+.+++.+||+.||.+||+..
T Consensus 212 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 11222345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.33 Aligned_cols=191 Identities=25% Similarity=0.272 Sum_probs=164.5
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.+.+.||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++..+...++|||++. +
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 3445679999999999999754 6789999532 2345689999999999999999999999999999999995 6
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..++|..++.|+.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.............
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 888887653 479999999999999999999999 8999999999999999999999999999987644322222234
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
..||+.|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 679999999999999999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.79 Aligned_cols=270 Identities=20% Similarity=0.201 Sum_probs=201.6
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC---CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+....+.+.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++|+||+++++++......+++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 33445778889999999999999853 3568999988643 2345799999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||++. ++|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99995 6888888777789999999999999999999999 8999999999999999999999999999986654433
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH---hhccch
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK---ILCGEE 398 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 398 (464)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.......... ......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS--SSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc--HHHHHHHHHHhccCccccCCccc
Confidence 3333456799999999999999999999999999999999999999864322211 11111111100000 000000
Q ss_pred hh----hhhhcCCccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 399 AR----IEEIVDPRLKGHFN-------KNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 399 ~~----~~~~~d~~l~~~~~-------~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. ... .....+..+. ......+.+++.+||+.||++|||+.+++..
T Consensus 319 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 0000010000 0123457788999999999999999999865
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.22 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=196.3
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.+.||+|+||.||+|.... +..+++|.+.... ...+.+.+|+++++.++|+|++++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999999754 6788999886543 3456788999999999999999999999999999999999999
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|..++.+ ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 999998765 4579999999999999999999999 899999999999999999999999999987543321 1123
Q ss_pred eeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 327 RIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
...++..|+|||.+. +..++.++|||||||++|||++|+.|+..... ....... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---------~~~~~~~----~------- 221 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---------MRVLLKI----A------- 221 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---------HHHHHHH----h-------
Confidence 456889999999874 44578899999999999999999998763210 0000000 0
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
....+.+ ..+......+.+++.+||+.||.+||++.++++.-
T Consensus 222 -~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 222 -KSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -hcCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0001111 11122345688999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.18 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=195.7
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
..+.+.+.||+|+||.||+|.. .++.+|+|.++... ....+.+|+.++++++|+|++++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 3466778999999999999986 56789999886533 345688999999999999999999998654 47999999999
Q ss_pred CChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999999754 358999999999999999999999 899999999999999999999999999987543221
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.|+.... ....... ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---------~~~~~~~----~~~--------- 212 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---------LKEVKEC----VEK--------- 212 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---------HHHHHHH----HhC---------
Confidence 12234567999999988899999999999999999998 888775221 1111111 100
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 213 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 ---GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01111122334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.60 Aligned_cols=264 Identities=21% Similarity=0.243 Sum_probs=199.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|+||.||++... ++..+|+|.+.... ....++.+|++++++++|+||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 455678999999999999965 57788999886432 233568899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.....+++.....++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~ 156 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 156 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cc
Confidence 999999998888899999999999999999999972 379999999999999999999999999987543221 23
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc---------
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE--------- 397 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 397 (464)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .....+............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA------KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch------hhHHHhhcCccccccccCCcccccCCC
Confidence 35688999999999888899999999999999999999999853211 000000000000000000
Q ss_pred -----h----hhhhhhcCCccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 398 -----E----ARIEEIVDPRLKGHFN-KNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 398 -----~----~~~~~~~d~~l~~~~~-~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
. .....++... ....+ ......+.+++.+||+.||++|||+.+|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 0000000000 00000 11344688999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=295.10 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=191.9
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc------chhHHHHHHHHHhhhccccceeccceeeee--CcEEeEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRLLV 241 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 241 (464)
...+.||+|+||.||++... ++..||+|++.... .....+.+|+.++++++|+||+++++++.+ +...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 44578999999999999974 57899999886321 123457889999999999999999998865 3678899
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
+||+++++|.+++.+...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999877789999999999999999999999 8899999999999999999999999999976543211
Q ss_pred -CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 -SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
........++..|+|||.+.+..++.++||||||+++|||++|+.||..... . . .....
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~-~---~~~~~-------- 221 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------M-A---AIFKI-------- 221 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------H-H---HHHHH--------
Confidence 1112335588899999999988899999999999999999999999863210 0 0 00000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+ .++....+.+..++ .||..+|++||+|.+|++
T Consensus 222 ~~~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0001112 22222333455555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.52 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=198.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||.|+||.||++... +++.+|+|.++.. ....+.+..|+.+++.++|+|++++++.+..+...+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 346688999999999999964 5789999987532 3344678889999999999999999999999999999999999
Q ss_pred CCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++.. ...++......++.|++.||.|||+ .+|+|+||||+||++++++.++++|||++........ .
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 156 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--Y 156 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--c
Confidence 9999998864 3468899999999999999999999 8999999999999999999999999999976543221 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..... .....+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---------~~~~~----~~~~~~~------- 216 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---------WKNLI----LKVCQGS------- 216 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---------HHHHH----HHHhcCC-------
Confidence 234568889999999998889999999999999999999999986311 00111 1111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. ...+......+.+++.+||+.||++|||+.+++..
T Consensus 217 ----~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ----Y-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----C-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 11122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.77 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=195.7
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
...+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++++++|+|++++++.+..+...++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 44578999999999999975 57899999886432 22345778999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988643 368999999999999999999999 8999999999999999999999999999876543221
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... . .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~----~-----------~ 219 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLV----K-----------E 219 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhh----h-----------h
Confidence 223468999999999999899999999999999999999999987432110 000000000 0 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
. . ..........+.+++..||+.||++||| +.++++
T Consensus 220 ~-~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 V-Q----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h-h----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 0 0111223345789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=294.75 Aligned_cols=251 Identities=23% Similarity=0.272 Sum_probs=198.4
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||++... +++.||+|.++... .....+.+|+.+++.++|+|++++++.+..+...++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 34566788999999999999964 57899999887543 23356788999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.....+++.+...++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccc
Confidence 999999999888889999999999999999999999 899999999999999999999999999987654321 112
Q ss_pred eeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 326 SRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
....|+..|+|||.+. ...++.++|||||||++|||++|+.|+...... ... +. . . ..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~--~~---~--~-------~~ 224 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RAL--FL---M--T-------KS 224 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhH--Hh---h--h-------cc
Confidence 3456899999999874 456889999999999999999999987532110 000 00 0 0 00
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+..... ......+.+++.+|++.+|++||++.+|++
T Consensus 225 ~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 NFQPPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011111110 112345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.36 Aligned_cols=247 Identities=30% Similarity=0.431 Sum_probs=198.8
Q ss_pred hhccccCccCceEEEEEEECC-----CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.||.|+||.||++...+ +..||+|.+..... ..+.+..|++.+..++|+|++++++++.+....+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999999754 47899999975543 45678999999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCC--CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 244 YVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999976543 9999999999999999999999 8999999999999999999999999999987654422
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.. .....+++.|+|||.+.+..++.++||||+|++++||++ |..|+... ........ ...+.
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---------~~~~~~~~----~~~~~--- 221 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---------SNEEVLEY----LKKGY--- 221 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------CHHHHHHH----HhcCC---
Confidence 11 112336789999999988889999999999999999999 66666421 00111111 11000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
....+......+.+++.+|++.||++|||+.++++.|
T Consensus 222 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111222455788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=309.68 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=206.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCcE-EeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH-RLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~E 243 (464)
.|...+.+|+|+||.++..+.+ +++.+++|.+...... .+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556688999999999998864 5678999988754332 2356899999999999999999999988877 999999
Q ss_pred eccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 244 YVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|++||+|.+.|.+. ..++......|+.|++.|+.|||+ ..|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999754 468899999999999999999998 889999999999999999999999999999887654
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
....++.||+.||.||.+.+.+|..|+|+|||||++|||++-+.+|... .....+..+ .
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---------~m~~Li~ki-----------~ 219 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---------NMSELILKI-----------N 219 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---------chHHHHHHH-----------h
Confidence 2356789999999999999999999999999999999999999998732 111111111 1
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
... -...+.....++..++..|++.+|..||++.+++.+
T Consensus 220 ~~~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGL-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hcc-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 223455566779999999999999999999999876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=296.46 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=196.8
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-----------hhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-----------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.||.|+||.||+|... +++.+|+|.++.... ..+.+..|+++++.++|+|++++++++......+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4468999999999999864 588999998753211 1245778999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++++|.+++.+...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++......
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 999999999999999887889999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCcceeeeccCCCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLP--ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
..........++..|+|||.+.... ++.++||||||+++||+++|..|+.... ...... ..... .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~-~~~~~----~ 228 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMF-KLGNK----R 228 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHH-Hhhcc----c
Confidence 2222233456889999999887654 8899999999999999999999985211 000000 00000 0
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
....+++ ....+....+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ---~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 ---SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111 1112335678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=302.60 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=194.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
++.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|++++++++|+|++++++++..+...++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3556678999999999999975 57789999987432 23346778999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
++ +|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 160 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T 160 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence 75 788777654 468999999999999999999999 8999999999999999999999999999976433221 1
Q ss_pred eeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HHHHhhcc
Q 040010 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VKEKILCG 396 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 396 (464)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........ ....+...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-----ELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCCHHHHhhhcch
Confidence 233457899999998765 468999999999999999999999986432110 00000000 00000000
Q ss_pred chhhhhhhcCCccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKG----HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~----~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .....-.+.... .........+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 D--EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred h--hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 000000000000 000123445789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.10 Aligned_cols=246 Identities=26% Similarity=0.294 Sum_probs=194.9
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
...+.||+|+||+||++... +++.+|+|.+.... .....+..|++++++++|+|++++.+.+..++..+++|||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34578999999999999974 57899999986432 22345778999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 156 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--- 156 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---
Confidence 999999888643 469999999999999999999999 899999999999999999999999999987653321
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... .... ........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-----~~~~----~~~~~~~~--------- 218 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-----KVKR----EEVDRRVL--------- 218 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-----HHHH----HHHHHhhh---------
Confidence 12345689999999999988999999999999999999999999863211 0000 01111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
... ..+.......+.+|+..|++.||++||+ +.++++
T Consensus 219 --~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 219 --ETE--EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --ccc--cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 000 0112223345788999999999999999 566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.56 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=194.2
Q ss_pred hhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc------E
Q 040010 171 SFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------H 237 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 237 (464)
.+.+.||+|+||.||+|.+. .+..||||++.... ...+++.+|+++++.++|+|++++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34578999999999999863 36789999987532 33466889999999999999999999885432 2
Q ss_pred EeEEEEeccCCChHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 238 RLLVYEYVENQSLDKHLFSS------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
.++++||+++|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 47889999999999887522 257899999999999999999999 899999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.... ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~------~~~---~~~--- 226 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE------NSE---IYN--- 226 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC------HHH---HHH---
Confidence 9986544322222223345678999999988889999999999999999999 777765211 010 111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
....+. .+ ..+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 -~~~~~~----------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 -YLIKGN----------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -HHHcCC----------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 010000 00 11122345799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=299.54 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=199.6
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3466678899999999999996 468899999987433 34466788999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.+ ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 99999999854 568999999999999999999999 8999999999999999999999999999876543221 12
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--------~~---------------~~~~~ 229 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------AL---------------YLIAT 229 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--------he---------------eeecc
Confidence 33468889999999999889999999999999999999999986321100 00 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........+......+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000112233456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=295.40 Aligned_cols=255 Identities=27% Similarity=0.356 Sum_probs=191.6
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc-----EEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-----HRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~E~~~~ 247 (464)
+.+|+|+||.||+|.+. +++.||||+.-...... -.|+++|+++.|||||+|+-++.... ...+|||||+.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 57999999999999975 46899999886544322 26899999999999999999885432 34589999986
Q ss_pred CChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccCCCCCC
Q 040010 248 QSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 248 gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|...+.. +..++.-...-+..||.+||+|||+ .+|+||||||.|+|+|.+ +.+||+|||.|+....+...
T Consensus 107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 88888863 4567777888899999999999999 999999999999999977 89999999999988765433
Q ss_pred cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH----HHHhhccc
Q 040010 323 SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV----KEKILCGE 397 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 397 (464)
.+...|+.|.|||.+.+. .|+.+.||||.|||+.||+-|+..|..... ...+...+... .+.+....
T Consensus 183 ---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-----~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 183 ---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-----VDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-----HHHHHHHHHHhCCCCHHHHhhcC
Confidence 456688899999988764 799999999999999999999998874211 11111111110 11111111
Q ss_pred hhhhhhhcCCccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGH-----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ -.+...+.+... +......+.++++.++++.+|.+|.++.|++.
T Consensus 255 ~~-y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PN-YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cc-cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 112223333221 33455678899999999999999999998874
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=300.40 Aligned_cols=193 Identities=25% Similarity=0.355 Sum_probs=158.8
Q ss_pred cccCccCceEEEEEEECC---CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeee--eCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTD---ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCT--EGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~E~~~~g 248 (464)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++|+|++++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 479999999999999753 4689999887543 2345778999999999999999999884 35678999999875
Q ss_pred ChHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE----cCCCCeEEeeecCccc
Q 040010 249 SLDKHLFS---------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL----DSEFEPKIADFGLAKL 315 (464)
Q Consensus 249 sL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~ 315 (464)
+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 77766631 1258899999999999999999999 899999999999999 5667899999999986
Q ss_pred cCCCCCC-cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 040010 316 SQRGSNS-SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWV 371 (464)
Q Consensus 316 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~ 371 (464)
....... .......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6443221 12334568999999998876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.39 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=198.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++.++|+|++++++++..+...++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456688999999999999985 47899999886432 23456889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|..+......+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07846 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VY 157 (286)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--cc
Confidence 999999887766679999999999999999999999 8899999999999999999999999999886544321 12
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc------cch
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC------GEE 398 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 398 (464)
....++..|+|||++.+ ..++.++||||||+++|||++|+.|+..... ........ ........ ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQLYHII-KCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHH-HHhCCCchhhHHHhccc
Confidence 33557889999998865 4578899999999999999999988753211 00000000 00000000 000
Q ss_pred hhhhhhcCCccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIVDPRLKGHF-----NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........+...... .......+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000001111111000 1123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=298.44 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=198.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|... +++.||||.+..... ....+..|++++++++|+|++++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345678999999999999975 588999999875432 2345678999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+ +++|.+++.... .+++..+..++.||++||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 899999997765 79999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
......+++.|+|||.+.+ ..++.++||||||+++|||++|..++..... ...+.. ............
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~ 226 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----IDQLGK----IFEALGTPTEEN 226 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----HHHHHH----HHHHcCCCchhh
Confidence 1223456788999998854 4678999999999999999999666652211 001111 100000000000
Q ss_pred ------hhhhcCCccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCC
Q 040010 401 ------IEEIVDPRLKGH-----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGC 449 (464)
Q Consensus 401 ------~~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~ 449 (464)
............ ........+.+++.+||+.||++|||+.+|++. +.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 000000000001 112235678899999999999999999999985 4443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=296.12 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=198.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++|+|++++++++..+...++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 456678999999999999976 58899999886432 23356789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|..++.....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 999999888776789999999999999999999999 8999999999999999999999999999987654321 12
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH----HHHHHHHHhhccchhh
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG----FIREVKEKILCGEEAR 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 400 (464)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ....... +........ .....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIF--STNQF 233 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhc--ccccc
Confidence 23457889999998865 567899999999999999999999986321110 0000000 000000000 00000
Q ss_pred hhhhcCCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+......+ ......+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00011111110001 112466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.64 Aligned_cols=196 Identities=16% Similarity=0.131 Sum_probs=163.8
Q ss_pred hccccCcc--CceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 172 FKEELGKG--GSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 172 ~~~~lG~G--~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.++||+| +||+||++.. .+++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999986 468899999987532 23355778999999999999999999999999999999999
Q ss_pred cCCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+............
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999964 3468999999999999999999999 899999999999999999999999998654332111100
Q ss_pred -----ceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 324 -----QFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 324 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0122346778999999875 4689999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.80 Aligned_cols=189 Identities=25% Similarity=0.289 Sum_probs=162.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++|+||+++++++..+...++|+||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 4667789999999999999975 4678999975432 23468999999999999999999999999999999995
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|.+++.. ...+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 214 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFL 214 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccc
Confidence 688887764 4579999999999999999999999 899999999999999999999999999997543221 123
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
...||+.|+|||.+.+..++.++|||||||++|||+++..++.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 4568999999999999999999999999999999999766653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.62 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=187.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeC--------cEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--------MHRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~ 239 (464)
.+.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3566789999999999999974 57899999885432 2234799999999999999999876332 2467
Q ss_pred EEEEeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCcc
Q 040010 240 LVYEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAK 314 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~ 314 (464)
+||||+++ +|.+++. ....+++.....++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99999985 6766654 34579999999999999999999999 8999999999999999665 69999999998
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
....... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+... ....
T Consensus 220 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-----~~~~~~i----~~~~ 287 (440)
T PTZ00036 220 NLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-----VDQLVRI----IQVL 287 (440)
T ss_pred hccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHH----HHHh
Confidence 6543221 233568999999998765 4689999999999999999999999864211 1111111 1000
Q ss_pred hccchhh-------hhhh-----cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEAR-------IEEI-----VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~-------~~~~-----~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....... ..++ ....+...++.....++.+|+.+||+.||.+|||+.++++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000 0000 0011111122223467889999999999999999999984
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=291.31 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=197.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee-CcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~E~ 244 (464)
|.+.+.||+|++|.||++... +++.+|+|++.... ...+.+..|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456788999999999999964 46789999986432 234568889999999999999999998764 4568899999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++++|.+++... ..+++.++..++.+++.|++|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999998753 468999999999999999999999 8999999999999999999999999999986643221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+.... ....... ..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---------~~~~~~~----~~-------- 215 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---------MNSLVYR----II-------- 215 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---------HHHHHHH----HH--------
Confidence 2234568899999999999999999999999999999999999876211 0011111 10
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+ ...+......+.+++.+|++.||++||++.++++.
T Consensus 216 ---~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 ---EGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---hcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001 11223445678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=299.46 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=197.9
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.+.||.|++|.||+|.. .+++.|++|.+.... ...+.+.+|+..++.++|+|++++++++..+...++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 45567899999999999986 568899999886443 3346688999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
++|..++.. ..+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ ....
T Consensus 101 ~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~ 174 (296)
T cd06655 101 GSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRST 174 (296)
T ss_pred CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCC
Confidence 999998854 468999999999999999999999 8999999999999999999999999999876543321 1233
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .... .... ...-+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~-~~~~------------~~~~~ 233 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRAL-YLIA------------TNGTP 233 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHH------------hcCCc
Confidence 4688899999999988899999999999999999999999863211 0000 0000 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ ..+......+.+++.+||+.||++||++.++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01 112223456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.57 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=204.8
Q ss_pred hhccccCccCceEEEEEEECC--C--cEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLTD--E--RAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.+.++||+|.||.|++|.|+. | -.||||.++.... ....|++|+.+|.+|+|+|+++|+|...+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 455789999999999999853 3 3689999986543 46789999999999999999999999887 678899999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
++.|||.+.|... ..|-......++.|||.||.||.. +++|||||..+|+||-..-.+||+||||.+.++.+...
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999863 467788889999999999999999 99999999999999999999999999999988765543
Q ss_pred cceee-eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 323 SQFSR-IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 323 ~~~~~-~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
..+.. ..-...|.|||.+....++.++|||+|||++|||+|+ ..|+-.... ..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------------------~q 323 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------------------IQ 323 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------------------------HH
Confidence 32222 2345579999999999999999999999999999995 445542210 01
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
+.+.+|.+-+-.-+..+.+++++++..||..+|.+|||+..+.+.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 4445555444455678899999999999999999999999998544
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=292.11 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=200.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|...+.||+|+||.||+|... +++.|++|.+..... ..+.+..|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345678999999999999964 678999999875433 4577899999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc-
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ- 324 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 324 (464)
++++|.+++.....+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999999999887789999999999999999999999 8899999999999999999999999999987654332211
Q ss_pred -eeeeccCCCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 325 -FSRIRGTKGYMAPEWASNLP---ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 325 -~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.....++..|+|||++.+.. ++.++||||||+++||+++|+.||..... . +... . ..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~-----~~~~-~-~~------- 219 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----E-----FQIM-F-HV------- 219 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----h-----HHHH-H-HH-------
Confidence 12356788999999988766 89999999999999999999999863210 0 0000 0 00
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....+.+.. .......+.+++.+||+.+|++|||+.+++.
T Consensus 220 -~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 -GAGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -hcCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001111111 1112456778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.42 Aligned_cols=255 Identities=21% Similarity=0.224 Sum_probs=195.9
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
+....+.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34456677789999999999999975 5788999998642 223355788999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++|+|.+++.. ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 99999999999999854 458888999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcceeeeccCCCccCcccccCC----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNL----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .... ..+..
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~~~----~~i~~ 261 (371)
T cd05622 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------VGTY----SKIMN 261 (371)
T ss_pred Cc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---------HHHH----HHHHc
Confidence 21 122346799999999998654 378999999999999999999999863210 0111 11110
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK--RPTMDSVVQTL 446 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPsm~~V~~~L 446 (464)
.. ..+.-.........+.+++..|++.++.+ ||++.++++..
T Consensus 262 ~~---------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HK---------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CC---------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00 00000111123456778888999844433 78899888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=291.22 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=200.0
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.+.||.|+||.||.+.. .+++.+++|.+... ......+.+|++++++++|+|++++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45668899999999999885 45788999987643 234466889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 999999999764 468999999999999999999999 8899999999999999999999999999986644331
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.... ...... ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---------~~~~~~----~~---------- 213 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---------PLNLVV----KI---------- 213 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---------HHHHHH----HH----------
Confidence 2234568999999999988889999999999999999999999886311 001111 11
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
...... .........+.+++.+||+.+|.+||++.++++.+
T Consensus 214 -~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 214 -VQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -HcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111111 11123345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=312.78 Aligned_cols=198 Identities=23% Similarity=0.243 Sum_probs=172.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||+|++... ......+..|+.++..++|+|++++++.+.++...++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345678999999999999975 5789999998642 22335678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-- 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 322 (464)
+++|+|.+++.+...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999999888889999999999999999999999 99999999999999999999999999998754321100
Q ss_pred -------------------------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 323 -------------------------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 323 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001235699999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=298.77 Aligned_cols=248 Identities=23% Similarity=0.215 Sum_probs=197.4
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+..|+++++.++|+||+++++.+..+...++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 4456789999999999999754 88999999874322 335688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+.+++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998753 578999999999999999999999 89999999999999999999999999998754322110
Q ss_pred ---------------------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCc
Q 040010 323 ---------------------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDS 375 (464)
Q Consensus 323 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~ 375 (464)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-- 237 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR-- 237 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch--
Confidence 011234578899999999988899999999999999999999999863211
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT----MDSVVQ 444 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs----m~~V~~ 444 (464)
... ...+.+....-.........+.+++.+||+.||++||| +.++++
T Consensus 238 ---~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 ---DET-------------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---HHH-------------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 000 11111111111111124567999999999999999999 566555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=291.51 Aligned_cols=247 Identities=23% Similarity=0.253 Sum_probs=194.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc------chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 240 (464)
+...+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+|++++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345678999999999999974 57899999875321 1234678899999999999999999988663 56789
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+|||+++++|.+++.+...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 99999999999999877788999999999999999999999 889999999999999999999999999997654321
Q ss_pred CC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... . . .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~---~----~----------- 217 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M---A----A----------- 217 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H---H----H-----------
Confidence 11 112335688899999999888899999999999999999999999862100 0 0 0
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+..........+......+..++..|+. +|++||++++|++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 -IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001111111122344455667788888985 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.41 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=207.5
Q ss_pred hhhccccCccCceEEEEEEECCC-cEEEEEEcCCc-cchhHHHHHHHHHhhhcc-ccceecccee-ee-----e-CcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDE-RAVAVKRLGDL-HQGEEVFWAEVSTIGKIY-HMNLVRMWGF-CT-----E-GMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~-~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~-----~-~~~~~ 239 (464)
..+.+.|.+|||+.||.+....+ ..+|+|++-.. ..+.+..++|+++|++|+ |+|||.+++. .. . .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 45567899999999999998766 99999988644 445577899999999997 9999999993 21 1 24678
Q ss_pred EEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 240 LVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
|+||||.+|+|-+++..+ ..|+..+.++|+.++++|+++||... ++|||||||-+||||+.+++.||+|||.+...-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999743 46999999999999999999999844 789999999999999999999999999997543
Q ss_pred CCCCC-cce------eeeccCCCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH
Q 040010 318 RGSNS-SQF------SRIRGTKGYMAPEWA---SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 318 ~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
..... ... -....|+-|.|||.+ .+.++++|+|||+|||+||-|+....||+...
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------- 262 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------- 262 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------------
Confidence 33211 111 113368999999965 67899999999999999999999999997321
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
-..|++....-.........+..|+..||+.||.+||++-+|++.+-.+..
T Consensus 263 -------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 -------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 234555555433345678899999999999999999999999999988765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=293.12 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=199.4
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeee-----CcEEeEEEE
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-----GMHRLLVYE 243 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~E 243 (464)
.+.||+|++|.|.++..+ +|+.||||++... ....++-.+|+++|+.++|+||+.+.+.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 467999999999999964 6899999999732 3344667899999999999999999998754 467899999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+| ..+|...|..+..|+......+..|+++||.|+|+ .+|+||||||+|+|++.+..+||+|||+|+.........
T Consensus 107 lM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred HH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence 99 56899999888889999999999999999999999 899999999999999999999999999999886553344
Q ss_pred ceeeeccCCCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh--
Q 040010 324 QFSRIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR-- 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 400 (464)
.++....|..|.|||.+ ....||...||||.||++.||++|+..|........ +..+..-+....+..
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q---------l~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ---------LQLILELLGTPSEEDLQ 253 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH---------HHHHHHhcCCCCHHHHH
Confidence 45778899999999976 456899999999999999999999998874321110 000000000000000
Q ss_pred ----------hhhhc--CCc-cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 ----------IEEIV--DPR-LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ----------~~~~~--d~~-l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..+- .+. ....++ ......++|+.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11000 000 000111 334568899999999999999999998753
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.44 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=196.4
Q ss_pred HhhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.++||.|+||.||+|.... +..+++|.+.... .....+..|+++++.++|+|++++++.+..+...++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 46677889999999999999754 7899999987543 334668899999999999999999999999999999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|..++.+ ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 167 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRR 167 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccc
Confidence 9999988764 4578999999999999999999999 899999999999999999999999999987543221 112
Q ss_pred eeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 326 SRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+..... ..... +..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---------~~~~~----~~~------ 228 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLL----KIA------ 228 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---------HHHHH----HHh------
Confidence 3456888999999884 34578899999999999999999998753110 00000 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+.. ..+......+.+++.+||+.||++||++.++++
T Consensus 229 --~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 229 --KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0011111 112233446888999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.32 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=198.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++++++|+|++++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3556678999999999999864 67899999876432 23467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.. ..+++.....++.+++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 99999999854 568999999999999999999999 8999999999999999999999999999876543221 12
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...... +.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---------~~~~~~----~~----------- 214 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---------MKVLFL----IP----------- 214 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---------HHHHHH----Hh-----------
Confidence 334678899999999888899999999999999999999998753110 001000 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......+......+.+++.+||+.+|.+||++.++++.
T Consensus 215 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 215 -KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 010111222334568889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.40 Aligned_cols=269 Identities=21% Similarity=0.250 Sum_probs=193.1
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC------cE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MH 237 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 237 (464)
..+.+.+.||+|+||.||++... ++..||+|++... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34666789999999999999964 5789999998643 23345678999999999999999999988644 35
Q ss_pred EeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 238 RLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
.++||||+++ +|...+. ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 7999999975 5665553 348889999999999999999999 899999999999999999999999999997543
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccch------hhhHHHHHHHH--
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ------EAELTGFIREV-- 389 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~-- 389 (464)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ......+....
T Consensus 175 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 175 TNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 221 1234568999999999999999999999999999999999999987431100000 00000000000
Q ss_pred -HHHhhccc----hhhhhhhcCCccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 390 -KEKILCGE----EARIEEIVDPRLK---GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 390 -~~~~~~~~----~~~~~~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
........ .....+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0000010000000 00111224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=295.17 Aligned_cols=250 Identities=26% Similarity=0.309 Sum_probs=194.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeee-----eCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCT-----EGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv 241 (464)
++.+.+.||+|+||.||++... +++.+|+|.++........+.+|+.+++++ +|+|++++++++. .+...++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 3455678999999999999874 578999998876555556788999999999 6999999999873 45678999
Q ss_pred EEeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 242 YEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 242 ~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
|||+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999999998875 23568899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCcceeeeccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
.... ......|++.|+|||.+.. ..++.++|||||||++|||++|+.|+..... ..... .
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--------~~~~~-----~ 240 (286)
T cd06638 176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------MRALF-----K 240 (286)
T ss_pred cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--------hHHHh-----h
Confidence 3221 1233568999999998753 4578999999999999999999999863211 00000 0
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
..... .....++ ......+.+++.+||+.||++|||+.+|++.+
T Consensus 241 ~~~~~---~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRNP---PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccccC---CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 0011111 11234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=290.22 Aligned_cols=250 Identities=26% Similarity=0.297 Sum_probs=200.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||.|+||.||++... +++.+++|.+.... ...+.+.+|++++++++|+|++++++++..+...+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3566788999999999999974 56789999887543 245678899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++... ..++......++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 158 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KR 158 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--cc
Confidence 99999998765 689999999999999999999999 8899999999999999999999999999876543211 12
Q ss_pred eeeccCCCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 326 SRIRGTKGYMAPEWASNL---PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... . .. .. .. ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----~----~~-~~----~~------~~ 219 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----R----AL-FL----IS------KS 219 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----H----HH-HH----HH------hc
Confidence 335678899999998776 8899999999999999999999998632110 0 00 00 00 01
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+.+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 220 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 220 NFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111111 112334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.05 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=197.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+++.+.||+|+||.||++... ++..||+|.++.. ......+.+|++++++++|+|++++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 566788999999999999975 6889999988643 2234678899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|..++... ..+++..+..++.+++.||.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 99999988753 3789999999999999999999962 479999999999999999999999999987553221
Q ss_pred ceeeeccCCCccCcccccCC------CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 324 QFSRIRGTKGYMAPEWASNL------PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||..... . .....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~----~~~~~--------- 218 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----A----NIFAQ--------- 218 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----h----hHHHH---------
Confidence 2234578899999988544 358899999999999999999999863210 0 01000
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..+.+.. ....+.+....+..++.+||+.+|++||++.+++..
T Consensus 219 ---~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 ---LSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---HHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 112233455678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=304.34 Aligned_cols=196 Identities=23% Similarity=0.222 Sum_probs=169.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+++.. +++.||+|.+... ......+..|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456788999999999999975 5788999998642 12234578899999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 158 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-V 158 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-e
Confidence 999999999976 4679999999999999999999999 9999999999999999999999999999976543322 1
Q ss_pred ceeeeccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 324 QFSRIRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
......||+.|+|||.+.+ ..++.++||||||++||||++|+.||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 1233569999999998865 467899999999999999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.36 Aligned_cols=265 Identities=25% Similarity=0.299 Sum_probs=200.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|++++++++|+|++++++++..++..+++|||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 556788999999999999975 4789999988743 223467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++.+..++.....+++.....++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++......... ..
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (288)
T cd07833 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PL 158 (288)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cc
Confidence 998888777666779999999999999999999999 89999999999999999999999999999876544321 22
Q ss_pred eeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc------cch
Q 040010 326 SRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC------GEE 398 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 398 (464)
....++..|+|||++.+. .++.++||||||+++|||++|+.|+..... ...+.. .......... ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYL-IQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHHHhCCCCHHHhhhcccC
Confidence 345678899999999887 889999999999999999999988863211 000000 0000000000 000
Q ss_pred hh-----hhhhcCCc-cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 AR-----IEEIVDPR-LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~-----~~~~~d~~-l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. ..+..++. +...++......+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 000112223577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=303.03 Aligned_cols=196 Identities=21% Similarity=0.202 Sum_probs=169.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.||+|.+... ....+.+..|..++..++|+||+++++++.++.+.++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456788999999999999975 5789999998642 22335588899999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++.+ ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV- 158 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-
Confidence 999999999975 4579999999999999999999999 89999999999999999999999999998765432221
Q ss_pred ceeeeccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 324 QFSRIRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 1223568999999998863 457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=290.51 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=198.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeee--eCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCT--EGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~E 243 (464)
+.+.+.||.|+||.||++... ++..+|+|.+... ....+.+..|++++++++|+|++++++++. .+...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 455678999999999999864 5788999988643 233456888999999999999999999775 3466899999
Q ss_pred eccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 244 YVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHEC--LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 244 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
|+++++|.+++.. ...+++...+.++.+++.||+|||..+ ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999999864 357999999999999999999999332 2889999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.... ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+.... ...... ....
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------~~~~~~----~~~~-- 224 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---------QLQLAS----KIKE-- 224 (265)
T ss_pred CCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---------HHHHHH----HHhc--
Confidence 4332 1233568999999999998889999999999999999999999986321 011111 1110
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
......+......+.+++.+|++.+|++||++.+|++.
T Consensus 225 ----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ----------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112233445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.62 Aligned_cols=193 Identities=26% Similarity=0.320 Sum_probs=164.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.+.+.+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++|+||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4666788999999999999964 57889999987532 2345678899999999999999999987543 457
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 999999975 6777664 348899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 179 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 179 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 21 12345689999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=290.68 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=198.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.+|++... +++.+|+|++... ....+++.+|+.++++++|+|++++++++...++.++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456688999999999999964 5789999988642 233457889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 156 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-- 156 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--
Confidence 999999998753 358899999999999999999999 8999999999999999999999999999976543221
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......|++.|+|||+..+..++.++|+||||+++++|++|+.|+.... ...... ....+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---------~~~~~~----~~~~~------- 216 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---------MKNLVL----KIIRG------- 216 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---------HHHHHH----HHhcC-------
Confidence 1223457889999999998889999999999999999999999886210 011111 11111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. ...+......+.+++.+||+.+|++||+|.+|++
T Consensus 217 ----~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 217 ----SY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----CC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 10 1122334556889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.41 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred hhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
...+.||+|++|.||++.. .+++.+|+|.+.... ...+.+..|++++++++|+|++++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3456899999999999986 567899999886432 12356889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 321 (464)
||+++++|.+++.+...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999877889999999999999999999999 8999999999999998776 599999999876644321
Q ss_pred C--cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 322 S--SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 322 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......++..|+|||.+.+..++.++||||+|+++++|++|..|+...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~------------ 221 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS------NHLALIF------------ 221 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc------chHHHHH------------
Confidence 1 1122346788999999998888999999999999999999999998632110 0001100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..........+......+.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 ---KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000011112334445567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.59 Aligned_cols=239 Identities=23% Similarity=0.205 Sum_probs=186.2
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc---cccceeccceeeeeCcEEeEEEEeccC
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI---YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
||+|+||+||+|... +++.||+|++.... .....+..|..++... +|+||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 58899999986432 1223345566666655 699999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence 9999999888889999999999999999999999 899999999999999999999999999987543221 12334
Q ss_pred eccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... ... ....+..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---------~~~----~~~~i~~~~--------- 213 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---------TQQ----MYRNIAFGK--------- 213 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---------HHH----HHHHHHcCC---------
Confidence 6799999999988754 48999999999999999999999986321 001 111111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPT----MDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs----m~~V~~ 444 (464)
..+.. ......+.+++.+||+.||.+||+ +.++++
T Consensus 214 ~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01110 112345778999999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=316.40 Aligned_cols=195 Identities=22% Similarity=0.290 Sum_probs=162.3
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccc------cceeccceeeeeC-cEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH------MNLVRMWGFCTEG-MHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~~~-~~~~ 239 (464)
..+.+.++||+|+||+||++... .++.||||+++........+..|++++..++| .+++++++++... .+.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 34666789999999999999974 57889999997544444556677777777754 4588888888654 5788
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----------------
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---------------- 303 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---------------- 303 (464)
+|||++ +++|.+++.....+++..+..|+.||+.||.|||+. .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 999988 778999988778899999999999999999999972 3899999999999998765
Q ss_pred CeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 304 EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 304 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.+||+|||++..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 286 ~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 286 RVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred eEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998754322 12346799999999999999999999999999999999999999964
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=304.15 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=192.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.+...+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++|+||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4566688999999999999864 57899999987532 2335677899999999999999999987543 357
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 999999975 6666664 358899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHH-----------H
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFI-----------R 387 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~ 387 (464)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+...+ .
T Consensus 172 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 172 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----IDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHH
Confidence 21 12345689999999999999999999999999999999999999863211 00000000 0
Q ss_pred HH---HHHhhccchh----hhhhhcCCcc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 388 EV---KEKILCGEEA----RIEEIVDPRL---KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 388 ~~---~~~~~~~~~~----~~~~~~d~~l---~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. .......... .........+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000000000 0000000000 001112234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=296.22 Aligned_cols=243 Identities=27% Similarity=0.389 Sum_probs=195.9
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
..||.|+||.||++... ++..||||.+.... ...+.+.+|+..++.++|+|++++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999974 57899999986433 34466889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccC
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt 331 (464)
+++.. ..+++.....++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ......|+
T Consensus 108 ~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~ 181 (292)
T cd06658 108 DIVTH-TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGT 181 (292)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecC
Confidence 98843 468999999999999999999999 8999999999999999999999999999875533221 12345688
Q ss_pred CCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCC
Q 040010 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKG 411 (464)
Q Consensus 332 ~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 411 (464)
..|+|||.+.+..++.++||||||+++|||++|+.|+..... . ..... +.....+.+..
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~----~~~~~------------~~~~~~~~~~~ 240 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----L----QAMRR------------IRDNLPPRVKD 240 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHH------------HHhcCCCcccc
Confidence 999999999888899999999999999999999999863210 0 00010 11111222111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 412 HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 412 ~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......+..++..||+.||.+|||+.++++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233467788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.53 Aligned_cols=259 Identities=25% Similarity=0.271 Sum_probs=189.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhc---cccceeccceeeee-----CcE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKI---YHMNLVRMWGFCTE-----GMH 237 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 237 (464)
+.+.+.||+|+||.||++... +++.||+|.++.... ....+..|+++++.+ +|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456678999999999999975 578999998874321 223456677777665 69999999998754 356
Q ss_pred EeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 238 RLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
.+++|||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 799999997 4888888653 358999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
...... .....+|..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.... .....
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-----~~~~~~~~----~~~~~ 225 (288)
T cd07863 158 YSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIF----DLIGL 225 (288)
T ss_pred ccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-----HHHHHHHH----HHhCC
Confidence 543221 2335678999999999888999999999999999999999988853211 11111111 00000
Q ss_pred cchhhh-------hhhcCCccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARI-------EEIVDPRLK---GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~-------~~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...... .....+... .....+..+.+.+++.+|++.||++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000000 0011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.13 Aligned_cols=263 Identities=23% Similarity=0.248 Sum_probs=193.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|++|.||+|+.. +++.||+|+++... .....+.+|+.++++++|+|++++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345678999999999999975 68899999986432 22356889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+ ++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 7 6888887542 468999999999999999999999 899999999999999999999999999997654321
Q ss_pred cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH---HH-hhc-c
Q 040010 323 SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK---EK-ILC-G 396 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~-~ 396 (464)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.|+...... ........... .. +.. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-----DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHhCCCChhhhhcch
Confidence 11233457889999998765 45789999999999999999999988632110 00000000000 00 000 0
Q ss_pred chhhhhhh----cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEI----VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~----~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........ ....+.. .......++.+++.+||+.||.+|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000000 01113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=282.17 Aligned_cols=258 Identities=26% Similarity=0.280 Sum_probs=197.7
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCccchh---HHHHHHHHHhhhccccceeccceeeeeC--cEEeEEEEecc
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVYEYVE 246 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E~~~ 246 (464)
.+.|++|.||.||+|+.+ +++.||+|+++.....+ -...+|+.+|.+++|||||.+-.+.... +..|+||||++
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 457999999999999974 57899999998654322 2357899999999999999998876543 67899999997
Q ss_pred CCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
. +|..++.+-. ++...+..-+..|+++|++|||. ..|+|||||++|+|++..|.+||+|||||+..+... ..+
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~ 234 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--KPY 234 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc--ccC
Confidence 5 8888887654 89999999999999999999999 999999999999999999999999999999877642 335
Q ss_pred eeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh----
Q 040010 326 SRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR---- 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 400 (464)
+..+-|..|.|||.+.+. .|++..|+||+|||+.||++++..|....+-+ .+ ..+++-+....+..
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-----Ql----~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-----QL----DKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-----HH----HHHHHHhCCCccccCCCc
Confidence 677889999999987765 69999999999999999999999887533211 11 11111111110000
Q ss_pred ----------hhhhcCCccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 ----------IEEIVDPRLKGHFNKN-QAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ----------~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.....-..++..+... ..+.-.+|+...+..||.+|.|+++-++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0011111122222222 34667788889999999999999998753
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.40 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=198.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||.|+||.||++... ++..+|+|.+.... ...+.+..|++++++++|+|++++++.+..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 3667788999999999999974 57899999987543 334568899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++... ..+++.....++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~ 160 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KR 160 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--cc
Confidence 99999998764 579999999999999999999999 8999999999999999999999999999876543221 22
Q ss_pred eeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 326 SRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....+++.|+|||.+. ...++.++||||||+++|||++|+.|+..... . ... .+...+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~----~~~----~~~~~~~--- 224 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----M----RVL----LKILKSE--- 224 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----H----HHH----HHHhcCC---
Confidence 3456899999999874 34578899999999999999999999863210 0 000 1111110
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+.+. .+......+.+++..||+.+|.+||++.+|++.
T Consensus 225 -----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 -----PPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01110 111233467889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.78 Aligned_cols=247 Identities=27% Similarity=0.361 Sum_probs=200.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.+.+.||+|++|.||+|... ++..+++|.+.......+.+.+|++.++.++|+|++++++.+......++++||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445568999999999999986 5789999999865545677889999999999999999999999999999999999999
Q ss_pred ChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++.... .+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 101 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 175 (286)
T cd06614 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNS 175 (286)
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhcc
Confidence 9999998766 89999999999999999999999 8999999999999999999999999999875543221 1233
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... . . ....... ... +
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~---~-~~~~~~~-----------~~~-~ 234 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----L---R-ALFLITT-----------KGI-P 234 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----H---H-HHHHHHh-----------cCC-C
Confidence 4578899999999888899999999999999999999999753110 0 0 0000000 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. .........+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00 011123456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=302.87 Aligned_cols=196 Identities=22% Similarity=0.229 Sum_probs=168.7
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++..++ ++.+|+|.+... ......+..|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 4566889999999999999754 678999998642 12234578899999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++.+ ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........ .
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~ 158 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 158 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-c
Confidence 999999999976 4679999999999999999999999 8999999999999999999999999999875433221 1
Q ss_pred ceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 324 QFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
......||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 123456999999999885 3468899999999999999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.86 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=194.1
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeee------eCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCT------EGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~------~~~~~~l 240 (464)
.+.+.+.||.|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+|++++++++. .....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 455667899999999999997 4578999999876555556788999999998 6999999999884 3467899
Q ss_pred EEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 241 VYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999998643 468888899999999999999999 8999999999999999999999999999875532
Q ss_pred CCCCcceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... .
T Consensus 174 ~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--------~~~~-~----- 237 (282)
T cd06636 174 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--------RALF-L----- 237 (282)
T ss_pred ccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--------hhhh-h-----
Confidence 211 123456889999999875 346888999999999999999999998632110 0000 0
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+.+ ........+.+++.+||+.||.+||++.++++
T Consensus 238 -------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011111 11123456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.10 Aligned_cols=249 Identities=27% Similarity=0.324 Sum_probs=208.6
Q ss_pred HHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccc----hhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 241 (464)
..|.+.++||+|.||.||+++.+. |+.+|+|.+..... ..+...+|+++|+++. |||+|.+.+.++.....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 446777899999999999999765 89999999975432 3367899999999998 99999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC----CCeEEeeecCccccC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE----FEPKIADFGLAKLSQ 317 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~~ 317 (464)
||++.||.|.+.|... .++...+..++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999776 49999999999999999999999 999999999999999543 479999999999876
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. .......+||+.|+|||.+....|+..+||||+||++|.|++|..||....... . . .++..++
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-----~---~-----~~i~~~~ 254 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-----I---F-----LAILRGD 254 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-----H---H-----HHHHcCC
Confidence 5 344678999999999999999999999999999999999999999997432111 0 0 0222121
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......-....+.+.+++..++..||.+|+|+.++++.
T Consensus 255 ---------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 ---------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112222233456778899999999999999999999984
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.89 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=198.0
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccc-eeccceeeeeCc------EE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMN-LVRMWGFCTEGM------HR 238 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~ 238 (464)
+...++||+|+||+||+|+. .+|+.||+|+++.... ......+|+.+++.++|+| ||++.+++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44456799999999999995 5688999999975433 2344678999999999999 999999998777 78
Q ss_pred eEEEEeccCCChHHhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 239 LLVYEYVENQSLDKHLFSSN----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
++|+||++ .+|..++.... .++......++.||+.||+|||+ ++|+||||||.|||+++++.+||+|||+|+
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999995 58999987544 57778899999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
...-.. ...+...+|..|.|||.+.+. .|+...|+||+||++.||++++..|....+ .+-+..+.+.+
T Consensus 169 a~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---------~~ql~~If~~l 237 (323)
T KOG0594|consen 169 AFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---------IDQLFRIFRLL 237 (323)
T ss_pred HhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---------HHHHHHHHHHc
Confidence 655322 225667789999999998776 799999999999999999999888874322 11111122211
Q ss_pred hccchhh---hhhhcCCc--c---C--CCCCH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 394 LCGEEAR---IEEIVDPR--L---K--GHFNK---NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 394 ~~~~~~~---~~~~~d~~--l---~--~~~~~---~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
....+.. +..+.|-. . . ..+.. .......+++.+|++.+|.+|.|+...+++
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111000 00000100 0 0 00001 111478899999999999999999999886
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.56 Aligned_cols=247 Identities=26% Similarity=0.299 Sum_probs=193.4
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeC-----cEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG-----MHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lv~ 242 (464)
+.+.+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.+++++ +|+|++++++++... ...++||
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 44556899999999999997 4678999999876555556778899999998 799999999998653 4689999
Q ss_pred EeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 243 EYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 243 E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
||+++++|.+++. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 9999999999885 24578999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCcceeeeccCCCccCcccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNL-----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
.... .....|+..|+|||.+... .++.++||||||+++|||++|+.|+..... .... .. .
T Consensus 181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~~----~~----~ 245 (291)
T cd06639 181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKTL----FK----I 245 (291)
T ss_pred cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHHH----HH----H
Confidence 2211 1234588899999987543 368999999999999999999999863210 0000 00 0
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+. .+.+. .+.+....+.+++.+||+.+|++||++.++++
T Consensus 246 ~~~~--------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRNP--------PPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcCC--------CCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 01111 11223456889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.61 Aligned_cols=261 Identities=22% Similarity=0.235 Sum_probs=194.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||++... +|+.+|+|++.... .....+.+|++++++++|+|++++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 455678999999999999975 58899999986432 22355778999999999999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ ++|.+++.+ ...+++.....++.||++||.|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 7 578777754 4679999999999999999999999 8999999999999999999999999999986543221 1
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh---h
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA---R 400 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 400 (464)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .. ............... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DD----QLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HH----HHHHHHHHhCCCChHHhHH
Confidence 2334578899999988664 4789999999999999999999986532110 11 111111100000000 0
Q ss_pred hhhhcCCccCC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKG---------HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~---------~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....+..... .........+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00111110000 001123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=290.31 Aligned_cols=253 Identities=25% Similarity=0.269 Sum_probs=196.1
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E~~ 245 (464)
.+.+.||.|++|.||++... +++.+|+|.+.... .....+.+|++++++++|+||+++++++... ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45578999999999999984 57899999887432 3456789999999999999999999988643 4789999999
Q ss_pred cCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999988753 3468999999999999999999999 899999999999999999999999999987543321
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .... +....... .. .
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~~~~~----~~---~ 225 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPI---ELLSYIVN----MP---N 225 (287)
T ss_pred ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChH---HHHHHHhc----CC---c
Confidence 123457889999999999999999999999999999999999987432100 0011 11111100 00 0
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+ .... .......+.+.+++.+||+.+|.+|||+.||++
T Consensus 226 ~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PEL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001 1010 001123567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.13 Aligned_cols=243 Identities=27% Similarity=0.291 Sum_probs=192.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++|+|++++.++|..+...++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 566678999999999999975 58899999886322 2235688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++ |+|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 97 577666653 4579999999999999999999999 88999999999999999999999999998765432
Q ss_pred ceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 QFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... . ..... ....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~---~~~~~----~~~~---- 229 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------M---SALYH----IAQN---- 229 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------H---HHHHH----HhcC----
Confidence 2345788999999874 45688999999999999999999998753210 0 00000 0000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
..+.+ ........+.+++.+||+.+|++||+|.+|+...
T Consensus 230 ----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 ----DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00111 1223456789999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.60 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=194.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||.|+||.||+|... +++.||+|.++.. ......+.+|+.+++.++|+||+++++++......++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3566678999999999999975 5789999988643 223346778999999999999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ ++|.+++.. ...+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........ .
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 160 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 160 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence 7 588888865 3568999999999999999999999 8999999999999999999999999999975433221 1
Q ss_pred eeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ...................
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~----~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EE----QLHFIFRILGTPTEETWPG 231 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHHHcCCCChhhchh
Confidence 233457889999998765 4578899999999999999999999863211 00 0111100000000000000
Q ss_pred hcC---------CccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVD---------PRLKGH----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d---------~~l~~~----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+++ +..... ........+.+++.+|++.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 110000 01122446788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=285.85 Aligned_cols=248 Identities=27% Similarity=0.309 Sum_probs=204.2
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E~ 244 (464)
...+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|++.+++++|+|++++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34568999999999999986 68899999987544 3457789999999999999999999999888 899999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.+...+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999877799999999999999999999999 8899999999999999999999999999987665432111
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....++..|+|||.+.+...+.++||||||+++++|++|+.|+..... .... ...+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~---------------~~~~ 216 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--------PMAA---------------LYKI 216 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHH---------------HHhc
Confidence 2345688899999999888899999999999999999999999863220 0000 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.........+......+.+++.+|++.||++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111112233344667999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=278.42 Aligned_cols=247 Identities=26% Similarity=0.327 Sum_probs=199.5
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-----chh----HHHHHHHHHhhhc-cccceeccceeeeeCcEE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-----QGE----EVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-----~~~----~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 238 (464)
+.-.+.||+|..++|-++.. .+|+..|+|++.... ... +.-..|+.+|+++ .||||+.+.++++.....
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 33456799999999999886 457889999885321 111 3346799999998 599999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++|+|.|+.|.|.++|.+.-.++.....+|+.|+.+|+.|||. .+||||||||+|||+|++.++||+|||++..+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999999988899999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCCCcceeeeccCCCccCcccccC------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
+. .....+|||+|+|||.+.. ..|+..+|.|+.||++|-|+.|..||-... ...+.+.
T Consensus 176 Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------------QmlMLR~ 239 (411)
T KOG0599|consen 176 GE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------------QMLMLRM 239 (411)
T ss_pred ch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------------HHHHHHH
Confidence 53 3456889999999998753 358889999999999999999999985211 0111122
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..|.- + ...+--.+....+.+|+.+||+.||.+|.|..|++.
T Consensus 240 ImeGky----q-----F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKY----Q-----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccc----c-----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 222210 0 111112345677889999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=288.26 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=196.7
Q ss_pred cCccCceEEEEEEECC-CcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLTD-ERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||.|++|.||+++... ++.+|+|.+.... ...+.+.+|+++++.++|+|++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999853 7899999986432 2346788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
.+++.+...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 9999887789999999999999999999999 899999999999999999999999999998665432 1233467
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccC
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 410 (464)
+..|++||.+.+..++.++|+||||+++|||++|..|+.....+ . ... ...+.+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~---~~~---------------~~~~~~~~~~ 212 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----P---MEI---------------YNDILKGNGK 212 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----H---HHH---------------HHHHhccCCC
Confidence 88999999998888999999999999999999999998643210 0 011 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 411 GHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 411 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
..++......+.+++.+||+.+|++||+ +.|+++
T Consensus 213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2223333567999999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.08 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=195.1
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
..||+|+||.||++... +++.||+|.+... ....+.+.+|+.+++.++|+|++++++++..++..++++||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999974 6889999998643 233456889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccC
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt 331 (464)
.++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ......++
T Consensus 107 ~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~ 180 (297)
T cd06659 107 DIVSQ-TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 180 (297)
T ss_pred HHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecC
Confidence 87743 568999999999999999999999 8999999999999999999999999999875443221 12345688
Q ss_pred CCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCC
Q 040010 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKG 411 (464)
Q Consensus 332 ~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 411 (464)
..|+|||++.+..++.++||||||+++|||++|+.||..... . ..+.. + .....+...
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~----~~~~~----~--------~~~~~~~~~- 238 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----V----QAMKR----L--------RDSPPPKLK- 238 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHH----H--------hccCCCCcc-
Confidence 999999999988999999999999999999999999863211 0 00000 0 000000100
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 412 HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 412 ~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
........+.+++.+||+.+|++||++.++++.
T Consensus 239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 -NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011223457889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.04 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=196.5
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||+|.. .+++.+|+|.+... ....+++.+|+.++++++ |+|++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 34557899999999999996 46889999988643 334466888999999997 9999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 83 YAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred cCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 9999999999855 479999999999999999999999 8999999999999999999999999999987654331
Q ss_pred ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+..... ...... +.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---------~~~~~~------------~~ 215 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---------FRAMML------------IP 215 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---------hhhhhc------------cc
Confidence 1233468889999998765 4578999999999999999999999863210 000000 01
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
....+.+... .....+.+++.+||+.||++||++.++++.
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111111 134568899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.27 Aligned_cols=246 Identities=23% Similarity=0.271 Sum_probs=197.7
Q ss_pred cCccCceEEEEEEECC-CcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLTD-ERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||.|+||.||+++..+ ++.+++|.+.... ...+.+.+|++++++++|+|++++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 8899999986443 2446688999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC------Ccc
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN------SSQ 324 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------~~~ 324 (464)
.+++.+...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 9999877789999999999999999999999 8999999999999999999999999999876543321 112
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....++..|+|||.......+.++||||||+++|||++|+.|+..... .... ....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---------~~~~----~~~~---------- 214 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------EEIF----QNIL---------- 214 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHH----HHHh----------
Confidence 2345578899999999888899999999999999999999999863210 1111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
...............+.+++.+||+.+|.+|||+.+|.+.|..
T Consensus 215 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 215 -NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0011000011125678899999999999999999777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.04 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=190.7
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.+...+.||+|+||.||++.. .+++.||||++.... .....+.+|++++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 456667899999999999996 467899999987532 2335577899999999999999999987533 456
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++++|++ +++|.+++. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 8999988 789988774 4579999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VK 390 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 390 (464)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+..+... ..
T Consensus 171 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred C-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHH
Confidence 2 233568999999999876 5789999999999999999999999863211 0001000000 00
Q ss_pred HHhhccchhhhhhhcC--CccCC-C---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 391 EKILCGEEARIEEIVD--PRLKG-H---FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d--~~l~~-~---~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+.... ....+. +.... . ........+.+++.+|++.||.+|||+.++++.
T Consensus 241 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEH---ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred Hhcchhh---HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000 00000 0 000112357789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=291.78 Aligned_cols=259 Identities=24% Similarity=0.289 Sum_probs=203.7
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.++.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++|+|++++++.+..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 34566788999999999999864 6788999998643 334466889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.+ ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 99999999854 468899999999999999999999 8999999999999999999999999999875543322 12
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....+++.|+|||.+....++.++||||||+++||+++|+.||........ . . ....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~----~--------------~~~~ 229 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----L----Y--------------LIAT 229 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----e----e--------------ehhc
Confidence 334688899999999888899999999999999999999999863211100 0 0 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCCCCCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEAESEV 455 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~~~~~ 455 (464)
.+......+......+.+++.+||+.+|++||++.+++.. +....+...+
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~ 281 (293)
T cd06647 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSL 281 (293)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccc
Confidence 0110011122334568889999999999999999999976 4444443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.90 Aligned_cols=253 Identities=21% Similarity=0.212 Sum_probs=199.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... .++.|++|.+.... .....+.+|+++++.++|+||+++++.+..+.+.++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999975 46789999887432 2335678899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-- 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 322 (464)
+++++|.+++.....+++.....++.+++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 9999999999877889999999999999999999999 89999999999999999999999999998742111000
Q ss_pred -----------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 323 -----------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 323 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
.......++..|+|||.+.+..++.++|+||||+++|||++|..||.... . ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~----~~~~~~--- 227 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----P----EELFGQ--- 227 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H----HHHHHH---
Confidence 00112457889999999988889999999999999999999999986211 0 011111
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.. ......+.... .....+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 -~~------~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 -VI------SDDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HH------hcccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 10 01111121111 234567899999999999999998777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.23 Aligned_cols=249 Identities=26% Similarity=0.319 Sum_probs=197.3
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeC------cEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG------MHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~ 239 (464)
..+.+.+.||+|++|.||+|... +++.+++|.+.......+.+.+|+++++++ +|+|++++++++... ...+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 34566789999999999999975 577899999887666667899999999999 699999999998654 4589
Q ss_pred EEEEeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 240 LVYEYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999998864 3579999999999999999999999 8999999999999999999999999999876
Q ss_pred cCCCCCCcceeeeccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
..... .......++..|+|||.+.. ..++.++||||||++++||++|+.||..... .. .. .
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~---~~-~--- 228 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MR---AL-F--- 228 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HH---HH-H---
Confidence 54322 11234568899999998753 3477899999999999999999999862110 00 00 0
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. .....+.+ ..+.+....+.+++.+||..||++|||+.++++
T Consensus 229 -~~--------~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -KI--------PRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -Hh--------hccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011111 112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.22 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=196.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|++++++++|+|++++++.+..+...++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456678999999999999864 5788999988643 223467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 322 (464)
++++|.+++... ..+++..+..++.+++.||+|||+ .+++|+||+|+||+++.+. .+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999753 358999999999999999999999 8999999999999998654 589999999986654321
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... .........
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---------~~~~~~~~~------------ 214 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---------LPALVLKIM------------ 214 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---------hHHHHHHHH------------
Confidence 223568889999999998889999999999999999999999985321 011111110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
... ....+......+.+++.+||+.+|++|||+.++++
T Consensus 215 ---~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 215 ---SGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---hcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000 00111223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=293.61 Aligned_cols=248 Identities=26% Similarity=0.285 Sum_probs=195.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+...+.||+|+||.||+++.. ++..+|+|.+.... .....+..|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445578999999999999964 57899999986432 2234688899999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++ |+|.+.+.. ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 97 477776653 5579999999999999999999999 89999999999999999999999999998754322
Q ss_pred ceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 QFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+..... .. ...
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~----~~~------------- 234 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MS----ALY------------- 234 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HH----HHH-------------
Confidence 2345888999999873 45689999999999999999999999763210 00 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+................+.+++.+||+.+|.+||++.+|++.+.-...
T Consensus 235 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 235 --HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0000011111122334568899999999999999999999987765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=286.78 Aligned_cols=251 Identities=27% Similarity=0.351 Sum_probs=200.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||.|+||+||+|... ++..+|+|++... ......+.+|++.++.++|+|++++++.+..+...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456788999999999999964 5788999998643 2345678999999999999999999999999999999999999
Q ss_pred CCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|.+++... ..+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++..........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999753 468999999999999999999999 899999999999999999999999999998665443221
Q ss_pred --ceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 --QFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
......|+..|+|||.+... .++.++|+||||+++|||++|+.|+..... ...... ....
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~--------~~~~---- 222 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-----MKVLML--------TLQN---- 222 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-----hhhHHH--------HhcC----
Confidence 12335688999999998776 789999999999999999999999863211 000000 0000
Q ss_pred hhhhcCCccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHF-NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+.+.... .......+.+++..||+.||++||++.++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 ----DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011111111 1233467889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.01 Aligned_cols=245 Identities=23% Similarity=0.261 Sum_probs=200.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||.|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++|||++++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456678999999999999975 58899999886432 3456788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 155 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---L 155 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---c
Confidence 9999999999877789999999999999999999999 889999999999999999999999999988654432 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~--------------- 213 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-------IRDQIRAK--------------- 213 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-------HHHHHHHH---------------
Confidence 23456888999999998888999999999999999999999998743211 01111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM--DSVV 443 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm--~~V~ 443 (464)
... .....+......+.+++.+||+.||.+||++ +|++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 000 1112223344678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.81 Aligned_cols=240 Identities=28% Similarity=0.290 Sum_probs=197.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456788999999999999975 57899999886432 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 9999999999888889999999999999999999999 89999999999999999999999999999865443
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+.... . . .... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~---~----~~~~-----------~~ 210 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------P---I----QIYE-----------KI 210 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------H---H----HHHH-----------HH
Confidence 233468899999999988889999999999999999999999986321 0 0 0011 11
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVV 443 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~ 443 (464)
..... .++......+.+++.+||+.||.+|| ++.+++
T Consensus 211 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 211 LEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred hcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11111 11222345788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=286.80 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=199.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|++|.||++... +++.+|+|++... .....++.+|++++++++|+|++++++.+..+...++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 345578999999999999986 5789999988754 2344678899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++... ..++......++.|++.||+|||+. .+++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 156 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---- 156 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence 99999999865 7889999999999999999999982 4699999999999999999999999999875532211
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ......+ ..+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~---------------~~~~ 217 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP----DGIFELL---------------QYIV 217 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc----ccHHHHH---------------HHHh
Confidence 12568889999999998899999999999999999999999986431110 0011111 1111
Q ss_pred CCccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKN-QAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ...+.. ....+.+++.+||..||++|||+.+++.
T Consensus 218 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 218 NEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 111111 4556889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.97 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=197.4
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeee--Cc
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GM 236 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~ 236 (464)
.++....+.+.+.||+|+||+||++... .+..+|+|.+... ......+..|+.++++++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3444456778889999999999999975 4678899988643 2334668899999999999999999998754 45
Q ss_pred EEeEEEEeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceEecCCCCCCEEEcCC------
Q 040010 237 HRLLVYEYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECL----EWVIHCDVKPENILLDSE------ 302 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~dlk~~NIll~~~------ 302 (464)
..+|||||+++|+|.++|.. ...+++...+.|+.||+.||.|||+... .+||||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 78999999999999999864 2479999999999999999999998431 459999999999999643
Q ss_pred -----------CCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 303 -----------FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 303 -----------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
..+||+|||++........ .....||+.|+|||.+.+ ..++.++|||||||+||||++|+.||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3489999999986543221 234568999999998854 458999999999999999999999986
Q ss_pred ccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHhh
Q 040010 370 WVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV--QTLL 447 (464)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~--~~L~ 447 (464)
... .....+.. +. . .+.+. .......+.+|+..||+.+|.+||++.+++ ..+.
T Consensus 245 ~~~--------~~~qli~~----lk--------~--~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 245 KAN--------NFSQLISE----LK--------R--GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cCC--------cHHHHHHH----Hh--------c--CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 321 11111111 10 0 01110 011235688999999999999999999998 4454
Q ss_pred C
Q 040010 448 G 448 (464)
Q Consensus 448 ~ 448 (464)
.
T Consensus 300 ~ 300 (1021)
T PTZ00266 300 N 300 (1021)
T ss_pred h
Confidence 3
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=281.72 Aligned_cols=245 Identities=28% Similarity=0.384 Sum_probs=200.0
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
...+.||+|++|.||++... ++..+++|++..... ....+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 44578999999999999985 678999999976543 5577899999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~ 156 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT 156 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence 999999765 589999999999999999999999 8999999999999999999999999999976654321 234
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ....... ....-+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~------------~~~~~~ 215 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---------MKALFKI------------ATNGPP 215 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---------HHHHHHH------------HhcCCC
Confidence 5688899999999888899999999999999999999998863210 0000000 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.. .......+.+++.+||+.||++|||+.++++
T Consensus 216 ~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 216 GLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcCc--ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0100 1112456889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=287.47 Aligned_cols=241 Identities=25% Similarity=0.263 Sum_probs=187.9
Q ss_pred ccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhh---ccccceeccceeeeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGK---IYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~---l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.||+|+||.||++... +++.+|+|.+.... .....+..|..+++. .+|+|++.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 57899999886432 122334455444433 479999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.....+++.....++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 99999999877889999999999999999999999 889999999999999999999999999987543321 12
Q ss_pred eeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...|+..|+|||.+. +..++.++||||||+++|||++|+.||....... .. ..... ....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~----~~~~~------------~~~~ 214 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KH----EIDRM------------TLTV 214 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---HH----HHHHH------------hhcC
Confidence 346899999999886 4568999999999999999999999986422111 00 00000 0001
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
.. ..+......+.+++.+||+.||.+|| |+.++++.
T Consensus 215 ~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred Cc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 12233455788999999999999999 59999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=289.25 Aligned_cols=243 Identities=27% Similarity=0.379 Sum_probs=196.2
Q ss_pred ccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 173 KEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
.+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++|+|++++++++..++..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999996 467899999886433 3345688999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ ......|
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~ 177 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVG 177 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccC
Confidence 999876 678999999999999999999999 8999999999999999999999999998875543221 1233458
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccC
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 410 (464)
++.|+|||.+.+..++.++||||||+++|||++|+.|+.... . ..... ... ....+.+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~---~~~~~----~~~--------~~~~~~~~ 236 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------P---LQAMK----RIR--------DNLPPKLK 236 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------H---HHHHH----HHH--------hcCCCCCc
Confidence 899999999988889999999999999999999999986311 0 01111 111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 411 GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 411 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .......+.+++.+||+.+|++||++.++++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1 1123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=282.80 Aligned_cols=248 Identities=21% Similarity=0.209 Sum_probs=202.7
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.++.+.||.|.-|+||.+.+++ +...|+|++.... ........|-++|+.+.||-++.|++.++.++..+++|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3555789999999999999876 4789999997542 2334567799999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC----
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR---- 318 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~---- 318 (464)
|+||+|..++++. +.++...+..++..++-||+|||- .|||+|||||+||||-++|++.|+||.|+..+..
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999854 579999999999999999999999 9999999999999999999999999999753211
Q ss_pred -----------------------------C-C--------------------CCcceeeeccCCCccCcccccCCCCCcc
Q 040010 319 -----------------------------G-S--------------------NSSQFSRIRGTKGYMAPEWASNLPITSK 348 (464)
Q Consensus 319 -----------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (464)
. . ........+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0011234669999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHc
Q 040010 349 VDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISC 428 (464)
Q Consensus 349 ~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~C 428 (464)
+|+|+|||+||||+.|+.||...... .. +..++-..+.-.-..+....+.+|++..
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~-----~T-------------------l~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNK-----ET-------------------LRNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCch-----hh-------------------HHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 99999999999999999999854221 11 3344443433222335667789999999
Q ss_pred cCCCCCCCCC----HHHHHH
Q 040010 429 VDEDRNKRPT----MDSVVQ 444 (464)
Q Consensus 429 l~~dp~~RPs----m~~V~~ 444 (464)
|.+||.+|.. +.||-+
T Consensus 372 LvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hccChhhhhccccchHHhhc
Confidence 9999999998 777754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=304.93 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=198.2
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcC-----CccchhHHHHHHHHHhhhccccceeccceeeeeCcE--EeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLG-----DLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH--RLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~ 242 (464)
.|.++||+|+|-+||||.+. +|-.||---++ ......+.|..|+.+|+.|+|+||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45568999999999999974 35666643332 233344779999999999999999999998876644 78999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~ 321 (464)
|.|..|+|..++.+...++......|++||++||.|||+.. ++|+|||||..||+|+.+ |.+||+|+|||.+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999999999999999999999999999999999977 799999999999999865 789999999999876543
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh-
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR- 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 400 (464)
...+.|||.|||||... ..|++.+||||||+.++||+|+.-|+.--. . ..++.+++-.|.++.
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--------n----~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--------N----PAQIYKKVTSGIKPAA 264 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--------C----HHHHHHHHHcCCCHHH
Confidence 34588999999999877 789999999999999999999998875211 1 233444444443332
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+-| .++.+++..|+.. ..+|||+.|+++
T Consensus 265 l~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVKD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 222223 3478899999999 999999999985
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.98 Aligned_cols=195 Identities=27% Similarity=0.371 Sum_probs=165.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|++|.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 456678999999999999975 678999999864322 23456789999999999999999999999999999999998
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+ +|.+++... ..+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+++........ .
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~ 160 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--Y 160 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--c
Confidence 5 899988654 468999999999999999999999 89999999999999999999999999998754322111 1
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22346788999998865 4589999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=288.31 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=188.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHH-hhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVST-IGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||++... +|+.||+|+++... .....+..|+.. ++..+|+|++++++++..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 455678999999999999975 58999999987543 233455666665 56678999999999999999999999999
Q ss_pred cCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 246 ENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 246 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+ |+|.+++.. ...+++...+.++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 688777653 3468999999999999999999998 6 79999999999999999999999999987653321
Q ss_pred CCcceeeeccCCCccCcccccC----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 321 NSSQFSRIRGTKGYMAPEWASN----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... ... ....
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~-~~~~------- 220 (283)
T cd06617 159 ---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQ-LKQV------- 220 (283)
T ss_pred ---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHH-HHHH-------
Confidence 1223457889999998754 45688999999999999999999998531110 000 0000
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..-..+.+. .......+.+++.+||+.+|++||++.++++
T Consensus 221 -----~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 -----VEEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----HhcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111111 1123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=303.72 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=200.6
Q ss_pred ccCccCceEEEEEEECC-CcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChHH
Q 040010 175 ELGKGGSGAVYKGVLTD-ERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDK 252 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~ 252 (464)
.||+|.||+||-|+..+ ...+|||-+... .+...-+..|+.+-++++|+|||+.+|.|.++++.-+.||.++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 557899988743 3344568899999999999999999999999999999999999999999
Q ss_pred hhhcC-CCC--CHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeecCccccCCCCCCcceeee
Q 040010 253 HLFSS-NFL--GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 253 ~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+|... +++ ++.+.-.+..||++||.|||+ +.|||||||-.|||++ -.|.+||+|||.++.+..-. ..+.+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 99754 566 788888999999999999999 8999999999999996 47889999999998765432 235667
Q ss_pred ccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 329 RGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
-||.-|||||.+..+ .|...+|||||||++.||.||+.||.-.... +.. +++ +-=
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAA--------MFk------------VGm 793 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAA--------MFK------------VGM 793 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHh--------hhh------------hcc
Confidence 799999999999765 5899999999999999999999999732211 000 000 000
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
-...++.+.+...+...++++|+.+||.+||++.++++
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12345678889999999999999999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=287.08 Aligned_cols=261 Identities=25% Similarity=0.265 Sum_probs=193.8
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.++||.|++|.||+|... +|..||+|++.... ...+.+.+|+++++.++|+|++++++++.++...+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 34578999999999999974 68999999987432 223568899999999999999999999999999999999995
Q ss_pred CCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 155 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T 155 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence 68999987655 79999999999999999999999 8999999999999999999999999999975543221 1
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH----------HHh
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK----------EKI 393 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 393 (464)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ........... ...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-----DQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhhhhhc
Confidence 2233568899999987654 5789999999999999999999988632110 00111110000 000
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ............ .........+.+++.+|++.||.+|||+.++++
T Consensus 231 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYK-PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhh-hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 000000000000 011122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=284.60 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=196.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... ++..+|+|.+... ....+.+.+|+++++.++|+|++++++.+..+...++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345678999999999999975 4788999988643 234456889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 322 (464)
++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999987543 58999999999999999999999 8899999999999999886 469999999976643221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......|++.|+|||+..+..++.++||||||+++|||++|+.|+.... ........ ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------~~~~~~~~-----------~~ 216 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---------LHQLVLKI-----------CQ 216 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHHHH-----------hc
Confidence 1233468899999999988889999999999999999999999985321 11111111 01
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+.+ ........+.+++.+|++.+|++|||+.++++.
T Consensus 217 ~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 GYFAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ccCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111 111233468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.85 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=203.9
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|++|.||+++..+ ++.+++|++.... .....+.+|++.+.+++|+|++++++++......++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 3456789999999999999864 8899999987543 345778999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.....+++..+..++.|+++||+|||+. .+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence 999999998778899999999999999999999973 46899999999999999999999999999866443222 23
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ......... +..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~---------------~~~ 217 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ------PSFFELMQA---------------ICD 217 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc------cCHHHHHHH---------------Hhc
Confidence 45688899999999988999999999999999999999999864321 011111111 111
Q ss_pred CccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 407 PRLKGHFNKN-QAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 407 ~~l~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
... ...+.. ....+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 GPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 112222 45678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=301.46 Aligned_cols=238 Identities=27% Similarity=0.316 Sum_probs=197.7
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
..||.|+||.||-++. .+.+.||||+++-+.. .-..+..|+..|++++|||.+.+-|++..+...|||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 4799999999999996 4678999999974422 23568899999999999999999999999999999999995 6
Q ss_pred ChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|-.+++. ...++..-+...|..+.+.||+|||+ .+.||||||+.||||++.|.+||+|||.|..... ...
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------Ans 181 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANS 181 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc------hhc
Confidence 8888876 34678899999999999999999999 8889999999999999999999999999987654 456
Q ss_pred eccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 328 IRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 328 ~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
+.|||.|||||++. .+.|+-|+||||||++-.||...+.|...+... ..+.. +..-
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------------SALYH---------IAQN 240 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------SALYH---------IAQN 240 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------------HHHHH---------HHhc
Confidence 78999999999863 568999999999999999999999987643211 11111 1222
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
-.|.+. ..+....+.+++..||+.-|.+|||..++++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 233433 45778889999999999999999999998764
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.48 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=197.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++|+|++++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456678999999999999974 68899999987443 23467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 9999999864 3579999999999999999999999 8999999999999999999999999999986654322 12
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh---
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR--- 400 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 400 (464)
.....++..|+|||.+.+. .++.++||||+|++++||++|..++.... ....+.. ............
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~~~ 227 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAI----VFRTLGTPNEETWPG 227 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHH----HHHHcCCCChHHHhh
Confidence 3345688999999987654 46899999999999999999976664211 0111110 111000000000
Q ss_pred ------hhhhcCCccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 ------IEEIVDPRLK----GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ------~~~~~d~~l~----~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+..+... .....+....+.+++.+|++.+|++|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00011234778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.96 Aligned_cols=259 Identities=25% Similarity=0.307 Sum_probs=205.0
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceecccee
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGF 231 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~ 231 (464)
.|+......+.+.||+|.||.|++|... ....||||.++... ...+.+..|+++|+.+ +|+|++.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444444456679999999999999853 14579999998543 3457799999999999 69999999999
Q ss_pred eeeCcEEeEEEEeccCCChHHhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 232 CTEGMHRLLVYEYVENQSLDKHLFSSN----------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 232 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
|..+...++|.||+..|+|.++|.... .++....+.++.|||.|++||++ .++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999997543 38889999999999999999999 88999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeec--cCCCccCcccccCCCCCccchhHHHHHHHHHHHhCC-CCCCccc
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR--GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGI-RLSNWVV 372 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~-~p~~~~~ 372 (464)
|||+.++..+||+|||+++......... ..... -...|||||.+....|+.|+|||||||+||||+|.. .|+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999998655433222 11122 234699999999999999999999999999999954 4543210
Q ss_pred cCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 373 EDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. ..+. .+.+.+.-+..-+..+..++.++++.||+.+|++||++.++++.++..
T Consensus 527 ~--------~~~l----------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P--------TEEL----------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c--------HHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 0111 111222222233555677899999999999999999999999999873
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=287.03 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=195.1
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E~ 244 (464)
.+.+.||+|++|.||+|... +++.+|+|++.... .....+.+|++++++++|+|++++++++... ...++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35678999999999999975 47899999997542 2335688899999999999999999999887 899999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++ +|.+++... ..+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 975 888888665 579999999999999999999999 8899999999999999999999999999986654332 1
Q ss_pred ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh--
Q 040010 324 QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR-- 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 400 (464)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ..... .............
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~----~~~~~~~~~~~~~~~ 227 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLE----KIFELCGSPTDENWP 227 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHH----HHHHHhCCCchhhcc
Confidence 1233456788999997764 4678999999999999999999998863211 11111 1110000000000
Q ss_pred -hhh-----------hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 -IEE-----------IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 -~~~-----------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
... .....+...+...+...+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000001111112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.42 Aligned_cols=261 Identities=23% Similarity=0.255 Sum_probs=192.3
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.||.|++|.||+|+.. +++.||||++..... ....+.+|++++++++|+|++++++++.++...++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 44578999999999999974 588999998874322 23568899999999999999999999999999999999996
Q ss_pred CCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
++|..++.. ...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 156 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 156 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--c
Confidence 689888864 3578999999999999999999999 8999999999999999999999999999876543221 1
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH----------HHh
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK----------EKI 393 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 393 (464)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||..... ............ ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-----IDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHhCCCChhhhhhhhHH
Confidence 2334568899999987654 468899999999999999999999863211 111111110000 000
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ..........+.. ........+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYK-PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHH-hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 0000000000000 00112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.34 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=195.4
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhc-cccceeccceeeee--CcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE--GMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~~~l 240 (464)
..+.+.+.||+|+||.||+|... +++.+|+|++... ......+..|+.+++++ +|+||+++++++.. +...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34666788999999999999975 5789999988532 22335577899999999 99999999998864 346899
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||++ ++|..++... .++|..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999997 5999888665 88999999999999999999999 899999999999999999999999999998664433
Q ss_pred CC---cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH-------
Q 040010 321 NS---SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV------- 389 (464)
Q Consensus 321 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 389 (464)
.. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-----QLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCCHHH
Confidence 21 12334568999999998754 567899999999999999999999986321110 000000000
Q ss_pred HHHhhccchhhhhhhcC----CccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 390 KEKILCGEEARIEEIVD----PRLK--GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d----~~l~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+.. .....+++ .... .....+....+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKS---PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHh---hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 00001111 0000 00011134678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.99 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=196.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 242 (464)
.+.+.+.||.|+||.||+|... +++.+|+|.++.... ....+.+|+.++++++|+|++++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3556678999999999999975 578999999874332 223567899999999999999999998877 8999999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||++ ++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9997 5999888654 369999999999999999999999 8899999999999999999999999999986654321
Q ss_pred CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH----------H
Q 040010 322 SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV----------K 390 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~ 390 (464)
......+++.|+|||.+.+. .++.++|+||||+++|||++|..||...... .......... .
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-----DQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchHHHHHh
Confidence 12334578899999988654 4689999999999999999999998642211 0010000000 0
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKN-QAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+...............+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000111111112222222 3566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=281.10 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=199.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||.|+||.||++... +++.+++|.+.... .....+..|++++++++|+|++++++++.++...++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345678999999999999864 67889999987432 23456778999999999999999999999999999999999
Q ss_pred cCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
++++|.+++.. ...+++.....++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999865 3578999999999999999999999 899999999999999999999999999998765431
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.....++..|+|||...+..++.++|+||||+++|||++|+.|+.... .. ... ...
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~---~~~----~~~-------- 213 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS------MQ---DLR----YKV-------- 213 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HH---HHH----HHH--------
Confidence 223457889999999999899999999999999999999999986321 00 000 011
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
........+......+.+++.+|++.+|++||++.++++.
T Consensus 214 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 ----QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111112233455678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.14 Aligned_cols=270 Identities=21% Similarity=0.277 Sum_probs=196.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 240 (464)
.+.+.+.||+|+||.||+|.. .+++.||+|.++.. ......+..|+.++++++|+|++++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 355678999999999999986 46889999998642 23345678899999999999999999987544 45799
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
++||+++ +|...+ ....+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9999974 787777 44579999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCc-ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSS-QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .... ............
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~----~~~~~~~~~~~~ 231 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQL----NLILGVLGTPSQ 231 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH----HHHHHHcCCCCH
Confidence 211 1233568899999998654 5689999999999999999999998853210 0000 000000000000
Q ss_pred hhhhhhcCCcc---------CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCCC
Q 040010 399 ARIEEIVDPRL---------KGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEAE 452 (464)
Q Consensus 399 ~~~~~~~d~~l---------~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~~ 452 (464)
.....+.+... ....+ ......+.+++.+||+.+|++|||+.++++. ++...++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00111110000 00000 1124568899999999999999999999986 6655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.50 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=200.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|++|.||++... +++.+++|.+.... ...+.+.+|++++++++|+|++++++++..+...+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 345678999999999999875 57899999987554 34467899999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~ 156 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--D 156 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--c
Confidence 999999999877889999999999999999999999 89999999999999999999999999999876543321 2
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....++..|+|||...+..++.++||||+|+++++|++|+.|+..... ...... . ..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~~~~~~-----~--------~~-- 213 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------MAALFR-----I--------VQ-- 213 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHH-----H--------hc--
Confidence 335678899999999888899999999999999999999998863210 000000 0 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+......+.+++.+||+.+|++|||+.+++.
T Consensus 214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0011122233456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.33 Aligned_cols=248 Identities=27% Similarity=0.325 Sum_probs=200.5
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.+.+.+.||+|.|+.||+... +.|+..|+|.+... ..+.+++.+|+++-+.++|||||++.....+....++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 456668899999999999985 46888888877532 33567788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCCCCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~ 321 (464)
|.|+.|..-|-.+...++..+-..+.||+++|.|.|. ++|||||+||.|++|.. .--+||+|||++.....+
T Consensus 92 m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 92 VTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 9999998777666677888889999999999999999 99999999999999943 345899999999987732
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......|||+|||||++...+|+..+|||+-||+||-|+.|..||.... +. .+.+++..|.
T Consensus 167 -~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~--------rlye~I~~g~---- 228 (355)
T KOG0033|consen 167 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QH--------RLYEQIKAGA---- 228 (355)
T ss_pred -cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HH--------HHHHHHhccc----
Confidence 33566789999999999999999999999999999999999999997311 11 1122222221
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
--+++... ....+...+|+.+||..||.+|.|+.|.++
T Consensus 229 -yd~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 -YDYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -cCCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11222222 234456788999999999999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.44 Aligned_cols=259 Identities=18% Similarity=0.179 Sum_probs=184.2
Q ss_pred HHHhhhccccCccCceEEEEEEECCC----cEEEEEEcCCccch---h---------HHHHHHHHHhhhccccceeccce
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDE----RAVAVKRLGDLHQG---E---------EVFWAEVSTIGKIYHMNLVRMWG 230 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~----~~vavK~l~~~~~~---~---------~~~~~E~~~l~~l~h~niv~l~g 230 (464)
...+.+.+.||+|+||.||+|...++ ..+|+|........ + .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 34567778999999999999997553 45666654322111 0 11223344556678999999999
Q ss_pred eeeeCc----EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeE
Q 040010 231 FCTEGM----HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306 (464)
Q Consensus 231 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 306 (464)
++.... ..++++|++. .++.+.+......++.....|+.|++.||+|||+ .+|+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 765443 4467777764 3666666555557888899999999999999999 8999999999999999999999
Q ss_pred EeeecCccccCCCCCC-----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhh
Q 040010 307 IADFGLAKLSQRGSNS-----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAE 381 (464)
Q Consensus 307 l~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 381 (464)
|+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~----~ 242 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN----L 242 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH----H
Confidence 9999999865432211 112335699999999999999999999999999999999999999974321111 0
Q ss_pred HHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 382 LTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
.......... .+..+.+. .......+.+++..|++.+|++||++.++.+.|+
T Consensus 243 ~~~~~~~~~~-----------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIK-----------RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHH-----------Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1000011111 11111111 0112456889999999999999999999998763
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.65 Aligned_cols=198 Identities=24% Similarity=0.315 Sum_probs=165.1
Q ss_pred hhhccccCccCceEEEEEEECC---CcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD---ERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 240 (464)
+.+.+.||+|+||.||+|.... +..||+|.+.... .....+.+|+.+++.++|||++++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4566789999999999999754 7899999987532 2235677899999999999999999999888 88999
Q ss_pred EEEeccCCChHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC----CCCeEEeeec
Q 040010 241 VYEYVENQSLDKHLFS-----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS----EFEPKIADFG 311 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg 311 (464)
||||+++ +|.+++.. ...++......++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 66666542 1268899999999999999999999 88999999999999999 9999999999
Q ss_pred CccccCCCCC-CcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 040010 312 LAKLSQRGSN-SSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWV 371 (464)
Q Consensus 312 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~ 371 (464)
++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9986644322 112234567889999998766 45899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.85 Aligned_cols=273 Identities=22% Similarity=0.272 Sum_probs=199.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 240 (464)
+...+.||+|+||+||++... +++.||||.+... ......+..|+.+++.++|+|++++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 455678999999999999964 5789999998643 22345677899999999999999999987644 35799
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||+. ++|.+++.....+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 999996 6899998877889999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH--------
Q 040010 321 NSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE-------- 391 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 391 (464)
.......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ..... .......
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~-~~~~~~~~~~~~~~~ 234 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLK-LITELLGSPSEEDLG 234 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHH-HHHHHhCCCChHHhh
Confidence 11233457889999998764 4689999999999999999999999863210 00000 0000000
Q ss_pred Hhhccc-hhhhh---hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCCCCCC
Q 040010 392 KILCGE-EARIE---EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEAESEV 455 (464)
Q Consensus 392 ~~~~~~-~~~~~---~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~~~~~ 455 (464)
...... ...+. ...++... ....+....+.+++.+||+.+|++|||+.++++. +....+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 000000 00000 00001000 0111245668899999999999999999999977 6665544333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=281.22 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=196.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc------cchhHHHHHHHHHhhhccccceeccceeeeeC--cEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL------HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 240 (464)
+.+.+.||+|+||.||+|... ++..||+|.+... ......+.+|++++++++|+|++++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456678999999999999964 5889999987421 12335688999999999999999999998654 56889
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
++||+++++|.+++.+...+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 99999999999999877789999999999999999999999 899999999999999999999999999998654321
Q ss_pred C-CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 N-SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ... .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~----~----------- 217 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--------AMA----A----------- 217 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--------HHH----H-----------
Confidence 1 111234568899999999998889999999999999999999999986311 000 0
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+..........+....+.+.+++.+|++ +|..||+..+++.
T Consensus 218 -~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 -IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011111111122344455678899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.46 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=190.8
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccC
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++..+...+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4467999999999999974 57899999987432 34456889999999996 99999999999999999999999864
Q ss_pred CChHHhh---h--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 248 QSLDKHL---F--SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 248 gsL~~~l---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|.++. . ....+++.....++.+++.||+|||+. .+++||||||+||+++.++.+||+|||++........
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 554433 2 235799999999999999999999972 3799999999999999999999999999976543221
Q ss_pred cceeeeccCCCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 323 SQFSRIRGTKGYMAPEWASNL---PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.... ...... .+...+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----------~~~~~~-~~~~~~--- 226 (288)
T cd06616 164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----------SVFDQL-TQVVKG--- 226 (288)
T ss_pred --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----------hHHHHH-hhhcCC---
Confidence 1234588899999998766 68999999999999999999999986211 000110 111000
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+.+...........+.+++.+||+.||++|||+.+|++.
T Consensus 227 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 -----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122222223345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=283.81 Aligned_cols=241 Identities=26% Similarity=0.326 Sum_probs=191.3
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||+|+||+||++... +++.+|+|.+... ......+..|++++++++|+|++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 5889999988642 22344567899999999999999999999999999999999999999
Q ss_pred HHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 251 DKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 251 ~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99997654 79999999999999999999999 899999999999999999999999999987654321 12334
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.++..|+|||.+.+..++.++||||||+++++|++|+.||........ .. .+... ...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~----~~~~~-----------~~~-- 212 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KE----ELKRR-----------TLE-- 212 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HH----HHHhc-----------ccc--
Confidence 578899999999888899999999999999999999999864321110 00 00000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
.....+......+.+++.+||+.||.+|| +..++++
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00112222355688999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=285.96 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=194.5
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
.+||+|+||.||++.. .+++.||||++.... .....+.+|+.+++.++|+|++++++++..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999987 468899999886433 34466889999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccC
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt 331 (464)
+++. ...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++
T Consensus 106 ~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 179 (292)
T cd06657 106 DIVT-HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGT 179 (292)
T ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccC
Confidence 9874 4468999999999999999999999 8999999999999999999999999999875543221 12335688
Q ss_pred CCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCC
Q 040010 332 KGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKG 411 (464)
Q Consensus 332 ~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 411 (464)
+.|+|||.+.+..++.++|+||||+++|||++|..|+..... . ..... +.....+.+..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~----~~~~~------------~~~~~~~~~~~ 238 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L----KAMKM------------IRDNLPPKLKN 238 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHH------------HHhhCCcccCC
Confidence 999999999888899999999999999999999999863210 0 01111 01111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 412 HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 412 ~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1122345778899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=281.55 Aligned_cols=257 Identities=21% Similarity=0.240 Sum_probs=190.1
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccceeccceeeeeC--cEEeEEEEe
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEG--MHRLLVYEY 244 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~E~ 244 (464)
.+.++||+|+||.||+|... +++.+|+|+++... ........|+..+.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999964 57899999987532 22334457888898885 99999999999877 889999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++ ++|.+.+.. ...++|..+..++.|++.||+|||+ .+++|+||+|+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 578777765 3579999999999999999999999 89999999999999999 9999999999986643322
Q ss_pred ceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh---
Q 040010 324 QFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA--- 399 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 399 (464)
.....++..|+|||.+. +..++.++|||||||++|||++|..||..... .. .+...........+.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~------~~---~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE------LD---QIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH------HH---HHHHHHHHcCCCCHHHHH
Confidence 22345788999999764 45678999999999999999999998863211 00 011110000000000
Q ss_pred -----hhhhhcCCccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 -----RIEEIVDPRLKG----HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 -----~~~~~~d~~l~~----~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.......+.... .........+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001134578999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.57 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=200.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||++... +++.+|+|++... ......+..|++++++++ |+||+++++++..+...++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456678999999999999975 6889999998742 233466888999999998 9999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS- 322 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 322 (464)
|+++++|.+++.....+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++.........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999999888889999999999999999999999 89999999999999999999999999999865443211
Q ss_pred -----------------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 323 -----------------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 323 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
.......++..|+|||...+..++.++||||||++++++++|+.|+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~- 230 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------YLT- 230 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------HHH-
Confidence 112334578899999999888899999999999999999999999873210 000
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM----DSVVQ 444 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm----~~V~~ 444 (464)
...+.+ .....+....+.+.+++.+||+.+|++||++ .++++
T Consensus 231 ---------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ---------------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---------------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111 1112222335678999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=291.76 Aligned_cols=267 Identities=23% Similarity=0.267 Sum_probs=194.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.+...+.||+|+||.||++... +++.||+|.+... ......+.+|+.++++++|+|++++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 4556678999999999999964 6889999998643 22335677899999999999999999987533 357
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+. ++|.+.+... ++......++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 99999996 5888877543 8999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhh-------hHHHHHHHH--
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA-------ELTGFIREV-- 389 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~-- 389 (464)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ....+....
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 171 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhhh
Confidence 221 2334578899999999999999999999999999999999999863211000 000 000000000
Q ss_pred -HHHhhc----cchhhhhhhcCCcc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 390 -KEKILC----GEEARIEEIVDPRL----KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 390 -~~~~~~----~~~~~~~~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...... .......++....+ ....+......+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000111111111 011122345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.78 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=194.0
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc--hhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.||+|++|+||+|... +++.|+||++..... ......+|+..+++++ |+|++++++++..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999985 478899999875433 3334567999999999 999999999999999999999999
Q ss_pred CCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+|+|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 889999887654 78999999999999999999999 8999999999999999999999999999986543221
Q ss_pred eeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh-------hhHHHHHHHHHHHhhcc
Q 040010 325 FSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE-------AELTGFIREVKEKILCG 396 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 396 (464)
.....++..|+|||.+. ...++.++|+||||++++||++|+.|+......+.... .....|..... ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 232 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK--LASK 232 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh--hhcc
Confidence 22345788999999874 45689999999999999999999988864321110000 00000100000 0000
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
............+....+ .....+.+++.+||+.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000000011 11467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=283.99 Aligned_cols=260 Identities=24% Similarity=0.241 Sum_probs=189.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhcc-ccceeccceeeeeCcE-----Ee
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMH-----RL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~~ 239 (464)
+...+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++ |+|++++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 445678999999999999975 588999998764322 2356788999999995 6999999999876655 89
Q ss_pred EEEEeccCCChHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCc
Q 040010 240 LVYEYVENQSLDKHLFSS-----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLA 313 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla 313 (464)
+||||+++ +|.+++... ..+++.....++.||+.||.|||+ .+++||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 788887532 358999999999999999999999 89999999999999998 889999999998
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..... .... ......
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~----~~~~~~ 227 (295)
T cd07837 159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----LQQL----LHIFKL 227 (295)
T ss_pred eecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----HHHH----HHHHHH
Confidence 75533211 1223356788999998765 4579999999999999999999988863211 1111 111111
Q ss_pred hhccchhhhhhhc---C----CccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 393 ILCGEEARIEEIV---D----PRLK----GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 393 ~~~~~~~~~~~~~---d----~~l~----~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
............. + +... ..........+.+++..||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000 0 0000 0001123466889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=280.70 Aligned_cols=243 Identities=21% Similarity=0.204 Sum_probs=189.9
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccc----hhHHHHHHHHHh-hhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ----GEEVFWAEVSTI-GKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.||.|+||.||+|... +++.||+|.+..... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999974 578999999864321 122344555444 445899999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 9999999887889999999999999999999999 8999999999999999999999999999875433 123
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..++..|+|||.+.+..++.++||||||+++|||++|..|+..... . ... .....+. .+
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~----~~~----~~~~~~~-------~~- 211 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----D----AVF----DNILSRR-------IN- 211 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----H----HHH----HHHHhcc-------cC-
Confidence 4578899999999888899999999999999999999999863210 0 111 1111000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
............+.+++.+||+.||++||++.++.+.|.
T Consensus 212 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 212 -WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 011111123456889999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=284.83 Aligned_cols=195 Identities=27% Similarity=0.341 Sum_probs=163.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.+++.++|+|++++.+++..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456678999999999999864 57899999986432 223467789999999999999999999999999999999996
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+.+.. ...+.+.....++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 160 (291)
T cd07870 87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TY 160 (291)
T ss_pred -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CC
Confidence 677666643 3568899999999999999999999 8899999999999999999999999999875433221 12
Q ss_pred eeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 326 SRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 234578899999988754 578999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=277.85 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=200.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||++... ++..+++|++.... .....+..|+++++.++|+|++++.+.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345578999999999999975 57899999987543 34466889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
++++|.+++.+. ..+++.....++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999999753 679999999999999999999999 899999999999999999999999999998765433
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......|++.|+|||...+..++.++||||+|+++++|++|+.|+.... ...... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---------~~~~~~----~~-------- 215 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---------LLELAL----KI-------- 215 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---------HHHHHH----HH--------
Confidence 12233568889999999988889999999999999999999999975321 011111 11
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ....+......+.+++.+||+.+|++|||+.++++
T Consensus 216 ---~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 ---LKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1110 11112233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.75 Aligned_cols=254 Identities=25% Similarity=0.239 Sum_probs=199.0
Q ss_pred hhhccccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 239 (464)
+.+.+.||+|++|.||++.. .++..||||.++... ...+.+..|++++.++ +|+|++++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 34567899999999999985 356789999886432 2335678899999999 5999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999999877789999999999999999999999 89999999999999999999999999998765433
Q ss_pred CCCcceeeeccCCCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLP--ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+...... ........ ...
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~----~~~--- 225 (288)
T cd05583 159 EEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-----NSQSEISR----RIL--- 225 (288)
T ss_pred ccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-----chHHHHHH----HHH---
Confidence 211 122356889999999987655 788999999999999999999998632111 00111111 110
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. ..+. .+......+.+++.+||+.||++|||+.+|.+.|.-.
T Consensus 226 ----~--~~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 ----K--SKPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----c--cCCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0111 1222334578899999999999999999888777553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=281.80 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=196.8
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.||+|++|.||++... +++.+++|.+..... ....+..|++++++++|+|++++++++..+...++++||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34568999999999999974 688999999875432 34678889999999999999999999999999999999997
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 5 888877653 589999999999999999999999 899999999999999999999999999998765433 112
Q ss_pred eeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ... ......+..........+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQL----FKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHH----HHHHHHcCCCchHhcccc
Confidence 234578889999998776 7899999999999999999999887532110 000 001011000000000000
Q ss_pred cC-----------Ccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VD-----------PRL--KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d-----------~~l--~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ ... ......+....+.+++..||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000 01112234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=281.55 Aligned_cols=241 Identities=24% Similarity=0.264 Sum_probs=188.1
Q ss_pred ccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHH---hhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVST---IGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.||+|+||.||++... +++.||+|.+.... .....+..|..+ ++...|+|++++.+++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 57899999886432 222334445443 444579999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 99999999877889999999999999999999999 889999999999999999999999999987543321 22
Q ss_pred eeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...|+..|+|||.+.+. .++.++||||||+++|||++|+.||........ .. ... .....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~------~~-~~~------------~~~~~ 214 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HE-IDR------------MTLTM 214 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch------HH-HHH------------Hhhcc
Confidence 34689999999998754 689999999999999999999999864321110 00 000 00011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~ 445 (464)
+..+ +......+.+++.+|++.+|.+|| ++.++++.
T Consensus 215 ~~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1122 222345788899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=280.54 Aligned_cols=260 Identities=25% Similarity=0.302 Sum_probs=193.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||.|++|.||+|+.. ++..||||.++... ...+.+..|++++++++|+|++++++++...+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345678999999999999975 58899999887542 234567789999999999999999999999999999999998
Q ss_pred CCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 5 888887643 368999999999999999999999 8899999999999999999999999999975543211
Q ss_pred ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......++..|++||.+.+ ..++.++||||||+++|||++|+.|+..... ........ +...........
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~ 226 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-----EDQLLKIF----RIMGTPTESTWP 226 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHH----HHhCCCChhhHH
Confidence 1233457889999998765 4578999999999999999999998864321 11111100 000000000000
Q ss_pred hhcC-----CccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVD-----PRLK-------GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d-----~~l~-------~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.+ .... ..........+.+++..|++.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0000 0011123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=297.77 Aligned_cols=193 Identities=28% Similarity=0.361 Sum_probs=171.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-c-----cceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-H-----MNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~lv 241 (464)
+|.+.+.||+|.||.|-++... +++.||||+++....-..+-..|+.+|..++ | -|+|+++++|...+|.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6677889999999999999964 5899999999988777777889999999997 4 3799999999999999999
Q ss_pred EEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC--CCeEEeeecCccccC
Q 040010 242 YEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE--FEPKIADFGLAKLSQ 317 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~ 317 (464)
+|.+. .+|.++|..++ .|+......++.||+.||.+||+ .+|||+||||+||||.+- ..+||.|||+|....
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99995 59999998654 68899999999999999999999 999999999999999654 469999999998654
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.. ......++.|.|||++.+.+|+.+.||||||||+.||++|...|..
T Consensus 343 q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 343 QR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred Cc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 32 2356678899999999999999999999999999999999777653
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=283.80 Aligned_cols=263 Identities=23% Similarity=0.248 Sum_probs=193.0
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc------
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------ 236 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 236 (464)
...+.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|++++++++|+|++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345667789999999999999985 57899999986432 22345778999999999999999999987654
Q ss_pred ----EEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 237 ----HRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 237 ----~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
..++|+||+++ +|...+... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 676666543 479999999999999999999999 899999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ...+... .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~----~ 231 (302)
T cd07864 162 LARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELI----S 231 (302)
T ss_pred ccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHH----H
Confidence 99866543321 1222346778999998764 4578999999999999999999988863211 1111111 1
Q ss_pred HHhhccchhhhhhh--------cC------CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEI--------VD------PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~--------~d------~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.............+ .+ ......+. .....+.+++..||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10000000000000 00 00000010 12457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.54 Aligned_cols=248 Identities=27% Similarity=0.288 Sum_probs=193.1
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.++...+.||.|+||.||+|... ++..+|+|.+... ......+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34455578999999999999974 5788999988632 123356788999999999999999999999999999999
Q ss_pred EeccCCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+. |+|.+.+. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 57777765 34568999999999999999999999 89999999999999999999999999998765432
Q ss_pred CcceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 322 SSQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... . ..... ..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~----~~~~~----~~---- 227 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----M----SALYH----IA---- 227 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----H----HHHHH----Hh----
Confidence 2345788999999874 35678899999999999999999998753210 0 00000 00
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
....+.. ........+.+++.+||+.+|++||++.+|++...-.
T Consensus 228 ----~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 228 ----QNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ----hcCCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0000111 1123345678899999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.85 Aligned_cols=197 Identities=20% Similarity=0.256 Sum_probs=157.3
Q ss_pred HHHhhhccccCccCceEEEEEEECC--CcEEEE------------------EEcCCccchhHHHHHHHHHhhhcccccee
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD--ERAVAV------------------KRLGDLHQGEEVFWAEVSTIGKIYHMNLV 226 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~--~~~vav------------------K~l~~~~~~~~~~~~E~~~l~~l~h~niv 226 (464)
...|.+.++||+|+||+||++..+. +...++ |.+.........+.+|+++|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4567788899999999999987532 222222 22222223345688999999999999999
Q ss_pred ccceeeeeCcEEeEEEEeccCCChHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC
Q 040010 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS 301 (464)
Q Consensus 227 ~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 301 (464)
++++++......++|+|++. ++|.+++... ..........|+.|++.||.|||+ .+|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999985 5676666432 223456677899999999999999 89999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 040010 302 EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLS 368 (464)
Q Consensus 302 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~ 368 (464)
++.+||+|||++......... ......||..|+|||.+.+..++.++|||||||++|||++|..++
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999876543221 123457999999999999999999999999999999999997644
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=289.94 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=195.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeee----eCcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCT----EGMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv 241 (464)
+.+.+.||.|+||.||+|... +++.||+|++.... .....+..|+.++++++|+||+++++++. .....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 455678999999999999964 58899999987532 23456778999999999999999999875 34578999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+. ++|.+++.....+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99995 6899999877789999999999999999999999 8999999999999999999999999999976543322
Q ss_pred C--cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH----Hhh
Q 040010 322 S--SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE----KIL 394 (464)
Q Consensus 322 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 394 (464)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ... ........ ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~-~~~~~~~g~~~~~~~ 236 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQL-KLILSVLGSPSEEVL 236 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHH-HHHHHHhCCChhHhh
Confidence 1 11234568899999998765 46899999999999999999999998632110 000 00000000 000
Q ss_pred c-cchhhhhhhcCC-ccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 395 C-GEEARIEEIVDP-RLKGHF-----NKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 395 ~-~~~~~~~~~~d~-~l~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. -....+.+..+. ...... .......+.+++.+||+.+|++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 000001111100 000011 12235678999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=284.82 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=190.4
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|...+ ++.||||.++... ....++..|+.++.+.+ |+|++++++++..+...+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4567899999999999999865 8899999987432 23355667887777775 999999999999999999999998
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ ++|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++........
T Consensus 97 ~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--- 170 (296)
T cd06618 97 S-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--- 170 (296)
T ss_pred C-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---
Confidence 5 477776654 45799999999999999999999972 3799999999999999999999999999876543221
Q ss_pred eeeeccCCCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 325 FSRIRGTKGYMAPEWASNLP----ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... . . +... ......
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~--~-~~~~----~~~~~~--- 235 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----E--F-EVLT----KILQEE--- 235 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----H--H-HHHH----HHhcCC---
Confidence 12335788999999987554 88999999999999999999999853110 0 0 0000 110000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.+.+. ........+.+++.+||+.||++||++.++++.-
T Consensus 236 -----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 -----PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -----CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00110 0112345688999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.95 Aligned_cols=269 Identities=23% Similarity=0.273 Sum_probs=203.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc-----EEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-----HRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 240 (464)
+.+.+.||.|++|.||+|... +++.+|+|++.... ...+.+..|+++++.++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456678999999999999975 48899999987543 23467889999999999999999999987765 7899
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+|||++ ++|.+++.+...+++..+..++.+++.||+|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999998 5899998877789999999999999999999999 899999999999999999999999999998765442
Q ss_pred CC-cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc--
Q 040010 321 NS-SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG-- 396 (464)
Q Consensus 321 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 396 (464)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... . ............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~----~~~~i~~~~~~~~~ 228 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----D----QLNLIVEVLGTPSE 228 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----H----HHHHHHHhcCCCCh
Confidence 11 112345578899999999887 8899999999999999999999998643210 0 001110000000
Q ss_pred ------chhhhhhhcC---CccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCC
Q 040010 397 ------EEARIEEIVD---PRLK---GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEA 451 (464)
Q Consensus 397 ------~~~~~~~~~d---~~l~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~ 451 (464)
......+.+. ..-. ..........+.+++.+||+.+|.+|||+.++++. +.+..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000001100 0000 00011234678899999999999999999999984 666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=282.91 Aligned_cols=260 Identities=25% Similarity=0.281 Sum_probs=190.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|++++++++|+|++++++++..+...++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456678999999999999975 67899999886432 23356889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+ ++|.+++.... .+++.....++.||+.||+|||+ .+++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 6 57887775443 35788888999999999999999 89999999999999985 55799999999976543211
Q ss_pred cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh-
Q 040010 323 SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR- 400 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 400 (464)
......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||..... ...... ............
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-----~~~~~~----~~~~~~~~~~~~~ 228 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-----IDELFK----IFRILGTPNEETW 228 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----HHHHhCCCChhhc
Confidence 1233457889999998865 4578999999999999999999999863211 111111 000000000000
Q ss_pred -----hhhhc--CCccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 -----IEEIV--DPRLKG----HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 -----~~~~~--d~~l~~----~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.... -+.... .........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000000 001122455889999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=283.98 Aligned_cols=262 Identities=23% Similarity=0.235 Sum_probs=191.5
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 242 (464)
.+.+.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.++++++|+|++++++++.+. ...++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 3556678999999999999974 588999998864322 223466899999999999999999998654 5689999
Q ss_pred EeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 88 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 88 EYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred ecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9997 478888765 3579999999999999999999999 8899999999999999999999999999987654321
Q ss_pred CcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ................
T Consensus 164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-----~~----~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 164 --PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-----IE----QLDLIIQLLGTPNESI 232 (309)
T ss_pred --CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHHhcCCCChhh
Confidence 1222345788999998865 5689999999999999999999998863211 00 1111111000000000
Q ss_pred h---------hhhc-CCccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 I---------EEIV-DPRLKGHFN---KNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ~---------~~~~-d~~l~~~~~---~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. .... ......... ......+.+++.+|++.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 000000000 0124567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=288.16 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=192.8
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEEeE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRLL 240 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 240 (464)
...+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+++++.++|+||+++++++... ...++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34468999999999999964 68899999986432 2234578899999999999999999988654 35689
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|+||+.+ +|..++ ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 98 v~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 98 VMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred Eeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 9999964 777665 3468999999999999999999999 88999999999999999999999999998754322
Q ss_pred CCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HHHH
Q 040010 321 NSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VKEK 392 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~ 392 (464)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...... ....
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCCHHHHHH
Confidence 223457888999998866 4689999999999999999999999863211 1111100000 0000
Q ss_pred hhccchhhhhhhcC--Cc-cCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCCCCCCC
Q 040010 393 ILCGEEARIEEIVD--PR-LKGHFN---KNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEAESEVP 456 (464)
Q Consensus 393 ~~~~~~~~~~~~~d--~~-l~~~~~---~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~~~~~~ 456 (464)
..... ....++ +. ...... ......+.+++.+||+.||++||++.+++. .+++..+..+.+
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 242 LEDKA---AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred hcccc---hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 00000 000000 00 000000 012346789999999999999999999994 477766544333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.72 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=202.8
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E 243 (464)
..|...++||+||.+.||++...+.+.+|+|++... .+...-|++|+..|.+++ |.+||++++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 345666789999999999999988889999987633 344467999999999995 9999999999999999999999
Q ss_pred eccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 244 YVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|= +.+|..+|.... ..+| .+..+..|++.++.++|+ .+|||.||||.|+|+-. |.+||.|||+|.....+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 76 569999998654 3446 677889999999999999 99999999999999865 5899999999998888777
Q ss_pred CcceeeeccCCCccCcccccCCC-----------CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLP-----------ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
........||+.||+||.+.... .++++||||+||+||+|+-|+.||... ...|.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----------~n~~a---- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----------INQIA---- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----------HHHHH----
Confidence 66677889999999999875432 567999999999999999999998621 11111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKN-QAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+.||...-+++.- ...++++++..||+.||++|||..++++
T Consensus 581 ---------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ---------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 16777888654344321 1122899999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=282.80 Aligned_cols=239 Identities=27% Similarity=0.312 Sum_probs=188.0
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.++||+|+||.||+|+.. +++.|++|++.... .....+.+|+++++.++|+|++++++++.++...++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 457999999999999974 57899999986432 223467889999999999999999999999999999999996
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
|+|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..... ..
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~ 175 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------AN 175 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CC
Confidence 577777654 4579999999999999999999999 8999999999999999999999999999864322 22
Q ss_pred eeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 327 RIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
...|+..|+|||++. ...++.++||||||+++|||++|..|+..... ......... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---------~~~~~~~~~----~------- 235 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYHIAQ----N------- 235 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHh----c-------
Confidence 356888999999874 45688999999999999999999999763210 000000000 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+.. ........+.+++.+||+.+|.+||++.+++..
T Consensus 236 -~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 -DSPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 111223457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.48 Aligned_cols=259 Identities=24% Similarity=0.234 Sum_probs=193.2
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCccchh---------------HHHHHHHHHhhhccccceeccceeeeeCc
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGE---------------EVFWAEVSTIGKIYHMNLVRMWGFCTEGM 236 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 236 (464)
.+.||.|+||.||+|... +++.||||.++...... ..+.+|+++++.++|+|++++++++..+.
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999965 68899999886432211 24678999999999999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
..++||||++ |+|.+++.....+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceeec
Confidence 9999999997 6999999877789999999999999999999999 89999999999999999999999999999765
Q ss_pred CCCCC------------CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHH
Q 040010 317 QRGSN------------SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELT 383 (464)
Q Consensus 317 ~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 383 (464)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-----~~~~- 243 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-----IDQL- 243 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH-
Confidence 42110 1112234468889999988764 478999999999999999999998863211 1111
Q ss_pred HHHHHHHHHhhccchhhhhh------------hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 384 GFIREVKEKILCGEEARIEE------------IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~------------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+.............. ...+.... ........+.+++..||+.+|++|||+.+++..
T Consensus 244 ---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 ---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111000000000000 00000000 011224568899999999999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=281.85 Aligned_cols=248 Identities=24% Similarity=0.233 Sum_probs=194.7
Q ss_pred hhccccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeE
Q 040010 171 SFKEELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.||.|+||.||++.. .+|..||+|++.... ...+.+..|+.+++++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999986 367899999987432 2335678899999999 59999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||+++++|.+++.....+++.....++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999999887889999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCcceeeeccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. ......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+..... .......... .
T Consensus 160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~~~~----~----- 224 (290)
T cd05613 160 VE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-----KNSQAEISRR----I----- 224 (290)
T ss_pred cc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-----cccHHHHHHH----h-----
Confidence 21 12345688999999988653 478899999999999999999999863211 1111111111 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
.... ..++......+.+++.+||+.||++|| ++.++++
T Consensus 225 ------~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 ------LKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------hccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 112223345688999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.16 Aligned_cols=264 Identities=15% Similarity=0.131 Sum_probs=191.8
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
.+.+|.|+++.||++.. +++.||||++... ....+.+..|+++++.++|+||+++++++.+....+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34566667777777665 6889999998643 2344678999999999999999999999999999999999999999
Q ss_pred hHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-----
Q 040010 250 LDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS----- 322 (464)
Q Consensus 250 L~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----- 322 (464)
|.+++... ..+++.....++.|++.||+|||+ .+|+|+||||+||+++.++.+|++|||.+.........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999753 468899999999999999999999 89999999999999999999999999988654322111
Q ss_pred cceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc-c---
Q 040010 323 SQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC-G--- 396 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 396 (464)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... . ............... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~-~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----Q-MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHHhccCccccccCchh
Confidence 11233457788999999865 35889999999999999999999998742110 0 000000000000000 0
Q ss_pred -chhhhhh----hcCCcc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 397 -EEARIEE----IVDPRL----KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 397 -~~~~~~~----~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
....... ..++.. ...........+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 001110 111223345678899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.58 Aligned_cols=247 Identities=25% Similarity=0.300 Sum_probs=204.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
..+.++||+|+||.|||+..+ .|+.+|||.+... .+..++..|+.+|++...+++|+++|.+-....+|+|||||.-|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 455678999999999999975 5899999988653 34567889999999999999999999988889999999999999
Q ss_pred ChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+.+.+. ++.+|+..+...+....++||+|||. ..-+|||||+.||||+.+|.+||+|||.+..+... -.....
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNT 188 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNT 188 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCc
Confidence 9999987 45689999999999999999999999 66799999999999999999999999999765432 122456
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
+.||+.|||||++..-.|+.++||||||++..||..|+.|+........- ++ +.----|
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------FM--------------IPT~PPP 247 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------FM--------------IPTKPPP 247 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------Ee--------------ccCCCCC
Confidence 88999999999999999999999999999999999999998743221100 00 0000112
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+ -+.+...++.+++.+||-.+|++|-|+.++++.
T Consensus 248 TF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 221 245678889999999999999999999988764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=277.24 Aligned_cols=258 Identities=25% Similarity=0.279 Sum_probs=191.5
Q ss_pred hhccccCccCceEEEEEEECC-CcEEEEEEcCCccc---hhHHHHHHHHHhhhc---cccceeccceeeeeCcE-----E
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ---GEEVFWAEVSTIGKI---YHMNLVRMWGFCTEGMH-----R 238 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 238 (464)
.+.+.||+|+||.||+|.... ++.+|+|+++.... ....+.+|+.++.++ +|+|++++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456789999999999999864 88999999974322 223466787777665 59999999999987766 8
Q ss_pred eEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 239 LLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
+++|||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99999997 4898888653 358999999999999999999999 88999999999999999999999999999776
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ......+. ......
T Consensus 158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-----~~~~~~~~----~~~~~~ 225 (287)
T cd07838 158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-----ADQLDKIF----DVIGLP 225 (287)
T ss_pred cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-----HHHHHHHH----HHcCCC
Confidence 44322 2234578899999999988999999999999999999999888763211 11111111 110000
Q ss_pred -chhhh------hhhcCCccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 -EEARI------EEIVDPRLK---GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 -~~~~~------~~~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+. ......... .....+....+.+++.+||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 000000000 1111234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.05 Aligned_cols=263 Identities=18% Similarity=0.233 Sum_probs=191.4
Q ss_pred cccCcc--CceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKG--GSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G--~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+||+| +||+||++... +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 99999999974 68999999987432 2235688899999999999999999999999999999999999
Q ss_pred CChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc-
Q 040010 248 QSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ- 324 (464)
Q Consensus 248 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 324 (464)
++|.+++... ..+++.....++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 358999999999999999999999 8999999999999999999999999986543221111100
Q ss_pred ----eeeeccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH-----------
Q 040010 325 ----FSRIRGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR----------- 387 (464)
Q Consensus 325 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 387 (464)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-----HHHHHhcCCCCCCccccc
Confidence 0112345679999998763 47899999999999999999999986432110 0000000
Q ss_pred --HHHHHhhccch-------------hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 388 --EVKEKILCGEE-------------ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 388 --~~~~~~~~~~~-------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........... .....+.+..+...........+.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000000 0000111222222233456678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=280.74 Aligned_cols=198 Identities=25% Similarity=0.309 Sum_probs=163.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc--------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-------- 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 236 (464)
.+.+.++||+|+||.||++... +++.||||.+.... .....+.+|++++++++|+|+++++++|....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3666789999999999999975 58899999886432 12334678999999999999999999986543
Q ss_pred EEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
..++||||+.+ +|.+.+... ..+++.+...++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999964 788777654 378999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCC--cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 316 SQRGSNS--SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 316 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 5433221 112334578899999987654 478899999999999999999988863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.87 Aligned_cols=235 Identities=28% Similarity=0.264 Sum_probs=193.7
Q ss_pred cCccCceEEEEEEEC-CCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 176 LGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
||.|+||.||++... +++.+|+|.+..... ....+..|++++++++|+|++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999975 478999998875322 345788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
.+++.....+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 9999877789999999999999999999999 889999999999999999999999999998664432 12334567
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccC
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 410 (464)
+..|++||...+...+.++|+||||+++|||++|+.|+..... ... .. .+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---------~~~----~~-----------~~~~~~-- 209 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---------KEI----YE-----------KILKDP-- 209 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------HHH----HH-----------HHhcCC--
Confidence 8899999999888899999999999999999999999863210 011 11 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040010 411 GHFNKNQAATLFRIGISCVDEDRNKRPTMDS 441 (464)
Q Consensus 411 ~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~ 441 (464)
..++......+.+++.+||..||++||++.+
T Consensus 210 ~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1122223566889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=274.41 Aligned_cols=239 Identities=22% Similarity=0.246 Sum_probs=185.7
Q ss_pred hhccc--cCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEecc
Q 040010 171 SFKEE--LGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 171 ~~~~~--lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+. ||+|+||.||++... ++..+|+|.+........ |+.....+ +|+|++++++.+...+..++||||++
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~ 92 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence 34444 599999999999964 578899998864322211 22222222 69999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++.+...+++.....++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++......
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------ 163 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------ 163 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------
Confidence 99999999877789999999999999999999999 8899999999999999998 9999999998765432
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......+... .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~----------------~ 223 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----ELDLESLLKR----------------Q 223 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hhhHHHHHHh----------------h
Confidence 2245888999999999889999999999999999999999998732111 1111111110 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-MDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-m~~V~~ 444 (464)
.... .........+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1110 111234556889999999999999996 688863
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=276.10 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=190.7
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCc------cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDL------HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.+.++||+|+||.||++.... +..+++|.++.. ......+..|+.+++.++|||++++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567889999999999998643 344555555421 123345667899999999999999999999999999999
Q ss_pred EeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 243 EYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 243 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998863 3579999999999999999999999 89999999999999975 5699999999876643
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......|++.|+|||...+..++.++|+||||+++|+|++|..|+.... ...... .
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---------~~~~~~----~------ 216 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---------FLSVVL----R------ 216 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHH----H------
Confidence 322 1233557889999999988889999999999999999999999875210 001111 1
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+... .....+......+.+++.+||+.+|++||++.++++
T Consensus 217 -----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 217 -----IVEG-PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----HHcC-CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1100 111123344567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=275.73 Aligned_cols=257 Identities=24% Similarity=0.270 Sum_probs=195.2
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.||+|++|.||+|+.. +++.+|+|.+.... ...+.+..|++++++++|+|++++++++.+....++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4567999999999999975 48899999987542 234567889999999999999999999999999999999998
Q ss_pred CChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|.+++... ..+++..+..++.+++.||+|||+ .+|+|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 5899999765 579999999999999999999999 8899999999999999999999999999986544321 123
Q ss_pred eeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh----
Q 040010 327 RIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI---- 401 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 401 (464)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ... ............+...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQ----LFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHH----HHHHHHHhCCCcHHHHHhhc
Confidence 34467789999988766 789999999999999999999888863211 000 0111100000000000
Q ss_pred ---------hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 ---------EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ---------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...........+ ......+.+++..||+.||++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.15 Aligned_cols=242 Identities=31% Similarity=0.433 Sum_probs=185.1
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeee----------------
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE---------------- 234 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------- 234 (464)
+.||+||||.|||++.+ ||+.+|||++... ........+|++++++|+|||+|+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 47999999999999964 8999999999754 3334557789999999999999987653210
Q ss_pred --------------------------------------------------------------C-----------------
Q 040010 235 --------------------------------------------------------------G----------------- 235 (464)
Q Consensus 235 --------------------------------------------------------------~----------------- 235 (464)
+
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------cEEeEEEEeccCCChHHhhhcCCCC-CHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 040010 236 ------------------------MHRLLVYEYVENQSLDKHLFSSNFL-GWKERFKVALGTAKGLAYLHHECLEWVIHC 290 (464)
Q Consensus 236 ------------------------~~~~lv~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 290 (464)
..+||-||||+..+|.+++..+... .-...++++++|++||+|+|+ .+||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHR 721 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHR 721 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceeec
Confidence 1236789999988888888665544 466778999999999999999 889999
Q ss_pred CCCCCCEEEcCCCCeEEeeecCccccC----------------CCCCCcceeeeccCCCccCcccccCCC---CCccchh
Q 040010 291 DVKPENILLDSEFEPKIADFGLAKLSQ----------------RGSNSSQFSRIRGTKGYMAPEWASNLP---ITSKVDV 351 (464)
Q Consensus 291 dlk~~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV 351 (464)
||||.||+||++..+||+|||+|.... .+......+...||.-|+|||.+.+.. |+.|+|+
T Consensus 722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM 801 (1351)
T ss_pred cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence 999999999999999999999998621 011112345678999999999987654 9999999
Q ss_pred HHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCC--CCHHHHHHHHHHHHHcc
Q 040010 352 FSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH--FNKNQAATLFRIGISCV 429 (464)
Q Consensus 352 ~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~~l~~~Cl 429 (464)
||+||||+||+- ||.-. ..... + +..+.++.+..+ +..+....-.+++.|++
T Consensus 802 YSLGIVlFEM~y---PF~Ts--------MERa~----i-----------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 802 YSLGIVLFEMLY---PFGTS--------MERAS----I-----------LTNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred HHHHHHHHHHhc---cCCch--------HHHHH----H-----------HHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 999999999985 34311 11111 1 233334443322 33445566778999999
Q ss_pred CCCCCCCCCHHHHHH
Q 040010 430 DEDRNKRPTMDSVVQ 444 (464)
Q Consensus 430 ~~dp~~RPsm~~V~~ 444 (464)
+.||.+|||+.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999974
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.22 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=199.4
Q ss_pred HhhhccccCccCceEEEEEEECCCc-EEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDER-AVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~-~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+++...||.|+||.|||++.++.. ..|-|.+... ....+.|+-|+++|....||+||+|++.+...+.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3566678999999999999976543 3466777643 3344779999999999999999999999888899999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
||-.+..+-. ...|...+..-++.+++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+..... .....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 9999998765 4689999999999999999999999 9999999999999999999999999999854322 22334
Q ss_pred eeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 326 SRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
..+.|||.|||||+++ ..+|+.++||||||++|.||..+..|..... . ++.+ -+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---------p---MRVl-lK-------- 246 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---------P---MRVL-LK-------- 246 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---------h---HHHH-HH--------
Confidence 6688999999999875 4579999999999999999999988765211 0 0111 11
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..--.|.+.. +......+.+++..||..||..||+++++++.
T Consensus 247 iaKSePPTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 247 IAKSEPPTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HhhcCCCcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11222233322 34566778899999999999999999998763
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=280.34 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=206.9
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.+.||+|.|..|-.++. -.|..||||++..... ....+.+|++-|+.++|||||+++.+......+|||.|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55667899999999998874 3789999999976543 3466889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
.+|+|.++|-+. ..+++....+++.||+.|+.|+|+ ..+|||||||+||.+- .-|-+||+|||++-.+..+.
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999764 579999999999999999999999 8899999999999874 56789999999997766543
Q ss_pred ceeeeccCCCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPIT-SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
..+..+|+..|.|||.+.+..|+ +++|||||||+||-|++|+.||+-....+ . +.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----T-------------------LT 229 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----T-------------------LT 229 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----h-------------------hh
Confidence 35668899999999999999886 58899999999999999999997332111 0 33
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.++|=.. ..+.....++.+|+..||..||++|.|.++|+..
T Consensus 230 mImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 MIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 4445433 4567788899999999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.70 Aligned_cols=266 Identities=22% Similarity=0.251 Sum_probs=190.6
Q ss_pred hhhccccCccCceEEEEEEECC---CcEEEEEEcCCcc---chhHHHHHHHHHhhhc-cccceeccceeeeeC----cEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD---ERAVAVKRLGDLH---QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG----MHR 238 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 238 (464)
+.+.+.||+|+||.||++.... +..||+|++.... .....+.+|+++++++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 3556789999999999999753 6789999987432 2245678899999999 599999999875432 457
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++++||+. ++|.+++.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88888886 6899999877889999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCC--cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH-------H
Q 040010 319 GSNS--SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR-------E 388 (464)
Q Consensus 319 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~ 388 (464)
.... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ...+...+. .
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGTPDEE 232 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCCCCHH
Confidence 2211 11234568999999998765 5689999999999999999999988763211 000000000 0
Q ss_pred HHHHhhccchhhhhhhcCCccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 389 VKEKILCGEEARIEEIVDPRLKG---HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+............+..-.. .........+.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000000 000112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.89 Aligned_cols=246 Identities=27% Similarity=0.320 Sum_probs=202.0
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
..||.|.||.||-+.. .+|.-.|+|-++.. ........+|+.++..++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 3799999999999995 56888899977633 3344667889999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC--cceee
Q 040010 250 LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS--SQFSR 327 (464)
Q Consensus 250 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~ 327 (464)
|.+.+......++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|.....+... .....
T Consensus 1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 99999888888888888899999999999999 99999999999999999999999999999877655311 12346
Q ss_pred eccCCCccCcccccCC---CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 328 IRGTKGYMAPEWASNL---PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
..||+.|||||.+.+. .-..+.||||+|||.+||+||++|+.... .+|. +.-.
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----------ne~a--------------IMy~ 1453 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----------NEWA--------------IMYH 1453 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----------chhH--------------HHhH
Confidence 7899999999998764 35568999999999999999999986221 1121 2222
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
+...-.+.++.....+-.+++..||+.||++|-++.|+++.=
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 222223445555677788999999999999999888887654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=278.64 Aligned_cols=266 Identities=22% Similarity=0.230 Sum_probs=189.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeC--------c
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--------M 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~ 236 (464)
.+.+.+.||+|+||.||+|... +++.+|+|++..... ....+.+|++++++++|+||+++++++.+. .
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 4566778999999999999975 578999998864322 224567899999999999999999987443 3
Q ss_pred EEeEEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 237 HRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
..++|+||+.+ +|...+.. ...+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++..
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 56999999975 67666654 4579999999999999999999999 8999999999999999999999999999976
Q ss_pred cCCCCCC---------cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 316 SQRGSNS---------SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 316 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~~~~~ 239 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQLHLI 239 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 5432211 11233467888999998765 45899999999999999999999988632211 000000
Q ss_pred HHHHHHHhhcc---chhhhhhhc----CCccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 386 IREVKEKILCG---EEARIEEIV----DPRLKGHF---NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 386 ~~~~~~~~~~~---~~~~~~~~~----d~~l~~~~---~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
... ....... ....+.... ........ .......+.+++.+||+.||.+|||+.+++.
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKL-CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHH-hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 0000000 000000000 00000000 0112256889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=282.25 Aligned_cols=271 Identities=22% Similarity=0.282 Sum_probs=195.7
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc------EE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------HR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 238 (464)
++.+.+.||+|+||.||++.. .++..||||++.... .....+.+|++++++++|+||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 355567899999999999986 468899999986432 23356789999999999999999999886543 45
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 8999999 679988875 4578999999999999999999999 8999999999999999999999999999976533
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH-------HHH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR-------EVK 390 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~ 390 (464)
. .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ......... ...
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-----LDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCCHHHH
Confidence 2 223457889999998875 4588999999999999999999999863211 000000000 000
Q ss_pred HHhhccchhh-hh---hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHhhCCCCCCCC
Q 040010 391 EKILCGEEAR-IE---EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV--QTLLGCEAESEV 455 (464)
Q Consensus 391 ~~~~~~~~~~-~~---~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~--~~L~~~~~~~~~ 455 (464)
..+....... .. ......+. .........+.+++.+|++.||++|||+.+++ ..+....+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~ 310 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence 0000000000 00 00000000 01112334588999999999999999999999 555555544333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=280.73 Aligned_cols=240 Identities=25% Similarity=0.284 Sum_probs=197.0
Q ss_pred ccccCccCceEEEEEEE-CCCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 173 KEELGKGGSGAVYKGVL-TDERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
-..||+||||.||-+.. .+|+.+|.|++... ..++...++|-.+|.+++.+-||.+--.++..+.++||+..|+|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 35899999999999986 46889999988643 45666788999999999999999999889999999999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|.-+|.+-+ .++...++.++.+|+.||++||. .+||+||+||+|||||+.|+++|+|.|||.....+.. .
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---I 343 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc---c
Confidence 99999998654 79999999999999999999999 9999999999999999999999999999987765432 3
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....||.+|||||++.++.|+...|+||+||+||||+.|+.||....+... .+-+. +... -
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------~eEvd---rr~~----------~ 404 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------REEVD---RRTL----------E 404 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------HHHHH---HHHh----------c
Confidence 445899999999999999999999999999999999999999974322111 00000 0000 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD 440 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~ 440 (464)
| ...++....++...|....|+.||.+|..-.
T Consensus 405 ~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 D---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred c---hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1234455566777888889999999996543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=282.41 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=190.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcE------Ee
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH------RL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 239 (464)
+.+...||+|++|.||+|... +++.||+|++... ......+.+|+.++++++|+|++++.+++..... .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 455678999999999999975 5789999998643 2233557789999999999999999998765544 89
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 97 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 999998 5699998854 579999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HHH
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VKE 391 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~ 391 (464)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...... ...
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-----IDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred -----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCCHHHHh
Confidence 233457889999998765 3678999999999999999999999863211 0001000000 000
Q ss_pred HhhccchhhhhhhcC---CccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 392 KILCGEEARIEEIVD---PRLKGHF---NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d---~~l~~~~---~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
++.... ....+. ......+ .......+.+++.+||+.||++|||+.+|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSES---ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchh---HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 000000 0000000 0112467889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=263.45 Aligned_cols=198 Identities=26% Similarity=0.364 Sum_probs=165.3
Q ss_pred hhhccccCccCceEEEEEEECC-----CcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeee-CcEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 240 (464)
++...+||+|.+|.|||++-++ ...+|+|+++....+ .....+|+.+++.++|+|++.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 5666789999999999997533 237899999865322 2446789999999999999999998866 788999
Q ss_pred EEEeccCCChHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC----CCeEEeeec
Q 040010 241 VYEYVENQSLDKHLF-----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE----FEPKIADFG 311 (464)
Q Consensus 241 v~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg 311 (464)
++||.+. +|...|+ ....++......|+.||+.|+.|||+ +.|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999975 7777775 22468889999999999999999999 999999999999999887 899999999
Q ss_pred CccccCCCCCCc-ceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCcc
Q 040010 312 LAKLSQRGSNSS-QFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWV 371 (464)
Q Consensus 312 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~ 371 (464)
+++...+.-..- ....++-|..|.|||.+.+. .||.+.|||+.||++.||+|-...|...
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999876542221 23457789999999988775 6999999999999999999998877643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=260.53 Aligned_cols=279 Identities=23% Similarity=0.320 Sum_probs=211.8
Q ss_pred HHHHHHHHhhhccccCccCceEEEEEE-ECCCcEEEEEEcCCccc-hhHHHHHHHHHhhhcc-ccceeccceeeeeCcEE
Q 040010 162 YAELKKATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 162 ~~el~~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 238 (464)
+.|+-+-|. +.||+|+++.|--++ +.+|.++|||++.+... ......+|++++.+.+ |+||+.++.||+++...
T Consensus 75 F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 456655544 579999999999988 57899999999986543 3456779999999985 99999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecCccc
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGLAKL 315 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~ 315 (464)
|||||-|.||+|..+|++...++..++.++..+||.||.|||. ++|.|||+||+|||..+... +||+||.|..-
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999999999999999999999999999999999 99999999999999966544 79999998764
Q ss_pred cCCCCC-----CcceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh--hhHH
Q 040010 316 SQRGSN-----SSQFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELT 383 (464)
Q Consensus 316 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~ 383 (464)
...... .....+..|+..|||||+.. ...|+.+.|.||||||||-|++|..||......+-+.. ..-.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 322211 12234577888999999752 23588999999999999999999999987665433221 1122
Q ss_pred HHHHHHHHHhhccchhhhhhhcCCccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCCCCCCCC
Q 040010 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNK----NQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEAESEVPV 457 (464)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~~~~~~~ 457 (464)
.-...+++.+.+|. . +++. ....+..+++...+-.|+.+|.++.+|++ ......++...|.
T Consensus 309 ~CQ~~LFesIQEGk-----------Y--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 309 VCQNKLFESIQEGK-----------Y--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred HHHHHHHHHHhccC-----------C--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 22223333333322 1 2222 33455667777788899999999999987 3444444444444
Q ss_pred CC
Q 040010 458 QT 459 (464)
Q Consensus 458 p~ 459 (464)
|+
T Consensus 376 p~ 377 (463)
T KOG0607|consen 376 PQ 377 (463)
T ss_pred Cc
Confidence 43
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=266.62 Aligned_cols=220 Identities=19% Similarity=0.131 Sum_probs=177.3
Q ss_pred cCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChHHhhhcC
Q 040010 179 GGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS 257 (464)
Q Consensus 179 G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~ 257 (464)
|.+|.||++... +++.+|+|++..... +..|...+....|||++++++++.+....+++|||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999974 678999999875432 234455555667999999999999999999999999999999999877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCc
Q 040010 258 NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337 (464)
Q Consensus 258 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP 337 (464)
..+++.....++.|++.||.|||+ .+++||||||+||+++.++.++++|||++...... .....++..|+||
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aP 151 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAP 151 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCC
Confidence 789999999999999999999999 89999999999999999999999999988655432 1223456789999
Q ss_pred ccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHH
Q 040010 338 EWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQ 417 (464)
Q Consensus 338 E~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 417 (464)
|...+..++.++||||+|+++|||++|+.|+...... ....... ..+...
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------------------~~~~~~~----~~~~~~ 201 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------------------INTHTTL----NIPEWV 201 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------------------ccccccc----CCcccC
Confidence 9998888999999999999999999998775421100 0000000 112223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHH
Q 040010 418 AATLFRIGISCVDEDRNKRPTMD 440 (464)
Q Consensus 418 ~~~~~~l~~~Cl~~dp~~RPsm~ 440 (464)
...+.+++.+|++.||++||++.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCC
Confidence 45688899999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.51 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=188.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeC-----------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG----------- 235 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 235 (464)
++.+.+.||.|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|+|++++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566788999999999999974 57899999886443 3346688999999999999999999866543
Q ss_pred ---cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeec
Q 040010 236 ---MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFG 311 (464)
Q Consensus 236 ---~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg 311 (464)
...++||||++ ++|.+++. ...+++.....++.||+.||.|||+ .+++||||||+||+++ +++.+|++|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 58888874 3468999999999999999999999 8899999999999997 45678999999
Q ss_pred CccccCCCCCCc-ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 312 LAKLSQRGSNSS-QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 312 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
++.......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~ 235 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-----QMQLILESV 235 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhc
Confidence 997653321111 1123457889999997654 568899999999999999999999986332100 000000000
Q ss_pred -------HHHhhccchhhhhhhcCCccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 390 -------KEKILCGEEARIEEIVDPRLKGHF-----NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 390 -------~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........ ............. .......+.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVI---PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhh---hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 0000000000000 0123356889999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=284.29 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=202.5
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+...||+|.|+.|..++. ..+..||||.+..... ....+.+|+++|..++|||||+++.+......+++||||.
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 45667899999999999996 4588999999875432 2234789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
.+|.++++|.+.+......+..+..|+.++++|+|+ +.|||||||++||||+.+.++||+|||++..+..... .
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---l 211 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---L 211 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccc---c
Confidence 999999999998888889999999999999999999 8899999999999999999999999999998875432 4
Q ss_pred eeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.+.+|++.|.|||++.+..| ++++|+||+|++||-|++|..||+... +.++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----------------------------lk~L 263 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----------------------------LKEL 263 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----------------------------cccc
Confidence 56789999999999998876 579999999999999999999998421 1111
Q ss_pred cCCccCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGH--FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~--~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
-++.+... .+.-...++.+++++.+-.+|.+|++++++.+-
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111111 122233457788899999999999999998753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.78 Aligned_cols=259 Identities=21% Similarity=0.233 Sum_probs=190.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeee-CcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~E~ 244 (464)
+.+.+.||.|+||.||++... +++.||+|++... ....+.+..|+++++.++|||++++.+++.. +...++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 455678999999999999864 6889999987532 2234567889999999999999999998865 5678999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+ +++|..++. ...+++.....++.|++.||.|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 92 ~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----- 161 (328)
T cd07856 92 L-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----- 161 (328)
T ss_pred h-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----
Confidence 8 568988875 3468888899999999999999999 89999999999999999999999999998754321
Q ss_pred eeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HHHHhhcc
Q 040010 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VKEKILCG 396 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 396 (464)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......... ..+....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-----VNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHHhccch
Confidence 123457888999998765 5689999999999999999999998863211 0011000000 00000000
Q ss_pred chhhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. ...-+..-......+. .....+.+++.+||+.+|++|||+.+++..
T Consensus 237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 N--TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred h--hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000111111 124678899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.62 Aligned_cols=261 Identities=23% Similarity=0.268 Sum_probs=188.6
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 239 (464)
+.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++|+||+++.+++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 34456899999999999986 468899999987432 2345678899999999999999999987543 3467
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
++++++ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 99 lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 99 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred EEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 888876 7899888754 469999999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HHH
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VKE 391 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~ 391 (464)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...... ...
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 174 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred -----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHh
Confidence 233467889999998766 5688999999999999999999999853211 0111110000 000
Q ss_pred HhhccchhhhhhhcCCccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 392 KILCGEEARIEEIVDPRLKGHFN---KNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+...........++......+. ......+.+++..|++.||.+||++.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000000000000000 0124467899999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=287.69 Aligned_cols=192 Identities=31% Similarity=0.411 Sum_probs=167.8
Q ss_pred ccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeC------cEEeEEEE
Q 040010 173 KEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRLLVYE 243 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~E 243 (464)
.+.||+|+||.||+|+. ..|+.||||.++.. ....+....|+++|++++|+|||++++.-.+. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 45799999999999995 56999999998753 33456678999999999999999999976544 36689999
Q ss_pred eccCCChHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc--CCC--CeEEeeecCcccc
Q 040010 244 YVENQSLDKHLFS---SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD--SEF--EPKIADFGLAKLS 316 (464)
Q Consensus 244 ~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgla~~~ 316 (464)
||++|||+..|.+ ...|+..+.+.+..++..||.|||+ ++|+||||||.||++- +++ ..||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999999974 3479999999999999999999999 9999999999999993 333 4799999999987
Q ss_pred CCCCCCcceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
+.+. ...+..||..|++||... ...|+..+|.|||||++||..||..||..
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 7654 578899999999999988 48899999999999999999999999963
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=257.66 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=190.4
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccC
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+...||+|..|.||+.+.. .|..+|||.+.... +..+.++..+.++.+-+ .|.||+.+|||..+...++-||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3467999999999999975 58899999987543 34466777888877775 8999999999999999999999984
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
.-++.++.. ..++++...-++...+..||.||.+. ++|+|||+||+|||+|+.|++|++|||++..+-... ..+
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---Aht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHT 249 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc---ccc
Confidence 345566553 35688888889999999999999884 579999999999999999999999999997654332 235
Q ss_pred eeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 327 RIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
...|-+.|||||.+.- ..|+.++||||||++|+||.||+.|+.....+. .. ..++.+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~-----ltkvln-------- 309 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EV-----LTKVLN-------- 309 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HH-----HHHHHh--------
Confidence 5678999999998854 468999999999999999999999997532211 11 111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
-.-|.+... ......+.+++..||+.|+.+||...++++
T Consensus 310 ~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 EEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111333221 114567999999999999999999988765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=272.44 Aligned_cols=244 Identities=26% Similarity=0.289 Sum_probs=200.5
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcE
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 237 (464)
.++.+..+|...||+|+||.|..+..++ .+.+|||+++..- .+.+--+.|-++|... +-|-++.++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4566678999999999999999998754 5679999998542 2223345677777776 57789999999999999
Q ss_pred EeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 238 RLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
+|+||||+.||+|..+|+.-+.+.++.+..+|..||-||-+||+ ++|++||||..||+||.+|++||+|||+++.--
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999999988999999999999999999999999 999999999999999999999999999998543
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. ....+.+.+|||.|+|||.+..++|+.++|+|||||+||||+.|+.||+...+ . +.
T Consensus 502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-----~----el------------ 558 (683)
T KOG0696|consen 502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----D----EL------------ 558 (683)
T ss_pred c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-----H----HH------------
Confidence 2 23446779999999999999999999999999999999999999999984211 1 11
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 438 (464)
...+.+... .++.....+...+...-+...|.+|..
T Consensus 559 ---F~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 559 ---FQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---HHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 223333332 345555666777777888889999854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.19 Aligned_cols=142 Identities=25% Similarity=0.326 Sum_probs=129.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.++||.|+||.||+|... +++.||||+++... .....+..|+.++..++|+||+++++++....+.++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456788999999999999976 57899999987432 2235688899999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
+++++|.+++.....+++...+.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999877789999999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=263.41 Aligned_cols=238 Identities=24% Similarity=0.227 Sum_probs=196.1
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..|.+.||+|.||.|..++- ..++.+|+|+++..-. ....-..|-++|+..+||.+..+--.++....+++||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 35678899999999999985 4688999999985421 223345688899999999999999899999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
..||.|.-+|.....++......+...|..||.|||+ .+||.||||.+|.|||.+|++||+||||++.--. ....
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t 324 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDT 324 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--ccce
Confidence 9999999999988899999999999999999999999 9999999999999999999999999999985432 2334
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
++..+|||.|+|||++....|...+|+|.+||++|||++|+.||.... .+..+.-.+ ..++
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kLFeLIl--------------~ed~ 385 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKLFELIL--------------MEDL 385 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHHHHHHH--------------hhhc
Confidence 678999999999999999999999999999999999999999998421 111111110 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs 438 (464)
.++.....+...|+.-.|..||.+|..
T Consensus 386 -------kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 -------KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred -------cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 234444556777888899999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=259.21 Aligned_cols=236 Identities=30% Similarity=0.333 Sum_probs=192.9
Q ss_pred CceEEEEEEECC-CcEEEEEEcCCccch--hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChHHhhhc
Q 040010 180 GSGAVYKGVLTD-ERAVAVKRLGDLHQG--EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256 (464)
Q Consensus 180 ~~g~Vy~g~~~~-~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~ 256 (464)
+||.||+|...+ ++.+++|++...... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 889999999754332 57899999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccC
Q 040010 257 SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336 (464)
Q Consensus 257 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 336 (464)
...+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++++|||.+....... ......++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 6669999999999999999999999 899999999999999999999999999998765432 2334568889999
Q ss_pred cccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHH
Q 040010 337 PEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKN 416 (464)
Q Consensus 337 PE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 416 (464)
||.+.+..++.++||||||+++++|++|..|+..... .. .... .. ............
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~---~~~~----~~-----------~~~~~~~~~~~~ 211 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LL---ELFK----KI-----------GKPKPPFPPPEW 211 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HH---HHHH----HH-----------hccCCCCccccc
Confidence 9999888899999999999999999999988863210 00 0111 00 011110000000
Q ss_pred -HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 417 -QAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 417 -~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+.+++.+|+..+|++||++.++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 4457889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=282.25 Aligned_cols=238 Identities=26% Similarity=0.275 Sum_probs=193.5
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+...+|.|+|+.|-.+.. .+++..+||++..... +-.+|+.++... +|+|++++.+.+.++.+.++|||.+.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 456667899999999999986 4578899999986522 223566555555 79999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE-cCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL-DSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++-|.+.+....... ..+..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++..... .
T Consensus 400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~ 470 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C 470 (612)
T ss_pred ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence 999888887666555 8888999999999999999 999999999999999 69999999999999876654 2
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...+-|..|.|||++....||+++|+||||++||+|++|+.|+.....+ .++...+ -
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------~ei~~~i-----------~ 527 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------IEIHTRI-----------Q 527 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------HHHHHhh-----------c
Confidence 3445688999999999999999999999999999999999999743211 1111111 1
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+ .+.....+...+|+.+||+.||.+||+|.++...
T Consensus 528 ~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CC----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11 2224455678889999999999999999998754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=255.58 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=195.7
Q ss_pred ccccCHHHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceee
Q 040010 157 FKRFSYAELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFC 232 (464)
Q Consensus 157 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 232 (464)
...|+..+|+.. ..||.|+||+|+|-..+ .|+..|||+++... ....+++.|+++..+- +.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 455666666543 46999999999999874 58999999998543 4556788888776554 799999999999
Q ss_pred eeCcEEeEEEEeccCCChHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLF-----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
-.++..|+-||.|. -||+.+-. ....+++...-.|..-...||.||-+.. .|+|||+||+|||||..|.+||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEee
Confidence 88889999999995 57665543 3457888888899999999999998864 4999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
+|||++..+... ...+...|-..|||||.+.. ..|+.+|||||||++|+|+.||..|+... ...
T Consensus 210 CDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----------~sv 275 (361)
T KOG1006|consen 210 CDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----------DSV 275 (361)
T ss_pred ecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----------HHH
Confidence 999998765432 12344568888999998753 35899999999999999999999997621 111
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+ ...+..|+++. +... .-..+-...+..++-.|+-+|..+||+..++.+
T Consensus 276 feq-l~~Vv~gdpp~----l~~~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 276 FEQ-LCQVVIGDPPI----LLFD---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHH-HHHHHcCCCCe----ecCc---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 12233333221 1111 111234567889999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=260.95 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=197.2
Q ss_pred HhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeee-CcEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 239 (464)
+...+..+-+|.||.||.|.+. +.+.|-||.++... .....+..|.-.+..+.|||+..+.|.+.+ ....+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3344557899999999999653 45678888887543 344668889989999999999999999865 46788
Q ss_pred EEEEeccCCChHHhhh-----c---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 240 LVYEYVENQSLDKHLF-----S---SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~-----~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
.+|.++.-|+|..+|. + ...++-.+...++.|++.|++|||. .++||.||.++|++||+...+||+|-.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccch
Confidence 9999999999999997 1 1246677788999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
+++.+-..+....-........||+||.+....|+..+|||||||+||||+| |+.|+.... ...
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID------PfE--------- 506 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID------PFE--------- 506 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC------HHH---------
Confidence 9986654433322223335668999999999999999999999999999998 666654211 111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+...+-...+-.-+-+++.++..++.-||..+|++||++++++.-|.++
T Consensus 507 ----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 ----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111111111122446788899999999999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=288.71 Aligned_cols=251 Identities=23% Similarity=0.200 Sum_probs=201.4
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCC---c-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGD---L-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~---~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
....+.+.+.||+|+||.|...+.+ .++.+|.|+++. . ......|+.|=.+|..-+.+-|+.++-.|.+..++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3455677789999999999999975 478899999985 2 3455779999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||||+||+|-.++.+...++...+..++..|.-||.-||+ .|+|||||||.|||||..|++||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999887789999999999999999999999 999999999999999999999999999997776443
Q ss_pred CCcceeeeccCCCccCccccc----C-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 321 NSSQFSRIRGTKGYMAPEWAS----N-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
. ......+|||.|++||++. + +.|++..|+||+||++|||+.|..||+. ..+.+. ..++.+
T Consensus 230 ~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---------dslveT----Y~KIm~ 295 (1317)
T KOG0612|consen 230 T-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---------DSLVET----YGKIMN 295 (1317)
T ss_pred c-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---------HHHHHH----HHHHhc
Confidence 2 3356678999999999874 2 5689999999999999999999999973 122222 122211
Q ss_pred cchhhhhhhcCCccCCCCC--HHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFN--KNQAATLFRIGISCVDEDRNKRPT---MDSVVQT 445 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~--~~~~~~~~~l~~~Cl~~dp~~RPs---m~~V~~~ 445 (464)
. .+.+ .|| .+..+...+|+..-+ -+|+.|.. +.++-..
T Consensus 296 h-----k~~l------~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 H-----KESL------SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred h-----hhhc------CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1 1111 122 234556667777666 47888887 7777653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=252.06 Aligned_cols=244 Identities=23% Similarity=0.236 Sum_probs=191.5
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeee----CcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE----GMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~E~~~~ 247 (464)
++||-|-.|.|-.+..+ .++..|+|++.+.... ++|+++--+. .|+|||.+++++.+ ...+++|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA----RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA----RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHHH----HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 57999999999999864 6788999999865543 4667654443 69999999998754 4677899999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCCCCCC
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|.|...|++++ .+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||+|+.....
T Consensus 144 GeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--- 217 (400)
T KOG0604|consen 144 GELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--- 217 (400)
T ss_pred hHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC---
Confidence 99999998765 59999999999999999999999 89999999999999954 456899999999876542
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
....+.+-|+.|.|||++..+.|+...|+||+||++|-|++|..||+...... +..- ...++..|. -
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------ispg---Mk~rI~~gq----y 284 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ISPG---MKRRIRTGQ----Y 284 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc------CChh---HHhHhhccC----c
Confidence 23456778999999999999999999999999999999999999998543211 1111 111221111 0
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
++ | ++--....+...++++..|..+|.+|.|+.+++..
T Consensus 285 ~F--P---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EF--P---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cC--C---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 00 0 11123456778889999999999999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=268.65 Aligned_cols=239 Identities=28% Similarity=0.362 Sum_probs=192.7
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+.||+|-||+||-|.. ++|+.||||++.+. ..++.++++|+.+|++++||.||.+-..|+..+..++|||-+.|--
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 5799999999999996 57999999988643 4566889999999999999999999999999999999999997766
Q ss_pred hHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeeecCccccCCCCCCcce
Q 040010 250 LDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 250 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+..|.. .++|+...-..++.||+.||.|||. ++|+|+||||+||||.+.. .+||+|||.|+..+.... .
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R 723 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R 723 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence 6666653 4689999989999999999999999 9999999999999996543 589999999998875432 4
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
..+.||+.|+|||++.+..|...-|+||.||++|--++|..||.- +++ +. +++. -.+++
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE---dEd-----In-------dQIQ------NAaFM 782 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE---DED-----IN-------DQIQ------NAAFM 782 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC---ccc-----hh-------HHhh------ccccc
Confidence 568899999999999999999999999999999999999999972 111 11 1111 01122
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSV 442 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V 442 (464)
-|. .--.+..+..++|+...||..-.+|-|...-
T Consensus 783 yPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 783 YPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred cCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 211 1123445567778888888888888776644
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=275.30 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=207.1
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeee-----eCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCT-----EGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 240 (464)
.+..|.+.||.|.+|.||+++. ++++.+|+|++......+++...|.++++.. +|||++.++|++. .++.+||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3457788999999999999994 5788999999988777788888999999988 6999999999884 3578999
Q ss_pred EEEeccCCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 241 VYEYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
|||||.+||.-+++.+ ...+.|.....|+..++.|+.+||. ..++|||||-.||||++++.+|+.|||.+..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999874 4579999999999999999999999 8899999999999999999999999999976653
Q ss_pred CCCCcceeeeccCCCccCcccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNL-----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
. .....+..||+.|||||++... .|+..+|+||||++..||-.|..|+..+.... .+
T Consensus 176 T--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------------aL---- 237 (953)
T KOG0587|consen 176 T--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------------AL---- 237 (953)
T ss_pred c--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------------hh----
Confidence 2 2234567899999999998654 47789999999999999999999987543210 00
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.-.-.|...-.-+....+.+.+++..||..|-++||++.++++
T Consensus 238 -------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 -------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11122333332335678899999999999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=270.60 Aligned_cols=256 Identities=20% Similarity=0.218 Sum_probs=174.7
Q ss_pred HhhhccccCccCceEEEEEEE-----------------CCCcEEEEEEcCCccch-h--------------HHHHHHHHH
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-----------------TDERAVAVKRLGDLHQG-E--------------EVFWAEVST 216 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~E~~~ 216 (464)
.+.+.++||+|+||.||+|.+ .+++.||||++....+. . +.+..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455667999999999999974 23467999998743321 1 223457777
Q ss_pred hhhccccce-----eccceeeee--------CcEEeEEEEeccCCChHHhhhcC------------------------CC
Q 040010 217 IGKIYHMNL-----VRMWGFCTE--------GMHRLLVYEYVENQSLDKHLFSS------------------------NF 259 (464)
Q Consensus 217 l~~l~h~ni-----v~l~g~~~~--------~~~~~lv~E~~~~gsL~~~l~~~------------------------~~ 259 (464)
+.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777776654 778888753 35689999999999999988632 13
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCccc
Q 040010 260 LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339 (464)
Q Consensus 260 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 339 (464)
++|..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......... .....+++.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhh
Confidence 4678889999999999999999 889999999999999999999999999997654322111 122335789999998
Q ss_pred ccCCC----------------------CCccchhHHHHHHHHHHHhCCC-CCCccccCccc---hhhhHHHHHHHHHHHh
Q 040010 340 ASNLP----------------------ITSKVDVFSYGVVILEMLKGIR-LSNWVVEDSEG---QEAELTGFIREVKEKI 393 (464)
Q Consensus 340 ~~~~~----------------------~~~~~DV~S~Gvvl~elltg~~-p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 393 (464)
+.... ...+.||||+||+++||++|.. |+......... .......|.. .
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-----~ 456 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-----Y 456 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-----h
Confidence 75322 1235799999999999999875 44321100000 0011111110 0
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDR---NKRPTMDSVVQ 444 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp---~~RPsm~~V~~ 444 (464)
. ..-.+-.. .....+...+++..++..+| .+|+|+.|+++
T Consensus 457 ~-------~~~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 K-------GQKYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c-------ccCCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 00011111 11234567788888888765 68999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=260.06 Aligned_cols=257 Identities=27% Similarity=0.297 Sum_probs=195.4
Q ss_pred HHHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc--------hhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ--------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
....+|-+.+.||+|||+.|||+.. ...+.||||+-..... ..+...+|..+-+.+.||.||++++|+.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3445566667899999999999984 5678999997542211 113356788999999999999999998644
Q ss_pred -cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc---CCCCeEEeeec
Q 040010 236 -MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD---SEFEPKIADFG 311 (464)
Q Consensus 236 -~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfg 311 (464)
+..+-|.||++|.+|+-+|.....++..++..|+.||+.||.||.+.. ++|||-||||.||||- ..|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 667899999999999999998899999999999999999999999855 8999999999999994 45789999999
Q ss_pred CccccCCCCCCc-----ceeeeccCCCccCcccccC----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhH
Q 040010 312 LAKLSQRGSNSS-----QFSRIRGTKGYMAPEWASN----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 312 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 382 (464)
|++.++.+.... .+....||..|++||.+.- ..++.|+||||.||++|..+-|++||..... +...+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----QQdIL 694 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----QQDIL 694 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----HHHHH
Confidence 999987665432 2456789999999997643 3578999999999999999999999974321 11111
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCc-cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPR-LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
.+ .-++..+ +.-+..+....+...++++||+.-.++|....++.
T Consensus 695 ----qe-------------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 ----QE-------------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----hh-------------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 10 0011111 00011122344567788899999888887666654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=276.34 Aligned_cols=258 Identities=22% Similarity=0.231 Sum_probs=165.2
Q ss_pred HhhhccccCccCceEEEEEEECC-----CcEEEEEEcCCccchhHHHHHHHHHhhhccccceecccee------eeeCcE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF------CTEGMH 237 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~~ 237 (464)
.+.+.+.||+|+||.||+|++.+ +..||||++......+. +..| .+....+.+++.++.. +..+..
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-WMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-HHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 35667899999999999999754 58999998864332211 1111 1222223333333222 245678
Q ss_pred EeEEEEeccCCChHHhhhcCCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 238 RLLVYEYVENQSLDKHLFSSNF--------------------LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
.++||||+++++|.+++..... ........++.|++.||+|||+ .+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 9999999999999999864321 1123345789999999999999 8999999999999
Q ss_pred EEcC-CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC----------------------CCCccchhHHH
Q 040010 298 LLDS-EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL----------------------PITSKVDVFSY 354 (464)
Q Consensus 298 ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DV~S~ 354 (464)
|+++ ++.+||+|||+++........ ......+++.|+|||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9986 579999999999865433221 23446789999999955321 24456799999
Q ss_pred HHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCC----CC--HHHHHHHHHHHHHc
Q 040010 355 GVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH----FN--KNQAATLFRIGISC 428 (464)
Q Consensus 355 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~----~~--~~~~~~~~~l~~~C 428 (464)
||+||||+++..+.+.. ...+...+.. ... +.......+.+..... +. ........+|+.+|
T Consensus 366 GviL~el~~~~~~~~~~----------~~~~~~~l~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----------LIQFNRQLKR-NDY-DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHhCcCCCchH----------HHHHHHHHHh-cCC-cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 99999999976553310 0111110000 000 0000011111110000 00 00122355899999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 040010 429 VDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 429 l~~dp~~RPsm~~V~~~ 445 (464)
|+.||++|||+.++++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=257.24 Aligned_cols=270 Identities=23% Similarity=0.291 Sum_probs=205.3
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccc--cc----eeccceee
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH--MN----LVRMWGFC 232 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~g~~ 232 (464)
|...|....++.+...+|+|.||.|-.+.... +..||||+++......+..+-|+++|+++.+ |+ +|.+.+|+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 44556667778888899999999999998643 6899999999887777778899999999942 22 78888999
Q ss_pred eeCcEEeEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---------
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--------- 301 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--------- 301 (464)
.-.++.++|+|.+ |-|+.++|.+++ +++......|+.|++++++|||+ ..++|-||||+|||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence 9999999999998 569999998765 68888999999999999999999 99999999999999832
Q ss_pred -----------CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 302 -----------EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 302 -----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
+..++|.|||.|...... ...+..|..|.|||++.+-.++..+||||+||+|.|+.||...|+.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 345899999999865433 2557789999999999999999999999999999999999998874
Q ss_pred cccCccchhhhHHHHHHHHH--------HHh------hcc-----chhh---hhhhcCCcc----CCCCCHHHHHHHHHH
Q 040010 371 VVEDSEGQEAELTGFIREVK--------EKI------LCG-----EEAR---IEEIVDPRL----KGHFNKNQAATLFRI 424 (464)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~--------~~~------~~~-----~~~~---~~~~~d~~l----~~~~~~~~~~~~~~l 424 (464)
... ...+ ..+..+. .+. ..| +... .....++-. .-.....+...+.+|
T Consensus 312 Hen-----~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 312 HEN-----LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred CCc-----HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 321 1111 0011000 000 000 0000 000111000 001234567789999
Q ss_pred HHHccCCCCCCCCCHHHHHH
Q 040010 425 GISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 425 ~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+|..||.+|+|+.|++.
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=219.10 Aligned_cols=257 Identities=22% Similarity=0.259 Sum_probs=189.7
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
++||+|.+|+|+||+.. .++.||+|+++-...+ .....+|+-+++.++|+|||++++....+..+-+|+|||. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 67999999999999964 5788999988743322 2457899999999999999999999999999999999995 47
Q ss_pred hHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 250 LDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 250 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
|..+..+ ++.++......++.|+++||.|.|+ .++.|||+||.|.||+.+|..|++|||+++.++-.-. -.+..
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--cysae 161 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAE 161 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeece
Confidence 8777765 4579999999999999999999999 8899999999999999999999999999997764321 23445
Q ss_pred ccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch---hhhhhh
Q 040010 329 RGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE---ARIEEI 404 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 404 (464)
.-|..|.+|.++.+. -|+...|+||-||++.|+....+|..... ...+-+..+.+.+....+ +.+..+
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--------dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--------DVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--------cHHHHHHHHHHHhCCCccccCCccccC
Confidence 678999999988775 48999999999999999998766654211 111122222222211111 112222
Q ss_pred cCCccCCCCC---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFN---------KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~---------~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
-|-..-..++ ......=.++....+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222212221 111222345666677779999999988765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=229.26 Aligned_cols=209 Identities=35% Similarity=0.529 Sum_probs=184.0
Q ss_pred cCccCceEEEEEEECC-CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChHH
Q 040010 176 LGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDK 252 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~ 252 (464)
||+|.+|.||++...+ ++.+++|++..... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 88999999986554 35678999999999999999999999999899999999999999999
Q ss_pred hhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 253 HLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 253 ~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
++... ..+++..+..++.++++++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99765 579999999999999999999999 89999999999999999 89999999999986654321 1233557
Q ss_pred CCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCcc
Q 040010 331 TKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409 (464)
Q Consensus 331 t~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 409 (464)
...|++||..... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999998877 888999999999999998
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 410 ~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
..+.+++..|++.||++||++.++++.+
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2477888899999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=271.50 Aligned_cols=239 Identities=31% Similarity=0.389 Sum_probs=183.5
Q ss_pred cccCccCce-EEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSG-AVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
+.+|.|+.| .||+|.. +|+.||||++-... .....+|+..|+.- .|+|||++++.-.+...+|+..|.| ..+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 468999887 4899999 67899999886432 23346899999888 6999999999999999999999999 47999
Q ss_pred HhhhcC-C---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---C--CCeEEeeecCccccCCCCCC
Q 040010 252 KHLFSS-N---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---E--FEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 252 ~~l~~~-~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~--~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++... . ...-...+.+..|++.||++||+ -+||||||||.||||+. + ..++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999763 1 11113456788999999999999 88999999999999976 2 56899999999988766544
Q ss_pred -cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 323 -SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 323 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.......||.||+|||.+....-+..+|++|+|||+|+.++| ..||......+ .++..+...
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------------~NIl~~~~~- 731 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------------ANILTGNYT- 731 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------------hhhhcCccc-
Confidence 234567899999999999988888899999999999999987 77876321100 011111100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+. .+.. ..++ ...+|+.+|++++|..||++.+|+.
T Consensus 732 L~-----~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LV-----HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee-----eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 0111 1111 6788999999999999999999973
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=238.65 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=193.2
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEecc
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...||+|++..|..+.+. ..+.+|+|+++..- ++..=...|-.+..+. +||.+|-+..++..+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 357999999999999974 56789999887432 1222244555566555 79999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.-+++....|+...+..+...|..||.|||+ .+|+.||||..|||||..|++|++|+|+++.--.. ...++
T Consensus 335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~--gd~ts 409 (593)
T KOG0695|consen 335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTS 409 (593)
T ss_pred CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC--Ccccc
Confidence 99999999988999999999999999999999999 99999999999999999999999999999864332 23467
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
+.+|||.|+|||.+.+..|...+|+|++||+++||+.|+.||+....+.. .....+++-++ ++.
T Consensus 410 tfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~--d~ntedylfqv--------------ile 473 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP--DMNTEDYLFQV--------------ILE 473 (593)
T ss_pred cccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc--ccchhHHHHHH--------------Hhh
Confidence 79999999999999999999999999999999999999999997654332 22223332222 222
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRP 437 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP 437 (464)
.+++ .+....-+...++..-++.||.+|.
T Consensus 474 kqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 KQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2221 2333444566677788899999885
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=237.62 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=189.7
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCC--ccc-hhHHHHHHHHHhhhccccceeccceeeee--------CcEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGD--LHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTE--------GMHR 238 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~--~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~~ 238 (464)
.-..+||+|.||.||+++.+ .|+.||+|+.-- ... -.....+|+++|..++|+|++.++..|.. ....
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 33457999999999999964 467788886532 122 22446789999999999999999998842 2457
Q ss_pred eEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 239 LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
++||++++. +|..+|.+. ..++..+..+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+++.+.
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999999975 888888765 579999999999999999999999 889999999999999999999999999997654
Q ss_pred CCCC--CcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh-
Q 040010 318 RGSN--SSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI- 393 (464)
Q Consensus 318 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 393 (464)
.... ....+...-|..|.+||.+.+ ..|+++.|||.-||++.||+||...+....+ .+.. ..+..+....
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte---qqql---~~Is~LcGs~t 249 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE---QQQL---HLISQLCGSIT 249 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH---HHHH---HHHHHHhccCC
Confidence 3322 233455667999999998765 4799999999999999999999887764321 1111 1111111100
Q ss_pred ---------------------hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 394 ---------------------LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 394 ---------------------~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
..+....+.+.+.+-.+ ..+.++|+..++..||.+||.+++++..-
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k-------d~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK-------DDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC-------ChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00110011111111111 23567788899999999999999987654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=251.35 Aligned_cols=209 Identities=24% Similarity=0.265 Sum_probs=174.3
Q ss_pred CHHHHHHHHh---hh--ccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccce
Q 040010 161 SYAELKKATN---SF--KEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWG 230 (464)
Q Consensus 161 ~~~el~~~~~---~~--~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g 230 (464)
.|..|+++.- -| .+.||-|+||.|.++.- +....+|.|.|++.. ......+.|-.+|.....+-+|+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 4555655532 22 34699999999999984 345678999887542 23345678889999999999999999
Q ss_pred eeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 040010 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310 (464)
Q Consensus 231 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 310 (464)
.|.+.+.+|+||+|++||++-.+|.+.+.+.+..+..++..++.|+++.|. .++|||||||+|||||.+|++||+||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeec
Confidence 999999999999999999999999999999999999999999999999999 99999999999999999999999999
Q ss_pred cCccccCC---------CCCC-------------------------------cceeeeccCCCccCcccccCCCCCccch
Q 040010 311 GLAKLSQR---------GSNS-------------------------------SQFSRIRGTKGYMAPEWASNLPITSKVD 350 (464)
Q Consensus 311 gla~~~~~---------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 350 (464)
||+.-+.. ++.. ......+||+.|+|||++....++...|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 99863311 0000 0012355999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCccc
Q 040010 351 VFSYGVVILEMLKGIRLSNWVV 372 (464)
Q Consensus 351 V~S~Gvvl~elltg~~p~~~~~ 372 (464)
+||.||+||||+.|+.||....
T Consensus 854 wws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCC
Confidence 9999999999999999997543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=254.47 Aligned_cols=241 Identities=24% Similarity=0.257 Sum_probs=199.0
Q ss_pred cccCccCceEEEEEEECCCcE-EEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTDERA-VAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~-vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
..||-||||.|=....+.... .|+|.++.. ...++....|-.+|...+.+.||+++--+.+....|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 359999999999998765443 788888643 234455778999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
.|...|..++.++..+...++..+++|++|||. ++||+|||||+|.+||.+|-+||.|||+|+....+. .+.+.
T Consensus 506 ElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTF 579 (732)
T KOG0614|consen 506 ELWTILRDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTF 579 (732)
T ss_pred hhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeee
Confidence 999999999999999999999999999999999 999999999999999999999999999999887654 36678
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
+|||.|.|||.+.+...+.++|.||||+++|||++|..||...... . ..+.+..|. ..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm------k-------tYn~ILkGi----d~----- 637 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM------K-------TYNLILKGI----DK----- 637 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH------H-------HHHHHHhhh----hh-----
Confidence 9999999999999999999999999999999999999999753211 1 111111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
-.++........++++.....+|.+|.. +.+|-+
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 1344455566778888888899999976 555554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=221.00 Aligned_cols=192 Identities=29% Similarity=0.321 Sum_probs=160.5
Q ss_pred ccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccCC
Q 040010 173 KEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.||+|++|.|=+-++ .+|+..|+|++... .+..++.+.|+.+..+- ..|.+|.++|........++.||.|. .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 46799999999988886 57899999999743 44556678888876554 79999999998888889999999995 5
Q ss_pred ChHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 249 SLDKHL----FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 249 sL~~~l----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
||+.+- ......++...-+|+..+.+||.|||+.. .++|||+||+||||+.+|++|++|||++..+.+.-.
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--- 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--- 204 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH---
Confidence 776653 35668899999999999999999999964 599999999999999999999999999977654321
Q ss_pred eeeeccCCCccCcccccC----CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 325 FSRIRGTKGYMAPEWASN----LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.+...|-..|||||.+.. ..|+.|+||||||+++.||.+++.|++.
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 222457778999998743 3689999999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=224.28 Aligned_cols=195 Identities=32% Similarity=0.428 Sum_probs=172.0
Q ss_pred hhccccCccCceEEEEEEECC-CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999999865 78999999986543 457788999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++|.+++..... +++.....++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~ 157 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK 157 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence 999999987666 8999999999999999999999 79999999999999999999999999999876544211 223
Q ss_pred eeccCCCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 327 RIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 327 ~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
...++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 45678889999988 66778889999999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=242.97 Aligned_cols=193 Identities=21% Similarity=0.277 Sum_probs=168.2
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhH---------HHHHHHHHhhhcc---ccceeccceeeeeCc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEE---------VFWAEVSTIGKIY---HMNLVRMWGFCTEGM 236 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~---------~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 236 (464)
+...+.+|+|+||.|+.+.++. ...|+||.+.+.+.-.. ..-.|+++|..++ |+||++++++|++.+
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4445689999999999999864 56789998865432221 2346999999997 999999999999999
Q ss_pred EEeEEEEec-cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 237 HRLLVYEYV-ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 237 ~~~lv~E~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
..+|+||-. ++-+|.++|.-+..+++.++..|..|++.|+++||+ ++|||||||-+||.++.+|-+||.|||.+..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999976 566899999888999999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPIT-SKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
...++ +...+||.+|.|||++.+.+|- ..-|||++|++||-++....|++
T Consensus 720 ~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 76654 5678999999999999998874 56799999999999998877765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-30 Score=229.71 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=191.5
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~E~ 244 (464)
+.||-|+||.||..+. ++|+.||.|++....+ ..+.+.+|+++|+..+|.|++..++...-. .+.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999996 5789999999875433 346788999999999999999988865433 346788888
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
|. .+|...|-+-..|+.....-+..||++||.|||+ .+|.||||||.|.|++.|..+||+|||+++..+..... .
T Consensus 139 mQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~-h 213 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL-N 213 (449)
T ss_pred HH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhh-h
Confidence 85 5888888777889988888999999999999999 89999999999999999999999999999976654333 2
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH----HHHHHhhccchh
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR----EVKEKILCGEEA 399 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 399 (464)
++...-|..|.|||.+++. .|+...||||.||++.||+..+..|.....-. +...+.+.+. +..+.--+|.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACEGA-- 289 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACEGA-- 289 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhhhh--
Confidence 4556678899999998875 69999999999999999999888876432111 1111111110 0000000011
Q ss_pred hhhhhcCCccCC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 400 RIEEIVDPRLKG---------HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 400 ~~~~~~d~~l~~---------~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
-.-++....+. ..+.+...+...+...++..||++|.+..+.+..+
T Consensus 290 -k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 -KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred -HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01111111110 01112334456677789999999999988877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=231.19 Aligned_cols=144 Identities=25% Similarity=0.352 Sum_probs=122.6
Q ss_pred cccCccccCHHHHHH-HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-----c---
Q 040010 153 LSSQFKRFSYAELKK-ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-----H--- 222 (464)
Q Consensus 153 ~~~~~~~~~~~el~~-~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h--- 222 (464)
-.++.+.....|..+ ++|...++||=|.|++||.+... +.+.||+|+.+......+....|+++|++++ |
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 344556666677777 88888999999999999999964 5679999999987777777889999999984 2
Q ss_pred cceeccceeee----eCcEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 223 MNLVRMWGFCT----EGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 223 ~niv~l~g~~~----~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
.+||+|+++|. .+.|.++|+|++ |-+|..+|... ..++.....+|+.||+.||.|||.+|. |||.||||+|
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPEN 218 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPEN 218 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcce
Confidence 36999999884 568999999999 56788888754 479999999999999999999999874 9999999999
Q ss_pred EEE
Q 040010 297 ILL 299 (464)
Q Consensus 297 Ill 299 (464)
|||
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=234.42 Aligned_cols=210 Identities=23% Similarity=0.261 Sum_probs=180.0
Q ss_pred CccccCHHHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc------ccceecc
Q 040010 156 QFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY------HMNLVRM 228 (464)
Q Consensus 156 ~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~------h~niv~l 228 (464)
+...+.+.|+....|.+..-.|+|-|++|..|... .|+.||||++.....-.+.=+.|+++|.+|+ .-|++++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34557788999999998889999999999999964 4779999999987766666678999999996 3579999
Q ss_pred ceeeeeCcEEeEEEEeccCCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-C
Q 040010 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-E 304 (464)
Q Consensus 229 ~g~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~ 304 (464)
+-.|...+|++||+|-+. .+|.+.|..- ..|.......++.|+.-||..|-. -+|+|.||||.|||+++.- .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 999999999999999884 6899999753 368888999999999999999999 8899999999999998764 5
Q ss_pred eEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 040010 305 PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVE 373 (464)
Q Consensus 305 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~ 373 (464)
+||+|||.|.....+. .+...-+..|.|||.+.+.+|+...|+||.||.||||.||+..|.....
T Consensus 576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 7999999998765433 3334456679999999999999999999999999999999999876543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=261.03 Aligned_cols=197 Identities=15% Similarity=0.165 Sum_probs=139.6
Q ss_pred hhccc-cceeccceee-------eeCcEEeEEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 040010 218 GKIYH-MNLVRMWGFC-------TEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288 (464)
Q Consensus 218 ~~l~h-~niv~l~g~~-------~~~~~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 288 (464)
+.++| .||++++++| .+....++++||+ +++|.++|.. ...+++.+++.++.||++||+|||+ ++|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 34556 6888899987 2334567788987 5699999965 3469999999999999999999999 8999
Q ss_pred ecCCCCCCEEEcCC-------------------CCeEEeeecCccccCCCCC--------------CcceeeeccCCCcc
Q 040010 289 HCDVKPENILLDSE-------------------FEPKIADFGLAKLSQRGSN--------------SSQFSRIRGTKGYM 335 (464)
Q Consensus 289 H~dlk~~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~ 335 (464)
||||||+||||+.. +.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653211000 00011245788999
Q ss_pred CcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCH
Q 040010 336 APEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNK 415 (464)
Q Consensus 336 aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 415 (464)
|||++.+..++.++|||||||+||||++|..|+... . ....... ...+.+.. .
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-------~----~~~~~~~-----------~~~~~~~~-----~ 235 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-------S----RTMSSLR-----------HRVLPPQI-----L 235 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-------H----HHHHHHH-----------HhhcChhh-----h
Confidence 999999999999999999999999999987764310 0 0111110 01111111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 416 NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 416 ~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
........++.+||+.+|.+||+|.+|++.
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 112345678889999999999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=204.18 Aligned_cols=264 Identities=17% Similarity=0.297 Sum_probs=192.4
Q ss_pred HhhhccccCccCceEEEEEE-ECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeC--cEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEG--MHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~E~ 244 (464)
.+.+.+++|+|.++.|+.|. ..+.+.++||+++... .+.+.+|+.+|..+. |+||+++++...+. ....|++||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 46667789999999999998 4567889999998543 456789999999997 99999999988654 566899999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 323 (464)
+.|.+...+- ..|+-.....++.+++.||.|+|+ .||.|||+||.|++||... .++|.|+|||.+...+..
T Consensus 117 v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-- 188 (338)
T KOG0668|consen 117 VNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
T ss_pred hccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCce--
Confidence 9987766543 346777788899999999999999 9999999999999998654 589999999988765433
Q ss_pred ceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH-----HHHHHHHhhccc
Q 040010 324 QFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF-----IREVKEKILCGE 397 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 397 (464)
.+....+..|-.||.+- .+.|+-+-|+|||||+|.+|+..+.||.....+.+ +...+... +..-..+..-.-
T Consensus 189 -YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred -eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHccCC
Confidence 34455677899999764 45688999999999999999999999985443322 11111100 000111111111
Q ss_pred hhhhhhhcCCccCCCC-------CHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHF-------NKN-QAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~-------~~~-~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
++....+++...+..+ +.. ...+.++++...|..|-++|||+.|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1222333322221111 111 2367888888999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=215.89 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=185.4
Q ss_pred ccCccCceEEEEEEE-CCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC------cEEeEEEEe
Q 040010 175 ELGKGGSGAVYKGVL-TDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRLLVYEY 244 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~E~ 244 (464)
.+|.|.- .|-.+.. -.++.||+|++... ....+...+|...+..++|+|+++++.+++-. .+.++|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4777766 4444442 24788999988643 22335567899999999999999999998643 456899999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
|. .+|...+. -.++-.+...|..|+..|+.|||+ .+|+||||||+||++..+..+||.|||+++..+.. -.
T Consensus 103 m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~ 173 (369)
T KOG0665|consen 103 MD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FM 173 (369)
T ss_pred hh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc---cc
Confidence 95 68888876 457788889999999999999999 99999999999999999999999999999855433 33
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCcc------chhhhHHHHHHHHHHH---hhc
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE------GQEAELTGFIREVKEK---ILC 395 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~---~~~ 395 (464)
.+....|..|.|||.+.+..+.+.+||||.||++.||++|+..|.....-+. ..+..-..+..++... ...
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 5667889999999999988899999999999999999999988863211000 0000001111111111 000
Q ss_pred cch----hhhhhhc-CCccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 396 GEE----ARIEEIV-DPRLKG--HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 396 ~~~----~~~~~~~-d~~l~~--~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+ -...+.+ |..... +.+.-.......++.+||-.||++|.|..++++.
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 0011111 111111 1112234567788999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=203.62 Aligned_cols=166 Identities=23% Similarity=0.199 Sum_probs=125.4
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
|+|.+++.. ...++|..++.|+.|++.||.|||+ .+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 789999976 4569999999999999999999999 44 999999999999999 99998654321
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..||+.|+|||.+.+..++.++|||||||++|||++|+.|+..... ............. . .+
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--------~~~~~~~~~~~~~--------~-~~ 125 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--------LSAILEILLNGMP--------A-DD 125 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--------hcHHHHHHHHHhc--------c-CC
Confidence 2588999999999999999999999999999999999999863211 1111111111110 0 00
Q ss_pred CccCCCCCHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 407 PRLKGHFNKNQAA--TLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 407 ~~l~~~~~~~~~~--~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.. ......... .+.+++.+||+.||.+||++.++++.+...
T Consensus 126 ~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 126 PRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000 011122222 689999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-27 Score=212.32 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=194.6
Q ss_pred HHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCC---ccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGD---LHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.-...++..+|.....|..|+|++.+ ..+++|++.. .....+.|..|...|+...||||..++|.|....++.++.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 33445677789999999999999955 4567777763 2334567889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 243 EYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
.||+.|||+..|++.. ..+-.++.+++.++|+|++|||+.. +-|.---|++..+++|++.+++|+--. .++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad-~kfs---- 340 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMAD-TKFS---- 340 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccc-ceee----
Confidence 9999999999998754 5778899999999999999999964 334445789999999999999886211 1110
Q ss_pred CCcceeeeccCCCccCcccccCCCCC---ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPIT---SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
-+.....-.+.||+||.++..+.+ ..+|+|||.++||||.|...||......+-+
T Consensus 341 --fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------------- 398 (448)
T KOG0195|consen 341 --FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------------- 398 (448)
T ss_pred --eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------------
Confidence 011122346789999999876543 4789999999999999999999754332211
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
..+.-+.++...+......+.+|+.-|.+.||.+||.+..|+-+|+.+.
T Consensus 399 ----mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 ----MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122233444455566677899999999999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-27 Score=234.29 Aligned_cols=247 Identities=23% Similarity=0.252 Sum_probs=196.3
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+...+.+|+|.+|.|||++. ..++..|||.++-... .......|+-+++..+|+|||.++|-+......|+.|||+.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 45567899999999999996 4678899999885433 335566788899999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+.-+-...++..+.....+...+||+|||+ .+=+|||||-.|||+++.+.+|++|||.+-..... -.....
T Consensus 97 gslQdiy~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Krks 171 (829)
T KOG0576|consen 97 GSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKS 171 (829)
T ss_pred CcccceeeecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--hhhhhc
Confidence 9999998888899999999999999999999999 77799999999999999999999999998654432 223466
Q ss_pred eccCCCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 328 IRGTKGYMAPEWA---SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 328 ~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
..||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|...... ...-++. ....
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~Lm-------------TkS~ 231 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLM-------------TKSG 231 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHh-------------hccC
Confidence 8899999999976 455799999999999999999887776543211 0111111 1111
Q ss_pred c-CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 405 V-DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 405 ~-d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
. .+.+++ .....+.+-+++..|+-.+|++||++...+
T Consensus 232 ~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 232 FQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1 222322 234456788999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=203.45 Aligned_cols=250 Identities=17% Similarity=0.236 Sum_probs=185.3
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccce-eeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWG-FCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g-~~~~~~~~~lv~E~~~ 246 (464)
+++.+.||+|.||.+-.+..+. .+.+++|-+.......++|.+|..-=-.+ .|.||+.-+. .|+..+..++++||++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 6777899999999999999754 67899999988888888999988543334 5999998876 4677778889999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE-cC-CCCeEEeeecCccccCCCCCCcc
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL-DS-EFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll-~~-~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
.|+|...+.. ..+.+....+++.|++.|+.|+|+ +++||||||.+|||| +. ...+||+|||+.+..+..
T Consensus 106 ~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----- 176 (378)
T KOG1345|consen 106 RGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----- 176 (378)
T ss_pred cchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce-----
Confidence 9999988843 568888889999999999999999 999999999999999 33 347999999998765432
Q ss_pred eeeeccCCCccCcccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 325 FSRIRGTKGYMAPEWASNL-----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.....-+..|.+||..... ...+.+|+|.||++++.++||..|++-.... ......|..|..+...
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----DKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc----CchHHHHHHHhcccCc-----
Confidence 2334456679999976432 3467899999999999999999999733222 2334455554332211
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.-|+.-..+ .+.+.++-.+-+.+++++|=...++.++.
T Consensus 248 -----~~P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 -----ALPKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -----cCchhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111111222 23455666677888888885555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=213.99 Aligned_cols=267 Identities=23% Similarity=0.282 Sum_probs=191.2
Q ss_pred hhccccCccCceEEEEEEEC----CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
...++||.|.|++||++++. ....||+|.+..... .....+|++.|..+. +.|++++.+++..++...+|+||+
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 44568999999999999963 467899999875332 344779999999994 999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccCCCC----
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGS---- 320 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~---- 320 (464)
+.-...++..+ ++......+...+..||+++|+ ++||||||||+|+|.+.. +.-.|.|||||...+...
T Consensus 118 ~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 118 EHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred CccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 99888887754 6688999999999999999999 999999999999999754 567899999997211000
Q ss_pred --------------------------------------CCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHH
Q 040010 321 --------------------------------------NSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEM 361 (464)
Q Consensus 321 --------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~el 361 (464)
.........||+||.|||++.. ...++++||||-||+++-+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 0000123559999999998754 5678999999999999999
Q ss_pred HhCCCCCCccccCccchhhhHHHHHHHHHHHhhc--cc------hh--hhhhh------cC-Ccc--------CC-CCCH
Q 040010 362 LKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC--GE------EA--RIEEI------VD-PRL--------KG-HFNK 415 (464)
Q Consensus 362 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------~~--~~~~~------~d-~~l--------~~-~~~~ 415 (464)
++++.||.....+-+.-.....-+-....++... |. .+ .+.+. ++ +.+ .. ....
T Consensus 272 ls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d 351 (418)
T KOG1167|consen 272 LSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSD 351 (418)
T ss_pred hccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccc
Confidence 9999999865444332221111111111111110 11 00 00000 11 000 00 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 416 NQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 416 ~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....++.+..+|+..||.+|.|+++.++
T Consensus 352 ~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 352 VFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 12347889999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=206.47 Aligned_cols=161 Identities=20% Similarity=0.173 Sum_probs=125.6
Q ss_pred HhhhccccCccCceEEEEEEEC--CCcEEEEEEcCCc------cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT--DERAVAVKRLGDL------HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.|.+.+.||+|+||+||+|... +++.+|||++... ......|.+|+++|++++|+|+++.+.. ....++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence 3667789999999999999874 5777899987532 1124568999999999999999853322 245799
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDV-KPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++++|... ... . ...++.+++++|.|||+ .+|+|||| ||+|||++.++.+||+|||+++.....
T Consensus 96 VmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 96 VRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 9999999999732 111 1 14678899999999999 99999999 999999999999999999999976543
Q ss_pred CCCcc------eeeeccCCCccCcccccC
Q 040010 320 SNSSQ------FSRIRGTKGYMAPEWASN 342 (464)
Q Consensus 320 ~~~~~------~~~~~gt~~y~aPE~~~~ 342 (464)
..... .....+++.|+|||.+..
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32211 235678889999998854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-21 Score=186.22 Aligned_cols=257 Identities=28% Similarity=0.359 Sum_probs=194.9
Q ss_pred hhccccCccCceEEEEEEECCCcEEEEEEcCCccc----hhHHHHHHHHHhhhcccc-ceeccceeeeeCcEEeEEEEec
Q 040010 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHM-NLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~E~~ 245 (464)
...+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++...+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45578999999999999986 7889998875432 356789999999999988 7999999997777789999999
Q ss_pred cCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 321 (464)
.++++.+++.... .+.......+..+++.++.|+|+ .+++|||+||+||+++... .+++.|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999997776554 78999999999999999999999 8899999999999999998 699999999985554332
Q ss_pred Cc----ceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 322 SS----QFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 322 ~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
.. ......|+..|++||.+.+ ..++...|+||+|++++++++|..|+...... ............ ..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~-~~ 231 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILE-LP 231 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHh-cC
Confidence 21 2456789999999999987 57899999999999999999999996533211 000000000000 00
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...................+.+++..|+..+|..|.++.+....
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 -------TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -------CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000011111112223567888889999999999999877653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=191.79 Aligned_cols=257 Identities=19% Similarity=0.213 Sum_probs=188.0
Q ss_pred HhhhccccCccCceEEEEEEECCC--cEEEEEEcCCcc-chhHHHHHHHHHhhhccc----cceeccceee-eeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDE--RAVAVKRLGDLH-QGEEVFWAEVSTIGKIYH----MNLVRMWGFC-TEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~--~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 240 (464)
.+.+.++||+|+||.||.+..... ..+|+|...... .....+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 466778999999999999997654 478888776432 222367889999999873 5788888888 57788999
Q ss_pred EEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-----CCeEEeeecCc
Q 040010 241 VYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-----FEPKIADFGLA 313 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla 313 (464)
||+.+ |.+|.++.... ..++..+.+.|+.|++.+|.+||+ .+++||||||.|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 78999987533 579999999999999999999999 999999999999999765 46899999999
Q ss_pred c--ccCCCCC----Ccc--eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 314 K--LSQRGSN----SSQ--FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 314 ~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
+ ....... ... ....+||..|.++....+...+.+.|+||++.++.|++.|..|+........ ..-
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------~~~ 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------KSK 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch------HHH
Confidence 8 3221111 111 2346699999999999999999999999999999999999988753221111 011
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+.... ....... . .......+.++...+-..+...+|....+...|....
T Consensus 249 ~~~~~----------~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 249 FEKDP----------RKLLTDR-F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHh----------hhhcccc-c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11110 0111111 1 1112234455555555588999999999988876554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=198.71 Aligned_cols=217 Identities=24% Similarity=0.355 Sum_probs=165.5
Q ss_pred hhhccccceeccceeeeeCcEEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCce-EecCCCC
Q 040010 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWV-IHCDVKP 294 (464)
Q Consensus 217 l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~dlk~ 294 (464)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... -.++|.....++.+|+.||+|||. .+| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 46788999999999999999999999999999999999874 479999999999999999999999 555 9999999
Q ss_pred CCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC-------CCCccchhHHHHHHHHHHHhCCCC
Q 040010 295 ENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-------PITSKVDVFSYGVVILEMLKGIRL 367 (464)
Q Consensus 295 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~Gvvl~elltg~~p 367 (464)
+|+++|..+.+|++|||+.................-...|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999999877531111112223345579999988764 146789999999999999999999
Q ss_pred CCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 368 SNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
|+......+. .+.+.. +..+. ....-|.+.... +..+.+..++.+||..+|.+||++..|-..++
T Consensus 158 ~~~~~~~~~~-----~eii~~----~~~~~----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 158 FDLRNLVEDP-----DEIILR----VKKGG----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred cccccccCCh-----HHHHHH----HHhcC----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 9854332221 112111 11111 111222221110 34447899999999999999999999999888
Q ss_pred CCCC
Q 040010 448 GCEA 451 (464)
Q Consensus 448 ~~~~ 451 (464)
.+..
T Consensus 223 ~~~~ 226 (484)
T KOG1023|consen 223 TINK 226 (484)
T ss_pred hhcc
Confidence 7654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=177.15 Aligned_cols=139 Identities=14% Similarity=0.140 Sum_probs=110.1
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccc---h-------hHHH-----------------HHHHHHhhhccccce
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---G-------EEVF-----------------WAEVSTIGKIYHMNL 225 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~ni 225 (464)
...||+|+||.||+|...+|+.||||+++.... . ...| ..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999999864321 1 1122 349999999988776
Q ss_pred eccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecCCCCCCEEEcCCCC
Q 040010 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 226 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
.....+.. ...++||||++++++...+.....++......++.|++.+|.|+ |+ .+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 44333322 22389999999988766544456789999999999999999999 67 7899999999999998 478
Q ss_pred eEEeeecCccccC
Q 040010 305 PKIADFGLAKLSQ 317 (464)
Q Consensus 305 ~kl~Dfgla~~~~ 317 (464)
++|.|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=179.71 Aligned_cols=198 Identities=21% Similarity=0.274 Sum_probs=169.9
Q ss_pred hhhccccCccCceEEEEEE-ECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.++||+|.||.++.|+ +-++++||||.- .......+++.|.+..+.|. .+.|...+-|..++.+-.||+|.+ |
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 5667899999999999999 457899999943 33445567888999888884 788999998999999999999988 7
Q ss_pred CChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-----CCeEEeeecCccccCCCCC
Q 040010 248 QSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-----FEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 248 gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla~~~~~~~~ 321 (464)
.||++++. ....++..+...+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.+.|||+|+...+...
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 89999886 45689999999999999999999999 889999999999999643 3488999999998766544
Q ss_pred Cc-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 040010 322 SS-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVV 372 (464)
Q Consensus 322 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~ 372 (464)
.. ..+...||.+||+-....+.+.+.+.|.-|+|-+++..+-|..|+....
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 32 2345779999999999999999999999999999999999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=210.78 Aligned_cols=252 Identities=21% Similarity=0.170 Sum_probs=187.9
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcC----Cc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLG----DL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~----~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
....+|.|.+|.|+..... .....+.|... .. ......+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3457899999977777642 22223333221 11 1111225567777788899999998888777766666699
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS- 322 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 322 (464)
|+++ +|..++.....+....+-.+..|+..|+.|+|+ .+|.|||+|++|++++.++.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 999999777789999999999999999999999 99999999999999999999999999999877665544
Q ss_pred -cceeeeccCCCccCcccccCCCCCc-cchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 323 -SQFSRIRGTKGYMAPEWASNLPITS-KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 323 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.......|+..|+|||.+.+..|++ ..||||.|+++..|++|+.|+......+... .. ...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~---~~~------ 540 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KT---NNY------ 540 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hh---hcc------
Confidence 4456788999999999999999876 5799999999999999999987654332210 00 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....-...-........+.+...++..+|+.||.+|.||.+|++
T Consensus 541 ~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000001011223456677888999999999999999999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=172.35 Aligned_cols=203 Identities=21% Similarity=0.260 Sum_probs=168.8
Q ss_pred HHHHhhhccccCccCceEEEEEE-ECCCcEEEEEEcCCccchhHHHHHHHHHhhhccc-cceeccceeeeeCcEEeEEEE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH-MNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E 243 (464)
....+.+.++||+|+||.+|.|. ..+|..||||.-+. .....++.-|.++.+.+++ ..|..+..|..+..+-.+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34456778899999999999998 57899999996543 3445567789999999975 567777888899999999999
Q ss_pred eccCCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC---CCeEEeeecCccccCCC
Q 040010 244 YVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE---FEPKIADFGLAKLSQRG 319 (464)
Q Consensus 244 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~ 319 (464)
.+ |.||++++. .+..++..+.+-++-|++.-++|+|. .+++||||||+|+|..-+ ..+.+.|||||+...+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 88 789999885 45679999999999999999999999 889999999999999654 35889999999876543
Q ss_pred CCCc-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 040010 320 SNSS-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVE 373 (464)
Q Consensus 320 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~ 373 (464)
.... ......||..|.+-....+.+.+.+.|+-|+|.+|..+.-|..|++....
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 3221 12346699999999888888889999999999999999999999986543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=168.29 Aligned_cols=141 Identities=18% Similarity=0.152 Sum_probs=111.4
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccch---------------------------hHHHHHHHHHhhhccccce
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQG---------------------------EEVFWAEVSTIGKIYHMNL 225 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 225 (464)
...||+|++|.||+|...+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999888999999998743210 1123578899999999987
Q ss_pred eccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 226 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
.....+... ..+|||||++++++.........++......++.+++.++.++|+. .+|+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCE
Confidence 544443332 2489999999886544433445678889999999999999999983 4799999999999999 8899
Q ss_pred EEeeecCccccCC
Q 040010 306 KIADFGLAKLSQR 318 (464)
Q Consensus 306 kl~Dfgla~~~~~ 318 (464)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-21 Score=173.88 Aligned_cols=171 Identities=12% Similarity=0.066 Sum_probs=130.9
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHH----------HHHHHHHhhhccccceeccceeeee
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV----------FWAEVSTIGKIYHMNLVRMWGFCTE 234 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~g~~~~ 234 (464)
+....+...+.||.|+||.||.... ++..+|||.+.......+. +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3445566678899999999999655 5678999999754322222 5789999999999999999888553
Q ss_pred C--------cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeE
Q 040010 235 G--------MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306 (464)
Q Consensus 235 ~--------~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 306 (464)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..+|+ .+++|||++|+||+++.++ ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence 2 35789999999999988742 222 345699999999999 9999999999999999988 99
Q ss_pred EeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHH
Q 040010 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362 (464)
Q Consensus 307 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ell 362 (464)
|.|||........... ..++....+..++|+||||+++.-+.
T Consensus 175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988654321110 11334445678999999999987754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=201.65 Aligned_cols=250 Identities=24% Similarity=0.251 Sum_probs=182.9
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCcc--chhHHHHHHHHH--hhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH--QGEEVFWAEVST--IGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.||++.|=.|.+++.+.|. |+||++-... ..-+.|.++++- ...++|||.+++.-+-......|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 455678999999999999998886 8899885332 223444443333 55568999999988877777788888888
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-cc
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 324 (464)
.+ +|+|.|..+..|...+...|+.|++.||.-+|. .+|+|||||.+||||+.-.-+.|+||...+...-.... ..
T Consensus 104 kh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 104 KH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred hh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 54 899999888889999999999999999999999 99999999999999999999999999887644322111 11
Q ss_pred ----eeeeccCCCccCcccccC----------CC-CCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHH
Q 040010 325 ----FSRIRGTKGYMAPEWASN----------LP-ITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 325 ----~~~~~gt~~y~aPE~~~~----------~~-~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
+.+.+....|+|||.+.. .. .+++-||||+||++.||++- +.+|... .....
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------------QL~aY 247 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------------QLLAY 247 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------------HHHhH
Confidence 223334457999996633 12 67899999999999999885 5555421 11111
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.... ....+.-++++-|+ .+.++++.|++.||.+|.|+.+.++.-.+.
T Consensus 248 r~~~-~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hccC-ccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0000 00111113334443 367899999999999999999999986553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=162.45 Aligned_cols=182 Identities=16% Similarity=0.097 Sum_probs=139.3
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccchhH-----HHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEecc
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEE-----VFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...|++|+||+||.... ++..++.+.++......+ .+.+|+++|++++ |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997766 677888888876554333 5789999999995 5789999886 34689999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCCEEEcCCCCeEEeeecCccccCCCCCC---
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDV-KPENILLDSEFEPKIADFGLAKLSQRGSNS--- 322 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~--- 322 (464)
|.+|...+.. ....++.+++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998765421 124577899999999999 99999999 799999999999999999999855433210
Q ss_pred ---cc-----eeeeccCCCccCcccccCC-CCC-ccchhHHHHHHHHHHHhCCCCCC
Q 040010 323 ---SQ-----FSRIRGTKGYMAPEWASNL-PIT-SKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 323 ---~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
.. ......++.|++|+...-. ..+ ...+.++.|.-+|.++|++.+.-
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 0113367888888854322 223 57799999999999999988764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=167.87 Aligned_cols=225 Identities=19% Similarity=0.221 Sum_probs=145.2
Q ss_pred ccccCccCceEEEEEEECC-CcEEEEEEcCCc----cchhHHHHHHHHHhhhcc----------ccceecccee------
Q 040010 173 KEELGKGGSGAVYKGVLTD-ERAVAVKRLGDL----HQGEEVFWAEVSTIGKIY----------HMNLVRMWGF------ 231 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~----------h~niv~l~g~------ 231 (464)
.+.||.|+++.||.++... ++++|||.+... ....+.+++|.-.+..+. |-.++..++.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4579999999999999864 889999987522 223456666665555532 2222222221
Q ss_pred ---eeeCc--------EEeEEEEeccCCChHHhhh---cCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 040010 232 ---CTEGM--------HRLLVYEYVENQSLDKHLF---SSN----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVK 293 (464)
Q Consensus 232 ---~~~~~--------~~~lv~E~~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk 293 (464)
..... +.+++|+-+ .++|.+++. ... .+....++.+..|+.+.+++||+ .++||+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 11111 235677777 468877754 221 24456677888999999999999 999999999
Q ss_pred CCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccC--------CCCCccchhHHHHHHHHHHHhCC
Q 040010 294 PENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN--------LPITSKVDVFSYGVVILEMLKGI 365 (464)
Q Consensus 294 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~Gvvl~elltg~ 365 (464)
|+|++++.+|.++|+||+.....+.. ......+..|.+||.... ..+|.+.|.|++|+++|.|++|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999877644321 111345578999997633 25788999999999999999999
Q ss_pred CCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040010 366 RLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKR 436 (464)
Q Consensus 366 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~R 436 (464)
.|+.......... ..+ ..+. +.++.+..|+..+|+.||.+|
T Consensus 248 lPf~~~~~~~~~~----------------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE----------------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG----------------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc----------------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998543221110 011 2445 778889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=186.01 Aligned_cols=201 Identities=20% Similarity=0.225 Sum_probs=161.8
Q ss_pred CHHHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc---ccceeccceeeeeCcE
Q 040010 161 SYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMH 237 (464)
Q Consensus 161 ~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~ 237 (464)
+.-++....+.+..+||+|+||+||+|+..+|+.||+|.-+.....+ |.--.+++.+|+ -+-|..+.....-.+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 33455555667778999999999999999889999999876543322 222233444444 1233444444445566
Q ss_pred EeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-------CCCCeEEeee
Q 040010 238 RLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-------SEFEPKIADF 310 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-------~~~~~kl~Df 310 (464)
-+||+||.+.|+|.+++...+.++|.....++.|+++.+..||. .+|||+||||+|.||. ++..++|.||
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 78999999999999999988899999999999999999999999 8999999999999993 2345899999
Q ss_pred cCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCC
Q 040010 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIR 366 (464)
Q Consensus 311 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~ 366 (464)
|-+..+.--.....+....+|-.+-.+|...|.+++.++|.|.|..+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99976655445556788899999999999999999999999999999999999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=160.50 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=110.1
Q ss_pred hhhccccCccCceEEEEEE--ECCCcEEEEEEcCCccc-------------------------hhHHHHHHHHHhhhccc
Q 040010 170 NSFKEELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQ-------------------------GEEVFWAEVSTIGKIYH 222 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~--~~~~~~vavK~l~~~~~-------------------------~~~~~~~E~~~l~~l~h 222 (464)
+.+.+.||+|+||.||+|. ..+|+.||+|++..... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3466789999999999998 56899999998864321 01225679999999976
Q ss_pred cc--eeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eEecCCCCCCEEE
Q 040010 223 MN--LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW-VIHCDVKPENILL 299 (464)
Q Consensus 223 ~n--iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlk~~NIll 299 (464)
.. +.+++++ . ..++||||+++.+|.........+.......++.|++.++.+||+ .+ ++|+||||+||++
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEE
Confidence 32 3344433 2 348999999998887765444556666778999999999999999 88 9999999999999
Q ss_pred cCCCCeEEeeecCccccC
Q 040010 300 DSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~ 317 (464)
+ ++.++|.|||.+...+
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.5e-20 Score=183.74 Aligned_cols=223 Identities=22% Similarity=0.174 Sum_probs=177.8
Q ss_pred cCccCceEEEEEE----ECCCcEEEEEEcCCccch---hHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccC
Q 040010 176 LGKGGSGAVYKGV----LTDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 176 lG~G~~g~Vy~g~----~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+|.|.||.|+... .+.+..+|.|.++..... ......|-.++..++ |+.+|++.-.+......+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999998865 234677888877643211 113456777888887 99999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|.|...+.....++......+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh------
Confidence 9999999888888888888888999999999999 8999999999999999999999999999986543321
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
.+||..|||||.+. .....+|.||||++++||+||..||.. +. ...++-
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------~~---------------~~~Il~- 201 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------DT---------------MKRILK- 201 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------HH---------------HHHHhh-
Confidence 27999999999988 567899999999999999999999873 01 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
.+..++.+.......+...++..+|.+|.-.
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1123455666667777777888888888665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=156.20 Aligned_cols=132 Identities=17% Similarity=0.206 Sum_probs=103.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCc-cchhHHHHHHHHHhhhc-----cccceeccceeeeeCc---E-EeEEEE
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDL-HQGEEVFWAEVSTIGKI-----YHMNLVRMWGFCTEGM---H-RLLVYE 243 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lv~E 243 (464)
+.||+|+||.||. .+.....+||++... ....+.+.+|+..++.+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 443333478887643 33456789999999999 5799999999998763 3 337899
Q ss_pred e--ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceEecCCCCCCEEEcC----CCCeEEeeecCc
Q 040010 244 Y--VENQSLDKHLFSSNFLGWKERFKVALGTAKGL-AYLHHECLEWVIHCDVKPENILLDS----EFEPKIADFGLA 313 (464)
Q Consensus 244 ~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgla 313 (464)
| +++|+|.+++.+. .++.. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5679999999653 45555 35677888777 99999 99999999999999974 347999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.1e-18 Score=155.36 Aligned_cols=133 Identities=19% Similarity=0.258 Sum_probs=113.2
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccc---------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.||+|++|.||+|.. .+..+++|+...... ....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999998 667788997653211 123577899999999999998888887777888999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
+++++|.+++.... + .+..++.+++.+|.++|+ .+++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 888999999999999999 8999999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=152.00 Aligned_cols=136 Identities=18% Similarity=0.202 Sum_probs=107.6
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccc-----------------------hhHHHHHHHHHhhhccccc--
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ-----------------------GEEVFWAEVSTIGKIYHMN-- 224 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-----------------------~~~~~~~E~~~l~~l~h~n-- 224 (464)
+.+.+.||+|+||.||++...+|+.||||++..... ....+..|...+..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 556688999999999999988899999998653221 0112567888888888874
Q ss_pred eeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC
Q 040010 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 225 iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++|+||+|+||++++++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCc
Confidence 4444432 345899999999999876431 3446788999999999999 89999999999999999999
Q ss_pred eEEeeecCccccCC
Q 040010 305 PKIADFGLAKLSQR 318 (464)
Q Consensus 305 ~kl~Dfgla~~~~~ 318 (464)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=173.71 Aligned_cols=133 Identities=21% Similarity=0.254 Sum_probs=109.2
Q ss_pred hccccCccCceEEEEEEECCCcEEEEEEcCCc-c-------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDL-H-------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
..+.||+|+||+||+|.+.+...++.++.... . ...+.+.+|++++..++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 35689999999999999865543332222211 1 122457899999999999999988888877778899999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
|+++++|.+++. .+..++.+++++|.|||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999874 457899999999999999 899999999999999 6789999999999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=150.68 Aligned_cols=129 Identities=19% Similarity=0.256 Sum_probs=106.8
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCcc----c-----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLH----Q-----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~----~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.||+|+||.||+|.+ ++..+++|...... . ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 56789999864321 1 1245778999999999988766666666667779999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
++++|.+.+..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754321 789999999999999 8999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=155.66 Aligned_cols=197 Identities=21% Similarity=0.233 Sum_probs=138.7
Q ss_pred cccceeccceeeee---------------------------CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHH
Q 040010 221 YHMNLVRMWGFCTE---------------------------GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA 273 (464)
Q Consensus 221 ~h~niv~l~g~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia 273 (464)
+|||||++.++|.+ +...|+||.-.+ .+|..++..+. .+...+.-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999997743 245688888774 58999986544 45566677889999
Q ss_pred HHHHHHhhcCCCceEecCCCCCCEEE--cCCCC--eEEeeecCccccCCCCCC----cceeeeccCCCccCcccccCCC-
Q 040010 274 KGLAYLHHECLEWVIHCDVKPENILL--DSEFE--PKIADFGLAKLSQRGSNS----SQFSRIRGTKGYMAPEWASNLP- 344 (464)
Q Consensus 274 ~gL~yLH~~~~~~ivH~dlk~~NIll--~~~~~--~kl~Dfgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~- 344 (464)
+|+.|||+ ++|.|||+|++|||+ |+|.. +.|+|||.+-..+..... +..-...|.-.-||||.....+
T Consensus 352 Eav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999 999999999999998 44443 688999988644332211 1122345777899999875432
Q ss_pred -----CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHH
Q 040010 345 -----ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAA 419 (464)
Q Consensus 345 -----~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 419 (464)
--.|+|.|+.|.+.||+++...||+...+.. .....+ ++--- ...+..++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L~~r~Y----------------qe~qL----Palp~~vpp 484 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----LDTRTY----------------QESQL----PALPSRVPP 484 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhe----echhhh----------------hhhhC----CCCcccCCh
Confidence 1258999999999999999999998522110 000000 00001 123344556
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 420 TLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 420 ~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.+.+++...++.||.+|||..-....|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHH
Confidence 788999999999999999976555544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-18 Score=166.46 Aligned_cols=122 Identities=25% Similarity=0.406 Sum_probs=106.9
Q ss_pred cEEeEEEEeccCCChHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
...++.|+++...+|.+||..+ ...+|...+.++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999744 368899999999999999999 5579999999999999999999999999
Q ss_pred ccccCCCC----CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh
Q 040010 313 AKLSQRGS----NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363 (464)
Q Consensus 313 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt 363 (464)
........ .....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 97665544 1223456779999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=132.20 Aligned_cols=133 Identities=23% Similarity=0.198 Sum_probs=115.0
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccc--cceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH--MNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..++++||++++++.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 579999999999999855 7899998875443 5678899999999987 58999999888888899999999988776
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
.+ +......++.++++++++||.....+++|+|++|.||++++++.+++.|||++..
T Consensus 82 ~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 6677788999999999999996555799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-16 Score=140.13 Aligned_cols=137 Identities=19% Similarity=0.197 Sum_probs=96.3
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccchh---HHH----------------------HHHHHHhhhccccc--e
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE---EVF----------------------WAEVSTIGKIYHMN--L 225 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i 225 (464)
.+.||+|+||.||++...+++.||||++....... ..+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999876432111 111 24555555554332 3
Q ss_pred eccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 226 v~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
.+.+++ ...++||||++++.+........... .....++.+++.++.++|.. .+|+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcE
Confidence 333332 24589999999954322111111111 56788999999999999973 4699999999999999 8999
Q ss_pred EEeeecCccccC
Q 040010 306 KIADFGLAKLSQ 317 (464)
Q Consensus 306 kl~Dfgla~~~~ 317 (464)
+++|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-16 Score=167.00 Aligned_cols=250 Identities=24% Similarity=0.260 Sum_probs=185.8
Q ss_pred hhhccccCccCceEEEEEEECC--CcEEEEEEcCCccchh---HHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD--ERAVAVKRLGDLHQGE---EVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+|+.|-...... ...+|+|.+....... .....|..+-..+. |+|++.+++........++..+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4555679999999998887643 3456667665443222 22334666666665 9999999999999999999999
Q ss_pred eccCCChHHhh-hcCC-CCCHHHHHHHHHHHHHHHHHHh-hcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCC-
Q 040010 244 YVENQSLDKHL-FSSN-FLGWKERFKVALGTAKGLAYLH-HECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQR- 318 (464)
Q Consensus 244 ~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~- 318 (464)
|..++++.+.+ .... ..+....-.+..|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999998 4443 6677778889999999999999 7 8899999999999999999 999999999998776
Q ss_pred CCCCcceeeecc-CCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 319 GSNSSQFSRIRG-TKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 319 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|...
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~----~~~~~~~~-------- 246 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG----RYSSWKSN-------- 246 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc----cceeeccc--------
Confidence 444444556778 9999999998884 456789999999999999999999875433221 11111110
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
-+ ...............++...++..+|..|.+.+++.
T Consensus 247 --------~~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 247 --------KG-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --------cc-ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 000011112233466777788889999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=136.42 Aligned_cols=133 Identities=20% Similarity=0.176 Sum_probs=104.1
Q ss_pred cccC-ccCceEEEEEEECCCcEEEEEEcCCcc--------------chhHHHHHHHHHhhhccccce--eccceeeeeC-
Q 040010 174 EELG-KGGSGAVYKGVLTDERAVAVKRLGDLH--------------QGEEVFWAEVSTIGKIYHMNL--VRMWGFCTEG- 235 (464)
Q Consensus 174 ~~lG-~G~~g~Vy~g~~~~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~- 235 (464)
..|| .||.|+||..... +..++||+..... .....+.+|++++.+++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999885 5678888774211 122457889999999998875 6777765432
Q ss_pred c---EEeEEEEeccC-CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 236 M---HRLLVYEYVEN-QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 236 ~---~~~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
. ..++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+ .+|+|+||||.|||++.++.++|+|||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999997 689988854 344443 35689999999999 999999999999999999999999999
Q ss_pred Cccc
Q 040010 312 LAKL 315 (464)
Q Consensus 312 la~~ 315 (464)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-15 Score=159.22 Aligned_cols=207 Identities=21% Similarity=0.235 Sum_probs=135.8
Q ss_pred hhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+-++.|..|++|.||..+++. .+..|.| +++.. - ++ +||..+-+ +.+.| |+
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~k-iNkq~---l-------il-----Rnilt~a~------npfvv------gD 137 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN---L-------IL-----RNILTFAG------NPFVV------GD 137 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhc-ccccc---h-------hh-----hccccccC------Cccee------ch
Confidence 345679999999999998754 4556663 22111 0 11 11222211 22222 44
Q ss_pred hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-------
Q 040010 250 LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS------- 322 (464)
Q Consensus 250 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~------- 322 (464)
=...+.+.+.++.. ++.+++|||+ .+|+|||+||+|.+|+.=|++|++|||+++........
T Consensus 138 c~tllk~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 44455444444432 2789999999 99999999999999999999999999998753221110
Q ss_pred ------cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 323 ------SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 323 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
-..+.++||+.|+|||++..+.|...+|+|++|+++||.+-|..||+.... +..+..++..
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----eelfg~visd-------- 273 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVISD-------- 273 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----HHHHhhhhhh--------
Confidence 112456899999999999999999999999999999999999999984321 1112111111
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
+.. ..+-+.....++..++.+.|+.+|..|--.
T Consensus 274 ~i~----------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 274 DIE----------WPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hcc----------ccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 000 011122234457778888999999999543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=138.57 Aligned_cols=161 Identities=20% Similarity=0.208 Sum_probs=108.8
Q ss_pred cccccCccccCHHHHHHHHh------------hhc-cccCccCceEEEEEEECCCcEEEEEEcCCccchh----------
Q 040010 151 RALSSQFKRFSYAELKKATN------------SFK-EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE---------- 207 (464)
Q Consensus 151 ~~~~~~~~~~~~~el~~~~~------------~~~-~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~---------- 207 (464)
..+..+.+.+++++++..-. .|. +.||+|++|.||+|++.+|+.||||+.+......
T Consensus 87 ~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~ 166 (437)
T TIGR01982 87 SLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFEEKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYR 166 (437)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCCCcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHH
Confidence 34445556677665543221 122 3599999999999999999999999986431000
Q ss_pred -------------------------------HHHHHHHHHhhhcc----ccceeccceee-eeCcEEeEEEEeccCCChH
Q 040010 208 -------------------------------EVFWAEVSTIGKIY----HMNLVRMWGFC-TEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 208 -------------------------------~~~~~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~E~~~~gsL~ 251 (464)
-.|..|++.+.+++ |.+-+.+-..+ ...+..+|||||++|++|.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~ 246 (437)
T TIGR01982 167 LARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLS 246 (437)
T ss_pred HHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccc
Confidence 01444555555542 22223322222 2234579999999999998
Q ss_pred HhhhcC-CCCCHHHHHHHHHHHHH-HHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 252 KHLFSS-NFLGWKERFKVALGTAK-GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 252 ~~l~~~-~~l~~~~~~~i~~~ia~-gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
+..... ... .+..++..++. .+..+|. .+++|+|++|.||++++++.+++.|||++....
T Consensus 247 ~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 247 DIAALDEAGL---DRKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred cHHHHHhcCC---CHHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 876422 122 24456666666 4678888 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-13 Score=127.53 Aligned_cols=151 Identities=23% Similarity=0.265 Sum_probs=115.0
Q ss_pred HHhhhccccceeccceeeeeC-----cEEeEEEEeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 040010 215 STIGKIYHMNLVRMWGFCTEG-----MHRLLVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLE 285 (464)
Q Consensus 215 ~~l~~l~h~niv~l~g~~~~~-----~~~~lv~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 285 (464)
.-|-++-|.|||+++.|+.+. ....++.|||+.|+|..+|.+. ..+......+|.-||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 344556799999999998644 4568999999999999999743 3577777788999999999999994 48
Q ss_pred ceEecCCCCCCEEEcCCCCeEEeeecCcc--ccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh
Q 040010 286 WVIHCDVKPENILLDSEFEPKIADFGLAK--LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363 (464)
Q Consensus 286 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt 363 (464)
+|+|+++..+.|++..++-+|+.--.-.. ..-............+.++|.+||+-.....+..+|||+||+..+||-.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999988885211100 0000000111233457889999999888788899999999999999987
Q ss_pred CCC
Q 040010 364 GIR 366 (464)
Q Consensus 364 g~~ 366 (464)
+..
T Consensus 278 lEi 280 (458)
T KOG1266|consen 278 LEI 280 (458)
T ss_pred hee
Confidence 743
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-13 Score=105.35 Aligned_cols=67 Identities=25% Similarity=0.499 Sum_probs=55.9
Q ss_pred CCcccccCCccccccccCHHHHHHHHhhcCCccceEEecCCcccee-EeeecccccccCCCCCceEEEec
Q 040010 1 VPKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCF-TKSELFNGYKAPNFPGDMYLKLP 69 (464)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~-~~~~l~~~~~~~~~~~~~~~k~~ 69 (464)
+++++|+++++.. .++++++|++.||+||+|+||+|. .++++|+ |.+++.+.+.....+.++||||+
T Consensus 17 ~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~-~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 17 LPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYN-NGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred eCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeec-CCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 4678888887655 888999999999999999999998 4467899 77888887765555688999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=114.92 Aligned_cols=129 Identities=19% Similarity=0.107 Sum_probs=96.6
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccccee-ccceeeeeCcEEeEEEEeccCCChHH
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLV-RMWGFCTEGMHRLLVYEYVENQSLDK 252 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~E~~~~gsL~~ 252 (464)
+.|+.|.++.||+.... +..+++|...........+..|++.+..+.+.+++ +++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999975 67899998765433334567899999998766654 444433 234589999999988764
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 253 HLFSSNFLGWKERFKVALGTAKGLAYLHHEC--LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 253 ~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
.- .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus 81 ~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 112345678999999999943 22369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.3e-13 Score=132.55 Aligned_cols=251 Identities=25% Similarity=0.252 Sum_probs=178.9
Q ss_pred HHHHHHHhhhccccCc--cCceEEEEEEE---CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhc-cccceeccceeee
Q 040010 163 AELKKATNSFKEELGK--GGSGAVYKGVL---TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKI-YHMNLVRMWGFCT 233 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~--G~~g~Vy~g~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 233 (464)
.+....+.++.+.+|+ |.+|.||.+.. .++..+|+|+-+... .....-.+|+..-.++ .|+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 4555566777888999 99999999987 356788998744221 2222234566666666 4999999888999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHH----HHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEE
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAK----GLAYLHHECLEWVIHCDVKPENILLDSE-FEPKI 307 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl 307 (464)
.++..++-+|++. .+|..+.+... .++....+.+..+... ||.++|. .+++|-|+||.||++.++ ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceeec
Confidence 9999999999885 68887776544 3666677777777777 9999999 999999999999999999 88999
Q ss_pred eeecCccccCCCCCCcce---eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH
Q 040010 308 ADFGLAKLSQRGSNSSQF---SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 384 (464)
+|||+............. ....|...|++||...+ -++..+|+|++|.+.++..++.......... .
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---------~ 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS---------S 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC---------C
Confidence 999999887765533222 23357778999998765 5788999999999999999987665422111 1
Q ss_pred HHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
|.. +.... +..++-..-..++.....++++.+|-.|++.+.+.
T Consensus 335 W~~-------------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 335 WSQ-------------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccc-------------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 111 00100 11111111112233477789999999999887764
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.5e-13 Score=98.05 Aligned_cols=54 Identities=28% Similarity=0.583 Sum_probs=45.6
Q ss_pred CCcccccCCcccc-ccccCHHHHHHHHhhcCCccceEEecC-Ccccee-Eeeecccc
Q 040010 1 VPKVDFYGFDLNF-SEHVSKEACMKLCLDDFRCSGFSYRLT-GERVCF-TKSELFNG 54 (464)
Q Consensus 1 ~~~~~~~~~~~~~-~~~~~~~~C~~~Cl~~c~C~a~~~~~~-~~~~c~-~~~~l~~~ 54 (464)
|+++++|+++... ..++++++|++.||+||||+||+|.+. ++++|+ |.++|+|.
T Consensus 10 l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 10 LPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred ECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 5789999997544 367999999999999999999999732 567899 88999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.1e-12 Score=130.90 Aligned_cols=162 Identities=17% Similarity=0.154 Sum_probs=98.4
Q ss_pred cccccCccccCHHHHHHHHh------------hhc-cccCccCceEEEEEEECC-CcEEEEEEcCCccch----------
Q 040010 151 RALSSQFKRFSYAELKKATN------------SFK-EELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQG---------- 206 (464)
Q Consensus 151 ~~~~~~~~~~~~~el~~~~~------------~~~-~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~---------- 206 (464)
..+....+.++++++++.-. .|. +.||+|++|.||++++++ |+.||||+++.....
T Consensus 89 ~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~ 168 (537)
T PRK04750 89 ALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDIKPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMY 168 (537)
T ss_pred HHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcChhhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHH
Confidence 34445566677665432211 122 369999999999999987 999999998743100
Q ss_pred -------------------------hH------HHHHHHHHhhhcc----ccceeccceeeee-CcEEeEEEEeccCCCh
Q 040010 207 -------------------------EE------VFWAEVSTIGKIY----HMNLVRMWGFCTE-GMHRLLVYEYVENQSL 250 (464)
Q Consensus 207 -------------------------~~------~~~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~E~~~~gsL 250 (464)
.+ .|..|+..+.+++ +.+.+.+-..+.+ .+..+|||||++|+.+
T Consensus 169 ~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l 248 (537)
T PRK04750 169 RLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPV 248 (537)
T ss_pred HHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccH
Confidence 01 1334444444442 3333333232222 3456899999999999
Q ss_pred HHhhh-cCCCCCHHHHHHHHHHHHH-HHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCccccCC
Q 040010 251 DKHLF-SSNFLGWKERFKVALGTAK-GLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAKLSQR 318 (464)
Q Consensus 251 ~~~l~-~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 318 (464)
.+.-. .....+.. .++...+. -+.-+.. .+++|+|+||.||+++.++ .+++.|||+......
T Consensus 249 ~d~~~l~~~g~d~~---~la~~~v~~~~~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 249 SDVAALRAAGTDMK---LLAERGVEVFFTQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhHHHHHhcCCCHH---HHHHHHHHHHHHHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 87421 11122211 12222111 1122233 7899999999999999988 999999999976543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=6e-11 Score=109.72 Aligned_cols=141 Identities=21% Similarity=0.219 Sum_probs=111.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccc--hhHHHHHHHHHhhhcccc--ceeccceeeeeC---cEEeEEEEecc
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHM--NLVRMWGFCTEG---MHRLLVYEYVE 246 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lv~E~~~ 246 (464)
+.|+.|.++.||++...+|..+++|....... ....+..|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778899998765433 345688999999999764 456777777654 25689999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC------------------------------------------- 283 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 283 (464)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9988876532 45778888888899999999998531
Q ss_pred ----------CCceEecCCCCCCEEEcC--CCCeEEeeecCccc
Q 040010 284 ----------LEWVIHCDVKPENILLDS--EFEPKIADFGLAKL 315 (464)
Q Consensus 284 ----------~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~ 315 (464)
...++|+|+++.||+++. +..+.|.||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-10 Score=105.20 Aligned_cols=137 Identities=11% Similarity=0.104 Sum_probs=98.2
Q ss_pred cccCccCceEEEEEEECC-------CcEEEEEEcCCcc-----------------------chhHHHH----HHHHHhhh
Q 040010 174 EELGKGGSGAVYKGVLTD-------ERAVAVKRLGDLH-----------------------QGEEVFW----AEVSTIGK 219 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~-----------------------~~~~~~~----~E~~~l~~ 219 (464)
..||.|--+.||.|.-.+ +..+|||+.+... .....+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 4789999764211 0011233 78888988
Q ss_pred ccc--cceeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecCCCCCC
Q 040010 220 IYH--MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPEN 296 (464)
Q Consensus 220 l~h--~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlk~~N 296 (464)
+.. -++.+++++ ...+|||||+.+..+....-....++......+..+++.+|..| |+ .++||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 864 355566654 45689999997654422211222455556677889999999999 78 789999999999
Q ss_pred EEEcCCCCeEEeeecCccccCC
Q 040010 297 ILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~ 318 (464)
|++++ +.+.|.|||.+.....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEEC-CcEEEEECCCceeCCC
Confidence 99974 6799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.7e-10 Score=115.15 Aligned_cols=165 Identities=19% Similarity=0.210 Sum_probs=123.1
Q ss_pred ECCCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHH
Q 040010 189 LTDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFK 267 (464)
Q Consensus 189 ~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~ 267 (464)
..++.+|.|...+.... ..+...+-++.|+.++||||++++......+..|||+|-+. .|..++.+. +.....-
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~ 108 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCL 108 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHH
Confidence 34678888888875544 23446678899999999999999999999999999999883 666666543 2444556
Q ss_pred HHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCc
Q 040010 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347 (464)
Q Consensus 268 i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 347 (464)
.+.||+.||.|||+.| +++|+++....|++++.|..||++|.++........ ......---.|..|+.+.... -
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence 6789999999999765 499999999999999999999999988754332211 011111222456666443222 3
Q ss_pred cchhHHHHHHHHHHHhC
Q 040010 348 KVDVFSYGVVILEMLKG 364 (464)
Q Consensus 348 ~~DV~S~Gvvl~elltg 364 (464)
..|.|-||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 56999999999999999
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-11 Score=91.59 Aligned_cols=52 Identities=17% Similarity=0.335 Sum_probs=44.9
Q ss_pred ccCHHHHHHHHhh---cCCccceEEecCCcccee-Eeeec-ccccccCCCCCceEEEe
Q 040010 16 HVSKEACMKLCLD---DFRCSGFSYRLTGERVCF-TKSEL-FNGYKAPNFPGDMYLKL 68 (464)
Q Consensus 16 ~~~~~~C~~~Cl~---~c~C~a~~~~~~~~~~c~-~~~~l-~~~~~~~~~~~~~~~k~ 68 (464)
.++.++|++.|++ ||||+||+|.+. +++|+ |.++| +|.+..++.+.++|+|.
T Consensus 24 ~~s~~eC~~~Cl~~~~nCsC~Aya~~~~-~~gC~~W~~~l~~d~~~~~~~g~~Ly~r~ 80 (80)
T cd00129 24 ANTADECANRCEKNGLPFSCKAFVFAKA-RKQCLWFPFNSMSGVRKEFSHGFDLYENK 80 (80)
T ss_pred ccCHHHHHHHHhcCCCCCCceeeeccCC-CCCeEEecCcchhhHHhccCCCceeEeEC
Confidence 3789999999999 999999999743 35799 88999 99888877788999983
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.7e-10 Score=96.35 Aligned_cols=130 Identities=21% Similarity=0.258 Sum_probs=100.4
Q ss_pred ccCccCceEEEEEEECCCcEEEEEE-cCCccc--------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKR-LGDLHQ--------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~-l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+++|+-+.+|.+.+-+.. +.+|. +++... ....-.+|+.+|.+++--.+.-..=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5788999999999874433 55553 332211 1133567999999987666555555666777888999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
++..|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.+.||||+...
T Consensus 82 ~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999998654 46778888888999999 9999999999999998875 999999999753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.4e-09 Score=103.17 Aligned_cols=166 Identities=18% Similarity=0.190 Sum_probs=127.8
Q ss_pred CceEEEEEEE-CCCcEEEEEEcCCccch-hHHHHHHHHHhhhccccceeccceeee----eCcEEeEEEEeccC-CChHH
Q 040010 180 GSGAVYKGVL-TDERAVAVKRLGDLHQG-EEVFWAEVSTIGKIYHMNLVRMWGFCT----EGMHRLLVYEYVEN-QSLDK 252 (464)
Q Consensus 180 ~~g~Vy~g~~-~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~E~~~~-gsL~~ 252 (464)
-..+.||+.. .||..+++||+...... ...-..-++.++++.|.|+|++..++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457888884 57899999999533221 112234578899999999999999875 34678899999986 57777
Q ss_pred hhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 253 HLFSS---------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 253 ~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
.-+.. ...++...+.++.|++.||.++|+ .|+.-+-|.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65421 246678899999999999999999 888889999999999999999999999887766
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p 367 (464)
.+... -+ +--.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~~----------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE----------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc----------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 54311 01 113467999999999999999665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.6e-10 Score=114.10 Aligned_cols=243 Identities=21% Similarity=0.196 Sum_probs=166.8
Q ss_pred hhhccccCccCceEEEEEEEC--CCcEEEEEEcCCccchh--H-HHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT--DERAVAVKRLGDLHQGE--E-VFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~l~~~~~~~--~-~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.++...||.|.|+.|++...+ ++..+++|.+....... + .-..|+.+...+ .|.+.++....+....+.++=-|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 344568999999999998743 57788999776432221 1 123455555555 48888887766666667778999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccCCCCCC
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 322 (464)
|++++++...+.-...++...++++..+++.++.++|+ +.++|+|++|+||++..+ +.-+++|||.+..+....
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-- 421 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-- 421 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec--
Confidence 99999988877555678888899999999999999999 889999999999999876 788999999986422111
Q ss_pred cceeeeccCCCc-cCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGY-MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y-~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
......+..| .+++......+-.+.|++|||.-..|.+++....... ..|
T Consensus 422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------~~~---------------- 472 (524)
T KOG0601|consen 422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------VQS---------------- 472 (524)
T ss_pred --ccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------ccc----------------
Confidence 1111122233 3555666677889999999999999999986543210 001
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
..+....+ ...+..- ..+..++.-+...++..||++.+.....+-
T Consensus 473 ~~i~~~~~-p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 LTIRSGDT-PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeeecccc-cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111111 0111111 445566667888999999998877655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.5e-09 Score=90.67 Aligned_cols=139 Identities=20% Similarity=0.262 Sum_probs=100.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEE-EcCCcc--------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVK-RLGDLH--------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK-~l~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+-+|+-+.|+++.+.+ +...|| ++.... -....-++|++.|.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 468889999999999855 555555 443221 1234567899999988755555444456666667899999
Q ss_pred ccC-CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeeecCcccc
Q 040010 245 VEN-QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADFGLAKLS 316 (464)
Q Consensus 245 ~~~-gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 316 (464)
+++ .++.+++.... .-........+..|-+.+.-||. ..|+|+||..+||+|..++ .+.+.|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 987 47888876432 22222236788899999999999 8999999999999996554 3589999998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-08 Score=95.84 Aligned_cols=130 Identities=14% Similarity=0.048 Sum_probs=97.4
Q ss_pred eEEEEEEECCCcEEEEEEcCCccch------------hHHHHHHHHHhhhccccc--eeccceeeee-----CcEEeEEE
Q 040010 182 GAVYKGVLTDERAVAVKRLGDLHQG------------EEVFWAEVSTIGKIYHMN--LVRMWGFCTE-----GMHRLLVY 242 (464)
Q Consensus 182 g~Vy~g~~~~~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lv~ 242 (464)
..|.+..+ +|+.+.||+....... ...+.+|...+.++...+ .+.++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667766 5678999977533211 113678999998885444 3445666543 23568999
Q ss_pred EeccCC-ChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-------CCCeEEeeecC
Q 040010 243 EYVENQ-SLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-------EFEPKIADFGL 312 (464)
Q Consensus 243 E~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-------~~~~kl~Dfgl 312 (464)
|++++. +|.+++.. ....+...+..++.+++..+.-||+ .+|+|+|++++|||++. +..+.+.||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999986 89998853 3445667788999999999999999 99999999999999975 46789999998
Q ss_pred ccc
Q 040010 313 AKL 315 (464)
Q Consensus 313 a~~ 315 (464)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-09 Score=115.92 Aligned_cols=193 Identities=22% Similarity=0.209 Sum_probs=138.7
Q ss_pred ccceeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC
Q 040010 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS 301 (464)
Q Consensus 222 h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 301 (464)
||-+++..--+.-.....|+++|..+++|...|++...++..........+...++|||. ..+.|+|++|.|.+...
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcc
Confidence 344554444455667889999999999999999988877777777777889999999999 66899999999999999
Q ss_pred CCCeEEeeecCccccCCC--------C-----------------CC----cceeeeccCCCccCcccccCCCCCccchhH
Q 040010 302 EFEPKIADFGLAKLSQRG--------S-----------------NS----SQFSRIRGTKGYMAPEWASNLPITSKVDVF 352 (464)
Q Consensus 302 ~~~~kl~Dfgla~~~~~~--------~-----------------~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~ 352 (464)
+++.+++|||+......- . .. .......||+.|.+||...+......+|+|
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 999999999844321100 0 00 011235689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCC
Q 040010 353 SYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDED 432 (464)
Q Consensus 353 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~d 432 (464)
++|+.++|.++|..||...... ..++++..++..+ ...+.+.......++..-+..+
T Consensus 1020 ~~g~~l~e~l~g~pp~na~tpq-------------~~f~ni~~~~~~~----------p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQ-------------QIFENILNRDIPW----------PEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred hhhhhhhhhhcCCCCCCCcchh-------------hhhhccccCCCCC----------CCCccccChhhhhhhhhhhccC
Confidence 9999999999999998743221 1112222111111 1122334445666666777888
Q ss_pred CCCCCCHH
Q 040010 433 RNKRPTMD 440 (464)
Q Consensus 433 p~~RPsm~ 440 (464)
|.+|-.|.
T Consensus 1077 ~~qr~~a~ 1084 (1205)
T KOG0606|consen 1077 PTQRLGAK 1084 (1205)
T ss_pred chhccCcc
Confidence 88887765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-08 Score=90.44 Aligned_cols=125 Identities=24% Similarity=0.291 Sum_probs=81.6
Q ss_pred EEEEEEECCCcEEEEEEcCCcc--------------c-------------hhHHHHHHHHHhhhcccc--ceeccceeee
Q 040010 183 AVYKGVLTDERAVAVKRLGDLH--------------Q-------------GEEVFWAEVSTIGKIYHM--NLVRMWGFCT 233 (464)
Q Consensus 183 ~Vy~g~~~~~~~vavK~l~~~~--------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 233 (464)
.||.|...+|..+|||.-+... . ......+|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999764211 0 012256799999999765 456666442
Q ss_pred eCcEEeEEEEecc--CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 040010 234 EGMHRLLVYEYVE--NQSLDKHLFSSNFLGWKERFKVALGTAKGLAY-LHHECLEWVIHCDVKPENILLDSEFEPKIADF 310 (464)
Q Consensus 234 ~~~~~~lv~E~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 310 (464)
...|||||++ +..+..+.... ++......++.+++..+.. +|. .+|+|+||.+.||+++++ .+.|.||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEec
Confidence 3379999998 54554433211 1134456677778776665 467 889999999999999988 9999999
Q ss_pred cCccccC
Q 040010 311 GLAKLSQ 317 (464)
Q Consensus 311 gla~~~~ 317 (464)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6e-08 Score=89.65 Aligned_cols=136 Identities=18% Similarity=0.176 Sum_probs=97.6
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCcc-----------------------chhHHHHHHHHHhhhcccc--c
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH-----------------------QGEEVFWAEVSTIGKIYHM--N 224 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-----------------------~~~~~~~~E~~~l~~l~h~--n 224 (464)
+.++.+||-|--+.||.|..++|.++|||.=+... .......+|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999421100 1112356788999998765 7
Q ss_pred eeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC
Q 040010 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 225 iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
+.+.+++ +...+||||+++-.|...- ++....-.++..|++-+.-+-. .++||+|+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence 7777765 3447999999987665432 1233333444455554444445 78999999999999999999
Q ss_pred eEEeeecCccccC
Q 040010 305 PKIADFGLAKLSQ 317 (464)
Q Consensus 305 ~kl~Dfgla~~~~ 317 (464)
+.+.||--+...+
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999997665433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.5e-07 Score=80.49 Aligned_cols=134 Identities=16% Similarity=0.121 Sum_probs=103.2
Q ss_pred cCccCceEEEEEEECCCcEEEEEEcCCc-------cchhHHHHHHHHHhhhccccc--eeccceeeee-----CcEEeEE
Q 040010 176 LGKGGSGAVYKGVLTDERAVAVKRLGDL-------HQGEEVFWAEVSTIGKIYHMN--LVRMWGFCTE-----GMHRLLV 241 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~~~~vavK~l~~~-------~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lv 241 (464)
-|+||.+.|+.-.+.+. .+-+|+-... ..+...|.+|...|.++...+ +.+.+ ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56789999999887444 6888876521 336678999999999996433 44444 3321 1345799
Q ss_pred EEeccC-CChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC--eEEeeecCcc
Q 040010 242 YEYVEN-QSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE--PKIADFGLAK 314 (464)
Q Consensus 242 ~E~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~ 314 (464)
+|-+++ -+|.+++.+. .+.+...+..+..+++..++-||+ .++.|+|+.+.||+++.++. +++.||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 5899988653 356788889999999999999999 99999999999999986666 8999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-08 Score=104.51 Aligned_cols=153 Identities=22% Similarity=0.265 Sum_probs=100.4
Q ss_pred HHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-------cceeeeccCCCccCcccccC
Q 040010 270 LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-------SQFSRIRGTKGYMAPEWASN 342 (464)
Q Consensus 270 ~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 342 (464)
.+++.|+.|+|.. ..+||++|.|++|.+++++..||+.|+.+.-....... ....-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3456999999985 45999999999999999999999999987644331110 00111334568999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHH
Q 040010 343 LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLF 422 (464)
Q Consensus 343 ~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 422 (464)
...+.++|+||+|+++|-+..|.++........ +... .....+..-...+..+.+.++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~------~~~~---------------~~~~~~~~~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL------LSYS---------------FSRNLLNAGAFGYSNNLPSELR 242 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc------chhh---------------hhhcccccccccccccCcHHHH
Confidence 888999999999999999995544432111100 0000 0000111111112234445566
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 040010 423 RIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 423 ~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+=+...+..++.-||++.++...
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhcc
Confidence 66667899999999988776543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.1e-07 Score=93.57 Aligned_cols=161 Identities=19% Similarity=0.238 Sum_probs=100.0
Q ss_pred cccCccccCHHHHHHHH------------hhhc-cccCccCceEEEEEEECCCcEEEEEEcCCccchh------------
Q 040010 153 LSSQFKRFSYAELKKAT------------NSFK-EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE------------ 207 (464)
Q Consensus 153 ~~~~~~~~~~~el~~~~------------~~~~-~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~------------ 207 (464)
+....+.|++++.+..- ..|. +.|+.++-|.||+|++++|+.||||+.+..-...
T Consensus 97 LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a 176 (517)
T COG0661 97 LQDRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLA 176 (517)
T ss_pred hhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHH
Confidence 34455667766543221 1333 3589999999999999999999999875321000
Q ss_pred -------------------H----------HHHHHHHHhhhcc----ccceeccceee-eeCcEEeEEEEeccCCChHHh
Q 040010 208 -------------------E----------VFWAEVSTIGKIY----HMNLVRMWGFC-TEGMHRLLVYEYVENQSLDKH 253 (464)
Q Consensus 208 -------------------~----------~~~~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~E~~~~gsL~~~ 253 (464)
+ .+..|...+.+++ +..-+++=..+ .-.+...|+|||++|-.+.+.
T Consensus 177 ~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~ 256 (517)
T COG0661 177 RLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDI 256 (517)
T ss_pred HHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccH
Confidence 0 1334444444442 22222222223 234567899999999998887
Q ss_pred hh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 254 LF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 254 l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
.. +....+-. .++..++++ |+.+.-..+++|.|.+|.||+++.++.+.+.|||+......
T Consensus 257 ~~l~~~g~d~k---~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 257 AALKSAGIDRK---ELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcCCCHH---HHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 43 22445532 233333222 11111126799999999999999999999999999875543
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-07 Score=72.33 Aligned_cols=66 Identities=29% Similarity=0.505 Sum_probs=50.1
Q ss_pred CCcccccCCccccccccCHHHHHHHHhh-cCCccceEEecCCcccee-Ee-eecccccccCCCCCceEEE
Q 040010 1 VPKVDFYGFDLNFSEHVSKEACMKLCLD-DFRCSGFSYRLTGERVCF-TK-SELFNGYKAPNFPGDMYLK 67 (464)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~c~C~a~~~~~~~~~~c~-~~-~~l~~~~~~~~~~~~~~~k 67 (464)
++++.+++.+.......++++|++.|++ +|+|.||+|.. +++.|+ |. +.+.+....++.+.++|.|
T Consensus 9 ~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~-~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 9 LPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN-GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC-CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3667777665544567799999999999 99999999975 567899 66 6777776555556677765
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.1e-07 Score=82.71 Aligned_cols=107 Identities=18% Similarity=0.184 Sum_probs=86.4
Q ss_pred hHHHHHHHHHhhhccc--cceeccceeeeeC----cEEeEEEEeccCC-ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 040010 207 EEVFWAEVSTIGKIYH--MNLVRMWGFCTEG----MHRLLVYEYVENQ-SLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279 (464)
Q Consensus 207 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL 279 (464)
.....+|...+..+.. -...+.+++.... ...++|+|++++. +|.+++.....++...+..++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3457788888888753 3455666666543 2458999999884 8999997655577788899999999999999
Q ss_pred hhcCCCceEecCCCCCCEEEcCCC---CeEEeeecCcccc
Q 040010 280 HHECLEWVIHCDVKPENILLDSEF---EPKIADFGLAKLS 316 (464)
Q Consensus 280 H~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 316 (464)
|+ .+|+|+|++++|||++.+. .+.+.||+-++..
T Consensus 135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 9999999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=85.38 Aligned_cols=261 Identities=17% Similarity=0.159 Sum_probs=154.1
Q ss_pred hccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceecccee------eee-CcEEeEEEE
Q 040010 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGF------CTE-GMHRLLVYE 243 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~------~~~-~~~~~lv~E 243 (464)
.+..||+|+-+.+|-----.+ .+-|+........+. +.+..|... .||-+-.-+.| ..+ +...-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhc--hhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 346799999999996432112 233554432221111 122333333 35543321221 112 222556777
Q ss_pred eccCC-ChHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 244 YVENQ-SLDKHLF------SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 244 ~~~~g-sL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.+++. ...++.. +-...+|...++.++.+|.+.+-||. .+.+-+|++++|+|+++++.+.+.|-......
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 76654 2333332 12358999999999999999999999 88899999999999999999999885544433
Q ss_pred CCCCCCcceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHH
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
. +........|...|.+||.-. +-.-+...|-|.+||++++++.| +.||.......+. ....+.
T Consensus 168 ~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a-p~p~E~------ 237 (637)
T COG4248 168 A---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA-PNPLET------ 237 (637)
T ss_pred c---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC-CCcchh------
Confidence 2 222345567889999999643 44567889999999999998887 7888653221111 000000
Q ss_pred HHhhccchhhhhhhcCCcc---CCCCCHH-HHHHHHHHHHHccCCC--CCCCCCHHHHHHHhhCCCC
Q 040010 391 EKILCGEEARIEEIVDPRL---KGHFNKN-QAATLFRIGISCVDED--RNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l---~~~~~~~-~~~~~~~l~~~Cl~~d--p~~RPsm~~V~~~L~~~~~ 451 (464)
.+..|......+ -.+.+ ..+.+.+ ....+..+-.+|+... +.-|||.+..+..|..+.+
T Consensus 238 -~Ia~g~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 238 -DIAHGRFAYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred -hhhcceeeechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000000000000 00001 1122222 3455666777888653 6789999998888866543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.2e-06 Score=76.62 Aligned_cols=136 Identities=15% Similarity=0.225 Sum_probs=84.6
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eeccceeeeeCcEEeEEEEeccCCC-h
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGFCTEGMHRLLVYEYVENQS-L 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~E~~~~gs-L 250 (464)
..||+|..+.||+. .+..+++|...... ......+|.++++.+.... +.+.++++..++...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 24456778776433 3345678999999987544 4677778777777889999999863 2
Q ss_pred HHhh---------------------hcC--CCCCHHHHHH-HHH----------HHHH-HHHHHhhc-CCCceEecCCCC
Q 040010 251 DKHL---------------------FSS--NFLGWKERFK-VAL----------GTAK-GLAYLHHE-CLEWVIHCDVKP 294 (464)
Q Consensus 251 ~~~l---------------------~~~--~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~~~~ivH~dlk~ 294 (464)
...+ +.- ...+...+.. +.. .+.. ...+|... ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 110 1111111110 000 0111 12222211 124578999999
Q ss_pred CCEEEcCCCCeEEeeecCcc
Q 040010 295 ENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 295 ~NIll~~~~~~kl~Dfgla~ 314 (464)
.||++++++ +.|.||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.9e-06 Score=86.17 Aligned_cols=160 Identities=22% Similarity=0.220 Sum_probs=99.5
Q ss_pred cccCccccCHHHHHHHH------------hhhc-cccCccCceEEEEEEECCCcEEEEEEcCCccch-------------
Q 040010 153 LSSQFKRFSYAELKKAT------------NSFK-EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQG------------- 206 (464)
Q Consensus 153 ~~~~~~~~~~~el~~~~------------~~~~-~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~------------- 206 (464)
+....+.++++|+.+-- ..|. +.||.-+.|.||++++++|+.||||+-+..-..
T Consensus 133 LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~ 212 (538)
T KOG1235|consen 133 LQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLA 212 (538)
T ss_pred HhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHH
Confidence 34456678887764321 1333 369999999999999999999999986532110
Q ss_pred -------------------------hHHHHHHHHHhhhc----cccce---eccceee-eeCcEEeEEEEeccCCChHHh
Q 040010 207 -------------------------EEVFWAEVSTIGKI----YHMNL---VRMWGFC-TEGMHRLLVYEYVENQSLDKH 253 (464)
Q Consensus 207 -------------------------~~~~~~E~~~l~~l----~h~ni---v~l~g~~-~~~~~~~lv~E~~~~gsL~~~ 253 (464)
+-.|.+|.+-..+. .|-++ |.+=.++ .-...+.|+||||+|..+.+.
T Consensus 213 ~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 213 KVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCH
Confidence 01134454433333 34441 1122222 223578999999999888776
Q ss_pred hh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC----CCCeEEeeecCccccC
Q 040010 254 LF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS----EFEPKIADFGLAKLSQ 317 (464)
Q Consensus 254 l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgla~~~~ 317 (464)
-. .+..++.... +..+.++ |+++.-..|++|+|-+|.||+++. ++.+.+.|||+.....
T Consensus 293 ~~i~~~gi~~~~i---~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 293 DAIDKRGISPHDI---LNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHcCCCHHHH---HHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 43 2334444433 2222222 233322267999999999999984 6789999999987554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-06 Score=76.03 Aligned_cols=136 Identities=24% Similarity=0.257 Sum_probs=89.3
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCccchh----------HHH---------------HHHHHHhhhcc--ccceec
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE----------EVF---------------WAEVSTIGKIY--HMNLVR 227 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~----------~~~---------------~~E~~~l~~l~--h~niv~ 227 (464)
.|.+|.-..||+|.-.++..+|||+.+...... ..| .+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 477788889999998889999999886432211 111 23555555552 333344
Q ss_pred cceeeeeCcEEeEEEEeccCCCh-HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeE
Q 040010 228 MWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306 (464)
Q Consensus 228 l~g~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 306 (464)
.+++. +-.|||||+..... .-.| +...+.......+..++++.+.-|-.. .++||+||+.-|||+. ++.+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEE
Confidence 44432 34799999965321 1112 111233335666777777777777653 4599999999999999 88999
Q ss_pred EeeecCccccCC
Q 040010 307 IADFGLAKLSQR 318 (464)
Q Consensus 307 l~Dfgla~~~~~ 318 (464)
|.|||-|....+
T Consensus 207 iID~~QaV~~~h 218 (268)
T COG1718 207 IIDVSQAVTIDH 218 (268)
T ss_pred EEECccccccCC
Confidence 999998876553
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=98.33 E-value=5e-07 Score=67.94 Aligned_cols=49 Identities=39% Similarity=0.610 Sum_probs=42.1
Q ss_pred CcccccCCccccccccCHHHHHHHHhhcCCccceEEecCCccceeEeeec
Q 040010 2 PKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSEL 51 (464)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~~l 51 (464)
++++|+|+|+......+.++|++.|+.+|+|.||.|. .+.+.|++|+..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~-~~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYN-TKSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEE-CCCCeEEcccCC
Confidence 5899999998766677999999999999999999997 456789977643
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=74.83 Aligned_cols=139 Identities=24% Similarity=0.214 Sum_probs=85.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eeccceeeee---CcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGFCTE---GMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~---~~~~~lv~E~~~~g 248 (464)
+.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.+.... +.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999999977 58999987765 45567788999998886443 4566665433 34578999999998
Q ss_pred ChHH----------------hh---hcC----CCCCHHH---------HHHH------------HHHHHH-HHHHHhh--
Q 040010 249 SLDK----------------HL---FSS----NFLGWKE---------RFKV------------ALGTAK-GLAYLHH-- 281 (464)
Q Consensus 249 sL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-- 281 (464)
.+.. .+ +.. ..+.+.. .... ...+.. .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 11 111 1111111 0000 112222 3333433
Q ss_pred --cCCCceEecCCCCCCEEEc-CCCCeEEeeecCcc
Q 040010 282 --ECLEWVIHCDVKPENILLD-SEFEPKIADFGLAK 314 (464)
Q Consensus 282 --~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~ 314 (464)
.....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2346799999999999999 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=74.98 Aligned_cols=136 Identities=15% Similarity=0.069 Sum_probs=84.1
Q ss_pred cCccCc-eEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccCCChHHh
Q 040010 176 LGKGGS-GAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKH 253 (464)
Q Consensus 176 lG~G~~-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~ 253 (464)
|-.|.+ ..||+....+ ..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 344444 7899997654 678888776543 345678999988884 34455777777766678999999999887643
Q ss_pred h-------------------hcCC----CCC--HHHHHHHHH--------------------HHHHHHHHHhh----cCC
Q 040010 254 L-------------------FSSN----FLG--WKERFKVAL--------------------GTAKGLAYLHH----ECL 284 (464)
Q Consensus 254 l-------------------~~~~----~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~ 284 (464)
. +... .+. ...+..... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1100 111 001110000 01111222211 112
Q ss_pred CceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 285 EWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 285 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..++|+|+.|.||+++++....|.||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.3e-06 Score=74.60 Aligned_cols=101 Identities=26% Similarity=0.317 Sum_probs=82.7
Q ss_pred HHHHHhhhccc-cceeccceeeeeCcEEeEEEEeccCCChHHh---hhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 040010 212 AEVSTIGKIYH-MNLVRMWGFCTEGMHRLLVYEYVENQSLDKH---LFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287 (464)
Q Consensus 212 ~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 287 (464)
.|.-+++.+++ +++.+++|+|-. +++.||...+++... +..--..+|..|.+||.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47778888876 599999999943 789999987765421 1122357899999999999999999999776678
Q ss_pred EecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 288 IHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 288 vH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.-.|++++|+-+++++++|+.|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.5e-07 Score=93.19 Aligned_cols=181 Identities=20% Similarity=0.115 Sum_probs=131.7
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc-eeccceeeeeCcEEeEEEEeccCC-ChH
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN-LVRMWGFCTEGMHRLLVYEYVENQ-SLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~E~~~~g-sL~ 251 (464)
+.+++|+.+.+||.+-...+....+.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 567899999999987544444444444322 44556889999999999 777777788888999999999877 222
Q ss_pred Hhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeecc
Q 040010 252 KHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330 (464)
Q Consensus 252 ~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 330 (464)
.... ..-.+...+...+.+.-+++++++|+ ..=+|+| ||+..+ ...+.+||+....+.... ......+
T Consensus 324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~ 392 (829)
T KOG0576|consen 324 LEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIG 392 (829)
T ss_pred ccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCCC
Confidence 2111 11133344445666777889999999 3348888 777665 678999999887655432 2455679
Q ss_pred CCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 331 TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 331 t~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
++.++|||......+....|+|+.|+--.++--|-.|..
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999999999999999999999999987777776766544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.4e-05 Score=69.42 Aligned_cols=130 Identities=15% Similarity=0.125 Sum_probs=80.8
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccchh-HH---------HHHHHHHhhhccc---cceeccceeee-----e
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE-EV---------FWAEVSTIGKIYH---MNLVRMWGFCT-----E 234 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~-~~---------~~~E~~~l~~l~h---~niv~l~g~~~-----~ 234 (464)
.+.+-......|.+-.. +|..+.+|..+...... +. ..+++..+.+++. .....++.+.. -
T Consensus 36 ~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 36 IKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred EEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 34455555555665555 45778888776432211 11 2233444444432 22223222222 2
Q ss_pred CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 235 GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 235 ~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
....+++|||++|..|.+... ++. .++..+++++.-||+ .|++|+|.+|+|+++++++ +++.||+..+
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 245578999999988776532 221 355678888999999 8999999999999999655 9999998665
Q ss_pred c
Q 040010 315 L 315 (464)
Q Consensus 315 ~ 315 (464)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.2e-05 Score=81.90 Aligned_cols=77 Identities=14% Similarity=0.317 Sum_probs=56.6
Q ss_pred cccCccCceEEEEEEECCC---cEEEEEEcCCcc--chhHHHHHHHHHhhhcc-ccce--eccceeeeeC---cEEeEEE
Q 040010 174 EELGKGGSGAVYKGVLTDE---RAVAVKRLGDLH--QGEEVFWAEVSTIGKIY-HMNL--VRMWGFCTEG---MHRLLVY 242 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv~ 242 (464)
+.++.|.+..+|+....++ ..+++|+..... .....+.+|.++|+.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4688999999999887654 367777765322 23356789999999995 6664 7788888764 4678999
Q ss_pred EeccCCCh
Q 040010 243 EYVENQSL 250 (464)
Q Consensus 243 E~~~~gsL 250 (464)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.3e-05 Score=70.35 Aligned_cols=73 Identities=15% Similarity=0.186 Sum_probs=45.7
Q ss_pred cccCccCce-EEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc---ceeccceeeeeC---cEEeEEEEecc
Q 040010 174 EELGKGGSG-AVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM---NLVRMWGFCTEG---MHRLLVYEYVE 246 (464)
Q Consensus 174 ~~lG~G~~g-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lv~E~~~ 246 (464)
+.|+.|+.. .||+. + ..+.+|..+. ......+..|.+++..+... .+.+.++..... ...+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~---~-~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---G-DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---C-CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777766 48875 2 3466776544 33345788899999888632 334444443322 23588999999
Q ss_pred CCChH
Q 040010 247 NQSLD 251 (464)
Q Consensus 247 ~gsL~ 251 (464)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00016 Score=70.05 Aligned_cols=75 Identities=12% Similarity=0.077 Sum_probs=55.9
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccc---cceeccceeeeeC---cEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH---MNLVRMWGFCTEG---MHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lv~E~~~~ 247 (464)
+.||.|..+.||.-...+++ +.+|..+. ......+..|.+.|+.+.. -.+.+++++|..+ +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 46999999999999876664 55665432 2234578899999998853 3678888887543 568999999998
Q ss_pred CCh
Q 040010 248 QSL 250 (464)
Q Consensus 248 gsL 250 (464)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00034 Score=63.29 Aligned_cols=126 Identities=17% Similarity=0.256 Sum_probs=88.3
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCcc-----------------chhHHHHHHHHHhhhcc------ccceeccce
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLH-----------------QGEEVFWAEVSTIGKIY------HMNLVRMWG 230 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~g 230 (464)
..||+|+.-.||.= +++....||+..... ....+..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999999954 455567788776444 23456667776665555 888999999
Q ss_pred eeeeCcEEeEEEEeccC------CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-
Q 040010 231 FCTEGMHRLLVYEYVEN------QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF- 303 (464)
Q Consensus 231 ~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~- 303 (464)
+...+...-+|+|.+.+ .+|.+++.+ +.++. .+...+-+-..||-+ ..|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLD---HHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHH---cCCeecCCCcccEEEEecCC
Confidence 99999889999998743 347777743 34544 233334444566666 7799999999999995432
Q ss_pred ---CeEEee
Q 040010 304 ---EPKIAD 309 (464)
Q Consensus 304 ---~~kl~D 309 (464)
.+.|.|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00025 Score=66.20 Aligned_cols=137 Identities=17% Similarity=0.163 Sum_probs=80.5
Q ss_pred cccCccCceEEEEEEECC--CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEeccCCCh
Q 040010 174 EELGKGGSGAVYKGVLTD--ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
+.|..|-...+|+....+ +..+++|+.............|+.++..+....+ .++++.+. ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 357778888999998764 5788889776433222233478888888854444 34444332 2489999998775
Q ss_pred HHh-------h----------hcCC-C----------CC-HHHHHHHHH----------------------HHHHHHHHH
Q 040010 251 DKH-------L----------FSSN-F----------LG-WKERFKVAL----------------------GTAKGLAYL 279 (464)
Q Consensus 251 ~~~-------l----------~~~~-~----------l~-~~~~~~i~~----------------------~ia~gL~yL 279 (464)
... + +... . .+ |.....+.. .+...+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 0 1110 1 11 222112111 111111122
Q ss_pred ----hhc-CCCceEecCCCCCCEEEcC-CCCeEEeeecCcc
Q 040010 280 ----HHE-CLEWVIHCDVKPENILLDS-EFEPKIADFGLAK 314 (464)
Q Consensus 280 ----H~~-~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~ 314 (464)
... ....++|+|+.+.|||+++ +..+.+.||..+.
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 2246999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.83 E-value=7.4e-05 Score=81.53 Aligned_cols=197 Identities=20% Similarity=0.172 Sum_probs=137.1
Q ss_pred HHHHHHhhhccccceeccceeeeeCcEE----eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 040010 211 WAEVSTIGKIYHMNLVRMWGFCTEGMHR----LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286 (464)
Q Consensus 211 ~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 286 (464)
..|.+.+.++.|+|++.+++|..+.... .+..|++..-++...+..-...+..+.+.+..++.+||+|+|+ ..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~---~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS---LS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH---hc
Confidence 3467778888999999999987655333 2456788888999999888899999999999999999999999 44
Q ss_pred eEecCCCCC---CEEEcCCCCeEEe--eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCc--cchhHHHHHHHH
Q 040010 287 VIHCDVKPE---NILLDSEFEPKIA--DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS--KVDVFSYGVVIL 359 (464)
Q Consensus 287 ivH~dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DV~S~Gvvl~ 359 (464)
..|.-+..+ +.-.+.++...++ ||+.+......... .....+..+.+||......++. ..|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 444444444 4445666677776 88887765443221 2223445677888776655544 479999999999
Q ss_pred HHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 360 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
.+..|..+...... ...+++... .. .+......|+..++++|++.
T Consensus 384 ~~~~~~~i~~~~~~---------------------------~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV---------------------------PVSLLDVLS----TS----ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred hhhhcCcccccccc---------------------------hhhhhcccc----ch----hhhhhhhhhcchhhhhccch
Confidence 99998665431100 111122111 10 35566678999999999999
Q ss_pred HHHHHHhhC
Q 040010 440 DSVVQTLLG 448 (464)
Q Consensus 440 ~~V~~~L~~ 448 (464)
.+++...--
T Consensus 429 ~~ll~~~f~ 437 (1351)
T KOG1035|consen 429 LELLTHPFL 437 (1351)
T ss_pred hhhhhchhc
Confidence 999876643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=62.77 Aligned_cols=130 Identities=19% Similarity=0.216 Sum_probs=85.6
Q ss_pred hccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceec-cceeeeeCcEEeEEEEeccCCCh
Q 040010 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVR-MWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
..+.|++|.+|.||+|.+.++ .+|+|.-+.. .....+..|+++|..+.--++.+ ++.|.. .++.|||+.|.+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 346799999999999999654 7888866532 23455778999998887655443 333322 2455999998888
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC-CCCEEEcCCCCeEEeeecCccccC
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVK-PENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk-~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
.+.-... + .+-...+++.---|.. .+|-|+.|+ |...+|-.+..+.|.||..|+.-.
T Consensus 100 ~~~~~~~---~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 100 GKLEIGG---D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhcc---c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 7764321 1 1223344455344455 778888887 444444444499999999987443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00024 Score=63.93 Aligned_cols=133 Identities=25% Similarity=0.341 Sum_probs=93.8
Q ss_pred CccccCHHHHHHHHhhhccccCccCc-eEEEEEEECCCcEEEEEEcCCc------------c----------chhHHHHH
Q 040010 156 QFKRFSYAELKKATNSFKEELGKGGS-GAVYKGVLTDERAVAVKRLGDL------------H----------QGEEVFWA 212 (464)
Q Consensus 156 ~~~~~~~~el~~~~~~~~~~lG~G~~-g~Vy~g~~~~~~~vavK~l~~~------------~----------~~~~~~~~ 212 (464)
.+.+|+.. .+...|.+.||.|.- |.|||... +|+.+|+|.++.- . ....-|..
T Consensus 28 KL~~F~~h---~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ 103 (207)
T PF13095_consen 28 KLEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC 103 (207)
T ss_pred CcCCcCCC---CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence 34556662 256678889999999 99999999 5579999993210 0 01134788
Q ss_pred HHHHhhhcc---ccce--eccceeeeeC------------------cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHH
Q 040010 213 EVSTIGKIY---HMNL--VRMWGFCTEG------------------MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVA 269 (464)
Q Consensus 213 E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~ 269 (464)
|.+..++++ +.++ |+.+||..-. ....||.||.+... .....-+
T Consensus 104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~ 170 (207)
T PF13095_consen 104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDI 170 (207)
T ss_pred HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHH
Confidence 999988885 4456 8999987211 12357888776533 1123345
Q ss_pred HHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 270 LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 270 ~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
.+|.+-|..+|. .+|+-+|+++.|.. .-||.|||.+
T Consensus 171 ~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 677788889999 89999999999976 3488999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00041 Score=65.71 Aligned_cols=134 Identities=15% Similarity=0.086 Sum_probs=78.1
Q ss_pred cCccCceEEEEEEECCCcEEEEEEcCCccchh-HHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEeccCCChHHh
Q 040010 176 LGKGGSGAVYKGVLTDERAVAVKRLGDLHQGE-EVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYVENQSLDKH 253 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~~~gsL~~~ 253 (464)
+..|-...+|+... ++..+++|......... -...+|.++++.+....+ .++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677788998874 56678888765432221 235678888888865434 33444332 3689999998765421
Q ss_pred -----------------hhcCC----CCCHHHHH-HHHHH---------HHHHHHHHhhc-----CCCceEecCCCCCCE
Q 040010 254 -----------------LFSSN----FLGWKERF-KVALG---------TAKGLAYLHHE-----CLEWVIHCDVKPENI 297 (464)
Q Consensus 254 -----------------l~~~~----~l~~~~~~-~i~~~---------ia~gL~yLH~~-----~~~~ivH~dlk~~NI 297 (464)
|+... .++...+. .+..+ +...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 12222211 11111 11112222211 124589999999999
Q ss_pred EEcCCCCeEEeeecCccc
Q 040010 298 LLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~ 315 (464)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00048 Score=66.71 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=85.6
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eecccee------eeeCcEEeEEEEec
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGF------CTEGMHRLLVYEYV 245 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~E~~ 245 (464)
+.|..|....+|+....++ .+++|+... ........|++++..+++.. +.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 3577787789999876554 688888765 23445667888888885433 4444432 12334568999999
Q ss_pred cCCChHH----hh----------hc---C--------CCCCHHHHH----------HHHHHHHHHHHHHhh----cCCCc
Q 040010 246 ENQSLDK----HL----------FS---S--------NFLGWKERF----------KVALGTAKGLAYLHH----ECLEW 286 (464)
Q Consensus 246 ~~gsL~~----~l----------~~---~--------~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~~~ 286 (464)
+|..+.. .. +. . ....|.... .....+...+.++.+ .....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9877532 10 10 0 012333221 011223344555543 22356
Q ss_pred eEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 287 VIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 287 ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
++|+|+.|.||+++++..+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0026 Score=63.87 Aligned_cols=74 Identities=15% Similarity=0.138 Sum_probs=53.2
Q ss_pred cccCccCceEEEEEEECCC-cEEEEEEcCCc--------cchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEE
Q 040010 174 EELGKGGSGAVYKGVLTDE-RAVAVKRLGDL--------HQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~-~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 241 (464)
+.||.|.+..||+....+| +.+.||.-... ....+.+..|.+.|..+. ..++.+++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4799999999999999877 48999974311 123456677888888763 345667777633 557899
Q ss_pred EEeccCCC
Q 040010 242 YEYVENQS 249 (464)
Q Consensus 242 ~E~~~~gs 249 (464)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=64.47 Aligned_cols=136 Identities=24% Similarity=0.253 Sum_probs=82.7
Q ss_pred ccCccCceEEEEEEECC-------CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLTD-------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+..|-...+|+....+ ++.+++|+.............|.+++..+....+ .++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45566667899988755 4788899876544333445678888888864333 345555542 36899999
Q ss_pred CCChHHh-----------------hhcCC-C--------CC--HHHHHHH--------------------------HHHH
Q 040010 247 NQSLDKH-----------------LFSSN-F--------LG--WKERFKV--------------------------ALGT 272 (464)
Q Consensus 247 ~gsL~~~-----------------l~~~~-~--------l~--~~~~~~i--------------------------~~~i 272 (464)
|..+... ++... . .+ |.....+ ...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8776431 11110 0 00 1111111 1122
Q ss_pred HHHHHHHhh------cCCCceEecCCCCCCEEEcCC----CCeEEeeecCcc
Q 040010 273 AKGLAYLHH------ECLEWVIHCDVKPENILLDSE----FEPKIADFGLAK 314 (464)
Q Consensus 273 a~gL~yLH~------~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~ 314 (464)
..-+..+.. .....++|+|+.+.||+++++ +.+++.||..+.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 223334432 234579999999999999985 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00019 Score=54.39 Aligned_cols=49 Identities=31% Similarity=0.520 Sum_probs=41.7
Q ss_pred CcccccCCccccccccCHHHHHHHHhhcCCccceEEecCCc--cceeEeee
Q 040010 2 PKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGE--RVCFTKSE 50 (464)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~--~~c~~~~~ 50 (464)
+|+||+|.|+......+.++|.+.|..+=.|.+|.|..... ..|++|..
T Consensus 7 ~~~df~G~Dl~~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~s 57 (79)
T smart00223 7 KNVDFRGSDINTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKDS 57 (79)
T ss_pred cCccccCceeeeeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCcC
Confidence 68999999998888999999999999999999999973221 27998754
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0054 Score=60.06 Aligned_cols=137 Identities=16% Similarity=0.130 Sum_probs=77.1
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eeccce------eeeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWG------FCTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g------~~~~~~~~~lv~E~~~ 246 (464)
.|+.|....+|+....+| .+++|+... ...+....|+.++..+.... +.+.+. +....+..++++||++
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 466777778999887665 578888762 22333444566666664222 333332 1123456789999999
Q ss_pred CCChHH-----------hh---hc--C-------C--CCCH-HHHHH------------HH-HHHHHHHHHHhhc----C
Q 040010 247 NQSLDK-----------HL---FS--S-------N--FLGW-KERFK------------VA-LGTAKGLAYLHHE----C 283 (464)
Q Consensus 247 ~gsL~~-----------~l---~~--~-------~--~l~~-~~~~~------------i~-~~ia~gL~yLH~~----~ 283 (464)
|..+.. .| +. . . .+.| ..... .. ..+...+..+.+. .
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 875421 11 10 0 0 1112 11111 01 1111222333211 3
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..+++|+|+++.||+++++...-|.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4679999999999999977656899998874
|
|
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00042 Score=47.72 Aligned_cols=45 Identities=29% Similarity=0.559 Sum_probs=18.1
Q ss_pred ccccCCcccc--ccccCHHHHHHHHhhcCCccceEEecC----CccceeEe
Q 040010 4 VDFYGFDLNF--SEHVSKEACMKLCLDDFRCSGFSYRLT----GERVCFTK 48 (464)
Q Consensus 4 ~~~~~~~~~~--~~~~~~~~C~~~Cl~~c~C~a~~~~~~----~~~~c~~~ 48 (464)
|||+|.|+.. ....+.++|.+.|.++=.|.+|+|... +.+.|++|
T Consensus 1 ~d~~G~dl~~~~~~~~s~~~C~~~C~~~~~C~~~~~~~~~~~~~~~~C~LK 51 (51)
T PF14295_consen 1 TDYPGGDLRSFPVTASSPEECQAACAADPGCQAFTFNPPGCPSSSGRCYLK 51 (51)
T ss_dssp -----------------HHHHHHHHHTSTT--EEEEETTEE----------
T ss_pred CcccccccccccccCCCHHHHHHHccCCCCCCEEEEECCCcccccccccCC
Confidence 6899999755 467799999999999999999999741 34567754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00053 Score=65.44 Aligned_cols=132 Identities=15% Similarity=0.115 Sum_probs=87.4
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCc-----------------cchh------HHHHHHHHHhhhccc--cc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL-----------------HQGE------EVFWAEVSTIGKIYH--MN 224 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~-----------------~~~~------~~~~~E~~~l~~l~h--~n 224 (464)
+.+.+.||-|.-+.||.+...+|++.++|.=+-. ..+. -...+|...|+.+.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999998999888832100 0011 112356777777743 23
Q ss_pred eeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC
Q 040010 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 225 iv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
+.+.++++ ..++|||++.+-.|...-+- .+.++. ...+..-+.-|-. .++||+|++--||+++++..
T Consensus 174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~v---~d~~~l---y~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDHN----RHCVVMELVDGYPLRQVRHV---EDPPTL---YDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCccccc----ceeeHHHhhcccceeeeeec---CChHHH---HHHHHHHHHHHHH---cCceecccchheeEEecCCC
Confidence 44555543 44789999988777654321 222332 2223333344444 89999999999999999999
Q ss_pred eEEeeecCcc
Q 040010 305 PKIADFGLAK 314 (464)
Q Consensus 305 ~kl~Dfgla~ 314 (464)
+++.||--..
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999996543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.014 Score=56.96 Aligned_cols=139 Identities=16% Similarity=0.160 Sum_probs=81.8
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eeccceee------eeCcEEeEEEEec
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGFC------TEGMHRLLVYEYV 245 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~E~~ 245 (464)
+.++.|....+|+....++ .+.+|+..... ..+....|++++..+.... +.+++... ..++..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 3467777788999876555 46678765422 2334556777777774322 34444421 2235678999999
Q ss_pred cCCChHH-----------h---hhc--CC----------CCCHHHHH------------HHHHHHHHHHHHHhh----cC
Q 040010 246 ENQSLDK-----------H---LFS--SN----------FLGWKERF------------KVALGTAKGLAYLHH----EC 283 (464)
Q Consensus 246 ~~gsL~~-----------~---l~~--~~----------~l~~~~~~------------~i~~~ia~gL~yLH~----~~ 283 (464)
+|..+.. . ++. .. .-.|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8865321 0 111 00 01122111 011123344555543 23
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..+++|+|+++.||+++++....|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4679999999999999998777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0091 Score=57.22 Aligned_cols=31 Identities=29% Similarity=0.545 Sum_probs=25.6
Q ss_pred CceEecCCCCCCEEEcCCCC-eEEeeecCccc
Q 040010 285 EWVIHCDVKPENILLDSEFE-PKIADFGLAKL 315 (464)
Q Consensus 285 ~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~ 315 (464)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0045 Score=59.50 Aligned_cols=72 Identities=18% Similarity=0.265 Sum_probs=47.8
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEEEEeccCC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999987 577889999776 344566888888888874 455778899887777789999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0087 Score=58.36 Aligned_cols=139 Identities=15% Similarity=0.156 Sum_probs=92.3
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCcc----------chhHH-----------------HHHHHHHhhhccccceec
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLH----------QGEEV-----------------FWAEVSTIGKIYHMNLVR 227 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~----------~~~~~-----------------~~~E~~~l~~l~h~niv~ 227 (464)
-|..|--..||.++-.+|..+|||+.+.+. .++-. ...|++-|.+++...|.-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 577888889999999999999999875331 01111 123555566655333221
Q ss_pred cceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 228 l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
.--... ....|||+|+.......-.-....++...+..+-.+++.-|.-|-+.|. +||.||+--|+|+.+ |.+.|
T Consensus 231 PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G~lyi 305 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-GKLYI 305 (520)
T ss_pred CCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-CEEEE
Confidence 111111 2346999999543222212233457777888899999999999988776 999999999999865 57889
Q ss_pred eeecCccccCC
Q 040010 308 ADFGLAKLSQR 318 (464)
Q Consensus 308 ~Dfgla~~~~~ 318 (464)
.|-+-+.....
T Consensus 306 IDVSQSVE~DH 316 (520)
T KOG2270|consen 306 IDVSQSVEHDH 316 (520)
T ss_pred EEccccccCCC
Confidence 99887765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.02 Score=56.73 Aligned_cols=136 Identities=19% Similarity=0.165 Sum_probs=79.6
Q ss_pred cCccCceEEEEEEECC-----CcEEEEEEcCCccchhHHHHHHHHHhhhcccccee-ccceeeeeCcEEeEEEEeccCCC
Q 040010 176 LGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLV-RMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
|-.|-.-.+|+....+ ++.+++|+........-...+|..++..+...++. ++++.+..+ .|+||+++.+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~ 119 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART 119 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence 4446667888887543 35788887765432222235788888888655544 455665443 5899998777
Q ss_pred hHHh-----------------hhcCC------CCCHHHHHHHHHH-----------------HHHHHHHHh----h-cCC
Q 040010 250 LDKH-----------------LFSSN------FLGWKERFKVALG-----------------TAKGLAYLH----H-ECL 284 (464)
Q Consensus 250 L~~~-----------------l~~~~------~l~~~~~~~i~~~-----------------ia~gL~yLH----~-~~~ 284 (464)
|... ++... ...|.+...+..+ +...+..|. . ...
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 11111 1112322222211 111222222 1 122
Q ss_pred CceEecCCCCCCEEEcC-CCCeEEeeecCccc
Q 040010 285 EWVIHCDVKPENILLDS-EFEPKIADFGLAKL 315 (464)
Q Consensus 285 ~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~ 315 (464)
..++|+|+++.||++++ +..+.+.||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 46899999999999986 46799999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.036 Score=53.84 Aligned_cols=133 Identities=20% Similarity=0.336 Sum_probs=75.9
Q ss_pred EEEEEECCCcEEEEEEcC--CccchhHHHHHHHHHhhhccc--cceeccceeeeeCc--EEeEEEEeccCCChHHhhhcC
Q 040010 184 VYKGVLTDERAVAVKRLG--DLHQGEEVFWAEVSTIGKIYH--MNLVRMWGFCTEGM--HRLLVYEYVENQSLDKHLFSS 257 (464)
Q Consensus 184 Vy~g~~~~~~~vavK~l~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lv~E~~~~gsL~~~l~~~ 257 (464)
+|....+ ++.+++.+-. ..........+|.++|+.+.- --..+.++.|.++. ..+.||+|.+|..+.+.+...
T Consensus 41 t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~ 119 (321)
T COG3173 41 TFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE 119 (321)
T ss_pred eEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc
Confidence 3433332 6677777221 112222344567778877743 34556777887776 779999999884332211100
Q ss_pred C--------------------------------------CCCHHHHHHHH--------HHHHHHHHHHhhcC-----CCc
Q 040010 258 N--------------------------------------FLGWKERFKVA--------LGTAKGLAYLHHEC-----LEW 286 (464)
Q Consensus 258 ~--------------------------------------~l~~~~~~~i~--------~~ia~gL~yLH~~~-----~~~ 286 (464)
. .-.|....+.+ -....-..+|++.. ...
T Consensus 120 ~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 120 SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 0 00111111100 01222344444422 245
Q ss_pred eEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 287 ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
++|+|+.+.|++++.+.-+-|.||+++.+-+
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 9999999999999998889999999997644
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.04 Score=53.69 Aligned_cols=31 Identities=16% Similarity=0.180 Sum_probs=28.0
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..+++|+|+.+.|+++++++.+.+.||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.032 Score=54.97 Aligned_cols=137 Identities=16% Similarity=0.209 Sum_probs=78.7
Q ss_pred ccCccCceEEEEEEECC----CcEEEEEEcCCccchhHHHHHHHHHhhhcccccee-ccceeeeeCcEEeEEEEeccCCC
Q 040010 175 ELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLV-RMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
.|..|-.-.+|+....+ +..|.+|+........-...+|..+++.+...++. ++++++..+ +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence 34446667788887643 23788887765433222235788888888765553 556665432 5899997766
Q ss_pred hHH-------hh----------hcCC-----CC-CHHHHHHHHHHH----------------------HHHHHHHhh---
Q 040010 250 LDK-------HL----------FSSN-----FL-GWKERFKVALGT----------------------AKGLAYLHH--- 281 (464)
Q Consensus 250 L~~-------~l----------~~~~-----~l-~~~~~~~i~~~i----------------------a~gL~yLH~--- 281 (464)
|.. .+ +... .. -|.....+..++ ..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 522 01 1111 11 133322222111 111222211
Q ss_pred --cCCCceEecCCCCCCEEEcC-CCCeEEeeecCccc
Q 040010 282 --ECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKL 315 (464)
Q Consensus 282 --~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~ 315 (464)
....-++|+|+.+.||++++ ++.+++.||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11124799999999999975 57899999998854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.066 Score=53.80 Aligned_cols=71 Identities=18% Similarity=0.215 Sum_probs=48.6
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCC-----cc---chhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEEE
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGD-----LH---QGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.||.|....||+.... +..+.||.-.. .. -....-..|.+.|+.+. ..++.++++++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 47899999999998864 45688987641 11 12233345566666553 3578888988874 457889
Q ss_pred EeccC
Q 040010 243 EYVEN 247 (464)
Q Consensus 243 E~~~~ 247 (464)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.058 Score=52.85 Aligned_cols=133 Identities=19% Similarity=0.258 Sum_probs=82.3
Q ss_pred CceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc------eeccce----eeeeCcEEeEEEEeccCCC
Q 040010 180 GSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN------LVRMWG----FCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 180 ~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g----~~~~~~~~~lv~E~~~~gs 249 (464)
.-..+|+....+|+. ++|..+.. ....+...|+..|..+.-.. +..+=| ....+...+-+++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 445688888877776 88887776 56667777888888874222 222222 1122247789999999988
Q ss_pred hHH-h----h----------h------c--C----CCCCHHH-------------HHHHHHHHHHHHHHHhhc----CCC
Q 040010 250 LDK-H----L----------F------S--S----NFLGWKE-------------RFKVALGTAKGLAYLHHE----CLE 285 (464)
Q Consensus 250 L~~-~----l----------~------~--~----~~l~~~~-------------~~~i~~~ia~gL~yLH~~----~~~ 285 (464)
+.. . + + . . ....|.. ......++...+..+.+. ...
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 772 1 1 1 0 1 1234431 011233344444444432 223
Q ss_pred c---eEecCCCCCCEEEcCCCC-eEEeeecCcc
Q 040010 286 W---VIHCDVKPENILLDSEFE-PKIADFGLAK 314 (464)
Q Consensus 286 ~---ivH~dlk~~NIll~~~~~-~kl~Dfgla~ 314 (464)
. +||+|+.|.||+++++.. ..+.||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999999885 8899998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.02 Score=52.45 Aligned_cols=119 Identities=23% Similarity=0.214 Sum_probs=60.4
Q ss_pred CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEeccCCChHHh-------h---------
Q 040010 192 ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYVENQSLDKH-------L--------- 254 (464)
Q Consensus 192 ~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~~~gsL~~~-------l--------- 254 (464)
.+.|+|++........-....|..+++.+...++ .++++++.++ .|+||+++..|... +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 3567888877654444455678889988865444 4566655443 57799976664221 1
Q ss_pred -hc--C----C-CCCHHHHHHH----------------------HHHHHHHHHHHhh----c-CCCceEecCCCCCCEEE
Q 040010 255 -FS--S----N-FLGWKERFKV----------------------ALGTAKGLAYLHH----E-CLEWVIHCDVKPENILL 299 (464)
Q Consensus 255 -~~--~----~-~l~~~~~~~i----------------------~~~ia~gL~yLH~----~-~~~~ivH~dlk~~NIll 299 (464)
+. . . .--|.....+ ...+..-+..+.+ . ...-+.|+|+.+.||++
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 00 0 0 0012222222 1112222222221 1 11358999999999999
Q ss_pred -cCCCCeEEeeecCcc
Q 040010 300 -DSEFEPKIADFGLAK 314 (464)
Q Consensus 300 -~~~~~~kl~Dfgla~ 314 (464)
+.++.+++.||..+.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 889999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.11 Score=51.35 Aligned_cols=72 Identities=19% Similarity=0.151 Sum_probs=46.1
Q ss_pred ccCccCceEEEEEEECCC-cEEEEEEcCC--------ccchhHHHHHHHHHhhhcc--cc-ceeccceeeeeCcEEeEEE
Q 040010 175 ELGKGGSGAVYKGVLTDE-RAVAVKRLGD--------LHQGEEVFWAEVSTIGKIY--HM-NLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~-~~vavK~l~~--------~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lv~ 242 (464)
+||.|....||++..++| +.|+||.-.. -........-|.+.|+... -| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 689999999999998755 5899985421 1222344556777776653 23 34444443 444567999
Q ss_pred EeccCC
Q 040010 243 EYVENQ 248 (464)
Q Consensus 243 E~~~~g 248 (464)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.3 Score=47.93 Aligned_cols=71 Identities=14% Similarity=0.056 Sum_probs=46.1
Q ss_pred CceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc--ceeccc---e--eeeeCcEEeEEEEeccCCCh
Q 040010 180 GSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM--NLVRMW---G--FCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 180 ~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---g--~~~~~~~~~lv~E~~~~gsL 250 (464)
.-..||+....++..+++|..+.......+...|++.+..+... .++... | ....++..+.++++++|...
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34568988887888899998765444556677788888777421 122222 2 22334567889999987653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.024 Score=57.56 Aligned_cols=50 Identities=20% Similarity=0.224 Sum_probs=37.5
Q ss_pred HHHHHHHHHhhhccccceeccceeeeeCc-EEeEEEEeccCCChHHhhhcCC
Q 040010 208 EVFWAEVSTIGKIYHMNLVRMWGFCTEGM-HRLLVYEYVENQSLDKHLFSSN 258 (464)
Q Consensus 208 ~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~E~~~~gsL~~~l~~~~ 258 (464)
.+..-....++.+.|+|+...+.+..... ...+|+|++ +.||++.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 44556678888999999999888765443 356788988 679999886543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.13 Score=50.07 Aligned_cols=29 Identities=31% Similarity=0.319 Sum_probs=25.4
Q ss_pred CceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 285 EWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 285 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 578899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.0033 Score=70.89 Aligned_cols=156 Identities=12% Similarity=0.006 Sum_probs=109.3
Q ss_pred HHHHHHHhhhccccceeccceeee--eCcEEeEEEEeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 040010 210 FWAEVSTIGKIYHMNLVRMWGFCT--EGMHRLLVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHEC 283 (464)
Q Consensus 210 ~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~ 283 (464)
...|...++...|+++.....-.. +....+.+++|+..|.+.+.|-++ ..++.........+......-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666678888776555432 335568899999999999988643 23333333333333345555555432
Q ss_pred --CCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHH
Q 040010 284 --LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361 (464)
Q Consensus 284 --~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~el 361 (464)
....+|+++|+-|.+|..+.++|++++|+.+...+ .........+++-|+.|+....-.++.++|+|..|.-+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23479999999999999999999999999983222 11223445677789999988888899999999999999998
Q ss_pred HhCCCC
Q 040010 362 LKGIRL 367 (464)
Q Consensus 362 ltg~~p 367 (464)
--|-.+
T Consensus 1434 s~~n~~ 1439 (2724)
T KOG1826|consen 1434 SDGNAY 1439 (2724)
T ss_pred hcccHH
Confidence 776443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 464 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-118
Identities = 119/301 (39%), Positives = 171/301 (56%), Gaps = 16/301 (5%)
Query: 156 QFKRFSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAVAVKRL-GDLHQGEEV-FW 211
Q KRFS EL+ A+++F + LG+GG G VYKG L D VAVKRL + QG E+ F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 212 AEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----SSNFLGWKERFK 267
EV I H NL+R+ GFC RLLVY Y+ N S+ L S L W +R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 268 VALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327
+ALG+A+GLAYLH C +IH DVK NILLD EFE + DFGLAKL ++ +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTA 194
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR 387
+RGT G++APE+ S + K DVF YGV++LE++ G R + + + + L +++
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDWVK 253
Query: 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447
+ +E ++E +VD L+G++ + L ++ + C +RP M VV+ L
Sbjct: 254 GLL------KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 448 G 448
G
Sbjct: 308 G 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-112
Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 32/313 (10%)
Query: 150 YRALSSQFKRFSYAELKKATNSFKEE--------LGKGGSGAVYKGVLTDERAVAVKRLG 201
++F FS+ ELK TN+F E +G+GG G VYKG + + VAVK+L
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 202 DL-----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256
+ + ++ F E+ + K H NLV + GF ++G LVY Y+ N SL L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 257 SN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313
+ L W R K+A G A G+ +LH IH D+K NILLD F KI+DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVE 373
+ S++ + + SRI GT YMAPE IT K D++S+GVV+LE++ G+ V+
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLP----AVD 235
Query: 374 DSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDR 433
+ + L E + EE IE+ +D ++ + ++ + C+ E +
Sbjct: 236 EHREPQL-LLDIKEE-----IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288
Query: 434 NKRPTMDSVVQTL 446
NKRP + V Q L
Sbjct: 289 NKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-106
Identities = 100/319 (31%), Positives = 154/319 (48%), Gaps = 19/319 (5%)
Query: 138 RRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEE--LGKGGSGAVYKGVLTDERAV 195
+ + + + R +L++ATN+F + +G G G VYKGVL D V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 196 AVKRL-GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL 254
A+KR + QG E F E+ T+ H +LV + GFC E +L+Y+Y+EN +L +HL
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 255 FSSNF----LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
+ S+ + W++R ++ +G A+GL YLH +IH DVK NILLD F PKI DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370
G++K + + ++GT GY+ PE+ +T K DV+S+GVV+ E+L
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS---- 239
Query: 371 VVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVD 430
+ S E+ E ++E+IVDP L + C+
Sbjct: 240 AIVQS--LPREMVNLAEWAVE---SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 431 EDRNKRPTMDSVVQTLLGC 449
RP+M V+ L
Sbjct: 295 LSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 6e-73
Identities = 73/306 (23%), Positives = 126/306 (41%), Gaps = 25/306 (8%)
Query: 160 FSYAELKKATNSFK--EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTI 217
L + + E +G G V+K L +E VAVK + EV ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEYEVYSL 72
Query: 218 GKIYHMNLVRMWGFCTEG----MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA 273
+ H N+++ G G + L+ + E SL L +N + W E +A A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMA 131
Query: 274 KGLAYLHHECLEW-------VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326
+GLAYLH + + H D+K +N+LL + IADFGLA + G ++
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 327 RIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAE 381
GT+ YMAPE ++D+++ G+V+ E+ ++ V++ E
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 382 LTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQA-ATLFRIGISCVDEDRNKRPTMD 440
G +++ E + + P L+ ++ K+ A L C D D R +
Sbjct: 252 EIGQHPSLEDMQ----EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 441 SVVQTL 446
V + +
Sbjct: 308 CVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-56
Identities = 80/335 (23%), Positives = 129/335 (38%), Gaps = 40/335 (11%)
Query: 160 FSYAELKKATNSFK--EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTI 217
+ +E ++ K E +G+G GAVYKG L DER VAVK ++ + + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61
Query: 218 GKIYHMNLVRMWGFCTEG-----MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT 272
+ H N+ R M LLV EY N SL K+L S + W ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSV 120
Query: 273 AKGLAYLHHECLEW------VIHCDVKPENILLDSEFEPKIADFGLAK------LSQRGS 320
+GLAYLH E + H D+ N+L+ ++ I+DFGL+ L + G
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 321 NSSQFSRIRGTKGYMAPE-------WASNLPITSKVDVFSYGVVILEMLKG--IRLSNWV 371
+ GT YMAPE +VD+++ G++ E+
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 372 VEDSEGQEAELTGFIREVKE--KILCGEEARIEEIVDPRLKGHFNKNQAA--TLFRIGIS 427
V + + G ++ ++ E+ R P+ + +N A +L
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQR------PKFPEAWKENSLAVRSLKETIED 294
Query: 428 CVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTIPD 462
C D+D R T + + E P
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 69/291 (23%), Positives = 130/291 (44%), Gaps = 45/291 (15%)
Query: 162 YAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY 221
Y E++ +E +G+G G V K + VA+K++ + + F E+ + ++
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWRAK-DVAIKQIESESERKA-FIVELRQLSRVN 59
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAY 278
H N+V+++G C + LV EY E SL L + + L ++G+AY
Sbjct: 60 HPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 279 LHHECLEWVIHCDVKPENILLDSEFE-PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
LH + +IH D+KP N+LL + KI DFG A Q + + +G+ +MAP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----THMTNNKGSAAWMAP 172
Query: 338 EWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILC 395
E + K DVFS+G+++ E++ ++ E+ G + +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVI-------------TRRKPFDEIGGPAFRIMWAVHN 219
Query: 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G + + + ++ +L C +D ++RP+M+ +V+ +
Sbjct: 220 GTRPPLIKNLPKPIE---------SLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 58/313 (18%)
Query: 154 SSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV--- 209
S+ + E++ +++++GKGG G V+KG + D+ VA+K L E
Sbjct: 10 KSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 210 -----FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWK 263
F EV + + H N+V+++G +V E+V L L ++ + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 264 ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE-----PKIADFGLAKLSQR 318
+ ++ L A G+ Y+ + ++H D++ NI L S E K+ADFGL++ S
Sbjct: 123 VKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 319 GSNSSQFSRIRGTKGYMAPE--WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
+ G +MAPE A T K D +S+ +++ +L
Sbjct: 182 SVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL-------------T 223
Query: 377 GQE--AELTGF-IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDR 433
G+ E + I+ + G I E PRL+ + C D
Sbjct: 224 GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR------------NVIELCWSGDP 271
Query: 434 NKRPTMDSVVQTL 446
KRP +V+ L
Sbjct: 272 KKRPHFSYIVKEL 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
KE++G G G V++ VAVK L + E F EV+ + ++ H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNF---LGWKERFKVALGTAKGLAYLHHECLE 285
G T+ + +V EY+ SL + L S L + R +A AKG+ YLH+
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
++H ++K N+L+D ++ K+ DFGL++L SS+ GT +MAPE + P
Sbjct: 160 -IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVLRDEPS 216
Query: 346 TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGF--IREVKEKILCGEEARI 401
K DV+S+GV++ E+ Q+ L + V K + I
Sbjct: 217 NEKSDVYSFGVILWELA-------------TLQQPWGNLNPAQVVAAVGFK---CKRLEI 260
Query: 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
++P++ A + C + KRP+ +++ L
Sbjct: 261 PRNLNPQV---------AAIIE---GCWTNEPWKRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRL-----GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+E +G GG G VY+ + VAVK D+ Q E E + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ G C + + LV E+ L++ L S + A+ A+G+ YLH E +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 287 VIHCDVKPENILLDSEFEP--------KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
+IH D+K NIL+ + E KI DFGLA+ R + S G +MAPE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMAPE 184
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
+ DV+SYGV++ E+L G
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTG 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-49
Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
+ +G G G VYKG + VAVK L + F EV + K H+N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWV 287
G+ T +V ++ E SL HL +S K+ +A TA+G+ YLH + +
Sbjct: 86 MGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE---WASNLP 344
IH D+K NI L + KI DFGLA R S S QF ++ G+ +MAPE + P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 345 ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404
+ + DV+++G+V+ E++ G + ++ I V L + +++
Sbjct: 202 YSFQSDVYAFGIVLYELMTG----QLPYSNINNRDQ----IIEMVGRGSLSPDLSKVRSN 253
Query: 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+K R+ C+ + R++RP+ ++ +
Sbjct: 254 CPKRMK------------RLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-48
Identities = 69/308 (22%), Positives = 113/308 (36%), Gaps = 37/308 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+++GKG G V+ G E+ VAVK + E+ + H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 232 CTEGMHR----LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW- 286
+G L+ +Y EN SL +L S L K K+A + GL +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 287 ----VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI--RGTKGYMAPE-- 338
+ H D+K +NIL+ IAD GLA +N GTK YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 339 ----WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVE------DSEGQEAELTGFIRE 388
++ D++S+G+++ E+ + V E D +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI-SCVDEDRNKRPTMDSVVQTLL 447
V C ++ R P ++ ++ + C + R T V +TL
Sbjct: 279 V-----CIKKLR------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 448 GCEAESEV 455
++
Sbjct: 328 KMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-47
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 37/299 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
E +GKG G V++G E VAVK + E+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 232 CTEGMHR----LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW- 286
H L+ Y E SL +L L ++ L A GLA+LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 287 ----VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI--RGTKGYMAPE-- 338
+ H D+K +NIL+ + IAD GLA + + +N GTK YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 339 ----WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVV------EDSEGQEAELTGFIRE 388
+VD++++G+V+ E+ + + + V D + +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI-SCVDEDRNKRPTMDSVVQTL 446
V C ++ R P + + + T + C ++ + R T + +TL
Sbjct: 250 V-----CVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 29/295 (9%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+E +GKG G V++G E VAVK + AE+ + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 232 CT----EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW- 286
LV +Y E+ SL +L + + + K+AL TA GLA+LH E +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 287 ----VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI--RGTKGYMAPE-- 338
+ H D+K +NIL+ IAD GLA +++ + GTK YMAPE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 339 ----WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE--K 392
+ + D+++ G+V E+ + + ED + +L V+E K
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCS-IGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI-SCVDEDRNKRPTMDSVVQTL 446
++C ++ R P + + +A + + C + R T + +TL
Sbjct: 283 VVCEQKLR------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 67/292 (22%), Positives = 106/292 (36%), Gaps = 45/292 (15%)
Query: 172 FKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVR 227
E LGKG G K + +K L + EE F EV + + H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEW 286
G + + EY++ +L + S + W +R A A G+AYLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR------------IRGTKGY 334
+IH D+ N L+ +ADFGLA+L + R + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394
MAPE + KVDVFS+G+V+ E++ + + + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-----------DYLPRTMDFGLNVR 237
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ P F I + C D D KRP+ + L
Sbjct: 238 GFLDRYCPPNCPPS------------FFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 60/299 (20%), Positives = 105/299 (35%), Gaps = 62/299 (20%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
E +GKG G VY G E VA++ + E+ F EV + H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWV 287
G C H ++ + ++L + + L + ++A KG+ YLH + +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPE------ 338
+H D+K +N+ D + I DFGL +S + ++R G ++APE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 339 ---WASNLPITSKVDVFSYGVVILEML------KGIRLSN--WVVEDSEGQEAELTGFIR 387
LP + DVF+ G + E+ K W +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL------- 263
Query: 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + + I + C ++ +RPT ++ L
Sbjct: 264 -------------SQIGMGKEIS------------DILLFCWAFEQEERPTFTKLMDML 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 57/290 (19%), Positives = 106/290 (36%), Gaps = 51/290 (17%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVR 227
+F +L + SG ++KG + VK L F E + H N++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 228 MWGFCTE--GMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLHHEC 283
+ G C H L+ ++ SL L + + K AL A+G+A+LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
+ + ++++D + +I+ + Q ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQKK 183
Query: 344 P---ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGEE 398
P D++S+ V++ E++ + A+L+ E+ K+ E
Sbjct: 184 PEDTNRRSADMWSFAVLLWELV-------------TREVPFADLSNM--EIGMKVAL-EG 227
Query: 399 AR--IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R I + P + + L + C++ED KRP D +V L
Sbjct: 228 LRPTIPPGISPHV---------SKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 43/293 (14%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRL--GDLHQGEEVFWAEVSTIGKI 220
L E++G+G G V+ G L D VAVK + F E + +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYL 279
H N+VR+ G CT+ +V E V+ L + L K ++ A G+ YL
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY----M 335
+C IH D+ N L+ + KI+DFG+++ G ++ G +
Sbjct: 230 ESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWT 282
Query: 336 APEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKI 393
APE + +S+ DV+S+G+++ E S G L+ ++ +E +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETF------------SLGASPYPNLSN--QQTREFV 328
Query: 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G RL + +FR+ C + +RP+ ++ Q L
Sbjct: 329 EKGG----------RLP--CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 47/308 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + +++LG G G V+ VAVK + E F AE + + + H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHH 281
LV++ T+ ++ E++ SL L S + + + A+G+A++
Sbjct: 244 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG---YMAPE 338
IH D++ NIL+ + KIADFGLA R ++++ G K + APE
Sbjct: 303 RN---YIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPE 355
Query: 339 WASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVKEKI 393
+ T K DV+S+G++++E++ G +SN EV +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------------PEVIRAL 398
Query: 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453
G R+ P N L+ I + C +RPT + + L +
Sbjct: 399 ERGY--RMPR---PE-------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
Query: 454 EVPVQTIP 461
E + IP
Sbjct: 447 ESQYEEIP 454
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVRM 228
++LG GG VY VA+K + + +E EV ++ H N+V M
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
E LV EY+E +L +++ S L G+ + H ++
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
H D+KP+NIL+DS KI DFG+AK + ++ +Q + + GT Y +PE A
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 349 VDVFSYGVVILEMLKG 364
D++S G+V+ EML G
Sbjct: 193 TDIYSIGIVLYEMLVG 208
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 172 FKEELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVR 227
F E+G+G VYKG+ T+ VA L D + F E + + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 228 ---MWGFCTEGMHRLLVY-EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
W +G +++ E + + +L +L + K KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 284 LEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
+IH D+K +NI + KI D GLA L + + + GT +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
VDV+++G+ +LEM
Sbjct: 205 -KYDESVDVYAFGMCMLEMATS 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 37/288 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + + +LG+G G V+ G VA+K L E F E + K+ H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHH 281
LV+++ +E +V EY+ SL L +L + +A A G+AY+
Sbjct: 240 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
+H D++ NIL+ K+ADFGLA R ++++ +G K + APE
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLA----RLIEDNEYTARQGAKFPIKWTAPE 351
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398
A T K DV+S+G+++ E+ R+ + + REV +++ G
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGY- 398
Query: 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+ P +L + C ++ +RPT + + L
Sbjct: 399 -RMPC---PP-------ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 45/292 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
ELK+ + +ELG G G V G + VAVK + + E+ F+ E T+ K+ H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHE 282
LV+ +G C++ +V EY+ N L +L S L + ++ +G+A+L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEW 339
IH D+ N L+D + K++DFG+ R Q+ GTK + APE
Sbjct: 124 Q---FIHRDLAARNCLVDRDLCVKVSDFGMT----RYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 340 ASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVKEKIL 394
+SK DV+++G+++ E+ G +N EV K+
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------------SEVVLKVS 219
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G R+ P + T+++I SC E KRPT ++ ++
Sbjct: 220 QGH--RLYR---PH-------LASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 37/288 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + + + +LG+G G V+ G VA+K L E F E + K+ H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHH 281
LV+++ +E +V EY+ SL L +L + +A A G+AY+
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
+H D++ NIL+ K+ADFGLA R ++++ +G K + APE
Sbjct: 382 MN---YVHRDLRAANILVGENLVCKVADFGLA----RLIEDNEYTARQGAKFPIKWTAPE 434
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398
A T K DV+S+G+++ E+ R+ + + REV +++ G
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGY- 481
Query: 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+ P +L + C ++ +RPT + + L
Sbjct: 482 -RMPC---PP-------ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 20/237 (8%)
Query: 138 RRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFK--EELGKGGSGAVYKGV-LTDERA 194
+ Q + ED L ++ + E ++ + +G+G G V++
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 195 VAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL 254
AVK++ L E+ + +V ++G EG + E +E SL + +
Sbjct: 86 CAVKKV-RLEVFRV---EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141
Query: 255 FSSNFLGWKERFKVALGTA---KGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADF 310
E +GL YLH ++H DVK +N+LL S+ + DF
Sbjct: 142 --KQMGCLPEDR-ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 311 GLAK-LSQRGSNSSQFSR--IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
G A L G S + I GT+ +MAPE P +KVD++S ++L ML G
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVRM 228
E LG GG V+ L D R VAVK L + F+ E + H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 229 --WGFCTEGMHRL--LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECL 284
G L +V EYV+ +L + + + K +V + L + H +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
IH DVKP NI++ + K+ DFG+A+ ++ G++ +Q + + GT Y++PE A
Sbjct: 138 ---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 344 PITSKVDVFSYGVVILEMLKG 364
+ ++ DV+S G V+ E+L G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTG 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 37/289 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH 222
E+++ + K +LG G G VY+GV VAVK L + E F E + + +I H
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLH 280
NLV++ G CT ++ E++ +L +L N + +A + + YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAP 337
+ IH ++ N L+ K+ADFGL+ R ++ G K + AP
Sbjct: 336 KKN---FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAP 388
Query: 338 EWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397
E + + K DV+++GV++ E+ ++ +V E +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYELLEKDY 436
Query: 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+E P ++ + +C + + RP+ + Q
Sbjct: 437 --RMER---PE-------GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 13/198 (6%)
Query: 174 EELGKGGSGAVYKGVLTD---ERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLV 226
+G+GG G VY+ D ER VA+K + + + VF E T G++ ++V
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ F + + L L L + L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA-- 155
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
H DVKPENIL+ ++ + DFG+A + +Q GT YMAPE S T
Sbjct: 156 -THRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 347 SKVDVFSYGVVILEMLKG 364
+ D+++ V+ E L G
Sbjct: 214 YRADIYALTCVLYECLTG 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-30
Identities = 63/292 (21%), Positives = 120/292 (41%), Gaps = 45/292 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ +F +ELG G G V G + VA+K + + E+ F E + + H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHE 282
LV+++G CT+ ++ EY+ N L +L + ++ ++ + + YL +
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEW 339
+H D+ N L++ + K++DFGL+ R +++ G+K + PE
Sbjct: 140 Q---FLHRDLAARNCLVNDQGVVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 340 ASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVKEKIL 394
+SK D++++GV++ E+ G +N E E I
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIA 235
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G R+ P + ++ I SC E ++RPT ++ +
Sbjct: 236 QGL--RLYR---PH-------LASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 39/289 (13%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
+ + +F +E+G G G V+ G ++ VA+K + + EE F E + K+ H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHE 282
LV+++G C E LV E++E+ L +L + + + L +G+AYL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEW 339
C VIH D+ N L+ K++DFG+ R Q++ GTK + +PE
Sbjct: 124 C---VIHRDLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGE 397
S +SK DV+S+GV++ E+ SEG+ + EV E I G
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVF------------SEGKIPYENRSN--SEVVEDISTGF 222
Query: 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
R+ + PR + +++I C E RP +++ L
Sbjct: 223 --RLYK---PR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 79/320 (24%), Positives = 139/320 (43%), Gaps = 55/320 (17%)
Query: 143 PSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTD-----ERAVAV 197
+ D +A+ E+ + + ++ +G G G VYKG+L E VA+
Sbjct: 24 GAMGSDPNQAVLKFTT-----EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78
Query: 198 KRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF 255
K L G + F E +G+ H N++R+ G ++ +++ EY+EN +LDK L
Sbjct: 79 KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 256 SSNF-LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
+ + + G A G+ YL + +H D+ NIL++S K++DFGL++
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 315 LSQRGSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEML-KGIR---- 366
+ + + G K + APE S TS DV+S+G+V+ E++ G R
Sbjct: 196 VLE--DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
Query: 367 LSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI 426
LSN EV + I G R+ P + + ++++ +
Sbjct: 254 LSN-----------------HEVMKAINDGF--RLPT---PM-------DCPSAIYQLMM 284
Query: 427 SCVDEDRNKRPTMDSVVQTL 446
C ++R +RP +V L
Sbjct: 285 QCWQQERARRPKFADIVSIL 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMW 229
K+ LG G G + + D R VAVKR+ L + EV + + H N++R +
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+ + + E + E + T GLA+LH ++H
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVH 141
Query: 290 CDVKPENILL-----DSEFEPKIADFGLAKLSQRGSNS-SQFSRIRGTKGYMAPE---WA 340
D+KP NIL+ + + I+DFGL K G +S S+ S + GT+G++APE
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 341 SNLPITSKVDVFSYGVVILEML 362
T VD+FS G V ++
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVI 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-29
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC 232
LGKG G VY G L+++ +A+K D + + E++ + H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGSF 88
Query: 233 TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA---KGLAYLHHECLEWVIH 289
+E + E V SL L S + T +GL YLH ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 290 CDVKPENILLDSEF-EPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPE--WASNLPI 345
D+K +N+L+++ KI+DFG +K L+ + F GT YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPRGY 202
Query: 346 TSKVDVFSYGVVILEMLKG 364
D++S G I+EM G
Sbjct: 203 GKAADIWSLGCTIIEMATG 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 47/293 (16%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
E+ + T E LG G G V+ G VAVK L + F AE + + ++ H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHH 281
LVR++ T+ ++ EY+EN SL L + + L + +A A+G+A++
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPE 338
IH D++ NIL+ KIADFGLA R ++++ G K + APE
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAPE 180
Query: 339 WASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVKEKI 393
+ T K DV+S+G+++ E++ G ++N EV + +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------------PEVIQNL 223
Query: 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G R+ P N L+++ C E RPT D + L
Sbjct: 224 ERGY--RMVR---P-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 85/319 (26%), Positives = 139/319 (43%), Gaps = 54/319 (16%)
Query: 143 PSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLT----DERAVAVK 198
P + ED + + +F + EL S + +G G G V G L E +VA+K
Sbjct: 25 PHTFEDPTQTVH-EFAK----ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 199 RL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256
L G + F E S +G+ H N++R+ G T+ ++V EY+EN SLD L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 257 -SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315
+ + G A G+ YL +H D+ NIL++S K++DFGL ++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 316 SQRGSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEML-KGIR----L 367
+ + RG K + +PE + TS DV+SYG+V+ E++ G R +
Sbjct: 197 LE--DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
Query: 368 SNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGIS 427
SN ++V + + G R+ P + A L+++ +
Sbjct: 255 SN-----------------QDVIKAVDEGY--RLPP---PM-------DCPAALYQLMLD 285
Query: 428 CVDEDRNKRPTMDSVVQTL 446
C +DRN RP + +V L
Sbjct: 286 CWQKDRNNRPKFEQIVSIL 304
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 81/324 (25%), Positives = 139/324 (42%), Gaps = 54/324 (16%)
Query: 138 RRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLT----DER 193
+ P + E+ RA S + + + ++ +G G SG V G L +
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIH-----IEKIIGSGDSGEVCYGRLRVPGQRDV 78
Query: 194 AVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251
VA+K L G + F +E S +G+ H N++R+ G T G ++V EY+EN SLD
Sbjct: 79 PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 252 KHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310
L + + + + G G+ YL +H D+ N+L+DS K++DF
Sbjct: 139 TFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDF 195
Query: 311 GLAKLSQRGSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEML-KGIR 366
GL+++ + +++ + G K + APE + +S DV+S+GVV+ E+L G R
Sbjct: 196 GLSRVLEDDPDAAYTT--TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
Query: 367 ----LSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLF 422
++N R+V + G R+ P L
Sbjct: 254 PYWNMTN-----------------RDVISSVEEGY--RLPA---PM-------GCPHALH 284
Query: 423 RIGISCVDEDRNKRPTMDSVVQTL 446
++ + C +DR +RP +V L
Sbjct: 285 QLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 49/292 (16%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRL-GDLHQGEEVFWAEVSTIGKIYH 222
L + +GKG G V G + VAVK + D + F AE S + ++ H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRH 245
Query: 223 MNLVRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYL 279
NLV++ G E L +V EY+ SL +L S LG K +L + + YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
+H D+ N+L+ + K++DFGL K + ++ + ++ + APE
Sbjct: 306 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VK----WTAPEA 357
Query: 340 ASNLPITSKVDVFSYGVVILEML-KGI----RLSNWVVEDSEGQEAELTGFIREVKEKIL 394
++K DV+S+G+++ E+ G R+ ++V ++
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVE 400
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
G +++ P ++ + +C D RPT + + L
Sbjct: 401 KGY--KMDA---PD-------GCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
LG+G G V K D R A+K++ + +EV + + H +VR +
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 231 FCTEGMHRL-------------LVYEYVENQSLDKHLFSSNFLGWKER----FKVALGTA 273
E + + + EY EN +L + S N ++ F+ L
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL--- 126
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---- 329
+ L+Y+H + +IH D+KP NI +D KI DFGLAK R + +
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 330 --------GTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
GT Y+A E K+D++S G++ EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC 232
E +G GG G V+K D + +KR+ E EV + K+ H+N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 233 TEGMHRL----------------LVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAK 274
+ + E+ + +L++ + + ++ K
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ Y+H + +I+ D+KP NI L + KI DFGL N + +R +GT Y
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRY 187
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIR 366
M+PE S+ +VD+++ G+++ E+L
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 60/305 (19%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD--------ERAVAVKRL--GDLHQGEEVFWAE 213
+++ F E LG+G ++KGV + E V +K L + E F+
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-FFEA 62
Query: 214 VSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGT 272
S + K+ H +LV +G C G +LV E+V+ SLD +L + N + + +VA
Sbjct: 63 ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 273 AKGLAYLHHECLEWVIHCDVKPENILLDSEFEP--------KIADFGLAKLSQRGSNSSQ 324
A + +L L IH +V +NILL E + K++D G++
Sbjct: 123 AAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--PKDIL 177
Query: 325 FSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AE 381
RI ++ PE N D +S+G + E+ S G + +
Sbjct: 178 QERIP----WVPPECIENPKNLNLATDKWSFGTTLWEIC------------SGGDKPLSA 221
Query: 382 LTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDS 441
L + + +L +AA L + +C+D + + RP+ +
Sbjct: 222 LDS--QRKLQFYEDRH----------QLP----APKAAELANLINNCMDYEPDHRPSFRA 265
Query: 442 VVQTL 446
+++ L
Sbjct: 266 IIRDL 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 70/315 (22%), Positives = 116/315 (36%), Gaps = 58/315 (18%)
Query: 147 EDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDER-----AVAVKRL- 200
E +AL K E K + LG G G VYKG+ E VA+K L
Sbjct: 2 EAPNQALLRILKE---TEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 201 -GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-N 258
+ + E + + + ++ R+ G C L+ + + L ++ +
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 259 FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
+G + + AKG+ YL L +H D+ N+L+ + KI DFGLAKL
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLG- 168
Query: 319 GSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDS 375
+ G K +MA E + T + DV+SYGV + E++ +
Sbjct: 169 --AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM------------T 214
Query: 376 EGQE--AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAAT--LFRIGISCVDE 431
G + + E+ + GE RL + T ++ I C
Sbjct: 215 FGSKPYDGIPA--SEISSILEKGE----------RLP----QPPICTIDVYMIMRKCWMI 258
Query: 432 DRNKRPTMDSVVQTL 446
D + RP ++
Sbjct: 259 DADSRPKFRELIIEF 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
+ GG G +Y + + R V +K L GD + + + AE + ++ H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 229 WGFCTEGMHRL-----LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
+ F +V EYV QSL + L E L L+YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSIG 202
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASN 342
L ++ D+KPENI+L E + K+ D G ++ G + GT G+ APE
Sbjct: 203 L---VYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGFQAPEIVRT 251
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
P T D+++ G + +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLD 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+ LG+GG G V++ D+ A+K RL + E EV + K+ H +VR +
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 231 FCTEG---------MHRLLVY---EYVENQSLDKHLFSSNFLGWKER---FKVALGTAKG 275
E ++ +Y + ++L + + +ER + L A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR------ 329
+ +LH + ++H D+KP NI + K+ DFGL +
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 330 ----GTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
GTK YM+PE + KVD+FS G+++ E+L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 70/244 (28%), Positives = 90/244 (36%), Gaps = 36/244 (14%)
Query: 138 RRQGIPSSLEDGYRALSSQFKRF--SYAELKKATNSFKEELGKGGSGAVYKGV-LTDERA 194
R +L+ S F S+ L + LG G G V+K D R
Sbjct: 33 FRGEASETLQSPGYDPSRPESFFQQSFQRLSR--------LGHGSYGEVFKVRSKEDGRL 84
Query: 195 VAVKRLGDLHQGE---EVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSL 250
AVKR +G AEV + K+ H VR+ EG L E SL
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSL 143
Query: 251 DKHLFSSNFLGWKERF------KVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304
+H W T LA+LH + ++H DVKP NI L
Sbjct: 144 QQHC-----EAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGR 195
Query: 305 PKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK 363
K+ DFGL L G+ Q G YMAPE + DVFS G+ ILE+
Sbjct: 196 CKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC 250
Query: 364 GIRL 367
+ L
Sbjct: 251 NMEL 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 72/283 (25%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 175 ELGKGGSGAVYKGVLTDERA---VAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
ELG G G V KG ++ VAVK L + ++ AE + + ++ + +VRM
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G C +LV E E L+K+L + + K ++ + G+ YL +
Sbjct: 84 IGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF---V 139
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWASNLPI 345
H D+ N+LL ++ KI+DFGL+K + N + K + APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECINYYKF 197
Query: 346 TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGEEARIEE 403
+SK DV+S+GV++ E S GQ+ + G EV + GE R+
Sbjct: 198 SSKSDVWSFGVLMWEAF------------SYGQKPYRGMKG--SEVTAMLEKGE--RMGC 241
Query: 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
P ++ + C D RP +V L
Sbjct: 242 ---PA-------GCPREMYDLMNLCWTYDVENRPGFAAVELRL 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 46/295 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERA----VAVKRL--GDLHQGEEVFWAEVSTI 217
+ + LG+G G VY+GV T+ + VAVK +E F +E +
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGL 276
+ H ++V++ G E ++ E L +L + N L +L K +
Sbjct: 68 KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---G 333
AYL +H D+ NIL+ S K+ DFGL+ R + + T+
Sbjct: 127 AYLESINC---VHRDIAVRNILVASPECVKLGDFGLS----RYIEDEDYYKASVTRLPIK 179
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKE 391
+M+PE + T+ DV+ + V + E+L S G++ L ++V
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEIL------------SFGKQPFFWLEN--KDVIG 225
Query: 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ G+ R+ + P L+ + C D D + RP +V +L
Sbjct: 226 VLEKGD--RLPK---PD-------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 60/322 (18%), Positives = 114/322 (35%), Gaps = 48/322 (14%)
Query: 137 FRRQGIPSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVA 196
F RQ + S + +K S +++G GGS V++ + ++ A
Sbjct: 25 FERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYA 84
Query: 197 VKR--LGDLHQGE-EVFWAEVSTIGKIYHMNL--VRMWGFCTEGMHRLLVYEYVENQSLD 251
+K L + + + E++ + K+ + +R++ + + +V E L+
Sbjct: 85 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLN 143
Query: 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311
L + ER + + +H ++H D+KP N L+ K+ DFG
Sbjct: 144 SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFG 199
Query: 312 LAKLSQRGSNSSQFSRIRGTKGYMAPE-----------WASNLPITSKVDVFSYGVVILE 360
+A Q + S G YM PE S I+ K DV+S G ++
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 361 MLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQA 418
M G+ ++ I ++ I E +I + L+ K
Sbjct: 260 MT-------------YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-DVLKC-- 303
Query: 419 ATLFRIGISCVDEDRNKRPTMD 440
C+ D +R ++
Sbjct: 304 ---------CLKRDPKQRISIP 316
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWG 230
++ LG G SG V R VAVKR+ L ++ E+ + + H N++R +
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 231 FCTEGMHRLLVYEYVENQSLD-----KHLFSSNFLGWKER--FKVALGTAKGLAYLHHEC 283
T + E +L K++ N KE + A G+A+LH
Sbjct: 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 284 LEWVIHCDVKPENILLDSEFEP-------------KIADFGLAKL--SQRGSNSSQFSRI 328
+IH D+KP+NIL+ + I+DFGL K S + S + +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 329 RGTKGYMAPE-------WASNLPITSKVDVFSYGVVILEML 362
GT G+ APE + +T +D+FS G V +L
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/286 (25%), Positives = 115/286 (40%), Gaps = 45/286 (15%)
Query: 173 KEELGKGGSGAVYKGVLT---DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
ELG G G+V +GV + VA+K L G E E + ++ + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ G C +LV E L K L + ++ + G+ YL +
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 131
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAPEWASNL 343
+H D+ N+LL + KI+DFGL+K G++ S ++ K + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKAL--GADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 344 PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILCGEEARI 401
+S+ DV+SYGV + E L S GQ+ ++ G EV I G+ R+
Sbjct: 189 KFSSRSDVWSYGVTMWEAL------------SYGQKPYKKMKG--PEVMAFIEQGK--RM 232
Query: 402 EEIVD-PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
E + P L+ + C RP +V Q +
Sbjct: 233 ECPPECP-----------PELYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 66/313 (21%), Positives = 125/313 (39%), Gaps = 37/313 (11%)
Query: 153 LSSQFKRFSYA---ELKKATNSFKEELGKGGSGAVYKGVLT-----DERAVAVKRLGDLH 204
+ S+ K + +K +LG+G G V VAVK L
Sbjct: 3 IVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 205 QGEEV--FWAEVSTIGKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSLDKHLFSS-NF 259
G + E+ + +YH N+V+ G CTE L+ E++ + SL ++L + N
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 260 LGWKERFKVALGTAKGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
+ K++ K A+ KG+ YL + +H D+ N+L++SE + KI DFGL K +
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIE- 177
Query: 319 GSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEML-KGIRLSNWVVED 374
++ ++ + APE DV+S+GV + E+L S+ +
Sbjct: 178 -TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
Query: 375 SEGQEAELTGFI-REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDR 433
+ + + G+ R+ P N ++++ C +
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLKEGK--RLPC---PP-------NCPDEVYQLMRKCWEFQP 284
Query: 434 NKRPTMDSVVQTL 446
+ R + ++++
Sbjct: 285 SNRTSFQNLIEGF 297
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH 222
E+++ + K +LG G G VY+GV VAVK L + E F E + + +I H
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLH 280
NLV++ G CT ++ E++ +L +L N + +A + + YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---GYMAP 337
+ IH D+ N L+ K+ADFGL+ R ++ G K + AP
Sbjct: 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAP 181
Query: 338 EWASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVKEK 392
E + + K DV+++GV++ E+ G+ + +V E
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYEL 224
Query: 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ R+E P + ++ + +C + + RP+ + Q
Sbjct: 225 LEKDY--RMER---P-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKR--LGDLHQGE-EVFWAEVSTIGKIYHMNL--VRM 228
+++G GGS V++ + ++ A+K L + + + E++ + K+ + +R+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + + +V E L+ L + ER + + +H ++
Sbjct: 94 YDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IV 149
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE---------- 338
H D+KP N L+ K+ DFG+A Q + S GT YM PE
Sbjct: 150 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 339 -WASNLPITSKVDVFSYGVVILEMLKG 364
S I+ K DV+S G ++ M G
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYG 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKR--LGDLHQGE-EVFWAEVSTIGKIYHMNL--VRM 228
+++G GGS V++ + ++ A+K L + + + E++ + K+ + +R+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + + +V E L+ L + ER + + +H ++
Sbjct: 75 YDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IV 130
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE---------- 338
H D+KP N L+ K+ DFG+A Q + S GT YM PE
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 339 -WASNLPITSKVDVFSYGVVILEMLKG 364
S I+ K DV+S G ++ M G
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGEEVFWA--EVSTIGKIYHMNLVRM 228
+++G+G VY+ L D VA+K ++ DL + E+ + ++ H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHL--FSSNFLGWKERF--KVALGTAKGLAYLHHECL 284
+ E +V E + L + + F ER K + L ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
V+H D+KP N+ + + K+ D GL + S ++ + GT YM+PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 345 ITSKVDVFSYGVVILEMLKG 364
K D++S G ++ EM
Sbjct: 213 YNFKSDIWSLGCLLYEMAAL 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 72/304 (23%), Positives = 118/304 (38%), Gaps = 45/304 (14%)
Query: 155 SQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERA---VAVKRL--GDLHQGEEV 209
+ K + ELG G G+V +GV + VA+K L G E
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKV 268
E + ++ + +VR+ G C +LV E L K L + ++
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 269 ALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328
+ G+ YL + +H ++ N+LL + KI+DFGL+K G++ S ++
Sbjct: 442 LHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKAL--GADDSYYTAR 496
Query: 329 RGTK---GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELT 383
K + APE + +S+ DV+SYGV + E L S GQ+ ++
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL------------SYGQKPYKKMK 544
Query: 384 GFIREVKEKILCGEEARIEEIVD-PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSV 442
G EV I G+ R+E + P L+ + C RP +V
Sbjct: 545 G--PEVMAFIEQGK--RMECPPECP-----------PELYALMSDCWIYKWEDRPDFLTV 589
Query: 443 VQTL 446
Q +
Sbjct: 590 EQRM 593
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 69/308 (22%), Positives = 112/308 (36%), Gaps = 54/308 (17%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLHQGEEV--FWAEVST 216
K +LG+G G V VAVK L + + E+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 217 IGKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK 274
+ +YH ++++ G C + LV EYV SL +L + +G + A +
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICE 145
Query: 275 GLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
G+AYLH IH D+ N+LLD++ KI DFGLAK +
Sbjct: 146 GMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKA------------VPEGHE 189
Query: 334 Y-------------MAPEWASNLPITSKVDVFSYGVVILEML-KGIRLSNWVVEDSEGQE 379
Y APE DV+S+GV + E+L + + E
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 380 AELTGFI-REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438
+ E + GE R+ P A ++ + +C + + + RPT
Sbjct: 250 IAQGQMTVLRLTELLERGE--RLPR---P-------DKCPAEVYHLMKNCWETEASFRPT 297
Query: 439 MDSVVQTL 446
++++ L
Sbjct: 298 FENLIPIL 305
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 38/301 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLT-----DERAVAVKRL--GDLHQGEEVFWAEVST 216
+ ++ F ++LGKG G+V VAVK+L + F E+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEI 64
Query: 217 IGKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTA 273
+ + H N+V+ G C R L+ EY+ SL +L + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
KG+ YL + IH D+ NIL+++E KI DFGL K+ + F +
Sbjct: 125 KGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEFFKVKEPGES 179
Query: 334 ---YMAPEWASNLPITSKVDVFSYGVVILEML---KGIRLSNWVVEDSEGQE--AELTGF 385
+ APE + + DV+S+GVV+ E+ + + G + ++
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV- 238
Query: 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445
+ E + R+ P ++ I C + + N+RP+ +
Sbjct: 239 -FHLIELLKNNG--RLPR---P-------DGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 446 L 446
+
Sbjct: 286 V 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE--EVFWAEVSTIGKIYHMNLVRMWG 230
E++G+G SG VY + + + VA++++ +L Q E+ E+ + + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
G +V EY+ SL + + + + V + L +LH VIH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 291 DVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K +NILL + K+ DFG A+++ S S GT +MAPE + KV
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKV 197
Query: 350 DVFSYGVVILEMLKG 364
D++S G++ +EM++G
Sbjct: 198 DIWSLGIMAIEMIEG 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM 223
L + +GKG G V G + VAVK + + + F AE S + ++ H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA-FLAEASVMTQLRHS 74
Query: 224 NLVRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLH 280
NLV++ G E L +V EY+ SL +L S LG K +L + + YL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
+H D+ N+L+ + K++DFGL K + ++ + ++ + APE
Sbjct: 135 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VK----WTAPEAL 186
Query: 341 SNLPITSKVDVFSYGVVILEML 362
++K DV+S+G+++ E+
Sbjct: 187 REKKFSTKSDVWSFGILLWEIY 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 46/296 (15%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDER-----AVAVKRL--GDLHQGEEVFWAEVST 216
K+ + LG G G V+KGV E V +K + Q + +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 217 IGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKG 275
IG + H ++VR+ G C LV +Y+ SL H+ LG + + AKG
Sbjct: 69 IGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK--- 332
+ YL + +H ++ N+LL S + ++ADFG+A L + K
Sbjct: 128 MYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLP---PDDKQLLYSEAKTPI 181
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVK 390
+MA E T + DV+SYGV + E++ + G E A L EV
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELM------------TFGAEPYAGLRL--AEVP 227
Query: 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + GE R+ + P+ ++ + + C D N RPT +
Sbjct: 228 DLLEKGE--RLAQ---PQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 38/301 (12%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLT-----DERAVAVKRL--GDLHQGEEVFWAEVST 216
+ ++ F ++LGKG G+V VAVK+L + F E+
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEI 95
Query: 217 IGKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTA 273
+ + H N+V+ G C R L+ EY+ SL +L + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
KG+ YL + IH D+ NIL+++E KI DFGL K+ + + +
Sbjct: 156 KGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEYYKVKEPGES 210
Query: 334 ---YMAPEWASNLPITSKVDVFSYGVVILEML---KGIRLSNWVVEDSEGQE--AELTGF 385
+ APE + + DV+S+GVV+ E+ + + G + ++
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV- 269
Query: 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445
+ E + R+ P ++ I C + + N+RP+ +
Sbjct: 270 -FHLIELLKNNG--RLPR---PD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALR 316
Query: 446 L 446
+
Sbjct: 317 V 317
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 45/197 (22%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMW 229
+++G+G G D R +K + + E E EV+ + + H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECLEWV 287
E +V +Y E L K + + + ++E + L ++H +
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---I 146
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+H D+K +NI L + ++ DFG+A++ S GT Y++PE N P +
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNN 204
Query: 348 KVDVFSYGVVILEMLKG 364
K D+++ G V+ E+
Sbjct: 205 KSDIWALGCVLYELCTL 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE--EVFWAEVSTIGKIYHMNLVRMWG 230
++G+G +G V R VAVK + DL + + E+ + EV + H N+V M+
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
G ++ E+++ +L + S L ++ V + LAYLH + VIH
Sbjct: 110 SYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHR 165
Query: 291 DVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D+K ++ILL + K++DFG A++S+ GT +MAPE S ++V
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRSLYATEV 222
Query: 350 DVFSYGVVILEMLKG 364
D++S G++++EM+ G
Sbjct: 223 DIWSLGIMVIEMVDG 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 72/312 (23%), Positives = 114/312 (36%), Gaps = 61/312 (19%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRL--GDLHQGEEV--FWAEVS 215
+ + E+LG G G V +G +VAVK L L Q E + F EV+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKV------A 269
+ + H NL+R++G +V E SL L + F + A
Sbjct: 74 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYA 127
Query: 270 LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329
+ A+G+ YL + IH D+ N+LL + KI DFGL + + +
Sbjct: 128 VQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--E 182
Query: 330 GTK---GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTG 384
K + APE + D + +GV + EM + GQE L G
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF------------TYGQEPWIGLNG 230
Query: 385 FIREVKEKI-LCGEEARIEEIVDPRLKGHFNKNQAAT--LFRIGISCVDEDRNKRPTMDS 441
++ KI GE RL + + ++ + + C RPT +
Sbjct: 231 --SQILHKIDKEGE----------RLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVA 274
Query: 442 VVQTLLGCEAES 453
+ LL +
Sbjct: 275 LRDFLLEAQPTD 286
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 54/313 (17%)
Query: 147 EDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDER-----AVAVKRL- 200
E +AL K E K + LG G G VYKG+ E VA+K L
Sbjct: 2 EAPNQALLRILKE---TEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 201 -GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-N 258
+ + E + + + ++ R+ G C L+ + + L ++ +
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 259 FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318
+G + + AKG+ YL L +H D+ N+L+ + KI DFGLAKL
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLG- 168
Query: 319 GSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDS 375
+ G K +MA E + T + DV+SYGV + E++ +
Sbjct: 169 --AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM------------T 214
Query: 376 EGQE--AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDR 433
G + + E+ + GE R+ + P ++ I + C D
Sbjct: 215 FGSKPYDGIPA--SEISSILEKGE--RLPQ---P-------PICTIDVYMIMVKCWMIDA 260
Query: 434 NKRPTMDSVVQTL 446
+ RP ++
Sbjct: 261 DSRPKFRELIIEF 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 29/214 (13%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
F ++LG+GG V L D A+KR+ + EE E H N++R+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ-READMHRLFNHPNILRL 91
Query: 229 WGFC---TEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERF------KVALGTAKGLAY 278
+C H L+ + + +L + + LG +GL
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI-------RGT 331
+H + H D+KP NILL E +P + D G + S+ + R T
Sbjct: 150 IHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 332 KGYMAPE---WASNLPITSKVDVFSYGVVILEML 362
Y APE S+ I + DV+S G V+ M+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTDER-----AVAVKRLGDLH-QGEEVFWAEVSTI 217
++ + +LGKG G+V VAVK+L + F E+ +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 218 GKIYHMNLVRMWGFCTEGMHR--LLVYEYVENQSLDK-------HLFSSNFLGWKERFKV 268
++ +V+ G + LV EY+ + L L +S L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------ 132
Query: 269 ALGTAKGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327
+ KG+ YL C +H D+ NIL++SE KIADFGLAKL + +
Sbjct: 133 SSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLP--LDKDYYVV 186
Query: 328 IRGTKG---YMAPEWASNLPITSKVDVFSYGVVILEML 362
+ + APE S+ + + DV+S+GVV+ E+
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 26/249 (10%), Positives = 57/249 (22%), Gaps = 47/249 (18%)
Query: 155 SQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDE-RAVAVK----RLGDLHQGEEV 209
++ S + E L G V+ + A+K + E
Sbjct: 49 AETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108
Query: 210 FWAEVSTIGKIYHMNLVRMWGFC--------------------------TEGMHRLLVYE 243
++ + + LL+
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 244 YVE------NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297
+LD G + + A L + ++H P+N+
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNL 225
Query: 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW--ASNLPITSKVDVFSYG 355
+ + + D ++ Y E+ AS T ++ + G
Sbjct: 226 FIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 356 VVILEMLKG 364
+ I +
Sbjct: 281 LSIYRVWCL 289
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 57/296 (19%)
Query: 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMN 224
F E +G+G G VY G L D + AVK L + EV F E + H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 225 LVRMWGFCTEG-MHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLH-H 281
++ + G C L+V Y+++ L + + + K+ L AKG+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG------YM 335
+ +H D+ N +LD +F K+ADFGLA R ++ + G +M
Sbjct: 148 KF----VHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 336 APEWASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVK 390
A E T+K DV+S+GV++ E++ +G ++ + ++
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----------------DIT 242
Query: 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+L G R+ + P L+ + + C RP+ +V +
Sbjct: 243 VYLLQGR--RLLQ---PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 52/298 (17%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRL--GDLHQGEEVFWAEVSTI 217
E+++ +G+G G V++G+ AVA+K E F E T+
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 218 GKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGL 276
+ H ++V++ G TE ++ E L L L A + L
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK---G 333
AYL + +H D+ N+L+ S K+ DFGL+ R S + + K
Sbjct: 130 AYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLS----RYMEDSTYYKASKGKLPIK 182
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIRE 388
+MAPE + TS DV+ +GV + E+L G++ + N +
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------------ND 225
Query: 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
V +I GE R+ P N TL+ + C D ++RP + L
Sbjct: 226 VIGRIENGE--RLPM---PP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 57/296 (19%)
Query: 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMN 224
F E +G+G G VY G L D + AVK L + EV F E + H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 225 LVRMWGFCTEGMH-RLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYL-HH 281
++ + G C L+V Y+++ L + + + K+ L AKG+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG------YM 335
+ +H D+ N +LD +F K+ADFGLA R +F + G +M
Sbjct: 212 KF----VHRDLAARNCMLDEKFTVKVADFGLA----RDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 336 APEWASNLPITSKVDVFSYGVVILEML-KGIR----LSNWVVEDSEGQEAELTGFIREVK 390
A E T+K DV+S+GV++ E++ +G ++ + ++
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----------------DIT 306
Query: 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+L G R+ + P L+ + + C RP+ +V +
Sbjct: 307 VYLLQGR--RLLQ---PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 40/255 (15%), Positives = 73/255 (28%), Gaps = 29/255 (11%)
Query: 136 LFRRQGIPSSLEDGYRALSSQFKRFSYAELKKATN---SFKEELGKGGSGAVYKGVLTDE 192
L P S + + + LG+G VY+ D
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 193 R------AVAVKRLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245
+K + E + + + ++ + +LV E
Sbjct: 90 NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELY 149
Query: 246 ENQSLDKHLFSSNFLGWK-----ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300
+L + K A+ + +H +IH D+KP+N +L
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG 206
Query: 301 SEFEP-----------KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
+ F + D G + + + F+ T G+ E SN P ++
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 350 DVFSYGVVILEMLKG 364
D F + ML G
Sbjct: 267 DYFGVAATVYCMLFG 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
LGKG G VY + +A+K +L ++ EV + H N++R++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR-REVEIQSHLRHPNILRLY 75
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
G+ + L+ EY ++ + L + + A L+Y H + VIH
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIH 132
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPEWASNLPIT 346
D+KPEN+LL S E KIADFG + + SR GT Y+ PE
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVH-------APSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 347 SKVDVFSYGVVILEMLKG 364
KVD++S GV+ E L G
Sbjct: 186 EKVDLWSLGVLCYEFLVG 203
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 52/227 (22%), Positives = 80/227 (35%), Gaps = 42/227 (18%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIY-HMNLVRM 228
E++G G G+V+K V D A+KR G E+ EV + H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF------KVALGTAKGLAYLHHE 282
+ E H L+ EY SL + S F + L +GL Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 283 CLEWVIHCDVKPENILLDSEFEP-------------------KIADFGLAKLSQRGSNSS 323
++H D+KP NI + P KI D G + S
Sbjct: 135 S---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--RISSPQV 189
Query: 324 QFSRIRGTKGYMAPE-WASNLPITSKVDVFSYGVVILEMLKGIRLSN 369
+ G ++A E N K D+F+ + ++ L
Sbjct: 190 E----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 77/293 (26%), Positives = 111/293 (37%), Gaps = 33/293 (11%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVKRLG-DLHQGEEVFWA-EVSTIGKIYHMNLVR 227
KE LG GG G V + + T E+ VA+K+ +L W E+ + K+ H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 228 M------WGFCTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGT----AKGL 276
LL EY E L K+L N G KE + L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE--GPIRTLLSDISSAL 134
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKG 333
YLH +IH D+KPENI+L + KI D G AK +G ++F GT
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQ 188
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKGIR--LSNWVVEDSEGQEAELTGFIREVKE 391
Y+APE T VD +S+G + E + G R L NW G+ E + V +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ G + P + + + + +R T
Sbjct: 249 DL-TGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPN 297
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 33/215 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYH 222
+ LG G G VY+G ++ VAVK L ++ ++ F E I K H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-------NFLGWKERFKVALGTAKG 275
N+VR G + + R ++ E + L L + + L + VA A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 276 LAYL-HHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGT 331
YL + IH D+ N LL KI DFG+A R + + R +G
Sbjct: 153 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYR-KGG 203
Query: 332 KGY-----MAPEWASNLPITSKVDVFSYGVVILEM 361
M PE TSK D +S+GV++ E+
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 72/319 (22%), Positives = 117/319 (36%), Gaps = 57/319 (17%)
Query: 143 PSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTD----ERAVAVK 198
ED Y S++ ++ +G+G G V++G+ AVA+K
Sbjct: 370 IIDEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 199 RL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256
E F E T+ + H ++V++ G TE ++ E L L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV 483
Query: 257 S-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315
L A + LAYL + +H D+ N+L+ S K+ DFGL+
Sbjct: 484 RKFSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLS-- 538
Query: 316 SQRGSNSSQFSRIRGTK---GYMAPEWASNLPITSKVDVFSYGVVILEML-KGIR----L 367
R S + + K +MAPE + TS DV+ +GV + E+L G++ +
Sbjct: 539 --RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 368 SNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGIS 427
N +V +I GE R+ P N TL+ +
Sbjct: 597 KN-----------------NDVIGRIENGE--RLPM---PP-------NCPPTLYSLMTK 627
Query: 428 CVDEDRNKRPTMDSVVQTL 446
C D ++RP + L
Sbjct: 628 CWAYDPSRRPRFTELKAQL 646
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 172 FKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNL 225
+GKG G VY G D A+K L + + ++V F E + + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 226 VRMWGFCTEGM-HRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYL-HHE 282
+ + G ++ Y+ + L + + S K+ L A+G+ YL +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG------YMA 336
+H D+ N +LD F K+ADFGLA R ++ ++ + + A
Sbjct: 145 F----VHRDLAARNCMLDESFTVKVADFGLA----RDILDREYYSVQQHRHARLPVKWTA 196
Query: 337 PEWASNLPITSKVDVFSYGVVILEML 362
E T+K DV+S+GV++ E+L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 33/215 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYH 222
+ LG G G VY+G ++ VAVK L ++ ++ F E I K H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-------NFLGWKERFKVALGTAKG 275
N+VR G + + R ++ E + L L + + L + VA A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 276 LAYL-HHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGT 331
YL + IH D+ N LL KI DFG+A R + + R +G
Sbjct: 194 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYR-KGG 244
Query: 332 KGY-----MAPEWASNLPITSKVDVFSYGVVILEM 361
M PE TSK D +S+GV++ E+
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 31/294 (10%)
Query: 171 SFKEELGKGGSGAVYKGV--LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+ LG+G + V++G T + A+K + +V E + K+ H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 227 RMWGF--CTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKER--FKVALGTAKGLAYLHH 281
+++ T H++L+ E+ SL L SN G E V G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 282 ECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
++H ++KP NI+ + K+ DFG A+ + + QF + GT+ Y+ P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHP 184
Query: 338 E--------WASNLPITSKVDVFSYGVVILEMLKGI---RLSNWVVEDSEGQEAELTGFI 386
+ + VD++S GV G R + E +TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD 440
+ E I+ D + ++ L + + ++ D+ K D
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 38/255 (14%)
Query: 141 GIPSSLEDGYRALSSQFKRFSYAELKKAT-NSFK--EELGKGGSGAVYKGVLTDERAVAV 197
G S++D S+ Y + K N ++ L +G + ++ A+
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKF-YAL 59
Query: 198 KRL--GDLHQGEEVFWA----------------EVSTIGKIYHMNLVRMWGFCTEGMHRL 239
K+ L + + + E+ I I + + G T
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK--------GLAYLHHECLEWVIHCD 291
++YEY+EN S+ K L + + K +Y+H+E + + H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRD 177
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS--KV 349
VKP NIL+D K++DFG ++ + RGT +M PE+ SN + KV
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 350 DVFSYGVVILEMLKG 364
D++S G+ + M
Sbjct: 234 DIWSLGICLYVMFYN 248
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 34/166 (20%), Positives = 64/166 (38%), Gaps = 16/166 (9%)
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVA 269
++ + N V + ++ + + ++L + L +E
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167
Query: 270 ---LGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326
+ A+ + +LH + ++H D+KP NI + K+ DFGL +
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 327 RIR----------GTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
GTK YM+PE + KVD+FS G+++ E+L
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMW 229
E++GKG G V+KG+ ++ VA+K + DL + E E E++ + + + + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
G + ++ EY+ S L L + + KGL YLH E IH
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK---KIH 142
Query: 290 CDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
D+K N+LL E K+ADFG+ +L+ + F GT +MAPE SK
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQSAYDSK 199
Query: 349 VDVFSYGVVILEMLKG 364
D++S G+ +E+ +G
Sbjct: 200 ADIWSLGITAIELARG 215
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGE-EVFWAEVSTIGKIYHMNLVRMW 229
+G G G K +D + + K G + + E ++ +EV+ + ++ H N+VR +
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 230 G-FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLG--WKERF--KVALGTAKGLAYLH--H 281
L +V EY E L + E F +V L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ V+H D+KP N+ LD + K+ DFGLA+ ++S GT YM+PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 342 NLPITSKVDVFSYGVVILEML 362
+ K D++S G ++ E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYELC 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 171 SFKEELGKGGSGAVYKGV--LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+ LG+G + V++G T + A+K + +V E + K+ H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 227 RMWGF--CTEGMHRLLVYEYVENQSLDKHLFS-SNFLGWKER--FKVALGTAKGLAYLHH 281
+++ T H++L+ E+ SL L SN G E V G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 282 ECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
++H ++KP NI+ + K+ DFG A+ + + QF + GT+ Y+ P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHP 184
Query: 338 E--------WASNLPITSKVDVFSYGVVILEMLKG 364
+ + VD++S GV G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 36/240 (15%), Positives = 72/240 (30%), Gaps = 58/240 (24%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL--------GDLHQGEE---------------- 208
LG+ A + + V + Q +E
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 209 -------VFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN------QSLDKHLF 255
+F ++ + M VR+ + R +Y +++ + L H
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 256 SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315
+ L R ++ L + LA LHH ++H ++P +I+LD + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 316 SQRGSNSSQFSRIRGTKGYMAPEWAS-----------NLPITSKVDVFSYGVVILEMLKG 364
++G+ PE + +T D ++ G+VI +
Sbjct: 256 DGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 174 EELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEVF---WAEVSTIGKIYHMNLVRMW 229
ELG G G V+K +A K + L + E+ + + +V +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 230 G-FCTEG-----MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
G F ++G M E+++ SLD+ L + + + KV++ KGL YL +
Sbjct: 98 GAFYSDGEISICM------EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
++H DVKP NIL++S E K+ DFG++ +L +NS GT+ YM+PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQG 204
Query: 343 LPITSKVDVFSYGVVILEMLKG 364
+ + D++S G+ ++EM G
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVG 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 33/234 (14%), Positives = 65/234 (27%), Gaps = 47/234 (20%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEE------------------------ 208
LG+ A + + V +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 209 -------VFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN------QSLDKHLF 255
+F ++ + M VR+ + R +Y +++ + L H
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 256 SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315
+ L R ++ L + LA LHH ++H ++P +I+LD + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLP-----ITSKVDVFSYGVVILEMLKG 364
+ S R A +T D ++ G+ I +
Sbjct: 261 DGASA-VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV-FWAEVSTIGKIYHM 223
K ELG+G G V+ + + VAVK L + + F E + + H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS---------------NFLGWKERFKV 268
++VR +G CTEG L+V+EY+ + L++ L S LG + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 269 ALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326
A A G+ YL H +H D+ N L+ KI DFG++ R S+ +
Sbjct: 164 ASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMS----RDIYSTDYY 214
Query: 327 RIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
R G + +M PE T++ DV+S+GVV+ E+
Sbjct: 215 R-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 172 FKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHM 223
ELG+G G VY+GV E VA+K + + E F E S + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTA 273
++VR+ G ++G L++ E + L +L S + ++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 274 KGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK 332
G+AYL+ ++ +H D+ N ++ +F KI DFG+ R + + R +G K
Sbjct: 149 DGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYR-KGGK 199
Query: 333 GY-----MAPEWASNLPITSKVDVFSYGVVILEML 362
G M+PE + T+ DV+S+GVV+ E+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC 232
E+LG+G G+VYK + + VA+K++ + + E+S + + ++V+ +G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 233 TEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
+ +V EY S+ D + L E + T KGL YLH IH D
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRD 150
Query: 292 VKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
+K NILL++E K+ADFG+ +L+ + + GT +MAPE + D
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGYNCVAD 207
Query: 351 VFSYGVVILEMLKG 364
++S G+ +EM +G
Sbjct: 208 IWSLGITAIEMAEG 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 58/198 (29%), Positives = 83/198 (41%), Gaps = 18/198 (9%)
Query: 176 LGKGGSGAVYKGVLTDE-RAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
LGKGG ++ D A K L HQ E++ E+S + H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-MEISIHRSLAHQHVVGFH 107
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
GF + +V E +SL + L E G YLH VIH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIH 164
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPEWASNLPIT 346
D+K N+ L+ + E KI DFGLA + R + GT Y+APE S +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEVLSKKGHS 219
Query: 347 SKVDVFSYGVVILEMLKG 364
+VDV+S G ++ +L G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 38/220 (17%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-Y 221
F + LG G G V + VAVK L +E +E+ + +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSL--------------DKHLFSSNFLGWKERFK 267
H N+V + G CT G L++ EY L +++ ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 268 VALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326
+ A+G+A+L C IH DV N+LL + KI DFGLA+ SN
Sbjct: 169 FSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---- 220
Query: 327 RIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
I +MAPE + T + DV+SYG+++ E+
Sbjct: 221 -IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYH 222
F EELG+ G VYKG L +AVA+K L D +G F E ++ H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL----------------FSSNFLGWKERF 266
N+V + G T+ +++ Y + L + L + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 267 KVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
+ A G+ YL HH V+H D+ N+L+ + KI+D GL R ++
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLF----REVYAAD 182
Query: 325 FSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
+ ++ G +MAPE + D++SYGVV+ E+
Sbjct: 183 YYKLLG-NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
LGKG G VY ++ +A+K +L ++ E+ + H N++RM+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR-REIEIQSHLRHPNILRMY 80
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + L+ E+ L K L F + + A L Y H VI
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHERK---VI 136
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR----GTKGYMAPEWASNLP 344
H D+KPEN+L+ + E KIADFG + + S R GT Y+ PE
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGTLDYLPPEMIEGKT 188
Query: 345 ITSKVDVFSYGVVILEMLKG 364
KVD++ GV+ E L G
Sbjct: 189 HDEKVDLWCAGVLCYEFLVG 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKR-LGDLHQGEEVFWAEVSTIGKI-YHMNLVRMW 229
+ L +GG VY+ + R A+KR L + + EV + K+ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 230 GFCTEGMHR--------LLVYEYVENQSLD--KHLFSSNFLGWKERFKVALGTAKGLAYL 279
+ G LL+ E + Q ++ K + S L K+ T + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---------- 329
H +IH D+K EN+LL ++ K+ DFG A + S ++ R
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 330 GTKGYMAPE---WASNLPITSKVDVFSYGVVILEML 362
T Y PE SN PI K D+++ G ++ +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 59/199 (29%), Positives = 84/199 (42%), Gaps = 20/199 (10%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LGKGG ++ T E A K L HQ E++ E+S + H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEV-FAGKIVPKSLLLKPHQREKMS-MEISIHRSLAHQHVVGF 80
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
GF + +V E +SL + L E G YLH VI
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPEWASNLPI 345
H D+K N+ L+ + E KI DFGLA + R + GT Y+APE S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEVLSKKGH 192
Query: 346 TSKVDVFSYGVVILEMLKG 364
+ +VDV+S G ++ +L G
Sbjct: 193 SFEVDVWSIGCIMYTLLVG 211
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 18/231 (7%)
Query: 143 PSSLEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGV-LTDERAVAVK--- 198
P S+ D A F + S A + LGKG G V + AVK
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSD-RYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 199 --RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256
++ E + EV + ++ H N+++++ F + + LV E L + S
Sbjct: 61 KRQVKQKTDKESLL-REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 119
Query: 257 SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLA 313
+ ++ G+ Y+H ++H D+KPEN+LL+S + +I DFGL+
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+ + GT Y+APE + K DV+S GV++ +L G
Sbjct: 177 THFEAS---KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVF---WAEVSTIGK-IYHMNLVRM 228
E+G+G G+V K V + +AVKR+ E+ ++ + + +V+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 229 WG---------FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
+G C E M Y S+ + LG K+ L T K L +L
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHL 141
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPE 338
+IH D+KP NILLD K+ DFG+ +L +S +R G + YMAPE
Sbjct: 142 KEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPE 195
Query: 339 ----WASNLPITSKVDVFSYGVVILEMLKG 364
AS + DV+S G+ + E+ G
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHMNLVRMW 229
E +G G + V + VA+KR+ +L + + + E+ + + +H N+V +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFK---------VALGTAKGLAYLH 280
LV + + S+ + + + + +GL YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSR--IRGTKGYMAP 337
IH DVK NILL + +IADFG+ A L+ G + R GT +MAP
Sbjct: 139 KNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 338 E-WASNLPITSKVDVFSYGVVILEMLKG 364
E K D++S+G+ +E+ G
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 172 FKEELGKGGSGAVYKGVLTD---ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-YHMNL 225
F++ +G+G G V K + A+KR+ + ++ F E+ + K+ +H N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKV----------------A 269
+ + G C + L EY + +L L S L F + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 270 LGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ--RGSNSSQFS 326
A+G+ YL + IH D+ NIL+ + KIADFGL++ + +
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEM 361
+R +MA E + T+ DV+SYGV++ E+
Sbjct: 205 -VR----WMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV-FWAEVSTIGKIYHM 223
K ELG+G G V+ + + VAVK L D F E + + H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHL----------------FSSNFLGWKERFK 267
++V+ +G C +G ++V+EY+++ L+K L + LG +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 268 VALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325
+A A G+ YL H +H D+ N L+ + KI DFG++ R S+ +
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDY 188
Query: 326 SRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
R+ G +M PE T++ DV+S+GV++ E+
Sbjct: 189 YRVGG-HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRL-GDLHQGEEV--FWAEVSTIGKIYHM 223
+ LG+G G+V +G L VAVK + D E+ F +E + + H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 224 NLVRMWGFCTEG-----MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKV------ALGT 272
N++R+ G C E +++ +++ L +L S + + +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 273 AKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330
A G+ YL + +H D+ N +L + +ADFGL+ + S + R +G
Sbjct: 157 ALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLS----KKIYSGDYYR-QG 206
Query: 331 TKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
++A E ++ TSK DV+++GV + E+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 8e-22
Identities = 70/257 (27%), Positives = 106/257 (41%), Gaps = 19/257 (7%)
Query: 146 LEDGYRALSSQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAV-AVKRL--GD 202
L+ Y Q+K + K T LGKGG G V + + A K+L
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 203 LHQGEEVFWA--EVSTIGKIYHMNLVRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNF 259
+ + + A E + K+ +V + + E L LV + L H++
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 260 LGWKE---RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316
G+ E F A GL LH E +++ D+KPENILLD +I+D GLA
Sbjct: 281 AGFPEARAVFYAA-EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336
Query: 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
G GT GYMAPE N T D ++ G ++ EM+ G S + +
Sbjct: 337 PEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG--QSPFQQRKKK 391
Query: 377 GQEAELTGFIREVKEKI 393
+ E+ ++EV E+
Sbjct: 392 IKREEVERLVKEVPEEY 408
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 37/208 (17%), Positives = 69/208 (33%), Gaps = 22/208 (10%)
Query: 174 EELGKGGS--GAVYKGV-LTDERAVAVKRLGDLHQGE----EVFWAEVSTIGKIYHMNLV 226
+GKG V V V+R+ +L E+ H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVAL---GTAKGLAYLHHEC 283
+V ++ S K L ++F+ +A G K L Y+HH
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG 148
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLA-----KLSQRGSNSSQFSRIRGTKGYMAPE 338
+H VK +IL+ + + ++ ++ +++PE
Sbjct: 149 ---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 339 --WASNLPITSKVDVFSYGVVILEMLKG 364
+ +K D++S G+ E+ G
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 62/224 (27%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-Y 221
SF + LG G G V + VAVK L E +E+ + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT--------- 272
HMN+V + G CT G L++ EY L L + A+
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 273 ---------AKGLAYLH-HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
AKG+A+L C IH D+ NILL KI DFGLA+ + SN
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN- 200
Query: 323 SQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
+ +MAPE N T + DV+SYG+ + E+
Sbjct: 201 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 171 SFKEELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLV 226
++LG G G V A+K + EV+ + + H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+++ F + + LV E + L + + + G+ YLH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 287 VIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
++H D+KPEN+LL+S+ + KI DFGL+ + + + GT Y+APE
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPE-VLRK 212
Query: 344 PITSKVDVFSYGVVILEMLKG 364
K DV+S GV++ +L G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 28/208 (13%)
Query: 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVF---WAEVSTIGK-IYHMNLVRM 228
ELG+G G V K + +AVKR+ + ++ + + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 229 WG-FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF------KVALGTAKGLAYLHH 281
+G EG + E + + SLDK F + + K+A+ K L +LH
Sbjct: 72 YGALFREG-DVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPE-- 338
+ VIH DVKP N+L+++ + K+ DFG+ L + G K YMAPE
Sbjct: 128 K--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERI 181
Query: 339 --WASNLPITSKVDVFSYGVVILEMLKG 364
+ + K D++S G+ ++E+
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 34/217 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGE---EVFWAEVSTIGKIYHM 223
+ LGKG G+V + L VAVK L E F E + + + H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 224 NLVRMWGFCTEG------MHRLLVYEYVENQSLDKHLFSS------NFLGWKERFKVALG 271
++ ++ G +++ ++++ L L +S L + + +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 272 TAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG 330
A G+ YL IH D+ N +L + +ADFGL+ R S + R +G
Sbjct: 146 IACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYR-QG 196
Query: 331 TKG-----YMAPEWASNLPITSKVDVFSYGVVILEML 362
++A E ++ T DV+++GV + E++
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 21/201 (10%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE-----EVFWAEVSTIGKIYHMNLVR 227
E+G G GAVY + + VA+K++ + + EV + K+ H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
G LV EY + D L E V G +GLAYLH +
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---M 175
Query: 288 IHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPEWASNL--- 343
IH DVK NILL K+ DFG + ++ S GT +MAPE +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWMAPEVILAMDEG 228
Query: 344 PITSKVDVFSYGVVILEMLKG 364
KVDV+S G+ +E+ +
Sbjct: 229 QYDGKVDVWSLGITCIELAER 249
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 21/200 (10%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
LGKG VY+ + VA+K + + V EV ++ H +++ ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ-NEVKIHCQLKHPSILELY 77
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ + + LV E N ++++L + F + R + G+ YLH +
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHG---I 133
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR---GTKGYMAPEWASNLP 344
+H D+ N+LL KIADFGLA + + GT Y++PE A+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-----KHYTLCGTPNYISPEIATRSA 188
Query: 345 ITSKVDVFSYGVVILEMLKG 364
+ DV+S G + +L G
Sbjct: 189 HGLESDVWSLGCMFYTLLIG 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVK----------RLGDLHQGEEVFWAEVSTIGK 219
KE LG+G S V + + T + AVK ++ + E EV + K
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKE-YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 220 I-YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAY 278
+ H N++++ LV++ ++ L +L L KE K+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 139
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH ++H D+KPENILLD + K+ DFG + G + + GT Y+APE
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPE 193
Query: 339 ------WASNLPITSKVDVFSYGVVILEMLKG 364
++ +VD++S GV++ +L G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMWG 230
ELG G G VYK A K + + EE+ + E+ + H +V++ G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 231 FCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
++ E+ ++ L L + V + L +LH + +IH
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIH 140
Query: 290 CDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPE-----WASNL 343
D+K N+L+ E + ++ADFG+ AK + F GT +MAPE +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAPEVVMCETMKDT 197
Query: 344 PITSKVDVFSYGVVILEMLKG 364
P K D++S G+ ++EM +
Sbjct: 198 PYDYKADIWSLGITLIEMAQI 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 57/229 (24%), Positives = 84/229 (36%), Gaps = 47/229 (20%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-Y 221
F + LG G G V VAVK L + E +E+ + ++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL-----------------------FSSN 258
H N+V + G CT L++EY L +L N
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 259 FLGWKERFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317
L +++ A AKG+ +L C +H D+ N+L+ KI DFGLA
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA---- 219
Query: 318 RGSNSSQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
R S +MAPE T K DV+SYG+++ E+
Sbjct: 220 RDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 49/231 (21%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYH 222
+ ++G+G G V++ VAVK L + + F E + + + +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS------------------------N 258
N+V++ G C G L++EY+ L++ L S
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 259 FLGWKERFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316
L E+ +A A G+AYL +H D+ N L+ KIADFGL+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLS--- 221
Query: 317 QRGSNSSQFSRIRGTKGY-----MAPEWASNLPITSKVDVFSYGVVILEML 362
R S+ + + M PE T++ DV++YGVV+ E+
Sbjct: 222 -RNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWA---EVSTIGK-IYHMNLVRM 228
E+G G G V+K +AVK++ +E ++ + K +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 229 WG-FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+G F T + E + + + + K+ + K L YL + V
Sbjct: 90 FGTFITNT-DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGV 146
Query: 288 IHCDVKPENILLDSEFEPKIADFGL-AKLSQRGSNSSQFSRIRGTKGYMAPE-----WAS 341
IH DVKP NILLD + K+ DFG+ +L + R G YMAPE +
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
+ DV+S G+ ++E+ G
Sbjct: 203 KPDYDIRADVWSLGISLVELATG 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 41/223 (18%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-Y 221
+ LG+G G V + R VAVK L + E +E+ + I +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 222 HMNLVRMWGFCT-EGMHRLLVYEYVENQSLDKHL----------------FSSNFLGWKE 264
H+N+V + G CT G +++ E+ + +L +L +FL +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 265 RFKVALGTAKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
+ AKG+ +L +C IH D+ NILL + KI DFGLA R
Sbjct: 150 LICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLA----RDIYKD 201
Query: 324 QFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
R +MAPE + T + DV+S+GV++ E+
Sbjct: 202 PDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-------RLGDLHQGEEVFWAEVSTIGK 219
EELG G V K E++ A K R E EVS + +
Sbjct: 15 DIGEELGSGQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
+ H N++ + +L+ E V L L L +E G+ YL
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
H + + H D+KPENI+L + P K+ DFGLA + +F I GT ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFV 185
Query: 336 APEWASNLPITSKVDVFSYGVVILEML 362
APE + P+ + D++S G VI +L
Sbjct: 186 APEIVNYEPLGLEADMWSIG-VITYIL 211
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 171 SFKEELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI 220
+ + LG+G G V VAVK L D +++ +E+ + I
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 221 -YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHL----------------FSSNFLGWK 263
H N++ + G CT+ ++ EY +L ++L + +K
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 264 ERFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321
+ A+G+ YL IH D+ N+L+ KIADFGLA R N
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLA----RDIN 208
Query: 322 SSQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
+ + + + T G +MAPE + T + DV+S+GV++ E+
Sbjct: 209 NIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 49/229 (21%)
Query: 172 FKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHM 223
+ LG+G G V K VAVK L + E+ +E + + ++ H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS------------------------NF 259
++++++G C++ LL+ EY + SL L S
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 260 LGWKERFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317
L + A ++G+ YL ++H D+ NIL+ + KI+DFGL+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLS---- 197
Query: 318 RGSNSSQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
R + ++G +MA E + T++ DV+S+GV++ E+
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 52/211 (24%), Positives = 81/211 (38%), Gaps = 27/211 (12%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVK---------RLGDLHQGEEVFWAEVSTIGKI 220
+ LG G G V T ++ VA++ E+ + K+
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 221 YHMNLVRMWGFC-TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
H ++++ F E + +V E +E L + + L + YL
Sbjct: 198 NHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
H +IH D+KPEN+LL S+ E KI DFG +K+ S + GT Y+A
Sbjct: 256 HENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLA 309
Query: 337 PE---WASNLPITSKVDVFSYGVVILEMLKG 364
PE VD +S GV++ L G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 48/214 (22%), Positives = 77/214 (35%), Gaps = 41/214 (19%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVK------RLGDLHQGEEVFWAEVSTIGKIYHMN 224
E +GKG V + + + AVK E E S + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 225 LVRMWGFCTEGMHRLLVYEYVE---------NQSLDKHLFSSNFLGWKER-----FKVAL 270
+V + + +V+E+++ ++ ++S E + L
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-------EAVASHYMRQIL 140
Query: 271 GTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSR 327
+ L Y H +IH DVKP +LL S+ K+ FG+A +
Sbjct: 141 ---EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGG 192
Query: 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVV--IL 359
GT +MAPE P VDV+ GV+ IL
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 34/205 (16%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLG-DLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
F E LG G V+ + A+K + + E++ + KI H N+V +
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 230 GFCTEGMHRLLVYEYVE-----NQSLDKHLFSSNFLGWKER-----FKVALGTAKGLAYL 279
H LV + V ++ L++ +++ E+ + L + YL
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQVLS---AVKYL 122
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
H ++H D+KPEN+L + E I DFGL+K+ Q G S GT GY+A
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVA 175
Query: 337 PEWASNLPITSKVDVFSYGVV--IL 359
PE + P + VD +S GV+ IL
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYIL 200
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 171 SFKEELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI 220
+ LG+G G V VAVK L +++ +E+ + I
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 221 -YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGT------- 272
H N++ + G CT+ ++ EY +L ++L + G + + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 273 ---------AKGLAYL-HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
A+G+ YL +C IH D+ N+L+ + KIADFGLA R +
Sbjct: 192 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA----RDIHH 243
Query: 323 SQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
+ + + T G +MAPE + T + DV+S+GV++ E+
Sbjct: 244 IDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 171 SFKEELGKGGSGAVYKGV-LTDERAVAVKRL--------------GDLHQGEEVFWAEVS 215
+LG G G V A+K + ++ + E + E+S
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 216 TIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKG 275
+ + H N+++++ + + LV E+ E L + + + + + + G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 276 LAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNSSQFSRIRGTK 332
+ YLH ++H D+KPENILL++ KI DFGL+ + + GT
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTA 212
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE K DV+S GV++ +L G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-------RLGDLHQGEEVFWAEVSTIGK 219
EELG G V K E++ A K R E EVS + +
Sbjct: 15 DIGEELGSGQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
+ H N++ + +L+ E V L L L +E G+ YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
H + + H D+KPENI+L + P K+ DFGLA + +F I GT ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFV 185
Query: 336 APEWASNLPITSKVDVFSYGVVILEML 362
APE + P+ + D++S G VI +L
Sbjct: 186 APEIVNYEPLGLEADMWSIG-VITYIL 211
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGE-EVFWAEVSTIGKIYHMNLV 226
+ LGKG G V K ++ AVK + + EV + K+ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 227 RMWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKER-----FKVALGTAKGLAYLH 280
+++ + +V E L D+ + F E K G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFS---GITYMH 138
Query: 281 HECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
++H D+KPENILL+S + + KI DFGL+ Q+ ++ GT Y+AP
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAP 192
Query: 338 EWASNLPITSKVDVFSYGVVILEMLKG 364
E K DV+S GV++ +L G
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 172 FKEELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI- 220
+ LG+G G V VAVK L D +++ +E+ + I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS----------------NFLGWKE 264
H N++ + G CT+ ++ EY +L ++L + + +K+
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 265 RFKVALGTAKGLAYL--HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322
A+G+ YL IH D+ N+L+ KIADFGLA R N+
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLA----RDINN 255
Query: 323 SQFSRIRGTKG-----YMAPEWASNLPITSKVDVFSYGVVILEM 361
+ + + T G +MAPE + T + DV+S+GV++ E+
Sbjct: 256 IDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 35/207 (16%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
KEELGKG V + V T A K + + + E K+ H N+VR
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 228 MWGFCTEGMHRLLVYEYVENQSL-----DKHLFSSNFLGWKER-----FKVALGTAKGLA 277
+ E LV++ V L + +S E + L + +A
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQIL---ESIA 119
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
Y H ++H ++KPEN+LL S+ + K+ADFGLA + GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGY 173
Query: 335 MAPEWASNLPITSKVDVFSYGVV--IL 359
++PE P + VD+++ GV+ IL
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYIL 200
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 53/246 (21%), Positives = 90/246 (36%), Gaps = 56/246 (22%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVK-----RLGDLHQGE-EVFWAEVSTIGKIYHMN 224
K +G+G G V + A+K ++ ++ + E EV + K++H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK---------- 274
+ R++ + + LV E L L + + T
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 275 ------------------------------GLAYLHHECLEWVIHCDVKPENILLDS--E 302
L YLH++ + H D+KPEN L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 303 FEPKIADFGLAKLSQRGSNSSQF--SRIRGTKGYMAPE--WASNLPITSKVDVFSYGVVI 358
FE K+ DFGL+K + +N + + GT ++APE +N K D +S GV++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 359 LEMLKG 364
+L G
Sbjct: 267 HLLLMG 272
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 173 KEELGKGGSGAVYKGVLTDERA----VAVKRL-GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
E LG G G V+K E A +A K + + +E E+S + ++ H NL++
Sbjct: 94 TEILGGGRFGQVHKCE---ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 228 MWGFCTEGMHRLLVYEYVENQSL------DKHLFSSNFLGWKER-----FKVALGTAKGL 276
++ +LV EYV+ L + + + E K G+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-------ELDTILFMKQICE---GI 200
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
++H +++H D+KPENIL + KI DFGLA+ R + GT +
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEF 254
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEML 362
+APE + ++ D++S G VI ML
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVG-VIAYML 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-----RLGDLHQGE--EVFWAEVSTIGK 219
EELG G V K ++ A K RL +G E EV+ + +
Sbjct: 8 EMGEELGSGQFAIVRKCR---QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
I H N++ + +L+ E V L L L E + G+ YL
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
H + + H D+KPENI+L + P K+ DFG+A + G+ +F I GT ++
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFV 178
Query: 336 APEWASNLPITSKVDVFSYGVVILEML 362
APE + P+ + D++S G VI +L
Sbjct: 179 APEIVNYEPLGLEADMWSIG-VITYIL 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVKRL---------GDLHQGEEVFWAEVSTIGKI 220
K+ +G+G S V + V T AVK + L + E E + ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHE-FAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 221 Y-HMNLVRMWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAY 278
H +++ + LV++ + L D L L KE + + +++
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSEKETRSIMRSLLEAVSF 215
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
LH ++H D+KPENILLD + +++DFG + + G + + GT GY+APE
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPE 269
Query: 339 ------WASNLPITSKVDVFSYGVV--IL 359
++ +VD+++ GV+ L
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTL 298
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+ ELG+G + VY+ ++ A+K L +++ E+ + ++ H N++++
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 231 FCTEGMHRLLVYEYVENQSL-----DKHLFSSNFLGWKER-----FKVALGTAKGLAYLH 280
LV E V L +K +S ER K L +AYLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYS-------ERDAADAVKQILE---AVAYLH 165
Query: 281 HECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
++H D+KPEN+L + KIADFGL+K+ + + GT GY AP
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAP 219
Query: 338 EWASNLPITSKVDVFSYGVV--IL 359
E +VD++S G++ IL
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYIL 243
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 44/213 (20%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-----RLGDLHQGEEVFWAEVSTIGKIY 221
EELG G G V++ V E+A K D + E+S + +++
Sbjct: 54 DILEELGSGAFGVVHRCV---EKATGRVFVAKFINTPYPLD----KYTVKNEISIMNQLH 106
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSL------DKHLFSSNFLGWKERFKVALGTAK- 274
H L+ + + +L+ E++ L + + S E + +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-------EA--EVINYMRQ 157
Query: 275 ---GLAYLHHECLEWVIHCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIR 329
GL ++H ++H D+KPENI+ +++ KI DFGLA + +
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTT 211
Query: 330 GTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
T + APE P+ D+++ G V+ +L
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVL 243
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-----RLGDLHQGEEVFWAEVSTIGKIY 221
EELG G G V++ ERA A K D +E E+ T+ +
Sbjct: 160 DIHEELGTGAFGVVHRVT---ERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLR 212
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAYLH 280
H LV + + +++YE++ L +K N + E + KGL ++H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 281 HECLEWVIHCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
+H D+KPENI+ ++ K+ DFGL GT + APE
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPE 326
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGI 365
A P+ D++S GV+ +L G+
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 171 SFKEELGKGGSGAVYKGVLTDERA----VAVK-----RLGDLHQGE--EVFWAEVSTIGK 219
EELG G V K E++ A K R +G E EVS + +
Sbjct: 14 DTGEELGSGQFAVVKKCR---EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
I H N++ + +L+ E V L L L +E + G+ YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 280 HHECLEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
H + H D+KPENI+L P KI DFGLA G+ +F I GT ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 184
Query: 336 APEWASNLPITSKVDVFSYGVVILEML 362
APE + P+ + D++S G VI +L
Sbjct: 185 APEIVNYEPLGLEADMWSIG-VITYIL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 31/257 (12%)
Query: 155 SQFKRFSYAELKKAT-NSFKEE--LGKGGSGAVYKGVLTDERAV-AVKRL--GDLHQGEE 208
+F ++ + E + + F + LG+GG G V+ + + A K+L L + +
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 209 VFWA--EVSTIGKIYHMNLVRMWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKER 265
A E + K++ +V + + E L LV + + H++ N
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY--NVDEDNPG 285
Query: 266 FKVALGTAK--------GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317
F+ A GL +LH +I+ D+KPEN+LLD + +I+D GLA +
Sbjct: 286 FQEP--RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 318 RGSNSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376
G ++ ++ GT G+MAPE VD F+ GV + EM+ + +
Sbjct: 341 AGQTKTKGYA---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA--RGPFRARGEK 395
Query: 377 GQEAELTGFIREVKEKI 393
+ EL + E
Sbjct: 396 VENKELKQRVLEQAVTY 412
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVR---- 227
E +G G G VYKG + + A+K + EE E++ + K +H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 228 -MWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHEC 283
+ +L LV E+ S+ + ++ KE + + +GL++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE----- 338
VIH D+K +N+LL E K+ DFG++ +Q + + GT +MAPE
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
+ K D++S G+ +EM +G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 172 FKEELGKGGSGAVYKGV--LT-DERAVAV--KRLGDLHQGEEVFWAEVSTIGKIYHMNLV 226
KEELGKG V + V T E A + + +++ E K+ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIV 91
Query: 227 RMWGFCTEGMHRLLVYEYV---ENQSLDKHLFSSNFLGWKERF--KVALGTAK----GLA 277
R+ E LV++ V E LF + +E + A + +A
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGE-------LF--EDIVAREFYSEADASHCIQQILESIA 142
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
Y H ++H ++KPEN+LL S+ + K+ADFGLA + GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGY 196
Query: 335 MAPEWASNLPITSKVDVFSYGVV--IL 359
++PE P + VD+++ GV+ IL
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 171 SFKEELGKGGSGAVYKGV--LT-DERAVAVKRLGDLHQGE-EVFWAEVSTIGKIYHMNLV 226
EELGKG V + V L E A + L + + E + H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 227 RMWGFCTEGMHRLLVYEYVE-----NQSLDKHLFSSNFLGWKER-----FKVALGTAKGL 276
R+ +E H L+++ V + + +S E + L +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-------EADASHCIQQILE---AV 123
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+ H V+H ++KPEN+LL S+ + K+ADFGLA + + GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPG 178
Query: 334 YMAPEWASNLPITSKVDVFSYGVV--IL 359
Y++PE P VD+++ GV+ IL
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYIL 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 172 FKEELGKGGSGAVYKGVLTD-ERAVAVKRLG-----DLHQGEEVFWAEVSTIGKIYHMNL 225
F + LG+G V R A+K L ++ V E + ++ H
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLDHPFF 92
Query: 226 VRMWG-FCTEGMHRL-LVYEYVENQSLDKHLFSSN-FLGWKERFKVA-LGTAKGLAYLHH 281
V+++ F + +L Y +N L K++ F RF A + +A L YLH
Sbjct: 93 VKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHG 148
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ +IH D+KPENILL+ + +I DFG AK+ S ++ + GT Y++PE +
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
D+++ G +I +++ G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAG 228
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGE-EVFWAEVSTIGKIYHMNLVR 227
LGKG G V K ++ AVK + + EV + K+ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 228 MWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKER-----FKVALGTAKGLAYLHH 281
++ + +V E L D+ + F E K G+ Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFS---GITYMHK 139
Query: 282 ECLEWVIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
++H D+KPENILL+S+ + KI DFGL+ Q+ ++ GT Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE 193
Query: 339 WASNLPITSKVDVFSYGVVILEMLKG 364
K DV+S GV++ +L G
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSG 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 25/202 (12%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLG-DLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
+ +G+G G V V A K++ + + F E+ + + H N++R++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 230 GFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKER-----FKVALGTAKGLAYLHHEC 283
+ LV E L ++ + F +E K L +AY H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIMKDVL---SAVAYCHKLN 126
Query: 284 LEWVIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
V H D+KPEN L ++ K+ DFGLA + G GT Y++P+
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVL 180
Query: 341 SNLPITSKVDVFSYGVVILEML 362
+ D +S G V++ +L
Sbjct: 181 EG-LYGPECDEWSAG-VMMYVL 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 12/197 (6%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWG 230
+ LG+G K V +A AVK + + E E++ + H N+V++
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
+ +H LV E + L + + E + ++++H V+H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHR 130
Query: 291 DVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
D+KPEN+L E + KI DFG A+L ++ T Y APE +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 348 KVDVFSYGVVILEMLKG 364
D++S GV++ ML G
Sbjct: 189 SCDLWSLGVILYTMLSG 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 21/243 (8%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLG-DLHQGEEVFWAEVSTIGKIY-HMNLVRMW 229
++ LG+G V + L + AVK + + EV + + H N++ +
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
F E LV+E + S+ H+ E V A L +LH++ + H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 290 CDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIR-----GTKGYMAPE--- 338
D+KPENIL + + KI DF L + + S S G+ YMAPE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 339 --WASNLPITSKVDVFSYGVVILEMLKGIR--LSNWVVEDSEGQEAELTGFIREVKEKIL 394
+ D++S GV++ +L G + + + + E I
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 395 CGE 397
G+
Sbjct: 255 EGK 257
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 171 SFKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVR 227
FK +LG G G V+ + +K + E AE+ + + H N+++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 228 MWGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGW-KER-----FKVALGTAKGLAYLH 280
++ + + +V E E L ++ + + E K + LAY H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFH 141
Query: 281 HECLEWVIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAP 337
+ V+H D+KPENIL KI DFGLA+L + + GT YMAP
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAP 195
Query: 338 EWASNLPITSKVDVFSYGVVILEML 362
E +T K D++S G V++ L
Sbjct: 196 E-VFKRDVTFKCDIWSAG-VVMYFL 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 40/196 (20%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 171 SFKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
E+LG+G G V++ V + ++ K + + + E+S + H N++ +
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 230 GFCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
++++E++ + ++ S+ L +E + L +LH +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 289 HCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
H D++PENI+ + KI +FG A+ + G F + Y APE + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 347 SKVDVFSYGVVILEML 362
+ D++S G ++ +L
Sbjct: 182 TATDMWSLG-TLVYVL 196
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 39/210 (18%)
Query: 172 FKEELGKGGSGAVYKGV--LTDERAVAVK---------RLGDLHQGEEVFWAEVSTIGKI 220
+ LG G G V T ++ VA+K E+ + K+
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 221 YHMNLVRMWG-FCTEGMHRLLVYEYVENQSL-DKHLFSSNFLGWKER-----FKVALGTA 273
H ++++ F E + +V E +E L DK + + KE F L
Sbjct: 73 NHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKRL---KEATCKLYFYQMLL-- 125
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRG 330
+ YLH +IH D+KPEN+LL S+ E KI DFG +K+ S + G
Sbjct: 126 -AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCG 178
Query: 331 TKGYMAPE---WASNLPITSKVDVFSYGVV 357
T Y+APE VD +S GV+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 33/208 (15%)
Query: 173 KEELGKGGSGAVYKGVLTDERA----VAVK-----RLGDLHQGEEVFWAEVSTIGKIYHM 223
+ELG+G V + + ++ A K R G E++ +
Sbjct: 34 SKELGRGKFAVVRQCI---SKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSC 88
Query: 224 -NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKER-----FKVALGTAKGLA 277
++ + +L+ EY + E K L G+
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVY 145
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
YLH ++H D+KP+NILL S + KI DFG+++ + ++ + I GT Y
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEY 199
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEML 362
+APE + PIT+ D+++ G +I ML
Sbjct: 200 LAPEILNYDPITTATDMWNIG-IIAYML 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
L YL ++ +IH D+KP+NILLD I DF +A + R + + + GTK Y
Sbjct: 127 ALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPY 180
Query: 335 MAPEWASNLPI---TSKVDVFSYGVVILEMLKGIR 366
MAPE S+ + VD +S GV E+L+G R
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 44/215 (20%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG+G G V + T R AVK +L + GE E+ + ++ H N++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCR-RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 229 ---WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF-KVALG-----TAK----- 274
+ +V EY G +E V A
Sbjct: 72 VDVLYNEEKQ-KMYMVMEYCVC-------------GMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 275 ---GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGT 331
GL YLH + ++H D+KP N+LL + KI+ G+A+ + +G+
Sbjct: 118 LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 332 KGYMAPEWASNLPI--TSKVDVFSYGVVILEMLKG 364
+ PE A+ L KVD++S GV + + G
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL--------GDLHQGEEVFWAEVSTIGKIYHM- 223
LG GG G+VY G+ ++D VA+K + G+L G V EV + K+
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP-MEVVLLKKVSSGF 107
Query: 224 -NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG------TAKGL 276
++R+ + +L+ E E + LF +F+ + + L + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV---QDLF--DFITERGALQEELARSFFWQVLEAV 162
Query: 277 AYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
+ H+ V+H D+K ENIL+D E K+ DFG L + ++ GT+ Y
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 215
Query: 336 APEWASNLPIT-SKVDVFSYGVVILEMLKG 364
PEW V+S G+++ +M+ G
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 23/198 (11%), Positives = 50/198 (25%), Gaps = 43/198 (21%)
Query: 174 EELGKGGSGAVYKGVLTDE---RAVAVKRL-GDLHQGEEV---FWAEVSTIGKIYHMNLV 226
G ++ + D R VA+ + ++V + + +I +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
R+ L+V E++ SL + +S + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
V P + + + + +A M
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA-------N 180
Query: 347 SKVDVFSYGVVILEMLKG 364
+ D+ G + +L
Sbjct: 181 PQDDIRGIGASLYALLVN 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 20/200 (10%)
Query: 176 LGKGGSGAVYKGVLTDERAV-AVKRL--GDLHQGEEVFWAEV-----STIGKIYHMNLVR 227
+G+GG G VY D + A+K L + + A S + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 228 MWGFCTEGMHRL-LVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLE 285
M + +L + + + L HL F RF A GL ++H+
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHNRF-- 312
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLP 344
V++ D+KP NILLD +I+D GLA + + GT GYMAPE +
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVA 367
Query: 345 ITSKVDVFSYGVVILEMLKG 364
S D FS G ++ ++L+G
Sbjct: 368 YDSSADWFSLGCMLFKLLRG 387
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 16/200 (8%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGD-LHQGEEVFWAEVSTIGK-IYHMNLVRM 228
KE++G G + + AVK + E E+ + + H N++ +
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITL 81
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+G + +V E ++ L + F +E V K + YLH + V+
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VV 138
Query: 289 HCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
H D+KP NIL E +I DFG AK + + + T ++APE
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLERQG 196
Query: 345 ITSKVDVFSYGVVILEMLKG 364
+ D++S GV++ ML G
Sbjct: 197 YDAACDIWSLGVLLYTMLTG 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 22/203 (10%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWG 230
K+ LG G +G V + + A+K L D EV + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPHIVCILD 89
Query: 231 FCTEGMHR----LLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECL 284
H L++ E +E L + + ER ++ + +LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN- 148
Query: 285 EWVIHCDVKPENILLDSEFEP---KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ H DVKPEN+L S+ + K+ DFG AK + + T Y+APE
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLG 202
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
D++S GV++ +L G
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCG 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLV 226
+ +GKG V +LT VA+K +L +++F EV + + H N+V
Sbjct: 21 KTIGKGNFAKVKLARHILTGRE-VAIKIIDKTQLNPTSL-QKLF-REVRIMKILNHPNIV 77
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+++ L+ EY + +L + + KE + Y H +
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
++H D+K EN+LLD++ KIADFG + G F G Y APE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKYD 191
Query: 347 -SKVDVFSYGVVILEMLKG 364
+VDV+S GV++ ++ G
Sbjct: 192 GPEVDVWSLGVILYTLVSG 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 52/220 (23%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---------- 221
LG G G V+ ++ V VK + + E W E +GK+
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKE-VVVKFI-KKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQS-----LDKH-----LFSSNFLGWKERFKVALG 271
H N++++ + ENQ ++KH LF F+ R L
Sbjct: 88 HANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLF--AFIDRHPRLDEPLA 132
Query: 272 TAK------GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325
+ + YL + +IH D+K ENI++ +F K+ DFG A +RG F
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLF 186
Query: 326 SRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKG 364
GT Y APE P +++++S GV + ++
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG+G G V +T+E AVAVK R D + + E+ + H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKF 70
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK------GLAYLHHE 282
+G EG + L EY LF + + G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSG----GELF--DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
+ H D+KPEN+LLD KI+DFGLA + + + +++ GT Y+APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 343 LPIT-SKVDVFSYGVVILEMLKG 364
VDV+S G+V+ ML G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 50/216 (23%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEEVFWA------EVSTIGKIYHMNL 225
++G+G G V+K T + VA+K+ + E+ E+ + ++ H NL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQI-VAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----------KG 275
V + LV+EY + ++ L +R++ + +
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCD-HTVLHEL---------DRYQRGVPEHLVKSITWQTLQA 114
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
+ + H IH DVKPENIL+ K+ DFG A+L S + T+ Y
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYR 169
Query: 336 APEWASNLPI-------TSKVDVFSYGVVILEMLKG 364
+PE + VDV++ G V E+L G
Sbjct: 170 SPE------LLVGDTQYGPPVDVWAIGCVFAELLSG 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 158 KRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTI 217
+ +Y K +G G G V++ L + VA+K+ + Q + E+ +
Sbjct: 38 REIAYTNCKV--------IGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIM 86
Query: 218 GKIYHMNLVRMWGFCTEGMHRL------LVYEYVENQSLDKHLFSSNFLGWKERFKVALG 271
+ H N+V + F + LV EYV +++ + K + + +
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHY----AKLKQTMPML 141
Query: 272 TAK--------GLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAK-LSQRGSN 321
K LAY+H + H D+KP+N+LLD K+ DFG AK L N
Sbjct: 142 LIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 322 SSQFSRIRGTKGYMAPEW---ASNLPITSKVDVFSYGVVILEMLKG 364
S ++ Y APE A+N T+ +D++S G V+ E+++G
Sbjct: 199 VSYIC----SRYYRAPELIFGATNY--TTNIDIWSTGCVMAELMQG 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 43/212 (20%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVRMW 229
E++G+G G VYK + R VA+KR+ L +E + E+S + +++H N+V +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----------KGLAYL 279
LV+E++E + L K L + K L + +G+A+
Sbjct: 86 DVIHSERCLTLVFEFME-KDLKKVL---------DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
H ++H D+KP+N+L++S+ K+ADFGLA+ G ++ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD- 189
Query: 340 ASNLPI-------TSKVDVFSYGVVILEMLKG 364
+ ++ VD++S G + EM+ G
Sbjct: 190 -----VLMGSKKYSTSVDIWSIGCIFAEMITG 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 44/213 (20%)
Query: 174 EELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEEV-FWA--EVSTIGKIYHMNLVRM 228
+G+G G V K T VA+K+ + + V A E+ + ++ H NLV +
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRI-VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----------KGLAY 278
C + LV+E+V+ ++ L E F L G+ +
Sbjct: 90 LEVCKKKKRWYLVFEFVD-HTILDDL---------ELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
H +IH D+KPENIL+ K+ DFG A+ + + T+ Y APE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPE 194
Query: 339 WASNLPI-------TSKVDVFSYGVVILEMLKG 364
+ VDV++ G ++ EM G
Sbjct: 195 ------LLVGDVKYGKAVDVWAIGCLVTEMFMG 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG+G G V +T+E AVAVK R D + + E+ + H N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKF 70
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK------GLAYLHHE 282
+G EG + L EY LF + + G+ YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSG----GELF--DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
+ H D+KPEN+LLD KI+DFGLA + + + +++ GT Y+APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 343 LPIT-SKVDVFSYGVVILEMLKG 364
VDV+S G+V+ ML G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 53/207 (25%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL--------GDLHQGEEVFWAEVSTI----GKI 220
LGKGG G V+ G LTD VA+K + L EV+ +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP-LEVALLWKVGAGG 95
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVEN-QSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
H ++R+ + +LV E Q L ++ LG + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 280 HHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE 338
H V+H D+K ENIL+D K+ DFG L ++ GT+ Y PE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208
Query: 339 WASNLPIT-SKVDVFSYGVVILEMLKG 364
W S V+S G+++ +M+ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 26/238 (10%)
Query: 143 PSSLEDGYRALSSQFKRFSYAELKKATNS-----FKEELGKGGSGAVYKGV-LTDERAVA 196
P+ QF S ++KK + LG G +G V + + A
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA 91
Query: 197 VKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFC----TEGMHRLLVYEYVENQSLD 251
+K L D EV + ++VR+ L+V E ++ L
Sbjct: 92 LKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 252 KHLFSSNFLGWKER--FKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP---K 306
+ + ER ++ + + YLH + H DVKPEN+L S+ K
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK 204
Query: 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
+ DFG AK + + + T Y+APE D++S GV++ +L G
Sbjct: 205 LTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 61/197 (30%), Positives = 82/197 (41%), Gaps = 15/197 (7%)
Query: 176 LGKGGSGAVYKGVLTDERAV-AVKRL--GDLHQGEEVFW--AEVSTIGKIYHMNLVRM-W 229
LGKG G V A+K L + +EV E + H L + +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
F T V EY L HL F + RF A L YLH E + V+
Sbjct: 216 SFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVV 271
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
+ D+K EN++LD + KI DFGL K + G+ F GT Y+APE +
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGR 328
Query: 348 KVDVFSYGVVILEMLKG 364
VD + GVV+ EM+ G
Sbjct: 329 AVDWWGLGVVMYEMMCG 345
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVRMW 229
E++G+G G VYK A+K++ L + +E + E+S + ++ H N+V+++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG-TAKGLAYLHHECLEWVI 288
+LV+E+++ Q L K L K L G+AY H V+
Sbjct: 67 DVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI--- 345
H D+KP+N+L++ E E KIADFGLA+ G +++ T Y AP+ +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPD------VLMG 174
Query: 346 ----TSKVDVFSYGVVILEMLKG 364
++ +D++S G + EM+ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 56/208 (26%), Positives = 81/208 (38%), Gaps = 41/208 (19%)
Query: 176 LGKGGSGAVY----KGVLTDERAVAVKRLG-----DLHQGEEVFWAEVSTIGKIYHMNLV 226
LG G G V K A+K L L Q E E + + LV
Sbjct: 49 LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNFPFLV 104
Query: 227 RMWG-FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK--------GL 276
++ F L +V EYV +FS L RF A+
Sbjct: 105 KLEFSFKDN--SNLYMVMEYVAG----GEMFS--HLRRIGRFSEP--HARFYAAQIVLTF 154
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
YLH +I+ D+KPEN+L+D + ++ DFG AK + + + + GT +A
Sbjct: 155 EYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALA 206
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLKG 364
PE + VD ++ GV+I EM G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVR 227
+LG+G G VYK +T+E VA+KR+ L EE EVS + ++ H N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNET-VAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ L++EY E L K++ + + + G+ + H
Sbjct: 98 LKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RC 153
Query: 288 IHCDVKPENILLDSEFEP-----KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
+H D+KP+N+LL KI DFGLA+ G QF+ T Y PE
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPE---- 207
Query: 343 LPI-------TSKVDVFSYGVVILEMLKG 364
I ++ VD++S + EML
Sbjct: 208 --ILLGSRHYSTSVDIWSIACIWAEMLMK 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG G G V G LT + VAVK ++ L ++ E+ + H +++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHK-VAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL 76
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + +V EYV L ++ + E ++ + Y H V+
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VV 133
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT-S 347
H D+KPEN+LLD+ KIADFGL+ + G G+ Y APE S
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGP 190
Query: 348 KVDVFSYGVVILEMLKG 364
+VD++S GV++ +L G
Sbjct: 191 EVDIWSCGVILYALLCG 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
GL +L + +I+ D+K +N++LDSE KIADFG+ K + G + F GT
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPD 186
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE + P VD +++GV++ EML G
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 41/208 (19%)
Query: 176 LGKGGSGAVY----KGVLTDERAVAVKRLG-----DLHQGEEVFWAEVSTIGKIYHMNLV 226
LG G G V+ + + R A+K L L Q E E + + H ++
Sbjct: 14 LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIVTHPFII 69
Query: 227 RMWG-FCTEGMHRL-LVYEYVENQSLDKHL-----FSSNFLGWKERF---KVALGTAKGL 276
RMWG F ++ ++ +Y+E L L F + +F +V L L
Sbjct: 70 RMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAEVCLA----L 119
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336
YLH + +I+ D+KPENILLD KI DFG AK + + + GT Y+A
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIA 171
Query: 337 PEWASNLPITSKVDVFSYGVVILEMLKG 364
PE S P +D +S+G++I EML G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG+G G V T ++ VA+K L V E+S + + H +++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQK-VALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL 74
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK------GLAYLHHE 282
+ T ++V EY + LF +++ K+R G + Y H
Sbjct: 75 YDVITTPTDIVMVIEYAGGE-----LF--DYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
++H D+KPEN+LLD KIADFGL+ + G+ G+ Y APE +
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVING 181
Query: 343 LPIT-SKVDVFSYGVVILEMLKG 364
+VDV+S G+V+ ML G
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L +LH + +I+ D+KPENI+L+ + K+ DFGL K S G+ + F GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
YMAPE VD +S G ++ +ML G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L YLH +++ D+KPENILLDS+ + DFGL K + + S +S F GT
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPE 204
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE P VD + G V+ EML G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
GL +L + +I+ D+K +N++LDSE KIADFG+ K + G + F GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPD 507
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE + P VD +++GV++ EML G
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 38/212 (17%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVK--RLGDLHQGEEVFWA----EVSTIGKIYHMNL 225
E+LG G VYKG T VA+K +L EE + E+S + ++ H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVY-VALKEVKLDS----EEGTPSTAIREISLMKELKHENI 65
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG------TAKGLAYL 279
VR++ LV+E+++ L K++ S ++ L +GLA+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
H ++H D+KP+N+L++ + K+ DFGLA+ G + FS T Y AP+
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPD- 178
Query: 340 ASNLPI-------TSKVDVFSYGVVILEMLKG 364
+ ++ +D++S G ++ EM+ G
Sbjct: 179 -----VLMGSRTYSTSIDIWSCGCILAEMITG 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 8e-15
Identities = 38/91 (41%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L +LH +I+ D+KPENILLD E K+ DFGL+K S + F GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVE 191
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
YMAPE + T D +S+GV++ EML G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 8e-15
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 22/154 (14%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK--RLGDLHQGEEVFWA----EVSTIGKIYHMNLV 226
+ LG+G VYK + VA+K +LG + ++ E+ + ++ H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVA------LGTAKGLAYLH 280
+ + LV++++E L+ + ++ + L T +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
W++H D+KP N+LLD K+ADFGLAK
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 60/248 (24%)
Query: 156 QFKRFSYAELKKATNSFKEELGKGGSGA---VYKGV---LTDERAVAVKRLGDLHQGEEV 209
FK +E ++ + F+ E K G G VYK D++ A+K++
Sbjct: 6 DFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-----TG 60
Query: 210 FWAEVSTIGKIY------HMNLVRMWGFCTE-GMHRL-LVYEYVENQSLD-KHLFSSNFL 260
+S +I H N++ + ++ L+++Y E D H+ +
Sbjct: 61 I--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE---HDLWHIIKFHRA 115
Query: 261 GWKERFKVALGTA----------KGLAYLHHECLEWVIHCDVKPENILLDSEFEP----K 306
+ V L G+ YLH WV+H D+KP NIL+ E K
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172
Query: 307 IADFGLAKLSQRGSNSSQFSRIRG---TKGYMAPEWASNLPI-------TSKVDVFSYGV 356
IAD G A+L S + + T Y APE + T +D+++ G
Sbjct: 173 IADMGFARLF--NSPLKPLADLDPVVVTFWYRAPE------LLLGARHYTKAIDIWAIGC 224
Query: 357 VILEMLKG 364
+ E+L
Sbjct: 225 IFAELLTS 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L +LH + +I+ D+K +N+LLD E K+ADFG+ K G ++ F GT
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPD 189
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE + VD ++ GV++ EML G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 174 EELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG-F 231
+ +G G G VY+ L D VA+K++ Q + E+ + K+ H N+VR+ F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 232 CTEGMHRL-----LVYEYVENQSLDKHLFSSNFLGWKERFKVALG------TAKGLAYLH 280
+ G + LV +YV + + ++ K+ V + LAY+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 281 HECLEWVIHCDVKPENILLDSEFEP-KIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPE 338
+ H D+KP+N+LLD + K+ DFG AK L + N S ++ Y APE
Sbjct: 174 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYRAPE 226
Query: 339 W---ASNLPITSKVDVFSYGVVILEMLKG 364
A++ TS +DV+S G V+ E+L G
Sbjct: 227 LIFGATDY--TSSIDVWSAGCVLAELLLG 253
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 28/203 (13%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA----EVSTIGKIYHMNLVR 227
E++G+G G V+K T E VA+KR+ L +E + E+ + ++ H N+VR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEI-VALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG-TAKGLAYLHHECLEW 286
+ LV+E+ + Q L K+ S N E K L KGL + H
Sbjct: 66 LHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI- 345
V+H D+KP+N+L++ E K+A+FGLA+ G +S T Y P+ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPD------VL 173
Query: 346 ------TSKVDVFSYGVVILEML 362
++ +D++S G + E+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELA 196
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L YLH +I+ D+K +N+LLDSE K+ D+G+ K + G +S F GT
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPN 175
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE VD ++ GV++ EM+ G
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L YLH V++ D+K EN++LD + KI DFGL K G+ F GT
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPE 170
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE + VD + GVV+ EM+ G
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
L YLH +I+ D+K +N+LLDSE K+ D+G+ K + G +S F GT
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPN 218
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE VD ++ GV++ EM+ G
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 7/91 (7%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS-QRGSNSSQFSRIRGTKG 333
GL +LH + +++ D+K +NILLD + KIADFG+ K + + ++ F GT
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---GTPD 183
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y+APE VD +S+GV++ EML G
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEV-FWA--EVSTIGKIYHMNLVRM 228
++LG+G VYKG LTD VA+K + L E A EVS + + H N+V +
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNL-VALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALG-TAKGLAYLHHECLEWV 287
LV+EY++ + L ++L + K+ L +GLAY H + V
Sbjct: 66 HDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI-- 345
+H D+KP+N+L++ E K+ADFGLA+ + + T Y P+ I
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEVVTLWYRPPD------ILL 173
Query: 346 -----TSKVDVFSYGVVILEMLKG 364
++++D++ G + EM G
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATG 197
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 34/219 (15%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-----------Y 221
+LG G V+ + + VA+K + E E+ + ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 222 HMNLVRMWGF----CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKG 275
+++++ G+H ++V+E V ++L + G + +++ G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEP------KIADFGLA-KLSQRGSNSSQFSRI 328
L Y+H C +IH D+KPEN+L++ P KIAD G A + +NS Q +R
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-TRE 200
Query: 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367
Y +PE P D++S +I E++ G L
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 43/227 (18%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVK-----RLGDLHQGEEVFWA-------------- 212
K+E+GKG G V D A+K +L
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 213 --------EVSTIGKIYHMNLVRM---WGFCTEGMHRLLVYEYVENQSL-DKHLFSSNFL 260
E++ + K+ H N+V++ E H +V+E V + + + L
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEV--PTLKPL 134
Query: 261 GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320
+ KG+ YLH++ +IH D+KP N+L+ + KIADFG++ +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS- 190
Query: 321 NSSQFSRIRGTKGYMAPEWASNLPIT---SKVDVFSYGVVILEMLKG 364
+ S GT +MAPE S +DV++ GV + + G
Sbjct: 191 -DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 56/200 (28%), Positives = 74/200 (37%), Gaps = 24/200 (12%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCT 233
+G G G LT E VAVK + +E E+ + H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 234 EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK------GLAYLHHECLEWV 287
H ++ EY L+ + RF G++Y H +
Sbjct: 87 TPTHLAIIMEYASG----GELY--ERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---I 137
Query: 288 IHCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
H D+K EN LLD P KI DFG +K S S GT Y+APE
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEY 194
Query: 346 T-SKVDVFSYGVVILEMLKG 364
DV+S GV + ML G
Sbjct: 195 DGKIADVWSCGVTLYVMLVG 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 50/204 (24%), Positives = 78/204 (38%), Gaps = 23/204 (11%)
Query: 176 LGKGGSGAVYKGVLTDERAV-AVKRL--GDLHQGEEV--FWAEVSTIGKIYHMNLVRMWG 230
+G+G G V L + V A+K L ++ + E F E + + +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 231 -FCTEGMHRL-LVYEYVENQSLDKHL--FSSNFLGWKERFKVA-LGTAKGLAYLHHECLE 285
F + L LV +Y L L F RF +A + A + +H
Sbjct: 142 AFQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQLH-- 195
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
+H D+KP+NIL+D ++ADFG + GT Y++PE +
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEG 253
Query: 346 TSK-----VDVFSYGVVILEMLKG 364
D +S GV + EML G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 5e-14
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVK--RLGDLHQGEEVFWA----EVST---IGKIYH 222
E+G G G VYK + VA+K R+ + G EV+ + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGH-FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 223 MNLVRMWGFCTEGMHRL-----LVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKG 275
N+VR+ C LV+E+V+ Q L +L + G + +G
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
L +LH ++H D+KPENIL+ S K+ADFGLA+
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 176 LGKGGSGAVYKG--VLTDERAVAVK-----RLGDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
LG G G V G LT + VAVK ++ L ++ E+ + H +++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHK-VAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKL 81
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + +V EYV L ++ + L KE ++ G+ Y H V+
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP-ITS 347
H D+KPEN+LLD+ KIADFGL+ + G G+ Y APE S
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGP 195
Query: 348 KVDVFSYGVVILEMLKG 364
+VD++S GV++ +L G
Sbjct: 196 EVDIWSSGVILYALLCG 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
L +LH +I+ D+K ENILLDS + DFGL+K + GT Y
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 335 MAPE--WASNLPITSKVDVFSYGVVILEMLKG 364
MAP+ + VD +S GV++ E+L G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVFWA----EVST---IGKIYHMN 224
E+G+G G V+K + R VA+KR+ + GEE EV+ + H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 225 LVRM----WGFCTEGMHRL-LVYEYVENQSLDKHL--FSSNFLGWKERFKVALGTAKGLA 277
+VR+ T+ +L LV+E+V+ Q L +L + + + +GL
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 278 YLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
+LH V+H D+KP+NIL+ S + K+ADFGLA+
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 21/204 (10%)
Query: 176 LGKGGSGAVYKGVLTDERAV-AVKRL--GDLHQGEEV--FWAEVSTIGKIYHMNLVRMWG 230
+G+G V + V A+K + D+ + EV F E + + ++
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 231 FCTEGMHRL-LVYEYVENQSLDKHL--FSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
F + + L LV EY L L F RF +A + +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---Y 183
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-------WA 340
+H D+KP+NILLD ++ADFG + + GT Y++PE
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGP 242
Query: 341 SNLPITSKVDVFSYGVVILEMLKG 364
+ D ++ GV EM G
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYG 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 24/203 (11%)
Query: 176 LGKGGSGAVY----KGVLTDERAVAVKRL--GDLHQGEEV--FWAEVSTIGKIYHMNLVR 227
+G+G G V K + A+K L ++ + + FW E + +V+
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 228 MWG-FCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE 285
++ F + L +V EY+ L + + + RF A L +H
Sbjct: 134 LFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL-ALDAIHSMG-- 188
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
IH DVKP+N+LLD K+ADFG + + + GT Y++PE +
Sbjct: 189 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 346 TSK----VDVFSYGVVILEMLKG 364
D +S GV + EML G
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVG 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRLGDLHQGEEVF----WAEVSTIGKIYHMNLVR 227
++G+G G V+K T + VA+K++ + +E F E+ + + H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQ-KVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 228 MWGFCTEGMHRL--------LVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAY 278
+ C LV+++ E L L + E +V GL Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 279 LHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313
+H ++H D+K N+L+ + K+ADFGLA
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
G+ +LH +IH D+KP NI++ S+ KI DFGLA+ + + + T+
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRY 191
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y APE + VD++S G ++ EM+KG
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF-SRIRGTK 332
G+ +LH +IH D+KP NI++ S+ KI DFGLA R + +S + T+
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTR 227
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y APE + VD++S G ++ EM++
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK----RLGDLHQGEEVFWAEVSTIGKI------YH 222
+GKG G V K ++ VA+K + L+Q + EV + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLH 280
+V + H LV+E + +L L ++NF G K A L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 281 HECLEWVIHCDVKPENILLDSEFEP--KIADFGLA-KLSQRGSNSSQFSRIRGTKGYMAP 337
L +IHCD+KPENILL + KI DFG + +L QR Q SR Y +P
Sbjct: 175 TPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRF-----YRSP 227
Query: 338 EWASNLPITSKVDVFSYGVVILEMLKGIRL 367
E +P +D++S G +++EM G L
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 51/230 (22%)
Query: 166 KKATNSFK--EELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVF---------WAE 213
+K + F+ G+G G V G +VA+K+ V
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---------VIQDPRFRNRELQI 69
Query: 214 VSTIGKIYHMNLVR-MWGFCTEGMHRL------LVYEYVENQSLDKHLFSSNFLGWKERF 266
+ + ++H N+V+ F T G +V EYV H N+ +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAP 126
Query: 267 KVALG------TAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRG 319
L + + LH + V H D+KP N+L++ ++ K+ DFG AK
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 320 SNSSQF--SRIRGTKGYMAPEW---ASNLPITSKVDVFSYGVVILEMLKG 364
+ + SR Y APE + T+ VD++S G + EM+ G
Sbjct: 186 EPNVAYICSRY-----YRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLG 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 32/213 (15%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWA------------EVSTIGKIY 221
+ G GAV GV ++ VA+KR+ + E+ + +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 222 HMNLVR----MWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKG 275
H N++ F MH+L LV E + L + + + + + + G
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 276 LAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYM 335
L LH V+H D+ P NILL + I DF LA+ +N + + + Y
Sbjct: 147 LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV---THRWYR 200
Query: 336 APE----WASNLPITSKVDVFSYGVVILEMLKG 364
APE + T VD++S G V+ EM
Sbjct: 201 APELVMQFKGF---TKLVDMWSAGCVMAEMFNR 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 34/212 (16%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVK----RLGDLHQGEEVFWAEVSTIGKI------YH 222
+ +GKG G V K + VA+K Q E E+ + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNT 158
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLH 280
MN++ M T H + +E + +L + + + F G+ K A + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 281 HECLEWVIHCDVKPENILLDSEFEP--KIADFGLA-KLSQRGSN--SSQFSRIRGTKGYM 335
+ IHCD+KPENILL + K+ DFG + QR S+F Y
Sbjct: 218 KNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------YR 266
Query: 336 APEWASNLPITSKVDVFSYGVVILEMLKGIRL 367
APE +D++S G ++ E+L G L
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPL 298
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF-SRIRGTK 332
+GL Y+H V+H D+KP N+LL++ + KI DFGLA+++ + + F + T+
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 333 GYMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
Y APE N T +D++S G ++ EML
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
KGL Y+H +IH D+KP N+ ++ + E KI DFGLA R ++S + T+
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYV-VTRW 190
Query: 334 YMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
Y APE N T VD++S G ++ EM+ G
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 16/97 (16%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQF--SRIRG 330
+ + ++H + H D+KP+N+L++S+ K+ DFG AK S + SR
Sbjct: 152 RAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-- 206
Query: 331 TKGYMAPEW---ASNLPITSKVDVFSYGVVILEMLKG 364
Y APE A+ T +D++S G V E++ G
Sbjct: 207 ---YRAPELMLGATEY--TPSIDLWSIGCVFGELILG 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
KGL Y+H V+H D+KP N+ ++ + E KI DFGLA+ ++ + T+
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 188
Query: 334 YMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
Y APE + VD++S G ++ EML G
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
+GL Y+H +IH D+KP N+ ++ + E KI DFGLA+ + + + T+
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRW 194
Query: 334 YMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
Y APE N VD++S G ++ E+L G
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 12/100 (12%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRG--- 330
+ + LH VIH D+KP N+L++S + K+ DFGLA++ + + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 331 -----TKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
T+ Y APE + +DV+S G ++ E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 54/267 (20%), Positives = 88/267 (32%), Gaps = 79/267 (29%)
Query: 171 SFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQGEEV--FWAEVSTIGKI-Y 221
+ LG+G G V + R VAVK L + E +E+ + I +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 222 HMNLV----------------------------------RMWGFCTEGMHRLLVYEYVEN 247
H+N+V + T+G +YV
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 248 QSLDKH---------------------------------LFSSNFLGWKERFKVALGTAK 274
+D +FL + + AK
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334
G+ +L + IH D+ NILL + KI DFGLA+ + + + R +
Sbjct: 205 GMEFL--ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 335 MAPEWASNLPITSKVDVFSYGVVILEM 361
MAPE + T + DV+S+GV++ E+
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSSQF-SRIRGT 331
+GL Y+H V+H D+KP N+ +++E KI DFGLA++ + S T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 332 KGYMAPE-WASNLPITSKVDVFSYGVVILEMLKG 364
K Y +P S T +D+++ G + EML G
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 42/185 (22%), Positives = 61/185 (32%), Gaps = 59/185 (31%)
Query: 234 EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGLAYLHHECLEWVIHCD 291
G H +V+E V L K + SN+ G K+ +GL YLH +C +IH D
Sbjct: 116 NGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTD 172
Query: 292 VKPENILLDSE------------------------------------------------- 302
+KPENILL
Sbjct: 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232
Query: 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEML 362
+ KIAD G A + F+ T+ Y + E + D++S + E+
Sbjct: 233 LKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
Query: 363 KGIRL 367
G L
Sbjct: 288 TGDYL 292
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 34/155 (21%), Positives = 65/155 (41%), Gaps = 23/155 (14%)
Query: 173 KEELGKGGSGAVYKGV--LTDERAVAVKRLGDLHQGEEVFWA-----EVSTIGKIYHMNL 225
+ +G G G V + L VA+K++ + + E++ + ++ H ++
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRV-VAIKKILRVFEDLID--CKRILREIAILNRLNHDHV 114
Query: 226 VR----MWGFCTEGMHRL-LVYEYVENQSLDKHLFSSNFLGWKERFKVAL-GTAKGLAYL 279
V+ + E L +V E + K + +L + K L G+ Y+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLT-ELHIKTLLYNLLVGVKYV 172
Query: 280 H-HECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313
H ++H D+KP N L++ + K+ DFGLA
Sbjct: 173 HSAG----ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 32/161 (19%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMW 229
+ LG G +G V + + A+K L D EV + ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 77
Query: 230 GFC----TEGMHRLLVYEYVEN-------QSLDKHLFSSNFLGWKERF--KVALGTAKGL 276
L+V E ++ Q F+ ER ++ + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-------EREASEIMKSIGEAI 130
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEP---KIADFGLAK 314
YLH + H DVKPEN+L S+ K+ DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSSQFSRIR-GT 331
K L Y H ++H DVKP N+++D E + ++ D+GLA + Q +R +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVAS 193
Query: 332 KGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKG 364
+ + PE + + +D++S G ++ M+
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 24/122 (19%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA----------KLSQRGSNSS 323
G ++H +IH D+KP N LL+ + K+ DFGLA ++ N
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 324 QFSRIRGTKGYM----------APEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVV 372
+ K + APE T +D++S G + E+L ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 373 ED 374
+
Sbjct: 257 TN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 29/114 (25%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA---------KLSQRGSNSSQ 324
K + YLH ++H D+KP NILL++E K+ADFGL+ + S +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 325 FSRIRGTKGYM----------APE----WASNLPITSKVDVFSYGVVILEMLKG 364
+ + APE T +D++S G ++ E+L G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTK---YTKGIDMWSLGCILGEILCG 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 8e-08
Identities = 29/191 (15%), Positives = 49/191 (25%), Gaps = 56/191 (29%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRL---------GDLHQGEEVFWAEVSTIGKIYHMN 224
E++G+G G V++ + VA+K + G + E E+ ++
Sbjct: 26 EKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL-- 82
Query: 225 LVRMWGFCTEGMHRL-----------------------------------------LVYE 243
L TEG L +V E
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF 303
+ E +D + + LA H D+ N+LL
Sbjct: 143 F-EFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTS 199
Query: 304 EPKIADFGLAK 314
K+ K
Sbjct: 200 LKKLHYTLNGK 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 33/116 (28%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILL-DSEFEP------------------KIADFGLA- 313
L +LH L H D+KPENIL +SEFE ++ADFG A
Sbjct: 134 HALRFLHENQL---THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 314 KLSQRGSN--SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367
+ + +++ Y PE L DV+S G ++ E +G L
Sbjct: 191 FDHEHHTTIVATRH--------YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 33/116 (28%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILL-DSEFEP------------------KIADFGLA- 313
K + +LH L H D+KPENIL S++ K+ DFG A
Sbjct: 129 KSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 314 KLSQRGSN--SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367
+ S S++ Y APE L + DV+S G +++E G +
Sbjct: 186 YDDEHHSTLVSTRH--------YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 39/156 (25%), Positives = 60/156 (38%), Gaps = 27/156 (17%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM-----NLVR 227
+++G G G + G L VA+K L + E + Y + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEY----RFYKQLGSGDGIPQ 69
Query: 228 MWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK----GLAYLHHEC 283
++ F G + +V E + SL+ LF + K L A + Y+H +
Sbjct: 70 VYYFGPCGKYNAMVLELL-GPSLE-DLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 284 LEWVIHCDVKPENILLDSEFEPK-----IADFGLAK 314
L I+ DVKPEN L+ I DF LAK
Sbjct: 126 L---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 32/114 (28%), Positives = 44/114 (38%), Gaps = 23/114 (20%)
Query: 274 KGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF--SRIR-- 329
K L YL L H D+KPENILLD + K + + + I+
Sbjct: 148 KALNYLRKMSL---THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 330 --G--------------TKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367
G T+ Y APE NL D++S+G V+ E+ G L
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 26/170 (15%), Positives = 57/170 (33%), Gaps = 41/170 (24%)
Query: 176 LGKGGSGAVYKGV---------LTDERAVAVK---RLGDLHQGEEVF--------WAEVS 215
+ G +Y+ ++ ++K + G L + F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 216 TIGKIYHMNLVRMWGF-CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK 274
+ + + GF + +R LV + +SL + + ++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVS-----PKHVLSERSVL 162
Query: 275 GLA--------YLHHECLEWVIHCDVKPENILLDSEFEPKI--ADFGLAK 314
+A +LH +H +V ENI +D E + ++ A +G A
Sbjct: 163 QVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 33/159 (20%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTI---GKIYHM-----N 224
+G+G G +++G L + + VA+K E ++ + + Y +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 225 LVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK----GLAYLH 280
+ ++ F EG+H +LV + + SL+ L + G K K AK + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 281 HECLEWVIHCDVKPENILLDSEFEPK-----IADFGLAK 314
+ L ++ D+KP+N L+ + DFG+ K
Sbjct: 124 EKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 33/163 (20%)
Query: 170 NSFK--EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTI---GKIYHM 223
N F+ ++G G G +Y G + VA+K E + + KIY +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRI 58
Query: 224 -----NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK---- 274
+ + F EG + +LV + + SL+ LF NF K K L A
Sbjct: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLF--NFCSRKLSLKTVLMLADQMIN 114
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPK---IADFGLAK 314
+ ++H + +H D+KP+N L+ I DFGLAK
Sbjct: 115 RVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 45/163 (27%), Positives = 67/163 (41%), Gaps = 33/163 (20%)
Query: 170 NSFK--EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTI---GKIYHM 223
N ++ ++G G G +Y G + VA+K E + + KIY M
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKM 60
Query: 224 -----NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA----K 274
+ + EG + ++V E + SL+ LF NF K K L A
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE-DLF--NFCSRKFSLKTVLLLADQMIS 116
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPK---IADFGLAK 314
+ Y+H + IH DVKP+N L+ + I DFGLAK
Sbjct: 117 RIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 9e-05
Identities = 31/171 (18%), Positives = 61/171 (35%), Gaps = 43/171 (25%)
Query: 176 LGKGGSGAVYKGVLTDERAVAVKRL----------GDLHQ--------GEEVFWAEVSTI 217
+G+GG G +Y + +V G L + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 218 GKIYHMNLVRMWGF----CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTA 273
K+ ++ + + WG +R ++ + L K ++ +N +RF T
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEAN----AKRFS--RKTV 154
Query: 274 KGLA--------YLHHECLEWVIHCDVKPENILLDSEFEPKI--ADFGLAK 314
L+ Y+H +H D+K N+LL+ + ++ D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 27/162 (16%), Positives = 54/162 (33%), Gaps = 28/162 (17%)
Query: 176 LGKGGSGAVYKGV-LTDERAVAVK-------RLGDLH---------QGEEVFWAEVSTIG 218
+G GG G +Y A G L ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI-KKWIERK 103
Query: 219 KIYHMNLVRMWGF----CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAK 274
++ ++ + +G +R +V E + L K + ++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSEFEPKI--ADFGLAK 314
L Y+H +H D+K N+LL + ++ AD+GL+
Sbjct: 163 VLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2yil_A Microneme antigen L2; sugar binding protein, apple-domain tandem repeat, PAN_AP, P galactose-binding lectin, cellular adhesion; 1.95A {Sarcocystis muris} PDB: 2yio_A* 2yip_A* Length = 138 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 3e-04
Identities = 13/57 (22%), Positives = 19/57 (33%), Gaps = 1/57 (1%)
Query: 4 VDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSELFNGYKAPNF 60
+ L+ S + CMK C CS F+Y + C K+ Y
Sbjct: 16 IGSRTEQLSVVHVASAQDCMKECQALPTCSHFTYN-KNSKKCHLKAGAPEFYTYTGD 71
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 464 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.14 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.7 | |
| 4a5v_A | 161 | MIC4, micronemal protein 4; adhesion; NMR {Toxopla | 95.09 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 94.95 | |
| 4a5v_A | 161 | MIC4, micronemal protein 4; adhesion; NMR {Toxopla | 93.35 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.01 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.58 | |
| 2f83_A | 625 | Coagulation factor XI; protease, apple domain, hyd | 90.1 | |
| 2f83_A | 625 | Coagulation factor XI; protease, apple domain, hyd | 89.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.13 | |
| 2yil_A | 138 | Microneme antigen L2; sugar binding protein, apple | 89.03 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.06 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.76 | |
| 2yil_A | 138 | Microneme antigen L2; sugar binding protein, apple | 84.03 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.95 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 82.63 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 81.17 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 80.67 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=453.24 Aligned_cols=264 Identities=25% Similarity=0.324 Sum_probs=216.3
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceecccee
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGF 231 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~ 231 (464)
.++.|+..++..|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3344555566788999999999999999973 46789999997543 334789999999999999999999999
Q ss_pred eeeCcEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 232 CTEGMHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 232 ~~~~~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
|.++...+||||||++|+|.++|... ..++|..++.|+.|||.||+|||+ .+||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 99999999999999999999999632 359999999999999999999999 89999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccC
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVED 374 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~ 374 (464)
||||++++.+||+|||+++...............||+.|||||.+.+..++.++|||||||+||||+| |+.||....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-- 252 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-- 252 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987654433333455779999999999999999999999999999999999 888886321
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
. .+. ...+..+ ...+.+.+++..+.+|+.+||+.||++||||.||++.|+...+
T Consensus 253 ----~---~~~----~~~i~~~------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 253 ----N---QDV----VEMIRNR------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ----H---HHH----HHHHHTT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ----H---HHH----HHHHHcC------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1 111 1111111 1112334456678999999999999999999999999997654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=439.82 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=202.7
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
....+.++||+|+||+||+|++.+ .||||+++... ...+.|.+|+++|++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 334678899999999999999754 59999987432 334679999999999999999999999875 468999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.++|... ..++|..++.|+.|||.||+|||+ ++||||||||+||||++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999754 579999999999999999999999 899999999999999999999999999998765544444
Q ss_pred ceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 QFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
......||+.|||||++.+ ..|+.++|||||||+||||+||+.||..... .. .+... +
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~----~~~~~---~------- 250 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RD----QIIFM---V------- 250 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HH----HHHHH---H-------
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HH----HHHHH---H-------
Confidence 4566789999999999864 4689999999999999999999999963211 00 11111 1
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
......+.+. ..+.+.+..+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 251 ~~~~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 251 GRGYASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HTTCCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1112222221 2233455678999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=444.72 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=203.1
Q ss_pred hhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.++||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.++...+|||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356789999999999999974 47889999998543 34577999999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 243 EYVENQSLDKHLFSS---------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 243 E~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
||+++|+|.++|... ..++|.+++.|+.|||.||+|||+ ++||||||||+||||++++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEE
Confidence 999999999999643 359999999999999999999999 89999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
+|||+++...............||+.|||||.+.+..++.++|||||||+||||+| |+.||..... .+.+
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---------~~~~ 270 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---------TEAI 270 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---------HHHH
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---------HHHH
Confidence 99999987655444333456779999999999999999999999999999999999 8999863210 1111
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
..+..+. ....+...++.+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 271 ----~~i~~g~------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 ----DCITQGR------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----HHHHHTC------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHcCC------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 1122334456789999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=445.02 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=209.3
Q ss_pred HhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.++||+|+||+||+|++. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3467789999999999999874 46789999998543 3457799999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 242 YEYVENQSLDKHLFSS-------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
|||+++|+|.++|... ..++|.+++.|+.|||.||+|||+ ++||||||||+||||++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999643 369999999999999999999999 899999999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||+|+...............||+.|||||.+.+..|+.++|||||||+||||+| |+.||.... . .+.
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~------~---~~~-- 239 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------N---NEV-- 239 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------H---HHH--
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------H---HHH--
Confidence 9999987654333222334569999999999999999999999999999999999 899986321 0 111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...+..+. ....+...++.+.+|+.+||+.||++||||++|++.|+++..
T Consensus 240 --~~~i~~~~------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 240 --IECITQGR------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp --HHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHcCC------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111 012233445678999999999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=420.65 Aligned_cols=274 Identities=24% Similarity=0.269 Sum_probs=205.0
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc----EEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~E~~ 245 (464)
+.+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|.+.+ ..+|||||+
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 45668999999999999998 5789999999765544444556777778899999999999997653 679999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC-----LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
++|+|.++|.. ..++|..+.+++.|++.||+|||+.+ .++||||||||+||||+.++++||+|||+++......
T Consensus 84 ~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 84 EHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 99999999964 46999999999999999999999842 2489999999999999999999999999998765443
Q ss_pred CC--cceeeeccCCCccCcccccCC------CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhh--HHHHHHHHH
Q 040010 321 NS--SQFSRIRGTKGYMAPEWASNL------PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAE--LTGFIREVK 390 (464)
Q Consensus 321 ~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~ 390 (464)
.. .......||+.|||||++.+. .++.++|||||||+||||+||+.|+............. .........
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 22 123346799999999998764 36789999999999999999988765322111100000 000001111
Q ss_pred HHhhccchhhhhhhcCCccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHF-NKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
... ....++|.+.... +.+....+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 243 ~~~-------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 243 KVV-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHH-------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH-------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111 1222233332211 235677899999999999999999999999999887543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=430.47 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=211.5
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhccc-cceeccceeeee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYH-MNLVRMWGFCTE 234 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~ 234 (464)
|+....+.+.++||+|+||.||+|.+.+ ++.||||+++... ...+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 4555667888999999999999998643 3589999997543 234679999999999965 899999999976
Q ss_pred C-cEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 235 G-MHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 235 ~-~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
. ...++|||||++|+|.++|.+. ..++|..++.|+.|||+||+|||+ ++||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 6789999999999999999642 358999999999999999999999 8999999999999
Q ss_pred EEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCcc
Q 040010 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSE 376 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~ 376 (464)
|+++++.+||+|||+|+...............||+.|||||.+.+..|+.++|||||||+||||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999997765544444556789999999999999999999999999999999998 899986432110
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.+. ..+..+. +...+.....++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 296 -------~~~----~~i~~g~------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 -------EFC----RRLKEGT------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp -------HHH----HHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHH----HHHHcCC------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011 1111111 11222334557889999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=406.93 Aligned_cols=243 Identities=25% Similarity=0.352 Sum_probs=196.4
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee----CcEEeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE----GMHRLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 242 (464)
.|.++||+|+||+||+|... ++..||+|++.... ...+.|.+|+++|++++|||||++++++.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 57899999986432 234668999999999999999999999865 35689999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEcC-CCCeEEeeecCccccCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLDS-EFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 319 (464)
||+++|+|.++|.+...+++..+..|+.||+.||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999988899999999999999999999999 55 999999999999984 79999999999986433
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.......||+.|||||.+.+ .|+.++|||||||+||||+||+.||..... . ..+...+..+.
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--------~----~~~~~~i~~~~-- 246 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--------A----AQIYRRVTSGV-- 246 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------H----HHHHHHHTTTC--
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--------H----HHHHHHHHcCC--
Confidence 22456789999999998865 699999999999999999999999963211 0 01111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+.+... ..+.+.+|+.+||+.||++|||+.|+++
T Consensus 247 -----~~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 -----KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111 2345788999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=409.26 Aligned_cols=249 Identities=22% Similarity=0.230 Sum_probs=201.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.+.++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.++...+|||||+++|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 345678999999999999974 589999999975322 246999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCc---c
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSS---Q 324 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~---~ 324 (464)
+|.++|.+.+.+++..+..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+......... .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999999988899999999999999999999999 8999999999999999987 69999999999775433221 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|||||.+.+..|+.++|||||||+||||+||+.||....... . ... +..+.
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~----~~~----i~~~~------- 272 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----L----CLK----IASEP------- 272 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----C----HHH----HHHSC-------
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----H----HHH----HHcCC-------
Confidence 234679999999999999999999999999999999999999997432111 0 011 11000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
+.+ ...+......+.+++.+||+.||.+|||+.|+++.|..
T Consensus 273 --~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 273 --PPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --CGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 000 01222344568899999999999999999999887754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=406.89 Aligned_cols=245 Identities=22% Similarity=0.240 Sum_probs=207.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.|.+.+.||+|+||+||+++.. +++.||||++... ....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3677889999999999999974 6889999999743 2334678999999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.++|.+.+.+++.....++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.........
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999999988899999999999999999999999 999999999999999999999999999999876554444
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|||||.+.+..|+.++||||+||+||||+||+.||.... . .. +..++..+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~---~~----~~~~i~~~~------ 250 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------E---GL----IFAKIIKLE------ 250 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------H---HH----HHHHHHHTC------
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------H---HH----HHHHHHcCC------
Confidence 5567889999999999999999999999999999999999999996321 1 11 111111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSV 442 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V 442 (464)
..+ +......+.+|+.+||+.||++|||+.|+
T Consensus 251 ---~~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 251 ---YDF----PEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ---CCC----CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 111 22234567889999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=406.84 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=204.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..||||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 556678999999999999975 68999999996433 3446688999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.+ ..+++..+..|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+...... .....
T Consensus 156 g~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~ 229 (346)
T 4fih_A 156 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 229 (346)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCC
T ss_pred CcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Ccccc
Confidence 999999865 579999999999999999999999 999999999999999999999999999998765432 22456
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|||||.+.+..|+.++|||||||++|||++|+.||.... . ...+.. + ..-..+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~---~~~~~~----i--------~~~~~~ 288 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------P---LKAMKM----I--------RDNLPP 288 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------H---HHHHHH----H--------HHSSCC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------H---HHHHHH----H--------HcCCCC
Confidence 789999999999999999999999999999999999999996321 0 111111 1 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11233456889999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=410.62 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=197.5
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.|.+.++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3667789999999999999974 68999999986432 2346789999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.++|... ..+++...+.|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+..... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 9999999999744 357899999999999999999999 99999999999999999999999999999865432 1
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......||+.|||||.+.+..|+.++|||||||+||||+||+.||.... ....+ .++..+.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---------~~~~~----~~i~~~~----- 241 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---------MKNLV----LKIISGS----- 241 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---------HHHHH----HHHHHTC-----
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---------HHHHH----HHHHcCC-----
Confidence 12345679999999999999999999999999999999999999997321 11111 1111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. +. .+......+.+|+.+||+.||++|||+.|+++
T Consensus 242 --~-~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 --F-PP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --C-CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C-CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 11 12233456889999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=388.89 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=190.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.|.+.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467788999999999999996 468999999986432 234568999999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+ +|+|.+++.+...+++.....++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--- 166 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence 99 68999999888899999999999999999999999 999999999999999999999999999998654332
Q ss_pred ceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|||||.+.+..+ +.++||||+||++|||+||+.||.... .... ...+..+.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---------~~~~----~~~i~~~~----- 228 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---------IPVL----FKNISNGV----- 228 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---------HHHH----HHHHHHTC-----
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---------HHHH----HHHHHcCC-----
Confidence 2345789999999999998876 579999999999999999999996321 1111 11111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+ +......+.+|+.+||+.||++|||+.|+++
T Consensus 229 ----~~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 ----YTL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 2223456788999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=406.68 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=206.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
|.+.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556678999999999999975 58999999997433 3446688999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
|+|.+++.. ..+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...... .....
T Consensus 233 G~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~ 306 (423)
T 4fie_A 233 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 306 (423)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCC
T ss_pred CcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccc
Confidence 999999854 569999999999999999999999 999999999999999999999999999998765432 22456
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|||||.+.+..|+.++|||||||++|||++|+.||.... . ...+.. + ..-..+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~---~~~~~~----i--------~~~~~~ 365 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------P---LKAMKM----I--------RDNLPP 365 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------H---HHHHHH----H--------HHSCCC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------H---HHHHHH----H--------HcCCCC
Confidence 789999999999999999999999999999999999999996321 0 011111 1 111112
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCC
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGC 449 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~ 449 (464)
.+.. .......+.+|+.+||+.||++|||+.|+++ .+.+.
T Consensus 366 ~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 366 RLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CCSC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCcc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 2211 1223456889999999999999999999987 35443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=398.10 Aligned_cols=245 Identities=23% Similarity=0.219 Sum_probs=196.3
Q ss_pred HhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.|.+.+.||+|+||+||+++.. .++.||||+++... .....+.+|+++|++++|||||++++++.+.+..++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4678889999999999999862 46789999997532 2335688999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.++|.+...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999999999988899999999999999999999999 999999999999999999999999999998654322
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......||+.|||||.+.+..|+.++|||||||+||||+||+.||.... . .+.. ..+..+
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~---~~~~----~~i~~~----- 241 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------R---KETM----TMILKA----- 241 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHHH----HHHHHC-----
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------H---HHHH----HHHHcC-----
Confidence 22345789999999999999999999999999999999999999997321 0 1111 111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM-----DSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm-----~~V~~ 444 (464)
.. .++......+.+|+.+||+.||++|||+ +|+++
T Consensus 242 ------~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 ------KL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 1222334568899999999999999994 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=385.72 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=187.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCc---------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM--------- 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------- 236 (464)
.+.+.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3567789999999999999974 68899999986432 33467899999999999999999999886543
Q ss_pred ---EEeEEEEeccCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 040010 237 ---HRLLVYEYVENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310 (464)
Q Consensus 237 ---~~~lv~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 310 (464)
..++||||+++|+|.+++.... ..++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 4789999999999999997654 35677789999999999999999 89999999999999999999999999
Q ss_pred cCccccCCCCCCc----------ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhh
Q 040010 311 GLAKLSQRGSNSS----------QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA 380 (464)
Q Consensus 311 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 380 (464)
|+|+......... ..+...||+.|||||.+.+..|+.++|||||||++|||++ ||... ..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~ 232 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------ME 232 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cH
Confidence 9998765432211 1234679999999999999999999999999999999996 55411 00
Q ss_pred hHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCC
Q 040010 381 ELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGC 449 (464)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~ 449 (464)
. .. .. ..+.+.... ....+.......|+.+||+.||++|||+.|+++ .++++
T Consensus 233 -~---~~-~~-----------~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 233 -R---VR-TL-----------TDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp -H---HH-HH-----------HHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred -H---HH-HH-----------HHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 0 00 00 111111110 011223345678999999999999999999987 45544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=374.88 Aligned_cols=267 Identities=21% Similarity=0.240 Sum_probs=201.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee------CcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE------GMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 239 (464)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++|||||++++++.. ..+.|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 667789999999999999974 68999999997543 233568899999999999999999998753 36789
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|||||++ |+|.+++.+...+++..+..++.||+.||.|||+ .+||||||||+|||++.++.+||+|||+|+.....
T Consensus 136 ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9999996 6899999888899999999999999999999999 99999999999999999999999999999876433
Q ss_pred CC--CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 320 SN--SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 320 ~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.. ........||+.|||||.+.+. .++.++||||+||++|||++|+.||..... . ..+..+.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-----~----~~l~~I~~~~g~p 282 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-----V----HQLQLIMMVLGTP 282 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----H----HHHHHHHHHHCCC
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-----H----HHHHHHHHhcCCC
Confidence 21 2234567899999999998775 569999999999999999999999974211 1 1111111111000
Q ss_pred chhh--------hhhh---cCCccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCC
Q 040010 397 EEAR--------IEEI---VDPRLKGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEA 451 (464)
Q Consensus 397 ~~~~--------~~~~---~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~ 451 (464)
.... .... +.+. ...+. .....+.+|+.+||+.||++|||+.|+++ .+.+..+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred ChHHhhhhhhhhhhhhhhcCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 0000 0000 0000 01111 12356788999999999999999999987 4555433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=365.45 Aligned_cols=270 Identities=35% Similarity=0.563 Sum_probs=226.5
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.+.+.||+|+||.||+|...+++.||||++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 34456899999999999998889999999987543 34577899999999999999999999999999999999999999
Q ss_pred ChHHhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 249 SLDKHLFSSN----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 249 sL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+|.+++.... .++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...........
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997543 59999999999999999999999 8999999999999999999999999999987554333333
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......|.... ... ..+..+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~---~~~---~~~~~~ 268 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE---MVNLAEWAVES---HNN---GQLEQI 268 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS---CCCHHHHTHHH---HTT---TCCCSS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH---HHHHHHHhhhc---ccc---ccHHHh
Confidence 345668999999999988899999999999999999999999987543222 11222222221 111 125667
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+++.+......+....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 78887778888999999999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=370.23 Aligned_cols=291 Identities=41% Similarity=0.674 Sum_probs=237.2
Q ss_pred ccCccccCHHHHHHHHhhh--ccccCccCceEEEEEEECCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccc
Q 040010 154 SSQFKRFSYAELKKATNSF--KEELGKGGSGAVYKGVLTDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMW 229 (464)
Q Consensus 154 ~~~~~~~~~~el~~~~~~~--~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~ 229 (464)
......|++.++...+.+| .+.||+|+||.||+|...+++.||||++.... .....+.+|++++++++|+||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3456778999998877665 46899999999999998889999999997543 2334689999999999999999999
Q ss_pred eeeeeCcEEeEEEEeccCCChHHhhhcCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN----FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 230 g~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
+++......++||||+++|+|.+++.... .++|..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997543 49999999999999999999999433399999999999999999999
Q ss_pred EEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 306 KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
||+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......|
T Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~ 251 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND-DDVMLLDW 251 (326)
T ss_dssp EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT-SCSBHHHH
T ss_pred EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc-cchhHHHH
Confidence 9999999987654322 223446699999999999888899999999999999999999999964221111 11122222
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+... . .......+.+..+......+....+.+++.+||+.||.+|||+.+|+++|++....
T Consensus 252 ~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 252 VKGL---L---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp HTTT---T---SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHH---h---hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 2211 1 12225667777777888899999999999999999999999999999999986543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=369.70 Aligned_cols=195 Identities=25% Similarity=0.311 Sum_probs=167.0
Q ss_pred HhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.|.+.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +|||||++++++.+.++.++|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 3677789999999999999853 46789999987543 345578899999998 69999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccCCCCC-
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSN- 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~- 321 (464)
|+++|+|.+++. .+++.+...++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 58999999999999999999999 999999999999999877 7999999999986543211
Q ss_pred -------------------------CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 322 -------------------------SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 322 -------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
........||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 0112345799999999998775 589999999999999999999999964
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.99 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=200.1
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||+||+|.. +++.||||++.... ...+.+.+|++++++++|+||+++++++......++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 3456678999999999999988 57889999987543 2335688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 245 VENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 245 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+++|+|.+++.... .+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999997654 39999999999999999999999 77 999999999999999999999999999764432
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---------~~~~~~~~--------- 252 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------AQVVAAVG--------- 252 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---------HHHHHHHH---------
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHH---------
Confidence 2 123446799999999999999999999999999999999999999863211 01111100
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~ 455 (464)
.. ......+......+.+++.+||+.||.+|||+.++++.|+.+.....|
T Consensus 253 --~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 253 --FK----CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp --HS----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred --hc----CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 00 011122233445688999999999999999999999999988764333
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=349.78 Aligned_cols=281 Identities=38% Similarity=0.646 Sum_probs=229.3
Q ss_pred cCccccCHHHHHHHHhhhcc--------ccCccCceEEEEEEECCCcEEEEEEcCCc-----cchhHHHHHHHHHhhhcc
Q 040010 155 SQFKRFSYAELKKATNSFKE--------ELGKGGSGAVYKGVLTDERAVAVKRLGDL-----HQGEEVFWAEVSTIGKIY 221 (464)
Q Consensus 155 ~~~~~~~~~el~~~~~~~~~--------~lG~G~~g~Vy~g~~~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~ 221 (464)
.....|++.++.+++.+|.+ .||+|+||.||+|.. +++.||||++... ....+.+.+|++++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34678999999999999874 499999999999997 6789999998643 223467889999999999
Q ss_pred ccceeccceeeeeCcEEeEEEEeccCCChHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEE
Q 040010 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS---SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298 (464)
Q Consensus 222 h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 298 (464)
||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 99999999999999999999999999999999863 3469999999999999999999999 89999999999999
Q ss_pred EcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccch
Q 040010 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378 (464)
Q Consensus 299 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~ 378 (464)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--- 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence 99999999999999987655433333344679999999998865 58999999999999999999999987432211
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
....+..... .....+.+.+++.+. ..+......+.+++.+||+.||.+|||+.+|++.|+++.+
T Consensus 242 --~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 --LLLDIKEEIE-----DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --BTTHHHHHHH-----TTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHHHHHHhh-----hhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111111 111224555666553 4567788899999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=382.91 Aligned_cols=245 Identities=24% Similarity=0.264 Sum_probs=197.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHH---HHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFW---AEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+.+.+.||+|+||.||+++.. +|+.||||+++... ....... .++.+++.++|||||++++++.+.+..|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 456678999999999999975 58999999996421 2222233 346677788999999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||++||+|.++|.+...+++..+..++.||+.||+|||+ .+||||||||+||||+.++++||+|||+|+......
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 9999999999999988899999999999999999999999 999999999999999999999999999998765432
Q ss_pred CcceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....+||+.|||||.+. +..|+.++|||||||+||||++|+.||....... ... +......
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~------~~~----i~~~i~~----- 408 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHE----IDRMTLT----- 408 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC------HHH----HHHHHHH-----
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHH----HHHhhcC-----
Confidence 34568999999999986 4579999999999999999999999997432111 111 1111110
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
.... ++......+.+|+.+||+.||.+|++ +.||.+
T Consensus 409 ----~~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 ----MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111 22233456889999999999999998 577654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.43 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc----EEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~E~ 244 (464)
.+.+.+.||+|+||+||+|+.. ++.||||++.........+..|+.++++++||||+++++++.... ..++||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 3566789999999999999985 689999999876666666778999999999999999999997743 47999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------ceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE----------WVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
+++|+|.+++.. ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 104 HEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp CTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999999965 459999999999999999999999 6 99999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH-----
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNL-----PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG----- 384 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~----- 384 (464)
...............||+.|+|||.+.+. .++.++||||||+++|||+||+.||......... .+..
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~ 256 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML---PFEEEIGQH 256 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC---TTHHHHCSS
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc---chhhhhccC
Confidence 76654443334456799999999998763 4567899999999999999999998754322110 0000
Q ss_pred -HHHHHHHHhhccchhhhhhhcCCccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 385 -FIREVKEKILCGEEARIEEIVDPRLKGHF-NKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 385 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
......... ......+.+...+ .......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 257 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVV-------VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHH-------TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cchhhhhhhh-------hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000000 1111112111111 2245677999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=355.56 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=208.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||+||++... +++.||+|++... ....+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 3566789999999999999975 5889999988653 3455779999999999999999999999999999999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc--
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS-- 323 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 323 (464)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999986 5689999999999999999999999 899999999999999999999999999998765432211
Q ss_pred ----------ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 324 ----------QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 324 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+.................
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~-------- 239 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF-------- 239 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH--------
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc--------
Confidence 11245799999999999999999999999999999999999998864332221111111111
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...... ......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 240 -------~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 240 -------LDRYCP--------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -------HHHTCC--------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------ccccCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1122358889999999999999999999999988754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=363.10 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=208.0
Q ss_pred HHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhc-cccceeccceeeeeCc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGM 236 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 236 (464)
..+.+.+.||+|+||.||+|... ++..||||+++.... ..+.+.+|+++++++ +||||++++++|....
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 34567789999999999999862 346799999975432 346789999999999 8999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc
Q 040010 237 HRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 300 (464)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 999999999999999999753 248999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchh
Q 040010 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQE 379 (464)
Q Consensus 301 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 379 (464)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----E 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 999999999999987655433333344567889999999999999999999999999999999 8888863211 0
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.... .+.. ......+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 313 ----~~~~----~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 ----ELFK----LLKE------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ----GHHH----HHHT------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHH----HHhc------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1110 1111222334457889999999999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=381.62 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=204.2
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.|.+.+.||+|+||.||++... +|+.||+|++..... ..+.+.+|+++|+.++|||||++++++.+....+|||||++
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4677889999999999999974 589999999875433 44668899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC--CCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE--FEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+|+|.++|... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++..... .
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~ 311 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 311 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---S
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---C
Confidence 99999998654 579999999999999999999999 999999999999999854 89999999999877543 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|||||.+.+..|+.++|||||||++|||++|+.||..... . . ....+..+. -
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~----~----~~~~i~~~~-----~ 373 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----D----E----TLRNVKSCD-----W 373 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----H----H----HHHHHHTTC-----C
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----H----H----HHHHHHhCC-----C
Confidence 34567899999999999999999999999999999999999999973211 0 1 111111111 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
-.++.... .....+.+|+.+||+.||.+|||+.|+++
T Consensus 374 ~~~~~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111111 22346788999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=361.11 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=207.4
Q ss_pred HHHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
...+.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.+.+|++++++++|+||+++++++.++...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 344566788999999999999984 3457999999854 3344678999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999754 579999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 320 SNSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 320 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... . ... ..+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~---~~~----~~~~--- 268 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------R---DVI----SSVE--- 268 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------H---HHH----HHHH---
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------H---HHH----HHHH---
Confidence 3221 2233456778999999998899999999999999999999 9988863211 0 111 1110
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
. ......+......+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus 269 -----~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 269 -----E----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----c----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 111122333456788999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.74 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=211.8
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.+.||+|+||.||+|...++..||+|++.......+++.+|++++++++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 34566778999999999999999988899999998777677889999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 162 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SS 162 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-EC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cc
Confidence 999999997654 59999999999999999999999 89999999999999999999999999999876543221 12
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... ....+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~----~~~~~-------- 221 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---------SEVVL----KVSQG-------- 221 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHHH----HHHTT--------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---------HHHHH----HHHcC--------
Confidence 33446678999999998889999999999999999999 8888863211 01111 11000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
... ..+......+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 222 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 HRL----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCC----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCC----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 000 1111223468899999999999999999999999998865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.12 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=214.3
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
++....+.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++||||+++++++. ....++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3444556778899999999999999988899999999876667788999999999999999999999987 567899999
Q ss_pred eccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 244 YVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999754 378999999999999999999999 8999999999999999999999999999987643211
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.......++..|+|||.+....++.++||||||++||||+| |+.||..... .+.... +..+
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---------~~~~~~----i~~~---- 401 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---------PEVIRA----LERG---- 401 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------HHHHHH----HHHT----
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHHH----HHcC----
Confidence 11223446778999999998999999999999999999999 9988863210 111111 1100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVP 456 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~~ 456 (464)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+.......
T Consensus 402 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 402 --------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred --------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 011112234567899999999999999999999999999987654443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=366.70 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=205.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||+|.+. +++.||||.++... ...+.|.+|++++++++||||+++++++......++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34567789999999999999986 68899999987542 2335688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999754 469999999999999999999999 899999999999999999999999999998644321111
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ... ...
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~~-------~~~---------- 327 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQT-------REF---------- 327 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HHH-------HHH----------
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHH-------HHH----------
Confidence 1112335678999999998899999999999999999998 8888763211 000 011
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+........+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 328 --~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 328 --VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111111222334457889999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=372.01 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=209.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+....+.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++||||+++++++.+ ...++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3444567778999999999999999888899999998766666789999999999999999999999876 678999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 9999999999743 569999999999999999999999 8999999999999999999999999999987653221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+.. ..+..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---------~~~~----~~i~~------ 396 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVL----DQVER------ 396 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHH----HHHHT------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---------HHHH----HHHHc------
Confidence 11233457788999999998899999999999999999999 8888863210 0111 11111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVP 456 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~~ 456 (464)
......+....+.+.+++.+||+.||++|||+.+|++.|+.+.....++
T Consensus 397 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 397 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 1111223344567889999999999999999999999999987654443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.68 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=200.1
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCc----EEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||+||+|+.. +++ .||+|.+... ....+.+.+|+.++++++||||++++++|.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34566789999999999999964 333 4688988643 244577999999999999999999999998765 789
Q ss_pred EEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|+||+++|+|.+++.. ...+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999976 4579999999999999999999999 89999999999999999999999999999877655
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~---------------- 228 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EI---------------- 228 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GH----------------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------HH----------------
Confidence 44433445667889999999999999999999999999999999 99998642111 11
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
...+........+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 229 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111111111223334557889999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.36 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=209.8
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||+|...+++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||++++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 45677899999999999999988899999999877777788999999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .....
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 166 (269)
T 4hcu_A 91 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG 166 (269)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred cHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccC
Confidence 999999654 469999999999999999999999 8999999999999999999999999999986543211 11223
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .+. .-..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---------~~~~~----~~~--------~~~~ 225 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------SEVVE----DIS--------TGFR 225 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHHH----HHH--------TTCC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---------HHHHH----HHh--------cCcc
Confidence 456778999999999999999999999999999999 8888863211 01111 111 0011
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...+......+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 226 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11122234568899999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=376.31 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=215.2
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.++....+.+.+.||+|+||.||+|.+.. +..||||.++......+.|.+|+++|++++||||++++++|......++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34455567778899999999999999865 78999999987666678899999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 242 YEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999753 469999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. .......++..|+|||.+.+..++.++||||||++||||++ |+.|+..... .. ..
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~---~~------------ 429 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQ---VY------------ 429 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GG---HH------------
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HH---HH------------
Confidence 21 11223446778999999998899999999999999999999 8888763211 00 11
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+.+........+......+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 430 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 430 ----ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11111111122333456788999999999999999999999999988653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=344.58 Aligned_cols=260 Identities=24% Similarity=0.314 Sum_probs=210.7
Q ss_pred ccccCHHHHHHHHhh------------hccccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhccc
Q 040010 157 FKRFSYAELKKATNS------------FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYH 222 (464)
Q Consensus 157 ~~~~~~~el~~~~~~------------~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h 222 (464)
...|++++++.++.. +.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356889999888754 3357999999999999986 6899999998744 3345678899999999999
Q ss_pred cceeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC
Q 040010 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE 302 (464)
Q Consensus 223 ~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 302 (464)
+||+++++++..+...++||||+++++|.+++. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999999985 4579999999999999999999999 899999999999999999
Q ss_pred CCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhH
Q 040010 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 303 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 382 (464)
+.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~--- 246 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------P--- 246 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------H---
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------H---
Confidence 9999999999987654322 2345679999999999999999999999999999999999999986321 0
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...... +.....+.+. ........+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~------------~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 VQAMKR------------LRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH------------HHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHH------------HhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 1111111111 111234568899999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=363.31 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=195.8
Q ss_pred HHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|++. ++..||||+++... ...+.|.+|++++++++||||+++++++.++...++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 34566789999999999999864 46789999997542 3446799999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999997654 79999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---------~~~~----~~------ 262 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVI----KA------ 262 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---------HHHH----HH------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH----HH------
Confidence 211 1223345778999999999999999999999999999998 9988863210 0111 11
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
++.......+......+.+++.+||+.||.+||++.+|+++|+.+.
T Consensus 263 ------i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 263 ------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ------HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111111223344567899999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.27 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=208.0
Q ss_pred HHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
...+.+.+.||+|+||.||++...++..||+|++.......+++.+|++++++++|+||+++++++.+....++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 34566778999999999999999988899999998777677889999999999999999999999999999999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 178 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 178 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HST
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-ccc
Confidence 9999999976 4679999999999999999999999 8999999999999999999999999999986543211 112
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .+ ...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---------~~~~~----~~--------~~~ 237 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------SETAE----HI--------AQG 237 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHHH----HH--------HTT
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---------hHHHH----HH--------hcc
Confidence 23446778999999998899999999999999999998 9888863211 01111 11 111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
... ..+....+.+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 238 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 238 LRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111 112222356889999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.41 Aligned_cols=260 Identities=26% Similarity=0.305 Sum_probs=211.3
Q ss_pred HHHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhc-cccceeccceee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKI-YHMNLVRMWGFC 232 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~ 232 (464)
++....+.+.+.||+|+||.||+|... .+..||||++..... ....+.+|+++++++ +|+||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344456677889999999999999862 235799999975432 346788999999999 999999999999
Q ss_pred eeCcEEeEEEEeccCCChHHhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLFSSN----------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
...+..++||||+++|+|.+++.... .+++..++.|+.|++.||+|||+ .+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 99999999999999999999997543 59999999999999999999999 899999999999
Q ss_pred EEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCc
Q 040010 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDS 375 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~ 375 (464)
||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~--- 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 9999999999999999987665443333445667889999999999999999999999999999999 888886321
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...... .+. .-.. ...+......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 299 ------~~~~~~----~~~--------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 299 ------VEELFK----LLK--------EGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ------HHHHHH----HHH--------TTCC----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHH----HHH--------cCCC----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 111 1111 11122334568899999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=364.09 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=206.6
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.||+|.+. ++..||||+++.. ......+.+|+.++++++|+||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 345677889999999999999953 4568999999753 33446788999999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEe
Q 040010 239 LLVYEYVENQSLDKHLFSS-------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIA 308 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~ 308 (464)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999743 359999999999999999999999 8999999999999999554 59999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||..... ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---------~~~~- 296 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------QEVL- 296 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------HHHH-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH-
Confidence 9999986533322223344668999999999999999999999999999999998 8888863210 0111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..+.. ......+......+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus 297 ---~~i~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 ---EFVTS------------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ---HHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHc------------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11110 00111122334568899999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=344.66 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=209.2
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
..+.+.+.||+|+||.||+|...++..||||.+.......+.+.+|++++++++|+||+++++++.. +..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 4567778999999999999999888899999998766667789999999999999999999999874 458999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ ...
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 167 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR 167 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccc
Confidence 99999997543 79999999999999999999999 8999999999999999999999999999987654321 112
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ..+..+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------~~~~----~~~~~~-------- 226 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------PEVI----QNLERG-------- 226 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHH----HHHHTT--------
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---------HHHH----HHHhcc--------
Confidence 23456788999999988889999999999999999999 8888763210 0111 111100
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCCCCCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTI 460 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~~~p~~ 460 (464)
... ..+......+.+++.+||+.||++|||+.++++.|+.+......+.++.
T Consensus 227 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 278 (279)
T 1qpc_A 227 YRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQ 278 (279)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-------
T ss_pred cCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCCCC
Confidence 111 1122334578899999999999999999999999998765433333333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.32 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=202.7
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 356668899999999999996 568899999986433 345668899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ...
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 174 (297)
T 3fxz_A 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (297)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccC
Confidence 99999999654 69999999999999999999999 8999999999999999999999999999987654322 234
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ........ ...
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~----~~~~~~~~------------~~~ 233 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----L----RALYLIAT------------NGT 233 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H----HHHHHHHH------------HCS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHh------------CCC
Confidence 56799999999999999999999999999999999999999863210 0 00011000 001
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+ ..+......+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 112234456889999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.17 Aligned_cols=261 Identities=27% Similarity=0.341 Sum_probs=205.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 4567789999999999999964 5789999988532 2233678899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 167 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T 167 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-c
Confidence 99999999999888889999999999999999999999 8999999999999999999999999999986643322 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ...... .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---------~~---~~~~~~--------~ 227 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---------SI---AIKHIQ--------D 227 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---------HH---HHHHHS--------S
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---------HH---HHHHhh--------c
Confidence 234467999999999999999999999999999999999999998632110 00 000010 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhCCCCCCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-TMDSVVQTLLGCEAESE 454 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-sm~~V~~~L~~~~~~~~ 454 (464)
.. +........+.+..+.+++.+||+.||.+|| ++.++.+.|..+.....
T Consensus 228 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 228 SV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cC-CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 00 0000011122345688999999999999998 89999999998765433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=349.49 Aligned_cols=250 Identities=26% Similarity=0.316 Sum_probs=202.3
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++|+||+++++++.++...++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 566789999999999999975 68899999986432 234668899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 99999999888889999999999999999999999 899999999999999999999999999998765443333344
Q ss_pred eeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+ .
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~-------------------~ 222 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDW-------------------K 222 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS----HHHHHH-------------------H
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH----HHHHHH-------------------h
Confidence 5679999999999987765 779999999999999999999997432211 111111 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...............+.+|+.+||+.||.+|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000011234567889999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.65 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=206.4
Q ss_pred HHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCccc--hhHHHHHHHHHhhhc-cccceeccceeeeeCc
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGM 236 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 236 (464)
....+.+.+.||+|+||.||+|.+ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 345567778999999999999984 2457899999975432 346789999999999 7999999999987754
Q ss_pred -EEeEEEEeccCCChHHhhhcCCC--------------------------------------------------------
Q 040010 237 -HRLLVYEYVENQSLDKHLFSSNF-------------------------------------------------------- 259 (464)
Q Consensus 237 -~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 259 (464)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999975432
Q ss_pred ----------CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeec
Q 040010 260 ----------LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR 329 (464)
Q Consensus 260 ----------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 329 (464)
+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++................
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999 899999999999999999999999999998765544433445567
Q ss_pred cCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 330 GTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 330 gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... . . .. .. ..-...
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~---~-~~---~~--------~~~~~~- 315 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----E---F-CR---RL--------KEGTRM- 315 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----H---H-HH---HH--------HHTCCC-
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----H---H-HH---HH--------HcCCCC-
Confidence 8999999999999999999999999999999998 999986432111 0 0 00 00 110111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
..+......+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 316 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 316 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 112223456889999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.21 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=203.3
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++.++||||+++++++......++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 56678999999999999997 578999999986432 23456889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 97 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~ 170 (328)
T 3fe3_A 97 SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KL 170 (328)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GG
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---cc
Confidence 999999999888889999999999999999999999 899999999999999999999999999998665432 23
Q ss_pred eeeccCCCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPIT-SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....||+.|+|||.+.+..++ .++||||||+++|||++|+.||.... .... ...+..+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---------~~~~----~~~i~~~-------- 229 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---------LKEL----RERVLRG-------- 229 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---------HHHH----HHHHHHC--------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---------HHHH----HHHHHhC--------
Confidence 456799999999999888775 79999999999999999999986321 1111 1111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. ..+......+.+++.+||+.||.+|||+.++++.
T Consensus 230 ---~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 ---KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1122234568889999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=347.01 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=207.5
Q ss_pred HHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||++.. .++..||||++.... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 4456778999999999999986 245789999997543 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 240 LVYEYVENQSLDKHLFSSN------------------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 9999999999999997543 38999999999999999999999 89999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccC
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVED 374 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~ 374 (464)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987654433222344567888999999998889999999999999999999 9888863211
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
... .. .+ .. ......+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 259 -----~~~---~~----~~--------~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 -----ERL---FN----LL--------KT----GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -----GGH---HH----HH--------HT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHH---HH----Hh--------hc----CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 00 01 00 0111122234457889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=361.83 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=202.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc-EEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-HRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.. ..++||||+++
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 4556778999999999999985 6799999998644 4567999999999999999999999987665 78999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~ 343 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 343 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----c
Confidence 99999998654 47999999999999999999999 89999999999999999999999999999854322 1
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ... .+..
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~----~i~~--------- 401 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVP----RVEK--------- 401 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---------HHH----HHHT---------
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHH----HHHc---------
Confidence 22357889999999999999999999999999999998 998886432110 111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
......+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 402 ---~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 402 ---GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111223334567889999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.53 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=199.0
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhh--ccccceeccceeeee----CcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGK--IYHMNLVRMWGFCTE----GMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~lv~ 242 (464)
.+.+.+.||+|+||+||+|+. +++.||||++.... ...+..|.+++.. ++||||+++++++.. ....++||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 456778999999999999998 67899999987543 3445566666666 799999999998654 35689999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH--------HECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
||+++|+|.+++. ...+++..++.++.|++.||+||| + .+|+||||||+|||++.++.+||+|||++.
T Consensus 86 e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999994 457999999999999999999999 6 899999999999999999999999999998
Q ss_pred ccCCCCCCc--ceeeeccCCCccCcccccCC------CCCccchhHHHHHHHHHHHhC----------CCCCCccccCcc
Q 040010 315 LSQRGSNSS--QFSRIRGTKGYMAPEWASNL------PITSKVDVFSYGVVILEMLKG----------IRLSNWVVEDSE 376 (464)
Q Consensus 315 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltg----------~~p~~~~~~~~~ 376 (464)
......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 665433221 12334799999999998876 455799999999999999999 666653322211
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLK-GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. ....... . ......+.+. ...+......+.+++.+||+.||++|||+.+|++.|+++
T Consensus 242 ~----~~~~~~~----~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 S----FEDMRKV----V-------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C----HHHHHHH----H-------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c----hhhhhHH----H-------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 1111000 0 0111111111 112235678899999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=351.70 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=209.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.+.||+|+||.||+|.. .++..||||++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3445567788999999999999996 24568999999743 23446789999999999 899999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSSN-----------------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDV 292 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl 292 (464)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 99999999999999999997542 37999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 040010 293 KPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWV 371 (464)
Q Consensus 293 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~ 371 (464)
||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987655443333445667889999999998999999999999999999998 98888643
Q ss_pred ccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 372 VEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.... .. . ..+........+......+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 279 ~~~~-----~~----~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 279 PVDA-----NF----Y---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSH-----HH----H---------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcHH-----HH----H---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 2110 00 0 1111111112222334678899999999999999999999999998765
Q ss_pred C
Q 040010 452 E 452 (464)
Q Consensus 452 ~ 452 (464)
.
T Consensus 335 ~ 335 (344)
T 1rjb_A 335 D 335 (344)
T ss_dssp -
T ss_pred H
Confidence 3
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=352.03 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=207.6
Q ss_pred HHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||+|... +++.||||.++... ...+.+.+|++++++++||||+++++++.++...+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 34566789999999999999974 34789999997543 23467899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCC
Q 040010 240 LVYEYVENQSLDKHLFSS------------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPE 295 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 295 (464)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 999999999999999753 569999999999999999999999 89999999999
Q ss_pred CEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccC
Q 040010 296 NILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVED 374 (464)
Q Consensus 296 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~ 374 (464)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 99999999999999999986543322222344568899999999998899999999999999999999 8888863210
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
.... ..+. +... ...+......+.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 283 --------~~~~----~~~~-----------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 --------EEVI----YYVR-----------DGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --------HHHH----HHHH-----------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --------HHHH----HHHh-----------CCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 0111 1111 1111 111223345788999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.41 Aligned_cols=258 Identities=30% Similarity=0.383 Sum_probs=209.8
Q ss_pred HHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeCcE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 237 (464)
...+.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34567788999999999999985 346789999997543 2346789999999999 99999999999999999
Q ss_pred EeEEEEeccCCChHHhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE
Q 040010 238 RLLVYEYVENQSLDKHLFSSN------------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll 299 (464)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 999999999999999997543 48999999999999999999999 899999999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccch
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQ 378 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 378 (464)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence 9999999999999987765443333344567889999999999999999999999999999999 888886432110
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.. ... +...... ..+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 256 --~~----~~~-----------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 256 --KF----YKM-----------IKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp --HH----HHH-----------HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HH----HHH-----------hccCCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 00 111 1111111 1122234568899999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.26 Aligned_cols=268 Identities=23% Similarity=0.296 Sum_probs=203.8
Q ss_pred HHhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeeeeC--cEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 239 (464)
..+.+.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++++++|+||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4567778999999999999985 3578999999985443 346789999999999999999999998543 5689
Q ss_pred EEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999997654 59999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccc---hhhhHHHHHHHHHHHhh
Q 040010 319 GSNS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEG---QEAELTGFIREVKEKIL 394 (464)
Q Consensus 319 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 394 (464)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------ 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH------
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH------
Confidence 3322 1123345777899999999999999999999999999999999987642110000 00000000001
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+.+.+........+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 241 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 241 ------LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp ------HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111122223344567899999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=348.39 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=197.7
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccc--cceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYH--MNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~E~ 244 (464)
|.+.+.||+|+||.||++...+++.||||++.... ...+.+.+|++++.+++| +||+++++++..+...++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 56678999999999999999889999999986432 234678899999999976 999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+.+++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||++...........
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 90 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 5688999999988899999999999999999999999 8999999999999997 57899999999987655443333
Q ss_pred eeeeccCCCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 325 FSRIRGTKGYMAPEWASN-----------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... . ..
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~----~~----- 229 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------I----SK----- 229 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------H----HH-----
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------H----HH-----
Confidence 445679999999999864 67899999999999999999999998632110 0 00
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..++++.....++......+.+++.+||+.||.+|||+.++++.
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 223333333333333334568899999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=343.66 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=204.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||++... +++.+|+|.+.........+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 3567789999999999999975 578999999987666667789999999999999999999999999999999999999
Q ss_pred CChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC--CCCeEEeeecCccccCCCCCCcc
Q 040010 248 QSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--EFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 248 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++....... .
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~ 159 (321)
T 1tki_A 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159 (321)
T ss_dssp CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---E
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---c
Confidence 9999999765 479999999999999999999999 89999999999999987 7899999999998765432 2
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~----i~~~~~~----- 221 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------QQIIEN----IMNAEYT----- 221 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHH----HHHTCCC-----
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---------HHHHHH----HHcCCCC-----
Confidence 4556799999999999988899999999999999999999999863211 111111 1100000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..... +....+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000001 12456889999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=342.53 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=212.8
Q ss_pred HHHHHHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
++....+.+.+.||+|+||.||+|.... +..||+|.+.......+.+.+|++++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 3444556777899999999999999864 788999999877777788999999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 243 EYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 243 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999753 459999999999999999999999 889999999999999999999999999998765432
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...... . ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~------~---~~~------------ 223 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------Q---VYE------------ 223 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------G---HHH------------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H---HHH------------
Confidence 2 22334557889999999999999999999999999999999 88887632110 0 101
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.+........+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 224 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 224 ----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11111111222233467899999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.55 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=191.3
Q ss_pred HHHhhhccccCccCceEEEEEEECCCc----EEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEE-
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTDER----AVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR- 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~----~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~- 238 (464)
...+.+.+.||+|+||.||+|...... .||||+++.. ....+.+.+|++++++++|+||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 345677889999999999999965432 7999999753 33457789999999999999999999999877655
Q ss_pred -----eEEEEeccCCChHHhhhcCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 239 -----LLVYEYVENQSLDKHLFSSN------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 239 -----~lv~E~~~~gsL~~~l~~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986432 69999999999999999999999 89999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFI 386 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 386 (464)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~---~~ 249 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------E---IY 249 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G---HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------H---HH
Confidence 99999987654433333344567889999999999999999999999999999999 88888632111 0 10
Q ss_pred HHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 387 REVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. .+.... ....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 250 ~---------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 250 N---------------YLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp H---------------HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---------------HHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 011100 11122234457899999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=335.22 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=193.4
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|... ++.||||++.... ...+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3566789999999999999985 7899999987432 223678899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC--------CCCeEEeeecCccc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--------EFEPKIADFGLAKL 315 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--------~~~~kl~Dfgla~~ 315 (464)
|+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 999999999985 557999999999999999999999933223999999999999986 67899999999976
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ..
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~---~~---------- 222 (271)
T 3dtc_A 166 WHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------L---AV---------- 222 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------H---HH----------
T ss_pred ccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H---HH----------
Confidence 54332 2245689999999999999999999999999999999999999863211 0 00
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.............+......+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 -----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111111112222333456788999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=349.53 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=200.3
Q ss_pred HhhhccccCccCceEEEEEEECC-Cc----EEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-ER----AVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+.||+|+||.||+|.... ++ .||+|.+.... .....+.+|+.++++++|+||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 34566889999999999999743 33 38888876432 33356778999999999999999999986 4568899
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999764 579999999999999999999999 899999999999999999999999999999876554
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.........+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+..+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~-------~~~~~~~-- 234 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------EVP-------DLLEKGE-- 234 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------HHH-------HHHHTTC--
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------HHH-------HHHHcCC--
Confidence 4444556778889999999999999999999999999999999 99998743211 000 1111010
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....+......+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 235 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 ----------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111122335778999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=340.80 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=196.3
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||++... ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 3456788999999999999985 688999999753 345678999999999999999999999874 478999999999
Q ss_pred ChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC-eEEeeecCccccCCCCCCcc
Q 040010 249 SLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE-PKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 249 sL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~~~ 324 (464)
+|.+++.... .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 9999998654 4789999999999999999999966568999999999999998887 799999999755432
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ... .... ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~---~~~----~~~~--------~~ 220 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AF---RIM----WAVH--------NG 220 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HH---HHH----HHHH--------TT
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HH---HHH----HHHh--------cC
Confidence 23346899999999999999999999999999999999999998632111 00 000 0010 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..+.+.. .....+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 221 ~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 221 TRPPLIK----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCCCBT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCCccc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111112 233568899999999999999999999999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=341.09 Aligned_cols=248 Identities=26% Similarity=0.286 Sum_probs=195.6
Q ss_pred HHHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhc-cccceeccceeeeeCc
Q 040010 162 YAELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGM 236 (464)
Q Consensus 162 ~~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 236 (464)
..++....+.+.++||+|+||+||+|... +++.||||++..... ....+..|+..+.++ +|+||++++++|.++.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34556677888889999999999999986 689999999865332 233455666666555 8999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
..++||||+ +++|.+++... ..++|..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999999 67898888754 469999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|..++... .. + ..+.
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------~~---~-----~~~~- 265 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------EG---W-----QQLR- 265 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--------HH---H-----HHHT-
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--------cH---H-----HHHh-
Confidence 64432 2334569999999998876 7999999999999999999998776521 00 0 0110
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....+.+. ......+.+++.+||+.||++|||+.++++
T Consensus 266 ------~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 ------QGYLPPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------TTCCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------ccCCCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000111111 122456889999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=343.54 Aligned_cols=245 Identities=24% Similarity=0.228 Sum_probs=203.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++... +++.||+|+++.. ......+.+|+.+++.++||||+++++++......++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3566789999999999999975 5889999999743 2334568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 160 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--A 160 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--C
Confidence 99999999999888889999999999999999999999 899999999999999999999999999998643222 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . .... ..+.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~---~~~~----~~i~--------- 218 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------H---ERLF----ELIL--------- 218 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------H---HHHH----HHHH---------
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------H---HHHH----HHHH---------
Confidence 2445679999999999999999999999999999999999999986321 0 0111 1111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
...+ .++......+.+++.+||+.||++|| ++.+|++
T Consensus 219 --~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 219 --MEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --HCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --cCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0111 12223345688999999999999999 8999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.39 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=209.2
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
.+.+.+.||+|+||.||++...+++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 45667899999999999999988899999999877666788999999999999999999999999999999999999999
Q ss_pred ChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceee
Q 040010 249 SLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 249 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ .....
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 164 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG 164 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-ccccc
Confidence 999999765 569999999999999999999999 8999999999999999999999999999986543211 11223
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..... ..+..+ ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---------~~~~~----~~i~~~--------~~ 223 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVV----EDISTG--------FR 223 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------HHHHH----HHHHTT--------CC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---------HHHHH----HHHhcC--------Cc
Confidence 456778999999998899999999999999999999 788876321 01111 111111 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
. ..+......+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 224 ~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 L----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1122234568899999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=347.52 Aligned_cols=251 Identities=24% Similarity=0.226 Sum_probs=196.2
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
.|.+.+.||+|+||.||++... +++.||||++.......+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 4677789999999999999985 688999999987666667789999999999999999999999999999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC--eEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE--PKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...... ..
T Consensus 101 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~ 174 (361)
T 3uc3_A 101 GELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP 174 (361)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CC
Confidence 9999999888889999999999999999999999 89999999999999988776 9999999997433221 23
Q ss_pred eeeccCCCccCcccccCCCCCcc-chhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSK-VDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~-~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....||+.|+|||.+.+..++.+ +||||||+++|||++|+.||....... ..... +..+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~---------------~~~~ 234 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-----DYRKT---------------IQRI 234 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-----CHHHH---------------HHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-----HHHHH---------------HHHH
Confidence 44569999999999988887666 899999999999999999997432211 11111 1111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
................+.+|+.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111111223568899999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.45 Aligned_cols=248 Identities=24% Similarity=0.284 Sum_probs=202.9
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.+.||+|+||.||++... +|+.||+|.+..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 3567789999999999999975 588999999864322 24678999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCcccc
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAKLS 316 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~ 316 (464)
||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999999888889999999999999999999999 8999999999999998877 7999999999876
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... . ... ..+..+
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~----~~~----~~i~~~ 233 (361)
T 2yab_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q----ETL----ANITAV 233 (361)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H----HHH----HHHHTT
T ss_pred CCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----H----HHH----HHHHhc
Confidence 5432 23456799999999999999999999999999999999999999863210 0 111 111111
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. -.++.... .....+.+++..||+.||.+|||+.++++
T Consensus 234 ~~-----~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-----DFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-----CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-----CCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000001 12356889999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.99 Aligned_cols=249 Identities=26% Similarity=0.289 Sum_probs=203.7
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-------hhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45778889999999999999975 588999999864321 3467899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCccc
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAKL 315 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~ 315 (464)
+||||+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999999888889999999999999999999999 8999999999999999887 799999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ........
T Consensus 168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~----~~~~~~~~---- 231 (326)
T 2y0a_A 168 IDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q----ETLANVSA---- 231 (326)
T ss_dssp CCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H----HHHHHHHH----
T ss_pred CCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----H----HHHHHHHh----
Confidence 65432 23446799999999999999999999999999999999999999863210 0 11111100
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. ...............+.+++.+||+.||++|||+.++++
T Consensus 232 ~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 V---------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp T---------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c---------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000000000112346789999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=372.27 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=212.5
Q ss_pred HHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+....+.+.++||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++|+||+++++++.+ ...++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3444567778999999999999999888899999998766666789999999999999999999999876 678999999
Q ss_pred ccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.++|... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence 9999999999743 569999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......++..|+|||.+.+..++.++||||||++||||++ |+.||..... .+.. ..+..+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---------~~~~----~~i~~~----- 480 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVL----DQVERG----- 480 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---------HHHH----HHHHTT-----
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH----HHHHcC-----
Confidence 11123446778999999998899999999999999999999 8888863210 0111 111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~ 455 (464)
.....+......+.+|+.+||+.||++|||+.+|+++|+.+.....+
T Consensus 481 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 481 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 11112233456788999999999999999999999999998764443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=351.61 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=198.0
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhcc--ccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIY--HMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|++++++++ |+||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 5667899999999999999888999999998643 233467899999999996 5999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+.+++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++..........
T Consensus 137 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 5688999999888899999999999999999999999 8999999999999996 57899999999987654433333
Q ss_pred eeeeccCCCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 325 FSRIRGTKGYMAPEWASN-----------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... . ..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~----~~-------- 276 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I----SK-------- 276 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----H----HH--------
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----H----HH--------
Confidence 345679999999999865 46899999999999999999999998632110 0 00
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..++++.....++......+.+|+.+||+.||.+|||+.++++.
T Consensus 277 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 -------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 222333333222222234568899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=339.63 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=202.1
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhh--ccccceeccceeeeeC----c
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGK--IYHMNLVRMWGFCTEG----M 236 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~ 236 (464)
.+.....+.+.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++.. ++|+||+++++++... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3444567788899999999999999985 78999999864433 334445555544 4899999999999877 7
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC-----LEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 89999999999999999954 47999999999999999999999821 1289999999999999999999999999
Q ss_pred CccccCCCCCCcc--eeeeccCCCccCcccccCCCCCcc------chhHHHHHHHHHHHhC----------CCCCCcccc
Q 040010 312 LAKLSQRGSNSSQ--FSRIRGTKGYMAPEWASNLPITSK------VDVFSYGVVILEMLKG----------IRLSNWVVE 373 (464)
Q Consensus 312 la~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DV~S~Gvvl~elltg----------~~p~~~~~~ 373 (464)
++........... .....||+.|+|||.+.+...+.+ +||||||+++|||++| +.|+.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9976644332211 234579999999999988776665 9999999999999999 444432211
Q ss_pred CccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 374 DSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
... ...... .......+....+ .+....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 268 ~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 268 SDP----SYEDMR---------------EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp SSC----CHHHHH---------------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCC----chhhhH---------------HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 111 011110 0011111122222 2677889999999999999999999999999998
Q ss_pred CCCC
Q 040010 449 CEAE 452 (464)
Q Consensus 449 ~~~~ 452 (464)
+.+.
T Consensus 329 l~~~ 332 (337)
T 3mdy_A 329 MSES 332 (337)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 7654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.86 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=208.3
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC--------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeee
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT--------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCT 233 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 233 (464)
+....+.+.+.||+|+||.||+|... ++..||||++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34456677889999999999999863 46789999997543 2346788999999999 8999999999999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCE
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSSN----------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENI 297 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 297 (464)
.....++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 9999999999999999999997543 38999999999999999999999 8999999999999
Q ss_pred EEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCcc
Q 040010 298 LLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSE 376 (464)
Q Consensus 298 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~ 376 (464)
+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 264 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 264 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----
Confidence 999999999999999987654433223344567889999999988889999999999999999999 888886321
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....... +. .-... ..+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 265 -----~~~~~~~----~~--------~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 265 -----VEELFKL----LK--------EGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -----HHHHHHH----HH--------HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHH----Hh--------cCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111 11 00011 112233456889999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=344.67 Aligned_cols=268 Identities=26% Similarity=0.344 Sum_probs=208.8
Q ss_pred hhccccCccCceEEEEEEEC-----CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeee--CcEEeEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-----DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRLLV 241 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 241 (464)
.+.+.||+|+||.||++.+. +++.||||++.... ...+.+.+|++++++++|+||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 66789999999999998753 57899999998543 334678999999999999999999999987 4688999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999654 59999999999999999999999 8999999999999999999999999999987754432
Q ss_pred C-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 S-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+...... ...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~------~~~ 259 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF----LELIGIAQGQMT------VLR 259 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCHHHH------HHH
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh----hhhhcccccchh------HHH
Confidence 2 11234557888999999999899999999999999999999999986321100 000000000000 000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
+.+.++.......+......+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 2222222222333444556799999999999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.41 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=198.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+..|..++.++ +||||+++++++.+....++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3566789999999999999975 47889999987432 2334578899999887 8999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-- 207 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 207 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--
Confidence 999999999999888899999999999999999999999 899999999999999999999999999998533221
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ...+ ...
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~-~~~~---~~~---------- 273 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-EDYL---FQV---------- 273 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC-HHHH---HHH----------
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh-HHHH---HHH----------
Confidence 22455789999999999999999999999999999999999999997432211111100 1111 111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
+....+ .++......+.+|+..||+.||.+||++
T Consensus 274 -i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 274 -ILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -Hhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111 1222334568899999999999999995
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=333.40 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=201.3
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|+.+ ++.||||++.... ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4567789999999999999985 7889999997543 3346789999999999999999999999876 78899999
Q ss_pred eccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 244 YVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|+++|+|.+++.... .+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999998654 58999999999999999999999 67 99999999999999999999999988754322
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCc---cchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITS---KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .......
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~------- 223 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKV------- 223 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---------HHHHHHH-------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---------HHHHHHH-------
Confidence 2346899999999988765544 89999999999999999999863211 0010000
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
......+ ..+......+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 224 ----~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 ----ALEGLRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----HHSCCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----HhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111112 2223344568899999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.53 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=193.6
Q ss_pred HHHhhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
...+.+.+.||+|+||.||+|.... +..||+|++.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3456777899999999999999743 4579999987533 33467899999999999999999999985 456889
Q ss_pred EEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999997654 79999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... . ... .+..+.
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~---~~~----~i~~~~- 234 (281)
T 1mp8_A 170 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------D---VIG----RIENGE- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G---HHH----HHHTTC-
T ss_pred ccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------H---HHH----HHHcCC-
Confidence 221 1234457789999999998899999999999999999997 88888642211 0 111 111000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. ...+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 235 -------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 -------R----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------C----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 1122234457889999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=339.02 Aligned_cols=263 Identities=29% Similarity=0.463 Sum_probs=196.1
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
.|+....+.+.+.||+|+||.||+|+..+ .||||+++... ...+.+.+|++++++++|+||+++++++. ....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccE
Confidence 35555667788899999999999998643 59999987443 23466899999999999999999999764 45689
Q ss_pred EEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999999964 4579999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCcceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
...........||+.|+|||.+. +..++.++||||||+++|||++|+.||..... .. .... ...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~---~~~~-~~~---- 239 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RD---QIIE-MVG---- 239 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----HH---HHHH-HHH----
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----HH---HHHH-Hhc----
Confidence 33333345567999999999886 66788999999999999999999999864221 11 1111 110
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.....+.+. .........+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 240 ------~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 ------RGSLSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ------HTSCCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------ccccCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011111111 1122344678999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=331.63 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=200.3
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccch--------hHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQG--------EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
..+.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34567789999999999999974 6889999998643221 157889999999999999999999987665
Q ss_pred eEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEcCCCC-----eEEeee
Q 040010 239 LLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLDSEFE-----PKIADF 310 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~Df 310 (464)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999998888654 479999999999999999999999 77 999999999999988776 999999
Q ss_pred cCccccCCCCCCcceeeeccCCCccCcccc--cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH
Q 040010 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWA--SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 311 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
|+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....... . .....
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~---~~~~~ 241 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----I---KFINM 241 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----H---HHHHH
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----H---HHHHH
Confidence 99974432 24456799999999998 44567899999999999999999999986432110 0 01111
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+.........+......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 242 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 ---------------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111112222334456789999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.09 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=209.8
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCc--EEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM--HRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|.... ++.||||++.... ...+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 5667899999999999999864 8899999997543 33467889999999999999999999987664 78999999
Q ss_pred ccCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE----cCCCCeEEeeecCccccC
Q 040010 245 VENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL----DSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 245 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~~~ 317 (464)
+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999997543 39999999999999999999999 899999999999999 888889999999998765
Q ss_pred CCCCCcceeeeccCCCccCccccc--------CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWAS--------NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
.... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||....... .....+...
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~ 239 (319)
T 4euu_A 168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-----RNKEVMYKI 239 (319)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-----GCHHHHHHH
T ss_pred CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-----hhHHHHHHH
Confidence 4332 33456999999999876 5788999999999999999999999986322111 111112221
Q ss_pred HHHhhccchhhhhhhc--------CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 390 KEKILCGEEARIEEIV--------DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~--------d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
...........+.... +-.....+.......+..++.+||+.||++|||+.|+++...+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111000000000000 111122456788889999999999999999999999999887643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=347.16 Aligned_cols=263 Identities=17% Similarity=0.232 Sum_probs=201.4
Q ss_pred HHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCccch------------hHHHHHHHHHhhhccccceeccc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLHQG------------EEVFWAEVSTIGKIYHMNLVRMW 229 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~ 229 (464)
..+.+.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..++.++|+||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 346677899999999999999865 478999998654321 12234566677788899999999
Q ss_pred eeeeeC----cEEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc--CC
Q 040010 230 GFCTEG----MHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD--SE 302 (464)
Q Consensus 230 g~~~~~----~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~ 302 (464)
+++... ...++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++ .+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCC
Confidence 998764 5689999999 99999999765 679999999999999999999999 8999999999999999 88
Q ss_pred CCeEEeeecCccccCCCCCCc-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccc
Q 040010 303 FEPKIADFGLAKLSQRGSNSS-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEG 377 (464)
Q Consensus 303 ~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~ 377 (464)
+.+||+|||+++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-- 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-- 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--
Confidence 999999999998654332111 1234559999999999999999999999999999999999999997432211
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. +........ ...+.+++++.+.. ...+..+.+++..||+.||.+||++.+|++.|+.+
T Consensus 269 ---~---~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 269 ---K---YVRDSKIRY----RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp ---H---HHHHHHHHH----HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ---H---HHHHHHHHh----hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 111111111 01133334333221 12235688999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=340.45 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=206.2
Q ss_pred HHHhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC--cE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MH 237 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 237 (464)
...+.+.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++|+||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34466778999999999999984 367899999997443 3346789999999999999999999999776 66
Q ss_pred EeEEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 238 RLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 8999999999999999954 4579999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCc------cchhhhHHHHHHHH
Q 040010 317 QRGSNS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDS------EGQEAELTGFIREV 389 (464)
Q Consensus 317 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~ 389 (464)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~- 251 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV----TR- 251 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH----HH-
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH----HH-
Confidence 554322 12234567888999999999899999999999999999999998864221000 0000000 00
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+...+........+......+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 252 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 -----------LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp -----------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111111112223334456789999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=356.95 Aligned_cols=251 Identities=18% Similarity=0.162 Sum_probs=199.5
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||+|+..+ ++.||+|+++... .....+.+|..++..++|+||++++++|.+....++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4456789999999999999864 7899999986422 2234488999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 231 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 231 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-c
Confidence 999999999987 4689999999999999999999999 8999999999999999999999999999976644322 2
Q ss_pred ceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 324 QFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..... . +....+...
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~----~~~~~i~~~------ 296 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----V----ETYGKIMNH------ 296 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHHHHHHTH------
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----h----HHHHhhhhc------
Confidence 233467999999999986 56789999999999999999999999973211 1 111111100
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK--RPTMDSVVQT 445 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPsm~~V~~~ 445 (464)
...+.-+..... ....+.+|+.+||..+|++ ||++.|+++.
T Consensus 297 --~~~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 --KERFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --HHHCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --cccccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 001111111111 2346788899999888888 9999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=334.33 Aligned_cols=260 Identities=23% Similarity=0.251 Sum_probs=197.3
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
|.+.+.||+|+||+||++...+++.||+|++..... ....+.+|++++++++||||+++++++.++...++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 566789999999999999998899999999974432 23668899999999999999999999999999999999998
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+ +|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 103 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~ 176 (311)
T 3niz_A 103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SY 176 (311)
T ss_dssp E-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred C-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cc
Confidence 5 777777654 469999999999999999999999 8999999999999999999999999999987643322 23
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh--
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE-- 402 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 402 (464)
....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. ..+.............
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~----~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-----QL----PKIFSILGTPNPREWPQV 247 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----HH----HHHHHHHCCCCTTTSGGG
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----HH----HHHHHHHCCCChHHhhhh
Confidence 44568999999998876 568999999999999999999999997432211 11 1111111000000000
Q ss_pred ----hhcCCcc--CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 ----EIVDPRL--KGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ----~~~d~~l--~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+... ....+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 00000 112346789999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.72 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=201.3
Q ss_pred hhccccCccCceEEEEEEECC----CcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEE-eEEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR-LLVYE 243 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~E 243 (464)
...+.||+|+||.||+|...+ +..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345789999999999998632 23799999975433 346788999999999999999999999766554 99999
Q ss_pred eccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC-
Q 040010 244 YVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN- 321 (464)
Q Consensus 244 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 321 (464)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999976 4579999999999999999999999 8999999999999999999999999999986543221
Q ss_pred -CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 -SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
........+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ...... .
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----~~~~~~-------~------- 241 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----FDLTHF-------L------- 241 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----GGHHHH-------H-------
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----HHHHHH-------h-------
Confidence 12233456788999999999999999999999999999999977776432111 111110 0
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.... ....+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 242 -~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 242 -AQGR----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -HTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCC----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000 111122234568899999999999999999999999988753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=330.85 Aligned_cols=262 Identities=20% Similarity=0.202 Sum_probs=198.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||+||+|... +++.||||++.... .....+.+|++++++++|+||+++++++.++...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456789999999999999975 58899999986432 23367889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++.+..+......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 158 (292)
T 3o0g_A 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CY 158 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CC
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cc
Confidence 864444444446789999999999999999999999 8999999999999999999999999999987643322 23
Q ss_pred eeeccCCCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh---h
Q 040010 326 SRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR---I 401 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 401 (464)
....||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+..... .......+........... .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--------~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--------VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--------HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHHHHhCCCChhhhhhh
Confidence 4467899999999987765 89999999999999999999998753211 1111122211111100000 0
Q ss_pred hhhcCC---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDP---------RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~---------~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+. .............+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 0000111234456889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=341.89 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=201.6
Q ss_pred HHHhhhccccCccCceEEEEEEECC-C-------cEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD-E-------RAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~-~-------~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 237 (464)
...+.+.+.||+|+||.||+|.... + ..||+|++.... ...+.+.+|++++++++|+||+++++++..+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456777899999999999998643 2 479999997543 345678999999999999999999999999999
Q ss_pred EeEEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC--------eEEe
Q 040010 238 RLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE--------PKIA 308 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~ 308 (464)
.++||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999998655 49999999999999999999999 89999999999999998887 9999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... . ....
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~---~~~~ 229 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----Q---RKLQ 229 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---HHHH
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----H---HHHH
Confidence 9999865432 233558899999999887 67999999999999999999976665422110 0 0000
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~ 453 (464)
... ....+... ....+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 230 -~~~-------------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 230 -FYE-------------DRHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -HHH-------------TTCCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -Hhh-------------ccCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000 00111111 1234788999999999999999999999999987643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=338.62 Aligned_cols=247 Identities=20% Similarity=0.303 Sum_probs=194.8
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCc--------
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM-------- 236 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 236 (464)
..+.+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 34667789999999999999986 7899999998643 334577899999999999999999999886543
Q ss_pred -------------------------------------------------EEeEEEEeccCCChHHhhhcCC---CCCHHH
Q 040010 237 -------------------------------------------------HRLLVYEYVENQSLDKHLFSSN---FLGWKE 264 (464)
Q Consensus 237 -------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~---~l~~~~ 264 (464)
..++||||+++++|.+++.... ..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999997653 467778
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC----------cceeeeccCCCc
Q 040010 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS----------SQFSRIRGTKGY 334 (464)
Q Consensus 265 ~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~y 334 (464)
++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 89999999999999999999999999999876654221 112345699999
Q ss_pred cCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCC
Q 040010 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFN 414 (464)
Q Consensus 335 ~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 414 (464)
+|||.+.+..++.++||||||+++|||++|..|+.. . ... . ........ ....
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~---~~~----~-----------~~~~~~~~-~~~~ 295 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------R---VRI----I-----------TDVRNLKF-PLLF 295 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------H---HHH----H-----------HHHHTTCC-CHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------H---HHH----H-----------HHhhccCC-Cccc
Confidence 999999999999999999999999999998665320 0 000 0 01111110 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 415 KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 415 ~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+.+++.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 234456789999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=350.09 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=202.7
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
..|.+.+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 4577888999999999999986 468899999987543 234568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc---CCCCeEEeeecCccccCCCC
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD---SEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~ 320 (464)
|+++|+|.+.+.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999999888899999999999999999999999 8999999999999998 56789999999998665432
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... . .... ..+..+.
T Consensus 168 --~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~------~---~~~~----~~i~~~~--- 229 (444)
T 3soa_A 168 --QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED------Q---HRLY----QQIKAGA--- 229 (444)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS------H---HHHH----HHHHHTC---
T ss_pred --ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc------H---HHHH----HHHHhCC---
Confidence 22345679999999999999999999999999999999999999986321 0 1111 1111111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....+ ........+.+++..||+.||.+|||+.++++
T Consensus 230 -~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 -YDFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011 11123456889999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.19 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=197.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCc----EEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+.||+|+||.||+|... +++ .||+|.+... ....+.+.+|+.++++++||||+++++++..+. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 3566789999999999999964 333 4688887643 345577899999999999999999999998765 7899
Q ss_pred EEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+||+++|+|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 999999999999976 4579999999999999999999999 899999999999999999999999999998765544
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~----------------- 228 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EI----------------- 228 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GH-----------------
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HH-----------------
Confidence 3333444567889999999999999999999999999999999 99998643211 11
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
...+........+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 229 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 229 --SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111112223344568899999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.05 Aligned_cols=242 Identities=28% Similarity=0.314 Sum_probs=202.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3566789999999999999975 68899999987432 234567889999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 99999999999888889999999999999999999999 89999999999999999999999999999865432
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . .... ..+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~---~~~~----~~i---------- 215 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------T---MKTY----EKI---------- 215 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------H---HHHH----HHH----------
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------H---HHHH----HHH----------
Confidence 334679999999999999999999999999999999999999986321 0 0111 111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
+...+ .++......+.+++.+||+.||.+|| ++.++++
T Consensus 216 -~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 216 -LNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11111 11222345688999999999999999 8888874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=341.12 Aligned_cols=243 Identities=22% Similarity=0.278 Sum_probs=201.2
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+++++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 356778999999999999997 568899999986432 223568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+ +|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--- 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--- 162 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---
Confidence 99 78999999888899999999999999999999999 889999999999999999999999999998665432
Q ss_pred ceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------------------~~ 218 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------------------FK 218 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------------------BC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------------------HH
Confidence 2344679999999999988776 7899999999999999999999964221100 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.... ...+......+.+++.+||+.||.+|||+.|+++
T Consensus 219 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 KVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111110 1122233456889999999999999999999976
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=328.46 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=204.1
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++|+||+++++++.++...++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677889999999999999975 68899999986432 3446788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999999999877789999999999999999999999 8999999999999999999999999999986644332222
Q ss_pred eeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~----------------- 222 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDWK----------------- 222 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----HHHHHHH-----------------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----HHHHHhh-----------------
Confidence 345678999999999987665 789999999999999999999997432211 1111110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...............+.+++.+||+.||.+|||+.++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000000001123346788999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=340.61 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=206.7
Q ss_pred HHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCccc--hhHHHHHHHHHhhhc-cccceeccceeeeeC-c
Q 040010 167 KATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLHQ--GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG-M 236 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 236 (464)
...+.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++... .
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 44566778999999999999984 3467899999975433 345788999999999 799999999998765 4
Q ss_pred EEeEEEEeccCCChHHhhhcCCC----------------CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNF----------------LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 300 (464)
..++||||+++|+|.+++..... +++..++.++.|++.||.|||+ .+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999976543 8999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchh
Q 040010 301 SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQE 379 (464)
Q Consensus 301 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 379 (464)
.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---- 258 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 258 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH----
Confidence 999999999999987655443333445668899999999999999999999999999999998 888886432110
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
..... + ..-..... +......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 259 ----~~~~~----~--------~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 259 ----EFCRR----L--------KEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ----HHHHH----H--------HHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHH----h--------ccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111 1 00011111 1223456889999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=343.45 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=207.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 334456677899999999999999743 2479999997543 2346789999999999 899999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC
Q 040010 236 MHRLLVYEYVENQSLDKHLFS--------------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS 301 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 301 (464)
...++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECC
Confidence 999999999999999999864 2358999999999999999999999 89999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhh
Q 040010 302 EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEA 380 (464)
Q Consensus 302 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 380 (464)
++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-----S 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-----H
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-----H
Confidence 99999999999986654433333344567889999999998899999999999999999999 88887632211 0
Q ss_pred hHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 381 ELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. .... ....... .+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 275 ~~----~~~~-----------~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 KF----YKLV-----------KDGYQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HH----HHHH-----------HHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHH-----------hcCCCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 01 1110 1111111 11222456889999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=341.97 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=203.8
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
...+.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 455778889999999999999975 58899999986432 23356889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeeecCccccCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADFGLAKLSQRG 319 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~ 319 (464)
||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999999888889999999999999999999999 8999999999999998654 5999999999876533
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ..... .+..+.
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~------~---~~~~~----~i~~~~-- 246 (362)
T 2bdw_A 185 E---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------Q---HRLYA----QIKAGA-- 246 (362)
T ss_dssp C---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHHHH----HHHHTC--
T ss_pred c---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------H---HHHHH----HHHhCC--
Confidence 2 2344679999999999999999999999999999999999999986321 1 11111 111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.+ ............+.+++.+||+.||++|||+.++++.
T Consensus 247 -----~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 -----YD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CC--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000011234568899999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=334.17 Aligned_cols=246 Identities=24% Similarity=0.287 Sum_probs=193.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---------------------------hhHHHHHHHHHhhhc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---------------------------GEEVFWAEVSTIGKI 220 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~l 220 (464)
.+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 3567789999999999999974 578999999864321 125688999999999
Q ss_pred cccceeccceeeee--CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEE
Q 040010 221 YHMNLVRMWGFCTE--GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298 (464)
Q Consensus 221 ~h~niv~l~g~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 298 (464)
+||||+++++++.+ +...++||||+++++|.+++ ....+++..+..++.|++.||+|||+ .+|+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEE
Confidence 99999999999976 67899999999999998876 44579999999999999999999999 89999999999999
Q ss_pred EcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCccccCc
Q 040010 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP---ITSKVDVFSYGVVILEMLKGIRLSNWVVEDS 375 (464)
Q Consensus 299 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~ 375 (464)
++.++.+||+|||++....... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 244 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--- 244 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred ECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence 9999999999999998765432 2234467999999999987765 3788999999999999999999986321
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....... +. ...... .........+.+++.+||+.||++|||+.++++
T Consensus 245 ------~~~~~~~----~~-------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ------IMCLHSK----IK-------SQALEF----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHHHHH----HH-------HCCCCC----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHHHHH----Hh-------cccCCC----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0111111 11 000000 001123356889999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=346.46 Aligned_cols=248 Identities=24% Similarity=0.246 Sum_probs=198.6
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEe
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 239 (464)
....+.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3344667789999999999999975 5889999999743 22345678899999988 7999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999888899999999999999999999999 89999999999999999999999999999854322
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------~~~----~~~i------ 236 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------DDL----FEAI------ 236 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHH----HHHH------
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---------HHH----HHHH------
Confidence 2 224556799999999999988999999999999999999999999973211 011 1111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM------DSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm------~~V~~ 444 (464)
....+ .++......+.+++.+||+.||.+||++ .++++
T Consensus 237 -----~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 237 -----LNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----HHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----HcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11111 1122234568889999999999999998 66654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.24 Aligned_cols=269 Identities=23% Similarity=0.225 Sum_probs=209.6
Q ss_pred HHhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCccc-hhHHHHHHHHHhhhccccceeccceeee--eCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLHQ-GEEVFWAEVSTIGKIYHMNLVRMWGFCT--EGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 239 (464)
..+.+.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 3456778999999999999984 3578999999976533 4466899999999999999999999886 557789
Q ss_pred EEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999976 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh--hhHHHHHHHHHHHhhc
Q 040010 319 GSNSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILC 395 (464)
Q Consensus 319 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 395 (464)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........... .........
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 252 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR------- 252 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-------
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-------
Confidence 33221 12335578889999999998899999999999999999999999863211000000 000000001
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+.+.+........+......+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 253 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 253 -----LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred -----HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112222222223344455678999999999999999999999999987753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.77 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=187.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++|+||+++++++.+....++||||+++|
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 566789999999999999986 47899999987543 3456889999999999999999999999999999999999999
Q ss_pred ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCCCCCCcce
Q 040010 249 SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 249 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 134 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~ 207 (349)
T 2w4o_A 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LM 207 (349)
T ss_dssp BHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---cc
Confidence 999999888889999999999999999999999 89999999999999975 8899999999998654322 23
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ....+..+.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~--------~~~~i~~~~-------- 267 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----DQF--------MFRRILNCE-------- 267 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----HHH--------HHHHHHTTC--------
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----cHH--------HHHHHHhCC--------
Confidence 446799999999999999999999999999999999999999863211 000 111111110
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.........+....+.+++.+||+.||++|||+.++++.
T Consensus 268 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 -YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111112334568899999999999999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.84 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=205.8
Q ss_pred HHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.||+|... +++.||||.+..... ....+.+|++++++++|+||+++++++.++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345677789999999999999864 367899999975432 345688999999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 239 LLVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999998642 457999999999999999999999 899999999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.... . .....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~---~~~~~ 251 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------N---EQVLR 251 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------H---HHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------H---HHHHH
Confidence 9999986543322222233456889999999999999999999999999999999 777775321 0 01111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. ..... ...+......+.+++.+||+.||.+|||+.++++.|++..
T Consensus 252 ----~~-----------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 ----FV-----------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ----HH-----------HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ----HH-----------HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11 11111 1112233456889999999999999999999999998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=343.34 Aligned_cols=275 Identities=27% Similarity=0.276 Sum_probs=197.5
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeee-----eCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCT-----EGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|+. +++.||||++............|+..+..++|+||+++++.+. .....++|||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 356678999999999999988 6789999999754433333334455566689999999998543 3346789999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC------LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
|+++|+|.+++... .+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 93 YYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171 (336)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence 99999999999544 4599999999999999999999921 1199999999999999999999999999998765
Q ss_pred CCCC------CcceeeeccCCCccCcccccC-------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH
Q 040010 318 RGSN------SSQFSRIRGTKGYMAPEWASN-------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 318 ~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 384 (464)
.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp SSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred cccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 4321 112234569999999999876 456779999999999999999988775332211110000000
Q ss_pred -----HHHHHHHHhhccchhhhhhhcCCccCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 385 -----FIREVKEKILCGEEARIEEIVDPRLKGH--FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 385 -----~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
......... ......+.+... ........+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 252 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 252 VGNHPTFEDMQVLV-------SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HCSSCCHHHHHHHH-------TTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCchHHHHHhhh-------cccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000000000 001111111111 1234677899999999999999999999999999886543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=335.07 Aligned_cols=256 Identities=19% Similarity=0.189 Sum_probs=204.2
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+.+.||+|+||.||+|.. .+++.||||.+.... ..+.+..|+++++++ +|+||+++++++..+...++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 55678999999999999996 568899999986443 234688999999999 9999999999999999999999999 9
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC-----eEEeeecCccccCCCCC
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE-----PKIADFGLAKLSQRGSN 321 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~~~~~ 321 (464)
++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.......
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 89 PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 999999976 4689999999999999999999999 89999999999999999887 99999999987654332
Q ss_pred Cc-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 322 SS-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 322 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+.....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~------~~~~~~~i~~~~~-- 237 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT------LKERYQKIGDTKR-- 237 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS------HHHHHHHHHHHHH--
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc------HHHHHHHHHhhhc--
Confidence 21 1245679999999999999999999999999999999999999997532211 1111111110000
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
....+. +...+ + .+.+++..||+.||.+||++.+|++.|+.+
T Consensus 238 --~~~~~~----~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 238 --ATPIEV----LCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp --HSCHHH----HTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred --cCCHHH----HhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000000 01111 2 689999999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.45 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=201.9
Q ss_pred Hhhhcc-ccCccCceEEEEEEE---CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKE-ELGKGGSGAVYKGVL---TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~-~lG~G~~g~Vy~g~~---~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+ .||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+++++.++||||+++++++ .....++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 345556 899999999999965 246789999997542 2346789999999999999999999999 56678999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++++|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999999888889999999999999999999999 8999999999999999999999999999987654332
Q ss_pred Cc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 322 SS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 322 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . .. ...+..+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~---~~----~~~~~~~--- 236 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------S---EV----TAMLEKG--- 236 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------H---HH----HHHHHTT---
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------H---HH----HHHHHcC---
Confidence 21 1223446788999999988889999999999999999999 9999863211 0 11 1111101
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.....+......+.+++.+||+.||.+|||+.+|++.|+++-
T Consensus 237 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 237 ---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122334557899999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=333.21 Aligned_cols=260 Identities=17% Similarity=0.213 Sum_probs=207.4
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.++...++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 356678999999999999996 568899999886432 345678999999999 7999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC-----eEEeeecCccccCCCC
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE-----PKIADFGLAKLSQRGS 320 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~~~~ 320 (464)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99999999864 469999999999999999999999 89999999999999988776 9999999998765543
Q ss_pred CC-----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 321 NS-----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 321 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~----~~~~~~~~~~~~ 239 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--K----QKYERIGEKKQS 239 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--H----HHHHHHHHHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--H----HHHHHHHhhccC
Confidence 22 123456799999999999999999999999999999999999999975322111 1 111111110000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
....+ +... ....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 240 ---~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 ---TPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp ---SCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---ccHHH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 00111 1111 23568899999999999999999999999987653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=337.77 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=198.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+..|..++.++ +||||+++++++.+....++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 566789999999999999985 57899999997432 2335578899999988 89999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~ 165 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 165 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--C
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC--C
Confidence 99999999999887889999999999999999999999 899999999999999999999999999998543222 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ... ....+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~---~~~~i---------- 231 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-EDY---LFQVI---------- 231 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C-HHH---HHHHH----------
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc-HHH---HHHHH----------
Confidence 2455679999999999999999999999999999999999999997432211100000 011 11111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
....+ .++......+.+++.+||+.||.+||++
T Consensus 232 -~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 232 -LEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -HcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111 1222334568899999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.22 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=198.3
Q ss_pred cccCccCceEEEEEEEC---CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
++||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++++++|+|||+++++|.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999753 457899999975432 34679999999999999999999999965 457899999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-ccee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQFS 326 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 326 (464)
|+|.+++.....+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 9999999888889999999999999999999999 89999999999999999999999999999876543322 1223
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... . .. ...+
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~---~~----~~~i------------ 585 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------S---EV----TAML------------ 585 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------H---HH----HHHH------------
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------H---HH----HHHH------------
Confidence 3457789999999999999999999999999999998 9999863211 0 01 1111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
........+......+.+|+..||+.||++|||+.+|+++|+.+
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111122334456789999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=332.86 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=198.8
Q ss_pred hhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceee-eeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFC-TEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|...+ ...+|+|.+.... ...+.+.+|+.++++++||||+++++++ ..+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4566889999999999999643 2368999987533 2346789999999999999999999986 4556789999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999753 568999999999999999999999 8999999999999999999999999999986644321
Q ss_pred C--cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 322 S--SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 322 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... .. ... ..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~---~~~----~~----- 246 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DI---TVY----LL----- 246 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----TH---HHH----HH-----
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HH---HHH----Hh-----
Confidence 1 12234567889999999999999999999999999999999666543221111 00 000 00
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..... ..+......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 247 ---~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 247 ---QGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00001 1112233568899999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=328.61 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=197.1
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
|.+.+.||+|+||.||+|...+++.||+|++..... ....+.+|++++++++||||+++++++......++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 456789999999999999998899999999875432 23678899999999999999999999999999999999998
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+ +|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 157 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY 157 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cc
Confidence 5 898888754 679999999999999999999999 8999999999999999999999999999986643221 23
Q ss_pred eeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh---h
Q 040010 326 SRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR---I 401 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 401 (464)
....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... . ................. .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~----~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----A----DQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHHHHCCCChhhchhh
Confidence 345689999999998764 589999999999999999999999864211 1 11111111111000000 0
Q ss_pred hh--hcCCccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EE--IVDPRLK-------GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~--~~d~~l~-------~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+ ..++... ..........+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0111110 0011123456889999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=340.43 Aligned_cols=242 Identities=23% Similarity=0.205 Sum_probs=202.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3566789999999999999975 58899999986432 234568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 99999999999888889999999999999999999999 89999999999999999999999999999866432
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ... ...+.
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~---~~~----~~~i~--------- 251 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------P---IQI----YEKIV--------- 251 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHH----HHHHH---------
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------H---HHH----HHHHH---------
Confidence 234679999999999999999999999999999999999999986321 0 011 11111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
...+ .++......+.+++.+||+.||.+||+ +.+|++
T Consensus 252 --~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 --SGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --HCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --cCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111 112233456889999999999999998 888865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=336.64 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=201.0
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeee----eCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCT----EGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||++.. .+++.||||++... ....+.+.+|++++++++||||+++++++. .....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 466778999999999999997 56899999988643 334567899999999999999999999986 345789999
Q ss_pred EeccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 243 EYVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 243 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999875 4679999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCc-------ceeeeccCCCccCcccccCCC---CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH
Q 040010 319 GSNSS-------QFSRIRGTKGYMAPEWASNLP---ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 319 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .. ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~----~~ 258 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----SV----AL 258 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS----CH----HH
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc----hh----hH
Confidence 11110 012345799999999987654 68999999999999999999999853211100 00 00
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
. ... .............+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 259 ~-----------~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 A-----------VQN----QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-----------HHC----C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred H-----------hhc----cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 000 11111112234568899999999999999999999999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=338.16 Aligned_cols=265 Identities=15% Similarity=0.175 Sum_probs=199.8
Q ss_pred HHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCccc------------hhHHHHHHHHHhhhccccceecccee
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLHQ------------GEEVFWAEVSTIGKIYHMNLVRMWGF 231 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~g~ 231 (464)
..+.+.+.||+|+||.||+|... ++..+|||+...... ....+.+|+..++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 44677789999999999999985 567899998865422 11336678888999999999999999
Q ss_pred eee----CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC--Ce
Q 040010 232 CTE----GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF--EP 305 (464)
Q Consensus 232 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~--~~ 305 (464)
+.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence 987 78899999999 99999999877799999999999999999999999 8999999999999998887 99
Q ss_pred EEeeecCccccCCCCCC-----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhh
Q 040010 306 KIADFGLAKLSQRGSNS-----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA 380 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 380 (464)
||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~ 268 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP----V 268 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH----H
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc----H
Confidence 99999999866432211 11244679999999999999999999999999999999999999986321111 1
Q ss_pred hHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 381 ELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..... ........+..+...... ......+.+++..||+.||++|||+.+|++.|+....
T Consensus 269 ~~~~~----~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTA----KTNLLDELPQSVLKWAPS-------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHH----HHHHHHTTTHHHHHHSCT-------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHH----HHhhcccccHHHHhhccc-------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111 111100000001111110 0223468899999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.87 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=193.2
Q ss_pred HHHhhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc---
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM--- 236 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--- 236 (464)
...+.+.+.||+|+||.||+|... .+..||+|++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 344566788999999999999864 24589999987442 23366889999999999999999999987654
Q ss_pred --EEeEEEEeccCCChHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEe
Q 040010 237 --HRLLVYEYVENQSLDKHLF------SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIA 308 (464)
Q Consensus 237 --~~~lv~E~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 308 (464)
..++||||+++|+|.+++. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 3499999999999999984 33579999999999999999999999 899999999999999999999999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... . ...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~---~~~ 260 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------E---MYD 260 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------G---HHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------H---HHH
Confidence 9999987654433222344567889999999999999999999999999999999 77777532110 0 111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
. ...+ ..+ ..+......+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 261 ~----~~~~--------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 261 Y----LLHG--------HRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp H----HHTT--------CCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHcC--------CCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 1000 011 1122334578899999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.34 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=197.8
Q ss_pred HhhhccccCccCceEEEEEEECC-----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+.||+|+||.||+|.... +..||||++.... .....+.+|++++++++|+||+++++++......++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 34556789999999999998643 2469999997543 2345688999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999764 579999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... ..+.
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~~~~----~~~~---- 264 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------HEVM----KAIN---- 264 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHH----HHHH----
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---------HHHH----HHHH----
Confidence 211 1223456788999999999999999999999999999999 9998853210 0111 1111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+. .....+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 265 -------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 265 -------DG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------TT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 10 011122234567889999999999999999999999997653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=345.50 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=190.0
Q ss_pred hhhccccCccCceEEEEEEEC--CC--cEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeee-CcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT--DE--RAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~--~~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|.+. ++ ..||||.++... ...+.+.+|+.++++++||||++++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 345678999999999999963 22 468999987532 345679999999999999999999998754 56789999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999764 468999999999999999999999 8999999999999999999999999999986543322
Q ss_pred C--cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 322 S--SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 322 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
. .......+|+.|+|||.+.+..++.++||||||+++|||++| ..|+..... . ... .. ...+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-~-----~~~---~~----~~~~~- 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-F-----DIT---VY----LLQGR- 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-S-----CHH---HH----HHTTC-
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-H-----HHH---HH----HHcCC-
Confidence 1 112345578899999999999999999999999999999995 555542211 1 000 00 10010
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. ..+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 314 -------~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 -------RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 111223456889999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.09 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=204.0
Q ss_pred hhhcc-ccCccCceEEEEEEEC---CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKE-ELGKGGSGAVYKGVLT---DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~-~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+ .||+|+||.||+|... ++..||||+++... ...+.+.+|++++++++||||+++++++ .....++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 33444 8999999999999864 57789999998643 3456789999999999999999999999 4567899999
Q ss_pred eccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 244 YVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 244 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999999754 569999999999999999999999 89999999999999999999999999999876543221
Q ss_pred -cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 323 -SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 323 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... . ... ..+..+
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~---~~~----~~i~~~---- 229 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------P---EVM----AFIEQG---- 229 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------H---HHH----HHHHTT----
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------H---HHH----HHHhcC----
Confidence 11233456889999999988889999999999999999998 9999863211 0 111 111100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.....+......+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 230 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 --------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0112223345678899999999999999999999999988754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=336.09 Aligned_cols=240 Identities=22% Similarity=0.258 Sum_probs=201.6
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---------hhHHHHHHHHHhhhccccceeccceeeeeCcE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH 237 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 237 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+|++++++++|+||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4566778999999999999996 4688999999875421 23457789999999999999999999999999
Q ss_pred EeEEEEeccCC-ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 238 RLLVYEYVENQ-SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 238 ~~lv~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
.++||||+.+| +|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 999999888899999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
..... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 181 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----------------------- 234 (335)
T 3dls_A 181 ERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----------------------- 234 (335)
T ss_dssp CTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-----------------------
T ss_pred CCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH-----------------------
Confidence 54322 345679999999999988776 889999999999999999999986311
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+........ +......+.+++.+||+.||++|||+.++++.
T Consensus 235 -------~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 235 -------ETVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------GGTTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HHHhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111110 11123468899999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=336.98 Aligned_cols=246 Identities=23% Similarity=0.241 Sum_probs=193.6
Q ss_pred HHhhhccccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
..+.+.+.||+|+||.||++.. .+++.||+|+++... .....+.+|+++++.++||||+++++++..+...
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3467778999999999999997 468899999997532 2335578899999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999999888889999999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~----i----- 233 (327)
T 3a62_A 174 DG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------KKTIDK----I----- 233 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHH----H-----
T ss_pred CC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---------HHHHHH----H-----
Confidence 21 123345799999999999999999999999999999999999999863210 011111 1
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
..... .++......+.+++.+||+.||.+|| ++.++++
T Consensus 234 ------~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 ------LKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------HHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------HhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111 11222345688999999999999999 6777765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.85 Aligned_cols=271 Identities=24% Similarity=0.286 Sum_probs=210.3
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhh--ccccceeccceeeeeCc-
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGK--IYHMNLVRMWGFCTEGM- 236 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~- 236 (464)
+...+.....+.+.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++|+||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 334455566788889999999999999998 5789999999643 34567788888887 78999999999998775
Q ss_pred ---EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCCEEEcCCCCe
Q 040010 237 ---HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLH--------HECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 237 ---~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
..++||||+++|+|.+++.+ ..+++..++.++.|++.||+||| + .+|+||||||+||+++.++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 78999999999999999964 46999999999999999999999 6 899999999999999999999
Q ss_pred EEeeecCccccCCCCCCc--ceeeeccCCCccCcccccCCC------CCccchhHHHHHHHHHHHhC----------CCC
Q 040010 306 KIADFGLAKLSQRGSNSS--QFSRIRGTKGYMAPEWASNLP------ITSKVDVFSYGVVILEMLKG----------IRL 367 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gvvl~elltg----------~~p 367 (464)
||+|||++.......... ......||+.|+|||.+.+.. ++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433211 123457999999999987652 34789999999999999999 556
Q ss_pred CCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 368 SNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGH-FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
|........ ....+... . ......+.+... ...+....+.+|+.+||+.||++|||+.+|++.|
T Consensus 267 ~~~~~~~~~----~~~~~~~~----~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 267 YYDLVPSDP----SVEEMRKV----V-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp TTTTSCSSC----CHHHHHHH----H-------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccCcCcc----cHHHHHHH----H-------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 653221111 11111111 0 111122222111 1236778899999999999999999999999999
Q ss_pred hCCCCC
Q 040010 447 LGCEAE 452 (464)
Q Consensus 447 ~~~~~~ 452 (464)
+.+.+.
T Consensus 332 ~~i~~~ 337 (342)
T 1b6c_B 332 SQLSQQ 337 (342)
T ss_dssp HHHHHT
T ss_pred HHHHHH
Confidence 987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=364.44 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=197.1
Q ss_pred ccCccCceEEEEEEEC---CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 175 ELGKGGSGAVYKGVLT---DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+++|++++|+|||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 4568999999854 2345789999999999999999999999976 56899999999999
Q ss_pred hHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc-ceee
Q 040010 250 LDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS-QFSR 327 (464)
Q Consensus 250 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 327 (464)
|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 469999999999999999999999 899999999999999999999999999998765432211 1223
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . +. ...+..
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~---~~----~~~i~~----------- 554 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------P---EV----MAFIEQ----------- 554 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------H---HH----HHHHHT-----------
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------H---HH----HHHHHc-----------
Confidence 446789999999999999999999999999999998 9999864211 0 01 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
......+......+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 555 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 555 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111122334456789999999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=339.27 Aligned_cols=257 Identities=24% Similarity=0.301 Sum_probs=193.2
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCc----EEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 239 (464)
.+.+.+.||+|+||.||++.. .+++.||||++..... ....+.+|++++++++||||+++++++.... ..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 466778999999999999996 5688999999975422 2356889999999999999999999987654 349
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++++|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999999888889999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... ..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---------~~~~~~~~~----~~- 235 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---------VSVAYQHVR----ED- 235 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHHH----CC-
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhc----CC-
Confidence 222 223446689999999999999999999999999999999999999863211 001111000 00
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH-HHHhhCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSV-VQTLLGCE 450 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V-~~~L~~~~ 450 (464)
...+.. ........+.+++.+||+.||++||++.++ ...|....
T Consensus 236 -----~~~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 -----PIPPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----CCCHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----CCCccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 000000 001123568899999999999999976554 44554443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.17 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=202.6
Q ss_pred HHHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCc
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM 236 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 236 (464)
+....+.+.+.||+|+||.||+|.. .++..||||++... ......+.+|+.++++++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3445567788999999999999984 24678999999643 334567889999999999999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeE
Q 040010 237 HRLLVYEYVENQSLDKHLFSS-------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPK 306 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~k 306 (464)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999754 348999999999999999999999 89999999999999984 45699
Q ss_pred EeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHH
Q 040010 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 307 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 385 (464)
|+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... .. ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~---~~ 254 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQ---EV 254 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HH---HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------HH---HH
Confidence 999999986544333222344567899999999988899999999999999999998 888876321 00 11
Q ss_pred HHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.. .+..+ ... ..+......+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 255 ~~----~~~~~--------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 255 LE----FVTSG--------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HH----HHHTT--------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHhcC--------CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11 11100 011 1122334568899999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=341.02 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=202.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+++++.++||||+++++++.+....++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4567789999999999999975 47899999986432 234668899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--- 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--- 169 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---
Confidence 99999999999888899999999999999999999999 899999999999999999999999999998765332
Q ss_pred ceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 QFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..........
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~~~~~~~--------- 234 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS------SKEIVHTFET--------- 234 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC------HHHHHHHHHH---------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHhh---------
Confidence 2455779999999999864 458999999999999999999999997432211 1111111000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-MDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-m~~V~~ 444 (464)
... .++......+.+|+.+||+.||.+||+ +.+|.+
T Consensus 235 ----~~~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 ----TVV----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccc----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 001 122233457889999999999999999 677664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=339.92 Aligned_cols=250 Identities=22% Similarity=0.240 Sum_probs=201.0
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc------cchhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL------HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
...|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+++++.++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 456788899999999999999974 5889999998532 123567899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecC
Q 040010 240 LVYEYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGL 312 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgl 312 (464)
+||||+++++|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887642 358999999999999999999999 89999999999999987655 99999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ... ..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~----~~~----~~ 243 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------E----RLF----EG 243 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------H----HHH----HH
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------H----HHH----HH
Confidence 98765432 12344679999999999999999999999999999999999999986321 1 111 11
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+.. ..++.... .....+.+++.+||+.||++|||+.++++
T Consensus 244 i~~~~~-----~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 244 IIKGKY-----KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTCC-----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCC-----CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111100 00000001 12356889999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.33 Aligned_cols=245 Identities=24% Similarity=0.295 Sum_probs=201.6
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+....++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 34566789999999999999985 5889999999753 22345677899999887 899999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999999999888889999999999999999999999 899999999999999999999999999998543222
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ... ...+..+
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~---~~~----~~~i~~~----- 233 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------E---EEL----FHSIRMD----- 233 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHH----HHHHHHC-----
T ss_pred -CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC------H---HHH----HHHHHhC-----
Confidence 22455779999999999999999999999999999999999999986321 0 011 1111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD-SVV 443 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~-~V~ 443 (464)
.+. ++......+.+++.+||+.||++||++. +|+
T Consensus 234 ----~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 ----NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 1222345688999999999999999997 664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=330.26 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=205.8
Q ss_pred HHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee--------
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-------- 234 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 234 (464)
......+.+.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 344556777889999999999999986 68999999987543 456789999999999999999998854
Q ss_pred --------CcEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC
Q 040010 235 --------GMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE 304 (464)
Q Consensus 235 --------~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 304 (464)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence 45689999999999999999753 579999999999999999999999 89999999999999999999
Q ss_pred eEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH
Q 040010 305 PKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 305 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 384 (464)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----------~~ 226 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----------SK 226 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----------HH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----------HH
Confidence 99999999987654322 23456899999999999999999999999999999999998875310 01
Q ss_pred HHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
. ...+.+..+...++ ..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 227 ~---------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 F---------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp H---------------HHHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred H---------------HHHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 11111122222233 3578899999999999999999999999988764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=332.70 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=197.1
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++++++|+||+++++++......++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 467778999999999999997 46889999998742 2234668899999999999999999999999999999999
Q ss_pred eccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 244 YVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 244 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999863 4579999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ..+.
T Consensus 190 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~----~~~~----- 251 (310)
T 2wqm_A 190 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLC----KKIE----- 251 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-------CHHHHH----HHHH-----
T ss_pred Cc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-------hHHHHH----HHhh-----
Confidence 21 12345689999999999999999999999999999999999999863211 011111 1111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESE 454 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~ 454 (464)
....+.+ ........+.+++.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 252 ---~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 252 ---QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---TTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---cccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1001111 112234568899999999999999999999999998865433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=327.98 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=196.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 456789999999999999985 488999999865432 2456789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 159 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YY 159 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--cc
Confidence 999999999888889999999999999999999999 8999999999999999999999999999987653322 23
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc--------
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG-------- 396 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 396 (464)
....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ... ..........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-----DQL----YLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH----HHHHHHHCSCCHHHHHHH
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHH----HHHHHHhccccccccccc
Confidence 44578999999998876 67899999999999999999999998643211 000 0110000000
Q ss_pred -chhhhhhhcCCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 397 -EEARIEEIVDPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 397 -~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..........+......+ ......+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 1234568899999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=332.86 Aligned_cols=259 Identities=22% Similarity=0.241 Sum_probs=198.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 3567789999999999999975 688999999875432 23668899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~ 190 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-T 190 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-c
Confidence 99999999999888889999999999999999999999 8999999999999999999999999999976544321 1
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. .+... +.. .
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~----~~~~~---~~~-------~ 250 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ------LS----VMGAH---INQ-------A 250 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH------HH----HHHHH---HHS-------C
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch------HH----HHHHH---hcc-------C
Confidence 2334568999999999999999999999999999999999999986321 10 11111 100 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhCCCCCCC
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-TMDSVVQTLLGCEAESE 454 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-sm~~V~~~L~~~~~~~~ 454 (464)
...+ ..........+.+++.+||+.||++|| ++.++++.|+.......
T Consensus 251 ~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 251 IPRP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CCCG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0000 011122234688899999999999999 99999999998876443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=338.35 Aligned_cols=246 Identities=25% Similarity=0.264 Sum_probs=201.7
Q ss_pred HHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||++.... ++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+....++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 346677899999999999999864 788999998743 22345678899999988 899999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999999999887889999999999999999999999 899999999999999999999999999998543222
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ... ...+
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~---~~~----~~~i-------- 233 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------E---DEL----FQSI-------- 233 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHH----HHHH--------
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------H---HHH----HHHH--------
Confidence 22445679999999999999999999999999999999999999986321 0 111 1111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
+...+ .++......+.+++.+||+.||.+||+ +.++++
T Consensus 234 ---~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 234 ---MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---HHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---HhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111 122233456889999999999999996 466654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.54 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=203.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc-------hhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ-------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778899999999999999975 588999999864321 3467899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCccc
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAKL 315 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~ 315 (464)
+||||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999888889999999999999999999999 8999999999999999888 799999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .... .+..
T Consensus 169 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~----~~~~----~i~~ 232 (321)
T 2a2a_A 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q----ETLA----NITS 232 (321)
T ss_dssp CCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H----HHHH----HHHT
T ss_pred cCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----H----HHHH----HHHh
Confidence 654322 3445699999999999999999999999999999999999999863210 0 1111 1110
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. ...++.... .....+.+++.+||+.||++|||+.++++
T Consensus 233 ~~-----~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VS-----YDFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TC-----CCCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc-----cccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000111 12346889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.65 Aligned_cols=249 Identities=20% Similarity=0.256 Sum_probs=202.9
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++|+||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3667789999999999999975 57899999987543 344578899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC--CCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--EFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++.......
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 205 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence 999999997654 79999999999999999999999 89999999999999974 5779999999998765432
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ...... +..+. .
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~---~~~~~~----i~~~~-----~ 267 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------D---LETLQN----VKRCD-----W 267 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------H---HHHHHH----HHHCC-----C
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------H---HHHHHH----HHhCC-----C
Confidence 2345679999999999999999999999999999999999999986321 0 011111 11000 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..++.. .......+.+++.+||+.||.+|||+.++++.
T Consensus 268 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011111 11234568899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=334.98 Aligned_cols=248 Identities=25% Similarity=0.279 Sum_probs=181.1
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
+.||+|+||.||++... +++.||||++... ....+.+|+.++..+. ||||+++++++.++...++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999985 5889999998643 3456778999999997 999999999999999999999999999999
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeeecCccccCCCCCCcceeee
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++........ .....
T Consensus 95 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 169 (325)
T 3kn6_A 95 ERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTP 169 (325)
T ss_dssp HHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccccc
Confidence 999988899999999999999999999999 8999999999999997765 799999999986544322 23456
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ......+ ....
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~----~~~~~~i-----------~~~~ 232 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--CTSA----VEIMKKI-----------KKGD 232 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCH----HHHHHHH-----------TTTC
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--cccH----HHHHHHH-----------HcCC
Confidence 689999999999999999999999999999999999999974321110 0000 1111111 1111
Q ss_pred cC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 409 LK--GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 409 l~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11 00011235678899999999999999999999843
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.77 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=199.2
Q ss_pred HhhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 45667899999999999998643 2469999987542 3456789999999999999999999998754 568999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999764 469999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. .....
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~------~~---~~~~~---------- 228 (281)
T 3cc6_A 169 Y-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK------DV---IGVLE---------- 228 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG------GH---HHHHH----------
T ss_pred c-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH------HH---HHHHh----------
Confidence 1 1234557889999999998899999999999999999998 99998643211 11 11100
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
..... ..+....+.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 229 --~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 229 --KGDRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00001 111223456889999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.15 Aligned_cols=199 Identities=16% Similarity=0.132 Sum_probs=173.2
Q ss_pred HhhhccccCcc--CceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKG--GSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G--~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.|.+.+.||+| +||.||++... +++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46677899999 99999999986 68999999997442 23356888999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 243 EYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 243 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999765 679999999999999999999999 899999999999999999999999999986543221
Q ss_pred CC-----cceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 321 NS-----SQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 321 ~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 11 11223468999999999987 6799999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=338.08 Aligned_cols=244 Identities=27% Similarity=0.300 Sum_probs=196.5
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3456667899999999999996 568899999986432 22356889999999999999999999999999999999
Q ss_pred EeccCCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||++ |+|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9997 67877775 45689999999999999999999999 8999999999999999999999999999976543
Q ss_pred CcceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 322 SSQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.....||+.|+|||.+. ...++.++||||||+++|||++|+.||..... ........
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------~~~~~~~~-------- 266 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYHIA-------- 266 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHH--------
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHH--------
Confidence 23356999999999884 56789999999999999999999999863210 01111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.-..+.+. .......+.+++.+||+.||++|||+.++++.
T Consensus 267 ----~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 ----QNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----HSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----hcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00111111 11223568899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.94 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=195.1
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeC-cEEeEEEEeccC
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-MHRLLVYEYVEN 247 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~E~~~~ 247 (464)
.+.+.+.||+|+||.||++... ++.||||.++... ..+.+.+|++++++++|+||+++++++.+. ...++||||+++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 4567789999999999999984 7899999997543 456788999999999999999999987544 578999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...... .
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~ 171 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 171 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc-----c
Confidence 99999997654 38999999999999999999999 89999999999999999999999999998755432 2
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .... .+ .
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---------~~~~----~~--------~-- 228 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------DVVP----RV--------E-- 228 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---------GHHH----HH--------T--
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHH----HH--------h--
Confidence 23457889999999998999999999999999999998 88888632110 0111 11 1
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.......+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 229 --KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11111222233457889999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.70 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=201.7
Q ss_pred HHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||+|.... +..+|+|++... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 356777899999999999999754 678999998754 344577899999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999999999888889999999999999999999999 899999999999999 888999999999998765432
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... . .... .+..+.
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~----~~~~----~~~~~~----- 223 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----S----EVML----KIREGT----- 223 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHH----HHHHCC-----
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----H----HHHH----HHHhCC-----
Confidence 23445699999999988764 89999999999999999999999864211 0 1111 111000
Q ss_pred hhcCCccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNK----NQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. ..+. .....+.+++.+||+.||.+|||+.++++
T Consensus 224 ------~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ------F--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------C--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111 12456889999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.15 Aligned_cols=244 Identities=21% Similarity=0.262 Sum_probs=193.9
Q ss_pred ccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 173 KEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999974 58899999997543 3557799999999999999999999999999999999999999999
Q ss_pred HHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE--cCCCCeEEeeecCccccCCCCCCcceee
Q 040010 251 DKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL--DSEFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 251 ~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9988654 479999999999999999999999 899999999999999 6778899999999987654322 234
Q ss_pred eccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 328 IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....+.. .. .. ..+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~----~~~~~i~~----~~----~~-~~~ 309 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----A----ETLNNILA----CR----WD-LED 309 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHHHHHHH----TC----CC-SCS
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHh----cc----CC-CCh
Confidence 5699999999999998999999999999999999999999863211 1 11111110 00 00 001
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... .....+.+|+.+||+.||.+|||+.++++
T Consensus 310 ~~~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQ----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhc----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111 22356889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=335.34 Aligned_cols=197 Identities=27% Similarity=0.316 Sum_probs=175.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-----ccceeccceeeeeCcEE
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-----HMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~ 238 (464)
+....+.+.++||+|+||.||+|.. .+++.||||+++........+..|+++++.++ |+||+++++++......
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3344567778999999999999997 46789999999876666677888999999986 99999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---------------
Q 040010 239 LLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--------------- 301 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--------------- 301 (464)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 999999997654 59999999999999999999999 89999999999999976
Q ss_pred ----------CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 302 ----------EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 302 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999865432 2345689999999999999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.93 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=204.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3566789999999999999975 68999999986432 233568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--- 170 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--- 170 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc---
Confidence 99999999999888889999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ... ...+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~----~~~i--------- 228 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------PTL----FKKI--------- 228 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---------HHH----HHHH---------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---------HHH----HHHH---------
Confidence 2344679999999999988765 6899999999999999999999873211 011 1111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhC
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLG 448 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~ 448 (464)
.+... ..+......+.+++.+||+.||.+|||+.++++ .+..
T Consensus 229 --~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 229 --CDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --HTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --hcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 11111 111122346889999999999999999999987 4444
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.80 Aligned_cols=244 Identities=21% Similarity=0.273 Sum_probs=180.4
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|.. .+++.||||.+.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 55678899999999999997 468899999986432 2236688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999765 579999999999999999999999 8999999999999999999999999999987653322
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------------------~~~ 223 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------------------LNK 223 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------------------
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------------------HHH
Confidence 12345689999999999998999999999999999999999999864321100 111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..... ..+......+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111111 112223456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=335.58 Aligned_cols=248 Identities=15% Similarity=0.137 Sum_probs=201.3
Q ss_pred HHhhhccccCccCceEEEEEE------ECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGV------LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~------~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 238 (464)
..+.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++..++ |+|++++++++...+..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 345667889999999999994 456789999999754 3456777888887776 99999999999999999
Q ss_pred eEEEEeccCCChHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-----------C
Q 040010 239 LLVYEYVENQSLDKHLFS-----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-----------E 302 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----------~ 302 (464)
++||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999973 4579999999999999999999999 89999999999999998 8
Q ss_pred CCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhH
Q 040010 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 303 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 382 (464)
+.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+.||.......
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 9999999999986654333444566789999999999999999999999999999999999999985321110
Q ss_pred HHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhCCC
Q 040010 383 TGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKR-PTMDSVVQTLLGCE 450 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~R-Psm~~V~~~L~~~~ 450 (464)
..+...+..... .+.+.+++..|++.+|.+| |++.++.+.|+...
T Consensus 293 --------------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 --------------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 001111111112 3456678889999999999 67888888887653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=329.64 Aligned_cols=264 Identities=25% Similarity=0.263 Sum_probs=196.9
Q ss_pred HHHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc------chhHHHHHHHHHhhhcc---ccceeccceeeee
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH------QGEEVFWAEVSTIGKIY---HMNLVRMWGFCTE 234 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 234 (464)
+....+.+.+.||+|+||+||+|.. .+++.||||++.... .....+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3445677888999999999999996 468899999986322 12345677888777765 9999999999977
Q ss_pred Cc-----EEeEEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 235 GM-----HRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 235 ~~-----~~~lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
.. ..++||||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence 54 5799999997 69999997654 39999999999999999999999 88999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ....
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~----~~~~ 229 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----A----DQLG 229 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----H----HHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHH
Confidence 9999998664332 23456789999999999999999999999999999999999999864211 1 1111
Q ss_pred HHHHHhhccchhhhhh-------hcCCccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 388 EVKEKILCGEEARIEE-------IVDPRLKG---HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~-------~~d~~l~~---~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.............. ...+.... ....+..+.+.+++.+||+.||++|||+.++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111111000000000 00000000 000123456889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.60 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=195.5
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee----CcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE----GMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 241 (464)
+.+.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 355678999999999999974 57789999986432 334668899999999999999999998865 4668999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEc-CCCCeEEeeecCccccCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLD-SEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 318 (464)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .+ |+||||||+||+++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999887889999999999999999999999 66 99999999999997 789999999999975443
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .... .....+.
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~----~~~~~~~- 246 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--------AQIY----RRVTSGV- 246 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--------HHHH----HHHTTTC-
T ss_pred c----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--------HHHH----HHHhccC-
Confidence 2 2344679999999998764 5899999999999999999999998632110 0111 1111110
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..... +......+.+++..||+.||.+|||+.++++
T Consensus 247 ------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 ------KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------Ccccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01111 1112246889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.30 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=195.4
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
+.||+|+||.||++.. .+++.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999996 468899999996543 3456788999999885 799999999999999999999999999999
Q ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecCccccCCCCCC-----
Q 040010 251 DKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSNS----- 322 (464)
Q Consensus 251 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~~----- 322 (464)
.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.........
T Consensus 99 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 175 (316)
T 2ac3_A 99 LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175 (316)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccc
Confidence 9999888889999999999999999999999 89999999999999998776 999999999765432211
Q ss_pred cceeeeccCCCccCcccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh--hhHHHHHHHHHHHhhc
Q 040010 323 SQFSRIRGTKGYMAPEWASN-----LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE--AELTGFIREVKEKILC 395 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 395 (464)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .............+.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~- 254 (316)
T 2ac3_A 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ- 254 (316)
T ss_dssp ------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH-
T ss_pred cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh-
Confidence 11234569999999999865 4588999999999999999999999975432211000 000000111111111
Q ss_pred cchhhhhhhcCCccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCCCCCCCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNK----NQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEAESEVPVQ 458 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~~~~~~~p 458 (464)
.... .++. .....+.+++.+||+.||.+|||+.++++ .+.+......+|.|
T Consensus 255 ----------~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 311 (316)
T 2ac3_A 255 ----------EGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP 311 (316)
T ss_dssp ----------HCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred ----------ccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence 1111 1111 12356889999999999999999999998 44544443333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=327.10 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=188.5
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4566788999999999999964 58899999986432 23467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 246 ENQSLDKHLFSS------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 246 ~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+ |+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 6999988643 358999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ....+.........
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~----~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 162 VN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EE----QLKLIFDIMGTPNE 230 (317)
T ss_dssp CC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHHHCSCCT
T ss_pred cc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HH----HHHHHHHHhCCCCh
Confidence 21 2344578999999999876 4689999999999999999999999864211 11 11111111100000
Q ss_pred h---------------------hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 A---------------------RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~---------------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .+.+.+.+..... ....+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0001111111111 2346889999999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.08 Aligned_cols=250 Identities=20% Similarity=0.226 Sum_probs=199.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3455678999999999999985 4789999998642 2233458899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~ 224 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224 (410)
T ss_dssp CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence 9999999999864 468999999999999999999999 8999999999999999999999999999987654321 1
Q ss_pred ceeeeccCCCccCcccccCCC----CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 324 QFSRIRGTKGYMAPEWASNLP----ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..... . .....+.. +.
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~----~~~~~i~~----~~-- 289 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----V----GTYSKIMN----HK-- 289 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHHHHHHT----HH--
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----h----hHHHHHHh----cc--
Confidence 234567999999999987765 78999999999999999999999973210 1 11111110 00
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK--RPTMDSVVQT 445 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~--RPsm~~V~~~ 445 (464)
..+.-+. .. .....+.+|+.+||+.+|.+ ||++.||++.
T Consensus 290 --~~~~~p~-~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 --NSLTFPD-DN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HHCCCCT-TC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --ccccCCC-cc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011111 01 12346888999999999988 9999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=323.80 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=200.8
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-------chhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
...+.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345778889999999999999986 58899999886432 1356789999999999999999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCcc
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAK 314 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~ 314 (464)
++||||+++++|.+++.+...+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999888889999999999999999999999 8999999999999998877 79999999998
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ... ..+.
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~----~~~----~~~~ 224 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----Q----ETL----TNIS 224 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHH----HHHH
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----H----HHH----HHhH
Confidence 764432 23345689999999999999999999999999999999999999863211 0 011 1110
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ..++.... .....+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~-----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 225 AVNY-----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TTCC-----CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccc-----CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 00000001 12346889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.19 Aligned_cols=250 Identities=23% Similarity=0.249 Sum_probs=194.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc------cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL------HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 45778889999999999999974 5789999998632 2344678999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhc----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 040010 241 VYEYVENQSLDKHLFS----------------------------------------SNFLGWKERFKVALGTAKGLAYLH 280 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH 280 (464)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999852 112356778899999999999999
Q ss_pred hcCCCceEecCCCCCCEEEcCCC--CeEEeeecCccccCCCCCC--cceeeeccCCCccCcccccC--CCCCccchhHHH
Q 040010 281 HECLEWVIHCDVKPENILLDSEF--EPKIADFGLAKLSQRGSNS--SQFSRIRGTKGYMAPEWASN--LPITSKVDVFSY 354 (464)
Q Consensus 281 ~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~ 354 (464)
+ .+|+||||||+||+++.++ .+||+|||++......... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp H---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred H---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9 8999999999999998776 8999999999865432221 12345679999999999865 678999999999
Q ss_pred HHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccC--CCCCHHHHHHHHHHHHHccCCC
Q 040010 355 GVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK--GHFNKNQAATLFRIGISCVDED 432 (464)
Q Consensus 355 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~~~l~~~Cl~~d 432 (464)
|+++|||++|+.||..... . ...... +..... ..........+.+++.+||+.|
T Consensus 263 G~il~el~~g~~pf~~~~~-----~----~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVND-----A----DTISQV---------------LNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSH-----H----HHHHHH---------------HHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHCCCCCCCCCh-----H----HHHHHH---------------HhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 9999999999999863211 0 111111 111110 0001123456889999999999
Q ss_pred CCCCCCHHHHHH
Q 040010 433 RNKRPTMDSVVQ 444 (464)
Q Consensus 433 p~~RPsm~~V~~ 444 (464)
|.+|||+.++++
T Consensus 319 p~~Rps~~~~l~ 330 (345)
T 3hko_A 319 VDERFDAMRALQ 330 (345)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhHCCCHHHHhc
Confidence 999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=323.85 Aligned_cols=248 Identities=25% Similarity=0.314 Sum_probs=201.6
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.+.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3566789999999999999975 58899999986443 2335688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecCccccCCCCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGLAKLSQRGSN 321 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~ 321 (464)
+++++|.+.+.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++........
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9999999999888889999999999999999999999 89999999999999987665 99999999976654322
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ..... ...+.
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~---~~~~~----~~~~~---- 223 (284)
T 3kk8_A 164 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QH---RLYAQ----IKAGA---- 223 (284)
T ss_dssp ---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH---HHHHH----HHHTC----
T ss_pred ---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc------hh---HHHHH----HHhcc----
Confidence 334679999999999999999999999999999999999999986321 10 11111 11000
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..... .........+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YDYPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 011123456889999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=348.88 Aligned_cols=246 Identities=23% Similarity=0.227 Sum_probs=193.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++... +++.||||++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 3566779999999999999974 5889999998742 2233567889999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--c
Confidence 999999999998888999999999999999999999962 579999999999999999999999999997543322 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~~~~----i---------- 361 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------EKLFEL----I---------- 361 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHH----H----------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---------HHHHHH----H----------
Confidence 23457799999999999999999999999999999999999999863210 011111 1
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
..... .++......+.+|+.+||+.||.+|| ++.++++
T Consensus 362 -~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 -LMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -HhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 10111 11222345688999999999999999 9999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=322.86 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=198.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+|... ++..||+|++.... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 556688999999999999975 46789999986432 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 163 (279)
T 3fdn_A 91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 163 (279)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc----
Confidence 9999999999888889999999999999999999999 899999999999999999999999999986543321
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... + ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~----~--------~~- 221 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------QETYKR----I--------SR- 221 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHH----H--------HH-
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---------HHHHHH----H--------Hh-
Confidence 2345789999999999999999999999999999999999999863210 011111 0 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.... ++......+.+++.+||+.||.+|||+.++++.
T Consensus 222 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 VEFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TCCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111 122234567899999999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=339.64 Aligned_cols=260 Identities=18% Similarity=0.198 Sum_probs=202.2
Q ss_pred HhhhccccCccCceEEEEEEECC---------CcEEEEEEcCCccchhHHHHHHHHHhhhccccceec------------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD---------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVR------------ 227 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 227 (464)
.+.+.+.||+|+||.||+|.... ++.||||.+... +.+.+|++++++++|+|+++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 45677899999999999999764 789999998643 46789999999999999998
Q ss_pred ---cceeeee-CcEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC
Q 040010 228 ---MWGFCTE-GMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS 301 (464)
Q Consensus 228 ---l~g~~~~-~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 301 (464)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcC
Confidence 5667765 68899999999 99999999875 689999999999999999999999 89999999999999999
Q ss_pred CC--CeEEeeecCccccCCCCCC-----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccC
Q 040010 302 EF--EPKIADFGLAKLSQRGSNS-----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVED 374 (464)
Q Consensus 302 ~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~ 374 (464)
++ .+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999866432211 1123357999999999999999999999999999999999999998743211
Q ss_pred ccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 375 SEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.... ......... . ...+.+.... .......+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 275 ----~~~~----~~~~~~~~~-~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 275 ----TEDI----MKQKQKFVD-K---PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp ----HHHH----HHHHHHHHH-S---CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----HHHH----HHHHHhccC-C---hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 1111 111111100 0 1111111110 00123568899999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.97 Aligned_cols=243 Identities=25% Similarity=0.295 Sum_probs=202.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|++++++++|+||+++++++.++...++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4566789999999999999975 5778999998643 2234678899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 99999999999888889999999999999999999999 899999999999999999999999999997654322
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . ... ..+..
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~----~~~----~~~~~-------- 226 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----T----ETH----RRIVN-------- 226 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHH----HHHHT--------
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----h----HHH----HHHhc--------
Confidence 2345689999999999999999999999999999999999999863211 0 000 11100
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.. ++......+.+++.+||+.||.+|||+.++++
T Consensus 227 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 227 -VDLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -TCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111 12223456889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.29 Aligned_cols=244 Identities=24% Similarity=0.271 Sum_probs=202.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 556788999999999999986 47889999886432 2346688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 171 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 171 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--c
Confidence 9999999999887889999999999999999999999 8999999999999999999999999999987653322 2
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~----~~~~---------- 228 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETY----LRIK---------- 228 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHH----HHHH----------
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH----HHHh----------
Confidence 3346689999999999998999999999999999999999999863211 0110 1110
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ..+......+.+++.+||+.||++|||+.++++
T Consensus 229 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 -KNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -TTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -hccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1110 111223346888999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.67 Aligned_cols=246 Identities=27% Similarity=0.294 Sum_probs=192.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHH-hhhccccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVST-IGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||+++.. +++.||+|+++... .....+..|..+ ++.++||||+++++++.+....++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4567789999999999999985 47889999996432 223456667776 57789999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-- 193 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 193 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC--
Confidence 999999999999888889999999999999999999999 899999999999999999999999999998643322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ..+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------~~~~----~~i--------- 251 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------AEMY----DNI--------- 251 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---------HHHH----HHH---------
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------HHHH----HHH---------
Confidence 224557799999999999999999999999999999999999999863210 1111 111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+...+ .++......+.+++.+||+.||.+||++.+.++.
T Consensus 252 --~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 252 --LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp --HHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred --Hhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 11111 1112233568899999999999999998644333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=334.45 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=200.7
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcE--EEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERA--VAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~--vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|... ++.. +|+|++... ....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34567789999999999999964 4554 599988643 33446788999999999 899999999999999999999
Q ss_pred EEeccCCChHHhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCe
Q 040010 242 YEYVENQSLDKHLFSSN----------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEP 305 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 305 (464)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 69999999999999999999999 899999999999999999999
Q ss_pred EEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHH
Q 040010 306 KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTG 384 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 384 (464)
||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~~ 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------AE 249 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---------HH
Confidence 99999999743321 11233457889999999988889999999999999999998 9999863210 01
Q ss_pred HHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
....+. .- .....+......+.+++.+||+.||.+|||+.++++.|..+.+
T Consensus 250 ----~~~~~~--------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 250 ----LYEKLP--------QG----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp ----HHHHGG--------GT----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHhh--------cC----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 10 1111222334578899999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=322.42 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..+.+.+.||+|+||.||+|... +++.||||++... ......+.+|+..+..+ +||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45677789999999999999985 6899999998743 33456788999999999 9999999999999999999999
Q ss_pred EeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-----------------
Q 040010 243 EYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS----------------- 301 (464)
Q Consensus 243 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~----------------- 301 (464)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999754 679999999999999999999999 89999999999999984
Q ss_pred --CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccch
Q 040010 302 --EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378 (464)
Q Consensus 302 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~ 378 (464)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 234 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------- 234 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence 4479999999998765432 23489999999998765 6678999999999999999998765421
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. + ..+ ..-..+.+.. .....+.+++.+||+.||++|||+.++++
T Consensus 235 -~~---~-----~~~--------~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 -DQ---W-----HEI--------RQGRLPRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HH---H-----HHH--------HTTCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hH---H-----HHH--------HcCCCCCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 0 001 1111112222 23456889999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=322.76 Aligned_cols=247 Identities=25% Similarity=0.301 Sum_probs=194.3
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||++... ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45778889999999999999974 57899999987543 3447789999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccC
Q 040010 245 VENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 245 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 317 (464)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999864 3679999999999999999999999 899999999999999 556789999999998654
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..... ...... ..
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---------~~~~~~----~~--- 238 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---------EEVQQK----AT--- 238 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHH----HH---
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---------HHHHhh----hc---
Confidence 432 234466899999999876 4689999999999999999999999863210 111110 00
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+..... .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ------~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 ------YKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------HCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ------cCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111000 0012346788999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=323.48 Aligned_cols=261 Identities=19% Similarity=0.198 Sum_probs=202.9
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceee-eeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC-TEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++.... ....+..|+++++.++|+|++..++++ ..+...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 3467778999999999999996 568899999865432 234578899999999988887777765 6778889999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999974 4579999999999999999999999 899999999999999 7899999999999987655432
Q ss_pred Cc-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 322 SS-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 322 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......... .. .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~---~~-~ 237 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKK---MS-T 237 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHH---HH-S
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhccc---cc-c
Confidence 21 223567999999999999999999999999999999999999999753322111 1111111000 00 0
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.... +...+ ...+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 238 ----~~~~----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 ----PIEV----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ----CHHH----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hhhh----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0000 01112 3468899999999999999999999999987653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=328.25 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=195.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhcc--ccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIY--HMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||++...+++.||||++... ....+.+.+|++++.+++ |+||+++++++......++|||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 45667899999999999999988999999998643 234467899999999997 5999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+.+++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||++++ +.+||+|||++..........
T Consensus 109 -~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp -CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred -cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 6688999999888899999999999999999999999 89999999999999965 899999999998765443332
Q ss_pred ceeeeccCCCccCcccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 324 QFSRIRGTKGYMAPEWASN-----------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... . ..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~-~~------- 248 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------I-SK------- 248 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------H-HH-------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------H-HH-------
Confidence 3345678999999999865 47889999999999999999999998632110 0 00
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..++++.....++......+.+++.+||+.||.+|||+.++++.
T Consensus 249 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 122223322222222234568899999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=340.23 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=190.6
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---------chhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
....+.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3445777889999999999999975 57899999986432 112357899999999999999999999854
Q ss_pred cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC---CCeEEeeecC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE---FEPKIADFGL 312 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgl 312 (464)
...++||||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5679999999999999999888899999999999999999999999 899999999999999654 4599999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..
T Consensus 289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----~~~----- 355 (419)
T 3i6u_A 289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----LKD----- 355 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-----HHH-----
T ss_pred ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-----HHH-----
Confidence 98765322 2345679999999998853 5788999999999999999999999974321111 000
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+..... +.... .....+.+++.+||+.||++|||+.++++
T Consensus 356 --~i~~~~~~~~-----~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 --QITSGKYNFI-----PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HHHTTCCCCC-----HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHhcCCCCCC-----chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0100000000 00001 12456889999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.83 Aligned_cols=244 Identities=22% Similarity=0.220 Sum_probs=187.0
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhh-ccccceeccceeeee----CcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGK-IYHMNLVRMWGFCTE----GMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++... +++.||||++... ..+.+|++++.+ .+|+||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999975 5789999998642 456678888744 589999999998865 6778999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCCCCCC
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|+|.+++.... .+++..+..|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-- 218 (400)
T 1nxk_A 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218 (400)
T ss_dssp EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC--
Confidence 99999997643 69999999999999999999999 89999999999999998 7899999999998654322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..... +..+.
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~----i~~~~----- 283 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----GMKTR----IRMGQ----- 283 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-----SHHHH----HHHTC-----
T ss_pred -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-----HHHHH----HHcCc-----
Confidence 2345678999999999999999999999999999999999999997432211100 00000 10000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
...+ ..........+.+|+.+||+.||++|||+.++++.
T Consensus 284 -~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 -YEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00011234568899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=328.83 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=200.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeee--eCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCT--EGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++|+||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3566789999999999999975 68899999986432 33466889999999999999999999874 467899999
Q ss_pred EeccCCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 243 EYVENQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEW-----VIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 243 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999743 359999999999999999999999 66 999999999999999999999999999
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .. .. ...+
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~---~~----~~~i 228 (279)
T 2w5a_A 164 RILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QK---EL----AGKI 228 (279)
T ss_dssp HHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HH---HH----HHHH
T ss_pred eeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HH---HH----HHHH
Confidence 8654322 11234568999999999999899999999999999999999999986321 10 11 1111
Q ss_pred hccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 394 LCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
..+. .+. .+......+.+++.+||+.||++|||+.+|++.+....
T Consensus 229 ~~~~--------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 229 REGK--------FRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHTC--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred hhcc--------ccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1111 111 12233456889999999999999999999998876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=334.36 Aligned_cols=267 Identities=23% Similarity=0.310 Sum_probs=205.5
Q ss_pred HhhhccccCccCceEEEEEEE-----CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeC--cEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-----TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG--MHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 240 (464)
.+.+.+.||+|+||.||++.+ .+++.||||++.... ...+.+.+|++++++++|+||+++++++... ...++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 456778999999999999984 358899999997543 3446789999999999999999999988654 37899
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999999765 469999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcc-eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCcc---chhhhHHHHHHHHHHHhhc
Q 040010 320 SNSSQ-FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE---GQEAELTGFIREVKEKILC 395 (464)
Q Consensus 320 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 395 (464)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ............
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 271 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH------- 271 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH-------
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH-------
Confidence 32111 2234567789999999988899999999999999999999988753210000 000000000001
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
+.+.+........+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 272 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 272 -----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111223334567899999999999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=328.43 Aligned_cols=244 Identities=24% Similarity=0.273 Sum_probs=202.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 556788999999999999985 47889999986432 3446688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 123 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (335)
T 2owb_A 123 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 197 (335)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--c
Confidence 9999999999887889999999999999999999999 8999999999999999999999999999987653322 2
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... +
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~----~-------- 256 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKK----N-------- 256 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHHHHH----T--------
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---------HHHHHHHhc----C--------
Confidence 3446699999999999998999999999999999999999999863210 011111100 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+.. .....+.+++.+||+.||++|||+.++++
T Consensus 257 -~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 -EYSIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111 22346788999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=322.90 Aligned_cols=259 Identities=19% Similarity=0.191 Sum_probs=203.6
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceee-eeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFC-TEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~E~~~~ 247 (464)
+.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.++|++++..++++ .++...++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 56678999999999999997 578999999886543 234688999999999998877777665 6678889999999 9
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccCCCCCCc
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++..........
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 89 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 999999973 4579999999999999999999999 899999999999999 588999999999998765543211
Q ss_pred -----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 324 -----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 324 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ............ .
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~----~-- 237 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKKMS----T-- 237 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHHHH----S--
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhhhcccccC----C--
Confidence 124567999999999999999999999999999999999999999753322111 111111110000 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
... .+...+ ...+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 238 --~~~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 238 --PIE----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp --CHH----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred --chH----HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 000 011122 3468899999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.00 Aligned_cols=250 Identities=16% Similarity=0.106 Sum_probs=197.7
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..++..++|+||+++++++.+....++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 455678999999999999985 68999999996432 2234588999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++|+|.+++.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....... .
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~ 218 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-V 218 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-c
Confidence 9999999999764 479999999999999999999999 8999999999999999999999999999987654322 1
Q ss_pred ceeeeccCCCccCccccc-------CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 324 QFSRIRGTKGYMAPEWAS-------NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||..... . .....+.. .
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~----~~~~~i~~----~ 285 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----A----ETYGKIVH----Y 285 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHHHHHHT----H
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----H----HHHHHHHh----c
Confidence 123467999999999886 45789999999999999999999999963211 1 11111110 0
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKR---PTMDSVVQT 445 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~R---Psm~~V~~~ 445 (464)
. ....-+... ......+.+|+.+||+ +|.+| |++.++++.
T Consensus 286 ~----~~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 K----EHLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H----HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred c----cCcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 001111111 1234568899999999 99998 589988753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.21 Aligned_cols=252 Identities=25% Similarity=0.244 Sum_probs=201.6
Q ss_pred HhhhccccCccCceEEEEEEE----CCCcEEEEEEcCCcc-----chhHHHHHHHHHhhhc-cccceeccceeeeeCcEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL----TDERAVAVKRLGDLH-----QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 238 (464)
.+.+.+.||+|+||.||+++. .+++.||||+++... ...+.+.+|+++++++ +|+||+++++++......
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 466778999999999999997 368899999987432 2345677899999999 699999999999999999
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 9999999999999999888889999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 212 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~----~~-- 279 (355)
T 1vzo_A 212 DET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRR----IL-- 279 (355)
T ss_dssp GGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHHHHHH----HH--
T ss_pred CCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-----HHHHHHH----Hh--
Confidence 221 12334679999999999875 3578999999999999999999999874322111 1111111 10
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQTL 446 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~~L 446 (464)
. ..+ .++.+....+.+|+.+||+.||.+|| ++.++++..
T Consensus 280 ------~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 ------K-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------H-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------c-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 011 12223345688999999999999999 999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.18 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=202.4
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
...+.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 345777889999999999999975 68899999987543 2345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccCCCCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999888889999999999999999999999 899999999999999 78899999999999754332
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... . ..... .+..+.
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~---~~~~~----~i~~~~---- 223 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET------E---SKLFE----KIKEGY---- 223 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------H---HHHHH----HHHHCC----
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------H---HHHHH----HHHcCC----
Confidence 1234568999999999999999999999999999999999999986321 0 11111 111110
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .............+.+++.+||+.||++|||+.++++
T Consensus 224 ---~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 ---Y--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---C--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---C--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0011111233456889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.89 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=199.5
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEec
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
..+.+.+.||+|+||.||++... +++.||||++..... ...+|++++.++ +||||+++++++.++...++||||+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 45777889999999999999975 588999999975432 234688888888 7999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC----CCeEEeeecCccccCCCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE----FEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~~~~~~ 321 (464)
++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||++........
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999999888889999999999999999999999 899999999999998543 3499999999987654322
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ..+..+.
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~~----~~i~~~~---- 239 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT------PEEIL----ARIGSGK---- 239 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC------HHHHH----HHHHHCC----
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC------HHHHH----HHHccCC----
Confidence 2345678999999999988889999999999999999999999997421111 11111 1111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+...........+.+|+.+||+.||++|||+.++++
T Consensus 240 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 -----FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111233456889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.30 Aligned_cols=252 Identities=22% Similarity=0.253 Sum_probs=198.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc-----cchhHHHHHHHHHhhhccccceeccceee--eeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-----HQGEEVFWAEVSTIGKIYHMNLVRMWGFC--TEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~l 240 (464)
.|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++++++|+||+++++++ .+....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3567789999999999999974 5789999999743 23456789999999999999999999998 45568899
Q ss_pred EEEeccCCChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 241 VYEYVENQSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
||||++++ |.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999877 7777654 4579999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcceeeeccCCCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLP--ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
...........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.... ..... ..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------~~~~~----~~i~~~ 228 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---------IYKLF----ENIGKG 228 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---------HHHHH----HHHHHC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---------HHHHH----HHHhcC
Confidence 44333445567999999999987654 3789999999999999999999986321 11111 111100
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCE 450 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~ 450 (464)
...+ +......+.+++.+||+.||.+|||+.++++ .+.+..
T Consensus 229 ---------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 229 ---------SYAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ---------CCCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ---------CCCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 0111 1223456889999999999999999999996 455443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=337.83 Aligned_cols=198 Identities=28% Similarity=0.398 Sum_probs=159.4
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhcc-ccceeccceeeeeC--cEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEG--MHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~l 240 (464)
..+.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++..+. |+||+++++++... ...++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 34667789999999999999974 6889999998643 233456788999999997 99999999998754 47899
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||++ ++|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999997 689988864 579999999999999999999999 899999999999999999999999999998653311
Q ss_pred -------------------CCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 321 -------------------NSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 321 -------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1112344679999999999876 6799999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=334.75 Aligned_cols=196 Identities=26% Similarity=0.300 Sum_probs=173.5
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||++... ++..||+|++... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34566778999999999999985 5889999998754 23346789999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++++|.+++.....+++..+..++.+++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 9999999999888889999999999999999999998 5 7999999999999999999999999999754321
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12345789999999999999999999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=338.31 Aligned_cols=267 Identities=20% Similarity=0.281 Sum_probs=209.0
Q ss_pred hhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCc--EEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM--HRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~E~ 244 (464)
|.+.+.||+|+||.||+|.... ++.||||++.... ...+.+.+|++++++++|+||+++++++.... ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 5667899999999999999854 8899999997543 33467889999999999999999999987654 78999999
Q ss_pred ccCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE----cCCCCeEEeeecCccccC
Q 040010 245 VENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL----DSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 245 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~~~ 317 (464)
+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999997543 39999999999999999999999 899999999999999 788889999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccC--------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASN--------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....+...
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~-----~~~~~~~~ 239 (396)
T 4eut_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-----NKEVMYKI 239 (396)
T ss_dssp CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT-----CHHHHHHH
T ss_pred CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc-----hHHHHHHH
Confidence 432 2334669999999998764 4678899999999999999999999864221111 11111111
Q ss_pred HHHhhccchhhh----hhhc--------CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 390 KEKILCGEEARI----EEIV--------DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 390 ~~~~~~~~~~~~----~~~~--------d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.. +.+... .... +......+.......+.+++..||+.||++|||+.++++.+..+..
T Consensus 240 ~~----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 IT----GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HH----SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hc----CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11 111000 0000 0111224457788899999999999999999999999999877543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=329.81 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=198.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.+.+.+.||+|+||.||++... +++.||||++..... ..+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 3566789999999999999985 488999998864332 235578999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 180 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--V 180 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--c
Confidence 9999999988777889999999999999999999999 8999999999999999999999999999976543221 2
Q ss_pred eeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH------HHHhhccc
Q 040010 325 FSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV------KEKILCGE 397 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 397 (464)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ........... ..... ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~ 254 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-----IDQLYHIMMCLGNLIPRHQELF-NK 254 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHH-HH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHHHhCCCChhhhhHh-hh
Confidence 3445689999999998775 789999999999999999999999864221 11111111000 00000 00
Q ss_pred hhhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.........+.+....+. ...+.+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000111112222211111 23567899999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.22 Aligned_cols=251 Identities=24% Similarity=0.260 Sum_probs=184.5
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhcc-ccceeccceee--------eeCcE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIY-HMNLVRMWGFC--------TEGMH 237 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--------~~~~~ 237 (464)
.+.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++.++. |+||+++++++ .....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4567789999999999999974 6889999988543 334567889999999996 99999999998 34456
Q ss_pred EeEEEEeccCCChHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 238 RLLVYEYVENQSLDKHLFS---SNFLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
.++||||+. |+|.+++.. ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 899999996 799888864 4579999999999999999999999 77 99999999999999999999999999
Q ss_pred ccccCCCCCCc----------ceeeeccCCCccCcccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchh
Q 040010 313 AKLSQRGSNSS----------QFSRIRGTKGYMAPEWA---SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE 379 (464)
Q Consensus 313 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 379 (464)
+.......... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----- 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence 98765432211 11245589999999988 5667899999999999999999999998632110
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+++...............+.+++.+||+.||.+|||+.++++.|..+..
T Consensus 260 -----------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -----------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000011001111112347789999999999999999999999988764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.16 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=199.9
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---------hhHHHHHHHHHhhhc-cccceeccceeeeeCc
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---------GEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGM 236 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 236 (464)
..+.+.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34566689999999999999985 689999998864321 134578899999999 7999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999887889999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCcceeeeccCCCccCcccccC------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASN------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
.... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... .. ....
T Consensus 251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~---~~~~--- 315 (365)
T 2y7j_A 251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QI---LMLR--- 315 (365)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HH---HHHH---
T ss_pred CCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HH---HHHH---
Confidence 5432 2344679999999998853 358899999999999999999999986321 00 0111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+...... +. .. .....+.+++.+||+.||++|||+.++++
T Consensus 316 -~i~~~~~~~~~----~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 -MIMEGQYQFSS----PE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHTCCCCCH----HH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHhCCCCCCC----cc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11101000000 00 00 12346889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=337.47 Aligned_cols=273 Identities=22% Similarity=0.243 Sum_probs=206.4
Q ss_pred cCHHHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc--------ccceeccce
Q 040010 160 FSYAELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY--------HMNLVRMWG 230 (464)
Q Consensus 160 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g 230 (464)
+...++....+.+.+.||+|+||.||+|... +++.||||++.......+.+.+|+++++.++ |+||+++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 3444444556778889999999999999964 5789999999876666678899999999986 788999999
Q ss_pred eee----eCcEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCC
Q 040010 231 FCT----EGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEF 303 (464)
Q Consensus 231 ~~~----~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~ 303 (464)
++. .+...++||||+ +++|.+.+... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 987 567899999999 55666665443 469999999999999999999999 7 899999999999999775
Q ss_pred -------------------------------------------------CeEEeeecCccccCCCCCCcceeeeccCCCc
Q 040010 304 -------------------------------------------------EPKIADFGLAKLSQRGSNSSQFSRIRGTKGY 334 (464)
Q Consensus 304 -------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 334 (464)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999999876432 2345689999
Q ss_pred cCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch------hhhhhhcCCc
Q 040010 335 MAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE------ARIEEIVDPR 408 (464)
Q Consensus 335 ~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~d~~ 408 (464)
+|||.+.+..++.++||||||+++|||++|+.||............ ............... ....+.....
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE---DHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHH---HHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchH---HHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999999999999999999999999999999743322111111 111111110000000 0000000000
Q ss_pred --c-----------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 409 --L-----------------KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 409 --l-----------------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+ ....+.+....+.+|+.+||+.||++|||+.++++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 11345677889999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.91 Aligned_cols=235 Identities=15% Similarity=0.098 Sum_probs=184.5
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCC----ccchhHHHHHHH---HHhhhccccceeccc-------eeeee
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGD----LHQGEEVFWAEV---STIGKIYHMNLVRMW-------GFCTE 234 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~----~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~ 234 (464)
+.+.+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+ +.+++++|||||+++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 45567899999999999996 5689999999863 223446788999 556666899999999 55444
Q ss_pred Cc-----------------EEeEEEEeccCCChHHhhhcCCC-------CCHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 040010 235 GM-----------------HRLLVYEYVENQSLDKHLFSSNF-------LGWKERFKVALGTAKGLAYLHHECLEWVIHC 290 (464)
Q Consensus 235 ~~-----------------~~~lv~E~~~~gsL~~~l~~~~~-------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 290 (464)
.+ ..++||||+ +|+|.+++..... +++..++.|+.||+.||+|||+ .+|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 32 378999999 6899999975433 3458889999999999999999 899999
Q ss_pred CCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC-----------CCCccchhHHHHHHHH
Q 040010 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-----------PITSKVDVFSYGVVIL 359 (464)
Q Consensus 291 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~Gvvl~ 359 (464)
||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++||||||+++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999985332 2345567 999999999887 8999999999999999
Q ss_pred HHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 360 EMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 360 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
||++|+.||........ ...+... ...+ ...+.+++.+||+.||++|||+
T Consensus 305 elltg~~Pf~~~~~~~~------------------------~~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 305 WIWCADLPITKDAALGG------------------------SEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHSSCCC------CC------------------------SGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHCCCCCcccccccc------------------------hhhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCH
Confidence 99999999863211100 1111111 0122 3468889999999999999999
Q ss_pred HHHHH
Q 040010 440 DSVVQ 444 (464)
Q Consensus 440 ~~V~~ 444 (464)
.++++
T Consensus 355 ~e~l~ 359 (377)
T 3byv_A 355 LQAME 359 (377)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.81 Aligned_cols=247 Identities=25% Similarity=0.267 Sum_probs=201.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||++... +|+.||+|++... ......+.+|+++|+.++||||+++++++.+....++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445578999999999999975 6899999998643 23345688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 245 VENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 245 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999999997654 49999999999999999999999 899999999999999999999999999998765432
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...... .+.
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-----~~~i~~----~i~-------- 402 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVER----LVK-------- 402 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----HHHHHH----HHH--------
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----HHHHHH----Hhh--------
Confidence 23446799999999999998999999999999999999999999974322111 011111 110
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
. ... .++......+.+|+.+||+.||.+|| ++.||++
T Consensus 403 ~-~~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 E-VPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp H-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c-ccc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 011 12223345688999999999999999 6788874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.83 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=195.5
Q ss_pred HHhhhccccCccCceEEEEEEEC--CCc--EEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT--DER--AVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~--~~~--~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||+|.+. +++ .||||+++.. ....+.+.+|++++++++|+||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34667789999999999999863 233 6899988743 234467889999999999999999999998765 88
Q ss_pred EEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 240 LVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999764 579999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 319 GSNSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 319 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
..... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~--------- 235 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---------SQILH--------- 235 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHHH---------
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---------HHHHH---------
Confidence 33221 1234557888999999988889999999999999999999 9998863210 01111
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+.........+......+.+++.+||+.||.+|||+.++++.|.++..
T Consensus 236 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 ------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111111222344678999999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=323.62 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=201.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+...+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 556678999999999999974 5889999998643 3345778999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+++|.+++.. ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 177 (303)
T 3a7i_A 104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 177 (303)
T ss_dssp TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBC
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccC
Confidence 9999999854 579999999999999999999999 8999999999999999999999999999987654321 234
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... . ..... +.....
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~---~~~~~------------~~~~~~ 236 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------M---KVLFL------------IPKNNP 236 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------H---HHHHH------------HHHSCC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------H---HHHHH------------hhcCCC
Confidence 46789999999999999999999999999999999999999863210 0 11111 111111
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+.+...+ ...+.+++..||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2222223 3468899999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.83 Aligned_cols=245 Identities=25% Similarity=0.271 Sum_probs=203.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 242 (464)
.+.+.+.||+|+||.||++... +++.||||+++.. ....+.+..|..++..+ +|+||+++++++.+....++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 4566678999999999999975 5788999998743 23345678899999987 7999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-- 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-- 496 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCC--
Confidence 999999999999988899999999999999999999999 899999999999999999999999999998643322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
.......||+.|+|||++.+..++.++||||||++||||++|+.||..... .. . ..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---------~~----~-----------~~ 552 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------DE----L-----------FQ 552 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HH----H-----------HH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---------HH----H-----------HH
Confidence 224557899999999999999999999999999999999999999974210 01 1 11
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM-----DSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm-----~~V~~ 444 (464)
.++...+ .++......+.+|+..||+.||++||++ .+|++
T Consensus 553 ~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 553 SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1222211 2233445678899999999999999998 66653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.65 Aligned_cols=258 Identities=19% Similarity=0.269 Sum_probs=203.2
Q ss_pred cCHHHHHHHHhhhc-cccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhc-cccceeccceeee
Q 040010 160 FSYAELKKATNSFK-EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKI-YHMNLVRMWGFCT 233 (464)
Q Consensus 160 ~~~~el~~~~~~~~-~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 233 (464)
|...+.....+.+. +.||+|+||.||++... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44445555566665 78999999999999975 58899999987532 2346788999999999 5699999999999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEe
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIA 308 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~ 308 (464)
+....++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999998653 679999999999999999999999 89999999999999988 7899999
Q ss_pred eecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH
Q 040010 309 DFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 309 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....
T Consensus 177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~----~~~~~ 244 (327)
T 3lm5_A 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----Q----ETYLN 244 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHH
T ss_pred eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----h----HHHHH
Confidence 9999987654321 3446799999999999999999999999999999999999999863211 0 01111
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.. .. ...............+.+++.+||+.||.+|||+.++++.
T Consensus 245 i~------------~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 IS------------QV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH------------HT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HH------------hc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 00 0111111112334568899999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.56 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=193.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3566789999999999999986 68899999986432 234578899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--- 165 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc---
Confidence 99999999999888889999999999999999999999 889999999999999999999999999998765432
Q ss_pred ceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ...... .+..+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---------~~~~~~----~~~~~~----- 227 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---------VPTLFK----KIRGGV----- 227 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---------HHHHHH----HHHHCC-----
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---------HHHHHH----HhhcCc-----
Confidence 1234568999999999987765 689999999999999999999986321 011111 111000
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..+ +......+.+++.+||+.||.+|||+.++++.
T Consensus 228 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ----FYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----ccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 11223468889999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=345.77 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=204.3
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
....|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456788889999999999999975 6889999998533 2345678999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 317 (464)
||||+.+|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999999888899999999999999999999999 899999999999999 567899999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ..... .+..+.
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~----~i~~~~ 243 (484)
T 3nyv_A 181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---------YDILK----KVEKGK 243 (484)
T ss_dssp CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH----HHHHCC
T ss_pred ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---------HHHHH----HHHcCC
Confidence 432 2344679999999999876 699999999999999999999999873211 01111 111110
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..... .........+.+++.+||+.||.+|||+.++++
T Consensus 244 -------~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 -------YTFEL--PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------CCCCS--GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCC--cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000 001123456889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=336.47 Aligned_cols=259 Identities=23% Similarity=0.257 Sum_probs=191.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.+++.++|+||+++++++... .+.
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3566788999999999999964 5889999999753 23346688999999999999999999998644 467
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||++++ |.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999999764 6665533 48999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc-
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE- 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 397 (464)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+ ..+...+....
T Consensus 217 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-----~~~~----~~i~~~lg~p~~ 284 (464)
T 3ttj_A 217 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----IDQW----NKVIEQLGTPCP 284 (464)
T ss_dssp CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH----HHHHHHHCSCCH
T ss_pred Cc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH----HHHHHhcCCCCH
Confidence 22 23456799999999999999999999999999999999999999964211 1111 11111100000
Q ss_pred ------hhhhhhhcC---------------CccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 ------EARIEEIVD---------------PRLKGH---FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ------~~~~~~~~d---------------~~l~~~---~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
.......+. ..+... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011111 110000 011235678999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.00 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=201.8
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
...|.+.+.||+|+||+||++... +++.||||++... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888899999999999999975 6889999998632 234567889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc---CCCCeEEeeecCccccCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD---SEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 319 (464)
||+++|+|.+.+.....+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999999888889999999999999999999999 8999999999999995 4567999999999866543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ..... .+..+.
T Consensus 178 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~----~i~~~~-- 238 (486)
T 3mwu_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---------YDILK----RVETGK-- 238 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH----HHHHTC--
T ss_pred C---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH----HHHhCC--
Confidence 2 2344679999999999876 599999999999999999999999863211 11111 111110
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
..... .........+.+++.+||+.||.+|||+.++++.
T Consensus 239 -----~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 -----YAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----CCSCS--GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CCCCC--cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0011234568899999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.48 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=182.5
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccch---hHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQG---EEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
..+.+.+.||+|+||.||++.. .+++.||||++...... .+.+..+...++.++||||+++++++.++...++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 3456778999999999999997 46889999999754222 2334455556888899999999999999999999999
Q ss_pred eccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 244 YVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 244 ~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
|++ |+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 997 58877765 34689999999999999999999999 7 899999999999999999999999999986644
Q ss_pred CCCCcceeeeccCCCccCcccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWA----SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... .... .
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-~------- 224 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQL-K------- 224 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHH-H-------
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHH-H-------
Confidence 322 2334699999999996 5667899999999999999999999998632110 0000 0
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+...............+.+++.+||+.||++|||+.++++
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 225 --------QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 011111111111123456889999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.40 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=191.9
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
.+.+.+.||+|+||+||++... +++.||||+++.... ..+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4566789999999999999964 688999999974432 235577999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-----CCCCeEEeeecCccccCCC
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-----SEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~Dfgla~~~~~~ 319 (464)
++ |+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++......
T Consensus 115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 98 5999999888889999999999999999999999 8999999999999994 4556999999999876433
Q ss_pred CCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... . ...............
T Consensus 191 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~----~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 191 IR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-----I----DQLFKIFEVLGLPDD 259 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHHHCCCCT
T ss_pred cc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-----H----HHHHHHHHHhCCCch
Confidence 21 23445689999999998774 589999999999999999999999863211 1 111111111110000
Q ss_pred hhhhhhc--------CCccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIV--------DPRLKGH-----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~--------d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....... .+..... ........+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 0000000 00112356889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=328.35 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=196.1
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||+|+||.||+|...+ .+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 35677899999999999999854 49999987432 23356778999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC---
Q 040010 246 ENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN--- 321 (464)
Q Consensus 246 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 321 (464)
++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++ ++.+||+|||++........
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999997654 79999999999999999999999 8999999999999998 67999999999876532211
Q ss_pred CcceeeeccCCCccCcccccC---------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 322 SSQFSRIRGTKGYMAPEWASN---------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .... ..
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~----~~ 254 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---------EAII----WQ 254 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---------HHHH----HH
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH----HH
Confidence 122334568999999998864 4578999999999999999999999863211 0111 11
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
...+ ..+.+. .......+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 255 ~~~~--------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 MGTG--------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHTT--------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred hccC--------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 111111 111223588999999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.76 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=198.1
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
....+.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++++++|+||+++++++......++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3444667789999999999999985 48899999987533 346688999999999999999999999999999999999
Q ss_pred ccCCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++++|.+++. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 180 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-- 180 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--
Confidence 99999999997 45689999999999999999999999 8999999999999999999999999999986644321
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . ...... ..
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~---~~~~~~------------~~ 239 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------M---RAIFMI------------PT 239 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------H---HHHHHH------------HH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------H---HHHHHH------------hc
Confidence 23345689999999999999999999999999999999999999863210 0 000000 00
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+.. ..+......+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 240 NPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111 111222456889999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.75 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.2
Q ss_pred HHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
...|.+.+.||+|+||+||++... ++..||+|++... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345778889999999999999975 5789999998643 234567889999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC---CCeEEeeecCccccCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE---FEPKIADFGLAKLSQRG 319 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~ 319 (464)
||+++|+|.+.+.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999999888889999999999999999999999 899999999999999764 45999999999876543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||..... ..... .+..+.
T Consensus 193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~----~i~~~~-- 253 (494)
T 3lij_A 193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---------QEILR----KVEKGK-- 253 (494)
T ss_dssp B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH----HHHHTC--
T ss_pred c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH----HHHhCC--
Confidence 2 234467999999999876 4699999999999999999999999863211 11111 111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...+..... .....+.+++.+||+.||.+|||+.++++
T Consensus 254 ---~~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 ---YTFDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ---CCCCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCCCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000111111 22346889999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.91 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=196.6
Q ss_pred hccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.||+|+||.||+++.. +|+.||+|++.... .....+..|++++++++||||+++++++......++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3457999999999999985 58999999996432 234568899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 247 NQSLDKHLFSS----NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 247 ~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~- 344 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT- 344 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence 99999998753 369999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....... +
T Consensus 345 -~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-----~~~~~~~----i--------- 405 (543)
T 3c4z_A 345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQR----V--------- 405 (543)
T ss_dssp -CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-----HHHHHHH----H---------
T ss_pred -ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-----HHHHHHH----H---------
Confidence 23445799999999999999999999999999999999999999974321111 1111111 1
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm 439 (464)
..... .++......+.+++..||+.||.+||++
T Consensus 406 --~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 406 --LEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --HHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --hhccc--CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11111 1222334568899999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=316.99 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=193.2
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee------------
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE------------ 234 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------ 234 (464)
..+.+.+.||+|+||.||+|... +++.||||++.......+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 34677789999999999999974 68899999997655556778999999999999999999998754
Q ss_pred -CcEEeEEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 235 -GMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 235 -~~~~~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
....++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 467899999999999999997543 68899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCC------------CcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchh
Q 040010 313 AKLSQRGSN------------SSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE 379 (464)
Q Consensus 313 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~ 379 (464)
+........ ........||+.|+|||.+.+. .++.++||||||+++|||++ |+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-------- 231 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-------- 231 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--------
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--------
Confidence 986543211 1123346689999999998764 78999999999999999998 43311
Q ss_pred hhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....... ..+.. ....+...++......+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNIL----KKLRS---------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH----HHHHS---------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHH----Hhccc---------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0001111 11110 1112222334445567889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=320.54 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=202.9
Q ss_pred HHhhhccccCccCceEEEEEEE--CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc------eeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL--TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN------LVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~--~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||++.. .+++.||||+++......+.+.+|+++++.++|+| ++++++++......+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 3567788999999999999997 36789999999876666677899999999998765 999999999999999
Q ss_pred EEEEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC----------------
Q 040010 240 LVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---------------- 301 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---------------- 301 (464)
+||||+ +++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 899999997654 68999999999999999999999 89999999999999987
Q ss_pred ---CCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccch
Q 040010 302 ---EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378 (464)
Q Consensus 302 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~ 378 (464)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS----- 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-----
T ss_pred cccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-----
Confidence 678999999999865432 2345689999999999999999999999999999999999999864211
Q ss_pred hhhHHHHHHHHHH--------Hhhccc---------------hhhhhhhcCCcc-CCCCCHHHHHHHHHHHHHccCCCCC
Q 040010 379 EAELTGFIREVKE--------KILCGE---------------EARIEEIVDPRL-KGHFNKNQAATLFRIGISCVDEDRN 434 (464)
Q Consensus 379 ~~~~~~~~~~~~~--------~~~~~~---------------~~~~~~~~d~~l-~~~~~~~~~~~~~~l~~~Cl~~dp~ 434 (464)
.... ..+..... ...... .........+.. .........+.+.+++.+||+.||.
T Consensus 240 ~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 240 KEHL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 1000 00100000 000000 000000000000 0112335677899999999999999
Q ss_pred CCCCHHHHHH
Q 040010 435 KRPTMDSVVQ 444 (464)
Q Consensus 435 ~RPsm~~V~~ 444 (464)
+|||+.|+++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=326.79 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=194.3
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++.++|+||+++++++... ...
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 356678899999999999997 468999999996432 2345688999999999999999999998765 346
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999999 8899999865 579999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VK 390 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 390 (464)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...... ..
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHHHH
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCCHHHH
Confidence 2 334578999999998877 6899999999999999999999999874211 1111111000 00
Q ss_pred HHhhccc-hhhhhh---hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCC
Q 040010 391 EKILCGE-EARIEE---IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEA 451 (464)
Q Consensus 391 ~~~~~~~-~~~~~~---~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~ 451 (464)
..+.... ...+.. .....+. .........+.+|+.+||+.||.+|||+.++++ .+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0000000 000000 0000110 111223456889999999999999999999988 4555544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=334.20 Aligned_cols=197 Identities=23% Similarity=0.372 Sum_probs=166.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC-----cEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 239 (464)
.+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667789999999999999975 57889999997532 2346788999999999999999999998766 5789
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||++ ++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999986 5999999888889999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCC--------------------cceeeeccCCCccCcccc-cCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 320 SNS--------------------SQFSRIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 320 ~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
... .......||+.|+|||.+ ....++.++|||||||++|||++|..|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 221 123567799999999985 56679999999999999999998755543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=343.87 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=197.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--------------chhHHHHHHHHHhhhccccceeccceeee
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--------------QGEEVFWAEVSTIGKIYHMNLVRMWGFCT 233 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 233 (464)
.|.+.++||+|+||+||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4667789999999999999975 57899999986432 23467889999999999999999999999
Q ss_pred eCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC---CeEEeee
Q 040010 234 EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF---EPKIADF 310 (464)
Q Consensus 234 ~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Df 310 (464)
++...++||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999999888899999999999999999999999 8999999999999998776 6999999
Q ss_pred cCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 311 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
|++....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .....
T Consensus 194 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~--- 257 (504)
T 3q5i_A 194 GLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND---------QDIIK--- 257 (504)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH---
T ss_pred CCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH---
Confidence 9998765432 2344679999999998874 689999999999999999999999873211 11111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+... .+..... .....+.+++.+||+.||.+|||+.++++
T Consensus 258 -~i~~~~~~-----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 -KVEKGKYY-----FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHCCCC-----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHcCCCC-----CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111100 0000001 12356889999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=325.16 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=196.3
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee--------Cc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--------GM 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 236 (464)
.+.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+++++.++|+||+++++++.. ++
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 466778999999999999998 468899999986432 233567899999999999999999999876 45
Q ss_pred EEeEEEEeccCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 237 HRLLVYEYVENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
..++||||+++ +|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999985 66666654 3579999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCC--cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 316 SQRGSNS--SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 316 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------QHQLALISQLCGS 247 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCC
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCC
Confidence 6533221 22345678999999998876 4689999999999999999999999874211 1111111111000
Q ss_pred hhccchhhhhhhcCCc--------cCCCCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 393 ILCGEEARIEEIVDPR--------LKGHFN-KN------QAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~--------l~~~~~-~~------~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
. ........-+.. ...... .+ ....+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 I---TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp C---CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C---ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 000000000000 000000 11 13457899999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.27 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=192.6
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeee------CcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE------GMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~lv 241 (464)
+.+.+.||+|+||.||+|.. .+++.||||++.......+.+.+|+.+++++ +|+||+++++++.. ....++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 45678999999999999997 4688999999976666677899999999999 79999999999876 5688999
Q ss_pred EEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 242 YEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999999754 579999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCcceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
.. ......||+.|+|||.+. +..++.++||||||+++|||++|+.||..... . ......
T Consensus 183 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~----~~~~~~----- 246 (326)
T 2x7f_A 183 VG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----M----RALFLI----- 246 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----H----HHHHHH-----
T ss_pred cc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----H----HHHHHh-----
Confidence 11 123456899999999986 56789999999999999999999999863210 0 000000
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.....+.+. .......+.+++.+||+.||.+|||+.++++
T Consensus 247 -------~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 -------PRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------HHSCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------hcCccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000111111 1122346889999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=327.23 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=193.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
|.+.+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++|+||+++++++..+...++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456788999999999999985 688999999874432 22345679999999999999999999999999999999997
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~ 157 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 157 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--ccc
Confidence 5888888754 469999999999999999999999 899999999999999999999999999998654322 123
Q ss_pred eeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 326 SRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... . .....+...............
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~----~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----E----EQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHHHhCCCChHhchhh
Confidence 44568999999998876 5789999999999999999999999864211 1 111111111110000000000
Q ss_pred c---------CCccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCC
Q 040010 405 V---------DPRLKGH----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCE 450 (464)
Q Consensus 405 ~---------d~~l~~~----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~ 450 (464)
. .+..... ........+.+|+.+||+.||.+|||+.|+++ .+.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0 0000000 00112356789999999999999999999987 444443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.60 Aligned_cols=193 Identities=25% Similarity=0.299 Sum_probs=170.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhc------cccceeccceeeeeCcEEeEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKI------YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~lv 241 (464)
.+.+.+.||+|+||.||+|... +++.||||++.........+..|+++++.+ +|+||+++++++....+.++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 3667789999999999999875 478999999987666667788888888887 567999999999999999999
Q ss_pred EEeccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC--eEEeeecCccccC
Q 040010 242 YEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE--PKIADFGLAKLSQ 317 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~ 317 (464)
|||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 69999887553 59999999999999999999999 89999999999999999987 9999999997644
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 254 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 254 QR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 32 2345789999999999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=323.92 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=196.8
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++|+||+++++++.+....++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 44667789999999999999975 588999999874321 12467899999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 241 VYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
||||+++ +|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999986 888888654 469999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|..||.... .. ..+..+.........
T Consensus 166 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-----~~----~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 166 NR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DL----DQLTRIFETLGTPTE 234 (346)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HH----HHHHHHHHHHCCCCT
T ss_pred cc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HH----HHHHHHHHHcCCCCh
Confidence 21 23446789999999998654 58999999999999999999998876321 11 111111111110000
Q ss_pred hhhh------hhcCCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 040010 399 ARIE------EIVDPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446 (464)
Q Consensus 399 ~~~~------~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L 446 (464)
.... +.+........+ ......+.+++.+||+.||.+|||+.|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000 000000000111 12246789999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.23 Aligned_cols=243 Identities=25% Similarity=0.308 Sum_probs=193.1
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
..||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.+++.++|+||+++++++......++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999997 457899999987543 34567899999999999999999999999999999999999999999
Q ss_pred HhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-CCCeEEeeecCccccCCCCCCcceee
Q 040010 252 KHLFSS---NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-EFEPKIADFGLAKLSQRGSNSSQFSR 327 (464)
Q Consensus 252 ~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 327 (464)
+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccc
Confidence 999754 256789999999999999999999 89999999999999987 89999999999986643221 1234
Q ss_pred eccCCCccCcccccCCC--CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 328 IRGTKGYMAPEWASNLP--ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 328 ~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
..||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...... . ...... .....
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~------------~~~~~ 243 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----Q---AAMFKV------------GMFKV 243 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----H---HHHHHH------------HHHCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----h---HHHHhh------------ccccc
Confidence 56899999999987643 889999999999999999999998632110 0 000000 00011
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.+ +......+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1222 2233456889999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=318.63 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=200.2
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----------chhHHHHHHHHHhhhcc-ccceeccceeeeeCc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----------QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGM 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 236 (464)
.+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++++. ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3566678999999999999985 57899999986432 12355789999999996 999999999999999
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 999999999999999999888889999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCcceeeeccCCCccCccccc------CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHH
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWAS------NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVK 390 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 390 (464)
.... ......|++.|+|||.+. ...++.++||||||+++|||++|+.|+.... .. ....
T Consensus 175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~---~~~~--- 239 (298)
T 1phk_A 175 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QM---LMLR--- 239 (298)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH---HHHH---
T ss_pred CCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HH---HHHH---
Confidence 5432 234456899999999874 4568999999999999999999999986321 00 1111
Q ss_pred HHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+. . .............+.+++.+||+.||.+|||+.++++
T Consensus 240 -~~~~~~-------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 -MIMSGN-------Y--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHTC-------C--CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHhcCC-------c--ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111000 0 0000111233456889999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=336.87 Aligned_cols=192 Identities=23% Similarity=0.348 Sum_probs=153.7
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee-----CcEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-----GMHRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 239 (464)
.+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++|++++|+||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4667789999999999999965 68899999986532 234678899999999999999999999843 36789
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+ +++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999998 57999999888889999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCC-------------------------cceeeeccCCCccCcccc-cCCCCCccchhHHHHHHHHHHHhC
Q 040010 320 SNS-------------------------SQFSRIRGTKGYMAPEWA-SNLPITSKVDVFSYGVVILEMLKG 364 (464)
Q Consensus 320 ~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltg 364 (464)
... .......||+.|+|||.+ ....++.++|||||||+||||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 123456789999999976 566799999999999999999994
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=325.48 Aligned_cols=277 Identities=21% Similarity=0.236 Sum_probs=208.0
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-----------ccceeccceeeeeC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-----------HMNLVRMWGFCTEG 235 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~ 235 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++.......+.+.+|++++++++ |+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4567788999999999999997 46889999999876666677889999999886 89999999998765
Q ss_pred c----EEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEc------CC
Q 040010 236 M----HRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLD------SE 302 (464)
Q Consensus 236 ~----~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~------~~ 302 (464)
. ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCc
Confidence 4 789999999 89999999753 469999999999999999999999 7 899999999999994 44
Q ss_pred CCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhH
Q 040010 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAEL 382 (464)
Q Consensus 303 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 382 (464)
+.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~ 246 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK---D 246 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C---H
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC---h
Confidence 57999999999866432 233568999999999999999999999999999999999999997432111000 0
Q ss_pred HHHHHHHHHHhhccch------hhh---------------------hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCC
Q 040010 383 TGFIREVKEKILCGEE------ARI---------------------EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNK 435 (464)
Q Consensus 383 ~~~~~~~~~~~~~~~~------~~~---------------------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~ 435 (464)
...+..+......-.. ... ...+.. ...++......+.+|+.+||+.||++
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111111000000 000 000000 11345678889999999999999999
Q ss_pred CCCHHHHHH--HhhCCCCCCCCCCC
Q 040010 436 RPTMDSVVQ--TLLGCEAESEVPVQ 458 (464)
Q Consensus 436 RPsm~~V~~--~L~~~~~~~~~~~p 458 (464)
|||+.++++ .+.+.........|
T Consensus 325 Rpt~~ell~hp~f~~~~~~~~~~~~ 349 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTLGMEEIRVP 349 (373)
T ss_dssp CBCHHHHHTCGGGTTCTTCTTCCCT
T ss_pred cCCHHHHhhChhhhcccCcccccCc
Confidence 999999997 55555444444333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=321.74 Aligned_cols=251 Identities=23% Similarity=0.277 Sum_probs=196.4
Q ss_pred HHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---------chhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
....+.+.+.||+|+||.||+|... +++.||||.+.... .....+.+|++++++++|+||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3456788899999999999999975 57899999986432 1224578999999999999999999998766
Q ss_pred cEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGL 312 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgl 312 (464)
. .++||||+++++|.+++.....+++.....++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 89999999999999999888899999999999999999999999 89999999999999987664 99999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
+...... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ +...
T Consensus 164 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~---- 231 (322)
T 2ycf_A 164 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----LKDQ---- 231 (322)
T ss_dssp CEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-----HHHH----
T ss_pred ceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-----HHHH----
Confidence 9876432 1223456899999999863 56789999999999999999999999864322111 1110
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+... ..+.... .....+.+++.+||+.||++|||+.++++
T Consensus 232 ---~~~~~~~-----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ---ITSGKYN-----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHHTCCC-----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHhCccc-----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000000 0000001 12356889999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=334.91 Aligned_cols=249 Identities=11% Similarity=0.030 Sum_probs=179.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHHHHHHhhhc--cccceeccc-------eeeeeC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKI--YHMNLVRMW-------GFCTEG 235 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~ 235 (464)
+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++.+ +|||+++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456689999999999999975 68899999998643 2345677886555555 699988755 333222
Q ss_pred -----------------cEEeEEEEeccCCChHHhhhcC-CCCCHHHH------HHHHHHHHHHHHHHhhcCCCceEecC
Q 040010 236 -----------------MHRLLVYEYVENQSLDKHLFSS-NFLGWKER------FKVALGTAKGLAYLHHECLEWVIHCD 291 (464)
Q Consensus 236 -----------------~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH~d 291 (464)
...++||||++ |+|.+++... ..+.+..+ +.++.||+.||+|||+ .+|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCc
Confidence 44799999999 8999999753 34566666 7888999999999999 8999999
Q ss_pred CCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 292 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999865421 224567799999999987 679999999999999999999999997
Q ss_pred ccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 370 WVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......... + ........................+.+|+.+||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~------~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGS------W-----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTC------C-----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccc------h-----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 542211000 0 000001111111111111234567889999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.47 Aligned_cols=261 Identities=18% Similarity=0.262 Sum_probs=198.4
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeee--CcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTE--GMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~E~ 244 (464)
.+.+.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ |+||+++++++.+ ....++||||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 456778999999999999986 56889999999743 3466889999999997 9999999999987 6788999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++++|.+++.. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++........
T Consensus 115 ~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp CCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred cCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 999999998853 8999999999999999999999 8999999999999999776 899999999987654322
Q ss_pred ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH--------HHHHhh
Q 040010 324 QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE--------VKEKIL 394 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 394 (464)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+...... ......
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch----HHHHHHHHHhcCCchhhhHHHHhc
Confidence 334568999999999877 67899999999999999999999998632211 1111111000 000000
Q ss_pred ccchhhhhhhcCCc--------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPR--------LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~--------l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........++.... ............+.+|+.+||+.||++|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000011111110 011111123567899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=324.64 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=182.5
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3456678999999999999986 46789999988643 23446788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 245 VENQSLDKHLFS--------SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 245 ~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999863 3469999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCCC---cceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 317 QRGSNS---SQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 317 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... . .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~----~~~~~--- 239 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----K----VLMLT--- 239 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----G----HHHHH---
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----h----HHHHH---
Confidence 443211 11234578999999998865 56899999999999999999999998643211 0 00000
Q ss_pred hhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.............++.....+ ...+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000111112222222 346889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=326.31 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=200.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccch------------------hHHHHHHHHHhhhccccceeccce
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQG------------------EEVFWAEVSTIGKIYHMNLVRMWG 230 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~------------------~~~~~~E~~~l~~l~h~niv~l~g 230 (464)
.+.+.+.||+|+||.||++.. +++.||||++...... .+.+.+|++++++++|+||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 466778999999999999999 8899999998643211 177899999999999999999999
Q ss_pred eeeeCcEEeEEEEeccCCChHHh------hhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC
Q 040010 231 FCTEGMHRLLVYEYVENQSLDKH------LFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE 302 (464)
Q Consensus 231 ~~~~~~~~~lv~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 302 (464)
++.+.+..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.+
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCC
Confidence 99999999999999999999999 665 56899999999999999999999972 579999999999999999
Q ss_pred CCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC-CCCc-cchhHHHHHHHHHHHhCCCCCCccccCccchhh
Q 040010 303 FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-PITS-KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEA 380 (464)
Q Consensus 303 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 380 (464)
+.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------ 258 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL------ 258 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS------
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH------
Confidence 99999999999876443 23456789999999999877 6666 999999999999999999998743211
Q ss_pred hHHHHHHHHHHHhhccchhhh---hhhcCCcc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 381 ELTGFIREVKEKILCGEEARI---EEIVDPRL---KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~---~~~~d~~l---~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
... ...+..+..... .....+.. ...........+.+++.+||+.||.+|||+.++++
T Consensus 259 --~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011 111111100000 00000000 00001234467889999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.47 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=201.6
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEE
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 238 (464)
+....+.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 334456667889999999999999743 4679999987533 234678999999999999999999999854 568
Q ss_pred eEEEEeccCCChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 239 LLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999997554 79999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..... . ..... +..+
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~---~~~~~----i~~~ 608 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------N---DVIGR----IENG 608 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------H---HHHHH----HHHT
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------H---HHHHH----HHcC
Confidence 4322 12234557789999999998899999999999999999997 8888863211 0 11111 1101
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. .. ..+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 609 ~--------~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 E--------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp C--------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C--------CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 01 122233457889999999999999999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=325.36 Aligned_cols=266 Identities=18% Similarity=0.172 Sum_probs=187.7
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcE-------Ee
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH-------RL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~ 239 (464)
..+.+.+.||+|+||.||+|... +++.||||++.........+..+++.++.++|+||+++++++..... .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 34566789999999999999984 58899999987655555667788899999999999999999865433 78
Q ss_pred EEEEeccCCChHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCceEecCCCCCCEEEcC-CCCeEEeeecC
Q 040010 240 LVYEYVENQSLDKHL----FSSNFLGWKERFKVALGTAKGLAYLH--HECLEWVIHCDVKPENILLDS-EFEPKIADFGL 312 (464)
Q Consensus 240 lv~E~~~~gsL~~~l----~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgl 312 (464)
+||||++++ |...+ .....+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 999999864 44333 35568999999999999999999999 7 89999999999999997 89999999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
+........ .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+. .+..
T Consensus 179 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~----~~~~ 246 (360)
T 3e3p_A 179 AKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLH----EIVR 246 (360)
T ss_dssp CBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH----HHHH
T ss_pred ceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHHH----HHHH
Confidence 987654322 2345689999999988655 489999999999999999999999874211 11111 1111
Q ss_pred HhhccchhhhhhhcCCc----------------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCC
Q 040010 392 KILCGEEARIEEIVDPR----------------LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCE 450 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~----------------l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~ 450 (464)
........... .+++. ............+.+|+.+||+.||.+|||+.|+++. +.+..
T Consensus 247 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 247 VLGCPSREVLR-KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHCCCCHHHHH-HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HcCCCCHHHHH-hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 11000000000 00000 0011112245679999999999999999999999863 44443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=333.09 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=180.8
Q ss_pred ccccCccCceEEEEEEEC---CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeee--eCcEEeEEEEeccC
Q 040010 173 KEELGKGGSGAVYKGVLT---DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCT--EGMHRLLVYEYVEN 247 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~E~~~~ 247 (464)
.++||+|+||.||+|... +++.||||++..... ...+.+|+++|++++||||+++++++. .+...++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 347999999999999975 478899999975432 346789999999999999999999994 4678999999997
Q ss_pred CChHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE----cCCCCeEEeeecCcc
Q 040010 248 QSLDKHLFSS---------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL----DSEFEPKIADFGLAK 314 (464)
Q Consensus 248 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 314 (464)
++|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 5787777521 249999999999999999999999 899999999999999 778899999999998
Q ss_pred ccCCCCCC-cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 315 LSQRGSNS-SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 315 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....+...........+..+...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 76543211 223456799999999998774 5899999999999999999999999743321110000001111111111
Q ss_pred hhccchhhhhhh------------cCCccCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 393 ILCGEEARIEEI------------VDPRLKGHFNK---------NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 393 ~~~~~~~~~~~~------------~d~~l~~~~~~---------~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
+..........+ ........... .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 110000000000 00000000000 013457899999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=314.10 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=202.3
Q ss_pred HHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
+.....+.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++++++|+||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344566788899999999999999985 6889999998643 234567889999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC---CCeEEeeecCcccc
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE---FEPKIADFGLAKLS 316 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~ 316 (464)
+|+||+++++|.+.+.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999999999877889999999999999999999999 899999999999999764 46999999999866
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
..... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .. .... .+..+
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~---~~~~----~~~~~ 237 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EY---DILK----RVETG 237 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH---HHHH----HHHHC
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HH---HHHH----HHHcC
Confidence 54322 233458899999998876 48999999999999999999999986321 10 1111 11111
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. ..+..... .....+.+++.+||+.||++|||+.++++
T Consensus 238 ~~-----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KY-----AFDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC-----CCCSGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-----CCCchhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00000001 22346889999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=320.73 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=194.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+++++.++||||+++++++......++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 3567789999999999999986 48899999987543 345778899999999999999999999999999999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 174 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKR 174 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--ccc
Confidence 9999999875 4679999999999999999999999 899999999999999999999999999875332110 112
Q ss_pred eeeccCCCccCcccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 326 SRIRGTKGYMAPEWA-----SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~-----~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
....||+.|+|||.+ .+..++.++||||||+++|||++|+.|+..... ...... ...+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~----~~~~~--- 238 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLK----IAKSD--- 238 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHH----HHHSC---
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---------HHHHHH----HhccC---
Confidence 335689999999988 466789999999999999999999999863211 011111 10000
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.. ..+......+.+++.+||+.||.+|||+.++++
T Consensus 239 -----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -----PPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----Cccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 112223456889999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=331.17 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=202.2
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccc-cceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH-MNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.+.+.+.||+|+||.||+|.. .+++.||||++.... ...++..|+++++.++| +++..+..++.++...++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 356678999999999999996 568899999876433 23457899999999987 55556666778888999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE---cCCCCeEEeeecCccccCCCCCC
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL---DSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+++|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9999999974 5679999999999999999999999 899999999999999 68899999999999876654322
Q ss_pred c-----ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 323 S-----QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 323 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. ......||+.|+|||.+.+..++.++||||||++||||++|+.||........ . .....+........
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~----~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--K----QKYEKISEKKVATS 236 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--H----HHHHHHHHHHHHSC
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--H----HHHHHHhhcccccc
Confidence 1 12356799999999999999999999999999999999999999975432211 1 11111111110000
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
+..+. ..+ ...+.+++..||+.||++||++.+|++.|+.+
T Consensus 237 ---~~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 ---IEALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ---HHHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ---HHHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 112 34688999999999999999999999998765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.01 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=196.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 240 (464)
.+.+.+.||+|+||.||++... +++.||||++.... .....+.+|++++++++|+||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667789999999999999975 67889999997433 2336788999999999999999999998654 46899
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999997 589998854 569999999999999999999999 899999999999999999999999999998765332
Q ss_pred CC-cceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NS-SQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. .......||+.|+|||.+. +..++.++||||||+++|||++|+.||....... .+.. +.........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~----i~~~~~~~~~ 253 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNH----ILGILGSPSQ 253 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-----HHHH----HHHHHCSCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-----HHHH----HHHHhCCCCH
Confidence 21 1134467999999999865 4558999999999999999999999986432111 1111 1000000000
Q ss_pred hhhh--------hhc-CCccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIE--------EIV-DPRLKGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~--------~~~-d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ... ........+ ......+.+|+.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000 000000111 112356889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=328.21 Aligned_cols=257 Identities=19% Similarity=0.219 Sum_probs=191.0
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee-------------
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE------------- 234 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------- 234 (464)
.+.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++|+||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 456778999999999999997 5689999998864332 22379999999999999999999843
Q ss_pred -------------------------CcEEeEEEEeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 040010 235 -------------------------GMHRLLVYEYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLE 285 (464)
Q Consensus 235 -------------------------~~~~~lv~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 285 (464)
....++||||++ |+|.+.+. ....+++..+..++.|++.||+|||+ .
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~ 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---L 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Confidence 344889999998 57776664 45689999999999999999999999 8
Q ss_pred ceEecCCCCCCEEEc-CCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHh
Q 040010 286 WVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLK 363 (464)
Q Consensus 286 ~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~ellt 363 (464)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999987644322 2345689999999988765 58999999999999999999
Q ss_pred CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh-------hhhcCCccC-----CCCCHHHHHHHHHHHHHccCC
Q 040010 364 GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI-------EEIVDPRLK-----GHFNKNQAATLFRIGISCVDE 431 (464)
Q Consensus 364 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~d~~l~-----~~~~~~~~~~~~~l~~~Cl~~ 431 (464)
|+.||..... ...+ ..+...........+ .+..-+.+. ..++......+.+|+.+||+.
T Consensus 238 g~~pf~~~~~-----~~~~----~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 238 GKPLFSGETS-----IDQL----VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp SSCSSCCSSH-----HHHH----HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred CCCCCCCCCh-----HHHH----HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999874211 1111 111111100000000 000001110 011222345688999999999
Q ss_pred CCCCCCCHHHHHH
Q 040010 432 DRNKRPTMDSVVQ 444 (464)
Q Consensus 432 dp~~RPsm~~V~~ 444 (464)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=326.21 Aligned_cols=261 Identities=19% Similarity=0.221 Sum_probs=189.3
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccc------------hhHHHHHHHHHhhhccccceeccceeeee--
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ------------GEEVFWAEVSTIGKIYHMNLVRMWGFCTE-- 234 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 234 (464)
.+.+.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 3455679999999999999988899999999864221 12678999999999999999999999843
Q ss_pred ---CcEEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeee
Q 040010 235 ---GMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADF 310 (464)
Q Consensus 235 ---~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 310 (464)
....++||||++ |+|.+.+... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEec
Confidence 347899999998 5787777654 479999999999999999999999 89999999999999999999999999
Q ss_pred cCccccCCCCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 311 GLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 311 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
|++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... . .....+
T Consensus 179 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~----~~~~~i 246 (362)
T 3pg1_A 179 NLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-----Y----NQLNKI 246 (362)
T ss_dssp TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHH
T ss_pred Cccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-----H----HHHHHH
Confidence 9997544322 2344568999999998876 6799999999999999999999999874211 1 111111
Q ss_pred HHHhhccc--------hhhhhhhcCCccCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 390 KEKILCGE--------EARIEEIVDPRLKGH-------FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 390 ~~~~~~~~--------~~~~~~~~d~~l~~~-------~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
........ .......+...+... ........+.+|+.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11110000 000111111111100 011224568899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.16 Aligned_cols=196 Identities=26% Similarity=0.284 Sum_probs=169.4
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-cc-----ceeccceeeeeCcEEeE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HM-----NLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~l 240 (464)
..+.+.+.||+|+||+||+|... +++.||||+++.......++..|+++++.++ |+ +++++++++......++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 34667789999999999999975 5789999999866555677888999988885 44 49999999999999999
Q ss_pred EEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc--CCCCeEEeeecCcccc
Q 040010 241 VYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD--SEFEPKIADFGLAKLS 316 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~ 316 (464)
||||++ ++|.+++... ..+++..+..++.|++.||.|||... .+|+||||||+|||++ .++.+||+|||++...
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 5999999765 46999999999999999999999521 6899999999999994 5788999999999876
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 212 GQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 432 2345789999999999999999999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.60 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=198.5
Q ss_pred HhhhccccCccCceEEEEEEE--CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhc---cccceeccceeee-----eC
Q 040010 169 TNSFKEELGKGGSGAVYKGVL--TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKI---YHMNLVRMWGFCT-----EG 235 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~--~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~ 235 (464)
.+.+.+.||+|+||.||++.. .+++.||+|++..... ....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 356678999999999999998 4678999999864322 234567788877776 8999999999987 56
Q ss_pred cEEeEEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCc
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLA 313 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 313 (464)
...++||||++ |+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 78899999998 6999999754 359999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 314 KLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 314 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....+....
T Consensus 168 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~----~~~~~i~~~~ 235 (326)
T 1blx_A 168 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----V----DQLGKILDVI 235 (326)
T ss_dssp CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHHHHHH
T ss_pred ccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----H----HHHHHHHHHc
Confidence 765432 123446789999999999999999999999999999999999999874211 1 1111111111
Q ss_pred hccc-hhhhhh------hcC---CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCC
Q 040010 394 LCGE-EARIEE------IVD---PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGC 449 (464)
Q Consensus 394 ~~~~-~~~~~~------~~d---~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~ 449 (464)
.... ..+... ... ......+.......+.+++.+||+.||++|||+.++++ .+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0000 000000 000 00000111223456889999999999999999999994 34443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=323.04 Aligned_cols=263 Identities=24% Similarity=0.246 Sum_probs=188.8
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCc------EE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------HR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 238 (464)
.+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3566788999999999999974 58899999986432 23456889999999999999999999987654 78
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999999974 7888775 458999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH-----------
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR----------- 387 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 387 (464)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.....
T Consensus 180 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 180 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-----IDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHC-CCCCCHHHHT
T ss_pred cc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHH
Confidence 21 23446789999999999999999999999999999999999999864211 000000000
Q ss_pred -------HHHHHhhccchhhhhhhcCCccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 388 -------EVKEKILCGEEARIEEIVDPRLKGH---FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 388 -------~~~~~~~~~~~~~~~~~~d~~l~~~---~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
......................... ........+.+|+.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000000001111000000 112336788999999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=324.93 Aligned_cols=264 Identities=21% Similarity=0.241 Sum_probs=193.8
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc------EEeEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------HRLLVY 242 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv~ 242 (464)
.|.+.+.||+|+||.||+|....+..+|+|++...... ..+|+++++.++|+||+++++++.... ..++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 35677899999999999999987777999988543222 236999999999999999999985433 378999
Q ss_pred EeccCCChHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeecCccccCC
Q 040010 243 EYVENQSLDKHLF---SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 243 E~~~~gsL~~~l~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 318 (464)
||++++.+..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9998765444332 35679999999999999999999999 8999999999999999 799999999999987644
Q ss_pred CCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+.. +........
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~l~~----i~~~~g~p~ 262 (394)
T 4e7w_A 195 GEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-----IDQLVE----IIKVLGTPS 262 (394)
T ss_dssp TCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH----HHHHHCCCC
T ss_pred CCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----HHHHhCCCC
Confidence 322 2345689999999988765 589999999999999999999999874211 111111 111110000
Q ss_pred hhhhh----hhcC---CccC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCC
Q 040010 398 EARIE----EIVD---PRLK-----GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCE 450 (464)
Q Consensus 398 ~~~~~----~~~d---~~l~-----~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~ 450 (464)
...+. .... +... ..+.......+.+|+.+||+.||.+|||+.++++. +.++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000 0000 1110 01111234578999999999999999999999874 44443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.44 Aligned_cols=256 Identities=25% Similarity=0.286 Sum_probs=189.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeC------cEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++|+||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 556678999999999999985 58999999986432 2234799999999999999999988432 3467999
Q ss_pred EeccCCChHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCccccC
Q 040010 243 EYVENQSLDKHLF----SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQ 317 (464)
Q Consensus 243 E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~ 317 (464)
||+++ +|.+.+. ....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 5655543 34679999999999999999999999 899999999999999965 568999999998764
Q ss_pred CCCCCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+.. +...+...
T Consensus 209 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-----~~~~l~~----i~~~lg~p 276 (420)
T 1j1b_A 209 RGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-----GVDQLVE----IIKVLGTP 276 (420)
T ss_dssp TTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH----HHHHHCSC
T ss_pred cCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH----HHHHhCCC
Confidence 4322 2345789999999998765 79999999999999999999999987421 1111111 11111100
Q ss_pred chhhhh-------hhcCCccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIE-------EIVDPRLKGH-----FNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~-------~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+. +...+.+... +.......+.+|+.+||+.||.+|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000011 1111111110 11223467899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=319.92 Aligned_cols=258 Identities=21% Similarity=0.245 Sum_probs=179.3
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeC------cEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG------MHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 238 (464)
.+.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++.++|+||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 356678999999999999996 468899999997532 2346688999999999999999999998653 567
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 9999999 6899988854 679999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. .+..+........
T Consensus 185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~----~l~~i~~~~g~p~ 250 (367)
T 2fst_X 185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----ID----QLKLILRLVGTPG 250 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHHHCSCC
T ss_pred c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHHHhCCCC
Confidence 2 344678999999999876 6799999999999999999999999864211 11 1111111110000
Q ss_pred hhh--------hhhhcCCcc-CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EAR--------IEEIVDPRL-KGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~--------~~~~~d~~l-~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
... ....+..-. ....+. .....+.+|+.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000000000 000111 123568899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=319.40 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=191.8
Q ss_pred HHHHHHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc-------hhHHHHHHHHHhhhc----cccceecccee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ-------GEEVFWAEVSTIGKI----YHMNLVRMWGF 231 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~g~ 231 (464)
+.....+.+.+.||+|+||.||+|.. .+++.||||++..... ....+..|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44455678889999999999999986 4678999999975432 223456799999998 89999999999
Q ss_pred eeeCcEEeEEEEe-ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEee
Q 040010 232 CTEGMHRLLVYEY-VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIAD 309 (464)
Q Consensus 232 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~D 309 (464)
+...+..++|+|| +.+++|.+++.....+++..++.++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 7899999999888889999999999999999999999 8899999999999999 889999999
Q ss_pred ecCccccCCCCCCcceeeeccCCCccCcccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH
Q 040010 310 FGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT-SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE 388 (464)
Q Consensus 310 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 388 (464)
||++....... .....||+.|+|||.+.+..+. .++||||||+++|||++|+.||.... .
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------------~ 244 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------------E 244 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------------H
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------------H
Confidence 99998765432 3445689999999998776664 58999999999999999999986210 0
Q ss_pred HHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 389 VKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 389 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .. ... .++......+.+++.+||+.||++|||+.++++
T Consensus 245 ~-----------~~----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 I-----------LE----AEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-----------HH----TCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-----------hh----hcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 000 111223456889999999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=316.92 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcE------E
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH------R 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 238 (464)
.+.+.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++.++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556678999999999999974 588999999975332 24568899999999999999999999977654 4
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||++ ++|.+++.. .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 688888743 59999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... . ..+..+........
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~----~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----L----DQLTQILKVTGVPG 244 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----H----HHHHHHHHHHCBCC
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHHHhCCCC
Confidence 2 234568999999998876 6789999999999999999999999874211 1 11111111000000
Q ss_pred hhh------------hhhhc---CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCC
Q 040010 398 EAR------------IEEIV---DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCE 450 (464)
Q Consensus 398 ~~~------------~~~~~---d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~ 450 (464)
... +..+. .+.+ ..........+.+++.+||+.||++|||+.++++. +....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 000 00000 0001 01112345678899999999999999999999863 44443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=321.04 Aligned_cols=238 Identities=23% Similarity=0.305 Sum_probs=197.0
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc-------hhHHHHHHHHHhhhcc--ccceeccceeeeeCcE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ-------GEEVFWAEVSTIGKIY--HMNLVRMWGFCTEGMH 237 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 237 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++..... ....+..|+.++++++ |+|++++++++.....
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 3466778999999999999996 4688999999864321 2245778999999996 5999999999999999
Q ss_pred EeEEEEeccC-CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeecCccc
Q 040010 238 RLLVYEYVEN-QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKL 315 (464)
Q Consensus 238 ~~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~ 315 (464)
.++|+||+.+ ++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999976 8999999888889999999999999999999999 8999999999999999 788999999999987
Q ss_pred cCCCCCCcceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 316 SQRGSNSSQFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 316 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
..... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... . .
T Consensus 200 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~----~----- 255 (320)
T 3a99_A 200 LKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------E----I----- 255 (320)
T ss_dssp CCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------H----H-----
T ss_pred ccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------h----h-----
Confidence 65322 334569999999999877665 688999999999999999999986210 0 0
Q ss_pred ccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... ......+ ...+.+++.+||+.||++|||+.++++
T Consensus 256 ------~~~~--~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 ------IRGQ--VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------HHCC--CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hccc--ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0011122 346889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=320.21 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=192.1
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEE------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHR------ 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 238 (464)
.+.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++.++|+||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3566788999999999999975 588999999975332 346788999999999999999999999877654
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 68888874 349999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. .............
T Consensus 197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~----~~~~i~~~~~~~~ 262 (371)
T 4exu_A 197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LD----QLTQILKVTGVPG 262 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHHHCCCC
T ss_pred C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-----HH----HHHHHHHHhCCCc
Confidence 2 334568999999999877 6899999999999999999999999874211 11 1111111000000
Q ss_pred hhh-----------hhhhcCCccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 398 EAR-----------IEEIVDPRLKGHF---NKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 398 ~~~-----------~~~~~d~~l~~~~---~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
... ....+.......+ .......+.+|+.+||+.||++|||+.++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 0000000000000 01224578899999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.67 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=174.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHH-HhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVS-TIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||||++.... ....++..|+. +++.++|+||+++++++...+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 455678999999999999985 68899999997542 23345556665 777889999999999999999999999999
Q ss_pred cCCChHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 246 ENQSLDKHLFS-----SNFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 246 ~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
++ +|.+++.. ...+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 85 88777752 5679999999999999999999999 7 8999999999999999999999999999765433
Q ss_pred CCCcceeeeccCCCccCcccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWA----SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .
T Consensus 180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~------ 238 (327)
T 3aln_A 180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------------Q------ 238 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------------
T ss_pred cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------------H------
Confidence 21 2334689999999998 566789999999999999999999999863211000 0
Q ss_pred cchhhhhhhcC---CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARIEEIVD---PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~~~~~d---~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..+.. +.+...........+.+++.+||+.||.+|||+.++++
T Consensus 239 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 -----LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111 11111111223457889999999999999999999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.66 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=199.2
Q ss_pred HHhhhccccCccCceEEEEEEEC-C-CcEEEEEEcCCccchhHHHHHHHHHhhhccccc------eeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-D-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN------LVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||.||++... + ++.||+|+++......+.+..|++++++++|+| ++.+.+++......+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 45677889999999999999974 3 468999999876666677889999999998877 899999999999999
Q ss_pred EEEEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE------------------
Q 040010 240 LVYEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL------------------ 299 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll------------------ 299 (464)
+||||+ +++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 56777766544 379999999999999999999999 899999999999999
Q ss_pred -cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccch
Q 040010 300 -DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378 (464)
Q Consensus 300 -~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~ 378 (464)
+.++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN----- 244 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----
T ss_pred ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 67889999999999864432 2345689999999999999999999999999999999999999974211
Q ss_pred hhhHHHHHHHHH--------HHhhccch---------------hhhhhhcCCc-cCCCCCHHHHHHHHHHHHHccCCCCC
Q 040010 379 EAELTGFIREVK--------EKILCGEE---------------ARIEEIVDPR-LKGHFNKNQAATLFRIGISCVDEDRN 434 (464)
Q Consensus 379 ~~~~~~~~~~~~--------~~~~~~~~---------------~~~~~~~d~~-l~~~~~~~~~~~~~~l~~~Cl~~dp~ 434 (464)
.... ..+.... ........ ....+...+. ............+.+|+.+||+.||+
T Consensus 245 ~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 REHL-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHH-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHH-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 0000 0111000 00000000 0000000000 00011234566889999999999999
Q ss_pred CCCCHHHHHH
Q 040010 435 KRPTMDSVVQ 444 (464)
Q Consensus 435 ~RPsm~~V~~ 444 (464)
+|||+.++++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=311.85 Aligned_cols=267 Identities=24% Similarity=0.288 Sum_probs=190.8
Q ss_pred HhhhccccCccCceEEEEEEECC-CcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceee--------------
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFC-------------- 232 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~-------------- 232 (464)
.+.+.+.||+|+||.||+|.... ++.||+|++.... ...+.+.+|++++++++||||+++++++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 35566889999999999999864 8899999887543 3446788999999999999999999887
Q ss_pred eeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc-CCCCeEEeeec
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD-SEFEPKIADFG 311 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg 311 (464)
.+....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 34578899999998 69999985 4578999999999999999999999 8999999999999997 56799999999
Q ss_pred CccccCCCCC-CcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 312 LAKLSQRGSN-SSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 312 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
++........ ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~----~~~~~ 237 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-----LE----QMQLI 237 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-----HH----HHHHH
Confidence 9987643221 112334567999999998765 6789999999999999999999999874221 00 11111
Q ss_pred HHHhhccchhhhhh------------hcCCccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCC
Q 040010 390 KEKILCGEEARIEE------------IVDPRLK-GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGC 449 (464)
Q Consensus 390 ~~~~~~~~~~~~~~------------~~d~~l~-~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~ 449 (464)
.............+ ...+... ..........+.+++.+||+.||++|||+.++++ .+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 11000000000000 0000000 0000112456889999999999999999999987 45543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.15 Aligned_cols=267 Identities=19% Similarity=0.224 Sum_probs=197.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeC-----cEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv 241 (464)
+.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++++++|+||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 566788999999999999975 58899999997433 2345678999999999999999999988654 678999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99997 689998865 579999999999999999999999 8999999999999999999999999999987653321
Q ss_pred Cc--------ceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 322 SS--------QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 322 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~----~~~~~~~~ 238 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RH----QLLLIFGI 238 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHH
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HH----HHHHHHHH
Confidence 11 1223568999999998754 6789999999999999999999999874211 00 11111110
Q ss_pred hhccc---------hhhhhhhcCCc-cCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCC
Q 040010 393 ILCGE---------EARIEEIVDPR-LKGHF-----NKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCE 450 (464)
Q Consensus 393 ~~~~~---------~~~~~~~~d~~-l~~~~-----~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~ 450 (464)
..... .....+.+... ..... .......+.+++.+||+.||++|||+.++++ .+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 00000000000 00000 0123456889999999999999999999987 455544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.87 Aligned_cols=244 Identities=28% Similarity=0.324 Sum_probs=184.7
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.++...++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998776678999999998643 234578899999886 89999999999999999999999995 6999
Q ss_pred HhhhcCCCC-------CHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-------------CCeEEeeec
Q 040010 252 KHLFSSNFL-------GWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-------------FEPKIADFG 311 (464)
Q Consensus 252 ~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-------------~~~kl~Dfg 311 (464)
+++...... ++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999755422 233457899999999999999 899999999999999754 489999999
Q ss_pred CccccCCCCCCc--ceeeeccCCCccCcccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhh
Q 040010 312 LAKLSQRGSNSS--QFSRIRGTKGYMAPEWASN-------LPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAE 381 (464)
Q Consensus 312 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 381 (464)
+++......... ......||+.|+|||.+.+ ..++.++|||||||++|||++ |+.||...... .
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~-- 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----E-- 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----H--
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----H--
Confidence 998775543221 1334679999999999865 678999999999999999999 88888632110 0
Q ss_pred HHHHHHHHHHHhhccchhhhhhhc-CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 382 LTGFIREVKEKILCGEEARIEEIV-DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. .. +.... .+.+....+......+.+++.+||+.||.+|||+.+|++
T Consensus 248 -~----~i-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -S----NI-----------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H----HH-----------HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H----HH-----------hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 00 01111 111222234567788999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=315.97 Aligned_cols=251 Identities=19% Similarity=0.204 Sum_probs=171.5
Q ss_pred hhhc-cccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee----CcEEeEEEE
Q 040010 170 NSFK-EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE----GMHRLLVYE 243 (464)
Q Consensus 170 ~~~~-~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~E 243 (464)
+.+. +.||+|+||.||+|... +++.||||++........ .....++.+.|+|++++++++.. +...++|||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 4553 46999999999999986 688999999865433222 22334566799999999999876 456899999
Q ss_pred eccCCChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCC
Q 040010 244 YVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQR 318 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 318 (464)
|+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999997653 69999999999999999999999 89999999999999976 45599999999986543
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ........
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~---~~~~~~~~---- 246 (336)
T 3fhr_A 184 NA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI------S---PGMKRRIR---- 246 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred cc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh------h---hhHHHhhh----
Confidence 22 3345689999999999888899999999999999999999999864321110 0 00000000
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLG 448 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~ 448 (464)
... ..............+.+++.+||+.||.+|||+.++++ .+.+
T Consensus 247 --~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 247 --LGQ---YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --ccc---cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000 00011111223456889999999999999999999998 4444
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.58 Aligned_cols=246 Identities=27% Similarity=0.321 Sum_probs=183.0
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
+...+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +|||||++++++.+....++||||++ |
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 455678999999996655556789999999865332 2356899999999 79999999999999999999999996 6
Q ss_pred ChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-----CCCeEEeeecCccccCCCCCC
Q 040010 249 SLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-----EFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 249 sL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|.+++.... .+.+..+..++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++........
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9999997554 45666678999999999999999 89999999999999943 346889999999876543221
Q ss_pred -cceeeeccCCCccCccccc---CCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 323 -SQFSRIRGTKGYMAPEWAS---NLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 323 -~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.......||+.|+|||.+. ...++.++|||||||++|||++ |..||..... .. ... .
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~----~~~----~---- 241 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQ----ANI----L---- 241 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HH----HHH----H----
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HH----HHH----H----
Confidence 2234567999999999987 4567889999999999999999 8888752210 00 000 0
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
......+.. .........+.+|+.+||+.||.+|||+.+|++
T Consensus 242 ---~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 ---LGACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---TTCCCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---hccCCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000011 112234556789999999999999999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=307.46 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=174.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccch--h-HHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQG--E-EVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~--~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|... +++.||||++...... . +.+..+..+++.++|+||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 456678999999999999985 6889999998754322 2 33444556788889999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLE-WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
++.+..+... ...+++..+..++.|++.||.|||+ . +|+|+||||+||+++.++.+||+|||++.......
T Consensus 107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (318)
T 2dyl_A 107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--- 179 (318)
T ss_dssp -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---
Confidence 4555555543 4679999999999999999999998 6 79999999999999999999999999997654322
Q ss_pred ceeeeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 324 QFSRIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ......... +
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~----~-- 245 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--------FEVLTKVLQ----E-- 245 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--------HHHHHHHHH----S--
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------HHHHHHHhc----c--
Confidence 123456899999999984 557899999999999999999999998632110 011111110 0
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+.+.. .......+.+++.+||+.||.+|||+.++++
T Consensus 246 ------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 ------EPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111110 1122346889999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=301.12 Aligned_cols=228 Identities=12% Similarity=0.046 Sum_probs=181.0
Q ss_pred HHhhhccccCccCceEEEEEEECC-CcEEEEEEcCCccc----hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQ----GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
..|.+.+.||+|+||.||+|.... ++.||||++..... ..+.+.+|+..+.+++|+||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 446777899999999999999854 89999999975433 2367899999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
||+++++|.+++... ....+...|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 4566788999999999999999 899999999999999999999997443
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
|++ .++.++||||||+++|||++|+.||........... ..
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------------------~~ 215 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------------------AE 215 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------------------CC
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------------------HH
Confidence 333 368999999999999999999999975322110000 00
Q ss_pred hhcCCccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 403 EIVDPRLK--GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 403 ~~~d~~l~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
..+..... .....+....+.+++.+||+.||++| |+.++++.|..+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00000000 00011234568899999999999999 99999999988654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=335.85 Aligned_cols=236 Identities=25% Similarity=0.317 Sum_probs=189.5
Q ss_pred HHhhhccccCccCceEEEEEEEC--CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcE-----E
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT--DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMH-----R 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~ 238 (464)
..+.+.+.||+|+||.||++... +++.||||++.... .....+.+|++++++++||||+++++++..... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45677889999999999999985 58899999986432 334568899999999999999999999987655 7
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+++++|.+++.. .+++..++.|+.||+.||.|||+ .+|+||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999988754 79999999999999999999999 899999999999999986 899999999987643
Q ss_pred CCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
. ....||+.|+|||.+.+.. +.++||||||+++|||++|..|+........
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------- 284 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------- 284 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------------
T ss_pred C------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------------
Confidence 2 3456999999999987654 8999999999999999999887653211100
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-MDSVVQTLLG 448 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-m~~V~~~L~~ 448 (464)
. ...........+.+++.+||+.||.+||+ +.++...|.+
T Consensus 285 ------~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ------P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00001122356889999999999999996 5566665554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.91 Aligned_cols=258 Identities=27% Similarity=0.295 Sum_probs=195.9
Q ss_pred HHhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeee------CcEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE------GMHR 238 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 238 (464)
..+.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4577889999999999999997 45889999998753 2344678999999999999999999998755 6778
Q ss_pred eEEEEeccCCChHHhhhcCC---CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC---eEEeeecC
Q 040010 239 LLVYEYVENQSLDKHLFSSN---FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---PKIADFGL 312 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgl 312 (464)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 69999999999999999999999 89999999999999997765 99999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHH
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (464)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|.......
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--------~~~~~~i~~~ 239 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--------VQWHGKVREK 239 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--------HHSSTTCC--
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--------hhhhhhhhcc
Confidence 987654322 34467999999999999999999999999999999999999998632100 0000000000
Q ss_pred hhccchhhhhhhcCC------c--cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040010 393 ILCGEEARIEEIVDP------R--LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDS 441 (464)
Q Consensus 393 ~~~~~~~~~~~~~d~------~--l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~ 441 (464)
.. ......+.... . ............+.+++..||+.||++|||+.+
T Consensus 240 ~~--~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SN--EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cc--hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 00000000000 0 112344556788999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=290.27 Aligned_cols=218 Identities=22% Similarity=0.224 Sum_probs=173.2
Q ss_pred cccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHh-hhccccceeccceeeee----CcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTI-GKIYHMNLVRMWGFCTE----GMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~E~~~~ 247 (464)
+.||+|+||.||++.. .+++.||+|+++. ...+.+|++++ +..+|+||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6799999999999997 4688999999864 34566888887 55689999999999877 6788999999999
Q ss_pred CChHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccCCCCCC
Q 040010 248 QSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 248 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~ 322 (464)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----- 171 (299)
T 3m2w_A 100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171 (299)
T ss_dssp CBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----
Confidence 99999997653 69999999999999999999999 89999999999999998 7889999999986433
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
+..++.++||||||+++|||++|+.||......... ... ..
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------------~~~---~~ 212 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------------PGM---KT 212 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------------CCS---CC
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------------HHH---HH
Confidence 134678999999999999999999998632111000 000 00
Q ss_pred hhcCCccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFN----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..... ..+ ......+.+++.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0101100 111 123457889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.50 Aligned_cols=233 Identities=15% Similarity=0.086 Sum_probs=173.9
Q ss_pred hhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccc-cceecccee-------------
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYH-MNLVRMWGF------------- 231 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h-~niv~l~g~------------- 231 (464)
...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++| +|......+
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 3456899999999999996 468899999987322 234678999999999977 322111111
Q ss_pred --------eee-----CcEEeEEEEeccCCChHHhhh------c-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecC
Q 040010 232 --------CTE-----GMHRLLVYEYVENQSLDKHLF------S-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291 (464)
Q Consensus 232 --------~~~-----~~~~~lv~E~~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~d 291 (464)
+.. ....+++|+++ +++|.+++. . ...+++..++.++.|++.||+|||+ .+|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 111 12345666655 689998884 1 2358889999999999999999999 8999999
Q ss_pred CCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccc----------cCCCCCccchhHHHHHHHHHH
Q 040010 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA----------SNLPITSKVDVFSYGVVILEM 361 (464)
Q Consensus 292 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~S~Gvvl~el 361 (464)
|||+|||++.++.+||+|||+++..... .....| +.|+|||.+ .+..++.++|||||||++|||
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999998765432 344567 999999998 555688999999999999999
Q ss_pred HhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040010 362 LKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDS 441 (464)
Q Consensus 362 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~ 441 (464)
++|+.||........ ...++... ..+ ++.+.+|+.+||+.||++|||+.+
T Consensus 311 ltg~~Pf~~~~~~~~------------------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 311 WCADLPNTDDAALGG------------------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHSSCCCCTTGGGSC------------------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHCCCCCCCcchhhh------------------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHH
Confidence 999999864221100 11111111 122 256889999999999999999766
Q ss_pred HH
Q 040010 442 VV 443 (464)
Q Consensus 442 V~ 443 (464)
++
T Consensus 361 ~l 362 (413)
T 3dzo_A 361 AM 362 (413)
T ss_dssp HT
T ss_pred HH
Confidence 53
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.08 Aligned_cols=241 Identities=13% Similarity=0.129 Sum_probs=184.1
Q ss_pred HHHHhhhccccCccCceEEEEEEECCCcEEEEEEcCCcc---------chhHHHHHHHHHhhhcc---------------
Q 040010 166 KKATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH---------QGEEVFWAEVSTIGKIY--------------- 221 (464)
Q Consensus 166 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~--------------- 221 (464)
....+.+.+.||+|+||.||+|+. +++.||||++.... ...+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345678889999999999999998 67999999987432 12267889999998886
Q ss_pred -----------ccceeccceeeee-------------CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 040010 222 -----------HMNLVRMWGFCTE-------------GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLA 277 (464)
Q Consensus 222 -----------h~niv~l~g~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~ 277 (464)
||||+++++++.+ ....++||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5555666665554 7889999999999977666643 67899999999999999999
Q ss_pred HHh-hcCCCceEecCCCCCCEEEcCCC--------------------CeEEeeecCccccCCCCCCcceeeeccCCCccC
Q 040010 278 YLH-HECLEWVIHCDVKPENILLDSEF--------------------EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMA 336 (464)
Q Consensus 278 yLH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 336 (464)
||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a 245 (336)
T 2vuw_A 176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD 245 (336)
T ss_dssp HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence 999 8 8899999999999999887 8999999999876532 3479999999
Q ss_pred cccccCCCCCccchhHHHHHH-HHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh-cCCccCCCCC
Q 040010 337 PEWASNLPITSKVDVFSYGVV-ILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI-VDPRLKGHFN 414 (464)
Q Consensus 337 PE~~~~~~~~~~~DV~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~l~~~~~ 414 (464)
||.+.+.. +.++||||+|.+ .+++++|..||.. ..|.......+. ... ..........
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------------~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 305 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------------VLWLHYLTDKML-------KQMTFKTKCNTPAM 305 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------------HHHHHHHHHHHH-------HTCCCSSCCCSHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------------hhhhhHHHHhhh-------hhhccCcccchhhh
Confidence 99998776 899999998777 7778888887641 112122211111 000 1111111123
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 415 KNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 415 ~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
......+.+|+.+||+.| |+.|++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 457788999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-31 Score=279.80 Aligned_cols=184 Identities=14% Similarity=0.051 Sum_probs=131.8
Q ss_pred ccCccCceEEEEEE-ECCCcEEEEEEcCCc-----------cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEE
Q 040010 175 ELGKGGSGAVYKGV-LTDERAVAVKRLGDL-----------HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~-~~~~~~vavK~l~~~-----------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.|++|.+..++ .--|+.+|+|.+... ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777666544 224778999998532 12235699999999999 799999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||++|++|.+.|.....++.. +|+.||+.||+|+|+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 9999999999999988888764 488999999999999 999999999999999999999999999998765432
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL 367 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p 367 (464)
.......||++|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22455789999999999876 467789999999998887766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=248.50 Aligned_cols=182 Identities=15% Similarity=0.160 Sum_probs=146.4
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccc---------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.||+|+||.||+|.. .+..+++|+...... ..+.+.+|++++++++|+||+++..++......++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45899999999999955 567888987643211 12447899999999999999988887778888899999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++++|.+++.. +..++.|++.||.|||+ .+|+||||||+|||++. .+||+|||+++.........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999965 56899999999999999 89999999999999999 99999999998775432111
Q ss_pred -----ceeeeccCCCccCcccccC--CCCCccchhHHHHHHHHHHHhCCCCC
Q 040010 324 -----QFSRIRGTKGYMAPEWASN--LPITSKVDVFSYGVVILEMLKGIRLS 368 (464)
Q Consensus 324 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltg~~p~ 368 (464)
......||+.|||||.+.. ..|+...|+||..+-.++-+.++.++
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235679999999999876 56888999999999999988776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-24 Score=202.72 Aligned_cols=141 Identities=16% Similarity=0.087 Sum_probs=116.2
Q ss_pred hccccCccCceEEEEEEECCCcEEEEEEcCCccc-------------------hhHHHHHHHHHhhhccccceeccceee
Q 040010 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ-------------------GEEVFWAEVSTIGKIYHMNLVRMWGFC 232 (464)
Q Consensus 172 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~g~~ 232 (464)
+.+.||+|+||.||+|...+|+.||||.++.... ....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4478999999999999997799999999864321 2356889999999999 5 7777766
Q ss_pred eeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecC
Q 040010 233 TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312 (464)
Q Consensus 233 ~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 312 (464)
.. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred ec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 44 45699999999999998 522 2345799999999999999 9999999999999999 99999999999
Q ss_pred ccccCCCCCCcceeeeccCCCccCcccccC
Q 040010 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342 (464)
Q Consensus 313 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (464)
++. +..++|||++..
T Consensus 239 a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE---------------VGEEGWREILER 253 (282)
T ss_dssp CEE---------------TTSTTHHHHHHH
T ss_pred CeE---------------CCCCCHHHHHHH
Confidence 863 234788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.4e-20 Score=172.75 Aligned_cols=134 Identities=15% Similarity=0.120 Sum_probs=104.8
Q ss_pred hhccccCccCceEEEEEEE-CCCcE--EEEEEcCCccch-------------------------hHHHHHHHHHhhhccc
Q 040010 171 SFKEELGKGGSGAVYKGVL-TDERA--VAVKRLGDLHQG-------------------------EEVFWAEVSTIGKIYH 222 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~h 222 (464)
.+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..|.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3557899999999999998 67888 999987532111 1257889999999998
Q ss_pred cce--eccceeeeeCcEEeEEEEeccC-C----ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceEecCCCC
Q 040010 223 MNL--VRMWGFCTEGMHRLLVYEYVEN-Q----SLDKHLFSSNFLGWKERFKVALGTAKGLAYLH-HECLEWVIHCDVKP 294 (464)
Q Consensus 223 ~ni--v~l~g~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dlk~ 294 (464)
+++ ..++++ ...+|||||+.+ | +|.+.... .++.....++.|++.||.||| + .+|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE---AELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCH
Confidence 864 333332 356899999942 4 67666532 234567889999999999999 8 8899999999
Q ss_pred CCEEEcCCCCeEEeeecCcccc
Q 040010 295 ENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 295 ~NIll~~~~~~kl~Dfgla~~~ 316 (464)
+|||++. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=161.05 Aligned_cols=139 Identities=12% Similarity=0.026 Sum_probs=98.4
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccc---------------hhHHHHHHHHHhhhccccceeccceeeee
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---------------GEEVFWAEVSTIGKIYHMNLVRMWGFCTE 234 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 234 (464)
+.+...||+|++|.||+|...+|+.||||+++.... .....+.++++.....|+|+++++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456678999999999999998999999998753211 01112233333333345555554432111
Q ss_pred ------CcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC----
Q 040010 235 ------GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE---- 304 (464)
Q Consensus 235 ------~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---- 304 (464)
....+|||||+++++|..+... .....++.|++.+|.|||+ .+||||||||.|||+++++.
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCcccc
Confidence 1123699999999888765432 2335688999999999999 88999999999999988763
Q ss_pred ------eEEeeecCccccC
Q 040010 305 ------PKIADFGLAKLSQ 317 (464)
Q Consensus 305 ------~kl~Dfgla~~~~ 317 (464)
+.|.||+-+....
T Consensus 248 ~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECCCTTCEETT
T ss_pred cccccceEEEEeCCcccCC
Confidence 8999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=116.07 Aligned_cols=139 Identities=12% Similarity=-0.003 Sum_probs=109.2
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCcc-chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
+.+...++.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. +.++.++++++...+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 344567888888999999864 6789999987432 23346889999999985 67788999999998999999999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC-------------------------------------------- 283 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 283 (464)
.+|.+.+. +......++.+++++|+.||+..
T Consensus 95 ~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 95 VLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp EEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred eehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 99987642 12234578899999999999811
Q ss_pred ------------CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 ------------LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ------------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
...++|+|+++.||+++++..+.|.||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-11 Score=111.92 Aligned_cols=130 Identities=17% Similarity=0.040 Sum_probs=99.2
Q ss_pred ccC-ccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eeccceeeeeCcEEeEEEEeccCCChH
Q 040010 175 ELG-KGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 175 ~lG-~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
.++ .|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 55669999998777788999987654 2355788999999996555 456888888778889999999998884
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 040010 252 KHLFSSNFLGWKERFKVALGTAKGLAYLHHEC------------------------------------------------ 283 (464)
Q Consensus 252 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 283 (464)
... .+ ...++.++++.|+.||+..
T Consensus 104 --~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 12 2367788888888888732
Q ss_pred -------CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 -------LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 -------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
...++|+|++|.||+++++..+.|.||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.5e-10 Score=110.61 Aligned_cols=139 Identities=16% Similarity=0.247 Sum_probs=106.2
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcC--Ccc--chhHHHHHHHHHhhhcc--ccceeccceeeeeC---cEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLG--DLH--QGEEVFWAEVSTIGKIY--HMNLVRMWGFCTEG---MHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~E~ 244 (464)
+.|+.|.++.||+....+ ..+++|+.. ... .....+..|+.+++.+. +.++.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999998755 578888776 322 22356788999999997 45678899988776 458999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC----------------------------------------- 283 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 283 (464)
++|..+.+.. -..++...+..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 123 VSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred cCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 9998875422 234778889999999999999999831
Q ss_pred --------------CCceEecCCCCCCEEEcCCCC--eEEeeecCccc
Q 040010 284 --------------LEWVIHCDVKPENILLDSEFE--PKIADFGLAKL 315 (464)
Q Consensus 284 --------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~ 315 (464)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997754 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=5.2e-10 Score=107.54 Aligned_cols=182 Identities=20% Similarity=0.184 Sum_probs=120.7
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccc--eeccceeeeeCc---EEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMN--LVRMWGFCTEGM---HRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lv~E~~~~ 247 (464)
+.++.|.+..||+.. ..+++|+.... .....+..|.++|+.+. +.. +.+++.....+. ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 358899999999863 45888876543 34466889999998884 332 344554443332 45899999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC-------------------------------------------- 283 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 283 (464)
.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88875432 34677788888999999999998611
Q ss_pred -----------CCceEecCCCCCCEEEcC--CCCeEEeeecCccccCCCCCCcceeeeccCCCc---cCcccccC-----
Q 040010 284 -----------LEWVIHCDVKPENILLDS--EFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGY---MAPEWASN----- 342 (464)
Q Consensus 284 -----------~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~----- 342 (464)
...++|+|+++.||++++ +..+.|.||+.+........ ......+ ..|+....
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHHHHHHc
Confidence 135899999999999998 45678999999865432100 0000011 22221110
Q ss_pred CCC---------CccchhHHHHHHHHHHHhCCCCC
Q 040010 343 LPI---------TSKVDVFSYGVVILEMLKGIRLS 368 (464)
Q Consensus 343 ~~~---------~~~~DV~S~Gvvl~elltg~~p~ 368 (464)
+.. ....+.|++|.++|++.+|..++
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 12368999999999999996553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.5e-06 Score=83.36 Aligned_cols=136 Identities=21% Similarity=0.191 Sum_probs=94.0
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc---ceeccceeee-eCcEEeEEEEeccCCC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM---NLVRMWGFCT-EGMHRLLVYEYVENQS 249 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~E~~~~gs 249 (464)
+.++.|....||+. +..+++|+... ......+..|.++|+.+.+. .+.+.+.++. ..+..++||||++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 35788888899987 45678887532 23346788999999999753 3556666664 3456789999999988
Q ss_pred hHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 040010 250 LDKHLFSSNFLGWKERFKVALGTAKGLAYLHHE----------------------------------------------- 282 (464)
Q Consensus 250 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 282 (464)
|..... ..++...+..++.++++.|+.||+.
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 876321 1234455555555666655555542
Q ss_pred ----------CCCceEecCCCCCCEEEcC---CCCe-EEeeecCcccc
Q 040010 283 ----------CLEWVIHCDVKPENILLDS---EFEP-KIADFGLAKLS 316 (464)
Q Consensus 283 ----------~~~~ivH~dlk~~NIll~~---~~~~-kl~Dfgla~~~ 316 (464)
....++|+|+++.||+++. ++.+ .|.||+.+...
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 4554 89999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.1e-06 Score=79.31 Aligned_cols=133 Identities=17% Similarity=0.052 Sum_probs=93.7
Q ss_pred cCccCce-EEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccCCChHH
Q 040010 176 LGKGGSG-AVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSLDK 252 (464)
Q Consensus 176 lG~G~~g-~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~ 252 (464)
+..|..| .||+.... ++..+.+|+-... ....+..|...|+.+. +-.+.++++++.+++..++|||++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445444 68987754 4567888876532 3456778999988884 3446788899999999999999999988776
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------------
Q 040010 253 HLFSSNFLGWKERFKVALGTAKGLAYLHHEC------------------------------------------------- 283 (464)
Q Consensus 253 ~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------- 283 (464)
..... ......+..+++..|+-||+..
T Consensus 110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 54321 1223345556666666666421
Q ss_pred ------CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 ------LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
...++|+|+.+.||+++++..+-|.||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1127999999999999988777799998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.4e-06 Score=85.40 Aligned_cols=79 Identities=11% Similarity=0.042 Sum_probs=56.4
Q ss_pred ccc-CccCceEEEEEEEC-------CCcEEEEEEcCCcc---c-hhHHHHHHHHHhhhccc---cceeccceeeeeC---
Q 040010 174 EEL-GKGGSGAVYKGVLT-------DERAVAVKRLGDLH---Q-GEEVFWAEVSTIGKIYH---MNLVRMWGFCTEG--- 235 (464)
Q Consensus 174 ~~l-G~G~~g~Vy~g~~~-------~~~~vavK~l~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~--- 235 (464)
+.| +.|....+|+.... ++..+++|+..... . ....+..|+.+++.+.. -.+.++++++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78888999998764 25678888765432 1 23457789999998853 3567788887665
Q ss_pred cEEeEEEEeccCCChHH
Q 040010 236 MHRLLVYEYVENQSLDK 252 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~ 252 (464)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.3e-05 Score=77.79 Aligned_cols=73 Identities=16% Similarity=0.130 Sum_probs=48.4
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCcc--------chhHHHHHHHHHhhhccc--cc-eeccceeeeeCcEEeEE
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--------QGEEVFWAEVSTIGKIYH--MN-LVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~~lv 241 (464)
+.||.|.++.||++... +++.++||...... .....+..|.++++.+.. +. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46999999999999754 46789999764321 123456788888888742 33 3455544 34456899
Q ss_pred EEeccCC
Q 040010 242 YEYVENQ 248 (464)
Q Consensus 242 ~E~~~~g 248 (464)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.7e-05 Score=74.30 Aligned_cols=136 Identities=15% Similarity=0.197 Sum_probs=81.2
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc--ceeccce------eeeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM--NLVRMWG------FCTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g------~~~~~~~~~lv~E~~~ 246 (464)
.|+.|..+.||+....++ .+++|+.... ...+..|+.+++.+... ++.+++. +...++..+++|||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677889999988665 4889988752 23344566666665422 2344443 1234667899999999
Q ss_pred CCChH-----------H---hhhc--C----C--------CCCHHHHH-------------------------------H
Q 040010 247 NQSLD-----------K---HLFS--S----N--------FLGWKERF-------------------------------K 267 (464)
Q Consensus 247 ~gsL~-----------~---~l~~--~----~--------~l~~~~~~-------------------------------~ 267 (464)
|.++. . .++. . . ...|...+ .
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 0 1111 0 0 12343211 0
Q ss_pred HHHHHHHHHHHHhh----------cCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 268 VALGTAKGLAYLHH----------ECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 268 i~~~ia~gL~yLH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
+...+..++.+|++ .....++|+|+++.||+++.++.+.|.||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345666663 124679999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=6.7e-05 Score=71.92 Aligned_cols=134 Identities=16% Similarity=0.171 Sum_probs=90.3
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEEEEeccCCCh
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3589999999999886 4567888876532 3456888999998884 35688899988888889999999998765
Q ss_pred HH-----------hhhcC---C-------------------CCCHHHHH---HHHH----------------HHHHH-HH
Q 040010 251 DK-----------HLFSS---N-------------------FLGWKERF---KVAL----------------GTAKG-LA 277 (464)
Q Consensus 251 ~~-----------~l~~~---~-------------------~l~~~~~~---~i~~----------------~ia~g-L~ 277 (464)
.. .|+.. . .-+|.... ++.. .+... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 11211 1 02465322 1111 11111 22
Q ss_pred HHhh-cCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 278 YLHH-ECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 278 yLH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
.|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2246799999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00028 Score=66.58 Aligned_cols=73 Identities=23% Similarity=0.269 Sum_probs=53.5
Q ss_pred cccCccCceEEEEEEECCCcEEEEEEcCCcc-chhHHHHHHHHHhhhcccc---ceeccceeeeeCcEEeEEEEeccCCC
Q 040010 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHM---NLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+.+|.|..+.||+.++.+|+.+.+|+..... .....|..|...|+.+... .+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 4689999999999999999999999876433 2345678899999888532 244455442 2378999998765
Q ss_pred h
Q 040010 250 L 250 (464)
Q Consensus 250 L 250 (464)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00018 Score=72.01 Aligned_cols=78 Identities=9% Similarity=0.075 Sum_probs=48.4
Q ss_pred CCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeec--cCCCccCcccccCCC---CCccchhHHHHHHH
Q 040010 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIR--GTKGYMAPEWASNLP---ITSKVDVFSYGVVI 358 (464)
Q Consensus 284 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl 358 (464)
...++|+|+++.||+++.++ ++|.||+.+........ ..... -...|.+|+...... .....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 37899999999999998876 99999998865321100 00000 012356665543211 11235566888888
Q ss_pred HHHHhCC
Q 040010 359 LEMLKGI 365 (464)
Q Consensus 359 ~elltg~ 365 (464)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00049 Score=69.03 Aligned_cols=72 Identities=17% Similarity=0.235 Sum_probs=50.1
Q ss_pred cccCccCceEEEEEEECC--------CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~ 244 (464)
+.|+.|....+|+....+ +..+++|+.... ...+.+..|..+++.+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 468888887432 122456689999988864444 566666543 289999
Q ss_pred ccCCCh
Q 040010 245 VENQSL 250 (464)
Q Consensus 245 ~~~gsL 250 (464)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00079 Score=64.62 Aligned_cols=138 Identities=17% Similarity=0.148 Sum_probs=82.6
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eecccee-----eeeCcEEeEEEEeccC
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGF-----CTEGMHRLLVYEYVEN 247 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~E~~~~ 247 (464)
.++ |....||+....+|+.+++|...........+..|..++..+.... +++++.. ...++..+++|||++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 366 7778899887777777999988744334556777888888875322 3444443 1234566889999987
Q ss_pred CChH-----Hh---------hhc---------CCCCCHHHH----HHHH---------------HHHHHHHHHHhhc---
Q 040010 248 QSLD-----KH---------LFS---------SNFLGWKER----FKVA---------------LGTAKGLAYLHHE--- 282 (464)
Q Consensus 248 gsL~-----~~---------l~~---------~~~l~~~~~----~~i~---------------~~ia~gL~yLH~~--- 282 (464)
..+. .. ++. ....++... ..+. ..+...+..+.+.
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 10 110 012233211 0011 1111223333221
Q ss_pred -CCCceEecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 283 -CLEWVIHCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 283 -~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999999 4 899999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00017 Score=68.54 Aligned_cols=71 Identities=11% Similarity=0.063 Sum_probs=44.2
Q ss_pred ccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEec-cCCCh
Q 040010 173 KEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYV-ENQSL 250 (464)
Q Consensus 173 ~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~-~~gsL 250 (464)
.+.|+.|....+|+. ..+++|+.............|+.+++.+....+ .++++++ ....++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 356888999999998 457888776432222223568888877754333 3555543 33357899999 65444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00059 Score=67.11 Aligned_cols=136 Identities=20% Similarity=0.271 Sum_probs=81.4
Q ss_pred ccCccCceEEEEEEECC--------CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEec
Q 040010 175 ELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~ 245 (464)
.|..|-...+|+....+ ++.+.+|+..........+.+|.++++.+...++ .++++++.++ +||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEe
Confidence 46667777889988642 4688898865433334556689999988853333 5666666542 899999
Q ss_pred cCCChHHh-----------------hhcC-----CCCC--HHHHHHHHHHHHH-------------------HHHHHh--
Q 040010 246 ENQSLDKH-----------------LFSS-----NFLG--WKERFKVALGTAK-------------------GLAYLH-- 280 (464)
Q Consensus 246 ~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~ia~-------------------gL~yLH-- 280 (464)
+|.+|..- |+.. .... |.+..++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 98665311 1111 1122 4444445443321 233332
Q ss_pred --h-cCCCceEecCCCCCCEEEcCC----CCeEEeeecCcc
Q 040010 281 --H-ECLEWVIHCDVKPENILLDSE----FEPKIADFGLAK 314 (464)
Q Consensus 281 --~-~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~ 314 (464)
. .....++|+|+.+.||+++.+ +.+.+.||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 122469999999999999876 689999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00044 Score=66.20 Aligned_cols=138 Identities=14% Similarity=0.108 Sum_probs=80.7
Q ss_pred ccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccc--eecccee------eeeCcEEeEEEEecc
Q 040010 175 ELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN--LVRMWGF------CTEGMHRLLVYEYVE 246 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~E~~~ 246 (464)
.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+.... +.+++.. ....+..+++++|++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 467788889999988666 5778887652 12345567888887775333 2334421 123356789999999
Q ss_pred CCChHH--------------hhhcC------C---CC---CHHHHHHH------------HHHHHHHHHHHhhc----CC
Q 040010 247 NQSLDK--------------HLFSS------N---FL---GWKERFKV------------ALGTAKGLAYLHHE----CL 284 (464)
Q Consensus 247 ~gsL~~--------------~l~~~------~---~l---~~~~~~~i------------~~~ia~gL~yLH~~----~~ 284 (464)
|..+.. .++.. . .. .|...+.- ...+.+.+.++++. ..
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 865421 01110 0 01 24331110 11244455666542 23
Q ss_pred CceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 285 EWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 285 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
..++|+|+++.||+++++..+.|.||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 579999999999999987656899998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00085 Score=67.72 Aligned_cols=73 Identities=14% Similarity=0.123 Sum_probs=47.4
Q ss_pred cccCccCceEEEEEEECC-CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEeccCCCh
Q 040010 174 EELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYVENQSL 250 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~~~gsL 250 (464)
+.|+.|-...+|+....+ +..+++|+........-....|..+++.+...++ .++++.+.. .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 458888889999999865 4678888775322111112578888888865555 467776642 259999987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0019 Score=62.09 Aligned_cols=137 Identities=14% Similarity=0.021 Sum_probs=72.2
Q ss_pred ccCccCceE-EEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc--ceeccceeeeeCcEEeEEEEeccCCChH
Q 040010 175 ELGKGGSGA-VYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM--NLVRMWGFCTEGMHRLLVYEYVENQSLD 251 (464)
Q Consensus 175 ~lG~G~~g~-Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lv~E~~~~gsL~ 251 (464)
.|+.|+... +|+....++..+++|...... ...+..|+.+++.+... .+.+++.+..+.+ +++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 455554443 667765446667777654322 13345677777777432 3456666644333 7899999776664
Q ss_pred HhhhcC--------------------------CCCCHHHHH-------HH-------------HHHHHHHHHHHhh---c
Q 040010 252 KHLFSS--------------------------NFLGWKERF-------KV-------------ALGTAKGLAYLHH---E 282 (464)
Q Consensus 252 ~~l~~~--------------------------~~l~~~~~~-------~i-------------~~~ia~gL~yLH~---~ 282 (464)
+.+... ..++..... .+ ...+...+..+.+ .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 433210 011111100 00 0111122222211 1
Q ss_pred CCCceEecCCCCCCEEEcCC----CCeEEeeecCccc
Q 040010 283 CLEWVIHCDVKPENILLDSE----FEPKIADFGLAKL 315 (464)
Q Consensus 283 ~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~ 315 (464)
....++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23679999999999999875 6789999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0011 Score=65.02 Aligned_cols=73 Identities=10% Similarity=0.094 Sum_probs=44.6
Q ss_pred cccCccCceEEEEEEECC---------CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEE
Q 040010 174 EELGKGGSGAVYKGVLTD---------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E 243 (464)
+.|+.|..-.+|+....+ +..+++|+.............|.++++.+...++ .++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357778888999998754 2678888775432222224578888888864444 3566543 2 268999
Q ss_pred eccCCCh
Q 040010 244 YVENQSL 250 (464)
Q Consensus 244 ~~~~gsL 250 (464)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0096 Score=57.48 Aligned_cols=68 Identities=10% Similarity=0.108 Sum_probs=43.8
Q ss_pred CccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccc---cceecccee------eeeCcEEeEEEEeccC
Q 040010 177 GKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH---MNLVRMWGF------CTEGMHRLLVYEYVEN 247 (464)
Q Consensus 177 G~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~------~~~~~~~~lv~E~~~~ 247 (464)
|.|....||+....+| .+++|+...... ..|+.++..+.. +++++.+.. ...++..+++|+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444678999987777 889997765432 245666666532 224454432 2345678999999998
Q ss_pred CCh
Q 040010 248 QSL 250 (464)
Q Consensus 248 gsL 250 (464)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0076 Score=53.76 Aligned_cols=104 Identities=13% Similarity=0.014 Sum_probs=67.6
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
.-||.+.|.. +.+++..+++.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.+-+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3478999875 468999999999999999987762211 11 1333456899999999988763 1110
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLS 368 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~ 368 (464)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1122366888653 34567889999999999988755543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.026 Score=56.21 Aligned_cols=72 Identities=8% Similarity=0.097 Sum_probs=46.9
Q ss_pred ccCccCceEEEEEEECC--------CcEEEEEEcCCccchhHHHHHHHHHhhhccccce-eccceeeeeCcEEeEEEEec
Q 040010 175 ELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL-VRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 175 ~lG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~E~~ 245 (464)
.+..|-...+|+....+ +..+++++........-...+|..+++.+...++ .++++.+. -++||||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEe
Confidence 46677788899998763 5778888865432222223578888888854333 44555332 26899999
Q ss_pred cCCCh
Q 040010 246 ENQSL 250 (464)
Q Consensus 246 ~~gsL 250 (464)
+|..|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98664
|
| >4a5v_A MIC4, micronemal protein 4; adhesion; NMR {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.022 Score=48.49 Aligned_cols=48 Identities=23% Similarity=0.463 Sum_probs=40.1
Q ss_pred CcccccCC-cc-ccccccCHHHHHHHHhhcCCccceEEecCCccceeEeee
Q 040010 2 PKVDFYGF-DL-NFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSE 50 (464)
Q Consensus 2 ~~~~~~~~-~~-~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~~ 50 (464)
+++||.|+ |. ......+.++|.+.|..+=.|.+|+|. .....|++|..
T Consensus 87 ~~vD~~G~~dl~~~~~~~s~~~Cq~~C~~~~~C~~fTy~-~~~~~C~LK~~ 136 (161)
T 4a5v_A 87 QHVSYEGAPDVMTAMVTSQSADCQAACAADPSCEIFTYN-EHDQKCTFKGR 136 (161)
T ss_dssp ESEEECSSCBSSCCCBCSCHHHHHHHHHHCTTCCEEEEE-TTTTEEEEECT
T ss_pred CCCcccCchhccccccCCCHHHHHHHcccCCCCCEEEee-CCCCeeEeCCC
Confidence 47899999 65 436778999999999999999999997 45678998754
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=94.95 E-value=0.027 Score=41.70 Aligned_cols=35 Identities=23% Similarity=0.584 Sum_probs=30.4
Q ss_pred cccCHHHHHHHHhhcCCccceEEecCCccceeEeee
Q 040010 15 EHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKSE 50 (464)
Q Consensus 15 ~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~~ 50 (464)
..+++++|+..|+.+=.|+||.|. .....|++|+.
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN-~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYN-VKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEE-TTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEec-cCCCceEcccC
Confidence 578999999999999999999997 44568998864
|
| >4a5v_A MIC4, micronemal protein 4; adhesion; NMR {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=93.35 E-value=0.11 Score=44.17 Aligned_cols=48 Identities=21% Similarity=0.365 Sum_probs=41.0
Q ss_pred CCcccccCCcc-ccccccCHHHHHHHHhhcCCccceEEecCCccceeEee
Q 040010 1 VPKVDFYGFDL-NFSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKS 49 (464)
Q Consensus 1 ~~~~~~~~~~~-~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~ 49 (464)
++|+.|-|.|+ ......+.++|..+|-.+-.|.+|+|. .....|++|.
T Consensus 14 ~~n~~~~g~~i~~~~~~~s~~~Cq~~C~~~p~C~~fTf~-~~~~~C~LK~ 62 (161)
T 4a5v_A 14 SDNKGSRAPTIGEPVPDVSLEQCAAQCKAVDGCTHFTYN-DDSKMCHVKE 62 (161)
T ss_dssp CSSEEECSCBCSCCBTTCCHHHHHHHHHHSTTCSEEEEE-TTTCCEEEEC
T ss_pred CCCccccCCCeeeeecCCCHHHHHHHCcCCCCCcEEEEE-CCCCEEEEeC
Confidence 46888999998 667788999999999999999999997 3456899875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.01 E-value=0.14 Score=32.81 Aligned_cols=26 Identities=23% Similarity=0.321 Sum_probs=13.1
Q ss_pred hHHHHHHHHHHHHHHHHHHhhhcCCC
Q 040010 117 FALAIGAIEVLFIVSGWWLLFRRQGI 142 (464)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~rr~~~ 142 (464)
.+++.|+++++++++++|+++||++.
T Consensus 15 ~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 15 TGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34444455555555555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.58 E-value=0.19 Score=32.17 Aligned_cols=25 Identities=16% Similarity=0.256 Sum_probs=11.9
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCCC
Q 040010 118 ALAIGAIEVLFIVSGWWLLFRRQGI 142 (464)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~rr~~~ 142 (464)
+++.|++.++++++++|+++||++.
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3333344444455555555555443
|
| >2f83_A Coagulation factor XI; protease, apple domain, hydrolase; HET: NAG; 2.87A {Homo sapiens} PDB: 2j8j_A 2j8l_A | Back alignment and structure |
|---|
Probab=90.10 E-value=0.17 Score=52.94 Aligned_cols=48 Identities=17% Similarity=0.373 Sum_probs=39.9
Q ss_pred CcccccCCccccccccCHHHHHHHHhhcCCccceEEecCC------ccceeEee
Q 040010 2 PKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRLTG------ERVCFTKS 49 (464)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~------~~~c~~~~ 49 (464)
++++|.|.|+......+.++|.++|.++=.|.+|+|...+ ...|++|.
T Consensus 206 ~~~d~~g~d~~~~~~~~~~~C~~~C~~~~~C~~fT~~~~~~~~~~~~~~C~LK~ 259 (625)
T 2f83_A 206 PNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKT 259 (625)
T ss_dssp EEEECCSEEEEEEECSSHHHHHHHHHTCSSCSEEEEECTTCSSGGGTTEEEEEE
T ss_pred cCccccCcceeeeecCCHHHHHHhccCCCCCcEEEEecCCccCcccCCeEEeec
Confidence 4789999998777778999999999999999999996322 35799764
|
| >2f83_A Coagulation factor XI; protease, apple domain, hydrolase; HET: NAG; 2.87A {Homo sapiens} PDB: 2j8j_A 2j8l_A | Back alignment and structure |
|---|
Probab=89.99 E-value=0.17 Score=53.00 Aligned_cols=48 Identities=29% Similarity=0.588 Sum_probs=40.2
Q ss_pred CcccccCCccccccccCHHHHHHHHhhcCCccceEEec------CCccceeEee
Q 040010 2 PKVDFYGFDLNFSEHVSKEACMKLCLDDFRCSGFSYRL------TGERVCFTKS 49 (464)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~~c~C~a~~~~~------~~~~~c~~~~ 49 (464)
+++||.|.|+......+.++|.+.|-++=.|.+|+|.. .....|++|.
T Consensus 116 ~~~d~~G~d~~~~~~~s~~~C~~~C~~~~~C~~fTy~~~~~~~~~~~~~C~LK~ 169 (625)
T 2f83_A 116 VDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKH 169 (625)
T ss_dssp EEEEEECEEEEEEECSCHHHHHHHHHTSSSCSEEEEECSSCSCSSSTTEEEEEE
T ss_pred cccceecceeeeEeeCCHHHHHHhccCCCCCcEEEecCCcccCCCCCceeEecc
Confidence 47899999987767779999999999999999999952 2345799875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.13 E-value=0.18 Score=49.64 Aligned_cols=29 Identities=28% Similarity=0.401 Sum_probs=24.5
Q ss_pred eEecCCCCCCEEE------cCCCCeEEeeecCccc
Q 040010 287 VIHCDVKPENILL------DSEFEPKIADFGLAKL 315 (464)
Q Consensus 287 ivH~dlk~~NIll------~~~~~~kl~Dfgla~~ 315 (464)
++|+|+.+.||++ +++..+++.||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988753
|
| >2yil_A Microneme antigen L2; sugar binding protein, apple-domain tandem repeat, PAN_AP, P galactose-binding lectin, cellular adhesion; 1.95A {Sarcocystis muris} PDB: 2yio_A* 2yip_A* | Back alignment and structure |
|---|
Probab=89.03 E-value=0.38 Score=39.47 Aligned_cols=47 Identities=26% Similarity=0.436 Sum_probs=36.5
Q ss_pred CcccccCCccc---cccccCHHHHHHHHhhcCCccceEEecCCccceeEee
Q 040010 2 PKVDFYGFDLN---FSEHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKS 49 (464)
Q Consensus 2 ~~~~~~~~~~~---~~~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~ 49 (464)
++.+..|+|+. .....|.++|.++|.+.=.|..|+|. ..+..|++|.
T Consensus 11 ~h~~n~G~~~~~i~~~~v~Sa~~Cq~~C~~~~~C~~FTf~-~~~k~C~LK~ 60 (138)
T 2yil_A 11 AHDKNIGSRTEQLSVVHVASAQDCMKECQALPTCSHFTYN-KNSKKCHLKA 60 (138)
T ss_dssp CSSSCEEECSCEEEEEECSSHHHHHHHHHHSTTCCEEEEE-TTTCEEEEEC
T ss_pred cccCccCcchhcccccCCCCHHHHHHHccCCCCCCEEEEE-CCCCEEEecc
Confidence 34455677764 24677999999999999999999996 4556899774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.92 E-value=2 Score=37.99 Aligned_cols=116 Identities=10% Similarity=0.145 Sum_probs=79.4
Q ss_pred cccceeccceeeeeCcEEeEEEEeccCC-ChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE
Q 040010 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQ-SLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 221 ~h~niv~l~g~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll 299 (464)
.||+++.. ..-.+.+...+.|+.-+.+ ++.. + ..++...+++++..|+....+++. -+|--+.|.|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57777765 4455556666666654422 2222 2 357889999999999998866664 3788999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
+.++.+++.-.|+-.. ++|. .++...=.-.+=+++..+++++..|..
T Consensus 113 ~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999987665432 2222 123333355677888899998877753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.06 E-value=0.88 Score=29.04 Aligned_cols=6 Identities=17% Similarity=0.495 Sum_probs=2.4
Q ss_pred HHHHHH
Q 040010 118 ALAIGA 123 (464)
Q Consensus 118 ~~~~~~ 123 (464)
+.++|.
T Consensus 16 ~~vVGv 21 (44)
T 2jwa_A 16 SAVVGI 21 (44)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 334443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.76 E-value=0.085 Score=53.10 Aligned_cols=60 Identities=8% Similarity=0.006 Sum_probs=18.6
Q ss_pred hhccccCccCceEEEEEEECC-CcEEEE------EEcCCcc---chhHHHHHHHHHhhhccccceeccceeee
Q 040010 171 SFKEELGKGGSGAVYKGVLTD-ERAVAV------KRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCT 233 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~-~~~vav------K~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 233 (464)
.+.++|| ||.||+|.+.. ..+||| |..+... .....|.+|..+++..+|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456777 99999999864 367888 7665422 22245788889999999999999988754
|
| >2yil_A Microneme antigen L2; sugar binding protein, apple-domain tandem repeat, PAN_AP, P galactose-binding lectin, cellular adhesion; 1.95A {Sarcocystis muris} PDB: 2yio_A* 2yip_A* | Back alignment and structure |
|---|
Probab=84.03 E-value=0.73 Score=37.76 Aligned_cols=45 Identities=13% Similarity=0.125 Sum_probs=36.0
Q ss_pred CcccccCCccccc--cccCHHHHHHHHhhcCCccceEEecCCccceeEee
Q 040010 2 PKVDFYGFDLNFS--EHVSKEACMKLCLDDFRCSGFSYRLTGERVCFTKS 49 (464)
Q Consensus 2 ~~~~~~~~~~~~~--~~~~~~~C~~~Cl~~c~C~a~~~~~~~~~~c~~~~ 49 (464)
.+++|.|+|..-. +..+..+|.+.|..+=.|..|+|.. ..|+.+.
T Consensus 85 ~~vdy~G~d~~~~~~s~~~a~~CQ~~C~~~~~C~~fTf~~---~tC~lk~ 131 (138)
T 2yil_A 85 ACWMDGNNPLAVWDYSGQPPALCWAACMGTPGCDLYTFQG---MTCKLYS 131 (138)
T ss_dssp SEETTCCCCSEEEECTTCCTHHHHHHHHTSTTCCEEECGG---GEEEEEC
T ss_pred cCCCccCccccccccccCCHHHHHHHhCCCCCCcEEEEeC---CeeEEEC
Confidence 4789999997442 3357999999999999999999972 6788654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.95 E-value=2 Score=38.08 Aligned_cols=115 Identities=11% Similarity=0.078 Sum_probs=75.1
Q ss_pred cccceeccceeeeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCceEecCCCCCCEEE
Q 040010 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLA-YLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 221 ~h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~dlk~~NIll 299 (464)
.||++ -...-.+++...+.|+--+++.=...+ ..++...+++++..|+.... +++. -+|--+.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence 57776 233335566777777765443222222 35788999999999888776 5554 5888999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSN 369 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~ 369 (464)
|.++.+++.-.|+-. -++|.- .++.-=.-.+=+++..++.++..|+
T Consensus 118 ~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999998776532 233321 1222224466777777887766554
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.63 E-value=0.96 Score=28.41 Aligned_cols=24 Identities=21% Similarity=0.382 Sum_probs=10.1
Q ss_pred hhHHHHHHHHHHHHHHHHHHhhhc
Q 040010 116 WFALAIGAIEVLFIVSGWWLLFRR 139 (464)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~rr 139 (464)
+.+++.|.+++++++..+|+++||
T Consensus 16 ~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 16 IGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EeehhHHHHHHHHHHHHheeEeee
Confidence 334444444433234444444444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=81.17 E-value=0.19 Score=50.91 Aligned_cols=31 Identities=13% Similarity=-0.018 Sum_probs=25.4
Q ss_pred chhHHHHHHHHHhhhccccceeccceeeeeC
Q 040010 205 QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG 235 (464)
Q Consensus 205 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 235 (464)
.+.++|..|++.+++++|+|+|+++|||...
T Consensus 321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 321 QGSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred ccHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 3467899999999999999999999999764
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.67 E-value=2.1 Score=28.61 Aligned_cols=26 Identities=19% Similarity=0.392 Sum_probs=10.6
Q ss_pred hHHHHHHHHHHHHHHHHH--HhhhcCCC
Q 040010 117 FALAIGAIEVLFIVSGWW--LLFRRQGI 142 (464)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~--~~~rr~~~ 142 (464)
++++.|.+++.+++++.| -+++|++.
T Consensus 17 ~svl~GLllL~li~~~LwK~GFFkR~~~ 44 (54)
T 2knc_A 17 VGVLGGLLLLTILVLAMWKVGFFKRNRP 44 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHcCcccCCCC
Confidence 333344444444444444 23444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 464 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-64
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+ +G G G VYKG + AV + + Q + F EV + K H+N++ G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+ T +V ++ E SL HL + +A TA+G+ YLH + +IH
Sbjct: 72 YSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA---SNLPIT 346
D+K NI L + KI DFGLA + R S S QF ++ G+ +MAPE P +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
+ DV+++G+V+ E++ G + ++ I V L + +++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP----YSNINNRDQ----IIFMVGRGYLSPDLSKVRSNCP 239
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+K R+ C+ + R++RP ++ ++
Sbjct: 240 KAMK------------RLMAECLKKKRDERPLFPQILASI 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-59
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
F +E+G G G V+ G ++ VA+K + + EE F E + K+ H LV+++G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLG-WKERFKVALGTAKGLAYLHHECLEWVIHC 290
C E LV+E++E+ L +L + L + + L +G+AYL C VIH
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
D+ N L+ K++DFG+ + + + + + +PE S +SK D
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 351 VFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410
V+S+GV++ E+ ++ +S EV E I G + +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNS------------EVVEDISTGFRLYKPRLASTHVY 232
Query: 411 GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+I C E RP +++ L
Sbjct: 233 ------------QIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 6e-59
Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 25/304 (8%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+E +GKG G V++G E VAVK + AE+ + H N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 232 CTEG----MHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW- 286
+ LV +Y E+ SL +L + + K+AL TA GLA+LH E +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 287 ----VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF--SRIRGTKGYMAPEWA 340
+ H D+K +NIL+ IAD GLA +++ + GTK YMAPE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 341 S------NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394
+ + D+++ G+V E+ + + + ED + +L V+E
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG-IHEDYQLPYYDLVPSDPSVEEMR- 242
Query: 395 CGEEARIEEIVDPRLKGHFNKNQAA-TLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453
+ E+ + P + + +A + +I C + R T + +TL +
Sbjct: 243 ---KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
Query: 454 EVPV 457
+ +
Sbjct: 300 GIKM 303
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-59
Identities = 57/277 (20%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
F +ELG G G V G + VA+K + + E+ F E + + H LV+++G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 232 CTEGMHRLLVYEYVENQSLDKHL-FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
CT+ ++ EY+ N L +L + ++ ++ + + YL + +H
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHR 124
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVD 350
D+ N L++ + K++DFGL++ + + + PE +SK D
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 351 VFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLK 410
++++GV++ E+ ++ +S E E I G + ++
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNS------------ETAEHIAQGLRLYRPHLASEKVY 231
Query: 411 GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447
I SC E ++RPT ++ +L
Sbjct: 232 ------------TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-58
Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
E LG G G V+ G VAVK L + F AE + + ++ H LVR++
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLHHECLEWVIH 289
T+ ++ EY+EN SL L + + L + +A A+G+A++ IH
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D++ NIL+ KIADFGLA+L + + + + + APE + T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 350 DVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409
DV+S+G+++ E++ R+ + + EV + + G + L
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNP------------EVIQNLERGYRMVRPDNCPEEL 239
Query: 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
++ C E RPT D + L
Sbjct: 240 Y------------QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 1e-57
Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 48/308 (15%)
Query: 160 FSYAELKKATNSFKEE-----------LGKGGSGAVYKGVLT----DERAVAVKRL--GD 202
F++ + +A F +E +G G G V G L E VA+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 203 LHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLG 261
+ F +E S +G+ H N++ + G T+ +++ E++EN SLD L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 262 WKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321
+ + G A G+ YL +H D+ NIL++S K++DFGL++ + ++
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 322 SSQFSR---IRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQ 378
++ + + APE TS DV+SYG+V+ E++ W + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---- 239
Query: 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT 438
++V I L ++ + C +DRN RP
Sbjct: 240 --------QDVINAIEQDYRLPPPMDCPSALH------------QLMLDCWQKDRNHRPK 279
Query: 439 MDSVVQTL 446
+V TL
Sbjct: 280 FGQIVNTL 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-57
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 31/277 (11%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+ +LG+G G V+ G VA+K L E F E + K+ H LV+++
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+E +V EY+ SL L +L + +A A G+AY+ +H
Sbjct: 81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 136
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKV 349
D++ NIL+ K+ADFGLA+L + + + + + APE A T K
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 350 DVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRL 409
DV+S+G+++ E+ ++G+ REV +++ G L
Sbjct: 196 DVWSFGILLTELT------------TKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 410 KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ C ++ +RPT + + L
Sbjct: 244 H------------DLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-56
Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 29/303 (9%)
Query: 165 LKKATNSFK--EELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGK 219
++ + F+ ELG G G V+K +A K + E+ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 220 IYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
+V +G + E+++ SLD+ L + + + KV++ KGL YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
+ ++H DVKP NIL++S E K+ DFG++ S + GT+ YM+PE
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPER 174
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIR---------LSNWVVEDSEGQEAELTGFIREVK 390
+ + D++S G+ ++EM G L EG AE R
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 391 EKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGIS---------CVDEDRNKRPTMDS 441
+ + L + L S C+ ++ +R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 442 VVQ 444
++
Sbjct: 295 LMV 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-54
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 37/278 (13%)
Query: 172 FKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
+ +GKG G V G + VAVK + + F AE S + ++ H NLV++ G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNK-VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 232 CTEGMHRL-LVYEYVENQSLDKHLFSSN--FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
E L +V EY+ SL +L S LG K +L + + YL +
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 125
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
H D+ N+L+ + K++DFGL K + SS + + APE ++K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 349 VDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408
DV+S+G+++ E+ R+ + +++V ++ G + + P
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEKGYKMDAPDGCPPA 228
Query: 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + +C D RP+ + + L
Sbjct: 229 VY------------EVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-54
Identities = 69/279 (24%), Positives = 106/279 (37%), Gaps = 35/279 (12%)
Query: 175 ELGKGGSGAVYKGVL---TDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
ELG G G+V +GV + VA+K L G E E + ++ + +VR+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G C + +LV E L K L + ++ + G+ YL + +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 131
Query: 289 HCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
H D+ N+LL + KI+DFGL+K L S + S + + APE + +S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
+ DV+SYGV + E L S GQ+ EV I G+ P
Sbjct: 192 RSDVWSYGVTMWEAL------------SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
L + C RP +V Q +
Sbjct: 240 ELY------------ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-53
Identities = 68/279 (24%), Positives = 109/279 (39%), Gaps = 35/279 (12%)
Query: 175 ELGKGGSGAVYKGVLTDE---RAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRM 228
ELG G G V KG + + VAVK L + + AE + + ++ + +VRM
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G C +LV E E L+K+L + + K ++ + G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 289 HCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
H D+ N+LL ++ KI+DFGL+K L + + + + APE + +S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
K DV+S+GV++ E S GQ+ EV + GE
Sbjct: 190 KSDVWSFGVLMWEAF------------SYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + C D RP +V L
Sbjct: 238 EMY------------DLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 4e-53
Identities = 64/320 (20%), Positives = 109/320 (34%), Gaps = 61/320 (19%)
Query: 161 SYAELKKATNSFK--EELGKGGSGAVYKGVLT------DERAVAVKRL--GDLHQGEEVF 210
L+ N+ + ++G+G G V++ VAVK L + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 211 WAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF----------- 259
E + + + + N+V++ G C G L++EY+ L++ L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 260 -------------LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPK 306
L E+ +A A G+AYL +H D+ N L+ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 307 IADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIR 366
IADFGL++ +M PE T++ DV++YGVV+ E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 367 LSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI 426
+ + EV + G E L +
Sbjct: 241 QPYYGMAH------------EEVIYYVRDGNILACPENCPLELY------------NLMR 276
Query: 427 SCVDEDRNKRPTMDSVVQTL 446
C + RP+ S+ + L
Sbjct: 277 LCWSKLPADRPSFCSIHRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-53
Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 170 NSFKEE--LGKGGSGAVYKGVLTD-----ERAVAVKRL--GDLHQGEEVFWAEVSTIGKI 220
+ + +G G G VYKG+L E VA+K L G + F E +G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 221 YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYL 279
H N++R+ G ++ +++ EY+EN +LDK L + + + G A G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPE 338
+ +H D+ NIL++S K++DFGL++ L + S + + APE
Sbjct: 127 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 339 WASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398
S TS DV+S+G+V+ E++ W + + E
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------------- 221
Query: 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
+ + ++ + + + ++++ + C ++R +RP +V L
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 8e-53
Identities = 63/298 (21%), Positives = 122/298 (40%), Gaps = 31/298 (10%)
Query: 164 ELKKATNSFKEELGKGGSGAVYKGVLTD-ERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH 222
E+++ + K +LG G G VY+GV VAVK L + E F E + + +I H
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 72
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLH 280
NLV++ G CT ++ E++ +L +L N + +A + + YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 281 HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA 340
+ IH D+ N L+ K+ADFGL++L G + + + + APE
Sbjct: 133 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 188
Query: 341 SNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400
+ + K DV+++GV++ E+ ++ S+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------------------ 224
Query: 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQ 458
+ E+++ + + ++ + +C + + RP+ + Q ES + +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-52
Identities = 75/310 (24%), Positives = 116/310 (37%), Gaps = 53/310 (17%)
Query: 171 SFKEELGKGGSGAVYKGVLT------DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIY- 221
SF + LG G G V + VAVK L E +E+ + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN------------------FLGWK 263
HMN+V + G CT G L++ EY L L L +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 264 ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
+ + AKG+A+L + IH D+ NILL KI DFGLA+ + SN
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELT 383
R +MAPE N T + DV+SYG+ + E+ +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---------- 252
Query: 384 GFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443
+++ +++ + ++ A ++ I +C D D KRPT +V
Sbjct: 253 -------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 444 QTLLGCEAES 453
Q + +ES
Sbjct: 300 QLIEKQISES 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-52
Identities = 64/285 (22%), Positives = 108/285 (37%), Gaps = 37/285 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNL 225
F E +G+G G VY G L D + AVK L + EV F E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 226 VRMWGFCTEG-MHRLLVYEYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHEC 283
+ + G C L+V Y+++ L + ++ K+ L AKG+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKL--SQRGSNSSQFSRIRGTKGYMAPEWAS 341
+ +H D+ N +LD +F K+ADFGLA+ + + + + +MA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401
T+K DV+S+GV++ E++ G ++ +L G
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTR------------GAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
E L + + C RP+ +V +
Sbjct: 256 PEYCPDPLY------------EVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 38/282 (13%)
Query: 172 FKEELGKGGSGAVYKGVLTDE-RAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVR 227
F E+G+G VYKG+ T+ VA L D + F E + + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 228 MWGFC----TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
+ +LV E + + +L +L + K KGL +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 284 LEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASN 342
+IH D+K +NI + KI D GLA L + +S + GT +MAPE
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE 187
Query: 343 LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402
VDV+++G+ +LEM + +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYP-----------------YSECQNAAQI------YR 223
Query: 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ F+K + I C+ +++++R ++ ++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-51
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 38/278 (13%)
Query: 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLV 226
LGKG G VY + +A+K L E EV + H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
R++G+ + L+ EY ++ + L + + A L+Y H +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KR 126
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
VIH D+KPEN+LL S E KIADFG + + SS+ + + GT Y+ PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
KVD++S GV+ E L G +E ++I E + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRISRV-EFTFPDFVT 228
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ ++ + + ++RP + V++
Sbjct: 229 EGARDLISR------------LLKHNPSQRPMLREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 9e-51
Identities = 70/311 (22%), Positives = 110/311 (35%), Gaps = 59/311 (18%)
Query: 172 FKEELGKGGSGAVYKGVLTDER------AVAVKRLGDLHQGEEV--FWAEVSTIGKIY-H 222
F + LG G G V VAVK L + E +E+ + ++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-----------------------NF 259
N+V + G CT L++EY L +L S N
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 260 LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319
L +++ A AKG+ +L + +H D+ N+L+ KI DFGLA+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE 379
SN R +MAPE T K DV+SYG+++ E+ +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP------ 271
Query: 380 AELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTM 439
+A +++ K ++ I SC D KRP+
Sbjct: 272 -----------------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 440 DSVVQTLLGCE 450
++ LGC+
Sbjct: 315 PNLTS-FLGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 30/277 (10%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
+ LG+G G V V E AVAVK + E E+ + H N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+G EG + L EY L + + + + G+ YLH +
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GIT 125
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI-TS 347
H D+KPEN+LLD KI+DFGLA + + + +++ GT Y+APE
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
VDV+S G+V+ ML G + + + E + + +D
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----------EYSDWKEKKTYLNPWKKIDS 234
Query: 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+K + E+ + R T+ + +
Sbjct: 235 APLALLHK------------ILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-50
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 39/285 (13%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGE-EVFWAEVSTIGKIYHMNLVR 227
+G G G K +D + + K L G + + E ++ +EV+ + ++ H N+VR
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 228 MWGFCTEGMHRLL--VYEYVENQSLDKHLFSSN----FLGWKERFKVALGTAKGLAYLH- 280
+ + + L V EY E L + +L + +V L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 281 -HECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
+ V+H D+KP N+ LD + K+ DFGLA++ ++S GT YM+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQ 185
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399
+ + K D++S G ++ E+ + + +E+ KI G+
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------KELAGKIREGKFR 232
Query: 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
RI L I ++ RP+++ +++
Sbjct: 233 RIPYRYSDELN------------EIITRMLNLKDYHRPSVEEILE 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-49
Identities = 61/299 (20%), Positives = 105/299 (35%), Gaps = 34/299 (11%)
Query: 171 SFKEELGKGGSGAVYKGVLTDE-----RAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHM 223
+ LG G G VYKG+ E VA+K L + + E + + +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
++ R+ G C +L+ LD + +G + + AKG+ YL
Sbjct: 72 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
++H D+ N+L+ + KI DFGLAKL + +MA E +
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 344 PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403
T + DV+SYGV + E++ + G + E+ + GE
Sbjct: 189 IYTHQSDVWSYGVTVWELM------------TFGSKPYDGIPASEISSILEKGERLPQPP 236
Query: 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEVPVQTIPD 462
I + I + C D + RP ++ + + + D
Sbjct: 237 ICTIDVY------------MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-49
Identities = 67/327 (20%), Positives = 121/327 (37%), Gaps = 57/327 (17%)
Query: 155 SQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTD---ERAVAVKRLGDL--HQGEEV 209
+ + + ++K F++ +G+G G V K + A+KR+ +
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 210 FWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF--------- 259
F E+ + K+ H N++ + G C + L EY + +L L S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 260 -------LGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGL 312
L ++ A A+G+ YL + IH D+ NIL+ + KIADFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 173
Query: 313 AKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVV 372
++ + + R +MA E + T+ DV+SYGV++ E++ +
Sbjct: 174 SRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230
Query: 373 EDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDED 432
+ E+ EK+ G D + + C E
Sbjct: 231 TCA------------ELYEKLPQGYRLEKPLNCDDEVY------------DLMRQCWREK 266
Query: 433 RNKRPTMDSVVQTLLGCEAESEVPVQT 459
+RP+ ++ +L E + V T
Sbjct: 267 PYERPSFAQILVSLNRMLEERKTYVNT 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 2e-49
Identities = 67/279 (24%), Positives = 101/279 (36%), Gaps = 41/279 (14%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
E+G G GAVY + + VA+K++ ++ + EV + K+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G LV EY + D L E V G +GLAYLH +I
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 137
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL---PI 345
H DVK NILL K+ DFG A + + GT +MAPE +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQY 191
Query: 346 TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405
KVDV+S G+ +E+ + L I +
Sbjct: 192 DGKVDVWSLGITCIELAERKPP-----------------LFNMNAMSAL----YHIAQNE 230
Query: 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
P L+ SC+ + RPT + +++
Sbjct: 231 SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-47
Identities = 68/292 (23%), Positives = 107/292 (36%), Gaps = 41/292 (14%)
Query: 172 FKEELGKGGSGAVYKGVLT----DERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHM 223
E+LG G G V +G +VAVK L + + F EV+ + + H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHE 282
NL+R++G + +V E SL L + A+ A+G+ YL +
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWAS 341
IH D+ N+LL + KI DFGL + L Q + + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL-CGEEAR 400
+ D + +GV + EM + GQE + ++ KI GE
Sbjct: 188 TRTFSHASDTWMFGVTLWEMF------------TYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452
E + + + C RPT ++ LL EA+
Sbjct: 236 RPEDCPQDIY------------NVMVQCWAHKPEDRPTFVALRDFLL--EAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 36/282 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTDE----RAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNL 225
+G+G G V++G+ AVA+K E F E T+ + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECL 284
V++ G TE ++ E L L + L A + LAYL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
+H D+ N+L+ S K+ DFGL++ + S + S+ + +MAPE +
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRR 185
Query: 345 ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404
TS DV+ +GV + E+L G + +V +I GE +
Sbjct: 186 FTSASDVWMFGVCMWEIL------------MHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
P L + C D ++RP + L
Sbjct: 234 CPPTLY------------SLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-46
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 172 FKEELGKGGSGAVYKGVLTD-ERAVAVKRL-GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
ELG G G VYK + A K + + E + E+ + H N+V++
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ ++ E+ ++D + L + V T L YLH +I
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWA-----SNL 343
H D+K NIL + + K+ADFG++ + R + GT +MAPE +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 344 PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403
P K DV+S G+ ++EM + + E + V KI E +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH---ELNP----------MRVLLKIAKSEPPTLA- 236
Query: 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
++ C++++ + R T ++Q
Sbjct: 237 ---------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-45
Identities = 56/297 (18%), Positives = 108/297 (36%), Gaps = 45/297 (15%)
Query: 171 SFKEELGKGGSGAVYKGVLT------DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYH 222
+ ELG+G G VY+GV E VA+K + + F E S + +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----------SSNFLGWKERFKVALGT 272
++VR+ G ++G L++ E + L +L + ++A
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 273 AKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTK 332
A G+AYL+ +H D+ N ++ +F KI DFG+ + + +
Sbjct: 143 ADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 333 GYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEK 392
+M+PE + T+ DV+S+GVV+ E+ + + +V
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------------QVLRF 247
Query: 393 ILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449
++ G + L + C + RP+ ++ ++
Sbjct: 248 VMEGGLLDKPDNCPDMLF------------ELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-44
Identities = 70/301 (23%), Positives = 119/301 (39%), Gaps = 52/301 (17%)
Query: 172 FKEELGKGGSGAVYKGV------LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKI-YH 222
+ LG+G G V + R VAVK L G H +E+ + I +H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 223 MNLVRMWGFCTE-GMHRLLVYEYVENQSLDKHLFS----------------SNFLGWKER 265
+N+V + G CT+ G +++ E+ + +L +L S +FL +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 266 FKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325
+ AKG+ +L IH D+ NILL + KI DFGLA+ + + +
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385
R +MAPE + T + DV+S+GV++ E+ V+ E
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------- 244
Query: 386 IREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445
E ++ G R + P + + + C + ++RPT +V+
Sbjct: 245 --EFCRRLKEGTRMRAPDYTTPEMY------------QTMLDCWHGEPSQRPTFSELVEH 290
Query: 446 L 446
L
Sbjct: 291 L 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-44
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 8/198 (4%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHMNLV 226
F + LG+G V L R A+K L E + ++ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+++ + Y +N L K++ TA+ ++ L + +
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSALEYLHGKG 128
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
+IH D+KPENILL+ + +I DFG AK+ S ++ + GT Y++PE +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 347 SKVDVFSYGVVILEMLKG 364
D+++ G +I +++ G
Sbjct: 189 KSSDLWALGCIIYQLVAG 206
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-44
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 31/273 (11%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLG-DLHQGEEVFWAEVSTIGKIYHMNLVRMWGF 231
E++G+G SG VY + + + VA++++ +E+ E+ + + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCD 291
G +V EY+ SL + + + V + L +LH VIH D
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 292 VKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDV 351
+K +NILL + K+ DFG S+ S + GT +MAPE + KVD+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 352 FSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKG 411
+S G++ +EM++G ++ E + L I P L+
Sbjct: 200 WSLGIMAIEMIEGEPP-----------------YLNENPLRAL----YLIATNGTPELQ- 237
Query: 412 HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ +A C+D D KR + ++Q
Sbjct: 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 7e-43
Identities = 63/302 (20%), Positives = 106/302 (35%), Gaps = 54/302 (17%)
Query: 172 FKEELGKGGSGAVYKGVLT--------DERAVAVKRL--GDLHQGEEVFWAEVSTIGKIY 221
+ LG+G G V VAVK L + +E+ + I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 222 -HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLF----------------SSNFLGWKE 264
H N++ + G CT+ ++ EY +L ++L L K+
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
A A+G+ YL + IH D+ N+L+ + KIADFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG 384
+ R +MAPE + T + DV+S+GV++ E+ V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----------- 242
Query: 385 FIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ E+ + + G L + C ++RPT +V+
Sbjct: 243 -VEELFKLLKEGHRMDKPSNCTNELY------------MMMRDCWHAVPSQRPTFKQLVE 289
Query: 445 TL 446
L
Sbjct: 290 DL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (381), Expect = 3e-42
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 33/278 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL-GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
EELG G G V++ A K + +E E+ T+ + H LV +
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ +++YE++ L + + + + E + KGL ++H +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 289 HCDVKPENILLDSEF--EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
H D+KPENI+ ++ E K+ DFGL + GT + APE A P+
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVG 203
Query: 347 SKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
D++S GV+ +L G+ + E+ + E + + +++
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP--FGGENDD-----------ETLRNVKSC-DWNMDDSAF 249
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ R + D N R T+ ++
Sbjct: 250 SGI-----SEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 9e-41
Identities = 60/276 (21%), Positives = 106/276 (38%), Gaps = 28/276 (10%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEVFWAEVSTIGKIYHMNLVRM 228
F++ LG G V ++ VA+K + L E E++ + KI H N+V +
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
G H L+ + V L + F ++ ++ + YLH +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
LD + + I+DFGL+K+ GS S GT GY+APE + P +
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYVAPEVLAQKPYSKA 189
Query: 349 VDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408
VD +S GV+ +L G + E+ ++ E+IL +
Sbjct: 190 VDCWSIGVIAYILLCGYPP--FYDENDA-----------KLFEQILKA---------EYE 227
Query: 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ + + + +++D KR T + +Q
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 3e-40
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL----------GDLHQGEEVFWAEVSTIGKI 220
KE LG+G S V + + + AVK + ++ + E EV + K+
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 221 -YHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYL 279
H N++++ LV++ ++ L +L L KE K+ + + L
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 126
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
H ++H D+KPENILLD + K+ DFG + G + + GT Y+APE
Sbjct: 127 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEI 180
Query: 340 AS------NLPITSKVDVFSYGVVILEMLKG 364
+ +VD++S GV++ +L G
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 53/277 (19%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
E+LG+G G V++ V + ++ K + + + E+S + H N++ +
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWVIH 289
++++E++ + + + +S F L +E + L +LH + H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 290 CDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITS 347
D++PENI+ + KI +FG A+ + G N F + Y APE + +++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVST 182
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
D++S G ++ +L GI ++ E ++ ++ E I+ E
Sbjct: 183 ATDMWSLGTLVYVLLSGINP--FLAETNQ-----------QIIENIMNAE---------Y 220
Query: 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
K + + ++R R T +Q
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (358), Expect = 9e-39
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 16/203 (7%)
Query: 171 SFKEELGKGGSGAVYKGVLTD-ERAVAVKRL----GDLHQGEEVFWAEV---STIGKIYH 222
S +G+GG G VY D + A+K L + QGE + E S +
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 223 MNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHE 282
+V M + + + L HL + A GL ++H+
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN- 125
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WAS 341
+V++ D+KP NILLD +I+D GLA + + GT GYMAPE
Sbjct: 126 --RFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGYMAPEVLQK 179
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
+ S D FS G ++ ++L+G
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (355), Expect = 2e-38
Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 11/198 (5%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL-GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
EELG G G V++ V R K + + E+S + +++H L+ +
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNF-LGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ +L+ E++ L + + ++ + E +GL ++H ++
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 289 HCDVKPENILLDSEFEP--KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
H D+KPENI+ +++ KI DFGLA T + APE P+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREPVG 206
Query: 347 SKVDVFSYGVVILEMLKG 364
D+++ GV+ +L G
Sbjct: 207 FYTDMWAIGVLGYVLLSG 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 11/199 (5%)
Query: 172 FKEELGKGGSGAVYKGVLT-DERAVAVKRL----GDLHQGEEVFWAEVSTIGKIY-HMNL 225
+ LGKG G V+ + A+K L + E E + + H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLE 285
M+ + V EY+ L H+ S + A GL +LH +
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 123
Query: 286 WVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI 345
+++ D+K +NILLD + KIADFG+ K + ++ + GT Y+APE
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 346 TSKVDVFSYGVVILEMLKG 364
VD +S+GV++ EML G
Sbjct: 181 NHSVDWWSFGVLLYEMLIG 199
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 3e-38
Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 12/278 (4%)
Query: 174 EELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMWG 230
E++G+G G VYK A+K++ + E + E+S + ++ H N+V+++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHC 290
+LV+E+++ L L G+AY H V+H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 291 DVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITSKV 349
D+KP+N+L++ E E KIADFGLA+ G +++ T Y AP+ + ++ +
Sbjct: 125 DLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 350 DVFSYGVVILEMLKGIRL---SNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406
D++S G + EM+ G L + + T + + + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
P F K + + + D N+R T ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-38
Identities = 65/281 (23%), Positives = 112/281 (39%), Gaps = 15/281 (5%)
Query: 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGE------EVFWAEVSTIGKIYHMNLV 226
+ LG+G VYK + VA+K++ H+ E E+ + ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ + LV++++E +S L L T +GL YLH W
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HW 120
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL-PI 345
++H D+KP N+LLD K+ADFGLAK GS + ++ T+ Y APE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 346 TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE-AELTGFIREVKEKILCGEEARIEEI 404
VD+++ G ++ E+L + + + E G E + +C +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 405 VDPRLKGHFNKNQAATLFRIGIS-CVDEDRNKRPTMDSVVQ 444
P + H + A I + R T ++
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 5e-38
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL-GDLHQGEEV---FWAEVSTIGKIYHMNLV 226
E LG GG V+ L R VAVK L DL + F E + H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 227 RMWGFCTE----GMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHE 282
++ G +V EYV+ +L + + + K +V + L + H
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130
Query: 283 CLEWVIHCDVKPENILLDSEFEPKIADFGLAK-LSQRGSNSSQFSRIRGTKGYMAPEWAS 341
+IH DVKP NI++ + K+ DFG+A+ ++ G++ +Q + + GT Y++PE A
Sbjct: 131 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 342 NLPITSKVDVFSYGVVILEMLKG 364
+ ++ DV+S G V+ E+L G
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTG 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (346), Expect = 1e-37
Identities = 59/198 (29%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHMNLV 226
LG G G V+ + R A+K L + E E + + H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
RMWG + ++ +Y+E L L S A L YLH +
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 124
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
+I+ D+KPENILLD KI DFG AK + GT Y+APE S P
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 347 SKVDVFSYGVVILEMLKG 364
+D +S+G++I EML G
Sbjct: 180 KSIDWWSFGILIYEMLAG 197
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-37
Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 37/294 (12%)
Query: 174 EELGKGGSGAVYKG--VLTDERAVAVKRL------GDLHQGEEVFWAEVSTIGKIYHMNL 225
E+G+G G V+K + R VA+KR+ + A + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 226 VRMWGFCTEGMHRLLVYEYVENQSLDKHLFS------SNFLGWKERFKVALGTAKGLAYL 279
VR++ CT + + +D+ L + + + + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 280 HHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
H V+H D+KP+NIL+ S + K+ADFGLA++ S + + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399
+ VD++S G + EM + L + + G I +V L GEE
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFR------GSSDVDQLGKILDV--IGLPGEED 238
Query: 400 RIEEIVDPRLKGHFNKNQAATLFRIGIS---------CVDEDRNKRPTMDSVVQ 444
++ PR H Q F I C+ + KR + S +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 3e-36
Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 34/287 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMN-LVRMW 229
+G+G G +++G L + + VA+K E T + + ++
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
F EG+H +LV + + D K A + +H + +++
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVY 124
Query: 290 CDVKPENILLDSEFEP-----KIADFGLAKLSQRGSNSS-----QFSRIRGTKGYMAPEW 339
D+KP+N L+ + DFG+ K + + + GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399
+ + D+ + G V + L+G + + Q+ E
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------------------ 226
Query: 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
RI E ++ + + P D +
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 68/306 (22%), Positives = 108/306 (35%), Gaps = 34/306 (11%)
Query: 155 SQFKRFSYAELKKATNSFKEELGKGGSGAVYKGVLTDE-RAVAVKRLGDLHQGEEVFWAE 213
+ + SY + K +G G G VY+ L D VA+K++ Q + E
Sbjct: 15 DRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRE 63
Query: 214 VSTIGKIYHMNLVRMWGFCTEG------MHRLLVYEYVENQSLDKHLFSSNF---LGWKE 264
+ + K+ H N+VR+ F ++ LV +YV S L
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSS 323
+ LAY+H + H D+KP+N+LLD + K+ DFG AK RG
Sbjct: 124 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--P 178
Query: 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELT 383
S I TS +DV+S G V+ E+L G + + Q E+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEII 236
Query: 384 GFIREVKEKILCGEEARIEEIVDPRLKGH-----FNKNQAATLFRIGISCVDEDRNKRPT 438
+ + + E P++K H F + ++ R T
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 439 MDSVVQ 444
Sbjct: 297 PLEACA 302
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 5e-35
Identities = 50/285 (17%), Positives = 88/285 (30%), Gaps = 32/285 (11%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
++G G G +Y G + VA+K + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 231 FC-TEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
+C EG + ++V E + D F S K +A + Y+H + IH
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 126
Query: 290 CDVKPENIL---LDSEFEPKIADFGLAKLSQRGSNSSQF-----SRIRGTKGYMAPEWAS 341
DVKP+N L I DFGLAK + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 342 NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401
+ + + D+ S G V++ G + ++K E ++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-------------TKRQKYERISEKKM 233
Query: 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTL 446
++ K + C + +P + Q
Sbjct: 234 STPIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 8e-35
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL-------GDLHQGEEVFWAEVSTIGKI--Y 221
LG GG G+VY G+ ++D VA+K + EV + K+
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSN-FLGWKERFKVALGTAKGLAYLH 280
++R+ + +L+ E E + L + + + + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 281 HECLEWVIHCDVKPENILLD-SEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
+ V+H D+K ENIL+D + E K+ DFG L + ++ GT+ Y PEW
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 340 ASNLPITSK-VDVFSYGVVILEMLKG 364
+ V+S G+++ +M+ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 30/288 (10%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
E++G+G G VYK VA+K++ + E+S + ++ H N+V++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 230 GFCTEGMHRLLVYEYVENQSLDK-HLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
LV+E++ + + +GLA+ H V+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVL 124
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPITS 347
H D+KP+N+L+++E K+ADFGLA+ G ++ T Y APE ++
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 348 KVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407
VD++S G + EM+ L ++E+ R + E P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPG--------DSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 408 RLKGHFNKNQAATLFRIGI-----------SCVDEDRNKRPTMDSVVQ 444
K F K ++ + D NKR + + +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 69/285 (24%), Positives = 109/285 (38%), Gaps = 40/285 (14%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL-------GDLHQGEEVFWAEVSTIGKIYHM 223
EELG G V K + A K + E EVS + +I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 224 NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
N++ + +L+ E V L L L +E + G+ YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL- 132
Query: 284 LEWVIHCDVKPENILLDSEFEP----KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW 339
+ H D+KPENI+L P KI DFGLA + ++F I GT ++APE
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEI 187
Query: 340 ASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399
+ P+ + D++S GV+ +L G F+ + K++ L A
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP-----------------FLGDTKQETL----A 226
Query: 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ V+ + + N +A + +D KR T+ +Q
Sbjct: 227 NVSA-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 50/280 (17%), Positives = 97/280 (34%), Gaps = 33/280 (11%)
Query: 173 KEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWG 230
+ LG G +G V + + A+K L D + EV + ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIVRIVD 72
Query: 231 FC----TEGMHRLLVYEYVENQSLDKHLFSSNF--LGWKERFKVALGTAKGLAYLHHECL 284
L+V E ++ L + +E ++ + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 285 EWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLP 344
+ H DVKPEN+L S+ I ++ ++ + + T Y+APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 345 ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404
D++S GV++ +L G + + IR + + E + + E
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE- 246
Query: 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444
+ L R + + + +R T+ +
Sbjct: 247 ------------EVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-34
Identities = 51/284 (17%), Positives = 102/284 (35%), Gaps = 16/284 (5%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV--FWAEVSTIGKIYHMNLVRMWG 230
+G+G G V ++ VA+K++ E+ + + H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFS---SNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ Y+ + L+ + L +GL Y+H V
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 288 IHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-SQFSRIRGTKGYMAPEWASN-LPI 345
+H D+KP N+LL++ + KI DFGLA+++ + + T+ Y APE N
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 346 TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE-AELTGFIREVKEKILCGEEARIEEI 404
T +D++S G ++ EML + + + G + + +AR +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 405 VDPRLKGHFNKNQAATLFRIGI----SCVDEDRNKRPTMDSVVQ 444
P + + + +KR ++ +
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 52/285 (18%), Positives = 106/285 (37%), Gaps = 24/285 (8%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
E++G+G G V+K VA+KR+ D E+ + ++ H N+VR+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 230 GFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIH 289
LV+E+ + + L + KGL + H V+H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 290 CDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPI-TSK 348
D+KP+N+L++ E K+A+FGLA+ G +S T Y P+ + ++
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 349 VDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408
+D++S G + E+ R + I + + + ++ D +
Sbjct: 183 IDMWSAGCIFAELANAGRPL-----FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 409 LKGHFNKNQAATLFRIGIS---------CVDEDRNKRPTMDSVVQ 444
+ + ++ + + +R + + +Q
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 54/292 (18%), Positives = 103/292 (35%), Gaps = 24/292 (8%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL---GDLHQGEEVFWAEVSTIGKIYHMNLVRMW 229
++G+G G V+K + VA+K++ + E+ + + H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 230 GFCTEGMHR--------LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHH 281
C LV+++ E+ E +V GL Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS--SQFSRIRGTKGYMAPEW 339
++H D+K N+L+ + K+ADFGLA+ NS ++++ T Y PE
Sbjct: 136 N---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 340 -ASNLPITSKVDVFSYGVVILEMLKGIRL--SNWVVEDSEGQEAELTGFIREVKEKILCG 396
+D++ G ++ EM + N EV +
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGI----SCVDEDRNKRPTMDSVVQ 444
E E+V + + ++ +A + + D +R D +
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-32
Identities = 50/198 (25%), Positives = 73/198 (36%), Gaps = 10/198 (5%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRL----GDLHQGEEVFWAEVSTIGKIYHMNLV 226
+ + LGKG G V R A+K L E + H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 227 RMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW 286
+ V EY L HL + A+ ++ L +
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYLHSRD 125
Query: 287 VIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPIT 346
V++ D+K EN++LD + KI DFGL K S+ + GT Y+APE +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 347 SKVDVFSYGVVILEMLKG 364
VD + GVV+ EM+ G
Sbjct: 184 RAVDWWGLGVVMYEMMCG 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 70/307 (22%), Positives = 117/307 (38%), Gaps = 32/307 (10%)
Query: 160 FSYAELKKATNSFK------EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV--- 209
F E+ K + + +G G GAV V VA+K+L Q E
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEG------MHRLLVYEYVENQSLDKHLFSSNFLGWK 263
+ E+ + + H N++ + T LV ++ L LG
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGED 121
Query: 264 ERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323
+ KGL Y+H +IH D+KP N+ ++ + E KI DFGLA+ S
Sbjct: 122 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADS 173
Query: 324 QFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQE-AE 381
+ + T+ Y APE N + T VD++S G ++ EM+ G L + +E +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 382 LTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGI----SCVDEDRNKRP 437
+TG + L +EA+ P L+ + + + + D +R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 438 TMDSVVQ 444
T +
Sbjct: 294 TAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (297), Expect = 2e-30
Identities = 47/196 (23%), Positives = 77/196 (39%), Gaps = 13/196 (6%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRL--GDLHQGEEV--FWAEVSTIGKIYHMNLVRM 228
+ LG G G V A+K L + + +++ E + + LV++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 229 WGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVI 288
+ + +V EYV + HL A YLH +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 289 HCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSK 348
+ D+KPEN+L+D + ++ DFG AK + + GT +APE +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 349 VDVFSYGVVILEMLKG 364
VD ++ GV+I EM G
Sbjct: 219 VDWWALGVLIYEMAAG 234
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 9e-28
Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 19/201 (9%)
Query: 174 EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEV---FWAEVSTIGKIYHMNLVRMW 229
+ +G G G V +R VA+K+L Q + + E+ + + H N++ +
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 230 GFCT------EGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC 283
T E LV E ++ + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSA- 138
Query: 284 LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNL 343
+IH D+KP NI++ S+ KI DFGLA+ + S + T+ Y APE +
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM 193
Query: 344 PITSKVDVFSYGVVILEMLKG 364
VD++S G ++ EM++
Sbjct: 194 GYKENVDIWSVGCIMGEMVRH 214
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 50/205 (24%), Positives = 75/205 (36%), Gaps = 16/205 (7%)
Query: 172 FKEELGKGGSGAVYKGVLT----DERAVAVKRL-----GDLHQGEEVFWAEVSTIGKIYH 222
+ LG G G V+ + A+K L + E E + I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 223 M-NLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHH 281
LV + L+ +Y+ L HL E + + L H
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV---GEIVLALEH 144
Query: 282 ECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEW-- 339
+I+ D+K ENILLDS + DFGL+K + + GT YMAP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAPDIVR 203
Query: 340 ASNLPITSKVDVFSYGVVILEMLKG 364
+ VD +S GV++ E+L G
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 4e-26
Identities = 40/199 (20%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMW 229
+LG+G V++ + +T+ V VK L + ++ E+ + + N++ +
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLA 96
Query: 230 GFCTEGMHRL--LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWV 287
+ + R LV+E+V N + + L + K L Y H +
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 288 IHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPE-WASNLPI 345
+H DVKP N+++D E + ++ D+GLA+ +++ ++ + PE
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 346 TSKVDVFSYGVVILEMLKG 364
+D++S G ++ M+
Sbjct: 208 DYSLDMWSLGCMLASMIFR 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (260), Expect = 2e-25
Identities = 38/211 (18%), Positives = 76/211 (36%), Gaps = 20/211 (9%)
Query: 172 FKEELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWG 230
+LG G V+ + + VA+K + E E+ + ++ + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 231 FCTEGMHRLLVYEYVENQSLDKHLFSSNFLGW----------------KERFKVALGTAK 274
+ +LL + + + + LG +++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 275 GLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLSQRGSNSSQFSRIRGTKG 333
GL Y+H C +IH D+KPEN+L++ + +A L ++ T+
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 334 YMAPEWASNLPITSKVDVFSYGVVILEMLKG 364
Y +PE P D++S +I E++ G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 7e-23
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 160 FSYAELKKA----TNSFK--EELGKGGSGAVYKGV-LTDERAVAVKRLGDLHQGE---EV 209
F EL K ++ +G G G+V VAVK+L Q +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 210 FWAEVSTIGKIYHMNLVRMWGFCTEG-----MHRLLVYEYVENQSLDKHLFSSNFLGWKE 264
+ E+ + + H N++ + T + + + ++ L+ ++ L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDH 122
Query: 265 RFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324
+ +GL Y+H +IH D+KP N+ ++ + E KI DFGLA+ +
Sbjct: 123 VQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 325 FSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKG 364
+R Y APE N + VD++S G ++ E+L G
Sbjct: 180 ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 2e-18
Identities = 24/158 (15%), Positives = 50/158 (31%), Gaps = 22/158 (13%)
Query: 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRL-----------GDLHQGEEVFWAEVSTIG 218
++ + +G+G AV+ VK G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 219 KIYHMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERF--KVALGTAKGL 276
+ L ++ G + Y + N L + + + + +V + +
Sbjct: 62 RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 277 AYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314
A +H ++H D+ N+L+ E I DF +
Sbjct: 117 AKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 464 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.36 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 86.43 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=415.12 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+.+.+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|...+..++||||+++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 45678999999999999999888999999998777777889999999999999999999999999999999999999999
Q ss_pred hHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 250 LDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 250 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
|.+++... ..++|..++.|+.|||.||+|||+ .+|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~ 162 (263)
T d1sm2a_ 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGT 162 (263)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-eecce
Confidence 99998754 578999999999999999999999 89999999999999999999999999999876543322 23346
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCc
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPR 408 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 408 (464)
.||+.|+|||.+.+..++.++|||||||++|||+|+..|+..... ...... .+..+.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~----~i~~~~----------- 219 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVE----DISTGF----------- 219 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHH----HHHHTC-----------
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHH----HHHhcC-----------
Confidence 789999999999999999999999999999999997666542111 111111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 409 LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 409 l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....+....+++.+|+.+||+.||++||||++|++.|+++.
T Consensus 220 -~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 220 -RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11112233457889999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-55 Score=417.83 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=218.2
Q ss_pred HHHHHHHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 163 AELKKATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 163 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
.|+....+.+.++||+|+||+||+|++. +++.||||+++......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3455556777889999999999999985 478999999987766778899999999999999999999999999999999
Q ss_pred EEeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 242 YEYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
|||+++|+|.+++... ..+++..++.|+.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999754 579999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.|+..... ...
T Consensus 169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--------~~~--------------- 224 (287)
T d1opja_ 169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQ--------------- 224 (287)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHH---------------
T ss_pred Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--------HHH---------------
Confidence 22 223445689999999999999999999999999999999998887652211 001
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAES 453 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~ 453 (464)
+.+.+........+...++.+.+|+.+||+.||++||||.+|++.|+.+.+..
T Consensus 225 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 225 -VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred -HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11111112222233344567899999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=413.61 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=208.6
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
..+.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 4567788999999999999999988999999998777777889999999999999999999998865 457899999999
Q ss_pred CChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|.+++... ..++|..++.|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+....... ...
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-ccc
Confidence 9999988644 369999999999999999999999 8999999999999999999999999999997754322 223
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....||+.|+|||.+.+..++.++|||||||++|||+||..|+..... . ... ...+..+ .
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~---~~~----~~~i~~~--------~ 227 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----N---PEV----IQNLERG--------Y 227 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----H---HHH----HHHHHTT--------C
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----H---HHH----HHHHHhc--------C
Confidence 446789999999999988999999999999999999998777652211 0 111 1111111 1
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.+ ..+....+.+.+|+.+||+.||++||||++|+++|+.+
T Consensus 228 ~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 228 RM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11 12223345688999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-54 Score=414.94 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred ccCHHHHHHHHhhhc-----------cccCccCceEEEEEEECC-C---cEEEEEEcCCc--cchhHHHHHHHHHhhhcc
Q 040010 159 RFSYAELKKATNSFK-----------EELGKGGSGAVYKGVLTD-E---RAVAVKRLGDL--HQGEEVFWAEVSTIGKIY 221 (464)
Q Consensus 159 ~~~~~el~~~~~~~~-----------~~lG~G~~g~Vy~g~~~~-~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~ 221 (464)
.++|+++..++.+|. +.||+|+||+||+|.+.. + ..||||++... ....+.|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 466777777776663 579999999999999753 2 36899998753 334467999999999999
Q ss_pred ccceeccceeeeeCcEEeEEEEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc
Q 040010 222 HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD 300 (464)
Q Consensus 222 h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 300 (464)
|||||+++|+|.+++..++||||+++|+|.+++... ..++|.+++.|+.|||+||+|||+ ++|+||||||+||||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEEC
Confidence 999999999999999999999999999999988764 579999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCCcc---eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCcc
Q 040010 301 SEFEPKIADFGLAKLSQRGSNSSQ---FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSE 376 (464)
Q Consensus 301 ~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~ 376 (464)
.++.+||+|||+++.......... .....||+.|+|||.+.+..++.++|||||||+||||+| |+.||.....
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--- 239 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--- 239 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999987654433221 223457899999999999999999999999999999998 7888863210
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+.. ..+. .......+.+.+..+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 240 ------~~~~----~~i~------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 ------QDVI----NAIE------------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------HHHH----HHHH------------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------HHHH----HHHH------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0111 1111 111122333455678999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=410.78 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=200.6
Q ss_pred HhhhccccCccCceEEEEEEECCCcEEEEEEcCCc---cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDL---HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.+.+.+.||+|+||+||+|++++ .||||+++.. ....+.|.+|+++|++++|||||+++|++.+ ...++||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 45667899999999999998643 5999998743 3344679999999999999999999999865 4679999999
Q ss_pred cCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
++|+|.+++... ..+++..++.|+.|||+||+|||+ ++||||||||+||||+.++.+||+|||+|+..........
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999754 579999999999999999999999 8999999999999999999999999999987765444444
Q ss_pred eeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 325 FSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
.....||+.|||||.+.+ ..++.++|||||||+||||+||+.||..... .. .+.....
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~~----~~~~~~~---------- 223 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RD----QIIFMVG---------- 223 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HH----HHHHHHH----------
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----HH----HHHHHHh----------
Confidence 566789999999999864 3589999999999999999999999863211 00 1111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.....+.+. ..+.+.++.+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 224 ~~~~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 224 RGYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HTSCCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111122211 1222344578899999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=408.47 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=208.8
Q ss_pred HHhhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
..+.+.+.||+|+||.||+|++++++.||||+++......+.|.+|+.++++++|+|||+++|+|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 3567888999999999999999988899999998777777889999999999999999999999965 457899999999
Q ss_pred CChHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 248 QSLDKHLFS--SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 248 gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
|+|..++.. ...++|..++.++.||+.||+|||+ ++|+||||||+|||||.++++||+|||+++....... ...
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence 999998874 3579999999999999999999999 8999999999999999999999999999987654322 223
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....||+.|+|||++....++.++||||||+++|||+||..|+..... ..+.+.. +.
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--------~~~~~~~----i~----------- 228 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQ----VE----------- 228 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHH----HH-----------
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--------HHHHHHH----HH-----------
Confidence 446789999999999999999999999999999999998777653211 1111111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCCCCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAESEV 455 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~~~~ 455 (464)
.......+.+..+.+.+++.+||+.||++||||.+|+++|+.......|
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 229 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp -TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 1111223334456789999999999999999999999999987765444
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=398.01 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=211.2
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQS 249 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~gs 249 (464)
+.|.++||+|+||+||+|++++++.||||+++......++|.+|++++++++||||++++|+|.+.+..++||||+++|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 35778999999999999999988999999998777777889999999999999999999999999999999999999999
Q ss_pred hHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcceeee
Q 040010 250 LDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRI 328 (464)
Q Consensus 250 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 328 (464)
|.+++.. ...+++..+.+++.|+|+||+|||+ .+|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 9999764 4579999999999999999999999 89999999999999999999999999999866543222 23446
Q ss_pred ccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCC
Q 040010 329 RGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDP 407 (464)
Q Consensus 329 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 407 (464)
.||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+. ...+..+
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---------~~~----~~~i~~~----------- 217 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------SET----AEHIAQG----------- 217 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---------HHH----HHHHHTT-----------
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---------HHH----HHHHHhC-----------
Confidence 78999999999999999999999999999999998 7888763211 111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 408 RLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 408 ~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.+...+....+.+.+|+.+||+.||++|||+++|++.|..+
T Consensus 218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11122233446789999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=400.07 Aligned_cols=249 Identities=26% Similarity=0.314 Sum_probs=202.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.+.+.||+|+||+||+|+.. +|+.||||++.... ...+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 566789999999999999974 68999999986432 334568999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.++|.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+|+............
T Consensus 87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 99999999888899999999999999999999999 899999999999999999999999999999776544434455
Q ss_pred eeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...||+.|||||.+.+..+ +.++|||||||++|||++|+.||....... .... ...
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~-------------------~~~ 220 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYS-------------------DWK 220 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHH-------------------HHH
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHHH-------------------HHh
Confidence 6789999999999988776 578999999999999999999997432111 0000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...............+.+|+.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011000111123356778999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=406.56 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred hhhccccCccCceEEEEEEECCC-----cEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDE-----RAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~-----~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.+.+.||+|+||.||+|.+++. ..||||+++... ....+|.+|++++++++|||||+++|+|.+....++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 45667899999999999997542 479999987433 33457899999999999999999999999999999999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+.++++.+.+... ..++|..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999988654 579999999999999999999999 8999999999999999999999999999987654432
Q ss_pred C-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 S-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
. .......||+.|+|||.+.+..++.++|||||||++|||++|..|+...... .... ..
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--------~~~~----~~-------- 225 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVM----KA-------- 225 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH----HH--------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--------HHHH----HH--------
Confidence 2 2234456899999999999999999999999999999999987776532110 1111 11
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+....+...+.+.+..+.+|+.+||+.||++||||.+|+++|+.+..
T Consensus 226 ----i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 226 ----INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ----HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11122223344455679999999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=399.65 Aligned_cols=246 Identities=26% Similarity=0.345 Sum_probs=199.1
Q ss_pred cccCccCceEEEEEEECC---CcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 174 EELGKGGSGAVYKGVLTD---ERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
++||+|+||+||+|.+.+ ++.||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 369999999999998643 4689999997432 234679999999999999999999999965 457899999999
Q ss_pred CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc-cee
Q 040010 248 QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS-QFS 326 (464)
Q Consensus 248 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 326 (464)
|+|.+++.....++|..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999988899999999999999999999999 899999999999999999999999999998765443322 233
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... .. + +...+..+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~---~----~~~~i~~~--------- 226 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GS---E----VTAMLEKG--------- 226 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HH---H----HHHHHHTT---------
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HH---H----HHHHHHcC---------
Confidence 4678999999999999999999999999999999998 888886321 11 1 11111111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
.....+...+..+.+|+.+||+.||++||||++|+++|+.
T Consensus 227 ---~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 227 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1112233445678899999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=409.90 Aligned_cols=256 Identities=27% Similarity=0.359 Sum_probs=207.1
Q ss_pred HHHHHhhhccccCccCceEEEEEEECC------CcEEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLTD------ERAVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.+.||+|+||+||+|+... ...||||++... ......+.+|+.+|.++ +|||||+++|++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 444556788899999999999999643 236999998643 33446789999999998 899999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS-----------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDV 292 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl 292 (464)
+..++||||+++|+|.++|... ..++|..++.++.||+.||+|||+ ++|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence 9999999999999999999643 248999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 040010 293 KPENILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWV 371 (464)
Q Consensus 293 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~ 371 (464)
||+|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665544434455778999999999999999999999999999999998 88888632
Q ss_pred ccCccchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 040010 372 VEDSEGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLL 447 (464)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~ 447 (464)
... ..+ .+++........+....+.+.+|+.+||+.||++||||+||+++|.
T Consensus 271 ~~~-----~~~-------------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD-----ANF-------------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS-----HHH-------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH-----HHH-------------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 011 1111111112223344567899999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=396.80 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=202.0
Q ss_pred hcc-ccCccCceEEEEEEEC---CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 172 FKE-ELGKGGSGAVYKGVLT---DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 172 ~~~-~lG~G~~g~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
+.+ +||+|+||+||+|.+. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 5999999999999864 35589999997543 344679999999999999999999999865 4679999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC-c
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS-S 323 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 323 (464)
++|+|.+++.. +..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 99999999765 4579999999999999999999999 89999999999999999999999999999877654322 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... . +. ...+..+.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~---~~----~~~i~~~~----- 229 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------P---EV----MAFIEQGK----- 229 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------H---HH----HHHHHTTC-----
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------H---HH----HHHHHcCC-----
Confidence 2334568999999999999999999999999999999998 8999863211 0 11 11111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhC
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLG 448 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~ 448 (464)
....+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112233445678899999999999999999999998874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=390.29 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=204.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 667789999999999999985 5889999998632 23346788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...... .
T Consensus 88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~ 160 (263)
T d2j4za1 88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 160 (263)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----C
T ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC----c
Confidence 9999999999888899999999999999999999999 89999999999999999999999999999765432 2
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++|||||||+||||++|+.||..... .. ....+..+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~----~~~~i~~~-------- 219 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------QE----TYKRISRV-------- 219 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HH----HHHHHHTT--------
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---------HH----HHHHHHcC--------
Confidence 3456799999999999999999999999999999999999999863210 01 11111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. .++....+.+.+|+.+||+.||++|||+.|+++
T Consensus 220 -~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11 122223456888999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=394.89 Aligned_cols=245 Identities=22% Similarity=0.247 Sum_probs=201.6
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||+|... +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 677889999999999999974 6889999998643 22346689999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++...+.+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+..........
T Consensus 90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 9999999999888899999999999999999999999 9999999999999999999999999999998765544444
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .. ....++..+.
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~-------~~~~~i~~~~------- 226 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EY-------LIFQKIIKLE------- 226 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HH-------HHHHHHHTTC-------
T ss_pred cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HH-------HHHHHHHcCC-------
Confidence 556789999999999999999999999999999999999999996321 10 0111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVV 443 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~ 443 (464)
.. ++....+.+.+|+.+||+.||++|||+.|++
T Consensus 227 --~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 --YD----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11 1222345688999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=387.60 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=195.9
Q ss_pred hhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee----CcEEeEEE
Q 040010 171 SFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE----GMHRLLVY 242 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 242 (464)
.|.++||+|+||+||+|+.. +++.||+|++.... ...+.|.+|+++|++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999975 57899999986432 234568899999999999999999999864 45689999
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eEecCCCCCCEEEc-CCCCeEEeeecCccccCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEW--VIHCDVKPENILLD-SEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~ 319 (464)
||+++|+|.+++.+...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999999888899999999999999999999999 55 99999999999996 5789999999999864432
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
......||+.|+|||.+.+ .++.++|||||||++|||++|+.||..... . . .+...+..+.
T Consensus 169 ----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~---~----~~~~~i~~~~-- 229 (270)
T d1t4ha_ 169 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----A---A----QIYRRVTSGV-- 229 (270)
T ss_dssp ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----H---H----HHHHHHTTTC--
T ss_pred ----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----H---H----HHHHHHHcCC--
Confidence 2345789999999998865 699999999999999999999999863211 0 0 1111111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+.+... ..+.+.+|+.+||+.||++|||+.|+++
T Consensus 230 -----~~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 -----KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCcccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01111111 2345788999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-52 Score=400.10 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=206.1
Q ss_pred HhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCccc--hhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLHQ--GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.+.+.+.||+|+||+||+|+.. +++.||||+++.... ..++|.+|++++++++|+|+++++++|......++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4566789999999999999964 357899999975432 34679999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 241 VYEYVENQSLDKHLFSS------------------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
+|||+++|+|.+++... ..+++..++.|+.|++.||+|||+ .+||||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 99999999999998632 248999999999999999999999 899999999999
Q ss_pred EEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCC-CCccccCc
Q 040010 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRL-SNWVVEDS 375 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p-~~~~~~~~ 375 (464)
||+|.++.+||+|||+++...............||+.|+|||.+.+..+|.++|||||||++|||++|..| +....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--- 247 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC---
Confidence 99999999999999999876544433334556789999999999999999999999999999999999764 43211
Q ss_pred cchhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 376 EGQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. +. ...+..+. ....+...+.++.+|+.+||+.||++||||.||+++|+.+.
T Consensus 248 ---~~---e~----~~~v~~~~------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 ---HE---EV----IYYVRDGN------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---HH---HH----HHHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HH---HH----HHHHHcCC------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 11 11111111 11223334457899999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=388.56 Aligned_cols=247 Identities=25% Similarity=0.327 Sum_probs=203.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.|.+.++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 366778999999999999996 468999999987433 345678999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|+|.+++.+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cccc
Confidence 9999998754 579999999999999999999999 899999999999999999999999999998765432 2234
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhcC
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIVD 406 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 406 (464)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . ..+...... . .
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~----~~~~~~~~~----------~--~ 233 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----L----RALYLIATN----------G--T 233 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H----HHHHHHHHH----------C--S
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----H----HHHHHHHhC----------C--C
Confidence 56799999999999999999999999999999999999999863210 0 111111100 0 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 407 PRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 407 ~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+.+ ..+......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 112233456889999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=388.31 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=188.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeee--CcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTE--GMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~E 243 (464)
+.+.+.||+|+||+||+|+.. +|+.||||.+..... ..+.+.+|++++++++|||||++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 567789999999999999974 688999999875432 33568899999999999999999999864 456899999
Q ss_pred eccCCChHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 244 YVENQSLDKHLFS----SNFLGWKERFKVALGTAKGLAYLHHEC--LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 244 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999863 457999999999999999999999843 1359999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.... . .+ ...++..+.
T Consensus 166 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~------~---~~----~~~~i~~~~ 230 (269)
T d2java1 166 HDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------Q---KE----LAGKIREGK 230 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------H---HH----HHHHHHHTC
T ss_pred cCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC------H---HH----HHHHHHcCC
Confidence 4322 2345789999999999999999999999999999999999999986321 1 11 111111111
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.+ +....+.+.+|+.+||+.||++|||+.|+++
T Consensus 231 --------~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 --------FRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 2223456889999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=391.22 Aligned_cols=243 Identities=28% Similarity=0.297 Sum_probs=199.9
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+...++||+|+||+||+|+. .+++.||||++.... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 466678999999999999996 468899999986432 223568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|..++.....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 99999998888778899999999999999999999999 8999999999999999999999999999986543
Q ss_pred ceeeeccCCCccCcccccC---CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 324 QFSRIRGTKGYMAPEWASN---LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.....||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||..... ..... .+..+
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---------~~~~~----~i~~~---- 229 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALY----HIAQN---- 229 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHH----HHHHS----
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---------HHHHH----HHHhC----
Confidence 234579999999999864 4589999999999999999999999863210 01111 11101
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+.+. +....+.+.+|+.+||+.||.+|||+.|+++
T Consensus 230 ----~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ----ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 1123456889999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=395.71 Aligned_cols=197 Identities=25% Similarity=0.300 Sum_probs=175.2
Q ss_pred HHhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
..+.+.++||+|+||+||+|+.. +|+.||+|+++.. ......+.+|+.+|++++|||||+++++|.+..+.++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34566789999999999999974 6889999998643 33346789999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++.+...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~ 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 159 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----T
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----c
Confidence 99999999998888999999999999999999999972 37999999999999999999999999999865432 1
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNW 370 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~ 370 (464)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3456899999999999999999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=389.02 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=204.4
Q ss_pred hhhccccCccCceEEEEEEECCC----cEEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeee-CcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDE----RAVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE-GMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~ 242 (464)
.+|.++||+|+||+||+|++.++ ..||||+++.. ....++|.+|+++|++++|||||+++|+|.+ +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35677899999999999997542 36899999743 3344779999999999999999999999875 46899999
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999998754 468899999999999999999999 8999999999999999999999999999987654432
Q ss_pred C--cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 322 S--SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 322 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......||+.|+|||.+.+..++.++||||||+++|||+||+.|+....... .+.. .+..+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--------~~~~----~i~~g~-- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITV----YLLQGR-- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------------CHH----HHHTTC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--------HHHH----HHHcCC--
Confidence 2 12334678999999999999999999999999999999999988876322110 1111 111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+...+......+.+|+.+||+.||++||||.||++.|+++..
T Consensus 252 ----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111122334568899999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=385.39 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=194.8
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeC-cEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEG-MHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~E~~~~g 248 (464)
+.|.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|++++++++||||++++|+|.+. +..++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 457789999999999999994 678999999754 3456799999999999999999999998654 5679999999999
Q ss_pred ChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 249 SLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 249 sL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
+|.++|... ..++|..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+|++|||+++..... ..
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~ 158 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD 158 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-----Cc
Confidence 999999754 359999999999999999999999 89999999999999999999999999999865432 23
Q ss_pred eeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhC-CCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 327 RIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKG-IRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
...+|..|+|||++.+..++.++||||||+++|||+|+ +.|+.... ... ... .+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~------~~~---~~~----~i------------ 213 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKD---VVP----RV------------ 213 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC------GGG---HHH----HH------------
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC------HHH---HHH----HH------------
Confidence 35688999999999999999999999999999999994 55554221 111 111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....+.+.+.....++.+|+.+||+.||.+||||.+|+++|+.+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111222333344567889999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=386.13 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=200.9
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc-cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL-HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~ 247 (464)
|.+.+.||+|+||+||+|... +++.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566788999999999999974 5889999998754 34457789999999999999999999999999999999999999
Q ss_pred CChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 248 QSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 248 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
|+|.+++.+ ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|....... ....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~ 168 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 168 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHT
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cccc
Confidence 999999765 4579999999999999999999999 899999999999999999999999999997543211 1234
Q ss_pred eeccCCCccCccccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhh
Q 040010 327 RIRGTKGYMAPEWAS-----NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARI 401 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (464)
...||+.|+|||.+. +..++.++|||||||++|||+||+.||..... .. .+. ++..+.
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~----~~~----~i~~~~---- 231 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MR----VLL----KIAKSE---- 231 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GG----HHH----HHHHSC----
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HH----HHH----HHHcCC----
Confidence 567999999999874 45689999999999999999999999863211 01 111 111111
Q ss_pred hhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+.+ ..+....+.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ----~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 ----PPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 112233457889999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=390.70 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=198.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCc----EEEEEEcCCc--cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DER----AVAVKRLGDL--HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 242 (464)
+.+.+.||+|+||+||+|.+. +|+ .||+|+++.. ....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 567789999999999999974 333 6899998743 34567899999999999999999999999875 567888
Q ss_pred EeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 243 EYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 243 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
||+.+|+|.+++... ..+++..+++|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999888754 589999999999999999999999 8999999999999999999999999999998766554
Q ss_pred CcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
........||+.|+|||.+.+..++.++|||||||++|||+| |..||..... ..+.. .+..+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~~~~~-------~i~~~---- 229 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISS-------ILEKG---- 229 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------GGHHH-------HHHHT----
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------HHHHH-------HHHcC----
Confidence 444455679999999999999999999999999999999999 6667653211 11111 11111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.+...+......+.+|+.+||+.||.+|||+.+|++.|..+
T Consensus 230 --------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122334456789999999999999999999999988654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=392.32 Aligned_cols=261 Identities=28% Similarity=0.357 Sum_probs=212.4
Q ss_pred HHHHHHhhhccccCccCceEEEEEEE------CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeee
Q 040010 164 ELKKATNSFKEELGKGGSGAVYKGVL------TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE 234 (464)
Q Consensus 164 el~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 234 (464)
|+....+.+.+.||+|+||.||+|++ .+++.||||+++... ....+|.+|+.+++++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 34455678889999999999999986 245689999997543 3345689999999999 69999999999999
Q ss_pred CcEEeEEEEeccCCChHHhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCC
Q 040010 235 GMHRLLVYEYVENQSLDKHLFSSN------------------FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPEN 296 (464)
Q Consensus 235 ~~~~~lv~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 296 (464)
....++||||+++|+|.+++.... .+++..++.++.||++||+|||+ ++++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence 999999999999999999986432 58999999999999999999999 899999999999
Q ss_pred EEEcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCcc
Q 040010 297 ILLDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSE 376 (464)
Q Consensus 297 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~ 376 (464)
|+++.++.+|++|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|++.|+.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~- 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999998766554444455789999999999999999999999999999999999666654221111
Q ss_pred chhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 377 GQEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
.. +.+++........+......+.+|+.+||+.||++||||.+|+++|++..
T Consensus 255 ---~~-------------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 ---SK-------------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---HH-------------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HH-------------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 11111111122223334567899999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-50 Score=387.31 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=189.9
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
.|.+.+.||+|+||+||+|... +++.||||++.... .....+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3677889999999999999975 58899999986432 33456789999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc---CCCCeEEeeecCccccCCCCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD---SEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
++|+|.++|.....+++..+..++.||+.||+|||+ .+|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 999999999888899999999999999999999999 8999999999999994 57899999999998664332
Q ss_pred cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh
Q 040010 323 SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE 402 (464)
Q Consensus 323 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .. . ....+..+.
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~---~----~~~~i~~~~----- 225 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DA---K----LFEQILKAE----- 225 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HH---H----HHHHHHTTC-----
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HH---H----HHHHHhccC-----
Confidence 2345679999999999999999999999999999999999999996321 00 1 111111111
Q ss_pred hhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.........+..+.+.+|+.+||+.||++|||+.|+++
T Consensus 226 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 ----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111122234457889999999999999999999988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=385.85 Aligned_cols=274 Identities=24% Similarity=0.266 Sum_probs=204.1
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCc----EEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~E~~ 245 (464)
+.+.+.||+|+||.||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|.+.. ..++||||+
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 45667899999999999998 5789999999755443333445666677889999999999997653 679999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHEC-----LEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
++|+|.++|.+ ..++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 84 EHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 99999999965 47999999999999999999999742 3689999999999999999999999999998775543
Q ss_pred CC--cceeeeccCCCccCcccccCCC------CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhh-H-HHHHHHHH
Q 040010 321 NS--SQFSRIRGTKGYMAPEWASNLP------ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAE-L-TGFIREVK 390 (464)
Q Consensus 321 ~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-~-~~~~~~~~ 390 (464)
.. .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+............. . ........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 22 1234577999999999987643 5779999999999999999988775432211110000 0 00001111
Q ss_pred HHhhccchhhhhhhcCCccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCCC
Q 040010 391 EKILCGEEARIEEIVDPRLKGHF-NKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEAE 452 (464)
Q Consensus 391 ~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~~ 452 (464)
... ..+..+|.+.... +.+....+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 243 ~~~-------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 243 KVV-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHH-------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 100 1122233322221 234667799999999999999999999999999877643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=383.88 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=194.1
Q ss_pred HHhhhccccCccCceEEEEEEECC----CcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLTD----ERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
..+.+.+.||+|+||.||+|++.. +..||||.++... ...+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 456778899999999999999743 3579999987543 234679999999999999999999999964 578999
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++|+|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999987654 579999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccchh
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA 399 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (464)
. .......||+.|+|||.+.+..++.++|||||||++|||+| |..|+..... .. . ...+..+.
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------~~---~----~~~i~~~~-- 226 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------ND---V----IGRIENGE-- 226 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GG---H----HHHHHTTC--
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH------HH---H----HHHHHcCC--
Confidence 2 22345678999999999999999999999999999999998 7777763211 11 1 11111111
Q ss_pred hhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 400 RIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 400 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
....+...++.+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 227 ----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223344567899999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=389.44 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=197.6
Q ss_pred HHHHHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 165 LKKATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 165 l~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
+....+.+.++||+|+||.||+|... +++.||||+++... ...+.+..|...+.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33455778889999999999999963 24689999997432 3446688888888877 689999999987654
Q ss_pred -cEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEE
Q 040010 236 -MHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENIL 298 (464)
Q Consensus 236 -~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 298 (464)
...++||||+++|+|.++|... ..+++..++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 5689999999999999999642 258999999999999999999999 89999999999999
Q ss_pred EcCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCC-CCCccccCccc
Q 040010 299 LDSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIR-LSNWVVEDSEG 377 (464)
Q Consensus 299 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~-p~~~~~~~~~~ 377 (464)
|++++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||.. ||......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--- 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987665544444556789999999999999999999999999999999999865 45421110
Q ss_pred hhhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 378 QEAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. .+... +. +-..+. .+....+.+.+++.+||+.||++||||.||++.|+++.
T Consensus 244 --~----~~~~~---~~--------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 --E----EFCRR---LK--------EGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp --H----HHHHH---HH--------HTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --H----HHHHH---Hh--------cCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 11111 11 111111 22233456889999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=388.15 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=208.6
Q ss_pred HHhhhccccCccCceEEEEEEEC------CCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCcEEe
Q 040010 168 ATNSFKEELGKGGSGAVYKGVLT------DERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 168 ~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 239 (464)
..+.+.+.||+|+||+||+|.+. +++.||||+++... .....|.+|++++++++|||||+++|+|......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34567789999999999999863 25789999997533 33356899999999999999999999999999999
Q ss_pred EEEEeccCCChHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEee
Q 040010 240 LVYEYVENQSLDKHLFSS----------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIAD 309 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 309 (464)
+||||+++|+|.+++... ..+++..+..++.|+|+||.|||+ .+|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999998632 357999999999999999999999 8999999999999999999999999
Q ss_pred ecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHH
Q 040010 310 FGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREV 389 (464)
Q Consensus 310 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 389 (464)
||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+.++.... .......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~~~-- 246 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVLR-- 246 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHHHH--
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHHHH--
Confidence 999987655444333445678999999999999999999999999999999999965443111 1111111
Q ss_pred HHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 390 KEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 390 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
.+.+... ...+......+.+++.+||+.||++||||.+|+++|++..+
T Consensus 247 -------------~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 -------------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------------HHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 11222344679999999999999999999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=381.16 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=194.0
Q ss_pred hhhccccCccCceEEEEEEECC--C--cEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD--E--RAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~--~--~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+.+.+.||+|+||.||+|++.. + ..||||+++.. ....+.|.+|+++|++++|||||+++|+|.+. ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 5677899999999999998632 2 37899988643 23346799999999999999999999999764 67899
Q ss_pred EEeccCCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 242 YEYVENQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
|||+++|+|.+++... ..+++..++.++.|||.||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887654 579999999999999999999999 899999999999999999999999999999775543
Q ss_pred CCc-ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 321 NSS-QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 321 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... . .+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~---~~~~~----------- 225 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------G---SQILH----------- 225 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------H---HHHHH-----------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------H---HHHHH-----------
Confidence 322 2234567889999999999999999999999999999998 888886321 1 11111
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
.+.......+.+...+..+.+|+.+||+.||++||||.+|++.|.++
T Consensus 226 ----~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ----KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111111222233445788999999999999999999999999753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=386.73 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=200.8
Q ss_pred hhhccccCccCceEEEEEEECC-Cc--EEEEEEcCCc--cchhHHHHHHHHHhhhc-cccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLTD-ER--AVAVKRLGDL--HQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||+||+|++.+ +. .||||+++.. ....+.|.+|+++|+++ +|||||+++|+|.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3567899999999999999754 33 5788887532 33456799999999998 79999999999999999999999
Q ss_pred eccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEE
Q 040010 244 YVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKI 307 (464)
Q Consensus 244 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 307 (464)
|+++|+|.++|+.. ..++|..++.++.|||.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 99999999999643 579999999999999999999999 89999999999999999999999
Q ss_pred eeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHH
Q 040010 308 ADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIR 387 (464)
Q Consensus 308 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 387 (464)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|..|+..... ...
T Consensus 169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~--- 234 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAE--- 234 (309)
T ss_dssp CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHH---
T ss_pred cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHH---
Confidence 99999976543221 2345689999999999999999999999999999999998765431110 111
Q ss_pred HHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCCC
Q 040010 388 EVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCEA 451 (464)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~~ 451 (464)
+...+..+ .+...+....+.+.+|+.+||+.||++||||.+|++.|+.+.+
T Consensus 235 -~~~~i~~~------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQG------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGT------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhc------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111 1122233445679999999999999999999999999988654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=386.14 Aligned_cols=256 Identities=25% Similarity=0.294 Sum_probs=204.6
Q ss_pred HHHhhhccccCccCceEEEEEEECC--------CcEEEEEEcCCcc--chhHHHHHHHHHhhhc-cccceeccceeeeeC
Q 040010 167 KATNSFKEELGKGGSGAVYKGVLTD--------ERAVAVKRLGDLH--QGEEVFWAEVSTIGKI-YHMNLVRMWGFCTEG 235 (464)
Q Consensus 167 ~~~~~~~~~lG~G~~g~Vy~g~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 235 (464)
...+.+.+.||+|+||.||+|+..+ +..||||+++... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3456778899999999999998532 3579999997543 3447788999999888 799999999999999
Q ss_pred cEEeEEEEeccCCChHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEE
Q 040010 236 MHRLLVYEYVENQSLDKHLFSS----------------NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILL 299 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll 299 (464)
...++||||+++|+|.++|... ..+++.+++.++.||+.||+|||+ .+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 9999999999999999999643 358999999999999999999999 999999999999999
Q ss_pred cCCCCeEEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHh-CCCCCCccccCccch
Q 040010 300 DSEFEPKIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLK-GIRLSNWVVEDSEGQ 378 (464)
Q Consensus 300 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 378 (464)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------
Confidence 9999999999999998766555544566779999999999999999999999999999999998 566664211
Q ss_pred hhhHHHHHHHHHHHhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCCC
Q 040010 379 EAELTGFIREVKEKILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGCE 450 (464)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~~ 450 (464)
. . .+...+.. ......+......+.+|+.+||+.||++|||+.||+++|+++.
T Consensus 243 ~---~----~~~~~i~~------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 243 V---E----ELFKLLKE------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp H---H----HHHHHHHT------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---H----HHHHHHHc------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 0 0 11111111 1111223334457899999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-48 Score=382.25 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=204.2
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.|.+.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677889999999999999974 68999999997543 344678899999999999999999999999999999999999
Q ss_pred CCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc--CCCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD--SEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+|+|.+++.+ ...+++..+..|+.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++......
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 180 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 180 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence 9999999864 4579999999999999999999999 9999999999999995 46789999999998765432
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|||||.+.+..++.++|||||||++|||++|+.||.... ..+.+.. +..+. -
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---------~~~~~~~----i~~~~-----~ 242 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------DDETLRN----VKSCD-----W 242 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---------HHHHHHH----HHHTC-----C
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---------HHHHHHH----HHhCC-----C
Confidence 2456789999999999999999999999999999999999999986321 0111111 11110 0
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
-.+... .....+.+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 NMDDSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSCCGG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 11233568899999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=376.02 Aligned_cols=248 Identities=26% Similarity=0.279 Sum_probs=203.3
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-------chhHHHHHHHHHhhhccccceeccceeeeeCcEEeE
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-------QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLL 240 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 240 (464)
.|.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||||++++++.+....++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467788999999999999997 468999999985321 234678999999999999999999999999999999
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC----CeEEeeecCcccc
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF----EPKIADFGLAKLS 316 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~ 316 (464)
||||+++|+|.++|.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+|++|||++...
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999999888899999999999999999999999 8999999999999998876 4999999999876
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhcc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCG 396 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (464)
..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . +. ...+..+
T Consensus 168 ~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~----~~----~~~i~~~ 231 (293)
T d1jksa_ 168 DFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q----ET----LANVSAV 231 (293)
T ss_dssp TTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HH----HHHHHTT
T ss_pred CCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----H----HH----HHHHHhc
Confidence 54322 3446789999999999999999999999999999999999999873210 0 11 1111111
Q ss_pred chhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 397 EEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 397 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
. ..............+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 N---------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C---------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 00000000112346789999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-48 Score=379.64 Aligned_cols=248 Identities=20% Similarity=0.254 Sum_probs=204.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc-chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+++|++++|||||++++++.++...++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 367788999999999999997 468999999987543 344668899999999999999999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc--CCCCeEEeeecCccccCCCCCCc
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD--SEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
+|+|.+++... ..+++.....|+.||+.||+|||+ .+|+||||||+||||+ .++.+||+|||+|.......
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--- 183 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 183 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence 99999887654 479999999999999999999999 9999999999999998 67899999999998775432
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ...+. .+..+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------~~~~~----~i~~~------- 243 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------LETLQ----NVKRC------- 243 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------HHHHH----HHHHC-------
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHH----HHHhC-------
Confidence 24567899999999999999999999999999999999999999963210 01111 11111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..............+.+|+.+||+.||.+|||+.|+++
T Consensus 244 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111112233456889999999999999999999987
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-48 Score=375.39 Aligned_cols=241 Identities=29% Similarity=0.316 Sum_probs=203.2
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+....++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 567789999999999999974 5899999998643 23346788999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|..++.....+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157 (316)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred cCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-----
Confidence 9999999999988999999999999999999999999 89999999999999999999999999999876532
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... . .. ...++..+.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~---~~----~~~~i~~~~------- 217 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------T---MK----TYEKILNAE------- 217 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------H---HH----HHHHHHHCC-------
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------H---HH----HHHHHHcCC-------
Confidence 345679999999999999999999999999999999999999996321 0 01 111111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
.. ++....+.+.+++.+||+.||.+|| |++++++
T Consensus 218 --~~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 --LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 1222335688999999999999996 8999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=376.57 Aligned_cols=244 Identities=24% Similarity=0.226 Sum_probs=204.1
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~ 244 (464)
+.+.+.||+|+||.||+++. .+++.||||+++.. ....+.+.+|+.+|++++||||+++++++.+....++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 56778999999999999997 46899999998743 22346688999999999999999999999999999999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
+++|+|.+++.....+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 87 ~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~ 161 (337)
T d1o6la_ 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 161 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CC
T ss_pred cCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC--cc
Confidence 9999999999988899999999999999999999999 999999999999999999999999999998654322 22
Q ss_pred eeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEI 404 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (464)
.....||+.|+|||.+.+..|+.++||||+||++|||++|+.||.... . ... ......+
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~------~---~~~----~~~i~~~-------- 220 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------H---ERL----FELILME-------- 220 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------H---HHH----HHHHHHC--------
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC------H---HHH----HHHHhcC--------
Confidence 455789999999999999999999999999999999999999987421 1 111 1111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 405 VDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 405 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
... ++......+.+|+.+||+.||.+||+ +.++++
T Consensus 221 -~~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 -EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111 22233456788999999999999995 777765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=368.17 Aligned_cols=262 Identities=22% Similarity=0.242 Sum_probs=198.5
Q ss_pred cccCccCceEEEEEEEC-CCcEEEEEEcCCccc------hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 174 EELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ------GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++|||||++++++..+++.++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999974 589999999864322 12468899999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++++..++..+..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~ 158 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYT 158 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCC
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc--ccc
Confidence 99888888777889999999999999999999999 8999999999999999999999999999986654322 234
Q ss_pred eeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhh---
Q 040010 327 RIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIE--- 402 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 402 (464)
...||+.|+|||.+.. ..++.++|||||||++|||++|+.||..... . +.+..+.+...........
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~----~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----L----DQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHHHCCCCTTTSSSTT
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----H----HHHHHHHHhcCCCChhhccchh
Confidence 4679999999998865 4689999999999999999999988863211 1 1111111111000000000
Q ss_pred ---hhcCCccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCC
Q 040010 403 ---EIVDPRLKGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGC 449 (464)
Q Consensus 403 ---~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~ 449 (464)
....-......+. ...+.+.+|+.+||+.||++|||++|+++ .+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000000001111 12356889999999999999999999987 46543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-47 Score=364.56 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=201.4
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc----------hhHHHHHHHHHhhhcc-ccceeccceeeeeCcE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ----------GEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMH 237 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 237 (464)
+.+.+.||+|+||+||+++. .+++.||||+++.... ..+.+.+|+.++++++ ||||+++++++.++++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 56678999999999999997 4688999999864321 1235789999999997 9999999999999999
Q ss_pred EeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccC
Q 040010 238 RLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQ 317 (464)
Q Consensus 238 ~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 317 (464)
.++||||+++|+|.++|.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999888899999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccC------CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHH
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASN------LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKE 391 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 391 (464)
.... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||.... .. .. ..
T Consensus 162 ~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~------~~---~~----~~ 225 (277)
T d1phka_ 162 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QM---LM----LR 225 (277)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH---HH----HH
T ss_pred CCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC------HH---HH----HH
Confidence 4322 344679999999998753 357889999999999999999999997321 00 01 11
Q ss_pred HhhccchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 392 KILCGEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 392 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.+..+. ............+.+.+|+.+||+.||++|||+.||++
T Consensus 226 ~i~~~~---------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGN---------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTC---------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCC---------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111 01111112234467889999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-48 Score=366.35 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=198.0
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc----chhHHHHHHHHHhhhccccceeccceeeeeCc----EEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH----QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRL 239 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 239 (464)
.|.+.+.||+|+||+||+|+. .+++.||||+++... .....+.+|++++++++|||||++++++.... ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 366778999999999999997 468999999997432 22356899999999999999999999986543 478
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+++++|.+++.....+++.++..++.||+.||+|||+ .+|+||||||+|||++.++..+++|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 999999999999999888899999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCC-cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch
Q 040010 320 SNS-SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE 398 (464)
Q Consensus 320 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (464)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... . ...... +. ..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~----~~~~~~---~~-~~- 230 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----V----SVAYQH---VR-ED- 230 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHH---HH-CC-
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----H----HHHHHH---Hh-cC-
Confidence 222 234557799999999999999999999999999999999999999863210 0 111111 10 00
Q ss_pred hhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhCC
Q 040010 399 ARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-TMDSVVQTLLGC 449 (464)
Q Consensus 399 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-sm~~V~~~L~~~ 449 (464)
...+. ....+.++.+.+++.+||+.||.+|| |++++++.|..+
T Consensus 231 -----~~~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 -----PIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----CCCGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----CCCCc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00000 11112335688999999999999999 899999888654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=371.44 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=204.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEeccCC
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVENQ 248 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~~g 248 (464)
|.+.+.||+|+||+||+|... +++.||||.++........+.+|+++|++++|||||++++++.+.+..++||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 567789999999999999975 5889999999877666677899999999999999999999999999999999999999
Q ss_pred ChHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC--CCCeEEeeecCccccCCCCCCcce
Q 040010 249 SLDKHLFSSN-FLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS--EFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 249 sL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
+|.++|.... .+++.+...|+.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++...... ..
T Consensus 87 ~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~ 160 (321)
T d1tkia_ 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NF 160 (321)
T ss_dssp BHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EE
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC---cc
Confidence 9999998665 79999999999999999999999 99999999999999985 4579999999998764432 24
Q ss_pred eeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhhhc
Q 040010 326 SRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEEIV 405 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (464)
....+|+.|+|||...+..++.++||||+||++|||++|+.||..... .... .++..+... .
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---------~~~~----~~i~~~~~~-----~ 222 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------QQII----ENIMNAEYT-----F 222 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHH----HHHHHTCCC-----C
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---------HHHH----HHHHhCCCC-----C
Confidence 556799999999999999999999999999999999999999873211 0111 111111100 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 406 DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 406 d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+..... .....+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001 12345789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-47 Score=373.58 Aligned_cols=242 Identities=24% Similarity=0.213 Sum_probs=203.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
.+.+.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3566789999999999999974 6899999998632 2234568899999999999999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+.+|+|..++.....+++.....++.||+.||.|||+ .+||||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 99999999999888899999999999999999999999 89999999999999999999999999999876532
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||.... . .... .++..+.
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~---~~~~----~~i~~~~------ 254 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------P---IQIY----EKIVSGK------ 254 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------H---HHHH----HHHHHCC------
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------H---HHHH----HHHhcCC------
Confidence 334679999999999999999999999999999999999999996321 0 1111 1111110
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRP-----TMDSVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RP-----sm~~V~~ 444 (464)
.. .+......+.+++.+||+.||.+|+ |++++++
T Consensus 255 ---~~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ---VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CC----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 1222345688999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=371.73 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=200.8
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCc----cchhHHHHHHHHHhh-hccccceeccceeeeeCcEEeEEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDL----HQGEEVFWAEVSTIG-KIYHMNLVRMWGFCTEGMHRLLVYE 243 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~E 243 (464)
+.+.+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567889999999999999975 6889999999643 223345667777665 6899999999999999999999999
Q ss_pred eccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCc
Q 040010 244 YVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 244 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 323 (464)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~ 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--A 158 (320)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc--c
Confidence 99999999999988899999999999999999999999 899999999999999999999999999998654332 2
Q ss_pred ceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 324 QFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... . . ...++..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~---~----~~~~i~~~------- 218 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------E---E----LFHSIRMD------- 218 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------H---H----HHHHHHHC-------
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------H---H----HHHHHHcC-------
Confidence 23456799999999999999999999999999999999999999973211 0 1 11111111
Q ss_pred hcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 040010 404 IVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMD-SVVQ 444 (464)
Q Consensus 404 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~-~V~~ 444 (464)
.+. ++......+.+|+.+||+.||.+|||+. ++++
T Consensus 219 --~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111 1222345688999999999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.8e-47 Score=373.79 Aligned_cols=245 Identities=24% Similarity=0.260 Sum_probs=197.0
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc----chhHHHHH---HHHHhhhccccceeccceeeeeCcEEeEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH----QGEEVFWA---EVSTIGKIYHMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~lv 241 (464)
+.+.+.||+|+||.||+|+.. +|+.||||++.... .....+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 566789999999999999975 58999999986321 22233444 46777778899999999999999999999
Q ss_pred EEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCC
Q 040010 242 YEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSN 321 (464)
Q Consensus 242 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 321 (464)
|||+++|+|.++|.+...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 9999999999999888899999999999999999999999 999999999999999999999999999998765432
Q ss_pred CcceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh
Q 040010 322 SSQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR 400 (464)
Q Consensus 322 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (464)
.....||+.|+|||.+. +..++.++|||||||+||||+||+.||....... .. ....
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~----~~~~--------- 219 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KH----EIDR--------- 219 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC------HH----HHHH---------
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH------HH----HHHH---------
Confidence 34467999999999986 4578999999999999999999999997432211 00 0111
Q ss_pred hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040010 401 IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ 444 (464)
Q Consensus 401 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~ 444 (464)
...... ...+......+.+|+.+||+.||++||| +.++++
T Consensus 220 --~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 --MTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --HSSSCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --hcccCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111 1112223456889999999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=365.08 Aligned_cols=245 Identities=21% Similarity=0.198 Sum_probs=194.7
Q ss_pred hhhc-cccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhc-cccceeccceeeee----CcEEeEEE
Q 040010 170 NSFK-EELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKI-YHMNLVRMWGFCTE----GMHRLLVY 242 (464)
Q Consensus 170 ~~~~-~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~ 242 (464)
|.+. +.||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ ..+.++||
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 4444 4599999999999997 5689999999864 34567899887655 89999999999865 46789999
Q ss_pred EeccCCChHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC---CCCeEEeeecCccccC
Q 040010 243 EYVENQSLDKHLFSS--NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS---EFEPKIADFGLAKLSQ 317 (464)
Q Consensus 243 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~ 317 (464)
||+++|+|.++|.+. ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999764 479999999999999999999999 99999999999999986 5679999999998765
Q ss_pred CCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 318 RGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.... .....||+.|+|||.+.+..|+.++|||||||+||||+||+.||........ ...+.
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---------~~~~~------- 226 (335)
T d2ozaa1 166 SHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGMK------- 226 (335)
T ss_dssp CCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------------
T ss_pred CCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---------HHHHH-------
Confidence 4332 3456799999999999999999999999999999999999999964321110 00000
Q ss_pred hhhhhhhcCCccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPRLK--GHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~l~--~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
..+...... ........+++.+|+.+||+.||++|||+.|+++
T Consensus 227 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 ----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111 1111234567899999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=359.24 Aligned_cols=237 Identities=24% Similarity=0.323 Sum_probs=195.3
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc-------chhHHHHHHHHHhhhcc--ccceeccceeeeeCcEE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH-------QGEEVFWAEVSTIGKIY--HMNLVRMWGFCTEGMHR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 238 (464)
.|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677789999999999999974 68999999986421 11234678999999996 89999999999999999
Q ss_pred eEEEEeccC-CChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCC-CCeEEeeecCcccc
Q 040010 239 LLVYEYVEN-QSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSE-FEPKIADFGLAKLS 316 (464)
Q Consensus 239 ~lv~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~ 316 (464)
++||||+.+ +++.+++.....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999975 6888888888899999999999999999999999 999999999999999854 78999999999865
Q ss_pred CCCCCCcceeeeccCCCccCcccccCCCC-CccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 317 QRGSNSSQFSRIRGTKGYMAPEWASNLPI-TSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 317 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||... . .+..
T Consensus 162 ~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~------------~i~~ 218 (273)
T d1xwsa_ 162 KDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------E------------EIIR 218 (273)
T ss_dssp CSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------H------------HHHH
T ss_pred ccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------h------------HHhh
Confidence 432 2345679999999999987765 57789999999999999999998621 0 0000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
+. ..+...+ ..++.+|+.+||+.||++|||+.|+++
T Consensus 219 ~~---------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 GQ---------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC---------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc---------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 1112223 346889999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=354.09 Aligned_cols=266 Identities=22% Similarity=0.219 Sum_probs=198.3
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.+.||+|+||+||+|+. .+++.||||+++... ...+.+.+|+++|++++|||||++++++.++.+.++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 45567999999999999997 568999999996433 23467889999999999999999999999999999999999
Q ss_pred cCCChHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcc
Q 040010 246 ENQSLDKHLFS-SNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQ 324 (464)
Q Consensus 246 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 324 (464)
.++.+...... ...+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~ 158 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 158 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--C
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc--c
Confidence 76544444333 4579999999999999999999999 8999999999999999999999999999987654322 2
Q ss_pred eeeeccCCCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhhhhh
Q 040010 325 FSRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEARIEE 403 (464)
Q Consensus 325 ~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (464)
.....||+.|+|||.+.... ++.++|||||||++|||++|+.||..... .. .+...........+.....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-----~~----~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-----ID----QLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHHHCCCCTTTSTT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-----HH----HHHHHHHhcCCCchhhccc
Confidence 34467999999999876655 58899999999999999999999863211 11 1111111111111000000
Q ss_pred hc-CCccCCC------CC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCC
Q 040010 404 IV-DPRLKGH------FN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGC 449 (464)
Q Consensus 404 ~~-d~~l~~~------~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~ 449 (464)
.. .+..... .+ ......+.+|+.+||+.||++|||+.|+++. +.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 0000000 00 1123567889999999999999999999984 6554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=352.24 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=199.2
Q ss_pred hhhccccCccCceEEEEEEECCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEecc
Q 040010 170 NSFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
|...++||+|+||+||+|+.++|+.||||+++.... ..+.+.+|+.+|++++|||||++++++...+..++++||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 456688999999999999999999999999975432 34678999999999999999999999999999999999999
Q ss_pred CCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCccee
Q 040010 247 NQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQFS 326 (464)
Q Consensus 247 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 326 (464)
++.+..+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++........ ...
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~ 158 (286)
T d1ob3a_ 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYT 158 (286)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccc
Confidence 88888888778899999999999999999999999 8999999999999999999999999999987654322 234
Q ss_pred eeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchhh---hh
Q 040010 327 RIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEAR---IE 402 (464)
Q Consensus 327 ~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 402 (464)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ... ............... ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-----~~~----~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQ----LMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHH----HHHHHHHHCCCCTTTSTTGG
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-----HHH----HHHHHHhhCCCChhhccchh
Confidence 45689999999988654 579999999999999999999999864211 111 111111110000000 00
Q ss_pred hh--cCCcc-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 403 EI--VDPRL-------KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 403 ~~--~d~~l-------~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.. .+... ...........+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 01111223456889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=349.56 Aligned_cols=261 Identities=24% Similarity=0.281 Sum_probs=193.6
Q ss_pred HhhhccccCccCceEEEEEEEC--CCcEEEEEEcCCcc---chhHHHHHHHHHhhhc---cccceeccceeeee-----C
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT--DERAVAVKRLGDLH---QGEEVFWAEVSTIGKI---YHMNLVRMWGFCTE-----G 235 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~ 235 (464)
.|.+.++||+|+||+||+|+.. +++.||||+++... .....+.+|+.+|+.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4567789999999999999973 36789999986432 2234466788777766 79999999999853 3
Q ss_pred cEEeEEEEeccCCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 236 MHRLLVYEYVENQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 236 ~~~~lv~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
...+++|||++++++..... ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 57899999999887765544 34579999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhh
Q 040010 315 LSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKIL 394 (464)
Q Consensus 315 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (464)
..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ... +..+.....
T Consensus 165 ~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~----~~~i~~~~~ 232 (305)
T d1blxa_ 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQ----LGKILDVIG 232 (305)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHH----HHHHHHHHC
T ss_pred hhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHH----HHHHHHhhC
Confidence 64332 234557799999999999999999999999999999999999999963211 111 111111110
Q ss_pred ccch-hh-----hh-hhc---CCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 395 CGEE-AR-----IE-EIV---DPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 395 ~~~~-~~-----~~-~~~---d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
.... .. .. ... .......+.....+.+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 00 000 000000111223456788999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=345.05 Aligned_cols=265 Identities=18% Similarity=0.185 Sum_probs=194.9
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeee--------Cc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTE--------GM 236 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 236 (464)
.|.+.++||+|+||+||+|+. .+|+.||||++.... .....+.+|+++|++++|+|++++++.+.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 456778999999999999997 478999999986432 234668899999999999999999998754 34
Q ss_pred EEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCcccc
Q 040010 237 HRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLS 316 (464)
Q Consensus 237 ~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 316 (464)
+.++||||++++++.........++......++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 678999999988888777777789999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCC--cceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHh
Q 040010 317 QRGSNS--SQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKI 393 (464)
Q Consensus 317 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (464)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... . ..........
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~----~~~~~i~~~~ 238 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----Q----HQLALISQLC 238 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHHHHHH
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----H----HHHHHHHHhc
Confidence 543221 223345799999999998765 689999999999999999999999863210 1 1111111111
Q ss_pred hccchhhhhhhcCCcc--------CCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 394 LCGEEARIEEIVDPRL--------KGHFNK-------NQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 394 ~~~~~~~~~~~~d~~l--------~~~~~~-------~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
................ ...... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000000000 000000 113456789999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=347.00 Aligned_cols=268 Identities=20% Similarity=0.243 Sum_probs=195.1
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc--chhHHHHHHHHHhhhccccceeccceeeeeCc----EEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH--QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM----HRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 242 (464)
|.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++|++++|||++++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 56678999999999999996 478999999997543 23467889999999999999999999986543 235556
Q ss_pred EeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCC
Q 040010 243 EYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 243 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
+|+.+|+|.+++.. ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 90 ~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 90 THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 67789999999964 479999999999999999999999 89999999999999999999999999999865443222
Q ss_pred -cceeeeccCCCccCccccc-CCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccch--
Q 040010 323 -SQFSRIRGTKGYMAPEWAS-NLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEE-- 398 (464)
Q Consensus 323 -~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 398 (464)
.......||+.|+|||.+. +..++.++||||+||++|||++|+.||......+ .. .... ........
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-----~~-~~~~---~~~~~~~~~~ 236 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QL-NHIL---GILGSPSQED 236 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HH-HHHH---HHHCSCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-----HH-HHHh---hhccCCChhh
Confidence 2234567999999999874 4567899999999999999999999986432110 00 0000 00000000
Q ss_pred --------hhhhhhcCCccCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCC
Q 040010 399 --------ARIEEIVDPRLKGHFNK-----NQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEA 451 (464)
Q Consensus 399 --------~~~~~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~ 451 (464)
........+.. ...+. ....++.+|+.+||+.||.+|||+.|+++. |....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00000001110 01111 112468899999999999999999999974 554443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-44 Score=344.59 Aligned_cols=258 Identities=19% Similarity=0.179 Sum_probs=194.9
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccc-eeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMW-GFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~E~~~ 246 (464)
+|.+.+.||+|+||.||+|+. .+++.||||++.... ...++..|+++++.++|+|++..+ ++..++...++||||+.
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 366788999999999999997 458899999876533 335678999999999877766555 45577889999999995
Q ss_pred CCChHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEc---CCCCeEEeeecCccccCCCCCC
Q 040010 247 NQSLDKHLF-SSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLD---SEFEPKIADFGLAKLSQRGSNS 322 (464)
Q Consensus 247 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~~~ 322 (464)
++|.+.+. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+........
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 -PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp -CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred -CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 55555544 45689999999999999999999999 9999999999999985 4567999999999977554322
Q ss_pred -----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 323 -----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 323 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||......... ...........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~------~~~~~~~~~~~--- 233 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR------QKYERISEKKM--- 233 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------------HHHHHHHHH---
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH------HHHHHhhcccC---
Confidence 1234567999999999999999999999999999999999999999743221111 00111000000
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
....+.+...+ +..+.+++..||+.||++||+++++.+.|+..
T Consensus 234 -----~~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 234 -----STPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HSCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----CCChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000111122 34688899999999999999999998888654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=346.91 Aligned_cols=268 Identities=23% Similarity=0.221 Sum_probs=209.0
Q ss_pred hhhccccCccCceEEEEEEEC----CCcEEEEEEcCCcc-----chhHHHHHHHHHhhhccc-cceeccceeeeeCcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT----DERAVAVKRLGDLH-----QGEEVFWAEVSTIGKIYH-MNLVRMWGFCTEGMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 239 (464)
+.+.+.||+|+||+||+|... +|+.||||.++... ...+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 778889999999999999852 47899999986432 234568899999999976 89999999999999999
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
++|||+.+|+|.+++.....++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999999988889999999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCcceeeeccCCCccCcccccCC--CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNL--PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........ ... +...
T Consensus 183 ~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-----~~~----i~~~----- 247 (322)
T d1vzoa_ 183 ETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAE----ISRR----- 247 (322)
T ss_dssp GGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHH----HHHH-----
T ss_pred ccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH----HHHh-----
Confidence 222 23456799999999988654 478899999999999999999999975432211 101 1010
Q ss_pred hhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH--HhhCCC----CCCCCCCCCCCCC
Q 040010 398 EARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPT-----MDSVVQ--TLLGCE----AESEVPVQTIPDC 463 (464)
Q Consensus 398 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPs-----m~~V~~--~L~~~~----~~~~~~~p~~p~~ 463 (464)
..... ...+.+...++.+++.+||+.||++||| ++|+++ .+.++. ....+|.|-.|++
T Consensus 248 ------~~~~~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~ 316 (322)
T d1vzoa_ 248 ------ILKSE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 316 (322)
T ss_dssp ------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred ------cccCC--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCC
Confidence 01111 1122334567889999999999999995 788876 344433 2334455555654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=348.44 Aligned_cols=257 Identities=24% Similarity=0.257 Sum_probs=190.1
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccccceeccceeeee------CcEEeEEE
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLVRMWGFCTE------GMHRLLVY 242 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lv~ 242 (464)
|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|+||+++++++.. ..+.++||
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 455678999999999999985 589999999865432 23479999999999999999999853 34578999
Q ss_pred EeccCCChHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCC
Q 040010 243 EYVENQSLDKHL---FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQR 318 (464)
Q Consensus 243 E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 318 (464)
||++++.+.... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++.....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999876544433 345679999999999999999999999 9999999999999999775 899999999987654
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE 397 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (464)
... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+.. +........
T Consensus 176 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-----~~~l~~----i~~~~g~~~ 243 (350)
T d1q5ka_ 176 GEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLVE----IIKVLGTPT 243 (350)
T ss_dssp TSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHHHHH----HHHHHCCCC
T ss_pred Ccc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-----HHHHHH----HHHHhCCCh
Confidence 322 334679999999998765 5789999999999999999999999864211 111111 111000000
Q ss_pred hhhhhh----hcCCc---c-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEE----IVDPR---L-----KGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~----~~d~~---l-----~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
...... ..+.. . ...........+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000 0 00111223456889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=335.88 Aligned_cols=262 Identities=20% Similarity=0.207 Sum_probs=202.7
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeeeeCcEEeEEEEec
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCTEGMHRLLVYEYV 245 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~E~~ 245 (464)
|.+.++||+|+||+||+|+. .+++.||||+++... .....+.+|+.+++.++|+||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 55668999999999999997 468899999986432 23467899999999999999999999999999999999999
Q ss_pred cCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCCCCcce
Q 040010 246 ENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGSNSSQF 325 (464)
Q Consensus 246 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 325 (464)
.+++|..++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++........ .
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~ 158 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--Y 158 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--C
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc--c
Confidence 999999998888899999999999999999999999 89999999999999999999999999999876543322 2
Q ss_pred eeeccCCCccCcccccCCC-CCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccchh---hh
Q 040010 326 SRIRGTKGYMAPEWASNLP-ITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGEEA---RI 401 (464)
Q Consensus 326 ~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 401 (464)
....+++.|+|||.+.... ++.++|||||||++|||++|+.||..... ..+............... ..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--------VDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--------HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--------HHHHHHHHHhhcCCCChhhhhhh
Confidence 3355788899999887654 69999999999999999999999753211 111111111111100000 00
Q ss_pred hhhcCCc---------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 402 EEIVDPR---------LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 402 ~~~~d~~---------l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
....+.. -.........+.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 001112233456888999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=343.11 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=192.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeeeCc------EE
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTEGM------HR 238 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 238 (464)
+|.+.++||+|+||+||+|... +|+.||||+++.... ..+.+.+|+++|++++|||+|+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4566788999999999999974 589999999975322 3356889999999999999999999987654 56
Q ss_pred eEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCC
Q 040010 239 LLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQR 318 (464)
Q Consensus 239 ~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 318 (464)
++||||+ +.+|..++ ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++....
T Consensus 99 ~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 55777666 45679999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCcceeeeccCCCccCcccccC-CCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHH-------HH
Q 040010 319 GSNSSQFSRIRGTKGYMAPEWASN-LPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIRE-------VK 390 (464)
Q Consensus 319 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 390 (464)
. .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...... ..
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHHHH
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-----HHHHHHHHhccCCCcHHHH
Confidence 2 345679999999998876 4578999999999999999999999864211 1111000000 00
Q ss_pred HHhhccchhh----hhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hhCCCC
Q 040010 391 EKILCGEEAR----IEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT--LLGCEA 451 (464)
Q Consensus 391 ~~~~~~~~~~----~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~--L~~~~~ 451 (464)
.......... ..+.....+. .........+.+|+.+||+.||++|||+.|+++. +.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000000 0000000000 0111223467889999999999999999999974 666554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-43 Score=337.60 Aligned_cols=258 Identities=18% Similarity=0.225 Sum_probs=202.0
Q ss_pred HhhhccccCccCceEEEEEEEC-CCcEEEEEEcCCccchhHHHHHHHHHhhhccc-cceeccceeeeeCcEEeEEEEecc
Q 040010 169 TNSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLHQGEEVFWAEVSTIGKIYH-MNLVRMWGFCTEGMHRLLVYEYVE 246 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~E~~~ 246 (464)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 3567889999999999999975 68899999875432 34557789999999965 89999999999999999999999
Q ss_pred CCChHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcC-----CCCeEEeeecCccccCCCC
Q 040010 247 NQSLDKHLFSS-NFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDS-----EFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 247 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~~ 320 (464)
+++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 68999988754 479999999999999999999999 99999999999999974 5679999999998765432
Q ss_pred CC-----cceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhc
Q 040010 321 NS-----SQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILC 395 (464)
Q Consensus 321 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (464)
.. .......||+.|||||.+.+..++.++||||||+++|||+||+.||........ . .....+......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~---~---~~~~~i~~~~~~ 234 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---K---QKYERIGEKKQS 234 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH---H---HHHHHHHHHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH---H---HHHHHHHhccCC
Confidence 22 123456799999999999999999999999999999999999999974322211 0 111111111000
Q ss_pred cchhhhhhhcCCccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhCC
Q 040010 396 GEEARIEEIVDPRLKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQTLLGC 449 (464)
Q Consensus 396 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~L~~~ 449 (464)
. ...+ +...++ +++.+++..|++.+|++||+++.+.+.|+.+
T Consensus 235 ~---~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 T---PLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp S---CHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred C---ChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 0111 112223 4588899999999999999999888877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.9e-42 Score=333.15 Aligned_cols=264 Identities=18% Similarity=0.261 Sum_probs=195.6
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-ccceeccceeeee--CcEEeEEEEe
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-HMNLVRMWGFCTE--GMHRLLVYEY 244 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~E~ 244 (464)
.+.+.++||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+++|+.++ ||||+++++++.. ....++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 467788999999999999997 46899999998753 3456889999999995 9999999999874 4568999999
Q ss_pred ccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCC-CeEEeeecCccccCCCCCCc
Q 040010 245 VENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEF-EPKIADFGLAKLSQRGSNSS 323 (464)
Q Consensus 245 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~ 323 (464)
+++++|.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++........
T Consensus 114 ~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp CCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred cCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCc--
Confidence 9999998764 469999999999999999999999 9999999999999998655 589999999987654332
Q ss_pred ceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHH-----HHHHHHHHhhccc
Q 040010 324 QFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTG-----FIREVKEKILCGE 397 (464)
Q Consensus 324 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 397 (464)
.....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||........ ....... .............
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH-HHHHHHHHHCCchhhhhhhhccccc
Confidence 3456789999999987765 579999999999999999999999874322111 0000000 0000001000000
Q ss_pred hhhhhhhcCCc--------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040010 398 EARIEEIVDPR--------LKGHFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQ 444 (464)
Q Consensus 398 ~~~~~~~~d~~--------l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~ 444 (464)
........... ...........++.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011111100 001111223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=334.42 Aligned_cols=262 Identities=23% Similarity=0.234 Sum_probs=186.4
Q ss_pred hhhccccCccCceEEEEEEEC-CCcEEEEEEcCCcc---chhHHHHHHHHHhhhccccceeccceeee------eCcEEe
Q 040010 170 NSFKEELGKGGSGAVYKGVLT-DERAVAVKRLGDLH---QGEEVFWAEVSTIGKIYHMNLVRMWGFCT------EGMHRL 239 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~~~ 239 (464)
|.+.++||+|+||+||+|... +|+.||||++.... .....+.+|+.++++++|||||++++++. ...+.+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 456679999999999999975 58999999997432 23356889999999999999999999985 347889
Q ss_pred EEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCC
Q 040010 240 LVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRG 319 (464)
Q Consensus 240 lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 319 (464)
+||||+.++++. .+ ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccc
Confidence 999999765554 44 2458999999999999999999999 99999999999999999999999999998865543
Q ss_pred CCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHH-------------
Q 040010 320 SNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFI------------- 386 (464)
Q Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 386 (464)
. ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...... .......
T Consensus 173 ~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 173 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-----DQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCHHHHTT
T ss_pred c---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-----HHHHHHHHhccCCCHHHHHH
Confidence 2 234567899999999999999999999999999999999999998632110 0000000
Q ss_pred -----HHHHHHhhccchhhhhhhcCCccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040010 387 -----REVKEKILCGEEARIEEIVDPRLKG---HFNKNQAATLFRIGISCVDEDRNKRPTMDSVVQT 445 (464)
Q Consensus 387 -----~~~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~~ 445 (464)
......................... .........+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000011111111111 1123456788999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=332.04 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=193.6
Q ss_pred hhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccc---hhHHHHHHHHHhhhccccceeccceeeee-----CcEEeE
Q 040010 170 NSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQ---GEEVFWAEVSTIGKIYHMNLVRMWGFCTE-----GMHRLL 240 (464)
Q Consensus 170 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~l 240 (464)
|...++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+++|++++|+|+|++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 56678999999999999996 4689999999975432 33568899999999999999999999853 334577
Q ss_pred EEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeecCccccCCCC
Q 040010 241 VYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFGLAKLSQRGS 320 (464)
Q Consensus 241 v~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 320 (464)
+++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++.....
T Consensus 100 i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp EEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc--
Confidence 7888899999999854 579999999999999999999999 8999999999999999999999999999975432
Q ss_pred CCcceeeeccCCCccCcccccCC-CCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHHHHHHHHHhhccc--
Q 040010 321 NSSQFSRIRGTKGYMAPEWASNL-PITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGFIREVKEKILCGE-- 397 (464)
Q Consensus 321 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 397 (464)
......||+.|+|||...+. .++.++|||||||++|||++|+.||..... ... ...+........
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~----~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQ----LKLILRLVGTPGAE 241 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHH----HHHHHHHHCCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-----HHH----HHHHHHhcCCCChH
Confidence 23446689999999987665 568999999999999999999999863211 000 001100000000
Q ss_pred ------hhhhhhhcCCcc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhhCCCC
Q 040010 398 ------EARIEEIVDPRL-KGHFN-----KNQAATLFRIGISCVDEDRNKRPTMDSVVQ--TLLGCEA 451 (464)
Q Consensus 398 ------~~~~~~~~d~~l-~~~~~-----~~~~~~~~~l~~~Cl~~dp~~RPsm~~V~~--~L~~~~~ 451 (464)
............ ....+ ......+.+|+.+||+.||.+|||+.|+++ .+.+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000000000000 00001 112356788999999999999999999998 5665544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-37 Score=307.11 Aligned_cols=283 Identities=19% Similarity=0.175 Sum_probs=200.0
Q ss_pred HhhhccccCccCceEEEEEEE-CCCcEEEEEEcCCccchhHHHHHHHHHhhhcc-----------ccceeccceeeeeC-
Q 040010 169 TNSFKEELGKGGSGAVYKGVL-TDERAVAVKRLGDLHQGEEVFWAEVSTIGKIY-----------HMNLVRMWGFCTEG- 235 (464)
Q Consensus 169 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~- 235 (464)
+|.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 477889999999999999997 46899999999876655667888999988875 57899999887543
Q ss_pred -cEEeEEEEeccCCChHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCC------e
Q 040010 236 -MHRLLVYEYVENQSLDKHL---FSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFE------P 305 (464)
Q Consensus 236 -~~~~lv~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~------~ 305 (464)
...+++++++..+...... .....+++.....++.||+.||+|||+. .+|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 5666777776554432222 2345789999999999999999999972 56999999999999987654 8
Q ss_pred EEeeecCccccCCCCCCcceeeeccCCCccCcccccCCCCCccchhHHHHHHHHHHHhCCCCCCccccCccchhhhHHHH
Q 040010 306 KIADFGLAKLSQRGSNSSQFSRIRGTKGYMAPEWASNLPITSKVDVFSYGVVILEMLKGIRLSNWVVEDSEGQEAELTGF 385 (464)
Q Consensus 306 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 385 (464)
+++|||.+...... .....||+.|+|||.+.+..++.++||||+||+++||++|+.||.......... ....
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~---~~~~ 243 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK---DDDH 243 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C---HHHH
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc---hhHH
Confidence 99999999765432 234569999999999999999999999999999999999999986432111100 0011
Q ss_pred HHHHHHHhhccc------hhhhhhhcCC-----c--------------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040010 386 IREVKEKILCGE------EARIEEIVDP-----R--------------LKGHFNKNQAATLFRIGISCVDEDRNKRPTMD 440 (464)
Q Consensus 386 ~~~~~~~~~~~~------~~~~~~~~d~-----~--------------l~~~~~~~~~~~~~~l~~~Cl~~dp~~RPsm~ 440 (464)
.......+.... ........+. . ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111111000000 0000000000 0 01234567788999999999999999999999
Q ss_pred HHHHH--hhCCCCCCCCCCCCCC
Q 040010 441 SVVQT--LLGCEAESEVPVQTIP 461 (464)
Q Consensus 441 ~V~~~--L~~~~~~~~~~~p~~p 461 (464)
|+++. +.+.....+.+.|+.|
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~ 346 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRE 346 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSC
T ss_pred HHhcCcccCCCCCcccCCCCCcc
Confidence 99884 6555444445555544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=5.9e-24 Score=189.48 Aligned_cols=162 Identities=15% Similarity=0.131 Sum_probs=119.5
Q ss_pred hhccccCccCceEEEEEEECCCcEEEEEEcCCccc-------------------hhHHHHHHHHHhhhccccceecccee
Q 040010 171 SFKEELGKGGSGAVYKGVLTDERAVAVKRLGDLHQ-------------------GEEVFWAEVSTIGKIYHMNLVRMWGF 231 (464)
Q Consensus 171 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~g~ 231 (464)
.+.++||+|+||+||+|+..+|+.||||+++.... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999998999999998753210 01224567888999999999887765
Q ss_pred eeeCcEEeEEEEeccCCChHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCCEEEcCCCCeEEeeec
Q 040010 232 CTEGMHRLLVYEYVENQSLDKHLFSSNFLGWKERFKVALGTAKGLAYLHHECLEWVIHCDVKPENILLDSEFEPKIADFG 311 (464)
Q Consensus 232 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 311 (464)
.. .+++|||+++..+.. ++......++.|++.+|+|||+ .+|+||||||+|||+++++ ++|.|||
T Consensus 83 ~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp ET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred cC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEEEECC
Confidence 32 379999998865543 3444556899999999999999 8999999999999999654 8999999
Q ss_pred CccccCCCCCCcceeeeccCCCccC------cccccCCCCCccchhHHHHHHH
Q 040010 312 LAKLSQRGSNSSQFSRIRGTKGYMA------PEWASNLPITSKVDVFSYGVVI 358 (464)
Q Consensus 312 la~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DV~S~Gvvl 358 (464)
+|.......... |.. .+++ ...|+.++|+||..--+
T Consensus 148 ~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 997654322111 111 1111 24578889999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=1.6e-06 Score=78.60 Aligned_cols=130 Identities=13% Similarity=0.025 Sum_probs=89.3
Q ss_pred cCceEEEEEEECCCcEEEEEEcCCcc-chhHHHHHHHHHhhhcc-ccceeccceeeeeCcEEeEEEEeccCCChHHhhhc
Q 040010 179 GGSGAVYKGVLTDERAVAVKRLGDLH-QGEEVFWAEVSTIGKIY-HMNLVRMWGFCTEGMHRLLVYEYVENQSLDKHLFS 256 (464)
Q Consensus 179 G~~g~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~E~~~~gsL~~~l~~ 256 (464)
++.+.||+... +++.+.+|+..... .....+.+|...+..+. +--+.+++.++..++..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 44568998875 45567788776433 23345678888888774 44467788888888999999999999888655422
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 040010 257 SNFLGWKERFKVALGTAKGLAYLHHEC----------------------------------------------------- 283 (464)
Q Consensus 257 ~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------------- 283 (464)
. .....++.++++.++.||+..
T Consensus 104 ~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (263)
T d1j7la_ 104 E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence 1 112234455555555555421
Q ss_pred ---CCceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 284 ---LEWVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 284 ---~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
...++|+|+.|.||+++++...-|.||+.+.
T Consensus 179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999987667799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=1.1e-05 Score=72.41 Aligned_cols=137 Identities=18% Similarity=0.067 Sum_probs=84.2
Q ss_pred cCccC-ceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhcccc--ceeccceeeeeCcEEeEEEEeccCCChHH
Q 040010 176 LGKGG-SGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHM--NLVRMWGFCTEGMHRLLVYEYVENQSLDK 252 (464)
Q Consensus 176 lG~G~-~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~lv~E~~~~gsL~~ 252 (464)
+..|. ...||+...+++..+.+|...... ...+..|...++.+... .+.++++++.+++..++||+|+++.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 44444 468999998888888888765433 23466788888877533 35667888888888999999998866533
Q ss_pred hh-----------------hc----CCCC--CHHHHHHHHH--------------------HHHHHHHHHhhcC----CC
Q 040010 253 HL-----------------FS----SNFL--GWKERFKVAL--------------------GTAKGLAYLHHEC----LE 285 (464)
Q Consensus 253 ~l-----------------~~----~~~l--~~~~~~~i~~--------------------~ia~gL~yLH~~~----~~ 285 (464)
.. +. ...+ .+.....-.. .....+..+.+.. ..
T Consensus 96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (255)
T d1nd4a_ 96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL 175 (255)
T ss_dssp SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred ccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence 11 00 0000 0110000000 0111223332211 12
Q ss_pred ceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 286 WVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 286 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
.++|+|+.|.||+++++..+-|.||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 38999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=0.00014 Score=69.75 Aligned_cols=74 Identities=16% Similarity=0.091 Sum_probs=47.2
Q ss_pred cccCccCceEEEEEEECC-CcEEEEEEcCCc--------cchhHHHHHHHHHhhhcc---ccceeccceeeeeCcEEeEE
Q 040010 174 EELGKGGSGAVYKGVLTD-ERAVAVKRLGDL--------HQGEEVFWAEVSTIGKIY---HMNLVRMWGFCTEGMHRLLV 241 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~-~~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv 241 (464)
+.||.|....||+....+ ++.++||.-... .........|.+.|+.+. ...+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999998654 568888864321 112234456888887663 23455566553 4456799
Q ss_pred EEeccCCC
Q 040010 242 YEYVENQS 249 (464)
Q Consensus 242 ~E~~~~gs 249 (464)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.0005 Score=63.85 Aligned_cols=132 Identities=17% Similarity=0.147 Sum_probs=81.0
Q ss_pred eEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccce--eccce-----eeeeCcEEeEEEEeccCCChH---
Q 040010 182 GAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL--VRMWG-----FCTEGMHRLLVYEYVENQSLD--- 251 (464)
Q Consensus 182 g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~E~~~~gsL~--- 251 (464)
-.||+....+|+.+++|.-+......+++..|+..+..+....+ +..+. ....+...+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 37999999999999999987766667778889998888854332 11111 234556788999999864431
Q ss_pred --Hh------h---h----c-----CCCCCHHH-------------------HHHHHHHHHHHHHHHhh----cCCCceE
Q 040010 252 --KH------L---F----S-----SNFLGWKE-------------------RFKVALGTAKGLAYLHH----ECLEWVI 288 (464)
Q Consensus 252 --~~------l---~----~-----~~~l~~~~-------------------~~~i~~~ia~gL~yLH~----~~~~~iv 288 (464)
.. + + . ...+++.. +..+...+.+.+..+.. ....+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 10 0 1 0 01222211 11122222233333322 2345789
Q ss_pred ecCCCCCCEEEcCCCCeEEeeecCccc
Q 040010 289 HCDVKPENILLDSEFEPKIADFGLAKL 315 (464)
Q Consensus 289 H~dlk~~NIll~~~~~~kl~Dfgla~~ 315 (464)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45889987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.63 E-value=0.004 Score=59.12 Aligned_cols=72 Identities=17% Similarity=0.227 Sum_probs=48.9
Q ss_pred cccCccCceEEEEEEECCC--------cEEEEEEcCCccchhHHHHHHHHHhhhcccccee-ccceeeeeCcEEeEEEEe
Q 040010 174 EELGKGGSGAVYKGVLTDE--------RAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNLV-RMWGFCTEGMHRLLVYEY 244 (464)
Q Consensus 174 ~~lG~G~~g~Vy~g~~~~~--------~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~E~ 244 (464)
+.|+.|-.=.+|+...+++ +.|.+++... ........+|..+++.+.-.+++ ++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4577788889999987543 4566666553 22333456788888888644554 67777754 579999
Q ss_pred ccCCCh
Q 040010 245 VENQSL 250 (464)
Q Consensus 245 ~~~gsL 250 (464)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.36 E-value=0.063 Score=48.53 Aligned_cols=137 Identities=12% Similarity=0.026 Sum_probs=72.3
Q ss_pred cCccCceEEEEEEECCCcEEEEEEcCCccchhHHHHHHHHHhhhccccce--eccc----e--eeeeCcEEeEEEEeccC
Q 040010 176 LGKGGSGAVYKGVLTDERAVAVKRLGDLHQGEEVFWAEVSTIGKIYHMNL--VRMW----G--FCTEGMHRLLVYEYVEN 247 (464)
Q Consensus 176 lG~G~~g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~----g--~~~~~~~~~lv~E~~~~ 247 (464)
|..|.--+.|+.+.++|+ +++|+.... ...+++..|++++..+...++ ...+ | +.........++.+..+
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g 103 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 103 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence 556666788998887765 788887643 233445567777777753332 1111 1 12233455667777665
Q ss_pred CChHHh--------------hh---cC-------CCCCHH-----------------HHHHHHHHHHHHHHHHhh-cCCC
Q 040010 248 QSLDKH--------------LF---SS-------NFLGWK-----------------ERFKVALGTAKGLAYLHH-ECLE 285 (464)
Q Consensus 248 gsL~~~--------------l~---~~-------~~l~~~-----------------~~~~i~~~ia~gL~yLH~-~~~~ 285 (464)
...... ++ .. ....+. .....+..+...+.-.+. ..+.
T Consensus 104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~ 183 (316)
T d2ppqa1 104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 183 (316)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence 432110 00 00 000000 011122222222222222 2346
Q ss_pred ceEecCCCCCCEEEcCCCCeEEeeecCcc
Q 040010 286 WVIHCDVKPENILLDSEFEPKIADFGLAK 314 (464)
Q Consensus 286 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 314 (464)
++||+|+.+.||+++++...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999998777899999874
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.43 E-value=0.34 Score=34.84 Aligned_cols=33 Identities=15% Similarity=0.502 Sum_probs=25.8
Q ss_pred ccCHHHHHHHHhhcC----CccceEEecCCccceeEee
Q 040010 16 HVSKEACMKLCLDDF----RCSGFSYRLTGERVCFTKS 49 (464)
Q Consensus 16 ~~~~~~C~~~Cl~~c----~C~a~~~~~~~~~~c~~~~ 49 (464)
..|.++|.+.|+++= .|.+|.|. .....|.+..
T Consensus 29 ~~s~eeCA~rC~~~~~~~f~CrSF~y~-~~~~~C~Ls~ 65 (91)
T d2qj2a1 29 VNTADQCANRCTRNKGLPFTCKAFVFD-KARKQCLWFP 65 (91)
T ss_dssp CSCHHHHHHHHHTTTTCSSCCCEEEEE-TTTTEEEEES
T ss_pred cCCHHHHHHHHHccCCCCceEEeEEEE-CCCCeEEEcc
Confidence 348999999999843 59999997 3456799654
|